Term,Overlap,n.hit,n.tot,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes,celltype,cluster
response to glucose (GO:0009749),7/48,7,48,2.6393739378872e-05,0.134687252050384,0,0,7.90424570912376,83.3295912880812,SLC30A8;EIF2B2;INS-IGF2;PDX1;GCK;INS;KLRG1,beta,1
response to hexose (GO:0009746),5/28,5,28,0.000144152999293048,0.245204251797475,0,0,9.67866821525358,85.6042908182934,SLC30A8;EIF2B2;INS-IGF2;INS;KLRG1,beta,1
peptide hormone secretion (GO:0030072),5/26,5,26,9.94512547807109e-05,0.253749876572984,0,0,10.4231811548885,96.0584004121552,GHSR;SLC30A8;FAM3B;PDX1;KLRG1,beta,1
insulin secretion (GO:0030073),4/19,4,19,0.000354785517055698,0.452617623383806,0,0,11.4106404221937,90.6460947469452,SLC30A8;PDX1;FAM3B;KLRG1,beta,1
potassium ion transport (GO:0006813),6/62,6,62,0.000975041819100865,0.995127680574343,0,0,5.24521374246001,36.3652252635758,KCNJ8;ABCC8;KCNK16;KCNA5;KCNK17;KCNA6,beta,1
membrane repolarization during cardiac muscle cell action potential (GO:0086013),3/15,3,15,0.0024034899855991,1,0,0,10.840108401084,65.3748882084521,KCNH2;KCNJ8;KCNA5,beta,1
nitric oxide mediated signal transduction (GO:0007263),3/15,3,15,0.0024034899855991,1,0,0,10.840108401084,65.3748882084521,PDX1;NDNF;KLRG1,beta,1
carbohydrate biosynthetic process (GO:0016051),4/37,4,37,0.00465658585152766,1,0,0,5.85951805464001,31.4625225181305,GALNT12;GALNT14;GALNT16;ST8SIA6,beta,1
acetylcholine receptor signaling pathway (GO:0095500),3/19,3,19,0.00484664067468199,1,0,0,8.55798031664527,45.6094947232962,LYNX1;RGS8;AGRN,beta,1
positive regulation of hormone metabolic process (GO:0032352),2/6,2,6,0.00484825127353537,1,0,0,18.06684733514,96.2807082422505,EGR1;HPN,beta,1
choline catabolic process (GO:0042426),2/6,2,6,0.00484825127353537,1,0,0,18.06684733514,96.2807082422505,DMGDH;SARDH,beta,1
regulation of relaxation of cardiac muscle (GO:1901897),2/6,2,6,0.00484825127353537,1,0,0,18.06684733514,96.2807082422505,CHGA;PDE4B,beta,1
aromatic compound catabolic process (GO:0019439),2/6,2,6,0.00484825127353537,1,0,0,18.06684733514,96.2807082422505,PON3;PON1,beta,1
alpha-beta T cell activation (GO:0046631),2/6,2,6,0.00484825127353537,1,0,0,18.06684733514,96.2807082422505,RSAD2;INS,beta,1
entrainment of circadian clock by photoperiod (GO:0043153),3/20,3,20,0.00562480412330955,1,0,0,8.13008130081301,42.1184484066725,CRTC1;ID2;BHLHE40,beta,1
protein localization to cell periphery (GO:1990778),7/118,7,118,0.00630950214669783,1,0,0,3.21528639015204,16.2876714585784,EHD3;ZDHHC22;F11R;ANK1;MRAP2;PACSIN1;WNT4,beta,1
peptidyl-threonine modification (GO:0018210),6/90,6,90,0.00642922418981969,1,0,0,3.613369467028,18.2363194319184,GALNT12;GALNT14;STK33;GALNT16;MYLK3;TTBK1,beta,1
protein O-linked glycosylation via threonine (GO:0018243),3/21,3,21,0.00647359214695389,1,0,0,7.74293457220286,39.0245770350718,GALNT12;GALNT14;GALNT16,beta,1
photoperiodism (GO:0009648),3/21,3,21,0.00647359214695389,1,0,0,7.74293457220286,39.0245770350718,CRTC1;ID2;BHLHE40,beta,1
oligosaccharide metabolic process (GO:0009311),5/64,5,64,0.00651274990432717,1,0,0,4.23441734417344,21.3160293852202,GALNT12;GALNT14;ST6GAL1;GALNT16;ST8SIA6,beta,1
positive regulation of cell projection organization (GO:0031346),5/64,5,64,0.00651274990432717,1,0,0,4.23441734417344,21.3160293852202,NTRK1;DPYSL3;NDNF;SERPINI1;INS,beta,1
positive regulation of multicellular organism growth (GO:0040018),2/7,2,7,0.00670502309752768,1,0,0,15.4858691444057,77.5052004248238,GHR;GHSR,beta,1
regulation of high voltage-gated calcium channel activity (GO:1901841),2/7,2,7,0.00670502309752768,1,0,0,15.4858691444057,77.5052004248238,PDE4B;SRI,beta,1
positive regulation of insulin receptor signaling pathway (GO:0046628),2/7,2,7,0.00670502309752768,1,0,0,15.4858691444057,77.5052004248238,INS-IGF2;INS,beta,1
protein O-linked glycosylation via serine (GO:0018242),3/22,3,22,0.00739454083997622,1,0,0,7.3909830007391,36.2676517025281,GALNT12;GALNT14;GALNT16,beta,1
negative regulation of protein secretion (GO:0050709),4/43,4,43,0.00798153779182231,1,0,0,5.04191088422512,24.3555766324757,KCNJ11;RSAD2;INHBB;INS,beta,1
cellular biogenic amine catabolic process (GO:0042402),2/8,2,8,0.00883149482223649,1,0,0,13.550135501355,64.0844307540994,DMGDH;SARDH,beta,1
positive regulation of neuron projection development (GO:0010976),6/98,6,98,0.0096233269357414,1,0,0,3.31840053094408,15.4092093538265,NTRK1;DPYSL3;NDNF;SERPINI1;PACSIN1;SYT17,beta,1
regulation of insulin secretion (GO:0050796),6/99,6,99,0.0100897148581243,1,0,0,3.28488133366182,15.0980987266646,SLC30A8;KCNJ11;ABCC8;INHBB;KCNA5;GCK,beta,1
metal ion homeostasis (GO:0055065),4/46,4,46,0.0101094510908762,1,0,0,4.71309060916696,21.6532793265257,KCNH2;CYP27B1;SLC7A8;FAM20A,beta,1
protein localization to membrane (GO:0072657),8/161,8,161,0.0101937996283883,1,0,0,2.69319463380969,12.3509249389025,EHD3;ZDHHC22;F11R;AGRN;ANK1;MRAP2;PACSIN1;WNT4,beta,1
regulation of transmembrane transport (GO:0034762),3/25,3,25,0.0106033443490845,1,0,0,6.50406504065041,29.5712899056561,KCNJ8;KCNJ11;INS,beta,1
aminoglycan biosynthetic process (GO:0006023),4/47,4,47,0.0108927081946797,1,0,0,4.61281208556766,20.8483500505078,GPC3;SDC1;HS3ST5;AGRN,beta,1
protein localization to plasma membrane (GO:0072659),7/131,7,131,0.0109214486290264,1,0,0,2.89621216822855,13.0822675743792,EHD3;ZDHHC22;F11R;ANK1;MRAP2;PACSIN1;WNT4,beta,1
ventricular cardiac muscle cell membrane repolarization (GO:0099625),2/9,2,9,0.01121713722475,1,0,0,12.0445648900933,54.0838610147905,KCNH2;KCNJ8,beta,1
neuronal ion channel clustering (GO:0045161),2/9,2,9,0.01121713722475,1,0,0,12.0445648900933,54.0838610147905,CNTNAP2;AGRN,beta,1
potassium ion export (GO:0071435),2/9,2,9,0.01121713722475,1,0,0,12.0445648900933,54.0838610147905,KCNH2;KCNA5,beta,1
receptor recycling (GO:0001881),2/9,2,9,0.01121713722475,1,0,0,12.0445648900933,54.0838610147905,EHD3;NSG1,beta,1
myeloid leukocyte mediated immunity (GO:0002444),2/9,2,9,0.01121713722475,1,0,0,12.0445648900933,54.0838610147905,ACE;CXCL5,beta,1
basement membrane organization (GO:0071711),2/9,2,9,0.01121713722475,1,0,0,12.0445648900933,54.0838610147905,HPN;NID2,beta,1
metal ion transport (GO:0030001),6/102,6,102,0.0115850582102654,1,0,0,3.18826717678942,14.2134197241726,KCNJ8;ABCC8;KCNK16;KCNA5;KCNK17;KCNA6,beta,1
regulation of voltage-gated calcium channel activity (GO:1901385),3/26,3,26,0.0118251866953234,1,0,0,6.25390869293308,27.7518671453455,AHNAK;PDE4B;SRI,beta,1
regulation of peptide hormone secretion (GO:0090276),5/74,5,74,0.0118608908308088,1,0,0,3.66219878415,16.2400526478557,KCNJ11;ABCC8;KCNA5;GCK;INS,beta,1
negative chemotaxis (GO:0050919),3/27,3,27,0.0131245951166226,1,0,0,6.02228244504667,26.096159706339,SEMA3D;SEMA4C;SLIT1,beta,1
monovalent inorganic cation transport (GO:0015672),6/105,6,105,0.0132303132327974,1,0,0,3.09717382888115,13.3960344566384,KCNJ8;ABCC8;KCNK16;KCNA5;KCNK17;KCNA6,beta,1
regulation of actin filament-based movement (GO:1903115),2/10,2,10,0.0138517159546727,1,0,0,10.840108401084,46.3885762425906,PDE4B;SRI,beta,1
negative regulation of gluconeogenesis (GO:0045721),2/10,2,10,0.0138517159546727,1,0,0,10.840108401084,46.3885762425906,GCK;INS,beta,1
peptidyl-serine modification (GO:0018209),8/171,8,171,0.0142673301809878,1,0,0,2.5356978715986,10.7761656016883,GALNT12;GALNT14;STK33;GALNT16;MAST3;NDNF;MYLK3;TTBK1,beta,1
regulation of blood vessel diameter (GO:0097746),3/28,3,28,0.0145022404110053,1,0,0,5.80720092915215,24.5845071451069,CHGA;ACE;INS,beta,1
regulation of protein secretion (GO:0050708),6/108,6,108,0.0150325220534101,1,0,0,3.01114122252334,12.6393835832668,RSAD2;KCNJ11;ABCC8;KCNA5;GCK;INS,beta,1
positive regulation of developmental growth (GO:0048639),4/52,4,52,0.0153926574511817,1,0,0,4.16927246195539,17.4019790375102,GHR;GHSR;AGRN;SYT17,beta,1
acute inflammatory response (GO:0002526),3/29,3,29,0.0159586705709791,1,0,0,5.60695262125035,23.2001849620836,CD6;MYLK3;INS,beta,1
negative regulation of blood vessel diameter (GO:0097756),2/11,2,11,0.0167252842863011,1,0,0,9.85464400098546,40.3137095385675,CHGA;INS,beta,1
negative regulation of peptide secretion (GO:0002792),2/11,2,11,0.0167252842863011,1,0,0,9.85464400098546,40.3137095385675,RSAD2;INS,beta,1
positive regulation of MAP kinase activity (GO:0043406),8/178,8,178,0.017749777624521,1,0,0,2.43597941597394,9.82036427961437,GHR;NTRK1;INS-IGF2;PDCD10;NTRK3;FGF18;TNFRSF11A;INS,beta,1
acylglycerol catabolic process (GO:0046464),3/31,3,31,0.0191094966499254,1,0,0,5.24521374246001,20.7582998200552,FABP5;FABP6;MGLL,beta,1
negative regulation of secretion by cell (GO:1903531),3/31,3,31,0.0191094966499254,1,0,0,5.24521374246001,20.7582998200552,CHGA;RSAD2;INS,beta,1
aminoglycan metabolic process (GO:0006022),3/31,3,31,0.0191094966499254,1,0,0,5.24521374246001,20.7582998200552,GPC3;SDC1;AGRN,beta,1
inflammatory response (GO:0006954),10/253,10,253,0.0195105900530238,1,0,0,2.14231391325771,8.43385687454517,NLRX1;LTB4R2;CD6;FOS;TNFRSF11A;F11R;MGLL;LTB4R;CXCL5;KLRG1,beta,1
positive regulation of cysteine-type endopeptidase activity (GO:2001056),4/56,4,56,0.0197260394881327,1,0,0,3.87146728610143,15.1986671104166,PDCD6;TNFSF10;CIDEB;TTBK1,beta,1
oligodendrocyte development (GO:0014003),2/12,2,12,0.0198281760509926,1,0,0,9.03342366757001,35.4169044259709,PRDM8;EIF2B2,beta,1
positive regulation of keratinocyte differentiation (GO:0045618),2/12,2,12,0.0198281760509926,1,0,0,9.03342366757001,35.4169044259709,CYP27B1;H2AFY2,beta,1
spliceosomal tri-snRNP complex assembly (GO:0000244),2/12,2,12,0.0198281760509926,1,0,0,9.03342366757001,35.4169044259709,PRPF6;SRSF12,beta,1
protein O-linked glycosylation (GO:0006493),6/116,6,116,0.02065609867051,1,0,0,2.80347631062518,10.8767722681365,GALNT12;ADAMTS5;GALNT14;ST6GAL1;GALNT16;ST8SIA6,beta,1
positive regulation of cell death (GO:0010942),4/58,4,58,0.0221473786367117,1,0,0,3.7379684141669,14.2417947312095,NTRK1;EGR1;CIDEB;FOS,beta,1
aminoglycan catabolic process (GO:0006026),3/33,3,33,0.022579208447838,1,0,0,4.92732200049273,18.6781265155435,GPC3;SDC1;AGRN,beta,1
positive regulation of glycogen biosynthetic process (GO:0045725),2/13,2,13,0.0231509987089624,1,0,0,8.33854492391078,31.4006033654744,GCK;INS,beta,1
oligosaccharide biosynthetic process (GO:0009312),3/34,3,34,0.0244338646414198,1,0,0,4.78240076518412,17.7512444465761,GALNT12;GALNT14;GALNT16,beta,1
carboxylic acid metabolic process (GO:0019752),3/34,3,34,0.0244338646414198,1,0,0,4.78240076518412,17.7512444465761,PON3;ST6GAL1;PON1,beta,1
oligodendrocyte differentiation (GO:0048709),2/14,2,14,0.0266846266031608,1,0,0,7.74293457220286,28.0578216187037,PRDM8;EIF2B2,beta,1
regulation of neural precursor cell proliferation (GO:2000177),2/14,2,14,0.0266846266031608,1,0,0,7.74293457220286,28.0578216187037,ID2;SHCBP1,beta,1
positive regulation of glycogen metabolic process (GO:0070875),2/14,2,14,0.0266846266031608,1,0,0,7.74293457220286,28.0578216187037,GCK;INS,beta,1
glycosaminoglycan metabolic process (GO:0030203),4/62,4,62,0.0275134743969764,1,0,0,3.49680916164,12.5643130212005,GPC3;SDC1;HS3ST5;AGRN,beta,1
negative regulation of protein complex assembly (GO:0031333),3/36,3,36,0.028382392063596,1,0,0,4.516711833785,16.0884657807307,IMPACT;SMAD6;INS,beta,1
regulation of ion transmembrane transport (GO:0034765),3/36,3,36,0.028382392063596,1,0,0,4.516711833785,16.0884657807307,KCNH2;KCNJ8;KCNJ11,beta,1
regulation of cardiac muscle contraction (GO:0055117),3/36,3,36,0.028382392063596,1,0,0,4.516711833785,16.0884657807307,CHGA;PDE4B;SRI,beta,1
neural crest cell development (GO:0014032),3/36,3,36,0.028382392063596,1,0,0,4.516711833785,16.0884657807307,SEMA3D;PDCD6;SEMA4C,beta,1
heparan sulfate proteoglycan biosynthetic process (GO:0015012),2/15,2,15,0.0304201943469207,1,0,0,7.22673893405601,25.2404596450496,NDST3;HS3ST5,beta,1
positive regulation of small GTPase mediated signal transduction (GO:0051057),2/15,2,15,0.0304201943469207,1,0,0,7.22673893405601,25.2404596450496,NTRK1;RASGRF1,beta,1
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),2/15,2,15,0.0304201943469207,1,0,0,7.22673893405601,25.2404596450496,PDCD10;SEMA4C,beta,1
lipoxygenase pathway (GO:0019372),2/15,2,15,0.0304201943469207,1,0,0,7.22673893405601,25.2404596450496,PON3;PON1,beta,1
negative regulation of insulin secretion (GO:0046676),2/15,2,15,0.0304201943469207,1,0,0,7.22673893405601,25.2404596450496,KCNJ11;INHBB,beta,1
negative regulation of axon extension involved in axon guidance (GO:0048843),2/15,2,15,0.0304201943469207,1,0,0,7.22673893405601,25.2404596450496,SEMA3D;SEMA4C,beta,1
positive regulation of cellular response to insulin stimulus (GO:1900078),2/15,2,15,0.0304201943469207,1,0,0,7.22673893405601,25.2404596450496,INS-IGF2;INS,beta,1
vesicle-mediated transport in synapse (GO:0099003),3/37,3,37,0.0304758492112818,1,0,0,4.39463854098,15.3408953556113,SNAPIN;PACSIN1;SYT17,beta,1
O-glycan processing (GO:0016266),4/66,4,66,0.0335909598574261,1,0,0,3.28488133366182,11.1472392217336,GALNT12;GALNT14;ST6GAL1;GALNT16,beta,1
regulation of systemic arterial blood pressure by hormone (GO:0001990),2/16,2,16,0.0343490903741549,1,0,0,6.77506775067751,22.8399711501772,ACE;CORIN,beta,1
stabilization of membrane potential (GO:0030322),2/16,2,16,0.0343490903741549,1,0,0,6.77506775067751,22.8399711501772,KCNK16;KCNK17,beta,1
ventricular cardiac muscle cell action potential (GO:0086005),2/16,2,16,0.0343490903741549,1,0,0,6.77506775067751,22.8399711501772,KCNH2;KCNJ8,beta,1
negative regulation of peptide hormone secretion (GO:0090278),2/16,2,16,0.0343490903741549,1,0,0,6.77506775067751,22.8399711501772,KCNJ11;INHBB,beta,1
G-protein coupled acetylcholine receptor signaling pathway (GO:0007213),2/16,2,16,0.0343490903741549,1,0,0,6.77506775067751,22.8399711501772,RGS8;AGRN,beta,1
protein localization to chromatin (GO:0071168),2/16,2,16,0.0343490903741549,1,0,0,6.77506775067751,22.8399711501772,H2AFY2;RAD21,beta,1
regulation of ossification (GO:0030278),3/39,3,39,0.0348995172596036,1,0,0,4.16927246195539,13.9890860203146,CYP27B1;SMOC1;SMAD6,beta,1
positive regulation of neuron differentiation (GO:0045666),5/99,5,99,0.0364551347040545,1,0,0,2.73740111138485,9.06537724303456,NTRK1;IMPACT;DPYSL3;NDNF;SERPINI1,beta,1
response to molecule of bacterial origin (GO:0002237),5/99,5,99,0.0364551347040545,1,0,0,2.73740111138485,9.06537724303456,CYP27B1;CD6;IL12A;TNFRSF11A;CXCL5,beta,1
positive regulation of peptide hormone secretion (GO:0090277),3/40,3,40,0.0372288529037837,1,0,0,4.0650406504065,13.3767122058713,SLC30A8;GCK;INS,beta,1
glycosaminoglycan biosynthetic process (GO:0006024),5/100,5,100,0.0378174091359597,1,0,0,2.710027100271,8.87530006295132,GPC3;SDC1;HS3ST5;AGRN;CHST3,beta,1
negative regulation of axon guidance (GO:1902668),2/17,2,17,0.0384629506323368,1,0,0,6.37653435357883,20.7751303826224,SEMA3D;SEMA4C,beta,1
positive regulation of epidermal cell differentiation (GO:0045606),2/17,2,17,0.0384629506323368,1,0,0,6.37653435357883,20.7751303826224,CYP27B1;H2AFY2,beta,1
negative regulation of cellular carbohydrate metabolic process (GO:0010677),2/17,2,17,0.0384629506323368,1,0,0,6.37653435357883,20.7751303826224,GCK;INS,beta,1
response to peptide hormone (GO:0043434),3/41,3,41,0.0396358252123322,1,0,0,3.96589331746976,12.801990452573,EIF2B2;INS-IGF2;INS,beta,1
regulation of kinase activity (GO:0043549),5/102,5,102,0.0406344817724162,1,0,0,2.65688931399118,8.51038383572541,EPHB6;NTRK1;VAC14;NTRK3;LDB2,beta,1
regulation of multicellular organism growth (GO:0040014),2/18,2,18,0.0427536524234902,1,0,0,6.02228244504667,18.9840448686666,GHR;GHSR,beta,1
response to nutrient levels (GO:0031667),2/18,2,18,0.0427536524234902,1,0,0,6.02228244504667,18.9840448686666,INS-IGF2;INS,beta,1
glycosphingolipid biosynthetic process (GO:0006688),2/18,2,18,0.0427536524234902,1,0,0,6.02228244504667,18.9840448686666,ST8SIA5;ST8SIA6,beta,1
regulation of cardiac muscle cell membrane repolarization (GO:0099623),2/18,2,18,0.0427536524234902,1,0,0,6.02228244504667,18.9840448686666,KCNH2;KCNA5,beta,1
negative regulation of protein transport (GO:0051224),2/18,2,18,0.0427536524234902,1,0,0,6.02228244504667,18.9840448686666,RSAD2;INS,beta,1
establishment of epithelial cell polarity (GO:0090162),2/18,2,18,0.0427536524234902,1,0,0,6.02228244504667,18.9840448686666,FERMT1;SIPA1L3,beta,1
phosphatidylcholine metabolic process (GO:0046470),4/72,4,72,0.0440611343790448,1,0,0,3.01114122252334,9.4013164459679,RARRES3;PON1;LPCAT1;PLBD1,beta,1
response to insulin (GO:0032868),4/72,4,72,0.0440611343790448,1,0,0,3.01114122252334,9.4013164459679,INS-IGF2;INHBB;GCK;INS,beta,1
glycolipid biosynthetic process (GO:0009247),3/43,3,43,0.0446802062734164,1,0,0,3.78143316316884,11.753543914193,ST8SIA5;ST8SIA6;MPPE1,beta,1
regulation of long-term synaptic potentiation (GO:1900271),2/19,2,19,0.0472133083870631,1,0,0,5.70532021109685,17.4187959993159,NSG1;INS,beta,1
positive regulation of toll-like receptor signaling pathway (GO:0034123),2/19,2,19,0.0472133083870631,1,0,0,5.70532021109685,17.4187959993159,RSAD2;TLR5,beta,1
eye development (GO:0001654),3/44,3,44,0.0473162321204015,1,0,0,3.69549150036955,11.2745819237327,SMOC1;SIPA1L3;FBN1,beta,1
fatty acid metabolic process (GO:0006631),5/107,5,107,0.0482211185146832,1,0,0,2.53273560772991,7.67914852069053,GHR;PON3;ACOT11;PON1;ACOT12,beta,1
positive regulation of cell cycle process (GO:0090068),5/108,5,108,0.0498322170225417,1,0,0,2.50928435210278,7.52557858063801,RAD21;ID2;GATA6;TP73;INS,beta,1
regulation of gluconeogenesis (GO:0006111),2/20,2,20,0.0518342606080721,1,0,0,5.42005420054201,16.0417558083804,GCK;INS,beta,1
negative regulation of cyclase activity (GO:0031280),2/20,2,20,0.0518342606080721,1,0,0,5.42005420054201,16.0417558083804,GABBR1;LTB4R2,beta,1
glial cell development (GO:0021782),2/20,2,20,0.0518342606080721,1,0,0,5.42005420054201,16.0417558083804,PRDM8;EIF2B2,beta,1
regulation of glycogen biosynthetic process (GO:0005979),2/20,2,20,0.0518342606080721,1,0,0,5.42005420054201,16.0417558083804,GCK;INS,beta,1
heparan sulfate proteoglycan metabolic process (GO:0030201),2/20,2,20,0.0518342606080721,1,0,0,5.42005420054201,16.0417558083804,NDST3;HS3ST5,beta,1
negative regulation of adenylate cyclase activity (GO:0007194),2/20,2,20,0.0518342606080721,1,0,0,5.42005420054201,16.0417558083804,GABBR1;LTB4R2,beta,1
regulation of transport (GO:0051049),2/20,2,20,0.0518342606080721,1,0,0,5.42005420054201,16.0417558083804,YRDC;SLC30A8,beta,1
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),6/145,6,145,0.0524038667026696,1,0,0,2.24278104850014,6.61345645829427,SMAD9;LTBP2;INHBB;FOS;F11R;SMAD6,beta,1
icosanoid metabolic process (GO:0006690),3/47,3,47,0.0556702369781567,1,0,0,3.45960906417575,9.99242214135287,PON3;PON1;MGLL,beta,1
negative regulation of cytokine biosynthetic process (GO:0042036),2/21,2,21,0.0566090748949321,1,0,0,5.16195638146858,14.8230015371912,GHSR;INHBB,beta,1
positive regulation of BMP signaling pathway (GO:0030513),2/21,2,21,0.0566090748949321,1,0,0,5.16195638146858,14.8230015371912,GATA6;ZNF423,beta,1
negative regulation of cAMP biosynthetic process (GO:0030818),2/21,2,21,0.0566090748949321,1,0,0,5.16195638146858,14.8230015371912,GABBR1;LTB4R2,beta,1
fibroblast growth factor receptor signaling pathway (GO:0008543),4/79,4,79,0.0583320864785054,1,0,0,2.74433124078076,7.79829980065004,FIBP;POLR2C;FGF18;SHCBP1,beta,1
negative regulation of cellular biosynthetic process (GO:0031327),3/48,3,48,0.0586006518398054,1,0,0,3.38753387533875,9.61046564673059,GCK;INS;WNT4,beta,1
positive regulation of protein autophosphorylation (GO:0031954),2/22,2,22,0.0615305351597608,1,0,0,4.92732200049273,13.7384662267826,ACE;INS,beta,1
cellular response to nerve growth factor stimulus (GO:1990090),2/22,2,22,0.0615305351597608,1,0,0,4.92732200049273,13.7384662267826,NTRK1;NTRK3,beta,1
peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),2/22,2,22,0.0615305351597608,1,0,0,4.92732200049273,13.7384662267826,ZDHHC21;ZDHHC22,beta,1
peptidyl-L-cysteine S-palmitoylation (GO:0018230),2/22,2,22,0.0615305351597608,1,0,0,4.92732200049273,13.7384662267826,ZDHHC21;ZDHHC22,beta,1
outflow tract septum morphogenesis (GO:0003148),2/22,2,22,0.0615305351597608,1,0,0,4.92732200049273,13.7384662267826,GATA6;SMAD6,beta,1
triglyceride catabolic process (GO:0019433),2/22,2,22,0.0615305351597608,1,0,0,4.92732200049273,13.7384662267826,FABP5;FABP6,beta,1
negative regulation of GTPase activity (GO:0034260),2/22,2,22,0.0615305351597608,1,0,0,4.92732200049273,13.7384662267826,GPSM1;F11R,beta,1
negative regulation of lyase activity (GO:0051350),2/22,2,22,0.0615305351597608,1,0,0,4.92732200049273,13.7384662267826,GABBR1;LTB4R2,beta,1
regulation of cell cycle arrest (GO:0071156),3/49,3,49,0.0616023835141251,1,0,0,3.31840053094408,9.24856384861494,ID2;GATA6;TP73,beta,1
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),12/397,12,397,0.0656010102150405,1,0,0,1.63830353668776,4.4630078163972,EPHB6;GHR;NTRK1;FIBP;EFS;POLR2C;NTRK3;HPN;FGF18;GAB1;SHCBP1;INS,beta,1
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),5/117,5,117,0.0657427451459853,1,0,0,2.31626247886411,6.30488025848837,GHR;ACE;INS-IGF2;IL12A;INS,beta,1
regulation of axon extension involved in axon guidance (GO:0048841),2/23,2,23,0.0665916379109913,1,0,0,4.71309060916696,12.7685932188559,SEMA3D;SEMA4C,beta,1
divalent inorganic cation homeostasis (GO:0072507),2/23,2,23,0.0665916379109913,1,0,0,4.71309060916696,12.7685932188559,CYP27B1;FAM20A,beta,1
regulation of ion homeostasis (GO:2000021),2/23,2,23,0.0665916379109913,1,0,0,4.71309060916696,12.7685932188559,SLC30A8;CORIN,beta,1
negative regulation of axon extension (GO:0030517),2/23,2,23,0.0665916379109913,1,0,0,4.71309060916696,12.7685932188559,SEMA3D;SEMA4C,beta,1
response to lipopolysaccharide (GO:0032496),6/156,6,156,0.0695424837315484,1,0,0,2.08463623097769,5.55725961319986,CYP27B1;CD6;PDE4B;IL12A;TNFRSF11A;CXCL5,beta,1
negative regulation of neuron death (GO:1901215),4/84,4,84,0.069859530204974,1,0,0,2.58097819073429,6.86867664068445,CHGA;NTRK1;NDNF;TP73,beta,1
coenzyme metabolic process (GO:0006732),3/52,3,52,0.0710253715546076,1,0,0,3.12695434646654,8.26991282030674,THTPA;ACOT11;ACOT12,beta,1
regulation of neuron projection development (GO:0010975),5/120,5,120,0.0716081601821006,1,0,0,2.2583559168925,5.95425980687841,NTRK1;DPYSL3;NDNF;SERPINI1;DBN1,beta,1
actin filament organization (GO:0007015),5/121,5,121,0.073625158715388,1,0,0,2.23969181840579,5.84283742365087,GHSR;EFS;DPYSL3;ERMN;DBN1,beta,1
macromolecule modification (GO:0043412),2/25,2,25,0.0771057881016967,1,0,0,4.3360433604336,11.1114446767511,ST6GAL1;ZFP64,beta,1
regulation of neuronal synaptic plasticity (GO:0048168),2/25,2,25,0.0771057881016967,1,0,0,4.3360433604336,11.1114446767511,DBN1;SHISA6,beta,1
action potential (GO:0001508),3/55,3,55,0.0810524443699205,1,0,0,2.95639320029564,7.42840760521901,KCNH2;SRI;NALCN,beta,1
peptide catabolic process (GO:0043171),2/26,2,26,0.0825458441355645,1,0,0,4.16927246195539,10.3998392890822,ACE;TRHDE,beta,1
positive regulation of filopodium assembly (GO:0051491),2/26,2,26,0.0825458441355645,1,0,0,4.16927246195539,10.3998392890822,DPYSL3;AGRN,beta,1
negative regulation of epithelial to mesenchymal transition (GO:0010719),2/26,2,26,0.0825458441355645,1,0,0,4.16927246195539,10.3998392890822,HPN;OVOL2,beta,1
negative regulation of multicellular organismal process (GO:0051241),5/126,5,126,0.0841691356522807,1,0,0,2.15081515894524,5.323110476368,HPN;HS3ST5;SMAD6;OVOL2;INS,beta,1
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),3/56,3,56,0.0845237532136759,1,0,0,2.90360046457607,7.17399152439217,ADAMTSL2;SMAD6;FBN1,beta,1
regulation of MAPK cascade (GO:0043408),7/204,7,204,0.0845810024989836,1,0,0,1.85982251979383,4.593846421264,EPHB6;NTRK1;INS-IGF2;NTRK3;INHBB;TNFRSF11A;INS,beta,1
cytoskeleton organization (GO:0007010),5/127,5,127,0.0863687928423556,1,0,0,2.1338796065126,5.22614613313828,ZMYM3;MAST3;ANK1;SIPA1L3;PACSIN1,beta,1
regulation of BMP signaling pathway (GO:0030510),3/57,3,57,0.0880575665767493,1,0,0,2.85266010554842,6.93129229134825,GATA6;ZNF423;SMAD6,beta,1
glycosaminoglycan catabolic process (GO:0006027),3/57,3,57,0.0880575665767493,1,0,0,2.85266010554842,6.93129229134825,GPC3;SDC1;AGRN,beta,1
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),2/27,2,27,0.0880995497274875,1,0,0,4.01485496336445,9.75323841003028,CCNC;TTBK1,beta,1
positive regulation of synapse assembly (GO:0051965),2/27,2,27,0.0880995497274875,1,0,0,4.01485496336445,9.75323841003028,AGRN;VSTM5,beta,1
regulation of cardiac muscle cell contraction (GO:0086004),2/27,2,27,0.0880995497274875,1,0,0,4.01485496336445,9.75323841003028,PDE4B;SRI,beta,1
phosphatidylethanolamine acyl-chain remodeling (GO:0036152),2/27,2,27,0.0880995497274875,1,0,0,4.01485496336445,9.75323841003028,RARRES3;PLBD1,beta,1
positive regulation of release of cytochrome c from mitochondria (GO:0090200),2/27,2,27,0.0880995497274875,1,0,0,4.01485496336445,9.75323841003028,TNFSF10;CIDEB,beta,1
endocrine system development (GO:0035270),2/27,2,27,0.0880995497274875,1,0,0,4.01485496336445,9.75323841003028,THRB;WNT4,beta,1
positive regulation of MAPK cascade (GO:0043410),9/290,9,290,0.0899063168952197,1,0,0,1.68208578637511,4.05212291703165,EPHB6;NTRK1;INS-IGF2;PDCD10;NTRK3;FGF18;SEMA4C;TNFRSF11A;INS,beta,1
regulation of macromolecule metabolic process (GO:0060255),5/130,5,130,0.0931466838360986,1,0,0,2.08463623097769,4.94805041239282,NLRX1;INS-IGF2;ZFP64;TP73;INS,beta,1
phosphatidylcholine acyl-chain remodeling (GO:0036151),2/28,2,28,0.0937608866375592,1,0,0,3.87146728610143,9.16379208958396,LPCAT1;PLBD1,beta,1
peptidyl-glutamic acid modification (GO:0018200),2/28,2,28,0.0937608866375592,1,0,0,3.87146728610143,9.16379208958396,PROS1;CEP41,beta,1
cardiac muscle cell development (GO:0055013),2/28,2,28,0.0937608866375592,1,0,0,3.87146728610143,9.16379208958396,SORBS2;MYLK3,beta,1
cellular response to fibroblast growth factor stimulus (GO:0044344),4/95,4,95,0.0989538171319903,1,0,0,2.28212808443874,5.27879510781527,FIBP;POLR2C;FGF18;SHCBP1,beta,1
carboxylic acid catabolic process (GO:0046395),2/29,2,29,0.0995240189520908,1,0,0,3.7379684141669,8.62482484794174,PON3;PON1,beta,1
cardiac muscle cell action potential involved in contraction (GO:0086002),2/29,2,29,0.0995240189520908,1,0,0,3.7379684141669,8.62482484794174,KCNH2;KCNA5,beta,1
neural crest cell migration (GO:0001755),2/29,2,29,0.0995240189520908,1,0,0,3.7379684141669,8.62482484794174,SEMA3D;SEMA4C,beta,1
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),2/29,2,29,0.0995240189520908,1,0,0,3.7379684141669,8.62482484794174,ACE;IFI30,beta,1
regulation of adenylate cyclase activity (GO:0045761),2/29,2,29,0.0995240189520908,1,0,0,3.7379684141669,8.62482484794174,GABBR1;LTB4R2,beta,1
carboxylic acid transport (GO:0046942),4/52,4,52,0.000395142543503676,1,0,0,11.5673799884326,90.6450432450131,SLC43A1;SLC25A21;SLC16A14;SLC38A4,beta,2
membrane fusion (GO:0061025),4/55,4,55,0.000490195103897515,1,0,0,10.9364319890636,83.3433446331025,HACE1;DNM1L;GDAP1;NAPG,beta,2
regulation of fat cell proliferation (GO:0070344),2/6,2,6,0.000646948912530899,1,0,0,50.125313283208,368.08236727421,TFDP1;GATA2,beta,2
Golgi organization (GO:0007030),5/122,5,122,0.00134256362903011,1,0,0,6.16294835449279,40.7566518968249,ATP8B4;HACE1;ATP8B1;COG1;SYNE1,beta,2
actomyosin structure organization (GO:0031032),4/72,4,72,0.00135545460936183,1,0,0,8.35421888053467,55.1680733154188,MYOM1;EPB41L4A;MYBPHL;EPB41L3,beta,2
cytoskeletal anchoring at plasma membrane (GO:0007016),2/9,2,9,0.00153248405490099,1,0,0,33.4168755221387,216.570268833428,EPB41L3;ANK3,beta,2
regulation of sodium ion transport (GO:0002028),3/36,3,36,0.00174839538288825,1,0,0,12.531328320802,79.5621157361227,NKAIN3;ANK3;FGF12,beta,2
myosin filament assembly (GO:0031034),2/11,2,11,0.00232097422392608,1,0,0,27.3410799726589,165.844655019584,MYOM1;MYBPHL,beta,2
striated muscle myosin thick filament assembly (GO:0071688),2/13,2,13,0.00326302259563222,1,0,0,23.1347599768652,132.448845265285,MYOM1;MYBPHL,beta,2
glutathione metabolic process (GO:0006749),3/50,3,50,0.00448568840544865,1,0,0,9.02255639097744,48.7837290642935,GSTM2;MGST2;GDAP1,beta,2
regulation of RIG-I signaling pathway (GO:0039535),2/16,2,16,0.00495496507761855,1,0,0,18.796992481203,99.762502991212,RNF125;DDX60,beta,2
peptide metabolic process (GO:0006518),4/105,4,105,0.00532375910405412,1,0,0,5.72860723236663,29.9925564004031,BACE1;GSTM2;PROC;GDAP1,beta,2
regulation of protein secretion (GO:0050708),4/108,4,108,0.00587827755666185,1,0,0,5.56947925368978,28.6075828043733,NEUROD1;MYOM1;G6PC2;DNM1L,beta,2
positive regulation of protein transport (GO:0051222),3/57,3,57,0.00647456375147758,1,0,0,7.91452314998021,39.888199825528,MYOM1;PRR5L;DNM1L,beta,2
organonitrogen compound biosynthetic process (GO:1901566),5/182,5,182,0.00744165136199808,1,0,0,4.13120713872594,20.2456518941923,GSTM2;SLC44A3;DDC;GADL1;MGST2,beta,2
phospholipid translocation (GO:0045332),2/21,2,21,0.00848505004125987,1,0,0,14.3215180809166,68.3057570024882,ATP8B4;ATP8B1,beta,2
mitochondrial fission (GO:0000266),2/21,2,21,0.00848505004125987,1,0,0,14.3215180809166,68.3057570024882,DNM1L;GDAP1,beta,2
second-messenger-mediated signaling (GO:0019932),3/63,3,63,0.00853742029726148,1,0,0,7.16075904045829,34.1088176851778,NEUROD1;MCTP1;PTGDR2,beta,2
glutathione derivative biosynthetic process (GO:1901687),2/22,2,22,0.00929319765245209,1,0,0,13.6705399863295,63.9572465026983,GSTM2;MGST2,beta,2
glutathione derivative metabolic process (GO:1901685),2/22,2,22,0.00929319765245209,1,0,0,13.6705399863295,63.9572465026983,GSTM2;MGST2,beta,2
lipid translocation (GO:0034204),2/22,2,22,0.00929319765245209,1,0,0,13.6705399863295,63.9572465026983,ATP8B4;ATP8B1,beta,2
neuropeptide signaling pathway (GO:0007218),3/71,3,71,0.0118253306985494,1,0,0,6.35391295139257,28.1955610226273,PTGDR2;SSTR1;RXFP3,beta,2
bile acid biosynthetic process (GO:0006699),2/27,2,27,0.0138186460808769,1,0,0,11.1389585073796,47.6940844727422,CYP7B1;SLC27A2,beta,2
positive regulation of apoptotic signaling pathway (GO:2001235),3/77,3,77,0.0147064841889394,1,0,0,5.85880285128406,24.7210240083915,HTRA2;G0S2;DNM1L,beta,2
peptidyl-glutamic acid modification (GO:0018200),2/28,2,28,0.0148174743186612,1,0,0,10.7411385606874,45.2411181254566,PROC;TTLL3,beta,2
regulation of autophagy of mitochondrion (GO:1903146),2/28,2,28,0.0148174743186612,1,0,0,10.7411385606874,45.2411181254566,HTRA2;DNM1L,beta,2
sensory perception of mechanical stimulus (GO:0050954),3/79,3,79,0.0157473048846494,1,0,0,5.71047872846674,23.7046885702173,PCDH15;TSPEAR;USH2A,beta,2
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),2/29,2,29,0.0158465022518242,1,0,0,10.3707544723879,42.9847703513632,HTRA2;G0S2,beta,2
organelle fission (GO:0048285),2/29,2,29,0.0158465022518242,1,0,0,10.3707544723879,42.9847703513632,DNM1L;GDAP1,beta,2
negative regulation of epithelial cell apoptotic process (GO:1904036),2/30,2,30,0.0169052903850118,1,0,0,10.0250626566416,40.9035455188655,NEUROD1;GATA2,beta,2
sensory perception of sound (GO:0007605),3/82,3,82,0.0173845539903193,1,0,0,5.50155877498625,22.2932688540689,PCDH15;TSPEAR;USH2A,beta,2
positive regulation of cation channel activity (GO:2001259),2/31,2,31,0.0179934036602126,1,0,0,9.70167353868542,38.978899360384,GSTM2;ANK3,beta,2
bile acid metabolic process (GO:0008206),2/31,2,31,0.0179934036602126,1,0,0,9.70167353868542,38.978899360384,CYP7B1;SLC27A2,beta,2
sarcomere organization (GO:0045214),2/32,2,32,0.0191104114130209,1,0,0,9.3984962406015,37.1947555665838,MYOM1;MYBPHL,beta,2
regulation of DNA recombination (GO:0000018),2/34,2,34,0.0214294094244428,1,0,0,8.84564352056612,33.9937286884727,SMARCAD1;USP51,beta,2
intra-Golgi vesicle-mediated transport (GO:0006891),2/34,2,34,0.0214294094244428,1,0,0,8.84564352056612,33.9937286884727,COG1;NAPG,beta,2
positive regulation of peptide secretion (GO:0002793),2/36,2,36,0.0238589255193852,1,0,0,8.35421888053467,31.2079941189878,MYOM1;DNM1L,beta,2
positive regulation of DNA replication (GO:0045740),2/36,2,36,0.0238589255193852,1,0,0,8.35421888053467,31.2079941189878,KITLG;BMP5,beta,2
cardiac muscle tissue development (GO:0048738),2/37,2,37,0.0251140967752435,1,0,0,8.12842918106076,29.9477826944501,MYOM1;BMP5,beta,2
plasma membrane organization (GO:0007009),2/37,2,37,0.0251140967752435,1,0,0,8.12842918106076,29.9477826944501,EPB41L3;ANK3,beta,2
regulation of metal ion transport (GO:0010959),2/38,2,38,0.0263956686488943,1,0,0,7.91452314998021,28.7657724465372,NKAIN3;ANK3,beta,2
regulation of sodium ion transmembrane transporter activity (GO:2000649),2/38,2,38,0.0263956686488943,1,0,0,7.91452314998021,28.7657724465372,ANK3;FGF12,beta,2
regulation of cellular localization (GO:0060341),2/41,2,41,0.0303947986890991,1,0,0,7.33541169998166,25.6261418005636,MCTP1;WWC1,beta,2
unsaturated fatty acid metabolic process (GO:0033559),2/45,2,45,0.03607271884985,1,0,0,6.68337510442774,22.2036318119761,GSTM2;SCD5,beta,2
positive regulation of action potential (GO:0045760),1/6,1,6,0.039247127688343,1,0,0,25.062656641604,81.1497999334919,ANK3,beta,2
type B pancreatic cell development (GO:0003323),1/6,1,6,0.039247127688343,1,0,0,25.062656641604,81.1497999334919,BMP5,beta,2
B cell chemotaxis (GO:0035754),1/6,1,6,0.039247127688343,1,0,0,25.062656641604,81.1497999334919,CYP7B1,beta,2
glandular epithelial cell development (GO:0002068),1/6,1,6,0.039247127688343,1,0,0,25.062656641604,81.1497999334919,BMP5,beta,2
equilibrioception (GO:0050957),1/6,1,6,0.039247127688343,1,0,0,25.062656641604,81.1497999334919,PCDH15,beta,2
negative regulation of mononuclear cell migration (GO:0071676),1/6,1,6,0.039247127688343,1,0,0,25.062656641604,81.1497999334919,BMP5,beta,2
spinal cord dorsal/ventral patterning (GO:0021513),1/6,1,6,0.039247127688343,1,0,0,25.062656641604,81.1497999334919,RFX4,beta,2
regulation of aldosterone biosynthetic process (GO:0032347),1/6,1,6,0.039247127688343,1,0,0,25.062656641604,81.1497999334919,BMP5,beta,2
indolalkylamine metabolic process (GO:0006586),1/6,1,6,0.039247127688343,1,0,0,25.062656641604,81.1497999334919,DDC,beta,2
regulation of digestive system process (GO:0044058),1/6,1,6,0.039247127688343,1,0,0,25.062656641604,81.1497999334919,NEUROD1,beta,2
regulation of cortisol biosynthetic process (GO:2000064),1/6,1,6,0.039247127688343,1,0,0,25.062656641604,81.1497999334919,BMP5,beta,2
inner ear receptor cell differentiation (GO:0060113),1/6,1,6,0.039247127688343,1,0,0,25.062656641604,81.1497999334919,USH2A,beta,2
positive regulation of sodium ion transmembrane transport (GO:1902307),1/6,1,6,0.039247127688343,1,0,0,25.062656641604,81.1497999334919,ANK3,beta,2
cellular response to magnesium ion (GO:0071286),1/6,1,6,0.039247127688343,1,0,0,25.062656641604,81.1497999334919,ANK3,beta,2
negative regulation of delayed rectifier potassium channel activity (GO:1902260),1/6,1,6,0.039247127688343,1,0,0,25.062656641604,81.1497999334919,ANK3,beta,2
negative regulation of neural precursor cell proliferation (GO:2000178),1/6,1,6,0.039247127688343,1,0,0,25.062656641604,81.1497999334919,GATA2,beta,2
myofibril assembly (GO:0030239),2/48,2,48,0.0405772061568715,1,0,0,6.265664160401,20.0786265334581,MYOM1;MYBPHL,beta,2
regulation of mitochondrion organization (GO:0010821),2/49,2,49,0.0421236038923173,1,0,0,6.13779346324996,19.4392943555683,HTRA2;DNM1L,beta,2
amino acid transport (GO:0006865),2/49,2,49,0.0421236038923173,1,0,0,6.13779346324996,19.4392943555683,SLC43A1;SLC38A4,beta,2
cellular response to oxidative stress (GO:0034599),3/116,3,116,0.0423433271378268,1,0,0,3.88903292714545,12.2969060212505,HTRA2;PRR5L;DHRS2,beta,2
organic hydroxy compound biosynthetic process (GO:1901617),2/50,2,50,0.0436918530405431,1,0,0,6.01503759398496,18.830638337076,CYP7B1;SLC27A2,beta,2
skeletal muscle myosin thick filament assembly (GO:0030241),1/7,1,7,0.0456380345107205,1,0,0,21.4822771213749,66.3160863582019,MYOM1,beta,2
cellular response to caffeine (GO:0071313),1/7,1,7,0.0456380345107205,1,0,0,21.4822771213749,66.3160863582019,GSTM2,beta,2
xenobiotic catabolic process (GO:0042178),1/7,1,7,0.0456380345107205,1,0,0,21.4822771213749,66.3160863582019,GSTM2,beta,2
positive regulation of membrane depolarization (GO:1904181),1/7,1,7,0.0456380345107205,1,0,0,21.4822771213749,66.3160863582019,ANK3,beta,2
negative regulation of leukocyte migration (GO:0002686),1/7,1,7,0.0456380345107205,1,0,0,21.4822771213749,66.3160863582019,BMP5,beta,2
response to caffeine (GO:0031000),1/7,1,7,0.0456380345107205,1,0,0,21.4822771213749,66.3160863582019,GSTM2,beta,2
protein C-linked glycosylation via tryptophan (GO:0018317),1/7,1,7,0.0456380345107205,1,0,0,21.4822771213749,66.3160863582019,DPY19L2,beta,2
positive regulation of RIG-I signaling pathway (GO:1900246),1/7,1,7,0.0456380345107205,1,0,0,21.4822771213749,66.3160863582019,DDX60,beta,2
negative regulation of RIG-I signaling pathway (GO:0039536),1/7,1,7,0.0456380345107205,1,0,0,21.4822771213749,66.3160863582019,RNF125,beta,2
pericardium morphogenesis (GO:0003344),1/7,1,7,0.0456380345107205,1,0,0,21.4822771213749,66.3160863582019,BMP5,beta,2
regulation of MDA-5 signaling pathway (GO:0039533),1/7,1,7,0.0456380345107205,1,0,0,21.4822771213749,66.3160863582019,DDX60,beta,2
selenocysteine incorporation (GO:0001514),1/7,1,7,0.0456380345107205,1,0,0,21.4822771213749,66.3160863582019,SECISBP2L,beta,2
long-chain fatty acid import (GO:0044539),1/7,1,7,0.0456380345107205,1,0,0,21.4822771213749,66.3160863582019,SLC27A2,beta,2
protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),1/7,1,7,0.0456380345107205,1,0,0,21.4822771213749,66.3160863582019,DPY19L2,beta,2
translational readthrough (GO:0006451),1/7,1,7,0.0456380345107205,1,0,0,21.4822771213749,66.3160863582019,SECISBP2L,beta,2
positive regulation of secretion by cell (GO:1903532),2/53,2,53,0.0485241857850309,1,0,0,5.67456376791034,17.1694874697474,MYOM1;DNM1L,beta,2
embryonic organ development (GO:0048568),2/54,2,54,0.0501763356839009,1,0,0,5.56947925368978,16.6650613430677,NEUROD1;KITLG,beta,2
monocarboxylic acid transport (GO:0015718),2/54,2,54,0.0501763356839009,1,0,0,5.56947925368978,16.6650613430677,ATP8B1;SLC16A14,beta,2
sensory perception (GO:0007600),2/55,2,55,0.0518486027084388,1,0,0,5.46821599453178,16.1827876604129,PCDH15;USH2A,beta,2
negative regulation of multicellular organismal process (GO:0051241),3/126,3,126,0.051877387302948,1,0,0,3.58037952022914,10.5938857185549,PROC;WWC1;BMP5,beta,2
"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",3/126,3,126,0.051877387302948,1,0,0,3.58037952022914,10.5938857185549,PTGDR2;SSTR1;RXFP3,beta,2
positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),1/8,1,8,0.0519867480478782,1,0,0,18.796992481203,55.5783165058719,GSTM2,beta,2
fatty acid alpha-oxidation (GO:0001561),1/8,1,8,0.0519867480478782,1,0,0,18.796992481203,55.5783165058719,SLC27A2,beta,2
negative regulation of voltage-gated potassium channel activity (GO:1903817),1/8,1,8,0.0519867480478782,1,0,0,18.796992481203,55.5783165058719,ANK3,beta,2
positive regulation of membrane potential (GO:0045838),1/8,1,8,0.0519867480478782,1,0,0,18.796992481203,55.5783165058719,ANK3,beta,2
myelin maintenance (GO:0043217),1/8,1,8,0.0519867480478782,1,0,0,18.796992481203,55.5783165058719,EPB41L3,beta,2
response to magnesium ion (GO:0032026),1/8,1,8,0.0519867480478782,1,0,0,18.796992481203,55.5783165058719,ANK3,beta,2
cellular response to purine-containing compound (GO:0071415),1/8,1,8,0.0519867480478782,1,0,0,18.796992481203,55.5783165058719,GSTM2,beta,2
membrane lipid catabolic process (GO:0046466),1/8,1,8,0.0519867480478782,1,0,0,18.796992481203,55.5783165058719,MGST2,beta,2
cytoskeletal anchoring at nuclear membrane (GO:0090286),1/8,1,8,0.0519867480478782,1,0,0,18.796992481203,55.5783165058719,SYNE1,beta,2
negative regulation of hippo signaling (GO:0035331),1/8,1,8,0.0519867480478782,1,0,0,18.796992481203,55.5783165058719,WWC1,beta,2
histone H4 deacetylation (GO:0070933),1/8,1,8,0.0519867480478782,1,0,0,18.796992481203,55.5783165058719,SMARCAD1,beta,2
regulation of response to oxidative stress (GO:1902882),1/8,1,8,0.0519867480478782,1,0,0,18.796992481203,55.5783165058719,MCTP1,beta,2
bone resorption (GO:0045453),1/8,1,8,0.0519867480478782,1,0,0,18.796992481203,55.5783165058719,IL7,beta,2
cytoskeleton organization (GO:0007010),3/127,3,127,0.0528833827171238,1,0,0,3.55218755550293,10.4422453938651,EPB41L3;ANK3;SYNE1,beta,2
long-chain fatty acid metabolic process (GO:0001676),2/56,2,56,0.0535406507802824,1,0,0,5.37056928034372,15.7213431038359,GSTM2;SLC27A2,beta,2
type B pancreatic cell differentiation (GO:0003309),1/9,1,9,0.0582935444675748,1,0,0,16.7084377610693,47.4897898295878,BMP5,beta,2
regulation of homotypic cell-cell adhesion (GO:0034110),1/9,1,9,0.0582935444675748,1,0,0,16.7084377610693,47.4897898295878,ANK3,beta,2
dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),1/9,1,9,0.0582935444675748,1,0,0,16.7084377610693,47.4897898295878,DNM1L,beta,2
myelin assembly (GO:0032288),1/9,1,9,0.0582935444675748,1,0,0,16.7084377610693,47.4897898295878,EPB41L3,beta,2
regulation of organ growth (GO:0046620),1/9,1,9,0.0582935444675748,1,0,0,16.7084377610693,47.4897898295878,WWC1,beta,2
regulation of amyloid precursor protein biosynthetic process (GO:0042984),1/9,1,9,0.0582935444675748,1,0,0,16.7084377610693,47.4897898295878,NECAB1,beta,2
pericardium development (GO:0060039),1/9,1,9,0.0582935444675748,1,0,0,16.7084377610693,47.4897898295878,BMP5,beta,2
peroxisome fission (GO:0016559),1/9,1,9,0.0582935444675748,1,0,0,16.7084377610693,47.4897898295878,DNM1L,beta,2
mitochondrial fragmentation involved in apoptotic process (GO:0043653),1/9,1,9,0.0582935444675748,1,0,0,16.7084377610693,47.4897898295878,DNM1L,beta,2
regulation of microvillus organization (GO:0032530),1/9,1,9,0.0582935444675748,1,0,0,16.7084377610693,47.4897898295878,ATP8B1,beta,2
protein autoprocessing (GO:0016540),1/9,1,9,0.0582935444675748,1,0,0,16.7084377610693,47.4897898295878,HTRA2,beta,2
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),1/9,1,9,0.0582935444675748,1,0,0,16.7084377610693,47.4897898295878,HTRA2,beta,2
positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409),1/9,1,9,0.0582935444675748,1,0,0,16.7084377610693,47.4897898295878,CCNH,beta,2
mitochondrion morphogenesis (GO:0070584),1/9,1,9,0.0582935444675748,1,0,0,16.7084377610693,47.4897898295878,DNM1L,beta,2
regulation of glycoprotein biosynthetic process (GO:0010559),1/9,1,9,0.0582935444675748,1,0,0,16.7084377610693,47.4897898295878,NECAB1,beta,2
phospholipid transport (GO:0015914),2/59,2,59,0.0587321731619424,1,0,0,5.09748948642794,14.4501980759279,ATP8B4;ATP8B1,beta,2
striated muscle contraction (GO:0006941),2/62,2,62,0.064089960688922,1,0,0,4.85083676934271,13.3275165987835,MYOM1;MYBPHL,beta,2
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),1/10,1,10,0.0645586982519235,1,0,0,15.0375939849624,41.2057205805686,RNF125,beta,2
dynamin family protein polymerization involved in membrane fission (GO:0003373),1/10,1,10,0.0645586982519235,1,0,0,15.0375939849624,41.2057205805686,DNM1L,beta,2
cellular response to thyroid hormone stimulus (GO:0097067),1/10,1,10,0.0645586982519235,1,0,0,15.0375939849624,41.2057205805686,LMO2,beta,2
protein kinase A signaling (GO:0010737),1/10,1,10,0.0645586982519235,1,0,0,15.0375939849624,41.2057205805686,MYOM1,beta,2
regulation of coagulation (GO:0050818),1/10,1,10,0.0645586982519235,1,0,0,15.0375939849624,41.2057205805686,PROC,beta,2
skeletal muscle thin filament assembly (GO:0030240),1/10,1,10,0.0645586982519235,1,0,0,15.0375939849624,41.2057205805686,MYOM1,beta,2
hair cell differentiation (GO:0035315),1/10,1,10,0.0645586982519235,1,0,0,15.0375939849624,41.2057205805686,USH2A,beta,2
myeloid dendritic cell differentiation (GO:0043011),1/10,1,10,0.0645586982519235,1,0,0,15.0375939849624,41.2057205805686,DHRS2,beta,2
muscle contraction (GO:0006936),3/138,3,138,0.0645611546542215,1,0,0,3.269042170644,8.95764096175786,MYOM1;MYBPHL;DYSF,beta,2
neuron differentiation (GO:0030182),3/140,3,140,0.0668022319839898,1,0,0,3.22234156820623,8.71971681868021,NEUROD1;ID1;USH2A,beta,2
carbohydrate homeostasis (GO:0033500),2/64,2,64,0.0677499714446409,1,0,0,4.69924812030075,12.6500528228559,NEUROD1;G6PC2,beta,2
modification-dependent protein catabolic process (GO:0019941),3/142,3,142,0.0690786425732943,1,0,0,3.17695647569628,8.49044692141749,RNF125;HACE1;RNF217,beta,2
cellular response to interferon-beta (GO:0035458),1/11,1,11,0.0707824821112975,1,0,0,13.6705399863295,36.2015548421641,HTRA2,beta,2
regulation of hippo signaling (GO:0035330),1/11,1,11,0.0707824821112975,1,0,0,13.6705399863295,36.2015548421641,WWC1,beta,2
mitochondrion distribution (GO:0048311),1/11,1,11,0.0707824821112975,1,0,0,13.6705399863295,36.2015548421641,DNM1L,beta,2
cell part morphogenesis (GO:0032990),1/11,1,11,0.0707824821112975,1,0,0,13.6705399863295,36.2015548421641,DNM1L,beta,2
embryonic hemopoiesis (GO:0035162),1/11,1,11,0.0707824821112975,1,0,0,13.6705399863295,36.2015548421641,KITLG,beta,2
drug transmembrane transport (GO:0006855),1/11,1,11,0.0707824821112975,1,0,0,13.6705399863295,36.2015548421641,ATP8B1,beta,2
morphogenesis of an epithelial sheet (GO:0002011),1/11,1,11,0.0707824821112975,1,0,0,13.6705399863295,36.2015548421641,BMP5,beta,2
glutathione biosynthetic process (GO:0006750),1/11,1,11,0.0707824821112975,1,0,0,13.6705399863295,36.2015548421641,MGST2,beta,2
regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),1/11,1,11,0.0707824821112975,1,0,0,13.6705399863295,36.2015548421641,CCNH,beta,2
protein carboxylation (GO:0018214),1/11,1,11,0.0707824821112975,1,0,0,13.6705399863295,36.2015548421641,PROC,beta,2
intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),1/11,1,11,0.0707824821112975,1,0,0,13.6705399863295,36.2015548421641,ZNF622,beta,2
peptidyl-glutamic acid carboxylation (GO:0017187),1/11,1,11,0.0707824821112975,1,0,0,13.6705399863295,36.2015548421641,PROC,beta,2
relaxation of muscle (GO:0090075),1/11,1,11,0.0707824821112975,1,0,0,13.6705399863295,36.2015548421641,GSTM2,beta,2
positive regulation of sodium ion transmembrane transporter activity (GO:2000651),1/11,1,11,0.0707824821112975,1,0,0,13.6705399863295,36.2015548421641,ANK3,beta,2
relaxation of cardiac muscle (GO:0055119),1/11,1,11,0.0707824821112975,1,0,0,13.6705399863295,36.2015548421641,GSTM2,beta,2
negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),1/11,1,11,0.0707824821112975,1,0,0,13.6705399863295,36.2015548421641,GSTM2,beta,2
icosanoid biosynthetic process (GO:0046456),1/11,1,11,0.0707824821112975,1,0,0,13.6705399863295,36.2015548421641,MGST2,beta,2
response to thyroid hormone (GO:0097066),1/11,1,11,0.0707824821112975,1,0,0,13.6705399863295,36.2015548421641,LMO2,beta,2
nonribosomal peptide biosynthetic process (GO:0019184),1/12,1,12,0.0769651670676442,1,0,0,12.531328320802,32.1353676093498,MGST2,beta,2
regulation of double-strand break repair via nonhomologous end joining (GO:2001032),1/12,1,12,0.0769651670676442,1,0,0,12.531328320802,32.1353676093498,USP51,beta,2
lysine metabolic process (GO:0006553),1/12,1,12,0.0769651670676442,1,0,0,12.531328320802,32.1353676093498,SLC25A21,beta,2
negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),1/12,1,12,0.0769651670676442,1,0,0,12.531328320802,32.1353676093498,GSTM2,beta,2
regulation of mononuclear cell migration (GO:0071675),1/12,1,12,0.0769651670676442,1,0,0,12.531328320802,32.1353676093498,BMP5,beta,2
regulation of DNA-dependent DNA replication (GO:0090329),1/12,1,12,0.0769651670676442,1,0,0,12.531328320802,32.1353676093498,BMP5,beta,2
skeletal myofibril assembly (GO:0014866),1/12,1,12,0.0769651670676442,1,0,0,12.531328320802,32.1353676093498,MYOM1,beta,2
regulation of cell communication by electrical coupling (GO:0010649),1/12,1,12,0.0769651670676442,1,0,0,12.531328320802,32.1353676093498,ANK3,beta,2
positive regulation of mRNA metabolic process (GO:1903313),1/12,1,12,0.0769651670676442,1,0,0,12.531328320802,32.1353676093498,PRR5L,beta,2
positive regulation of DNA-dependent DNA replication (GO:2000105),1/12,1,12,0.0769651670676442,1,0,0,12.531328320802,32.1353676093498,BMP5,beta,2
cardiac muscle fiber development (GO:0048739),1/12,1,12,0.0769651670676442,1,0,0,12.531328320802,32.1353676093498,MYOM1,beta,2
histone H3 deacetylation (GO:0070932),1/12,1,12,0.0769651670676442,1,0,0,12.531328320802,32.1353676093498,SMARCAD1,beta,2
lysine catabolic process (GO:0006554),1/12,1,12,0.0769651670676442,1,0,0,12.531328320802,32.1353676093498,SLC25A21,beta,2
regulation of establishment of endothelial barrier (GO:1903140),1/12,1,12,0.0769651670676442,1,0,0,12.531328320802,32.1353676093498,PROC,beta,2
monocarboxylic acid biosynthetic process (GO:0072330),2/69,2,69,0.0771907087920045,1,0,0,4.358722894192,11.1647648757961,CYP7B1;SLC27A2,beta,2
heart development (GO:0007507),3/150,3,150,0.0785297050401001,1,0,0,3.00751879699248,7.65196486501637,GATA2;FGF12;BMP5,beta,2
negative regulation of cell differentiation (GO:0045596),3/151,3,151,0.0797491063117402,1,0,0,2.98760145396604,7.55525492257836,GATA2;USH2A;BMP5,beta,2
calcium-mediated signaling (GO:0019722),2/71,2,71,0.0810770743248191,1,0,0,4.23594196759504,10.6421901593041,MCTP1;PTGDR2,beta,2
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),2/71,2,71,0.0810770743248191,1,0,0,4.23594196759504,10.6421901593041,RNF125;RNF217,beta,2
protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),2/71,2,71,0.0810770743248191,1,0,0,4.23594196759504,10.6421901593041,HACE1;RNF217,beta,2
positive regulation of intracellular protein transport (GO:0090316),3/153,3,153,0.0822126781285944,1,0,0,2.94854784018871,7.36678683081813,HTRA2;PRR5L;ANK3,beta,2
regulation of cation channel activity (GO:2001257),2/72,2,72,0.0830426915551863,1,0,0,4.17710944026734,10.3943209997273,ANK3;FGF12,beta,2
catecholamine biosynthetic process (GO:0042423),1/13,1,13,0.0831070223634689,1,0,0,11.5673799884326,28.7753160869349,DDC,beta,2
negative regulation of hemostasis (GO:1900047),1/13,1,13,0.0831070223634689,1,0,0,11.5673799884326,28.7753160869349,PROC,beta,2
positive regulation of sodium ion transport (GO:0010765),1/13,1,13,0.0831070223634689,1,0,0,11.5673799884326,28.7753160869349,ANK3,beta,2
regulation of neurotransmitter transport (GO:0051588),1/13,1,13,0.0831070223634689,1,0,0,11.5673799884326,28.7753160869349,MCTP1,beta,2
nucleotide metabolic process (GO:0009117),1/13,1,13,0.0831070223634689,1,0,0,11.5673799884326,28.7753160869349,SMARCAD1,beta,2
regulation of peptide hormone secretion (GO:0090276),2/74,2,74,0.0870173932313785,1,0,0,4.06421459053038,9.92337841133745,NEUROD1;G6PC2,beta,2
positive regulation of proteasomal protein catabolic process (GO:1901800),2/74,2,74,0.0870173932313785,1,0,0,4.06421459053038,9.92337841133745,RNF125;RNF217,beta,2
glucose homeostasis (GO:0042593),2/75,2,75,0.0890259260672631,1,0,0,4.01002506265664,9.69955948889927,NEUROD1;G6PC2,beta,2
nitrogen compound transport (GO:0071705),2/75,2,75,0.0890259260672631,1,0,0,4.01002506265664,9.69955948889927,SLC43A1;SLC38A4,beta,2
regulation of fibroblast migration (GO:0010762),1/14,1,14,0.0892083155265458,1,0,0,10.7411385606874,25.9589798104128,PRR5L,beta,2
ncRNA transcription (GO:0098781),1/14,1,14,0.0892083155265458,1,0,0,10.7411385606874,25.9589798104128,SNAPC3,beta,2
necroptotic process (GO:0070266),1/14,1,14,0.0892083155265458,1,0,0,10.7411385606874,25.9589798104128,DNM1L,beta,2
myeloid dendritic cell activation (GO:0001773),1/14,1,14,0.0892083155265458,1,0,0,10.7411385606874,25.9589798104128,DHRS2,beta,2
regulation of mRNA catabolic process (GO:0061013),1/14,1,14,0.0892083155265458,1,0,0,10.7411385606874,25.9589798104128,PRR5L,beta,2
positive regulation of mitochondrial fission (GO:0090141),1/14,1,14,0.0892083155265458,1,0,0,10.7411385606874,25.9589798104128,DNM1L,beta,2
regulation of neural precursor cell proliferation (GO:2000177),1/14,1,14,0.0892083155265458,1,0,0,10.7411385606874,25.9589798104128,GATA2,beta,2
positive regulation of response to cytokine stimulus (GO:0060760),1/14,1,14,0.0892083155265458,1,0,0,10.7411385606874,25.9589798104128,IL7,beta,2
neuromuscular process controlling balance (GO:0050885),1/14,1,14,0.0892083155265458,1,0,0,10.7411385606874,25.9589798104128,PCDH15,beta,2
amyloid-beta metabolic process (GO:0050435),1/14,1,14,0.0892083155265458,1,0,0,10.7411385606874,25.9589798104128,BACE1,beta,2
acyl-CoA biosynthetic process (GO:0071616),1/14,1,14,0.0892083155265458,1,0,0,10.7411385606874,25.9589798104128,SCD5,beta,2
regulation of hematopoietic stem cell differentiation (GO:1902036),2/77,2,77,0.0930839988966851,1,0,0,3.9058685675227,9.27352008412576,LMO2;GATA2,beta,2
positive regulation of programmed cell death (GO:0043068),4/258,4,258,0.0936313181720966,1,0,0,2.33140992014921,5.5216887698492,NEUROD1;HTRA2;ZNF622;DNM1L,beta,2
regulation of hematopoietic progenitor cell differentiation (GO:1901532),2/78,2,78,0.0951330050012155,1,0,0,3.85579332947754,9.0706740462584,LMO2;GATA2,beta,2
unsaturated fatty acid biosynthetic process (GO:0006636),1/15,1,15,0.0952693123651451,1,0,0,10.0250626566416,23.5693988073938,SCD5,beta,2
negative regulation of coagulation (GO:0050819),1/15,1,15,0.0952693123651451,1,0,0,10.0250626566416,23.5693988073938,PROC,beta,2
regulation of delayed rectifier potassium channel activity (GO:1902259),1/15,1,15,0.0952693123651451,1,0,0,10.0250626566416,23.5693988073938,ANK3,beta,2
catecholamine metabolic process (GO:0006584),1/15,1,15,0.0952693123651451,1,0,0,10.0250626566416,23.5693988073938,DDC,beta,2
maintenance of protein location in nucleus (GO:0051457),1/15,1,15,0.0952693123651451,1,0,0,10.0250626566416,23.5693988073938,SYNE1,beta,2
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),1/15,1,15,0.0952693123651451,1,0,0,10.0250626566416,23.5693988073938,HTRA2,beta,2
negative regulation of axon extension involved in axon guidance (GO:0048843),1/15,1,15,0.0952693123651451,1,0,0,10.0250626566416,23.5693988073938,SEMA4B,beta,2
nitric oxide mediated signal transduction (GO:0007263),1/15,1,15,0.0952693123651451,1,0,0,10.0250626566416,23.5693988073938,NEUROD1,beta,2
cellular biogenic amine biosynthetic process (GO:0042401),1/15,1,15,0.0952693123651451,1,0,0,10.0250626566416,23.5693988073938,DDC,beta,2
negative regulation of cell proliferation (GO:0008285),5/364,5,364,0.0959437778267352,1,0,0,2.06560356936297,4.8417601146638,TFDP1;SSTR1;GATA2;DHRS2;BMP5,beta,2
neuron projection morphogenesis (GO:0048812),3/164,3,164,0.096334486102696,1,0,0,2.75077938749312,6.43662822247966,EPB41L3;LRRN1;ANK3,beta,2
steroid biosynthetic process (GO:0006694),2/80,2,80,0.0992696434680371,1,0,0,3.7593984962406,8.68389270648425,CYP7B1;SLC27A2,beta,2
"positive regulation of transcription, DNA-templated (GO:0045893)",28/1121,28,1121,2.00774022098462e-05,0.0341516611589484,0,0,2.3675543586253,25.6072682243621,NFAT5;CEBPB;SRF;CEBPG;PRDM2;YEATS4;TRIAP1;NR3C1;FOXO3;ARNTL;NAMPT;ZNF821;MAP3K5;NCOA1;TCF12;EAF2;KLF4;TGFBR1;VEGFA;NFKB2;KLF6;PSRC1;CREB1;DDIT3;CTNNB1;SIM1;RHOQ;RNF187,beta,3
response to endoplasmic reticulum stress (GO:0034976),8/107,8,107,1.79077122719951e-05,0.0456915278619956,0,0,7.08685830712672,77.4613391307902,CEBPB;DDIT3;FAM129A;ATP2A2;TRIB3;HYOU1;TTC23L;MAP3K5,beta,3
positive regulation of transcription from RNA polymerase II promoter (GO:0045944),24/849,24,849,1.14103511545394e-05,0.0582270219416148,0,0,2.67948352954968,30.4951742328287,NCOA1;NFAT5;CEBPB;SRF;TCF12;CEBPG;EAF2;PRDM2;YEATS4;TRIAP1;NR3C1;FOXO3;KLF4;ARNTL;VEGFA;NFKB2;KLF6;CREB1;DDIT3;NAMPT;CTNNB1;ZNF821;SIM1;RHOQ,beta,3
"regulation of transcription, DNA-templated (GO:0006355)",34/1599,34,1599,6.68249186975673e-05,0.0682015120227372,0,0,2.01547768303057,19.3756627173949,CEBPB;CEBPG;PRDM2;YEATS4;BAZ2B;NR3C1;FOXO3;ARNTL;ATXN1;NFIL3;CREG1;UBN1;HIVEP2;MAP3K5;NCOA1;USP3;TCF12;BAZ1A;DEK;KLF4;POU3F2;TGFBR1;VEGFA;NFKB2;KLF6;ZEB1;PSRC1;CREB1;DDIT3;CTNNB1;TRIB3;SIM1;ZNF674;RNF187,beta,3
positive regulation of neuron death (GO:1901216),5/39,5,39,5.35906535776228e-05,0.0683682763016523,0,0,12.1521448535667,119.505843706941,DDIT3;CTNNB1;MAPT;FOXO3;MAP3K5,beta,3
regulation of transcription from RNA polymerase II promoter (GO:0006357),32/1479,32,1479,8.14280052681446e-05,0.0692545184805569,0,0,2.05082850267088,19.3101731713179,NFAT5;CEBPB;SRF;CEBPG;PRDM2;YEATS4;TRIAP1;NR3C1;FOXO3;ARNTL;NFIL3;CREG1;NAMPT;UBN1;BEND3;ZNF821;NCOA1;TCF12;EAF2;DEK;KLF4;POU3F2;VEGFA;NFKB2;KLF6;ZEB1;CREB1;DDIT3;CTNNB1;TRIB3;SIM1;RHOQ,beta,3
response to unfolded protein (GO:0006986),5/44,5,44,9.68513849198284e-05,0.0706046596065549,0,0,10.771219302025,99.551194189753,DNAJB2;HSP90AB1;DDIT3;HYOU1;STT3B,beta,3
protein complex disassembly (GO:0043241),5/47,5,47,0.000133335121699366,0.0756010140035403,0,0,10.0836946657255,89.9732266498852,GABARAPL1;VPS4A;LIX1L;CTNNB1;GABARAP,beta,3
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),4/25,4,25,0.000127993152125385,0.0816436319119799,0,0,15.1658767772512,135.939849016056,CEBPB;DDIT3;TRIB3;MAP3K5,beta,3
regulation of organelle organization (GO:0033043),7/114,7,114,0.000208694978240524,0.106497047396139,0,0,5.82023779828719,49.3244014665899,SCARB2;RHOT1;TAOK1;TBC1D30;RDX;TBC1D9;MAPT,beta,3
regulation of protein modification by small protein conjugation or removal (GO:1903320),3/14,3,14,0.000386712857330896,0.179399610087233,0,0,20.31144211239,159.603820806747,DNAJB2;HSP90AB1;TGFBR1,beta,3
"transcription, DNA-templated (GO:0006351)",12/357,12,357,0.000430181138993659,0.182934529357053,0,0,3.18610856664941,24.696496664958,NCOA1;NFAT5;CEBPB;SRF;EAF2;BAZ2B;HIVEP2;BAZ1A;DEK;NR3C1;FOXO3;KLF4,beta,3
positive regulation of axon extension (GO:0045773),3/19,3,19,0.000990184644346561,0.315807015006281,0,0,14.9663257670242,103.531341323802,RUFY3;MAPT;VEGFA,beta,3
positive regulation of cell differentiation (GO:0045597),8/195,8,195,0.00111979237862943,0.336135324008586,0,0,3.88868635314133,26.4221149090608,CEBPB;HSP90AB1;CREB1;SRF;CTNNB1;IL6R;TGFBR1;ARNTL,beta,3
positive regulation of neuron apoptotic process (GO:0043525),3/19,3,19,0.000990184644346561,0.3368608160067,0,0,14.9663257670242,103.531341323802,DDIT3;CTNNB1;FOXO3,beta,3
positive regulation of neurogenesis (GO:0050769),5/70,5,70,0.000864779248786663,0.339459115889103,0,0,6.77048070412999,47.7524460888101,ZEB1;TCF12;LIG4;CTNNB1;VEGFA,beta,3
regulation of sprouting angiogenesis (GO:1903670),3/19,3,19,0.000990184644346561,0.360922302864322,0,0,14.9663257670242,103.531341323802,TMEM2;KLF4;VEGFA,beta,3
positive regulation of gene expression (GO:0010628),18/772,18,772,0.00143257544398801,0.406135138370601,0,0,2.21005328684036,14.4720509302403,NCOA1;RDX;FAM129A;YEATS4;DEK;FOXO3;KLF4;TGFBR1;ARNTL;VEGFA;RIMS2;KLF6;PSRC1;CREB1;DDIT3;CTNNB1;MAP3K5;RNF187,beta,3
regulation of microtubule cytoskeleton organization (GO:0070507),3/23,3,23,0.00175438572183555,0.447631516926341,0,0,12.3634865031939,78.4541912142882,TAOK1;MAPT;PHLDB2,beta,3
autophagosome maturation (GO:0097352),3/23,3,23,0.00175438572183555,0.47119107044878,0,0,12.3634865031939,78.4541912142882,GABARAPL1;LIX1L;GABARAP,beta,3
amino acid import across plasma membrane (GO:0089718),2/7,2,7,0.00224655997724367,0.477674815161436,0,0,27.08192281652,165.155182985169,SLC1A1;SLC7A1,beta,3
regulation of cellular protein localization (GO:1903827),3/26,3,26,0.00251642069502259,0.493895954103857,0,0,10.93693036821,65.4566286501241,SETD2;CTNNB1;MAPT,beta,3
regulation of microtubule-based process (GO:0032886),3/27,3,27,0.00280914171693697,0.494312075225151,0,0,10.5318588730911,61.8733678894669,TAOK1;MAPT;PHLDB2,beta,3
regulation of response to biotic stimulus (GO:0002831),2/7,2,7,0.00224655997724367,0.498443285385846,0,0,27.08192281652,165.155182985169,SCARB2;CD55,beta,3
coronary vasculature morphogenesis (GO:0060977),2/8,2,8,0.00297463561266595,0.505985517714478,0,0,23.696682464455,137.858619209093,TGFBR1;VEGFA,beta,3
phosphorylation (GO:0016310),11/387,11,387,0.00280315818516977,0.510875579247191,0,0,2.69419645590703,15.8338156718198,NUAK1;MEX3B;CREB1;TAOK1;TESK2;TLK1;EIF2AK4;VRK2;MAPK6;TGFBR1;MAP3K5,beta,3
in utero embryonic development (GO:0001701),3/26,3,26,0.00251642069502259,0.513651792268011,0,0,10.93693036821,65.4566286501241,LIG4;TGFBR1;VEGFA,beta,3
positive regulation of nucleic acid-templated transcription (GO:1903508),13/503,13,503,0.00274125040429266,0.518096326411313,0,0,2.44975643767725,14.4519488641075,NCOA1;YEATS4;FOXO3;KLF4;TGFBR1;ARNTL;KLF6;PSRC1;CREB1;DDIT3;CTNNB1;MAP3K5;RNF187,beta,3
positive regulation of neuroblast proliferation (GO:0002052),2/7,2,7,0.00224655997724367,0.52109979835793,0,0,27.08192281652,165.155182985169,CTNNB1;VEGFA,beta,3
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),3/30,3,30,0.0038097613958688,0.525438173057257,0,0,9.47867298578199,52.7979973228514,CEBPB;DDIT3;VEGFA,beta,3
L-fucose catabolic process (GO:0042355),2/9,2,9,0.00379802420082522,0.538369930466975,0,0,21.0637177461822,117.393876663938,FUT5;FUT9,beta,3
regulation of cellular senescence (GO:2000772),3/25,3,25,0.00224337342470913,0.54513974220432,0,0,11.3744075829384,69.3813219277187,NUAK1;ARG2;ARNTL,beta,3
fucose catabolic process (GO:0019317),2/9,2,9,0.00379802420082522,0.553751928480317,0,0,21.0637177461822,117.393876663938,FUT5;FUT9,beta,3
L-fucose metabolic process (GO:0042354),2/9,2,9,0.00379802420082522,0.570038749906208,0,0,21.0637177461822,117.393876663938,FUT5;FUT9,beta,3
regulation of cytoskeleton organization (GO:0051493),5/96,5,96,0.00350398043496475,0.576800392245971,0,0,4.93680884676145,27.9120047864947,EPHA5;TAOK1;MAPT;PHLDB2;RHOQ,beta,3
neuron differentiation (GO:0030182),6/140,6,140,0.00373811366013517,0.57804830326272,0,0,4.062288422478,22.7048374965754,EPHA5;SRF;CTNNB1;POU3F2;TGFBR1;VEGFA,beta,3
regulation of actin filament-based process (GO:0032970),4/63,4,63,0.0044117716963455,0.592454499117133,0,0,6.01820507033777,32.6396083652949,EPHA5;TAOK1;ABRACL;RHOQ,beta,3
cellular response to growth factor stimulus (GO:0071363),6/140,6,140,0.00373811366013517,0.59611231273968,0,0,4.062288422478,22.7048374965754,CTNNB1;MAPT;NR3C1;KLF4;TGFBR1;VEGFA,beta,3
cellular protein modification process (GO:0006464),20/1002,20,1002,0.00476078610375197,0.607357287186157,0,0,1.89195069576487,10.1169083189586,PHLPP2;SDC2;TESK2;ALG3;EIF2AK4;VRK2;PTPRH;FBXO30;TGFBR1;FUT5;NUAK1;MEX3B;CREB1;FUT9;TAOK1;TLK1;STT3B;DCAF10;MAPK6;MAP3K5,beta,3
regulation of neuroblast proliferation (GO:1902692),2/10,2,10,0.00471465290255957,0.616894199019525,0,0,18.957345971564,101.556018600614,CTNNB1;VEGFA,beta,3
regulation of cellular response to stress (GO:0080135),5/105,5,105,0.00513076548906227,0.638592592455726,0,0,4.51365380275333,23.7982415382107,NUAK1;HSP90AB1;EIF2AK4;MAPT;ARNTL,beta,3
activation of MAPKK activity (GO:0000186),3/34,3,34,0.00544443583571166,0.661498954038967,0,0,8.3635349874547,43.6004555846512,TAOK1;TGFBR1;MAP3K5,beta,3
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),2/11,2,11,0.00572248163651786,0.679112181189549,0,0,17.23395088324,88.9849670855518,CEBPB;DDIT3,beta,3
negative regulation of protein kinase B signaling (GO:0051898),3/36,3,36,0.00639682938441931,0.741886826106631,0,0,7.89889415481833,39.9048406007616,PHLPP2;DDIT3;TRIB3,beta,3
regulation of protein localization to cell periphery (GO:1904375),2/12,2,12,0.0068195026239273,0.756520041084804,0,0,15.7977883096367,78.798874231108,VPS4A;SPTBN1,beta,3
mitochondrion transport along microtubule (GO:0047497),2/12,2,12,0.0068195026239273,0.773331597553356,0,0,15.7977883096367,78.798874231108,RHOT1;MAPT,beta,3
cellular response to nitrogen levels (GO:0043562),2/13,2,13,0.00800373994563505,0.785443941203378,0,0,14.58257382428,70.4024258598443,GABARAPL1;GABARAP,beta,3
positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),7/216,7,216,0.00815858401097798,0.78553309826454,0,0,3.07179217131824,14.7712798718238,EPHA5;DDIT3;SRF;CEBPG;CTNNB1;VEGFA;NFKB2,beta,3
cell migration involved in sprouting angiogenesis (GO:0002042),2/14,2,14,0.00927324909653392,0.78868983566021,0,0,13.54096140826,63.3801146237403,SRF;VEGFA,beta,3
regulation of cell differentiation (GO:0045595),5/122,5,122,0.00954768147562363,0.798718337214875,0,0,3.88470204335327,18.0695242459262,HSP90AB1;SRF;KLF4;PHLDB2;TGFBR1,beta,3
neuron fate commitment (GO:0048663),2/13,2,13,0.00800373994563505,0.800844802795602,0,0,14.58257382428,70.4024258598443,POU3F2;TGFBR1,beta,3
positive regulation of heart rate (GO:0010460),2/14,2,14,0.00927324909653392,0.802057459993434,0,0,13.54096140826,63.3801146237403,ATP2A2;ADM,beta,3
regulation of fat cell differentiation (GO:0045598),4/73,4,73,0.00743109265903372,0.806826932745724,0,0,5.19379341686684,25.4604031455149,CEBPB;CREB1;TRIB3;ARNTL,beta,3
regulation of actin cytoskeleton organization (GO:0032956),4/76,4,76,0.0085484561090469,0.807829102304932,0,0,4.98877525567473,23.7565706379639,EPHA5;TAOK1;RDX;RHOQ,beta,3
positive regulation of purine nucleotide metabolic process (GO:1900544),2/14,2,14,0.00927324909653392,0.815886036889873,0,0,13.54096140826,63.3801146237403,BEND3;ADM,beta,3
regulation of cell aging (GO:0090342),2/13,2,13,0.00800373994563505,0.816861698851514,0,0,14.58257382428,70.4024258598443,NUAK1;ARNTL,beta,3
nucleic acid-templated transcription (GO:0097659),4/77,4,77,0.0089439749929019,0.829838261614152,0,0,4.92398596664,23.2253346884317,NCOA1;BAZ1A;BAZ2B;NR3C1,beta,3
positive regulation of neural precursor cell proliferation (GO:2000179),2/14,2,14,0.00927324909653392,0.830199827010748,0,0,13.54096140826,63.3801146237403,CTNNB1;VEGFA,beta,3
cellular response to nitrogen starvation (GO:0006995),2/13,2,13,0.00800373994563505,0.833532345766851,0,0,14.58257382428,70.4024258598443,GABARAPL1;GABARAP,beta,3
positive regulation of stress-activated MAPK cascade (GO:0032874),4/81,4,81,0.010644936526669,0.835709401470649,0,0,4.68082616581827,21.2634530145272,UNC5CL;TAOK1;MAP3K5;VEGFA,beta,3
branching involved in blood vessel morphogenesis (GO:0001569),2/14,2,14,0.00927324909653392,0.845024823921654,0,0,13.54096140826,63.3801146237403,CTNNB1;VEGFA,beta,3
L-alpha-amino acid transmembrane transport (GO:1902475),2/15,2,15,0.010626116549627,0.847266761761669,0,0,12.6382306477093,57.4336869847607,SLC1A1;SLC7A1,beta,3
modulation by virus of host process (GO:0019054),2/13,2,13,0.00800373994563505,0.850897602970327,0,0,14.58257382428,70.4024258598443,KPNA4;EIF2AK4,beta,3
positive regulation of CREB transcription factor activity (GO:0032793),2/15,2,15,0.010626116549627,0.860715440519791,0,0,12.6382306477093,57.4336869847607,EPHA5;VEGFA,beta,3
"positive regulation of DNA-templated transcription, initiation (GO:2000144)",2/16,2,16,0.0120604593283546,0.866824281022441,0,0,11.8483412322275,52.3438744251202,SRF;CTNNB1,beta,3
negative regulation of adherens junction organization (GO:1903392),2/15,2,15,0.010626116549627,0.874597947624949,0,0,12.6382306477093,57.4336869847607,RDX;PHLDB2,beta,3
artery development (GO:0060840),2/16,2,16,0.0120604593283546,0.879207485037047,0,0,11.8483412322275,52.3438744251202,TGFBR1;VEGFA,beta,3
cytoplasmic sequestering of transcription factor (GO:0042994),2/16,2,16,0.0120604593283546,0.891949622501352,0,0,11.8483412322275,52.3438744251202,G3BP2;NFKBIE,beta,3
protein phosphorylation (GO:0006468),11/471,11,471,0.0116725263573202,0.902498515172806,0,0,2.21370282045864,9.85212286122514,NUAK1;MEX3B;CREB1;TAOK1;TESK2;TLK1;EIF2AK4;VRK2;MAPK6;TGFBR1;MAP3K5,beta,3
"negative regulation of transcription, DNA-templated (GO:0045892)",16/814,16,814,0.0127525791922284,0.903839050249185,0,0,1.86312982521513,8.12701279876837,CEBPB;NR3C1;FOXO3;KLF4;ARNTL;VEGFA;NFKB2;ZEB1;ATXN1;CREB1;NFIL3;DDIT3;BEND3;CTNNB1;TRIB3;ZNF674,beta,3
mRNA transcription from RNA polymerase II promoter (GO:0042789),2/16,2,16,0.0120604593283546,0.905066528714607,0,0,11.8483412322275,52.3438744251202,SRF;DDIT3,beta,3
positive regulation of stem cell proliferation (GO:2000648),2/17,2,17,0.0135744245722357,0.911451165685771,0,0,11.1513799832729,47.9461143333834,CTNNB1;VEGFA,beta,3
C21-steroid hormone biosynthetic process (GO:0006700),2/16,2,16,0.0120604593283546,0.918574984367064,0,0,11.8483412322275,52.3438744251202,FDX1;ADM,beta,3
regulation of protein localization to membrane (GO:1905475),2/17,2,17,0.0135744245722357,0.923603847894914,0,0,11.1513799832729,47.9461143333834,VPS4A;SPTBN1,beta,3
regulation of gene expression (GO:0010468),19/1038,19,1038,0.0139907167125705,0.927202953042174,0,0,1.73501721319709,7.40741527765826,SETD2;CEBPB;USP3;RDX;PRDM2;BAZ2B;BAZ1A;NR3C1;KLF4;TGFBR1;ARNTL;VEGFA;NFKB2;RIMS2;NFIL3;DDIT3;HIVEP2;MAPT;MAPK6,beta,3
aminoglycan biosynthetic process (GO:0006023),3/47,3,47,0.0133502348526375,0.933236280178209,0,0,6.05021679943531,26.1140746334542,EXT1;UGDH;SDC2,beta,3
peptidyl-lysine trimethylation (GO:0018023),2/17,2,17,0.0135744245722357,0.936084980974575,0,0,11.1513799832729,47.9461143333834,SETD2;BEND3,beta,3
regulation of neuron apoptotic process (GO:0043523),4/90,4,90,0.0152006481341505,0.94596228571427,0,0,4.21274354923644,17.636302102725,DDIT3;LIG4;CTNNB1;FOXO3,beta,3
regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),2/18,2,18,0.0151661891266679,0.955469914980079,0,0,10.5318588730911,44.1146574864961,SCARB2;CD55,beta,3
regulation of epithelial cell differentiation (GO:0030856),2/18,2,18,0.0151661891266679,0.96741328891733,0,0,10.5318588730911,44.1146574864961,CEBPB;ARNTL,beta,3
blood vessel endothelial cell migration (GO:0043534),2/18,2,18,0.0151661891266679,0.979659026751727,0,0,10.5318588730911,44.1146574864961,SRF;VEGFA,beta,3
acute-phase response (GO:0006953),2/18,2,18,0.0151661891266679,0.992218757863929,0,0,10.5318588730911,44.1146574864961,CEBPB;IL6R,beta,3
positive regulation of cellular protein metabolic process (GO:0032270),4/92,4,92,0.0163560194058254,1,0,0,4.1211621677313,16.9509964558632,PERP;RDX;FAM129A;KLF4,beta,3
positive regulation of heart contraction (GO:0045823),2/19,2,19,0.016833959118882,1,0,0,9.97755051134946,40.7518788394192,ATP2A2;ADM,beta,3
protein targeting to lysosome (GO:0006622),2/19,2,19,0.016833959118882,1,0,0,9.97755051134946,40.7518788394192,SCARB2;VPS4A,beta,3
regulation of cellular macromolecule biosynthetic process (GO:2000112),13/632,13,632,0.0169811640094362,1,0,0,1.94972703821465,7.94640607302904,CEBPB;USP3;PRDM2;BAZ2B;BAZ1A;NR3C1;FOXO3;TGFBR1;ARNTL;NFKB2;NFIL3;DDIT3;HIVEP2,beta,3
negative regulation of transcription from RNA polymerase II promoter (GO:0000122),12/566,12,566,0.0173454247285119,1,0,0,2.00961264716226,8.14782679505084,CEBPB;ZEB1;NFIL3;DDIT3;SRF;BEND3;TRIB3;NR3C1;FOXO3;KLF4;VEGFA;NFKB2,beta,3
positive regulation of developmental growth (GO:0048639),3/52,3,52,0.0175128381300335,1,0,0,5.46846518410499,22.1189631402511,RIMS2;RUFY3;MAPT,beta,3
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),4/94,4,94,0.0175650534425599,1,0,0,4.03347786629021,16.3026881141851,TRIAP1;KLF4;MAP3K5;VEGFA,beta,3
regulation of cell development (GO:0060284),2/20,2,20,0.0185759695513244,1,0,0,9.47867298578199,37.7809146271899,CTNNB1;ARNTL,beta,3
dopaminergic neuron differentiation (GO:0071542),2/20,2,20,0.0185759695513244,1,0,0,9.47867298578199,37.7809146271899,CTNNB1;VEGFA,beta,3
positive regulation of cellular component movement (GO:0051272),2/21,2,21,0.0203904839049939,1,0,0,9.02730760550666,35.140482619822,TGFBR1;VEGFA,beta,3
mRNA transcription (GO:0009299),2/21,2,21,0.0203904839049939,1,0,0,9.02730760550666,35.140482619822,SRF;DDIT3,beta,3
positive regulation of defense response to virus by host (GO:0002230),2/21,2,21,0.0203904839049939,1,0,0,9.02730760550666,35.140482619822,TRAF3IP2;EIF2AK4,beta,3
positive regulation of cell growth (GO:0030307),4/99,4,99,0.0208267354674976,1,0,0,3.82976686294222,14.8270104212831,RIMS2;RUFY3;MAPT;TGFBR1,beta,3
chordate embryonic development (GO:0043009),3/57,3,57,0.0223190820247597,1,0,0,4.98877525567473,18.9688863568858,LIG4;TGFBR1;VEGFA,beta,3
intrinsic apoptotic signaling pathway (GO:0097193),4/102,4,102,0.0229506235281198,1,0,0,3.71712666109098,14.0299606871607,CEBPB;DDIT3;TRIB3;MAP3K5,beta,3
regulation of neurogenesis (GO:0050767),3/58,3,58,0.0233579472946376,1,0,0,4.90276188919758,18.4187841030113,LIG4;CTNNB1;ARNTL,beta,3
cell junction assembly (GO:0034329),3/60,3,60,0.0255133013190706,1,0,0,4.739336492891,17.3865182107045,CDH6;CTNNB1;ACTG1,beta,3
viral life cycle (GO:0019058),4/108,4,108,0.0275815710058232,1,0,0,3.5106196243637,12.6052569649351,HSP90AB1;VPS4A;KPNA4;DEK,beta,3
cellular response to starvation (GO:0009267),4/108,4,108,0.0275815710058232,1,0,0,3.5106196243637,12.6052569649351,GABARAPL1;EIF2AK4;GABARAP;MAP3K5,beta,3
glycosaminoglycan metabolic process (GO:0030203),3/62,3,62,0.0277720007041905,1,0,0,4.58645467053967,16.4366011377541,EXT1;UGDH;SDC2,beta,3
regulation of nucleic acid-templated transcription (GO:1903506),12/608,12,608,0.0282545963713747,1,0,0,1.87079072087802,6.67217348069274,CEBPB;NFIL3;DDIT3;USP3;PRDM2;BAZ2B;HIVEP2;BAZ1A;NR3C1;TGFBR1;ARNTL;NFKB2,beta,3
positive regulation of microtubule polymerization (GO:0031116),2/25,2,25,0.0283398242446095,1,0,0,7.58293838862559,27.021704238188,PSRC1;MAPT,beta,3
regulation of chromosome organization (GO:0033044),2/25,2,25,0.0283398242446095,1,0,0,7.58293838862559,27.021704238188,LIG4;MAPT,beta,3
positive regulation of microtubule polymerization or depolymerization (GO:0031112),2/25,2,25,0.0283398242446095,1,0,0,7.58293838862559,27.021704238188,PSRC1;MAPT,beta,3
negative regulation of intracellular signal transduction (GO:1902532),5/162,5,162,0.0288266474112889,1,0,0,2.92551635363642,10.3752122821676,EPM2A;PHLPP2;DDIT3;TRIB3;ARNTL,beta,3
positive regulation of type I interferon production (GO:0032481),3/63,3,63,0.0289400142140246,1,0,0,4.51365380275333,15.9897543065852,SETD2;CTNNB1;NFKB2,beta,3
macroautophagy (GO:0016236),4/111,4,111,0.030091243655692,1,0,0,3.41573801289441,11.9671100567803,GABARAPL1;LIX1L;VPS4A;GABARAP,beta,3
respiratory tube development (GO:0030323),2/26,2,26,0.0304917791232681,1,0,0,7.29128691213999,25.4487653564886,HECA;VEGFA,beta,3
protein depolymerization (GO:0051261),2/26,2,26,0.0304917791232681,1,0,0,7.29128691213999,25.4487653564886,VPS4A;DSTN,beta,3
regulation of nervous system development (GO:0051960),2/26,2,26,0.0304917791232681,1,0,0,7.29128691213999,25.4487653564886,CTNNB1;ARNTL,beta,3
positive regulation of nitric oxide biosynthetic process (GO:0045429),2/26,2,26,0.0304917791232681,1,0,0,7.29128691213999,25.4487653564886,HSP90AB1;KLF4,beta,3
positive regulation of nitric oxide metabolic process (GO:1904407),2/26,2,26,0.0304917791232681,1,0,0,7.29128691213999,25.4487653564886,HSP90AB1;KLF4,beta,3
negative regulation of gene expression (GO:0010629),12/619,12,619,0.0317939663289258,1,0,0,1.83754565152478,6.33673712276976,MEX3B;ZEB1;SHQ1;ATXN1;DDIT3;CTNNB1;TRIB3;MAPT;KLF4;ZNF674;ARNTL;VEGFA,beta,3
response to growth factor (GO:0070848),2/27,2,27,0.0327063946551004,1,0,0,7.0212392487274,24.013934807762,CTNNB1;KLF4,beta,3
regulation of supramolecular fiber organization (GO:1902903),2/27,2,27,0.0327063946551004,1,0,0,7.0212392487274,24.013934807762,RDX;MAPT,beta,3
positive regulation of cellular protein localization (GO:1903829),3/67,3,67,0.033868538805556,1,0,0,4.24418193393223,14.3676964886841,HSP90AB1;RUFY3;MAPT,beta,3
transcription from RNA polymerase II promoter (GO:0006366),10/486,10,486,0.0339953414974397,1,0,0,1.95034423575761,6.59515101229603,NFAT5;SETD2;CEBPB;DDIT3;SRF;EAF2;HIVEP2;DEK;NR3C1;KLF4,beta,3
cellular response to oxidative stress (GO:0034599),4/116,4,116,0.0345650948501107,1,0,0,3.26850792613172,10.9982380306591,VRK2;MAPT;FOXO3;ARNTL,beta,3
negative regulation of cell-matrix adhesion (GO:0001953),2/28,2,28,0.0349821227117974,1,0,0,6.77048070412999,22.7008674857686,ADAM15;PHLDB2,beta,3
regulation of cilium assembly (GO:1902017),2/28,2,28,0.0349821227117974,1,0,0,6.77048070412999,22.7008674857686,CEP120;TBC1D30,beta,3
protein targeting to vacuole (GO:0006623),2/28,2,28,0.0349821227117974,1,0,0,6.77048070412999,22.7008674857686,SCARB2;VPS4A,beta,3
regulation of protein localization to cell surface (GO:2000008),2/28,2,28,0.0349821227117974,1,0,0,6.77048070412999,22.7008674857686,HSP90AB1;CTNNB1,beta,3
positive regulation of synaptic transmission (GO:0050806),3/68,3,68,0.03516443227193,1,0,0,4.18176749372735,13.9993873182762,RIMS2;UNC13B;EIF2AK4,beta,3
positive regulation of autophagy (GO:0010508),3/68,3,68,0.03516443227193,1,0,0,4.18176749372735,13.9993873182762,EPM2A;EIF2AK4;TRIM65,beta,3
regulation of protein localization to plasma membrane (GO:1903076),3/68,3,68,0.03516443227193,1,0,0,4.18176749372735,13.9993873182762,VPS4A;RHOQ;SPTBN1,beta,3
regulation of epithelial to mesenchymal transition (GO:0010717),3/69,3,69,0.0364856622783341,1,0,0,4.1211621677313,13.6444916952716,CTNNB1;PHLDB2;TGFBR1,beta,3
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),3/69,3,69,0.0364856622783341,1,0,0,4.1211621677313,13.6444916952716,TRIAP1;KLF4;VEGFA,beta,3
neuron projection extension (GO:1990138),2/29,2,29,0.0373174405791644,1,0,0,6.53701585226344,21.4956331803431,CTNNB1;EIF2AK4,beta,3
acute inflammatory response (GO:0002526),2/29,2,29,0.0373174405791644,1,0,0,6.53701585226344,21.4956331803431,CEBPB;IL6R,beta,3
positive regulation of sprouting angiogenesis (GO:1903672),2/29,2,29,0.0373174405791644,1,0,0,6.53701585226344,21.4956331803431,KLF4;VEGFA,beta,3
regulation of signal transduction (GO:0009966),6/234,6,234,0.0381432588044449,1,0,0,2.43042897071333,7.93876835396533,EPHA5;SAMD5;SCARB2;USP20;ABRACL;CD55,beta,3
vascular endothelial growth factor receptor signaling pathway (GO:0048010),3/71,3,71,0.0392037383831573,1,0,0,4.00507309258394,12.9723643407606,ELMO1;ACTG1;VEGFA,beta,3
negative regulation of cysteine-type endopeptidase activity (GO:2000117),3/73,3,73,0.0420219134870527,1,0,0,3.89534506265013,12.3465456615117,TRIAP1;KLF4;VEGFA,beta,3
cell-cell junction organization (GO:0045216),3/73,3,73,0.0420219134870527,1,0,0,3.89534506265013,12.3465456615117,CDH6;SDK1;PERP,beta,3
glycoprotein biosynthetic process (GO:0009101),3/73,3,73,0.0420219134870527,1,0,0,3.89534506265013,12.3465456615117,FUT5;FUT9;ALG3,beta,3
protein localization to lysosome (GO:0061462),2/31,2,31,0.0421608798642322,1,0,0,6.1152728940529,19.3625592742506,SCARB2;VPS4A,beta,3
regulation of cell migration involved in sprouting angiogenesis (GO:0090049),2/31,2,31,0.0421608798642322,1,0,0,6.1152728940529,19.3625592742506,KLF4;VEGFA,beta,3
regulation of defense response to virus by host (GO:0050691),2/31,2,31,0.0421608798642322,1,0,0,6.1152728940529,19.3625592742506,TRAF3IP2;EIF2AK4,beta,3
artery morphogenesis (GO:0048844),2/31,2,31,0.0421608798642322,1,0,0,6.1152728940529,19.3625592742506,TGFBR1;VEGFA,beta,3
nuclear envelope organization (GO:0006998),2/31,2,31,0.0421608798642322,1,0,0,6.1152728940529,19.3625592742506,SUN2;VPS4A,beta,3
cyclic purine nucleotide metabolic process (GO:0052652),2/31,2,31,0.0421608798642322,1,0,0,6.1152728940529,19.3625592742506,ADM;AMPD2,beta,3
activation of JUN kinase activity (GO:0007257),2/31,2,31,0.0421608798642322,1,0,0,6.1152728940529,19.3625592742506,TAOK1;MAP3K5,beta,3
positive regulation of reactive oxygen species biosynthetic process (GO:1903428),2/31,2,31,0.0421608798642322,1,0,0,6.1152728940529,19.3625592742506,HSP90AB1;KLF4,beta,3
positive regulation of cell motility (GO:2000147),5/180,5,180,0.042333090987824,1,0,0,2.63296471827278,8.32592471275701,SUN2;RUFY3;RDX;TGFBR1;VEGFA,beta,3
ER to Golgi vesicle-mediated transport (GO:0006888),5/181,5,181,0.0431783333358537,1,0,0,2.61841795187348,8.22815965200818,DCTN6;USO1;HYOU1;SPTBN1;CD55,beta,3
negative regulation of cell-cell adhesion (GO:0022408),2/32,2,32,0.0446660797307103,1,0,0,5.92417061611374,18.4155267070077,RDX;KLF4,beta,3
organelle transport along microtubule (GO:0072384),2/32,2,32,0.0446660797307103,1,0,0,5.92417061611374,18.4155267070077,RHOT1;MAPT,beta,3
liver development (GO:0001889),2/32,2,32,0.0446660797307103,1,0,0,5.92417061611374,18.4155267070077,CEBPB;CEBPG,beta,3
positive regulation of apoptotic process (GO:0043065),7/308,7,308,0.0454233605479971,1,0,0,2.154243860405,6.66033769227637,UNC13B;SHQ1;DDIT3;CTNNB1;FOXO3;TGFBR1;MAP3K5,beta,3
cAMP-mediated signaling (GO:0019933),3/76,3,76,0.0464347454680867,1,0,0,3.74158144175605,11.4855597726467,RIMS2;EPHA5;ADM,beta,3
central nervous system neuron differentiation (GO:0021953),2/33,2,33,0.0472250256245193,1,0,0,5.74465029441333,17.5374483584073,CTNNB1;MAPT,beta,3
negative regulation of fat cell differentiation (GO:0045599),2/33,2,33,0.0472250256245193,1,0,0,5.74465029441333,17.5374483584073,TRIB3;ARNTL,beta,3
regulation of nitric oxide biosynthetic process (GO:0045428),2/33,2,33,0.0472250256245193,1,0,0,5.74465029441333,17.5374483584073,HSP90AB1;KLF4,beta,3
cyclic-nucleotide-mediated signaling (GO:0019935),2/33,2,33,0.0472250256245193,1,0,0,5.74465029441333,17.5374483584073,RIMS2;EPHA5,beta,3
vasculogenesis (GO:0001570),2/33,2,33,0.0472250256245193,1,0,0,5.74465029441333,17.5374483584073,ADM;VEGFA,beta,3
positive regulation of JNK cascade (GO:0046330),3/77,3,77,0.0479546435440433,1,0,0,3.69298947498,11.2174542043362,UNC5CL;TAOK1;MAP3K5,beta,3
regulation of cytokinesis (GO:0032465),3/78,3,78,0.0494987811630432,1,0,0,3.64564345607,10.9581014680258,SETD2;VPS4A;RAB11FIP4,beta,3
negative regulation of mitochondrion organization (GO:0010823),2/34,2,34,0.0498363166140857,1,0,0,5.57568999163647,16.7215573540326,TRIAP1;MAPT,beta,3
positive regulation of cell-matrix adhesion (GO:0001954),2/34,2,34,0.0498363166140857,1,0,0,5.57568999163647,16.7215573540326,UTRN;VEGFA,beta,3
generation of neurons (GO:0048699),4/131,4,131,0.0501878391314539,1,0,0,2.89425129336855,8.6595493072139,CTNNB1;MAPT;POU3F2;ARNTL,beta,3
protein glycosylation (GO:0006486),4/131,4,131,0.0501878391314539,1,0,0,2.89425129336855,8.6595493072139,GALNT7;FUT5;FUT9;ALG3,beta,3
protein complex assembly (GO:0006461),5/190,5,190,0.0512421364110932,1,0,0,2.49438762783737,7.41130733005043,KHDRBS3;DDIT3;USO1;CTNNB1;MAPT,beta,3
epithelial tube morphogenesis (GO:0060562),2/35,2,35,0.05249857510947,1,0,0,5.41638456330399,15.9619187570745,CTNNB1;VEGFA,beta,3
regulation of double-strand break repair (GO:2000779),2/35,2,35,0.05249857510947,1,0,0,5.41638456330399,15.9619187570745,SETD2;DEK,beta,3
positive regulation of leukocyte migration (GO:0002687),2/35,2,35,0.05249857510947,1,0,0,5.41638456330399,15.9619187570745,IL6R;VEGFA,beta,3
regulation of axon extension (GO:0030516),2/35,2,35,0.05249857510947,1,0,0,5.41638456330399,15.9619187570745,RUFY3;MAPT,beta,3
cellular response to organic substance (GO:0071310),4/134,4,134,0.0537083415917048,1,0,0,2.82945462262149,8.27385429052159,NCOA1;CTNNB1;MAPK6;KLF4,beta,3
cellular response to hormone stimulus (GO:0032870),3/81,3,81,0.0542751022922038,1,0,0,3.5106196243637,10.2288561647095,NCOA1;RDX;NR3C1,beta,3
regulation of microtubule polymerization (GO:0031113),2/36,2,36,0.0552104465053309,1,0,0,5.26592943654555,15.2533075056309,PSRC1;MAPT,beta,3
erythrocyte differentiation (GO:0030218),2/36,2,36,0.0552104465053309,1,0,0,5.26592943654555,15.2533075056309,CEBPG;VEGFA,beta,3
regulation of phosphoprotein phosphatase activity (GO:0043666),2/36,2,36,0.0552104465053309,1,0,0,5.26592943654555,15.2533075056309,NUAK1;HSP90AB1,beta,3
positive regulation of telomerase activity (GO:0051973),2/36,2,36,0.0552104465053309,1,0,0,5.26592943654555,15.2533075056309,HSP90AB1;KLF4,beta,3
protein kinase B signaling (GO:0043491),2/36,2,36,0.0552104465053309,1,0,0,5.26592943654555,15.2533075056309,CREB1;FOXO3,beta,3
regulation of anatomical structure morphogenesis (GO:0022603),3/83,3,83,0.0575776264596559,1,0,0,3.42602638040313,9.78000759295988,CTNNB1;MAPT;PHLDB2,beta,3
ephrin receptor signaling pathway (GO:0048013),3/83,3,83,0.0575776264596559,1,0,0,3.42602638040313,9.78000759295988,EPHA5;SDC2;ACTG1,beta,3
regulation of cell morphogenesis involved in differentiation (GO:0010769),2/37,2,37,0.0579705988514034,1,0,0,5.12360701934162,14.5911070235243,SDC2;RUFY3,beta,3
regulation of muscle cell differentiation (GO:0051147),2/37,2,37,0.0579705988514034,1,0,0,5.12360701934162,14.5911070235243,SRF;CTNNB1,beta,3
positive regulation of transferase activity (GO:0051347),4/138,4,138,0.0586058122692658,1,0,0,2.7474414451542,7.79427543604746,EPHA5;HSP90AB1;TRIB3;KLF4,beta,3
response to cytokine (GO:0034097),4/139,4,139,0.0598663051428159,1,0,0,2.72767567936172,7.68015670665209,SETD2;SRF;IL6R;NFKB2,beta,3
epithelial to mesenchymal transition (GO:0001837),2/38,2,38,0.0607777225851691,1,0,0,4.98877525567473,13.9712245547611,CTNNB1;TGFBR1,beta,3
regulation of DNA repair (GO:0006282),2/38,2,38,0.0607777225851691,1,0,0,4.98877525567473,13.9712245547611,CEBPG;DEK,beta,3
positive regulation of axonogenesis (GO:0050772),2/38,2,38,0.0607777225851691,1,0,0,4.98877525567473,13.9712245547611,RUFY3;MAPT,beta,3
regulation of neuron differentiation (GO:0045664),3/85,3,85,0.0609732083251561,1,0,0,3.34541399498188,9.35819588204006,ZEB1;TCF12;EIF2AK4,beta,3
regulation of protein localization to early endosome (GO:1902965),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,RDX,beta,3
response to lead ion (GO:0010288),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,MAPT,beta,3
negative regulation of membrane potential (GO:0045837),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,MAPT,beta,3
polyamine biosynthetic process (GO:0006596),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,AMD1,beta,3
positive regulation of axon guidance (GO:1902669),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,VEGFA,beta,3
positive regulation of adaptive immune response (GO:0002821),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,EIF2AK4,beta,3
mesodermal cell fate commitment (GO:0001710),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,KLF4,beta,3
negative regulation of transforming growth factor beta production (GO:0071635),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,HSP90AB1,beta,3
positive regulation of deacetylase activity (GO:0090045),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,VEGFA,beta,3
amylin receptor signaling pathway (GO:0097647),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,ADM,beta,3
negative regulation of translation in response to stress (GO:0032055),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,EIF2AK4,beta,3
positive regulation of protein localization to endosome (GO:1905668),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,RDX,beta,3
plus-end-directed organelle transport along microtubule (GO:0072386),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,MAPT,beta,3
regulation of translational initiation in response to stress (GO:0043558),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,EIF2AK4,beta,3
viral release from host cell (GO:0019076),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,VPS4A,beta,3
positive regulation of protein localization to early endosome (GO:1902966),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,RDX,beta,3
"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,RHOT1,beta,3
negative regulation of cellular response to hypoxia (GO:1900038),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,HYOU1,beta,3
ventricular compact myocardium morphogenesis (GO:0003223),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,TGFBR1,beta,3
"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,EXT1,beta,3
positive regulation of phospholipid transport (GO:2001140),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,TRIAP1,beta,3
negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,ARNTL,beta,3
vascular smooth muscle cell development (GO:0097084),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,VEGFA,beta,3
positive regulation of protein acetylation (GO:1901985),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,ARNTL,beta,3
morphogenesis of an endothelium (GO:0003159),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,CTNNB1,beta,3
"regulation of wound healing, spreading of epidermal cells (GO:1903689)",1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,PHLDB2,beta,3
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,TGFBR1,beta,3
positive regulation of centrosome cycle (GO:0046607),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,CEP120,beta,3
venous blood vessel morphogenesis (GO:0048845),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,VEGFA,beta,3
spermine metabolic process (GO:0008215),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,AMD1,beta,3
regulation of histone deacetylase activity (GO:1901725),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,VEGFA,beta,3
surfactant homeostasis (GO:0043129),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,VEGFA,beta,3
regulation of ribonucleoprotein complex localization (GO:2000197),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,SETD2,beta,3
nucleus localization (GO:0051647),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,SUN2,beta,3
cellular response to cold (GO:0070417),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,EIF2AK4,beta,3
negative regulation of complement activation (GO:0045916),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,CD55,beta,3
negative regulation of cell size (GO:0045792),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,RDX,beta,3
nucleoside phosphate catabolic process (GO:1901292),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,SMPDL3A,beta,3
regulation of mRNA export from nucleus (GO:0010793),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,SETD2,beta,3
astrocyte activation (GO:0048143),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,MAPT,beta,3
embryonic skeletal joint morphogenesis (GO:0060272),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,CTNNB1,beta,3
L-amino acid import (GO:0043092),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,SLC1A1,beta,3
single strand break repair (GO:0000012),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,LIG4,beta,3
chemical homeostasis within a tissue (GO:0048875),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,VEGFA,beta,3
lymphoid progenitor cell differentiation (GO:0002320),1/6,1,6,0.0616610081887082,1,0,0,15.7977883096367,44.0142733946931,LIG4,beta,3
negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),4/141,4,141,0.0624303846042477,1,0,0,2.68898524419347,7.4584469479605,DDIT3;CEBPG;EIF2AK4;KLF4,beta,3
mitochondrion disassembly (GO:0061726),2/39,2,39,0.063630530111517,1,0,0,4.86085794142666,13.3900201269422,GABARAPL1;GABARAP,beta,3
positive regulation of fat cell differentiation (GO:0045600),2/40,2,40,0.06652775558227,1,0,0,4.739336492891,12.8442466408576,CEBPB;CREB1,beta,3
mitotic DNA damage checkpoint (GO:0044773),2/40,2,40,0.06652775558227,1,0,0,4.739336492891,12.8442466408576,MDC1;TAOK1,beta,3
cellular response to amino acid starvation (GO:0034198),2/40,2,40,0.06652775558227,1,0,0,4.739336492891,12.8442466408576,EIF2AK4;MAP3K5,beta,3
neuron development (GO:0048666),4/145,4,145,0.0677297319998543,1,0,0,2.61480634090538,7.03966013440875,EPHA5;SRF;MAPT;POU3F2,beta,3
positive regulation of protein complex assembly (GO:0031334),3/89,3,89,0.0680377291152991,1,0,0,3.19505830981415,8.58733549520823,UNC13B;CTNNB1;VEGFA,beta,3
androgen receptor signaling pathway (GO:0030521),2/41,2,41,0.069468154542925,1,0,0,4.62374291989365,12.3309991420008,NCOA1;CTNNB1,beta,3
negative regulation of TOR signaling (GO:0032007),2/41,2,41,0.069468154542925,1,0,0,4.62374291989365,12.3309991420008,EPM2A;ARNTL,beta,3
positive regulation of epithelial to mesenchymal transition (GO:0010718),2/41,2,41,0.069468154542925,1,0,0,4.62374291989365,12.3309991420008,CTNNB1;TGFBR1,beta,3
autophagy of mitochondrion (GO:0000422),2/41,2,41,0.069468154542925,1,0,0,4.62374291989365,12.3309991420008,GABARAPL1;GABARAP,beta,3
ubiquitin-dependent protein catabolic process (GO:0006511),7/342,7,342,0.0711806057616306,1,0,0,1.94007926609573,5.1267271474194,TRIM9;DDIT3;VPS4A;CTNNB1;UBE2G1;ARNTL;RNF187,beta,3
regulation of cyclic nucleotide metabolic process (GO:0030799),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,VEGFA,beta,3
adherens junction assembly (GO:0034333),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,CTNNB1,beta,3
purine nucleotide biosynthetic process (GO:0006164),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,AMPD2,beta,3
intracellular sterol transport (GO:0032366),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,VPS4A,beta,3
modulation by symbiont of host cellular process (GO:0044068),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,KPNA4,beta,3
positive regulation of lipid transport (GO:0032370),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,TRIAP1,beta,3
regulation of myosin-light-chain-phosphatase activity (GO:0035507),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,NUAK1,beta,3
regulation of chromatin assembly or disassembly (GO:0001672),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,TLK1,beta,3
regulation of glucocorticoid receptor signaling pathway (GO:2000322),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,ARNTL,beta,3
hemostasis (GO:0007599),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,HPS4,beta,3
regulation of cardiac muscle cell membrane potential (GO:0086036),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,ATP2A2,beta,3
ornithine transport (GO:0015822),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,SLC7A1,beta,3
cellular response to laminar fluid shear stress (GO:0071499),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,KLF4,beta,3
positive regulation of cellular senescence (GO:2000774),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,ARG2,beta,3
pri-miRNA transcription from RNA polymerase II promoter (GO:0061614),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,KLF4,beta,3
positive regulation of protein kinase C signaling (GO:0090037),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,VEGFA,beta,3
V(D)J recombination (GO:0033151),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,LIG4,beta,3
positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,VEGFA,beta,3
cellular response to histamine (GO:0071420),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,GABRB3,beta,3
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,HYOU1,beta,3
cytoplasmic sequestering of NF-kappaB (GO:0007253),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,G3BP2,beta,3
negative regulation of cytokinesis (GO:0032466),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,VPS4A,beta,3
positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,VEGFA,beta,3
regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,SRF,beta,3
exit from host cell (GO:0035891),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,VPS4A,beta,3
protein maturation by iron-sulfur cluster transfer (GO:0097428),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,ISCA1,beta,3
regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,DDIT3,beta,3
spermidine metabolic process (GO:0008216),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,AMD1,beta,3
store-operated calcium entry (GO:0002115),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,STIM2,beta,3
regulation of smooth muscle cell differentiation (GO:0051150),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,SRF,beta,3
regulation of transcription involved in cell fate commitment (GO:0060850),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,CEBPB,beta,3
response to type I interferon (GO:0034340),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,SETD2,beta,3
calcitonin family receptor signaling pathway (GO:0097646),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,ADM,beta,3
neuron fate specification (GO:0048665),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,POU3F2,beta,3
"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,CD55,beta,3
vascular endothelial growth factor signaling pathway (GO:0038084),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,VEGFA,beta,3
microglial cell activation (GO:0001774),1/7,1,7,0.0715634350434597,1,0,0,13.54096140826,35.7098309980969,MAPT,beta,3
regulation of JNK cascade (GO:0046328),3/91,3,91,0.0717036110769141,1,0,0,3.12483724806,8.23461539175047,UNC5CL;TAOK1;MAP3K5,beta,3
mesenchymal cell differentiation (GO:0048762),2/42,2,42,0.072450503610291,1,0,0,4.51365380275333,11.847671672746,CTNNB1;TGFBR1,beta,3
regulation of calcium-mediated signaling (GO:0050848),2/42,2,42,0.072450503610291,1,0,0,4.51365380275333,11.847671672746,TMBIM4;MAPT,beta,3
regulation of telomerase activity (GO:0051972),2/43,2,43,0.0754736002209976,1,0,0,4.40868510966604,11.3919204224473,HSP90AB1;KLF4,beta,3
negative regulation of cell differentiation (GO:0045596),4/151,4,151,0.0761008696007005,1,0,0,2.51090675120053,6.46733143868914,IQCB1;TRIB3;TGFBR1;ARNTL,beta,3
mitotic metaphase plate congression (GO:0007080),2/44,2,44,0.0785362622748025,1,0,0,4.30848772081,10.9616321458368,PSRC1;VPS4A,beta,3
branching morphogenesis of an epithelial tube (GO:0048754),2/44,2,44,0.0785362622748025,1,0,0,4.30848772081,10.9616321458368,CTNNB1;VEGFA,beta,3
regulation of multicellular organismal development (GO:2000026),2/44,2,44,0.0785362622748025,1,0,0,4.30848772081,10.9616321458368,PHLDB2;TGFBR1,beta,3
regulation of intracellular signal transduction (GO:1902531),8/423,8,423,0.0802702906951224,1,0,0,1.79265682946231,4.52171818158023,ARHGAP10;NUAK1;RHOT1;TMBIM4;ABRACL;MAPT;VRK2;RHOQ,beta,3
positive regulation of extracellular matrix assembly (GO:1901203),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,PHLDB2,beta,3
phospholipid homeostasis (GO:0055091),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,LIPG,beta,3
regulation of establishment of protein localization to mitochondrion (GO:1903747),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,MAPT,beta,3
positive regulation of cell aging (GO:0090343),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,ARG2,beta,3
stress-induced premature senescence (GO:0090400),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,ARNTL,beta,3
establishment of integrated proviral latency (GO:0075713),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,LIG4,beta,3
ventricular trabecula myocardium morphogenesis (GO:0003222),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,TGFBR1,beta,3
amyloid fibril formation (GO:1990000),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,MAPT,beta,3
cytoskeletal anchoring at nuclear membrane (GO:0090286),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,SUN2,beta,3
organophosphate catabolic process (GO:0046434),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,LIPG,beta,3
lagging strand elongation (GO:0006273),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,LIG4,beta,3
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,RHOT1,beta,3
desmosome organization (GO:0002934),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,PERP,beta,3
negative regulation of cilium assembly (GO:1902018),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,TBC1D30,beta,3
positive regulation of early endosome to late endosome transport (GO:2000643),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,RDX,beta,3
regulation of long term synaptic depression (GO:1900452),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,MAPT,beta,3
desensitization of G-protein coupled receptor protein signaling pathway (GO:0002029),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,ADM,beta,3
peptidyl-lysine monomethylation (GO:0018026),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,SETD2,beta,3
regulation of positive chemotaxis (GO:0050926),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,VEGFA,beta,3
aldehyde biosynthetic process (GO:0046184),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,TPI1,beta,3
dimeric G-protein coupled receptor signaling pathway (GO:0038042),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,ADM,beta,3
positive regulation of protein localization to cell surface (GO:2000010),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,HSP90AB1,beta,3
arginine catabolic process (GO:0006527),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,ARG2,beta,3
regulation of receptor binding (GO:1900120),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,ADAM15,beta,3
ketone biosynthetic process (GO:0042181),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,ADM,beta,3
angiogenesis involved in wound healing (GO:0060055),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,SRF,beta,3
negative regulation of establishment of protein localization (GO:1904950),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,MAPT,beta,3
regulation of type B pancreatic cell development (GO:2000074),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,ARNTL,beta,3
regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),1/8,1,8,0.0813618516395449,1,0,0,11.8483412322275,29.7256963140126,ATP2A2,beta,3
protein oligomerization (GO:0051259),5/218,5,218,0.0815910761295861,1,0,0,2.17400756554633,5.44813988466776,KHDRBS3;DDIT3;BEND3;MAPT;AASS,beta,3
regulation of focal adhesion assembly (GO:0051893),2/45,2,45,0.0816373278649919,1,0,0,4.21274354923644,10.5548969869794,PHLDB2;VEGFA,beta,3
sprouting angiogenesis (GO:0002040),2/45,2,45,0.0816373278649919,1,0,0,4.21274354923644,10.5548969869794,SRF;VEGFA,beta,3
cholesterol transport (GO:0030301),2/45,2,45,0.0816373278649919,1,0,0,4.21274354923644,10.5548969869794,VPS4A;LIPG,beta,3
adherens junction organization (GO:0034332),2/45,2,45,0.0816373278649919,1,0,0,4.21274354923644,10.5548969869794,CDH6;CTNNB1,beta,3
microtubule cytoskeleton organization involved in mitosis (GO:1902850),2/45,2,45,0.0816373278649919,1,0,0,4.21274354923644,10.5548969869794,SUN2;SETD2,beta,3
metaphase plate congression (GO:0051310),2/45,2,45,0.0816373278649919,1,0,0,4.21274354923644,10.5548969869794,PSRC1;VPS4A,beta,3
regulation of smooth muscle cell proliferation (GO:0048660),2/45,2,45,0.0816373278649919,1,0,0,4.21274354923644,10.5548969869794,CTNNB1;IL6R,beta,3
protein polymerization (GO:0051258),2/46,2,46,0.0847756550140264,1,0,0,4.1211621677313,10.1699850175166,GPX4;MAPT,beta,3
mitochondrial gene expression (GO:0140053),2/46,2,46,0.0847756550140264,1,0,0,4.1211621677313,10.1699850175166,GATC;FOXO3,beta,3
nucleus organization (GO:0006997),2/46,2,46,0.0847756550140264,1,0,0,4.1211621677313,10.1699850175166,SUN2;VPS4A,beta,3
positive regulation of cytokine production (GO:0001819),5/221,5,221,0.0853085994988455,1,0,0,2.14449615062941,5.27863441660721,CEBPB;DDIT3;CTNNB1;IL6R;NFKB2,beta,3
positive regulation of cell migration (GO:0030335),5/222,5,222,0.0865673612428765,1,0,0,2.13483625805901,5.22358657917008,SUN2;RUFY3;RDX;TGFBR1;VEGFA,beta,3
positive regulation of neuron differentiation (GO:0045666),3/99,3,99,0.087219894037928,1,0,0,2.87232514720666,7.00652831093203,SCARB2;ZEB1;TCF12,beta,3
regulation of G1/S transition of mitotic cell cycle (GO:2000045),2/47,2,47,0.0879501213173915,1,0,0,4.03347786629021,9.80532591876194,RDX;KLF4,beta,3
regulation of fibroblast proliferation (GO:0048145),2/47,2,47,0.0879501213173915,1,0,0,4.03347786629021,9.80532591876194,LIG4;CTNNB1,beta,3
regulation of cellular component movement (GO:0051270),2/47,2,47,0.0879501213173915,1,0,0,4.03347786629021,9.80532591876194,TGFBR1;VEGFA,beta,3
axon guidance (GO:0007411),4/159,4,159,0.088030843116676,1,0,0,2.38457182032251,5.79467175999037,EPHA5;CREB1;SPTBN1;VEGFA,beta,3
Ras protein signal transduction (GO:0007265),5/224,5,224,0.0891140900585074,1,0,0,2.11577522004062,5.11560134441933,RHOT1;ELMO1;G3BP2;RALGDS;RHOQ,beta,3
glycosaminoglycan biosynthetic process (GO:0006024),3/100,3,100,0.0892518307965823,1,0,0,2.8436018957346,6.87097633764684,EXT1;UGDH;SDC2,beta,3
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),6/292,6,292,0.0896746956599251,1,0,0,1.94767253132507,4.69694212045972,TRIM9;DDIT3;CTNNB1;STT3B;ARNTL;RNF187,beta,3
acidic amino acid transport (GO:0015800),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,SLC1A1,beta,3
negative regulation of protein sumoylation (GO:0033234),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,CTNNB1,beta,3
regulation of protein acetylation (GO:1901983),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,ARNTL,beta,3
ornithine metabolic process (GO:0006591),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,ARG2,beta,3
ATF6-mediated unfolded protein response (GO:0036500),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,DDIT3,beta,3
lactation (GO:0007595),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,VEGFA,beta,3
negative regulation of heterotypic cell-cell adhesion (GO:0034115),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,KLF4,beta,3
regulation of cell-cell adhesion involved in gastrulation (GO:0070587),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,KLF4,beta,3
negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,SRF,beta,3
sarcoplasmic reticulum calcium ion transport (GO:0070296),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,ATP2A2,beta,3
endothelial cell chemotaxis (GO:0035767),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,VEGFA,beta,3
regulation of endothelial cell differentiation (GO:0045601),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,ZEB1,beta,3
positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,NAMPT,beta,3
positive regulation of long-term synaptic potentiation (GO:1900273),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,EIF2AK4,beta,3
nuclear migration (GO:0007097),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,SUN2,beta,3
Cdc42 protein signal transduction (GO:0032488),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,RHOQ,beta,3
somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,LIG4,beta,3
regulation of hair cycle (GO:0042634),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,ARNTL,beta,3
small nucleolar ribonucleoprotein complex assembly (GO:0000491),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,SHQ1,beta,3
central nervous system neuron development (GO:0021954),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,MAPT,beta,3
regulation of homotypic cell-cell adhesion (GO:0034110),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,RDX,beta,3
establishment of viral latency (GO:0019043),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,LIG4,beta,3
negative regulation of transcription by competitive promoter binding (GO:0010944),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,CREB1,beta,3
axonal transport of mitochondrion (GO:0019896),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,MAPT,beta,3
protein polyglutamylation (GO:0018095),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,TTLL4,beta,3
regulation of skeletal muscle cell differentiation (GO:2001014),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,ARNTL,beta,3
regulation of nephron tubule epithelial cell differentiation (GO:0072182),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,CTNNB1,beta,3
peptidyl-amino acid modification (GO:0018193),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,TTLL4,beta,3
histone H3-K4 trimethylation (GO:0080182),1/9,1,9,0.0910573449576174,1,0,0,10.5318588730911,25.2371332971675,BEND3,beta,3
histone H4 acetylation (GO:0043967),2/48,2,48,0.0911596237428239,1,0,0,3.94944707740916,9.4594913193143,BEND3;YEATS4,beta,3
cellular response to heat (GO:0034605),2/48,2,48,0.0911596237428239,1,0,0,3.94944707740916,9.4594913193143,HYOU1;MAPT,beta,3
regulation of protein ubiquitination (GO:0031396),3/102,3,102,0.0933748667334815,1,0,0,2.78784499581823,6.61035144340278,DNAJB2;HSP90AB1;TGFBR1,beta,3
negative regulation of mitotic cell cycle (GO:0045930),2/49,2,49,0.0944030782927844,1,0,0,3.86884611664571,9.13117940740347,CTNNB1;HECA,beta,3
cytoplasmic microtubule organization (GO:0031122),2/49,2,49,0.0944030782927844,1,0,0,3.86884611664571,9.13117940740347,VPS4A;MAPT,beta,3
protein K48-linked ubiquitination (GO:0070936),2/49,2,49,0.0944030782927844,1,0,0,3.86884611664571,9.13117940740347,UBE2G1;RNF187,beta,3
positive regulation of chemotaxis (GO:0050921),2/49,2,49,0.0944030782927844,1,0,0,3.86884611664571,9.13117940740347,IL6R;VEGFA,beta,3
glycoprotein metabolic process (GO:0009100),2/49,2,49,0.0944030782927844,1,0,0,3.86884611664571,9.13117940740347,MAN1A2;STT3B,beta,3
cellular macromolecule catabolic process (GO:0044265),2/49,2,49,0.0944030782927844,1,0,0,3.86884611664571,9.13117940740347,UBE2G1;STT3B,beta,3
regulation of mitochondrion organization (GO:0010821),2/49,2,49,0.0944030782927844,1,0,0,3.86884611664571,9.13117940740347,RHOT1;MAPT,beta,3
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),9/513,9,513,0.0944732009027471,1,0,0,1.66292508522491,3.92357042160461,MEX3B;ZEB1;ATXN1;DDIT3;CTNNB1;TRIB3;KLF4;ZNF674;ARNTL,beta,3
regulation of protein kinase B signaling (GO:0051896),4/164,4,164,0.0959191115705293,1,0,0,2.31187145994683,5.41960474048762,PHLPP2;DDIT3;TRIB3;TGFBR1,beta,3
non-recombinational repair (GO:0000726),2/50,2,50,0.0976794197642294,1,0,0,3.7914691943128,8.81920147627288,MDC1;LIG4,beta,3
negative regulation of nucleic acid-templated transcription (GO:1903507),8/445,8,445,0.0999992024054513,1,0,0,1.70403109856755,3.92369019687326,ZEB1;ATXN1;DDIT3;CTNNB1;TRIB3;KLF4;ZNF674;ARNTL,beta,3
liver development (GO:0001889),4/32,4,32,0.000113473729215286,0.289528220092803,0,0,15.8227848101266,143.733215324244,PROX1;MET;E2F7;PCK2,beta,4
cellular protein modification process (GO:0006464),19/1002,19,1002,0.000361576798577991,0.461281600785872,0,0,2.40026276560802,19.0221690542786,DUSP4;ATG3;MAP2K1;UBE2I;DAPK1;KLHL21;LAMC1;SSH2;FBXO11;LTBP1;CP;DCAF6;ICK;RPS6KA5;TNIK;CDK13;SGK1;FBXO7;FRK,beta,4
negative regulation of cellular process (GO:0048523),14/535,14,535,9.16186065282658e-05,0.46752974911374,0,0,3.3124334555779,30.7985961207233,CD164;MAP2K1;TES;SMAD3;PROX1;ETS1;RTN4;DCBLD2;DLL4;REST;SESN2;TMBIM6;E2F7;FRK,beta,4
cellular response to glucocorticoid stimulus (GO:0071385),3/17,3,17,0.000303237949857023,0.515807752706795,0,0,22.3380491437081,180.960374108542,REST;KLF9;PCK2,beta,4
"positive regulation of transcription, DNA-templated (GO:0045893)",20/1121,20,1121,0.000547328868740694,0.558603843436752,0,0,2.25838141803769,16.9614849165946,MAP2K1;SMAD3;PROX1;ETS1;DCAF6;RUNX1;FOSL2;ADCYAP1;ZNF609;REST;RPS6KA5;MAPRE3;MAML3;CDK13;ATXN7L3;SQSTM1;MET;ATF3;E2F7;CREB5,beta,4
retinal ganglion cell axon guidance (GO:0031290),2/6,2,6,0.000911066241455874,0.581146378768666,0,0,42.1940928270042,295.396411411114,ROBO2;ALCAM,beta,4
positive regulation of calcium ion transmembrane transport (GO:1904427),3/26,3,26,0.00110054832033854,0.624010897631954,0,0,14.6056475170399,99.4928931402997,CACNB2;ANK2;SNCA,beta,4
regulation of transcription from RNA polymerase II promoter (GO:0006357),23/1479,23,1479,0.00136252801485605,0.632089132710039,0,0,1.96848708929229,12.9888917260506,SMAD3;UBE2I;SARS;PROX1;ETS1;DCAF6;RUNX1;FOSL2;DLL4;ADCYAP1;ZNF609;REST;RPS6KA5;KLF9;MAML3;CDK13;SQSTM1;ZNF367;MET;ATF3;E2F7;FRK;SNCA,beta,4
cardiac atrium development (GO:0003230),2/7,2,7,0.00126887853971689,0.647508718817528,0,0,36.1663652802893,241.215978597243,DLL4;ANK2,beta,4
negative regulation of calcium ion-dependent exocytosis (GO:0045955),2/6,2,6,0.000911066241455874,0.664167290021332,0,0,42.1940928270042,295.396411411114,SYT4;REST,beta,4
regulation of cell proliferation (GO:0042127),15/741,15,741,0.000802824917213055,0.682802592089703,0,0,2.56239430123507,18.2631422734588,CD164;MAP2K1;TIPIN;TES;IRS2;PROX1;GAB2;ETS1;DLL4;ZNF609;REST;CDK13;SGK1;E2F7;FRK,beta,4
axon guidance (GO:0007411),6/159,6,159,0.00167099781600283,0.710591821255202,0,0,4.77668975400048,30.5437513081913,ROBO2;RPS6KA5;ALCAM;IRS2;NCAM1;GAB2,beta,4
positive regulation of kinase activity (GO:0033674),5/114,5,114,0.00212312526447578,0.833408324970762,0,0,5.55185431934266,34.1709199116163,ADCYAP1;LMO4;TYRO3;MAPRE3;MET,beta,4
negative regulation of cell proliferation (GO:0008285),9/364,9,364,0.00247744585707686,0.903029014904514,0,0,3.12978161079427,18.7803395161621,DLL4;CD164;MAP2K1;REST;TES;PROX1;ETS1;E2F7;FRK,beta,4
regulation of transforming growth factor beta production (GO:0071634),2/10,2,10,0.00267699186437855,0.910712632261582,0,0,25.3164556962025,149.950925405826,SMAD3;PTGS2,beta,4
positive regulation of transport (GO:0051050),3/45,3,45,0.00538352787682693,0.947315267429236,0,0,8.43881856540084,44.0878597512597,C2CD5;SGK1;SNCA,beta,4
positive regulation of transcription from RNA polymerase II promoter (GO:0045944),15/849,15,849,0.00302726792411765,0.965509263548274,0,0,2.23643601556559,12.9715407734114,SMAD3;PROX1;ETS1;DCAF6;RUNX1;FOSL2;ADCYAP1;ZNF609;RPS6KA5;MAML3;CDK13;SQSTM1;MET;ATF3;E2F7,beta,4
regulation of apoptotic process (GO:0042981),14/816,14,816,0.00535185060137033,0.975374772099743,0,0,2.17175477786051,11.3589569674907,MAP2K1;TNFRSF12A;DAPK1;OMA1;RTN4;SH3RF1;REST;TYRO3;TMBIM6;TNIK;SGK1;SQSTM1;MET;SNCA,beta,4
mitochondrion disassembly (GO:0061726),3/39,3,39,0.00358891527313619,1,0,0,9.73709834469328,54.8189413288112,ATG3;FBXO7;SQSTM1,beta,4
phosphorylation (GO:0016310),9/387,9,387,0.00371407925690915,1,0,0,2.94377391816309,16.4722533889878,ICK;MAP2K1;RPS6KA5;DAPK1;ADK;TNIK;CDK13;SGK1;FRK,beta,4
regulation of sequestering of triglyceride (GO:0010889),2/12,2,12,0.00388574512144158,1,0,0,21.0970464135021,117.097901246875,OSBPL8;ABHD5,beta,4
autophagy of mitochondrion (GO:0000422),3/41,3,41,0.0041383256232094,1,0,0,9.26211793763507,50.8255388557333,ATG3;FBXO7;SQSTM1,beta,4
negative regulation of neuron death (GO:1901215),4/84,4,84,0.00443270044335569,1,0,0,6.02772754671489,32.6627263396692,TYRO3;FBXO7;BTBD10;SNCA,beta,4
atrial cardiac muscle cell action potential (GO:0086014),2/13,2,13,0.00456851382808375,1,0,0,19.4741966893866,104.938020033063,CACNB2;ANK2,beta,4
positive regulation of cellular carbohydrate metabolic process (GO:0010676),2/13,2,13,0.00456851382808375,1,0,0,19.4741966893866,104.938020033063,IRS2;SNCA,beta,4
positive regulation of transferase activity (GO:0051347),5/138,5,138,0.0048220583753059,1,0,0,4.58631443771785,24.4659438326012,PKIB;UBE2I;LMO4;TYRO3;MET,beta,4
cellular protein metabolic process (GO:0044267),10/485,10,485,0.00527673101612745,1,0,0,2.60994388620645,13.6877162957977,DLL4;ATG3;UBE2I;SARS;OMA1;LAMC1;FBXO11;LTBP1;CP;SNCA,beta,4
positive regulation of neural precursor cell proliferation (GO:2000179),2/14,2,14,0.00530240722468209,1,0,0,18.0831826401447,94.7485419204772,DLL4;PROX1,beta,4
regulation of neural precursor cell proliferation (GO:2000177),2/14,2,14,0.00530240722468209,1,0,0,18.0831826401447,94.7485419204772,DLL4;PROX1,beta,4
endoderm development (GO:0007492),2/15,2,15,0.00608658536130203,1,0,0,16.8776371308017,86.1041021184581,DUSP4;LAMC1,beta,4
positive regulation of macromolecule metabolic process (GO:0010604),7/277,7,277,0.00656813549131073,1,0,0,3.19883014211945,16.075801739374,DLL4;MAP2K1;TLE1;SMAD3;ANK2;ETS1;SNCA,beta,4
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),4/94,4,94,0.00659392245275443,1,0,0,5.38647993536224,27.0487847814466,REST;DAPK1;SH3RF1;SNCA,beta,4
aorta morphogenesis (GO:0035909),2/16,2,16,0.00692021821903622,1,0,0,15.8227848101266,78.6915818877683,DLL4;PROX1,beta,4
negative regulation of lipid storage (GO:0010888),2/16,2,16,0.00692021821903622,1,0,0,15.8227848101266,78.6915818877683,OSBPL8;ABHD5,beta,4
negative regulation of signal transduction (GO:0009968),7/284,7,284,0.00748925130748529,1,0,0,3.11998573720806,15.2701039034477,DLL4;TLE1;TYRO3;TMBIM6;CHAC1;MET;SNCA,beta,4
cardiac atrium morphogenesis (GO:0003209),2/17,2,17,0.00780248560737655,1,0,0,14.8920327624721,72.2756951368273,DLL4;PROX1,beta,4
membrane depolarization during cardiac muscle cell action potential (GO:0086012),2/17,2,17,0.00780248560737655,1,0,0,14.8920327624721,72.2756951368273,CACNB2;ANK2,beta,4
tRNA metabolic process (GO:0006399),2/18,2,18,0.00873257706679993,1,0,0,14.0646976090014,66.6764382002445,SARS;DTD2,beta,4
positive regulation of lipid catabolic process (GO:0050996),2/18,2,18,0.00873257706679993,1,0,0,14.0646976090014,66.6764382002445,IRS2;ABHD5,beta,4
regulation of kinase activity (GO:0043549),4/102,4,102,0.00875513469973113,1,0,0,4.96401092082403,23.5200542462119,LMO4;TYRO3;IRS2;MET,beta,4
axonogenesis (GO:0007409),6/224,6,224,0.00886175046479832,1,0,0,3.39059674502712,16.0239973931592,ROBO2;RPS6KA5;IRS2;NCAM1;GAB2;RTN4,beta,4
cell morphogenesis involved in differentiation (GO:0000904),3/55,3,55,0.0093988512768541,1,0,0,6.90448791714614,32.2244036945714,TYRO3;LAMC1;PROX1,beta,4
sulfur compound transport (GO:0072348),2/19,2,19,0.0097096917585614,1,0,0,13.3244503664224,61.7539072874635,SLC25A26;SLC19A2,beta,4
regulation of axonogenesis (GO:0050770),3/56,3,56,0.00987422703065646,1,0,0,6.78119349005425,31.3143800630777,ROBO2;SSH2;RTN4,beta,4
positive regulation of cellular catabolic process (GO:0031331),4/107,4,107,0.0103161389301205,1,0,0,4.73204779368272,21.6446029746259,DAPK1;IRS2;ABHD5;SNCA,beta,4
phosphatidylinositol-mediated signaling (GO:0048015),3/57,3,57,0.0103633780322781,1,0,0,6.66222518321119,30.4428849460806,TYRO3;IRS2;GAB2,beta,4
neuromuscular junction development (GO:0007528),2/20,2,20,0.0107330383795102,1,0,0,12.6582278481013,57.3978303246498,CACNB2;GPHN,beta,4
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),4/110,4,110,0.0113338965337517,1,0,0,4.6029919447641,20.6212075954625,REST;SMAD3;DAPK1;SNCA,beta,4
cellular response to peptide hormone stimulus (GO:0071375),4/111,4,111,0.0116869822448824,1,0,0,4.56152354886532,20.2954940597638,C2CD5;GNG5;IRS2;PCK2,beta,4
phosphatidylserine acyl-chain remodeling (GO:0036150),2/21,2,21,0.0118018350491819,1,0,0,12.0554550934298,53.5201958644825,OSBPL8;OSBPL10,beta,4
negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744),2/21,2,21,0.0118018350491819,1,0,0,12.0554550934298,53.5201958644825,MET;SNCA,beta,4
hepaticobiliary system development (GO:0061008),2/21,2,21,0.0118018350491819,1,0,0,12.0554550934298,53.5201958644825,PROX1;MET,beta,4
positive regulation of protein kinase activity (GO:0045860),5/173,5,173,0.0121815054368413,1,0,0,3.65844735494256,16.125837510991,ADCYAP1;MAP2K1;MAPRE3;TNIK;SNCA,beta,4
protein phosphorylation (GO:0006468),9/471,9,471,0.0127034081617679,1,0,0,2.41876965250343,10.5600700531932,ICK;MAP2K1;RPS6KA5;DAPK1;TYRO3;TNIK;CDK13;SGK1;FRK,beta,4
regulation of calcium ion transport into cytosol (GO:0010522),2/22,2,22,0.0129153092169155,1,0,0,11.5074798619102,50.0499644448504,ANK2;TMBIM6,beta,4
regulation of catecholamine secretion (GO:0050433),2/22,2,22,0.0129153092169155,1,0,0,11.5074798619102,50.0499644448504,SYT4;SNCA,beta,4
negative regulation of nervous system development (GO:0051961),2/22,2,22,0.0129153092169155,1,0,0,11.5074798619102,50.0499644448504,ROBO2;REST,beta,4
negative regulation of cell growth (GO:0030308),4/116,4,116,0.0135583181873705,1,0,0,4.36490615451768,18.7723921066869,SMAD3;SESN2;RTN4;DCBLD2,beta,4
cellular response to oxidative stress (GO:0034599),4/116,4,116,0.0135583181873705,1,0,0,4.36490615451768,18.7723921066869,DAPK1;TXNRD1;SESN2;SNCA,beta,4
kidney development (GO:0001822),3/64,3,64,0.0141786548111161,1,0,0,5.93354430379747,25.2532691511235,ROBO2;C1GALT1;PROX1,beta,4
negative regulation of transcription from RNA polymerase II promoter (GO:0000122),10/566,10,566,0.0146301176346806,1,0,0,2.23643601556559,9.44821090337346,DLL4;REST;SMAD3;UBE2I;SARS;PROX1;ATF3;E2F7;FRK;SNCA,beta,4
positive regulation of protein serine/threonine kinase activity (GO:0071902),4/119,4,119,0.0147674709243872,1,0,0,4.25486650356345,17.935659728441,MAP2K1;MAPRE3;PROX1;SNCA,beta,4
glucose metabolic process (GO:0006006),3/65,3,65,0.0147802436404089,1,0,0,5.84225900681597,24.6219895567586,IRS2;OMA1;PCK2,beta,4
negative regulation of growth (GO:0045926),4/121,4,121,0.0156102614432654,1,0,0,4.18453813160372,17.4069538493464,SMAD3;SESN2;RTN4;DCBLD2,beta,4
positive regulation of autophagy (GO:0010508),3/68,3,68,0.0166707800899496,1,0,0,5.58451228592703,22.8635393928326,DAPK1;SESN2;FBXO7,beta,4
positive regulation of nitric oxide biosynthetic process (GO:0045429),2/26,2,26,0.0178008510871531,1,0,0,9.73709834469328,39.2259884025525,SMAD3;PTGS2,beta,4
positive regulation of glucose transport (GO:0010828),2/26,2,26,0.0178008510871531,1,0,0,9.73709834469328,39.2259884025525,C2CD5;IRS2,beta,4
regulation of glucose metabolic process (GO:0010906),2/26,2,26,0.0178008510871531,1,0,0,9.73709834469328,39.2259884025525,IRS2;PDK1,beta,4
signal transduction in response to DNA damage (GO:0042770),2/26,2,26,0.0178008510871531,1,0,0,9.73709834469328,39.2259884025525,SESN2;E2F7,beta,4
positive regulation of nitric oxide metabolic process (GO:1904407),2/26,2,26,0.0178008510871531,1,0,0,9.73709834469328,39.2259884025525,SMAD3;PTGS2,beta,4
regulation of endothelial cell migration (GO:0010594),3/70,3,70,0.0180029189915731,1,0,0,5.4249547920434,21.7932443112205,DLL4;PROX1;ETS1,beta,4
positive regulation of nucleic acid-templated transcription (GO:1903508),9/503,9,503,0.0186876928560713,1,0,0,2.26489166268214,9.01401992360882,MAP2K1;REST;SMAD3;MAPRE3;PROX1;ETS1;ATXN7L3;RUNX1;CREB5,beta,4
positive regulation of endothelial cell migration (GO:0010595),3/71,3,71,0.0186905958163421,1,0,0,5.34854697807096,21.2857984264866,PROX1;ETS1;MET,beta,4
regulation of Notch signaling pathway (GO:0008593),3/71,3,71,0.0186905958163421,1,0,0,5.34854697807096,21.2857984264866,DLL4;CHAC1;MAML3,beta,4
positive regulation of protein kinase B signaling (GO:0051897),4/128,4,128,0.0187960179332603,1,0,0,3.95569620253165,15.7203727992176,OSBPL8;IRS2;MET;RTN4,beta,4
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),2/27,2,27,0.0191264443639075,1,0,0,9.3764650726676,37.0997035145371,MAPRE3;PROX1,beta,4
positive regulation of glucose import (GO:0046326),2/27,2,27,0.0191264443639075,1,0,0,9.3764650726676,37.0997035145371,OSBPL8;IRS2,beta,4
regulation of histone acetylation (GO:0035065),2/27,2,27,0.0191264443639075,1,0,0,9.3764650726676,37.0997035145371,RPS6KA5;SNCA,beta,4
regulation of cation channel activity (GO:2001257),3/72,3,72,0.019392701861464,1,0,0,5.27426160337553,20.7956670696156,CACNB2;DAPK1;ANK2,beta,4
response to insulin (GO:0032868),3/72,3,72,0.019392701861464,1,0,0,5.27426160337553,20.7956670696156,C2CD5;IRS2;PCK2,beta,4
positive regulation of gene expression (GO:0010628),12/772,12,772,0.0196705473784027,1,0,0,1.96760018364268,7.72997865590251,DLL4;MAP2K1;REST;TLE1;SMAD3;ANK2;MAPRE3;PROX1;ETS1;ATXN7L3;RUNX1;CREB5,beta,4
regulation of programmed cell death (GO:0043067),6/269,6,269,0.0202011728192233,1,0,0,2.82339654604489,11.0169345891567,MAP2K1;DAPK1;TNIK;OMA1;SGK1;RTN4,beta,4
regulation of calcium ion transmembrane transporter activity (GO:1901019),2/28,2,28,0.0204922704243538,1,0,0,9.04159132007233,35.1510625353569,CACNB2;ANK2,beta,4
phosphatidylserine metabolic process (GO:0006658),2/28,2,28,0.0204922704243538,1,0,0,9.04159132007233,35.1510625353569,OSBPL8;OSBPL10,beta,4
regulation of vascular endothelial growth factor production (GO:0010574),2/28,2,28,0.0204922704243538,1,0,0,9.04159132007233,35.1510625353569,SARS;PTGS2,beta,4
positive regulation of epithelial cell migration (GO:0010634),3/75,3,75,0.0215857190611676,1,0,0,5.06329113924051,19.4213839874768,PROX1;ETS1;RTN4,beta,4
cellular response to ketone (GO:1901655),2/29,2,29,0.0218976193734811,1,0,0,8.72981230903536,33.3599070491112,KLF9;PCK2,beta,4
positive regulation of phosphate metabolic process (GO:0045937),2/29,2,29,0.0218976193734811,1,0,0,8.72981230903536,33.3599070491112,BTBD10;SNCA,beta,4
regulation of cell growth (GO:0001558),5/202,5,202,0.0222732236212783,1,0,0,3.13322471487655,11.9199462853964,SMAD3;SESN2;SGK1;RTN4;DCBLD2,beta,4
hemopoiesis (GO:0030097),3/77,3,77,0.0231200470156547,1,0,0,4.93177708367582,18.5782765163453,CD164;CDK13;RUNX1,beta,4
synaptic vesicle endocytosis (GO:0048488),2/30,2,30,0.0233417898876836,1,0,0,8.43881856540084,31.70894487344,STON2;SNCA,beta,4
synaptic vesicle recycling (GO:0036465),2/30,2,30,0.0233417898876836,1,0,0,8.43881856540084,31.70894487344,STON2;SNCA,beta,4
negative regulation of Notch signaling pathway (GO:0045746),2/30,2,30,0.0233417898876836,1,0,0,8.43881856540084,31.70894487344,DLL4;CHAC1,beta,4
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),2/30,2,30,0.0233417898876836,1,0,0,8.43881856540084,31.70894487344,SESN2;ATF3,beta,4
post-translational protein modification (GO:0043687),7/358,7,358,0.0238707418550143,1,0,0,2.47507248426561,9.24464759246526,KLHL21;LAMC1;FBXO7;FBXO11;LTBP1;CP;DCAF6,beta,4
regulation of cell migration involved in sprouting angiogenesis (GO:0090049),2/31,2,31,0.0248240891390339,1,0,0,8.16659861167824,30.1832646876409,DLL4;PTGS2,beta,4
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),2/31,2,31,0.0248240891390339,1,0,0,8.16659861167824,30.1832646876409,MAPRE3;PROX1,beta,4
negative regulation of secretion by cell (GO:1903531),2/31,2,31,0.0248240891390339,1,0,0,8.16659861167824,30.1832646876409,SYT4;SNCA,beta,4
positive regulation of reactive oxygen species biosynthetic process (GO:1903428),2/31,2,31,0.0248240891390339,1,0,0,8.16659861167824,30.1832646876409,SMAD3;PTGS2,beta,4
positive regulation of phosphorylation (GO:0042327),5/209,5,209,0.0253340409708547,1,0,0,3.02828417418691,11.1307803727636,LMO4;TYRO3;TNIK;BTBD10;MET,beta,4
modification-dependent protein catabolic process (GO:0019941),4/142,4,142,0.0263052409185051,1,0,0,3.56569798538064,12.971963220478,UBE2I;FBXO7;FBXO11;SQSTM1,beta,4
substrate adhesion-dependent cell spreading (GO:0034446),2/33,2,33,0.0279003444771242,1,0,0,7.67165324127349,27.4577387294262,TYRO3;LAMC1,beta,4
regulation of nitric oxide biosynthetic process (GO:0045428),2/33,2,33,0.0279003444771242,1,0,0,7.67165324127349,27.4577387294262,SMAD3;PTGS2,beta,4
"negative regulation of transcription, DNA-templated (GO:0045892)",12/814,12,814,0.0281858224920299,1,0,0,1.8660778154449,6.65991262271275,DLL4;REST;RPS6KA5;TLE1;SMAD3;UBE2I;SARS;PROX1;ATF3;E2F7;FRK;SNCA,beta,4
positive regulation of calcium ion transport (GO:0051928),2/34,2,34,0.0294929565542222,1,0,0,7.44601638123604,26.2368116531504,CACNB2;ANK2,beta,4
positive regulation of Notch signaling pathway (GO:0045747),2/34,2,34,0.0294929565542222,1,0,0,7.44601638123604,26.2368116531504,DLL4;MAML3,beta,4
protein modification process (GO:0036211),3/85,3,85,0.0298352172850137,1,0,0,4.46760982874162,15.6905396655767,ATG3;UBE2I;FBXO11,beta,4
ventricular cardiac muscle tissue morphogenesis (GO:0055010),2/35,2,35,0.0311210091965435,1,0,0,7.23327305605787,25.098532737815,DLL4;PROX1,beta,4
response to amino acid (GO:0043200),2/35,2,35,0.0311210091965435,1,0,0,7.23327305605787,25.098532737815,SESN2;TMBIM6,beta,4
regulation of heart rate by cardiac conduction (GO:0086091),2/36,2,36,0.032783850710532,1,0,0,7.0323488045007,24.0352970550314,CACNB2;ANK2,beta,4
regulation of microtubule polymerization (GO:0031113),2/36,2,36,0.032783850710532,1,0,0,7.0323488045007,24.0352970550314,MET;SNCA,beta,4
regulation of synapse assembly (GO:0051963),2/36,2,36,0.032783850710532,1,0,0,7.0323488045007,24.0352970550314,ROBO2;SNCA,beta,4
sulfur compound catabolic process (GO:0044273),2/36,2,36,0.032783850710532,1,0,0,7.0323488045007,24.0352970550314,HEXB;CHAC1,beta,4
regulation of cell morphogenesis involved in differentiation (GO:0010769),2/37,2,37,0.0344808373642949,1,0,0,6.84228532329798,23.0403800750882,TNIK;SSH2,beta,4
vesicle-mediated transport in synapse (GO:0099003),2/37,2,37,0.0344808373642949,1,0,0,6.84228532329798,23.0403800750882,STON2;SNCA,beta,4
regulation of cell cycle process (GO:0010564),3/91,3,91,0.0354745115010715,1,0,0,4.17304214772569,13.9335407967508,TIPIN;KLHL21;CDK13,beta,4
chemical homeostasis (GO:0048878),2/39,2,39,0.0379747105557806,1,0,0,6.49139889646219,21.2322937520087,IRS2;ABHD5,beta,4
positive regulation of cellular biosynthetic process (GO:0031328),4/160,4,160,0.0382740933807499,1,0,0,3.16455696202532,10.325892483232,SMAD3;IRS2;PTGS2;SNCA,beta,4
signal transduction by p53 class mediator (GO:0072331),2/40,2,40,0.0397703487409952,1,0,0,6.32911392405063,20.4090737395865,SESN2;E2F7,beta,4
positive regulation of fat cell differentiation (GO:0045600),2/40,2,40,0.0397703487409952,1,0,0,6.32911392405063,20.4090737395865,TMEM64;PTGS2,beta,4
inositol lipid-mediated signaling (GO:0048017),2/40,2,40,0.0397703487409952,1,0,0,6.32911392405063,20.4090737395865,IRS2;GAB2,beta,4
clathrin-dependent endocytosis (GO:0072583),2/40,2,40,0.0397703487409952,1,0,0,6.32911392405063,20.4090737395865,STON2;SNCA,beta,4
regulation of plasma membrane bounded cell projection assembly (GO:0120032),2/40,2,40,0.0397703487409952,1,0,0,6.32911392405063,20.4090737395865,ATG3;SSH2,beta,4
positive regulation of peptide hormone secretion (GO:0090277),2/40,2,40,0.0397703487409952,1,0,0,6.32911392405063,20.4090737395865,ADCYAP1;IRS2,beta,4
neuron projection morphogenesis (GO:0048812),4/164,4,164,0.0412942601137937,1,0,0,3.08737264587836,9.83955470506131,ALCAM;TNIK;SGK1;RTN4,beta,4
regulation of protein kinase B signaling (GO:0051896),4/164,4,164,0.0412942601137937,1,0,0,3.08737264587836,9.83955470506131,OSBPL8;IRS2;MET;RTN4,beta,4
epithelial cell differentiation (GO:0030855),3/97,3,97,0.0416231852935727,1,0,0,3.91491582930967,12.445900801968,PROX1;E2F7;PCK2,beta,4
regulation of mitotic cell cycle (GO:0007346),4/166,4,166,0.0428537221405418,1,0,0,3.05017538508464,9.60793891501438,MAP2K1;SMAD3;TNIK;CDK13,beta,4
phosphatidic acid metabolic process (GO:0046473),2/42,2,42,0.0434559648014007,1,0,0,6.02772754671489,18.9029967271171,ABHD5;DGKH,beta,4
regulation of inflammatory response (GO:0050727),4/167,4,167,0.0436457965793902,1,0,0,3.03191086182066,9.49487849504817,TYRO3;PTGS2;ETS1;SNCA,beta,4
neuron projection development (GO:0031175),4/168,4,168,0.0444460973821007,1,0,0,3.01386377335744,9.38359891140651,ADCYAP1;TNIK;FRY;SGK1,beta,4
regulation of protein modification process (GO:0031399),2/43,2,43,0.0453447399242132,1,0,0,5.88754783632617,18.2129001918687,PPP1R14C;SESN2,beta,4
regulation of lipid metabolic process (GO:0019216),3/101,3,101,0.0460005782132379,1,0,0,3.75986965785186,11.5770195991442,TGS1;TXNRD1;IRS2,beta,4
positive regulation of protein phosphorylation (GO:0001934),7/413,7,413,0.0460242091391363,1,0,0,2.14546234713581,6.60499406843887,ADCYAP1;RPS6KA5;TYRO3;MAPRE3;TNIK;MET;SNCA,beta,4
regulation of response to wounding (GO:1903034),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,TNFRSF12A,beta,4
smooth muscle tissue development (GO:0048745),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,PROX1,beta,4
histone-serine phosphorylation (GO:0035404),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,RPS6KA5,beta,4
positive regulation of growth hormone secretion (GO:0060124),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,ADCYAP1,beta,4
positive regulation of histone phosphorylation (GO:0033129),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,RPS6KA5,beta,4
regulation of transforming growth factor beta2 production (GO:0032909),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,SMAD3,beta,4
negative regulation of translation in response to stress (GO:0032055),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,SESN2,beta,4
peripheral nervous system neuron development (GO:0048935),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,RUNX1,beta,4
regulation of aldosterone biosynthetic process (GO:0032347),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,REST,beta,4
negative regulation of catecholamine secretion (GO:0033604),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,SYT4,beta,4
negative regulation of cellular response to hypoxia (GO:1900038),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,TMBIM6,beta,4
regulation of nuclear cell cycle DNA replication (GO:0033262),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,TIPIN,beta,4
ventricular cardiac muscle cell development (GO:0055015),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,PROX1,beta,4
regulation of digestive system process (GO:0044058),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,SGK1,beta,4
regulation of cortisol biosynthetic process (GO:2000064),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,REST,beta,4
aggrephagy (GO:0035973),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,SQSTM1,beta,4
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,ATF3,beta,4
regulation of inositol phosphate biosynthetic process (GO:0010919),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,SNCA,beta,4
positive regulation of vesicle fusion (GO:0031340),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,C2CD5,beta,4
regulation of mesenchymal stem cell differentiation (GO:2000739),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,REST,beta,4
regulation of biosynthetic process (GO:0009889),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,SNCA,beta,4
positive regulation of fever generation (GO:0031622),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,PTGS2,beta,4
azole transport (GO:0045117),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,SLC19A2,beta,4
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,CDK13,beta,4
maintenance of protein location in extracellular region (GO:0071694),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,LTBP1,beta,4
positive regulation of granulocyte differentiation (GO:0030854),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,RUNX1,beta,4
venous blood vessel morphogenesis (GO:0048845),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,PROX1,beta,4
pyrimidine-containing compound transmembrane transport (GO:0072531),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,SLC19A2,beta,4
nucleus localization (GO:0051647),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,DCTN4,beta,4
spinal cord dorsal/ventral patterning (GO:0021513),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,DLL4,beta,4
regulation of sarcomere organization (GO:0060297),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,PROX1,beta,4
lens fiber cell development (GO:0070307),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,PROX1,beta,4
endoplasmic reticulum membrane organization (GO:0090158),1/6,1,6,0.0464791191856752,1,0,0,21.0970464135021,64.7416058441412,RTN4,beta,4
regulation of ERK1 and ERK2 cascade (GO:0070372),5/248,5,248,0.0472504272117663,1,0,0,2.55206206614945,7.78964266936606,DUSP4;ADCYAP1;MAP2K1;TYRO3;MET,beta,4
cardiac ventricle morphogenesis (GO:0003208),2/44,2,44,0.0472633703085243,1,0,0,5.75373993095512,17.5605275925093,DLL4;PROX1,beta,4
branching morphogenesis of an epithelial tube (GO:0048754),2/44,2,44,0.0472633703085243,1,0,0,5.75373993095512,17.5605275925093,DLL4;MET,beta,4
protein ubiquitination (GO:0016567),8/507,8,507,0.0484640748632399,1,0,0,1.99735350660375,6.04585420314063,ATG3;MARCH1;RNF19A;KLHL21;LONRF3;FBXO7;FBXO11;TRIM23,beta,4
protein autophosphorylation (GO:0046777),4/176,4,176,0.0511441417203675,1,0,0,2.87686996547756,8.55324316603807,DAPK1;TYRO3;TNIK;FRK,beta,4
hexose metabolic process (GO:0019318),2/46,2,46,0.0511878724358548,1,0,0,5.50357732526142,16.3580222426042,IRS2;OMA1,beta,4
positive regulation of blood vessel endothelial cell migration (GO:0043536),2/46,2,46,0.0511878724358548,1,0,0,5.50357732526142,16.3580222426042,PTGS2;ETS1,beta,4
positive regulation of cell proliferation (GO:0008284),7/425,7,425,0.0521806941901484,1,0,0,2.08488458674609,6.15675320006577,DLL4;TIPIN;IRS2;LAMC1;PROX1;GAB2;CDK13,beta,4
intraciliary transport (GO:0042073),2/47,2,47,0.0531925999737544,1,0,0,5.38647993536224,15.8030486967266,ICK;TNPO1,beta,4
icosanoid metabolic process (GO:0006690),2/47,2,47,0.0531925999737544,1,0,0,5.38647993536224,15.8030486967266,PLA2G4C;PTGS2,beta,4
negative regulation of autophagy (GO:0010507),2/47,2,47,0.0531925999737544,1,0,0,5.38647993536224,15.8030486967266,MET;SNCA,beta,4
positive regulation of ion transport (GO:0043270),2/47,2,47,0.0531925999737544,1,0,0,5.38647993536224,15.8030486967266,CACNB2;ANK2,beta,4
regulation of high voltage-gated calcium channel activity (GO:1901841),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,CACNB2,beta,4
replication fork protection (GO:0048478),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,TIPIN,beta,4
positive regulation of inositol phosphate biosynthetic process (GO:0060732),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,SNCA,beta,4
venous blood vessel development (GO:0060841),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,PROX1,beta,4
zinc II ion transmembrane import (GO:0071578),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,SLC39A14,beta,4
negative regulation of keratinocyte proliferation (GO:0010839),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,KLF9,beta,4
AV node cell action potential (GO:0086016),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,CACNB2,beta,4
positive regulation of triglyceride catabolic process (GO:0010898),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,ABHD5,beta,4
positive regulation of fatty acid beta-oxidation (GO:0032000),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,IRS2,beta,4
regulation of mitochondrial fusion (GO:0010635),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,OMA1,beta,4
pericardium morphogenesis (GO:0003344),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,DLL4,beta,4
thiamine-containing compound metabolic process (GO:0042723),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,SLC19A2,beta,4
regulation of DNA endoreduplication (GO:0032875),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,E2F7,beta,4
dorsal aorta development (GO:0035907),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,DLL4,beta,4
positive regulation of mast cell degranulation (GO:0043306),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,GAB2,beta,4
negative regulation of B cell apoptotic process (GO:0002903),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,IRS2,beta,4
pri-miRNA transcription from RNA polymerase II promoter (GO:0061614),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,ETS1,beta,4
ribosomal protein import into nucleus (GO:0006610),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,TNPO1,beta,4
negative regulation of transporter activity (GO:0032410),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,SNCA,beta,4
regulation of growth hormone secretion (GO:0060123),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,ADCYAP1,beta,4
nucleic acid transport (GO:0050657),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,CKAP5,beta,4
negative regulation of cytokinesis (GO:0032466),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,E2F7,beta,4
dorsal aorta morphogenesis (GO:0035912),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,DLL4,beta,4
nuclear body organization (GO:0030575),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,ETS1,beta,4
positive regulation of autophagy of mitochondrion (GO:1903599),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,FBXO7,beta,4
negative regulation of synapse organization (GO:1905809),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,ROBO2,beta,4
molybdopterin cofactor biosynthetic process (GO:0032324),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,GPHN,beta,4
molybdopterin cofactor metabolic process (GO:0043545),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,GPHN,beta,4
lymphatic endothelial cell differentiation (GO:0060836),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,PROX1,beta,4
SA node cell action potential (GO:0086015),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,ANK2,beta,4
regulation of transcription involved in cell fate commitment (GO:0060850),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,PROX1,beta,4
microglial cell activation (GO:0001774),1/7,1,7,0.0540141765073126,1,0,0,18.0831826401447,52.7759265634555,SNCA,beta,4
positive regulation of epithelial cell proliferation (GO:0050679),3/108,3,108,0.054184663343664,1,0,0,3.51617440225035,10.2509049743934,LAMC1;PROX1;RTN4,beta,4
ubiquitin-dependent protein catabolic process (GO:0006511),6/342,6,342,0.0545549567692533,1,0,0,2.22074172773706,6.45913103331202,UCHL1;UBE2I;RNF19A;FBXO7;FBXO11;SQSTM1,beta,4
response to glucose (GO:0009749),2/48,2,48,0.055224894247952,1,0,0,5.27426160337553,15.2760624715638,IRS2;PCK2,beta,4
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),2/48,2,48,0.055224894247952,1,0,0,5.27426160337553,15.2760624715638,CD164;ALCAM,beta,4
cellular response to insulin stimulus (GO:0032869),3/111,3,111,0.0578916981754032,1,0,0,3.42114266164899,9.7474556510461,C2CD5;IRS2;PCK2,beta,4
organic hydroxy compound biosynthetic process (GO:1901617),2/50,2,50,0.0593699722530508,1,0,0,5.06329113924051,14.2985655597775,OSBPL6;PSAT1,beta,4
lipid homeostasis (GO:0055088),2/50,2,50,0.0593699722530508,1,0,0,5.06329113924051,14.2985655597775,IRS2;ABHD5,beta,4
regulation of release of sequestered calcium ion into cytosol (GO:0051279),2/50,2,50,0.0593699722530508,1,0,0,5.06329113924051,14.2985655597775,ANK2;SNCA,beta,4
wound healing (GO:0042060),2/51,2,51,0.0614816679159087,1,0,0,4.96401092082403,13.8447070303961,SMAD3;DCBLD2,beta,4
regulation of stress-activated protein kinase signaling cascade (GO:0070302),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,MAP2K1,beta,4
neuron projection extension involved in neuron projection guidance (GO:1902284),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,ALCAM,beta,4
positive regulation of extracellular matrix assembly (GO:1901203),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,SMAD3,beta,4
regulation of brown fat cell differentiation (GO:0090335),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,PTGS2,beta,4
aminoglycoside antibiotic metabolic process (GO:0030647),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,AKR7A2,beta,4
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,CACNB2,beta,4
neurotransmitter receptor diffusion trapping (GO:0099628),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,GPHN,beta,4
regulation of chaperone-mediated autophagy (GO:1904714),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,SNCA,beta,4
response to epinephrine (GO:0071871),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,SNCA,beta,4
regulation of dopamine uptake involved in synaptic transmission (GO:0051584),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,SNCA,beta,4
response to magnesium ion (GO:0032026),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,SNCA,beta,4
ventricular trabecula myocardium morphogenesis (GO:0003222),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,DLL4,beta,4
negative regulation of anion transmembrane transport (GO:1903960),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,IRS2,beta,4
negative regulation of exocytosis (GO:0045920),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,SNCA,beta,4
microvillus organization (GO:0032528),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,TNIK,beta,4
positive regulation of transforming growth factor beta production (GO:0071636),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,PTGS2,beta,4
daunorubicin metabolic process (GO:0044597),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,AKR7A2,beta,4
response to hydroperoxide (GO:0033194),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,DAPK1,beta,4
SMAD protein complex assembly (GO:0007183),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,SMAD3,beta,4
negative regulation of monooxygenase activity (GO:0032769),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,SNCA,beta,4
short-chain fatty acid catabolic process (GO:0019626),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,PCK2,beta,4
negative regulation of cAMP-dependent protein kinase activity (GO:2000480),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,PKIB,beta,4
microvillus assembly (GO:0030033),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,TNIK,beta,4
transepithelial transport (GO:0070633),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,BEST1,beta,4
sequestering of extracellular ligand from receptor (GO:0035581),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,LTBP1,beta,4
positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,MAP2K1,beta,4
axon extension involved in axon guidance (GO:0048846),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,ALCAM,beta,4
regulation of cytoplasmic transport (GO:1903649),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,MAP2K1,beta,4
atrial cardiac muscle cell to AV node cell signaling (GO:0086026),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,ANK2,beta,4
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,SESN2,beta,4
insulin metabolic process (GO:1901142),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,PCSK2,beta,4
nodal signaling pathway (GO:0038092),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,SMAD3,beta,4
nose development (GO:0043584),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,PROX1,beta,4
postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,GPHN,beta,4
cellular response to epinephrine stimulus (GO:0071872),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,SNCA,beta,4
histone H4 deacetylation (GO:0070933),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,REST,beta,4
negative regulation of double-strand break repair via homologous recombination (GO:2000042),1/8,1,8,0.0614900644575437,1,0,0,15.8227848101266,44.1278428917202,HELB,beta,4
arachidonic acid metabolic process (GO:0019369),2/52,2,52,0.0636187540047814,1,0,0,4.86854917234664,13.4121079737776,PLA2G4C;PTGS2,beta,4
plasma membrane bounded cell projection morphogenesis (GO:0120039),2/53,2,53,0.065780703433882,1,0,0,4.77668975400048,12.9994208003033,TNIK;SGK1,beta,4
regulation of calcium ion transport (GO:0051924),2/53,2,53,0.065780703433882,1,0,0,4.77668975400048,12.9994208003033,CACNB2;ANK2,beta,4
protein localization to cell periphery (GO:1990778),3/118,3,118,0.0669929916967061,1,0,0,3.21819352070371,8.69931538276333,CACNB2;ANK2;TNIK,beta,4
regulation of calcium ion-dependent exocytosis (GO:0017158),2/54,2,54,0.0679669957567318,1,0,0,4.6882325363338,12.6054057578447,SYT4;REST,beta,4
mitochondrial protein processing (GO:0034982),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,OMA1,beta,4
Notch signaling involved in heart development (GO:0061314),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,DLL4,beta,4
positive regulation of protein sumoylation (GO:0033235),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,UBE2I,beta,4
regulation of sequestering of calcium ion (GO:0051282),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,ANK2,beta,4
actin filament reorganization (GO:0090527),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,FRY,beta,4
doxorubicin metabolic process (GO:0044598),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,AKR7A2,beta,4
regulation of bile acid biosynthetic process (GO:0070857),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,PROX1,beta,4
negative regulation of lymphocyte apoptotic process (GO:0070229),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,IRS2,beta,4
sarcoplasmic reticulum calcium ion transport (GO:0070296),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,ANK2,beta,4
pericardium development (GO:0060039),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,DLL4,beta,4
positive regulation of myeloid leukocyte mediated immunity (GO:0002888),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,GAB2,beta,4
sphingomyelin metabolic process (GO:0006684),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,SGMS2,beta,4
positive regulation of long-term synaptic potentiation (GO:1900273),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,SQSTM1,beta,4
nuclear migration (GO:0007097),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,DCTN4,beta,4
cellular response to leucine (GO:0071233),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,SESN2,beta,4
response to leucine (GO:0043201),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,SESN2,beta,4
negative regulation of microtubule polymerization (GO:0031115),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,SNCA,beta,4
mitochondrial fragmentation involved in apoptotic process (GO:0043653),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,ATG3,beta,4
histone phosphorylation (GO:0016572),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,RPS6KA5,beta,4
negative regulation of peptidyl-lysine acetylation (GO:2000757),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,SNCA,beta,4
histone H3-K4 trimethylation (GO:0080182),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,WDR82,beta,4
vitamin transmembrane transport (GO:0035461),1/9,1,9,0.0689072444303957,1,0,0,14.0646976090014,37.6229811865277,SLC19A2,beta,4
MAPK cascade (GO:0000165),5/279,5,279,0.0707965621986403,1,0,0,2.26849961435507,6.00686183924901,MAP2K1;IRS2;NCAM1;TNIK;MET,beta,4
positive regulation of cysteine-type endopeptidase activity (GO:2001056),2/56,2,56,0.0724105601475307,1,0,0,4.52079566003617,11.8689110842471,REST;DAPK1,beta,4
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),2/56,2,56,0.0724105601475307,1,0,0,4.52079566003617,11.8689110842471,SMAD3;LTBP1,beta,4
Notch signaling pathway (GO:0007219),2/56,2,56,0.0724105601475307,1,0,0,4.52079566003617,11.8689110842471,DLL4;MAML3,beta,4
protein polyubiquitination (GO:0000209),5/284,5,284,0.0751052367182041,1,0,0,2.2285612408629,5.76944418057347,MARCH1;RNF19A;LONRF3;FBXO7;FBXO11,beta,4
regulation of B cell apoptotic process (GO:0002902),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,IRS2,beta,4
cellular response to thyroid hormone stimulus (GO:0097067),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,KLF9,beta,4
negative regulation of protein maturation (GO:1903318),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,CHAC1,beta,4
intraciliary retrograde transport (GO:0035721),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,ICK,beta,4
negative regulation of oxidative stress-induced neuron death (GO:1903204),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,FBXO7,beta,4
negative regulation of cytosolic calcium ion concentration (GO:0051481),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,SMAD3,beta,4
regulation of mammary gland epithelial cell proliferation (GO:0033599),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,RTN4,beta,4
regulation of actin filament length (GO:0030832),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,SSH2,beta,4
negative regulation of stem cell differentiation (GO:2000737),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,REST,beta,4
neuron projection fasciculation (GO:0106030),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,RTN4,beta,4
positive regulation of alcohol biosynthetic process (GO:1902932),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,SNCA,beta,4
positive regulation of receptor recycling (GO:0001921),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,SNCA,beta,4
regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,SNCA,beta,4
skeletal muscle thin filament assembly (GO:0030240),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,PROX1,beta,4
regulation of phospholipase activity (GO:0010517),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,SNCA,beta,4
regulation of triglyceride catabolic process (GO:0010896),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,ABHD5,beta,4
regulation of actin filament-based movement (GO:1903115),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,ANK2,beta,4
positive regulation of glucose import in response to insulin stimulus (GO:2001275),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,OSBPL8,beta,4
epithelial cell morphogenesis (GO:0003382),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,MET,beta,4
nuclear pore complex assembly (GO:0051292),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,RTN4,beta,4
cellular response to leucine starvation (GO:1990253),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,SESN2,beta,4
regulation of granulocyte differentiation (GO:0030852),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,RUNX1,beta,4
primary miRNA processing (GO:0031053),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,SMAD3,beta,4
regulation of histone phosphorylation (GO:0033127),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,RPS6KA5,beta,4
quinone metabolic process (GO:1901661),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,AKR7A2,beta,4
regulation of fatty acid beta-oxidation (GO:0031998),1/10,1,10,0.0762661742978172,1,0,0,12.6582278481013,32.5762754943128,IRS2,beta,4
positive regulation of ERK1 and ERK2 cascade (GO:0070374),4/202,4,202,0.0764870636133548,1,0,0,2.50657977190124,6.44349832195159,ADCYAP1;MAP2K1;TYRO3;MET,beta,4
negative regulation of macromolecule metabolic process (GO:0010605),3/125,3,125,0.0767046194843269,1,0,0,3.0379746835443,7.80089117305893,DLL4;MAP2K1;REST,beta,4
"regulation of transcription, DNA-templated (GO:0006355)",18/1599,18,1599,0.0808034180093667,1,0,0,1.42494122117463,3.58477594545373,MAP2K1;TLE1;SMAD3;UBE2I;PROX1;ETS1;RUNX1;FOSL2;ZNF609;REST;RPS6KA5;KLF9;MAPRE3;ATXN7L3;ZNF367;ATF3;CREB5;ZNF860,beta,4
renal system development (GO:0072001),2/60,2,60,0.08156762572359,1,0,0,4.21940928270042,10.575201853667,C1GALT1;PROX1,beta,4
regulation of extrinsic apoptotic signaling pathway (GO:2001236),2/60,2,60,0.08156762572359,1,0,0,4.21940928270042,10.575201853667,TNFRSF12A;SH3RF1,beta,4
morphogenesis of an epithelial sheet (GO:0002011),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,DLL4,beta,4
intracellular protein transmembrane transport (GO:0065002),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,C2CD5,beta,4
positive regulation of extracellular matrix organization (GO:1903055),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,SMAD3,beta,4
positive regulation of leukocyte degranulation (GO:0043302),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,GAB2,beta,4
regulation of synaptic vesicle cycle (GO:0098693),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,SNCA,beta,4
negative regulation of chemotaxis (GO:0050922),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,ROBO2,beta,4
intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,PDK1,beta,4
cell-substrate junction assembly (GO:0007044),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,LAMC1,beta,4
carbohydrate phosphorylation (GO:0046835),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,ADK,beta,4
positive regulation of fatty acid oxidation (GO:0046321),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,IRS2,beta,4
cyclooxygenase pathway (GO:0019371),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,PTGS2,beta,4
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,ATF3,beta,4
positive regulation of glucose metabolic process (GO:0010907),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,IRS2,beta,4
response to thyroid hormone (GO:0097066),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,KLF9,beta,4
regulation of hemopoiesis (GO:1903706),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,RUNX1,beta,4
hemidesmosome assembly (GO:0031581),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,LAMC1,beta,4
glutathione biosynthetic process (GO:0006750),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,CHAC1,beta,4
negative regulation of histone acetylation (GO:0035067),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,SNCA,beta,4
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,DLL4,beta,4
negative regulation of cell division (GO:0051782),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,E2F7,beta,4
cochlea morphogenesis (GO:0090103),1/11,1,11,0.0835673084792737,1,0,0,11.5074798619102,28.5627489328987,MYO3B,beta,4
generation of neurons (GO:0048699),3/131,3,131,0.0854926654133056,1,0,0,2.89883080490869,7.12916617458354,MAP2K1;PROX1;RUNX1,beta,4
protein localization to plasma membrane (GO:0072659),3/131,3,131,0.0854926654133056,1,0,0,2.89883080490869,7.12916617458354,CACNB2;ANK2;TNIK,beta,4
actin cytoskeleton reorganization (GO:0031532),2/62,2,62,0.0862733639521223,1,0,0,4.08329930583912,10.0050403158528,TNIK;FRY,beta,4
negative regulation of MAP kinase activity (GO:0043407),2/62,2,62,0.0862733639521223,1,0,0,4.08329930583912,10.0050403158528,DUSP4;UCHL1,beta,4
axonal fasciculation (GO:0007413),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,RTN4,beta,4
regulation of DNA-dependent DNA replication (GO:0090329),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,TIPIN,beta,4
negative regulation of histone modification (GO:0031057),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,SNCA,beta,4
skeletal myofibril assembly (GO:0014866),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,PROX1,beta,4
negative regulation of oxidoreductase activity (GO:0051354),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,SNCA,beta,4
cellular modified amino acid catabolic process (GO:0042219),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,CHAC1,beta,4
cell differentiation in hindbrain (GO:0021533),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,PROX1,beta,4
entry of bacterium into host cell (GO:0035635),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,MET,beta,4
positive regulation of DNA-dependent DNA replication (GO:2000105),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,E2F7,beta,4
cellular response to arsenic-containing substance (GO:0071243),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,ATF3,beta,4
aromatic compound biosynthetic process (GO:0019438),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,PSAT1,beta,4
L-serine metabolic process (GO:0006563),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,PSAT1,beta,4
nonribosomal peptide biosynthetic process (GO:0019184),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,CHAC1,beta,4
PERK-mediated unfolded protein response (GO:0036499),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,ATF3,beta,4
regulation of antigen receptor-mediated signaling pathway (GO:0050854),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,RUNX1,beta,4
positive regulation of potassium ion transmembrane transporter activity (GO:1901018),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,ANK2,beta,4
"alternative mRNA splicing, via spliceosome (GO:0000380)",1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,CDK13,beta,4
keratan sulfate catabolic process (GO:0042340),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,HEXB,beta,4
positive regulation of neuron migration (GO:2001224),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,ZNF609,beta,4
positive regulation of SMAD protein import into nucleus (GO:0060391),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,SMAD3,beta,4
negative regulation by host of viral transcription (GO:0043922),1/12,1,12,0.0908110978807797,1,0,0,10.5485232067511,25.3056305642083,REST,beta,4
negative regulation of apoptotic process (GO:0043066),7/486,7,486,0.0912487413952133,1,0,0,1.82320154190759,4.36504728780716,TLE1;TYRO3;TMBIM6;SQSTM1;MET;SH3RF1;SNCA,beta,4
glycerophospholipid metabolic process (GO:0006650),2/65,2,65,0.0934804413546837,1,0,0,3.89483933787731,9.23078110201268,PLA2G4C;DGKH,beta,4
negative regulation of apoptotic signaling pathway (GO:2001234),2/66,2,66,0.0959205791176514,1,0,0,3.83582662063675,8.99207798532533,TMBIM6;SH3RF1,beta,4
protein modification by small protein conjugation (GO:0032446),6/399,6,399,0.0971335989507818,1,0,0,1.90349290948891,4.43831338979256,ATG3;UBE2I;KLHL21;FBXO7;FBXO11;TRIM23,beta,4
positive regulation of apoptotic process (GO:0043065),5/308,5,308,0.0977124826099066,1,0,0,2.05490711819826,4.77915083718508,REST;TNFRSF12A;DAPK1;SQSTM1;SNCA,beta,4
response to iron ion (GO:0010039),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,SNCA,beta,4
protein localization to endoplasmic reticulum (GO:0070972),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,ANK2,beta,4
regulation of acyl-CoA biosynthetic process (GO:0050812),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,PDK1,beta,4
regulation of endothelial cell chemotaxis (GO:2001026),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,MET,beta,4
regulation of plasma membrane bounded cell projection organization (GO:0120035),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,FBXO7,beta,4
prostanoid biosynthetic process (GO:0046457),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,PTGS2,beta,4
glycerolipid catabolic process (GO:0046503),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,PLA2G4C,beta,4
regulation of NMDA receptor activity (GO:2000310),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,DAPK1,beta,4
"Notch receptor processing, ligand-dependent (GO:0035333)",1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,DLL4,beta,4
renal absorption (GO:0070293),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,SGK1,beta,4
regulation of cAMP-dependent protein kinase activity (GO:2000479),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,PKIB,beta,4
muscle cell development (GO:0055001),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,ANK2,beta,4
regulation of glucose import in response to insulin stimulus (GO:2001273),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,OSBPL8,beta,4
chondroitin sulfate catabolic process (GO:0030207),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,HEXB,beta,4
positive regulation of glycogen biosynthetic process (GO:0045725),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,IRS2,beta,4
serine family amino acid biosynthetic process (GO:0009070),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,PSAT1,beta,4
placenta development (GO:0001890),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,E2F7,beta,4
atrial septum development (GO:0003283),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,ANK2,beta,4
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,MAP2K1,beta,4
positive regulation of endothelial cell chemotaxis (GO:2001028),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,MET,beta,4
catecholamine biosynthetic process (GO:0042423),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,SNCA,beta,4
cardiocyte differentiation (GO:0035051),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,PROX1,beta,4
endothelial cell differentiation (GO:0045446),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,PROX1,beta,4
tetrahydrofolate metabolic process (GO:0046653),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,MTHFD2,beta,4
regulation of synaptic vesicle transport (GO:1902803),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,SNCA,beta,4
neuron fate commitment (GO:0048663),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,DLL4,beta,4
protein kinase C-activating G-protein coupled receptor signaling pathway (GO:0007205),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,DGKH,beta,4
regulation of cellular carbohydrate metabolic process (GO:0010675),1/13,1,13,0.0979979899693764,1,0,0,9.73709834469328,22.6174129604525,PDK1,beta,4
positive regulation of cellular protein localization (GO:1903829),2/67,2,67,0.0983788676685971,1,0,0,3.77857547704515,8.76224922521641,SESN2;RTN4,beta,4
regulation of primary metabolic process (GO:0080090),3/140,3,140,0.0994326169783347,1,0,0,2.7124773960217,6.26114397973853,TGS1;TXNRD1;IRS2,beta,4
neuron differentiation (GO:0030182),3/140,3,140,0.0994326169783347,1,0,0,2.7124773960217,6.26114397973853,MAP2K1;PROX1;RUNX1,beta,4
actin cytoskeleton reorganization (GO:0031532),3/62,3,62,0.0039163699091121,0.951677887914239,0,0,9.4876660341556,52.5862438123044,DTNBP1;NEDD9;WHAMM,beta,5
focal adhesion assembly (GO:0048041),2/18,2,18,0.00373620859148075,0.953293622116314,0,0,21.7864923747277,121.779606260058,RCC2;WHAMM,beta,5
regulation of ATP biosynthetic process (GO:2001169),2/8,2,8,0.000706866209916387,1,0,0,49.0196078431373,355.621036583468,FLCN;PPARGC1A,beta,5
negative regulation of apoptotic process (GO:0043066),9/486,9,486,0.000851559707404434,1,0,0,3.63108206245461,25.6660891069581,BARD1;BNIP3L;LAMP3;SPHK1;IL31RA;NAA16;PPARGC1A;CRYAB;BIRC2,beta,5
actin filament reorganization (GO:0090527),2/9,2,9,0.000905806674747312,1,0,0,43.5729847494553,305.30216374605,NEDD9;WHAMM,beta,5
negative regulation of protein localization to nucleus (GO:1900181),2/11,2,11,0.00137468989178423,1,0,0,35.650623885918,234.9207524616,FLCN;CABP1,beta,5
positive regulation of fatty acid oxidation (GO:0046321),2/11,2,11,0.00137468989178423,1,0,0,35.650623885918,234.9207524616,MLYCD;PPARGC1A,beta,5
negative regulation of nucleocytoplasmic transport (GO:0046823),2/11,2,11,0.00137468989178423,1,0,0,35.650623885918,234.9207524616,BARD1;CABP1,beta,5
regulation of fatty acid oxidation (GO:0046320),2/13,2,13,0.00193663446258243,1,0,0,30.1659125188537,188.440531690486,MLYCD;PPARGC1A,beta,5
myeloid leukocyte differentiation (GO:0002573),3/51,3,51,0.0022455053639156,1,0,0,11.5340253748558,70.3439985778474,GPR183;IL31RA;TGFBR2,beta,5
branching involved in blood vessel morphogenesis (GO:0001569),2/14,2,14,0.00225190837181203,1,0,0,28.0112044817927,170.755665462322,NRARP;TGFBR2,beta,5
organonitrogen compound biosynthetic process (GO:1901566),5/182,5,182,0.00241416330288173,1,0,0,5.38677009265245,32.4628448089973,ACHE;CHKA;SPHK1;PLA2G4A;ASS1,beta,5
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),2/16,2,16,0.00294988226650646,1,0,0,24.5098039215686,142.793873016805,RCC2;CDC7,beta,5
regulation of RIG-I signaling pathway (GO:0039535),2/16,2,16,0.00294988226650646,1,0,0,24.5098039215686,142.793873016805,GPATCH3;BIRC2,beta,5
regulation of energy homeostasis (GO:2000505),2/16,2,16,0.00294988226650646,1,0,0,24.5098039215686,142.793873016805,FLCN;PPARGC1A,beta,5
chordate embryonic development (GO:0043009),3/57,3,57,0.00308614354448883,1,0,0,10.3199174406605,59.6577194157127,KIAA1217;FLCN;SULF1,beta,5
positive regulation of cell cycle G2/M phase transition (GO:1902751),2/17,2,17,0.00333211667699847,1,0,0,23.0680507497117,131.583564894677,RCC2;CDC7,beta,5
positive regulation of fatty acid metabolic process (GO:0045923),2/17,2,17,0.00333211667699847,1,0,0,23.0680507497117,131.583564894677,MLYCD;PPARGC1A,beta,5
modulation by virus of host morphology or physiology (GO:0019048),2/18,2,18,0.00373620859148075,1,0,0,21.7864923747277,121.779606260058,RRAGA;KPNA7,beta,5
membrane lipid metabolic process (GO:0006643),2/18,2,18,0.00373620859148075,1,0,0,21.7864923747277,121.779606260058,KDELC2;ALOXE3,beta,5
cell-substrate adherens junction assembly (GO:0007045),2/18,2,18,0.00373620859148075,1,0,0,21.7864923747277,121.779606260058,RCC2;WHAMM,beta,5
negative regulation of intracellular protein transport (GO:0090317),2/20,2,20,0.00460905291838391,1,0,0,19.6078431372549,105.484958505432,BARD1;CABP1,beta,5
negative regulation of programmed cell death (GO:0043069),7/409,7,409,0.00497001978339933,1,0,0,3.35586557361331,17.8006233320044,BARD1;BNIP3L;SPHK1;IL31RA;NAA16;CRYAB;BIRC2,beta,5
embryonic skeletal system development (GO:0048706),2/21,2,21,0.00507735361368677,1,0,0,18.6741363211951,98.6548103700638,KIAA1217;SULF1,beta,5
negative regulation of protein import into nucleus (GO:0042308),2/22,2,22,0.00556660835808801,1,0,0,17.825311942959,92.5306474666197,PDE2A;CABP1,beta,5
phosphatidylcholine metabolic process (GO:0046470),3/72,3,72,0.00595343395280002,1,0,0,8.16993464052288,41.8610056452495,ACHE;CHKA;PLA2G4A,beta,5
lamellipodium assembly (GO:0030032),2/23,2,23,0.00607659553385651,1,0,0,17.0502983802217,87.0129699048806,ABLIM1;WHAMM,beta,5
C-terminal protein lipidation (GO:0006501),3/76,3,76,0.00691548231439389,1,0,0,7.73993808049536,38.4983944836629,RAET1G;CD109;ULBP2,beta,5
lamellipodium organization (GO:0097581),2/26,2,26,0.00772876055202843,1,0,0,15.0829562594268,73.3455018370561,ABLIM1;WHAMM,beta,5
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),3/80,3,80,0.0079647229573542,1,0,0,7.35294117647059,35.5348023435973,FLCN;CD109;TGFBR2,beta,5
regulation of histone acetylation (GO:0035065),2/27,2,27,0.00831949464007076,1,0,0,14.5243282498184,69.5592413416108,FLCN;PPARGC1A,beta,5
regulation of apoptotic process (GO:0042981),10/816,10,816,0.00876640900769726,1,0,0,2.40292195309496,11.3822280364653,BARD1;BNIP3L;FLCN;AIFM2;SPHK1;IL31RA;NAA16;CRYAB;MAP3K4;BIRC2,beta,5
C-terminal protein amino acid modification (GO:0018410),3/83,3,83,0.00880992340887214,1,0,0,7.0871722182849,33.5356239031179,RAET1G;CD109;ULBP2,beta,5
glycerophospholipid biosynthetic process (GO:0046474),4/165,4,165,0.0101529758559619,1,0,0,4.7534165181224,21.8181268149066,ACHE;CHKA;PITPNM2;PLA2G4A,beta,5
amino acid transmembrane transport (GO:0003333),2/30,2,30,0.0102087472469367,1,0,0,13.0718954248366,59.928239908087,SLC7A5;SLC7A11,beta,5
positive regulation of TOR signaling (GO:0032008),2/33,2,33,0.0122691797110066,1,0,0,11.883541295306,52.2954827773356,FLCN;RRAGA,beta,5
phosphatidylcholine biosynthetic process (GO:0006656),2/33,2,33,0.0122691797110066,1,0,0,11.883541295306,52.2954827773356,ACHE;CHKA,beta,5
positive regulation of transcription factor import into nucleus (GO:0042993),2/33,2,33,0.0122691797110066,1,0,0,11.883541295306,52.2954827773356,SPHK1;CHERP,beta,5
carboxylic acid metabolic process (GO:0019752),2/34,2,34,0.0129930685283717,1,0,0,11.5340253748558,50.0961851654239,SLC2A1;PLA2G4A,beta,5
carboxylic acid transmembrane transport (GO:1905039),2/36,2,36,0.014495247518161,1,0,0,10.8932461873638,46.1212902031373,SLC7A5;SLC7A11,beta,5
natural killer cell activation (GO:0030101),2/37,2,37,0.0152731378962339,1,0,0,10.5988341282459,44.3207173998488,ULBP2;ULBP1,beta,5
positive regulation of cellular process (GO:0048522),7/520,7,520,0.0171296284810321,1,0,0,2.6395173453997,10.7347735994007,FOSL1;RRAGA;CNOT6L;SPHK1;IL31RA;CDC7;TGFBR2,beta,5
fatty acid metabolic process (GO:0006631),3/107,3,107,0.0174374916920785,1,0,0,5.49752611324904,22.2602127313942,MLYCD;PPARGC1A;ALOXE3,beta,5
positive regulation of mitotic cell cycle phase transition (GO:1901992),2/41,2,41,0.0185587789069548,1,0,0,9.56480153036824,38.1330688229516,RCC2;CDC7,beta,5
regulation of autophagy (GO:0010506),4/204,4,204,0.0205758846459028,1,0,0,3.84467512495194,14.9313169442047,FLCN;RRAGA;LAMP3;NEDD4,beta,5
branching morphogenesis of an epithelial tube (GO:0048754),2/44,2,44,0.021200386719572,1,0,0,8.9126559714795,34.3470218893164,NRARP;TGFBR2,beta,5
regulation of intracellular signal transduction (GO:1902531),6/423,6,423,0.021262998216538,1,0,0,2.78125434570992,10.7100177717533,BARD1;ARHGAP21;FLCN;DEPDC1B;STARD13;BIRC2,beta,5
positive regulation of cell proliferation (GO:0008284),6/425,6,425,0.0217019970562347,1,0,0,2.7681660899654,10.6030477299073,FOSL1;CNOT6L;SPHK1;IL31RA;CDC7;TGFBR2,beta,5
regulation of macroautophagy (GO:0016241),3/117,3,117,0.0220384832084574,1,0,0,5.02765208647562,19.1803173303599,BNIP3L;RRAGA;NEDD4,beta,5
amide biosynthetic process (GO:0043604),2/45,2,45,0.0221136967469456,1,0,0,8.71459694989107,33.2161925936954,ALOXE3;ASS1,beta,5
unsaturated fatty acid metabolic process (GO:0033559),2/45,2,45,0.0221136967469456,1,0,0,8.71459694989107,33.2161925936954,PLA2G4A;ALOXE3,beta,5
mitochondrial gene expression (GO:0140053),2/46,2,46,0.0230430830514443,1,0,0,8.52514919011083,32.14313417826,MRPS16;MRPS34,beta,5
icosanoid metabolic process (GO:0006690),2/47,2,47,0.0239883613313998,1,0,0,8.34376303712975,31.1237923302697,PLA2G4A;ALOXE3,beta,5
DNA replication (GO:0006260),3/121,3,121,0.0240468548328492,1,0,0,4.86144871171609,18.1222706230589,BARD1;ACHE;CDC7,beta,5
regulation of mitochondrion organization (GO:0010821),2/49,2,49,0.0259258637518775,1,0,0,8.0032012805122,29.2318063872573,FLCN;PPARGC1A,beta,5
amino acid transport (GO:0006865),2/49,2,49,0.0259258637518775,1,0,0,8.0032012805122,29.2318063872573,SLC7A5;SLC7A11,beta,5
cytoskeleton organization (GO:0007010),3/127,3,127,0.027239403600249,1,0,0,4.63177396943029,16.6887016776494,PALLD;MAST2;NEDD9,beta,5
protein lipidation (GO:0006497),3/128,3,128,0.0277924612332247,1,0,0,4.59558823529412,16.4659488682082,RAET1G;CD109;ULBP2,beta,5
regulation of ion transport (GO:0043269),2/51,2,51,0.0279247580309207,1,0,0,7.68935024990388,27.5143529336945,NEDD4;DTNBP1,beta,5
arachidonic acid metabolic process (GO:0019369),2/52,2,52,0.0289467813821827,1,0,0,7.54147812971342,26.7141497711334,PLA2G4A;ALOXE3,beta,5
positive regulation of secretion by cell (GO:1903532),2/53,2,53,0.0299836205898295,1,0,0,7.39918608953015,25.9497153293417,ACHE;DTNBP1,beta,5
corticosteroid receptor signaling pathway (GO:0031958),1/6,1,6,0.030216035137483,1,0,0,32.6797385620915,114.358906231893,NEDD4,beta,5
arginine biosynthetic process (GO:0006526),1/6,1,6,0.030216035137483,1,0,0,32.6797385620915,114.358906231893,ASS1,beta,5
N-terminal peptidyl-methionine acetylation (GO:0017196),1/6,1,6,0.030216035137483,1,0,0,32.6797385620915,114.358906231893,NAA16,beta,5
positive regulation of ATP biosynthetic process (GO:2001171),1/6,1,6,0.030216035137483,1,0,0,32.6797385620915,114.358906231893,PPARGC1A,beta,5
regulation of nuclear cell cycle DNA replication (GO:0033262),1/6,1,6,0.030216035137483,1,0,0,32.6797385620915,114.358906231893,CDC7,beta,5
regulation of T cell tolerance induction (GO:0002664),1/6,1,6,0.030216035137483,1,0,0,32.6797385620915,114.358906231893,TGFBR2,beta,5
negative regulation of necroptotic process (GO:0060546),1/6,1,6,0.030216035137483,1,0,0,32.6797385620915,114.358906231893,BIRC2,beta,5
cardiolipin acyl-chain remodeling (GO:0035965),1/6,1,6,0.030216035137483,1,0,0,32.6797385620915,114.358906231893,PLA2G4A,beta,5
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),1/6,1,6,0.030216035137483,1,0,0,32.6797385620915,114.358906231893,TGFBR2,beta,5
citrulline metabolic process (GO:0000052),1/6,1,6,0.030216035137483,1,0,0,32.6797385620915,114.358906231893,ASS1,beta,5
blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043),1/6,1,6,0.030216035137483,1,0,0,32.6797385620915,114.358906231893,NRARP,beta,5
chondrocyte development (GO:0002063),1/6,1,6,0.030216035137483,1,0,0,32.6797385620915,114.358906231893,SULF1,beta,5
negative regulation of cAMP-mediated signaling (GO:0043951),1/6,1,6,0.030216035137483,1,0,0,32.6797385620915,114.358906231893,PDE2A,beta,5
regulation of protein K63-linked ubiquitination (GO:1900044),1/6,1,6,0.030216035137483,1,0,0,32.6797385620915,114.358906231893,BIRC2,beta,5
regulation of NFAT protein import into nucleus (GO:0051532),1/6,1,6,0.030216035137483,1,0,0,32.6797385620915,114.358906231893,CHERP,beta,5
glucocorticoid receptor signaling pathway (GO:0042921),1/6,1,6,0.030216035137483,1,0,0,32.6797385620915,114.358906231893,NEDD4,beta,5
endoplasmic reticulum membrane organization (GO:0090158),1/6,1,6,0.030216035137483,1,0,0,32.6797385620915,114.358906231893,ATL2,beta,5
acetyl-CoA biosynthetic process (GO:0006085),1/6,1,6,0.030216035137483,1,0,0,32.6797385620915,114.358906231893,MLYCD,beta,5
negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),2/54,2,54,0.0310351011620458,1,0,0,7.26216412490922,25.2188556246205,CD109;TGFBR2,beta,5
regulation of cellular catabolic process (GO:0031329),2/56,2,56,0.0331812952335932,1,0,0,7.00280112044818,23.8499226779111,RRAGA;LAMP3,beta,5
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),2/56,2,56,0.0331812952335932,1,0,0,7.00280112044818,23.8499226779111,CD109;TGFBR2,beta,5
negative regulation of cellular response to growth factor stimulus (GO:0090288),2/56,2,56,0.0331812952335932,1,0,0,7.00280112044818,23.8499226779111,NEDD4;SULF1,beta,5
long-chain fatty acid metabolic process (GO:0001676),2/56,2,56,0.0331812952335932,1,0,0,7.00280112044818,23.8499226779111,PLA2G4A;ALOXE3,beta,5
fat cell differentiation (GO:0045444),2/56,2,56,0.0331812952335932,1,0,0,7.00280112044818,23.8499226779111,PPARGC1A;ALOXE3,beta,5
Notch signaling pathway (GO:0007219),2/56,2,56,0.0331812952335932,1,0,0,7.00280112044818,23.8499226779111,NRARP;YBX1,beta,5
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),2/57,2,57,0.0342756665277343,1,0,0,6.87994496044032,23.2082532318787,SPHK1;BIRC2,beta,5
cellular defense response (GO:0006968),2/57,2,57,0.0342756665277343,1,0,0,6.87994496044032,23.2082532318787,LGALS3BP;FOSL1,beta,5
protein localization to cytoplasmic stress granule (GO:1903608),1/7,1,7,0.0351634020883028,1,0,0,28.0112044817927,93.7744944161201,YBX1,beta,5
modification by symbiont of host morphology or physiology (GO:0044003),1/7,1,7,0.0351634020883028,1,0,0,28.0112044817927,93.7744944161201,RRAGA,beta,5
peroxisome proliferator activated receptor signaling pathway (GO:0035357),1/7,1,7,0.0351634020883028,1,0,0,28.0112044817927,93.7744944161201,ALOXE3,beta,5
modulation by symbiont of host cellular process (GO:0044068),1/7,1,7,0.0351634020883028,1,0,0,28.0112044817927,93.7744944161201,KPNA7,beta,5
progesterone receptor signaling pathway (GO:0050847),1/7,1,7,0.0351634020883028,1,0,0,28.0112044817927,93.7744944161201,NEDD4,beta,5
negative regulation of macrophage activation (GO:0043031),1/7,1,7,0.0351634020883028,1,0,0,28.0112044817927,93.7744944161201,IL31RA,beta,5
brown fat cell differentiation (GO:0050873),1/7,1,7,0.0351634020883028,1,0,0,28.0112044817927,93.7744944161201,PPARGC1A,beta,5
cellular response to laminar fluid shear stress (GO:0071499),1/7,1,7,0.0351634020883028,1,0,0,28.0112044817927,93.7744944161201,ASS1,beta,5
pri-miRNA transcription from RNA polymerase II promoter (GO:0061614),1/7,1,7,0.0351634020883028,1,0,0,28.0112044817927,93.7744944161201,FOSL1,beta,5
negative regulation of RIG-I signaling pathway (GO:0039536),1/7,1,7,0.0351634020883028,1,0,0,28.0112044817927,93.7744944161201,GPATCH3,beta,5
negative regulation of necrotic cell death (GO:0060547),1/7,1,7,0.0351634020883028,1,0,0,28.0112044817927,93.7744944161201,BIRC2,beta,5
"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",1/7,1,7,0.0351634020883028,1,0,0,28.0112044817927,93.7744944161201,TGFBR2,beta,5
cAMP catabolic process (GO:0006198),1/7,1,7,0.0351634020883028,1,0,0,28.0112044817927,93.7744944161201,PDE2A,beta,5
regulation of small GTPase mediated signal transduction (GO:0051056),3/141,3,141,0.0355241065939841,1,0,0,4.17188151856487,13.9238371045954,ARHGAP21;DEPDC1B;STARD13,beta,5
positive regulation of Wnt signaling pathway (GO:0030177),3/141,3,141,0.0355241065939841,1,0,0,4.17188151856487,13.9238371045954,DEPDC1B;NRARP;SULF1,beta,5
regulation of cell proliferation (GO:0042127),8/741,8,741,0.0356593470949023,1,0,0,2.11690614167394,7.05722309732462,FOSL1;CNOT6L;IL31RA;CDC7;SSTR4;BIRC2;CHERP;TGFBR2,beta,5
integrin-mediated signaling pathway (GO:0007229),2/59,2,59,0.0365061121411435,1,0,0,6.64672648720505,22.0024963542116,RCC2;NEDD9,beta,5
peptidyl-serine phosphorylation (GO:0018105),3/146,3,146,0.0387635176526737,1,0,0,4.0290088638195,13.0953897718154,MAST2;CDC7;TGFBR2,beta,5
positive regulation of extracellular matrix assembly (GO:1901203),1/8,1,8,0.0400857774256217,1,0,0,24.5098039215686,78.841511893331,PHLDB1,beta,5
cGMP-mediated signaling (GO:0019934),1/8,1,8,0.0400857774256217,1,0,0,24.5098039215686,78.841511893331,PDE2A,beta,5
negative regulation of protein homooligomerization (GO:0032463),1/8,1,8,0.0400857774256217,1,0,0,24.5098039215686,78.841511893331,CRYAB,beta,5
regulation of cytoplasmic mRNA processing body assembly (GO:0010603),1/8,1,8,0.0400857774256217,1,0,0,24.5098039215686,78.841511893331,CNOT6L,beta,5
positive regulation of alpha-beta T cell differentiation (GO:0046638),1/8,1,8,0.0400857774256217,1,0,0,24.5098039215686,78.841511893331,TGFBR2,beta,5
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),1/8,1,8,0.0400857774256217,1,0,0,24.5098039215686,78.841511893331,BNIP3L,beta,5
protein K6-linked ubiquitination (GO:0085020),1/8,1,8,0.0400857774256217,1,0,0,24.5098039215686,78.841511893331,BARD1,beta,5
negative regulation of vascular permeability (GO:0043116),1/8,1,8,0.0400857774256217,1,0,0,24.5098039215686,78.841511893331,PDE2A,beta,5
regulation of amyloid fibril formation (GO:1905906),1/8,1,8,0.0400857774256217,1,0,0,24.5098039215686,78.841511893331,CRYAB,beta,5
positive regulation of TORC1 signaling (GO:1904263),1/8,1,8,0.0400857774256217,1,0,0,24.5098039215686,78.841511893331,RRAGA,beta,5
osteoblast development (GO:0002076),1/8,1,8,0.0400857774256217,1,0,0,24.5098039215686,78.841511893331,ACHE,beta,5
regulation of dopamine receptor signaling pathway (GO:0060159),1/8,1,8,0.0400857774256217,1,0,0,24.5098039215686,78.841511893331,DTNBP1,beta,5
diol biosynthetic process (GO:0034312),1/8,1,8,0.0400857774256217,1,0,0,24.5098039215686,78.841511893331,SPHK1,beta,5
sphingosine biosynthetic process (GO:0046512),1/8,1,8,0.0400857774256217,1,0,0,24.5098039215686,78.841511893331,SPHK1,beta,5
positive regulation of catabolic process (GO:0009896),2/63,2,63,0.0411291639436783,1,0,0,6.22471210706505,19.8632917778526,BARD1;NEDD4,beta,5
positive regulation of programmed cell death (GO:0043068),4/258,4,258,0.0431390541028216,1,0,0,3.03997568019456,9.55563631093666,BARD1;BNIP3L;FLCN;AIFM2,beta,5
protein stabilization (GO:0050821),3/153,3,153,0.0435430155561446,1,0,0,3.84467512495194,12.0492347794354,NAA16;PPARGC1A;CRYAB,beta,5
response to UV-C (GO:0010225),1/9,1,9,0.0449832858833605,1,0,0,21.7864923747277,67.570027952534,MAP3K4,beta,5
atrioventricular valve development (GO:0003171),1/9,1,9,0.0449832858833605,1,0,0,21.7864923747277,67.570027952534,TGFBR2,beta,5
long-chain fatty acid biosynthetic process (GO:0042759),1/9,1,9,0.0449832858833605,1,0,0,21.7864923747277,67.570027952534,ALOXE3,beta,5
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),1/9,1,9,0.0449832858833605,1,0,0,21.7864923747277,67.570027952534,NEDD4,beta,5
mature B cell differentiation involved in immune response (GO:0002313),1/9,1,9,0.0449832858833605,1,0,0,21.7864923747277,67.570027952534,GPR183,beta,5
establishment of Golgi localization (GO:0051683),1/9,1,9,0.0449832858833605,1,0,0,21.7864923747277,67.570027952534,ARHGAP21,beta,5
negative regulation of mRNA 3'-end processing (GO:0031441),1/9,1,9,0.0449832858833605,1,0,0,21.7864923747277,67.570027952534,BARD1,beta,5
sphingoid biosynthetic process (GO:0046520),1/9,1,9,0.0449832858833605,1,0,0,21.7864923747277,67.570027952534,SPHK1,beta,5
L-ascorbic acid metabolic process (GO:0019852),1/9,1,9,0.0449832858833605,1,0,0,21.7864923747277,67.570027952534,SLC2A1,beta,5
sphingosine metabolic process (GO:0006670),1/9,1,9,0.0449832858833605,1,0,0,21.7864923747277,67.570027952534,SPHK1,beta,5
cyclic nucleotide catabolic process (GO:0009214),1/9,1,9,0.0449832858833605,1,0,0,21.7864923747277,67.570027952534,PDE2A,beta,5
intracellular steroid hormone receptor signaling pathway (GO:0030518),2/67,2,67,0.0459597600347484,1,0,0,5.85308750365818,18.0274454035193,NEDD4;PPARGC1A,beta,5
sphingolipid biosynthetic process (GO:0030148),2/67,2,67,0.0459597600347484,1,0,0,5.85308750365818,18.0274454035193,SPHK1;ALOXE3,beta,5
positive regulation of autophagy (GO:0010508),2/68,2,68,0.0471986449847516,1,0,0,5.76701268742791,17.6089394161066,FLCN;BNIP3L,beta,5
regulation of TOR signaling (GO:0032006),2/68,2,68,0.0471986449847516,1,0,0,5.76701268742791,17.6089394161066,FLCN;RRAGA,beta,5
regulation of epithelial to mesenchymal transition (GO:0010717),2/69,2,69,0.048449712497052,1,0,0,5.68343279340722,17.2050518594848,PHLDB1;TGFBR2,beta,5
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),2/69,2,69,0.048449712497052,1,0,0,5.68343279340722,17.2050518594848,LAMP3;BIRC2,beta,5
monocarboxylic acid biosynthetic process (GO:0072330),2/69,2,69,0.048449712497052,1,0,0,5.68343279340722,17.2050518594848,OSBPL3;MLYCD,beta,5
positive regulation of cellular biosynthetic process (GO:0031328),3/160,3,160,0.0486034375898573,1,0,0,3.67647058823529,11.1178713907188,VIM;PPARGC1A;ASS1,beta,5
regulation of programmed cell death (GO:0043067),4/269,4,269,0.0489507667362962,1,0,0,2.91566440702675,8.79638529474582,BNIP3L;AIFM2;MAP3K4;BIRC2,beta,5
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),1/10,1,10,0.0498560516752303,1,0,0,19.6078431372549,58.7963802400921,GPATCH3,beta,5
glomerular filtration (GO:0003094),1/10,1,10,0.0498560516752303,1,0,0,19.6078431372549,58.7963802400921,SULF1,beta,5
negative regulation of sodium ion transmembrane transport (GO:1902306),1/10,1,10,0.0498560516752303,1,0,0,19.6078431372549,58.7963802400921,NEDD4,beta,5
regulation of attachment of spindle microtubules to kinetochore (GO:0051988),1/10,1,10,0.0498560516752303,1,0,0,19.6078431372549,58.7963802400921,RCC2,beta,5
response to laminar fluid shear stress (GO:0034616),1/10,1,10,0.0498560516752303,1,0,0,19.6078431372549,58.7963802400921,ASS1,beta,5
negative regulation of sodium ion transmembrane transporter activity (GO:2000650),1/10,1,10,0.0498560516752303,1,0,0,19.6078431372549,58.7963802400921,NEDD4,beta,5
negative regulation of embryonic development (GO:0045992),1/10,1,10,0.0498560516752303,1,0,0,19.6078431372549,58.7963802400921,SULF1,beta,5
aspartate family amino acid metabolic process (GO:0009066),1/10,1,10,0.0498560516752303,1,0,0,19.6078431372549,58.7963802400921,ASS1,beta,5
"regulation of DNA-templated transcription, initiation (GO:2000142)",1/10,1,10,0.0498560516752303,1,0,0,19.6078431372549,58.7963802400921,FOSL1,beta,5
regulation of mRNA 3'-end processing (GO:0031440),1/10,1,10,0.0498560516752303,1,0,0,19.6078431372549,58.7963802400921,BARD1,beta,5
T cell chemotaxis (GO:0010818),1/10,1,10,0.0498560516752303,1,0,0,19.6078431372549,58.7963802400921,GPR183,beta,5
endothelial tube morphogenesis (GO:0061154),1/10,1,10,0.0498560516752303,1,0,0,19.6078431372549,58.7963802400921,STARD13,beta,5
negative regulation of reproductive process (GO:2000242),1/10,1,10,0.0498560516752303,1,0,0,19.6078431372549,58.7963802400921,SULF1,beta,5
myeloid dendritic cell differentiation (GO:0043011),1/10,1,10,0.0498560516752303,1,0,0,19.6078431372549,58.7963802400921,TGFBR2,beta,5
negative regulation of morphogenesis of an epithelium (GO:1905331),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,SULF1,beta,5
negative regulation of leukocyte activation (GO:0002695),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,IL31RA,beta,5
arginine metabolic process (GO:0006525),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,ASS1,beta,5
mononuclear cell differentiation (GO:1903131),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,IL31RA,beta,5
negative regulation of leukocyte cell-cell adhesion (GO:1903038),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,ASS1,beta,5
T-helper cell differentiation (GO:0042093),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,GPR183,beta,5
positive regulation of cytolysis (GO:0045919),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,RRAGA,beta,5
carbohydrate phosphorylation (GO:0046835),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,GNPTG,beta,5
urea cycle (GO:0000050),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,ASS1,beta,5
inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,BIRC2,beta,5
positive regulation of glucose metabolic process (GO:0010907),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,PPARGC1A,beta,5
embryonic hemopoiesis (GO:0035162),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,TGFBR2,beta,5
monocyte differentiation (GO:0030224),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,IL31RA,beta,5
positive regulation of mesenchymal cell proliferation (GO:0002053),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,TGFBR2,beta,5
positive regulation of chromosome segregation (GO:0051984),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,RCC2,beta,5
renal filtration (GO:0097205),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,SULF1,beta,5
sphingolipid catabolic process (GO:0030149),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,SPHK1,beta,5
response to sterol (GO:0036314),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,TGFBR2,beta,5
macrophage differentiation (GO:0030225),1/11,1,11,0.0547041984298952,1,0,0,17.825311942959,51.7970555927597,IL31RA,beta,5
mitochondrion organization (GO:0007005),3/168,3,168,0.0547240094104418,1,0,0,3.50140056022409,10.1731538409048,BNIP3L;AIFM2;PPARGC1A,beta,5
peptidyl-serine modification (GO:0018209),3/171,3,171,0.0571102693667582,1,0,0,3.43997248022016,9.84785459128365,MAST2;CDC7;TGFBR2,beta,5
mRNA processing (GO:0006397),4/284,4,284,0.0575403029457923,1,0,0,2.76166804750069,7.8853069757324,RSRC1;YBX1;PPARGC1A;CHERP,beta,5
hemopoiesis (GO:0030097),2/77,2,77,0.0588786300102408,1,0,0,5.09294626941686,14.4246349494338,FLCN;TGFBR2,beta,5
cellular response to fluid shear stress (GO:0071498),1/12,1,12,0.0595278491998326,1,0,0,16.3398692810458,46.0998533031839,ASS1,beta,5
regulation of mesenchymal cell proliferation (GO:0010464),1/12,1,12,0.0595278491998326,1,0,0,16.3398692810458,46.0998533031839,TGFBR2,beta,5
negative regulation of protein oligomerization (GO:0032460),1/12,1,12,0.0595278491998326,1,0,0,16.3398692810458,46.0998533031839,CRYAB,beta,5
regulation of leukocyte cell-cell adhesion (GO:1903037),1/12,1,12,0.0595278491998326,1,0,0,16.3398692810458,46.0998533031839,ASS1,beta,5
protein localization to kinetochore (GO:0034501),1/12,1,12,0.0595278491998326,1,0,0,16.3398692810458,46.0998533031839,RCC2,beta,5
"regulation of protein import into nucleus, translocation (GO:0033158)",1/12,1,12,0.0595278491998326,1,0,0,16.3398692810458,46.0998533031839,PDE2A,beta,5
mitochondrial outer membrane permeabilization (GO:0097345),1/12,1,12,0.0595278491998326,1,0,0,16.3398692810458,46.0998533031839,BNIP3L,beta,5
regulation of cytokine biosynthetic process (GO:0042035),1/12,1,12,0.0595278491998326,1,0,0,16.3398692810458,46.0998533031839,MAST2,beta,5
Golgi localization (GO:0051645),1/12,1,12,0.0595278491998326,1,0,0,16.3398692810458,46.0998533031839,ARHGAP21,beta,5
positive regulation of DNA-dependent DNA replication (GO:2000105),1/12,1,12,0.0595278491998326,1,0,0,16.3398692810458,46.0998533031839,CDC7,beta,5
negative regulation of ATP metabolic process (GO:1903579),1/12,1,12,0.0595278491998326,1,0,0,16.3398692810458,46.0998533031839,FLCN,beta,5
peptidyl-methionine modification (GO:0018206),1/12,1,12,0.0595278491998326,1,0,0,16.3398692810458,46.0998533031839,NAA16,beta,5
negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),1/12,1,12,0.0595278491998326,1,0,0,16.3398692810458,46.0998533031839,RCC2,beta,5
plasma membrane tubulation (GO:0097320),1/12,1,12,0.0595278491998326,1,0,0,16.3398692810458,46.0998533031839,WHAMM,beta,5
negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),1/12,1,12,0.0595278491998326,1,0,0,16.3398692810458,46.0998533031839,SULF1,beta,5
"positive regulation of transcription, DNA-templated (GO:0045893)",10/1121,10,1121,0.0597753790080367,1,0,0,1.74913854926449,4.92760564810843,FOSL1;FLCN;MAFF;FOXJ3;GLIS3;IL31RA;NAA16;GPATCH3;YBX1;PPARGC1A,beta,5
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),2/78,2,78,0.0602325671185912,1,0,0,5.02765208647562,14.1254001553997,CD109;TGFBR2,beta,5
regulation of endothelial cell proliferation (GO:0001936),2/80,2,80,0.0629723970464633,1,0,0,4.90196078431373,13.5542097584438,NRARP;SULF1,beta,5
modulation by virus of host process (GO:0019054),1/13,1,13,0.0643271264420606,1,0,0,15.0829562594268,41.3842211700618,KPNA7,beta,5
regulation of necrotic cell death (GO:0010939),1/13,1,13,0.0643271264420606,1,0,0,15.0829562594268,41.3842211700618,BIRC2,beta,5
regulation of viral life cycle (GO:1903900),1/13,1,13,0.0643271264420606,1,0,0,15.0829562594268,41.3842211700618,LAMP3,beta,5
"Notch receptor processing, ligand-dependent (GO:0035333)",1/13,1,13,0.0643271264420606,1,0,0,15.0829562594268,41.3842211700618,YBX1,beta,5
positive regulation of alpha-beta T cell proliferation (GO:0046641),1/13,1,13,0.0643271264420606,1,0,0,15.0829562594268,41.3842211700618,TGFBR2,beta,5
tricarboxylic acid metabolic process (GO:0072350),1/13,1,13,0.0643271264420606,1,0,0,15.0829562594268,41.3842211700618,ASS1,beta,5
regulation of cytolysis (GO:0042268),1/13,1,13,0.0643271264420606,1,0,0,15.0829562594268,41.3842211700618,RRAGA,beta,5
positive regulation of actin nucleation (GO:0051127),1/13,1,13,0.0643271264420606,1,0,0,15.0829562594268,41.3842211700618,WHAMM,beta,5
pathway-restricted SMAD protein phosphorylation (GO:0060389),1/13,1,13,0.0643271264420606,1,0,0,15.0829562594268,41.3842211700618,TGFBR2,beta,5
glutamine family amino acid biosynthetic process (GO:0009084),1/13,1,13,0.0643271264420606,1,0,0,15.0829562594268,41.3842211700618,ASS1,beta,5
cardiolipin metabolic process (GO:0032048),1/13,1,13,0.0643271264420606,1,0,0,15.0829562594268,41.3842211700618,PLA2G4A,beta,5
amyloid precursor protein metabolic process (GO:0042982),1/13,1,13,0.0643271264420606,1,0,0,15.0829562594268,41.3842211700618,ACHE,beta,5
B cell activation involved in immune response (GO:0002312),1/13,1,13,0.0643271264420606,1,0,0,15.0829562594268,41.3842211700618,GPR183,beta,5
positive regulation of muscle contraction (GO:0045933),1/13,1,13,0.0643271264420606,1,0,0,15.0829562594268,41.3842211700618,SPHK1,beta,5
regulation of cellular carbohydrate metabolic process (GO:0010675),1/13,1,13,0.0643271264420606,1,0,0,15.0829562594268,41.3842211700618,MLYCD,beta,5
positive regulation of protein catabolic process (GO:0045732),2/82,2,82,0.0657538944722182,1,0,0,4.78240076518412,13.0169123776267,BARD1;NEDD4,beta,5
negative regulation of cell death (GO:0060548),2/82,2,82,0.0657538944722182,1,0,0,4.78240076518412,13.0169123776267,BNIP3L;PPARGC1A,beta,5
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),2/83,2,83,0.0671599202216013,1,0,0,4.7247814788566,12.7601163933812,FLCN;SULF1,beta,5
positive regulation of protein ubiquitination (GO:0031398),2/84,2,84,0.0685759471556752,1,0,0,4.66853408029879,12.510800328134,SPHK1;BIRC2,beta,5
negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),1/14,1,14,0.0691021520388373,1,0,0,14.0056022408964,37.4253418047732,STARD13,beta,5
acetyl-CoA metabolic process (GO:0006084),1/14,1,14,0.0691021520388373,1,0,0,14.0056022408964,37.4253418047732,MLYCD,beta,5
myeloid dendritic cell activation (GO:0001773),1/14,1,14,0.0691021520388373,1,0,0,14.0056022408964,37.4253418047732,TGFBR2,beta,5
regulation of nucleocytoplasmic transport (GO:0046822),1/14,1,14,0.0691021520388373,1,0,0,14.0056022408964,37.4253418047732,NEDD4,beta,5
regulation of phosphate metabolic process (GO:0019220),1/14,1,14,0.0691021520388373,1,0,0,14.0056022408964,37.4253418047732,BARD1,beta,5
regulation of gastrulation (GO:0010470),1/14,1,14,0.0691021520388373,1,0,0,14.0056022408964,37.4253418047732,PHLDB1,beta,5
regulation of synapse organization (GO:0050807),1/14,1,14,0.0691021520388373,1,0,0,14.0056022408964,37.4253418047732,NEDD4,beta,5
endoplasmic reticulum tubular network organization (GO:0071786),1/14,1,14,0.0691021520388373,1,0,0,14.0056022408964,37.4253418047732,ATL2,beta,5
neurotransmitter biosynthetic process (GO:0042136),1/14,1,14,0.0691021520388373,1,0,0,14.0056022408964,37.4253418047732,ACHE,beta,5
negative regulation of Rho protein signal transduction (GO:0035024),1/14,1,14,0.0691021520388373,1,0,0,14.0056022408964,37.4253418047732,FLCN,beta,5
regulation of histone modification (GO:0031056),1/14,1,14,0.0691021520388373,1,0,0,14.0056022408964,37.4253418047732,FLCN,beta,5
acyl-CoA biosynthetic process (GO:0071616),1/14,1,14,0.0691021520388373,1,0,0,14.0056022408964,37.4253418047732,MLYCD,beta,5
negative regulation of focal adhesion assembly (GO:0051895),1/14,1,14,0.0691021520388373,1,0,0,14.0056022408964,37.4253418047732,RCC2,beta,5
histone H4-K16 acetylation (GO:0043984),1/14,1,14,0.0691021520388373,1,0,0,14.0056022408964,37.4253418047732,KANSL1,beta,5
cardiac left ventricle morphogenesis (GO:0003214),1/14,1,14,0.0691021520388373,1,0,0,14.0056022408964,37.4253418047732,TGFBR2,beta,5
positive regulation of smooth muscle contraction (GO:0045987),1/14,1,14,0.0691021520388373,1,0,0,14.0056022408964,37.4253418047732,SPHK1,beta,5
positive regulation of apoptotic process (GO:0043065),4/308,4,308,0.0728540817667478,1,0,0,2.54647313470843,6.66996872464461,BARD1;BNIP3L;FLCN;AIFM2,beta,5
positive regulation of peptidyl-lysine acetylation (GO:2000758),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,PPARGC1A,beta,5
atrioventricular valve morphogenesis (GO:0003181),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,TGFBR2,beta,5
response to cholesterol (GO:0070723),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,TGFBR2,beta,5
N-terminal protein amino acid acetylation (GO:0006474),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,NAA16,beta,5
histone H4-K8 acetylation (GO:0043982),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,KANSL1,beta,5
phosphatidylethanolamine biosynthetic process (GO:0006646),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,CHKA,beta,5
negative regulation of adherens junction organization (GO:1903392),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,RCC2,beta,5
regulation of protein homooligomerization (GO:0032462),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,CRYAB,beta,5
endocardial cushion morphogenesis (GO:0003203),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,TGFBR2,beta,5
positive regulation of collagen metabolic process (GO:0010714),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,VIM,beta,5
positive regulation of NF-kappaB import into nucleus (GO:0042346),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,SPHK1,beta,5
transport along microtubule (GO:0010970),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,ARHGAP21,beta,5
L-alpha-amino acid transmembrane transport (GO:1902475),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,SLC7A5,beta,5
lipoxygenase pathway (GO:0019372),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,ALOXE3,beta,5
positive regulation of cytokine production involved in immune response (GO:0002720),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,RAET1G,beta,5
anterograde synaptic vesicle transport (GO:0048490),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,DTNBP1,beta,5
unsaturated fatty acid biosynthetic process (GO:0006636),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,ALOXE3,beta,5
negative regulation of mRNA processing (GO:0050686),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,BARD1,beta,5
positive regulation of collagen biosynthetic process (GO:0032967),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,VIM,beta,5
synaptic vesicle transport along microtubule (GO:0099517),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,DTNBP1,beta,5
embryonic cranial skeleton morphogenesis (GO:0048701),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,TGFBR2,beta,5
inhibition of cysteine-type endopeptidase activity (GO:0097340),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,BIRC2,beta,5
intra-S DNA damage checkpoint (GO:0031573),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,EME2,beta,5
histone H4-K5 acetylation (GO:0043981),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,KANSL1,beta,5
cellular response to corticosteroid stimulus (GO:0071384),1/15,1,15,0.0738530472723681,1,0,0,13.0718954248366,34.0611504295229,SSTR4,beta,5
mitochondrial translational elongation (GO:0070125),2/88,2,88,0.0743373585606437,1,0,0,4.45632798573975,11.5826276587174,MRPS16;MRPS34,beta,5
RNA processing (GO:0006396),3/194,3,194,0.0769885677432779,1,0,0,3.03214069132808,7.7747069103028,RSRC1;PPARGC1A;DEDD2,beta,5
mitochondrial translational termination (GO:0070126),2/90,2,90,0.0772745814186409,1,0,0,4.35729847494553,11.1563843475144,MRPS16;MRPS34,beta,5
T cell migration (GO:0072678),1/16,1,16,0.0785799328413005,1,0,0,12.2549019607843,31.1720455821819,GPR183,beta,5
regulation of actin nucleation (GO:0051125),1/16,1,16,0.0785799328413005,1,0,0,12.2549019607843,31.1720455821819,WHAMM,beta,5
dendritic cell chemotaxis (GO:0002407),1/16,1,16,0.0785799328413005,1,0,0,12.2549019607843,31.1720455821819,GPR183,beta,5
Notch receptor processing (GO:0007220),1/16,1,16,0.0785799328413005,1,0,0,12.2549019607843,31.1720455821819,YBX1,beta,5
glucose transmembrane transport (GO:1904659),1/16,1,16,0.0785799328413005,1,0,0,12.2549019607843,31.1720455821819,SLC2A1,beta,5
establishment of skin barrier (GO:0061436),1/16,1,16,0.0785799328413005,1,0,0,12.2549019607843,31.1720455821819,ALOXE3,beta,5
regulation of dopamine secretion (GO:0014059),1/16,1,16,0.0785799328413005,1,0,0,12.2549019607843,31.1720455821819,DTNBP1,beta,5
negative regulation of response to wounding (GO:1903035),1/16,1,16,0.0785799328413005,1,0,0,12.2549019607843,31.1720455821819,CD109,beta,5
phosphatidylinositol acyl-chain remodeling (GO:0036149),1/16,1,16,0.0785799328413005,1,0,0,12.2549019607843,31.1720455821819,PLA2G4A,beta,5
regulation of water loss via skin (GO:0033561),1/16,1,16,0.0785799328413005,1,0,0,12.2549019607843,31.1720455821819,ALOXE3,beta,5
stabilization of membrane potential (GO:0030322),1/16,1,16,0.0785799328413005,1,0,0,12.2549019607843,31.1720455821819,KCNK1,beta,5
regulation of necroptotic process (GO:0060544),1/16,1,16,0.0785799328413005,1,0,0,12.2549019607843,31.1720455821819,BIRC2,beta,5
linoleic acid metabolic process (GO:0043651),1/16,1,16,0.0785799328413005,1,0,0,12.2549019607843,31.1720455821819,ALOXE3,beta,5
regulation of glucose transport (GO:0010827),1/16,1,16,0.0785799328413005,1,0,0,12.2549019607843,31.1720455821819,SLC2A1,beta,5
"positive regulation of DNA-templated transcription, initiation (GO:2000144)",1/16,1,16,0.0785799328413005,1,0,0,12.2549019607843,31.1720455821819,FOSL1,beta,5
cell-matrix adhesion (GO:0007160),2/91,2,91,0.0787568634300608,1,0,0,4.30941607412196,10.951906271953,RCC2;WHAMM,beta,5
regulation of cytokine-mediated signaling pathway (GO:0001959),2/91,2,91,0.0787568634300608,1,0,0,4.30941607412196,10.951906271953,SPHK1;BIRC2,beta,5
regulation of cell migration (GO:0030334),4/317,4,317,0.0790837164676856,1,0,0,2.47417579018989,6.27759828163655,FLCN;RCC2;SPHK1;SULF1,beta,5
regulation of protein catabolic process (GO:0042176),2/92,2,92,0.0802480872631193,1,0,0,4.26257459505541,10.75290857623,BARD1;NEDD4,beta,5
rRNA catabolic process (GO:0016075),1/17,1,17,0.0832829288371864,1,0,0,11.5340253748558,28.6679548643565,DEDD2,beta,5
regulation of collagen biosynthetic process (GO:0032965),1/17,1,17,0.0832829288371864,1,0,0,11.5340253748558,28.6679548643565,VIM,beta,5
DNA catabolic process (GO:0006308),1/17,1,17,0.0832829288371864,1,0,0,11.5340253748558,28.6679548643565,ISG20,beta,5
response to interferon-alpha (GO:0035455),1/17,1,17,0.0832829288371864,1,0,0,11.5340253748558,28.6679548643565,LAMP3,beta,5
N-terminal protein amino acid modification (GO:0031365),1/17,1,17,0.0832829288371864,1,0,0,11.5340253748558,28.6679548643565,NAA16,beta,5
chaperone-mediated protein complex assembly (GO:0051131),1/17,1,17,0.0832829288371864,1,0,0,11.5340253748558,28.6679548643565,PTGES3L,beta,5
positive regulation of telomere capping (GO:1904355),1/17,1,17,0.0832829288371864,1,0,0,11.5340253748558,28.6679548643565,MAP3K4,beta,5
cellular response to glucocorticoid stimulus (GO:0071385),1/17,1,17,0.0832829288371864,1,0,0,11.5340253748558,28.6679548643565,SSTR4,beta,5
negative regulation of intracellular transport (GO:0032387),1/17,1,17,0.0832829288371864,1,0,0,11.5340253748558,28.6679548643565,CRYAB,beta,5
regulation of cell death (GO:0010941),2/97,2,97,0.0878339041896192,1,0,0,4.0428542551041,9.83346553619324,BNIP3L;CRYAB,beta,5
positive regulation of protein metabolic process (GO:0051247),2/97,2,97,0.0878339041896192,1,0,0,4.0428542551041,9.83346553619324,BARD1;NEDD4,beta,5
translational termination (GO:0006415),2/97,2,97,0.0878339041896192,1,0,0,4.0428542551041,9.83346553619324,MRPS16;MRPS34,beta,5
regulation of viral process (GO:0050792),1/18,1,18,0.0879621547820787,1,0,0,10.8932461873638,26.4798324215742,LAMP3,beta,5
cellular response to gamma radiation (GO:0071480),1/18,1,18,0.0879621547820787,1,0,0,10.8932461873638,26.4798324215742,CRYAB,beta,5
positive regulation of p38MAPK cascade (GO:1900745),1/18,1,18,0.0879621547820787,1,0,0,10.8932461873638,26.4798324215742,MAP3K4,beta,5
phosphatidylglycerol acyl-chain remodeling (GO:0036148),1/18,1,18,0.0879621547820787,1,0,0,10.8932461873638,26.4798324215742,PLA2G4A,beta,5
regulation of cAMP-mediated signaling (GO:0043949),1/18,1,18,0.0879621547820787,1,0,0,10.8932461873638,26.4798324215742,PDE2A,beta,5
regulation of cellular response to growth factor stimulus (GO:0090287),1/18,1,18,0.0879621547820787,1,0,0,10.8932461873638,26.4798324215742,SULF1,beta,5
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),1/18,1,18,0.0879621547820787,1,0,0,10.8932461873638,26.4798324215742,NEDD4,beta,5
positive regulation of natural killer cell mediated immunity (GO:0002717),1/18,1,18,0.0879621547820787,1,0,0,10.8932461873638,26.4798324215742,RAET1G,beta,5
cellular response to organonitrogen compound (GO:0071417),2/98,2,98,0.0893761356656345,1,0,0,4.0016006402561,9.6634716738709,RRAGA;PDE2A,beta,5
negative regulation of cell motility (GO:2000146),2/98,2,98,0.0893761356656345,1,0,0,4.0016006402561,9.6634716738709,FLCN;SULF1,beta,5
response to UV (GO:0009411),2/99,2,99,0.0909264374481328,1,0,0,3.96118043176867,9.49774006366089,NEDD4;MAP3K4,beta,5
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),1/19,1,19,0.0926177296022899,1,0,0,10.3199174406605,24.553918382553,FLCN,beta,5
negative regulation of cell junction assembly (GO:1901889),1/19,1,19,0.0926177296022899,1,0,0,10.3199174406605,24.553918382553,RCC2,beta,5
protein targeting to lysosome (GO:0006622),1/19,1,19,0.0926177296022899,1,0,0,10.3199174406605,24.553918382553,NEDD4,beta,5
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),1/19,1,19,0.0926177296022899,1,0,0,10.3199174406605,24.553918382553,LAMP3,beta,5
endothelial cell development (GO:0001885),1/19,1,19,0.0926177296022899,1,0,0,10.3199174406605,24.553918382553,PDE2A,beta,5
DNA double-strand break processing (GO:0000729),1/19,1,19,0.0926177296022899,1,0,0,10.3199174406605,24.553918382553,BARD1,beta,5
hexose transmembrane transport (GO:0035428),1/19,1,19,0.0926177296022899,1,0,0,10.3199174406605,24.553918382553,SLC2A1,beta,5
osteoclast differentiation (GO:0030316),1/19,1,19,0.0926177296022899,1,0,0,10.3199174406605,24.553918382553,GPR183,beta,5
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),1/19,1,19,0.0926177296022899,1,0,0,10.3199174406605,24.553918382553,FLCN,beta,5
purine ribonucleotide catabolic process (GO:0009154),1/19,1,19,0.0926177296022899,1,0,0,10.3199174406605,24.553918382553,PDE2A,beta,5
cellular response to transforming growth factor beta stimulus (GO:0071560),2/101,2,101,0.0940507712222756,1,0,0,3.882741215298,9.17849164487748,PDE2A;TGFBR2,beta,5
regulation of gluconeogenesis (GO:0006111),1/20,1,20,0.0972497716409989,1,0,0,9.80392156862745,22.847771025989,PPARGC1A,beta,5
proteoglycan metabolic process (GO:0006029),1/20,1,20,0.0972497716409989,1,0,0,9.80392156862745,22.847771025989,SULF1,beta,5
regulation of toll-like receptor signaling pathway (GO:0034121),1/20,1,20,0.0972497716409989,1,0,0,9.80392156862745,22.847771025989,BIRC2,beta,5
negative regulation of ion transport (GO:0043271),1/20,1,20,0.0972497716409989,1,0,0,9.80392156862745,22.847771025989,NEDD4,beta,5
phosphatidylethanolamine metabolic process (GO:0046337),1/20,1,20,0.0972497716409989,1,0,0,9.80392156862745,22.847771025989,CHKA,beta,5
neuromuscular junction development (GO:0007528),1/20,1,20,0.0972497716409989,1,0,0,9.80392156862745,22.847771025989,NEDD4,beta,5
heparan sulfate proteoglycan metabolic process (GO:0030201),1/20,1,20,0.0972497716409989,1,0,0,9.80392156862745,22.847771025989,SULF1,beta,5
regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),1/20,1,20,0.0972497716409989,1,0,0,9.80392156862745,22.847771025989,SULF1,beta,5
Arp2/3 complex-mediated actin nucleation (GO:0034314),1/20,1,20,0.0972497716409989,1,0,0,9.80392156862745,22.847771025989,WHAMM,beta,5
regulation of transport (GO:0051049),1/20,1,20,0.0972497716409989,1,0,0,9.80392156862745,22.847771025989,SLC2A1,beta,5
positive regulation of gene expression (GO:0010628),7/772,7,772,0.0995782296959701,1,0,0,1.77791323783399,4.10131108641409,LAMP3;IL31RA;DTNBP1;NAA16;GPATCH3;VIM;PPARGC1A,beta,5
nitric oxide mediated signal transduction (GO:0007263),2/15,2,15,0.000257040841751126,1,0,0,83.3333333333333,688.856297364626,NOS3;NDNF,delta,1
regulation of nitric-oxide synthase activity (GO:0050999),2/37,2,37,0.00159496846755679,1,0,0,33.7837837837838,217.598017314109,S100A1;NOS3,delta,1
regulation of DNA binding (GO:0051101),2/53,2,53,0.00324789608431091,1,0,0,23.5849056603774,135.135562522197,CDT1;MDFI,delta,1
sterol metabolic process (GO:0016125),2/60,2,60,0.00414285210119861,1,0,0,20.8333333333333,114.299391979245,CYP27A1;NR0B2,delta,1
second-messenger-mediated signaling (GO:0019932),2/63,2,63,0.00455755366326491,1,0,0,19.8412698412698,106.963676126299,NOS3;NDNF,delta,1
monocarboxylic acid biosynthetic process (GO:0072330),2/69,2,69,0.00544208532146935,1,0,0,18.1159420289855,94.4491478335951,CYP27A1;ACSF3,delta,1
regulation of T cell tolerance induction (GO:0002664),1/6,1,6,0.00956277225126547,1,0,0,104.166666666667,484.362250991062,HLA-G,delta,1
inner ear receptor cell differentiation (GO:0060113),1/6,1,6,0.00956277225126547,1,0,0,104.166666666667,484.362250991062,USH2A,delta,1
ceramide transport (GO:0035627),1/6,1,6,0.00956277225126547,1,0,0,104.166666666667,484.362250991062,COL4A3BP,delta,1
immune response-inhibiting cell surface receptor signaling pathway (GO:0002767),1/6,1,6,0.00956277225126547,1,0,0,104.166666666667,484.362250991062,HLA-G,delta,1
iron ion import (GO:0097286),1/6,1,6,0.00956277225126547,1,0,0,104.166666666667,484.362250991062,TFR2,delta,1
positive regulation of cGMP biosynthetic process (GO:0030828),1/6,1,6,0.00956277225126547,1,0,0,104.166666666667,484.362250991062,NOS3,delta,1
cellular response to iron ion (GO:0071281),1/6,1,6,0.00956277225126547,1,0,0,104.166666666667,484.362250991062,TFR2,delta,1
steroid metabolic process (GO:0008202),2/100,2,100,0.0111345221222249,1,0,0,12.5,56.2213111990319,CYP27A1;DHRS2,delta,1
positive regulation of membrane depolarization (GO:1904181),1/7,1,7,0.0111479378107246,1,0,0,89.2857142857143,401.473281061796,MLLT11,delta,1
regulation of dendritic cell differentiation (GO:2001198),1/7,1,7,0.0111479378107246,1,0,0,89.2857142857143,401.473281061796,HLA-G,delta,1
positive regulation of angiogenesis (GO:0045766),2/104,2,104,0.0120000873782114,1,0,0,12.0192307692308,53.1591508137383,S100A1;NOS3,delta,1
positive regulation of cellular component organization (GO:0051130),2/107,2,107,0.012668114947714,1,0,0,11.6822429906542,51.0358303327398,CDT1;TFR2,delta,1
positive regulation of chromatin binding (GO:0035563),1/8,1,8,0.0127306462090213,1,0,0,78.125,340.917430079138,CDT1,delta,1
arginine catabolic process (GO:0006527),1/8,1,8,0.0127306462090213,1,0,0,78.125,340.917430079138,NOS3,delta,1
angiogenesis involved in wound healing (GO:0060055),1/8,1,8,0.0127306462090213,1,0,0,78.125,340.917430079138,NDNF,delta,1
microvillus assembly (GO:0030033),1/8,1,8,0.0127306462090213,1,0,0,78.125,340.917430079138,FXYD5,delta,1
positive regulation of regulatory T cell differentiation (GO:0045591),1/8,1,8,0.0127306462090213,1,0,0,78.125,340.917430079138,HLA-G,delta,1
microvillus organization (GO:0032528),1/8,1,8,0.0127306462090213,1,0,0,78.125,340.917430079138,FXYD5,delta,1
negative regulation of double-strand break repair via homologous recombination (GO:2000042),1/8,1,8,0.0127306462090213,1,0,0,78.125,340.917430079138,POLK,delta,1
positive regulation of mitotic metaphase/anaphase transition (GO:0045842),1/9,1,9,0.0143109010156189,1,0,0,69.4444444444445,294.912064120938,CDT1,delta,1
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",1/9,1,9,0.0143109010156189,1,0,0,69.4444444444445,294.912064120938,HLA-G,delta,1
removal of superoxide radicals (GO:0019430),1/9,1,9,0.0143109010156189,1,0,0,69.4444444444445,294.912064120938,NOS3,delta,1
vasodilation (GO:0042311),1/9,1,9,0.0143109010156189,1,0,0,69.4444444444445,294.912064120938,NOS3,delta,1
positive regulation of protein maturation (GO:1903319),1/9,1,9,0.0143109010156189,1,0,0,69.4444444444445,294.912064120938,TFR2,delta,1
cellular response to superoxide (GO:0071451),1/9,1,9,0.0143109010156189,1,0,0,69.4444444444445,294.912064120938,NOS3,delta,1
regulation of hair cycle (GO:0042634),1/9,1,9,0.0143109010156189,1,0,0,69.4444444444445,294.912064120938,TRPV3,delta,1
dorsal/ventral axis specification (GO:0009950),1/10,1,10,0.0158887058240638,1,0,0,62.5,258.884171730453,MDFI,delta,1
hair cell differentiation (GO:0035315),1/10,1,10,0.0158887058240638,1,0,0,62.5,258.884171730453,USH2A,delta,1
detection of light stimulus involved in visual perception (GO:0050908),1/10,1,10,0.0158887058240638,1,0,0,62.5,258.884171730453,EYS,delta,1
regulation of mitochondrial depolarization (GO:0051900),1/10,1,10,0.0158887058240638,1,0,0,62.5,258.884171730453,MLLT11,delta,1
myeloid dendritic cell differentiation (GO:0043011),1/10,1,10,0.0158887058240638,1,0,0,62.5,258.884171730453,DHRS2,delta,1
negative regulation of cell activation (GO:0050866),1/10,1,10,0.0158887058240638,1,0,0,62.5,258.884171730453,NOS3,delta,1
nitric oxide biosynthetic process (GO:0006809),1/11,1,11,0.0174640642408144,1,0,0,56.8181818181818,229.977839844911,NOS3,delta,1
detection of light stimulus involved in sensory perception (GO:0050962),1/11,1,11,0.0174640642408144,1,0,0,56.8181818181818,229.977839844911,EYS,delta,1
regulation of chromatin binding (GO:0035561),1/11,1,11,0.0174640642408144,1,0,0,56.8181818181818,229.977839844911,CDT1,delta,1
arginine metabolic process (GO:0006525),1/11,1,11,0.0174640642408144,1,0,0,56.8181818181818,229.977839844911,NOS3,delta,1
immune response-regulating cell surface receptor signaling pathway (GO:0002768),1/11,1,11,0.0174640642408144,1,0,0,56.8181818181818,229.977839844911,HLA-G,delta,1
iron ion transport (GO:0006826),1/12,1,12,0.0190369798873028,1,0,0,52.0833333333333,206.321452164825,TFR2,delta,1
positive regulation of lyase activity (GO:0051349),1/12,1,12,0.0190369798873028,1,0,0,52.0833333333333,206.321452164825,NOS3,delta,1
positive regulation of cyclase activity (GO:0031281),1/12,1,12,0.0190369798873028,1,0,0,52.0833333333333,206.321452164825,NOS3,delta,1
somatic hypermutation of immunoglobulin genes (GO:0016446),1/12,1,12,0.0190369798873028,1,0,0,52.0833333333333,206.321452164825,POLK,delta,1
positive regulation of DNA-dependent DNA replication (GO:2000105),1/12,1,12,0.0190369798873028,1,0,0,52.0833333333333,206.321452164825,CDT1,delta,1
kinetochore organization (GO:0051383),1/12,1,12,0.0190369798873028,1,0,0,52.0833333333333,206.321452164825,CDT1,delta,1
nitric oxide metabolic process (GO:0046209),1/12,1,12,0.0190369798873028,1,0,0,52.0833333333333,206.321452164825,NOS3,delta,1
regulation of DNA-dependent DNA replication (GO:0090329),1/12,1,12,0.0190369798873028,1,0,0,52.0833333333333,206.321452164825,CDT1,delta,1
attachment of mitotic spindle microtubules to kinetochore (GO:0051315),1/12,1,12,0.0190369798873028,1,0,0,52.0833333333333,206.321452164825,CDT1,delta,1
regulation of blood vessel size (GO:0050880),1/12,1,12,0.0190369798873028,1,0,0,52.0833333333333,206.321452164825,NOS3,delta,1
response to iron ion (GO:0010039),1/13,1,13,0.0206074563833083,1,0,0,48.0769230769231,186.639534054023,TFR2,delta,1
dicarboxylic acid catabolic process (GO:0043649),1/13,1,13,0.0206074563833083,1,0,0,48.0769230769231,186.639534054023,ACSF3,delta,1
negative regulation of blood pressure (GO:0045776),1/13,1,13,0.0206074563833083,1,0,0,48.0769230769231,186.639534054023,NOS3,delta,1
negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),2/141,2,141,0.0213185534337221,1,0,0,8.86524822695036,34.1150490442117,NR0B2;GLIS2,delta,1
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),1/14,1,14,0.0221754973519546,1,0,0,44.6428571428571,170.034255470513,CDT1,delta,1
positive regulation of blood vessel diameter (GO:0097755),1/14,1,14,0.0221754973519546,1,0,0,44.6428571428571,170.034255470513,NOS3,delta,1
myeloid dendritic cell activation (GO:0001773),1/14,1,14,0.0221754973519546,1,0,0,44.6428571428571,170.034255470513,DHRS2,delta,1
cytoplasmic sequestering of protein (GO:0051220),1/15,1,15,0.0237411064214928,1,0,0,41.6666666666667,155.856136878959,MDFI,delta,1
negative regulation of platelet activation (GO:0010544),1/15,1,15,0.0237411064214928,1,0,0,41.6666666666667,155.856136878959,NOS3,delta,1
intracellular lipid transport (GO:0032365),1/15,1,15,0.0237411064214928,1,0,0,41.6666666666667,155.856136878959,COL4A3BP,delta,1
regulation of systemic arterial blood pressure by hormone (GO:0001990),1/16,1,16,0.0253042872146084,1,0,0,39.0625,143.624275096941,NOS3,delta,1
cytoplasmic sequestering of transcription factor (GO:0042994),1/16,1,16,0.0253042872146084,1,0,0,39.0625,143.624275096941,MDFI,delta,1
positive regulation of immune system process (GO:0002684),1/16,1,16,0.0253042872146084,1,0,0,39.0625,143.624275096941,HLA-G,delta,1
positive regulation of nitric-oxide synthase activity (GO:0051000),1/16,1,16,0.0253042872146084,1,0,0,39.0625,143.624275096941,S100A1,delta,1
detection of visible light (GO:0009584),1/16,1,16,0.0253042872146084,1,0,0,39.0625,143.624275096941,EYS,delta,1
glutamine family amino acid catabolic process (GO:0009065),1/16,1,16,0.0253042872146084,1,0,0,39.0625,143.624275096941,NOS3,delta,1
negative regulation of DNA recombination (GO:0045910),1/16,1,16,0.0253042872146084,1,0,0,39.0625,143.624275096941,POLK,delta,1
positive regulation of hormone secretion (GO:0046887),1/17,1,17,0.0268650433589444,1,0,0,36.7647058823529,132.975343413457,TFR2,delta,1
DNA replication checkpoint (GO:0000076),1/17,1,17,0.0268650433589444,1,0,0,36.7647058823529,132.975343413457,CDT1,delta,1
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),1/18,1,18,0.0284233784701103,1,0,0,34.7222222222222,123.629975238859,ACSF3,delta,1
regulation of platelet activation (GO:0010543),1/19,1,19,0.0299792961708411,1,0,0,32.8947368421053,115.370008658102,NOS3,delta,1
negative regulation of smoothened signaling pathway (GO:0045879),1/19,1,19,0.0299792961708411,1,0,0,32.8947368421053,115.370008658102,GLIS2,delta,1
negative regulation of double-strand break repair (GO:2000780),1/19,1,19,0.0299792961708411,1,0,0,32.8947368421053,115.370008658102,POLK,delta,1
positive regulation of activated T cell proliferation (GO:0042104),1/19,1,19,0.0299792961708411,1,0,0,32.8947368421053,115.370008658102,HHLA2,delta,1
regulation of sprouting angiogenesis (GO:1903670),1/19,1,19,0.0299792961708411,1,0,0,32.8947368421053,115.370008658102,S100A1,delta,1
positive regulation of hydrolase activity (GO:0051345),2/173,2,173,0.0311369222845601,1,0,0,7.22543352601156,25.0676369382465,ARHGEF38;ARHGAP27,delta,1
dorsal/ventral pattern formation (GO:0009953),1/20,1,20,0.0315328000758389,1,0,0,31.25,108.0227188328,MDFI,delta,1
regulation of regulatory T cell differentiation (GO:0045589),1/20,1,20,0.0315328000758389,1,0,0,31.25,108.0227188328,HLA-G,delta,1
phospholipid translocation (GO:0045332),1/21,1,21,0.0330838937893812,1,0,0,29.7619047619048,101.449663913377,ATP11C,delta,1
dendritic cell differentiation (GO:0097028),1/21,1,21,0.0330838937893812,1,0,0,29.7619047619048,101.449663913377,DHRS2,delta,1
positive regulation of gene expression (GO:0010628),4/772,4,772,0.0336120606397391,1,0,0,3.23834196891192,10.9872743808548,MLLT11;TFR2;NR0B2;GLIS2,delta,1
C21-steroid hormone metabolic process (GO:0008207),1/22,1,22,0.034632580928247,1,0,0,28.4090909090909,95.5386475756602,DHRS2,delta,1
lipid translocation (GO:0034204),1/22,1,22,0.034632580928247,1,0,0,28.4090909090909,95.5386475756602,ATP11C,delta,1
positive regulation of monooxygenase activity (GO:0032770),1/23,1,23,0.0361788650960567,1,0,0,27.1739130434783,90.1978306460646,S100A1,delta,1
regulation of monooxygenase activity (GO:0032768),1/23,1,23,0.0361788650960567,1,0,0,27.1739130434783,90.1978306460646,NOS3,delta,1
cellular nitrogen compound biosynthetic process (GO:0044271),1/23,1,23,0.0361788650960567,1,0,0,27.1739130434783,90.1978306460646,NOS3,delta,1
negative regulation of transcription factor import into nucleus (GO:0042992),1/23,1,23,0.0361788650960567,1,0,0,27.1739130434783,90.1978306460646,MDFI,delta,1
receptor-mediated endocytosis (GO:0006898),2/189,2,189,0.0366000652779162,1,0,0,6.61375661375661,21.8763575067909,TFR2;ARHGAP27,delta,1
regulation of GTPase activity (GO:0043087),2/189,2,189,0.0366000652779162,1,0,0,6.61375661375661,21.8763575067909,ARHGEF38;ARHGAP27,delta,1
positive regulation of GTPase activity (GO:0043547),2/193,2,193,0.0380200490879604,1,0,0,6.47668393782383,21.1764355622655,ARHGEF38;ARHGAP27,delta,1
transition metal ion homeostasis (GO:0055076),1/25,1,25,0.0392642388923452,1,0,0,25,80.9360281553287,TFR2,delta,1
negative regulation of T cell proliferation (GO:0042130),1/25,1,25,0.0392642388923452,1,0,0,25,80.9360281553287,HLA-G,delta,1
negative regulation of endothelial cell apoptotic process (GO:2000352),1/25,1,25,0.0392642388923452,1,0,0,25,80.9360281553287,NDNF,delta,1
regulation of chromosome organization (GO:0033044),1/25,1,25,0.0392642388923452,1,0,0,25,80.9360281553287,CDT1,delta,1
long-chain fatty-acyl-CoA metabolic process (GO:0035336),1/26,1,26,0.0408033357136717,1,0,0,24.0384615384615,76.898832769855,ACSF3,delta,1
positive regulation of interleukin-12 production (GO:0032735),1/26,1,26,0.0408033357136717,1,0,0,24.0384615384615,76.898832769855,HLA-G,delta,1
negative regulation of cellular protein localization (GO:1903828),1/26,1,26,0.0408033357136717,1,0,0,24.0384615384615,76.898832769855,CDT1,delta,1
positive regulation of multicellular organismal process (GO:0051240),2/203,2,203,0.0416614408234431,1,0,0,6.1576354679803,19.5700693254377,HHLA2;HLA-G,delta,1
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/27,1,27,0.0423400439315087,1,0,0,23.1481481481481,73.194953140907,CDT1,delta,1
bile acid biosynthetic process (GO:0006699),1/27,1,27,0.0423400439315087,1,0,0,23.1481481481481,73.194953140907,CYP27A1,delta,1
positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/27,1,27,0.0423400439315087,1,0,0,23.1481481481481,73.194953140907,MLLT11,delta,1
transition metal ion transport (GO:0000041),1/28,1,28,0.0438743671245046,1,0,0,22.3214285714286,69.7862728083227,TFR2,delta,1
regulation of blood vessel diameter (GO:0097746),1/28,1,28,0.0438743671245046,1,0,0,22.3214285714286,69.7862728083227,NOS3,delta,1
regulation of double-strand break repair via homologous recombination (GO:0010569),1/28,1,28,0.0438743671245046,1,0,0,22.3214285714286,69.7862728083227,POLK,delta,1
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),1/29,1,29,0.0454063088797546,1,0,0,21.551724137931,66.6401771870699,HLA-G,delta,1
positive regulation of sprouting angiogenesis (GO:1903672),1/29,1,29,0.0454063088797546,1,0,0,21.551724137931,66.6401771870699,S100A1,delta,1
regulation of activated T cell proliferation (GO:0046006),1/30,1,30,0.0469358727577944,1,0,0,20.8333333333333,63.7286045486408,HHLA2,delta,1
negative regulation of epithelial cell apoptotic process (GO:1904036),1/30,1,30,0.0469358727577944,1,0,0,20.8333333333333,63.7286045486408,NDNF,delta,1
superoxide metabolic process (GO:0006801),1/30,1,30,0.0469358727577944,1,0,0,20.8333333333333,63.7286045486408,NOS3,delta,1
negative regulation of lymphocyte proliferation (GO:0050672),1/30,1,30,0.0469358727577944,1,0,0,20.8333333333333,63.7286045486408,HLA-G,delta,1
bile acid metabolic process (GO:0008206),1/31,1,31,0.0484630623370424,1,0,0,20.1612903225806,61.0272857359355,CYP27A1,delta,1
regulation of sodium ion transmembrane transport (GO:1902305),1/31,1,31,0.0484630623370424,1,0,0,20.1612903225806,61.0272857359355,FXYD5,delta,1
fatty-acyl-CoA biosynthetic process (GO:0046949),1/31,1,31,0.0484630623370424,1,0,0,20.1612903225806,61.0272857359355,ACSF3,delta,1
chondroitin sulfate metabolic process (GO:0030204),1/31,1,31,0.0484630623370424,1,0,0,20.1612903225806,61.0272857359355,NDNF,delta,1
positive regulation of cytokine production (GO:0001819),2/221,2,221,0.0485323518161082,1,0,0,5.65610859728507,17.1126960161842,HHLA2;HLA-G,delta,1
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),1/32,1,32,0.049987881166991,1,0,0,19.53125,58.515130460784,NOS3,delta,1
secondary alcohol metabolic process (GO:1902652),1/32,1,32,0.049987881166991,1,0,0,19.53125,58.515130460784,NR0B2,delta,1
negative regulation of cell-cell adhesion (GO:0022408),1/32,1,32,0.049987881166991,1,0,0,19.53125,58.515130460784,FXYD5,delta,1
positive regulation of T cell differentiation (GO:0045582),1/33,1,33,0.0515103328268519,1,0,0,18.9393939393939,56.1737282958871,HLA-G,delta,1
regulation of interleukin-12 production (GO:0032655),1/34,1,34,0.0530304208418841,1,0,0,18.3823529411765,53.9869402930829,HLA-G,delta,1
regulation of cell-substrate adhesion (GO:0010810),1/34,1,34,0.0530304208418841,1,0,0,18.3823529411765,53.9869402930829,NDNF,delta,1
negative regulation of T cell activation (GO:0050868),1/35,1,35,0.0545481487828968,1,0,0,17.8571428571429,51.9405625612699,HLA-G,delta,1
negative regulation of DNA binding (GO:0043392),1/35,1,35,0.0545481487828968,1,0,0,17.8571428571429,51.9405625612699,MDFI,delta,1
positive regulation of DNA replication (GO:0045740),1/36,1,36,0.0560635201791324,1,0,0,17.3611111111111,50.0220476068321,CDT1,delta,1
endothelial cell migration (GO:0043542),1/36,1,36,0.0560635201791324,1,0,0,17.3611111111111,50.0220476068321,NOS3,delta,1
positive regulation of peptide secretion (GO:0002793),1/36,1,36,0.0560635201791324,1,0,0,17.3611111111111,50.0220476068321,TFR2,delta,1
regulation of endothelial cell apoptotic process (GO:2000351),1/36,1,36,0.0560635201791324,1,0,0,17.3611111111111,50.0220476068321,NDNF,delta,1
transferrin transport (GO:0033572),1/37,1,37,0.0575765385764463,1,0,0,16.8918918918919,48.2202721391433,TFR2,delta,1
ferric iron transport (GO:0015682),1/37,1,37,0.0575765385764463,1,0,0,16.8918918918919,48.2202721391433,TFR2,delta,1
epithelial cell migration (GO:0010631),1/37,1,37,0.0575765385764463,1,0,0,16.8918918918919,48.2202721391433,NOS3,delta,1
regulation of blood circulation (GO:1903522),1/37,1,37,0.0575765385764463,1,0,0,16.8918918918919,48.2202721391433,S100A1,delta,1
negative regulation of blood coagulation (GO:0030195),1/37,1,37,0.0575765385764463,1,0,0,16.8918918918919,48.2202721391433,NOS3,delta,1
regulation of smoothened signaling pathway (GO:0008589),1/37,1,37,0.0575765385764463,1,0,0,16.8918918918919,48.2202721391433,GLIS2,delta,1
base-excision repair (GO:0006284),1/38,1,38,0.059087207499911,1,0,0,16.4473684210526,46.525342650693,POLK,delta,1
regulation of sodium ion transmembrane transporter activity (GO:2000649),1/38,1,38,0.059087207499911,1,0,0,16.4473684210526,46.525342650693,FXYD5,delta,1
negative regulation of transcription from RNA polymerase II promoter (GO:0000122),3/566,3,566,0.0610053892158759,1,0,0,3.31272084805654,9.26499471370369,NR0B2;MDFI;GLIS2,delta,1
regulation of immune response (GO:0050776),2/252,2,252,0.0612509032359193,1,0,0,4.96031746031746,13.8530589432398,HHLA2;HLA-G,delta,1
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),1/40,1,40,0.0621015110607877,1,0,0,15.625,43.4216399630757,NOS3,delta,1
positive regulation of peptide hormone secretion (GO:0090277),1/40,1,40,0.0621015110607877,1,0,0,15.625,43.4216399630757,TFR2,delta,1
regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,1,41,0.0636051527355535,1,0,0,15.2439024390244,41.9978779582807,MLLT11,delta,1
neuron migration (GO:0001764),1/41,1,41,0.0636051527355535,1,0,0,15.2439024390244,41.9978779582807,NDNF,delta,1
endocytosis (GO:0006897),2/264,2,264,0.0664519481502687,1,0,0,4.73484848484848,12.8374818973324,TFR2;ARHGAP27,delta,1
regulation of ion transmembrane transporter activity (GO:0032412),1/43,1,43,0.0666054334357438,1,0,0,14.5348837209302,39.3745511866895,FXYD5,delta,1
substantia nigra development (GO:0021762),1/44,1,44,0.06810207947577,1,0,0,14.2045454545455,38.1640274243206,S100A1,delta,1
mitotic metaphase plate congression (GO:0007080),1/44,1,44,0.06810207947577,1,0,0,14.2045454545455,38.1640274243206,CDT1,delta,1
positive regulation of transport (GO:0051050),1/45,1,45,0.0695964006373755,1,0,0,13.8888888888889,37.0144781661009,TFR2,delta,1
negative regulation of immune response (GO:0050777),1/45,1,45,0.0695964006373755,1,0,0,13.8888888888889,37.0144781661009,HLA-G,delta,1
negative regulation of immune system process (GO:0002683),1/45,1,45,0.0695964006373755,1,0,0,13.8888888888889,37.0144781661009,HLA-G,delta,1
protein complex subunit organization (GO:0071822),1/46,1,46,0.0710884004247531,1,0,0,13.5869565217391,35.9216182065312,CDT1,delta,1
positive regulation of blood vessel endothelial cell migration (GO:0043536),1/46,1,46,0.0710884004247531,1,0,0,13.5869565217391,35.9216182065312,NOS3,delta,1
peptide cross-linking (GO:0018149),1/48,1,48,0.0740654497913952,1,0,0,13.0208333333333,33.8907046880051,NDNF,delta,1
fatty acid biosynthetic process (GO:0006633),1/48,1,48,0.0740654497913952,1,0,0,13.0208333333333,33.8907046880051,ACSF3,delta,1
negative regulation of signal transduction (GO:0009968),2/284,2,284,0.0754367499779342,1,0,0,4.40140845070423,11.3752672643983,MDFI;GLIS2,delta,1
negative regulation of gene expression (GO:0010629),3/619,3,619,0.0754662155710327,1,0,0,3.02907915993538,7.82735318685802,NR0B2;MDFI;GLIS2,delta,1
negative regulation of mitotic cell cycle (GO:0045930),1/49,1,49,0.075550506342122,1,0,0,12.7551020408163,32.9458404107926,CDT1,delta,1
pattern recognition receptor signaling pathway (GO:0002221),1/49,1,49,0.075550506342122,1,0,0,12.7551020408163,32.9458404107926,S100A1,delta,1
organic hydroxy compound biosynthetic process (GO:1901617),1/50,1,50,0.0770332554327669,1,0,0,12.5,32.043975770354,CYP27A1,delta,1
double-strand break repair via nonhomologous end joining (GO:0006303),1/51,1,51,0.0785137005379157,1,0,0,12.2549019607843,31.1823791700587,POLK,delta,1
myeloid leukocyte differentiation (GO:0002573),1/51,1,51,0.0785137005379157,1,0,0,12.2549019607843,31.1823791700587,DHRS2,delta,1
blood circulation (GO:0008015),1/51,1,51,0.0785137005379157,1,0,0,12.2549019607843,31.1823791700587,NOS3,delta,1
regulation of blood vessel endothelial cell migration (GO:0043535),1/51,1,51,0.0785137005379157,1,0,0,12.2549019607843,31.1823791700587,NOS3,delta,1
positive regulation of cell-substrate adhesion (GO:0010811),1/53,1,53,0.0814676926408234,1,0,0,11.7924528301887,29.5701503141664,NDNF,delta,1
sensory perception (GO:0007600),1/55,1,55,0.0844125102691724,1,0,0,11.3636363636364,28.0913598003016,USH2A,delta,1
chromosome organization (GO:0051276),1/57,1,57,0.0873481810302957,1,0,0,10.9649122807018,26.7308450278754,CDT1,delta,1
cellular defense response (GO:0006968),1/57,1,57,0.0873481810302957,1,0,0,10.9649122807018,26.7308450278754,HLA-G,delta,1
DNA-dependent DNA replication (GO:0006261),1/57,1,57,0.0873481810302957,1,0,0,10.9649122807018,26.7308450278754,POLK,delta,1
cellular iron ion homeostasis (GO:0006879),1/57,1,57,0.0873481810302957,1,0,0,10.9649122807018,26.7308450278754,TFR2,delta,1
phospholipid transport (GO:0015914),1/59,1,59,0.0902747323888046,1,0,0,10.593220338983,25.4756109769369,ATP11C,delta,1
membrane lipid biosynthetic process (GO:0046467),1/61,1,61,0.0931921917759997,1,0,0,10.2459016393443,24.3144604511039,COL4A3BP,delta,1
positive regulation of T cell proliferation (GO:0042102),1/62,1,62,0.0946475205245445,1,0,0,10.0806451612903,23.7660846564928,HHLA2,delta,1
regulation of T cell proliferation (GO:0042129),1/63,1,63,0.096100586502737,1,0,0,9.92063492063492,23.2376970235947,HLA-G,delta,1
negative regulation of neuron apoptotic process (GO:0043524),1/64,1,64,0.0975513931445902,1,0,0,9.765625,22.7282805730107,NDNF,delta,1
iron ion homeostasis (GO:0055072),1/64,1,64,0.0975513931445902,1,0,0,9.765625,22.7282805730107,TFR2,delta,1
positive regulation of cell projection organization (GO:0031346),1/64,1,64,0.0975513931445902,1,0,0,9.765625,22.7282805730107,NDNF,delta,1
cellular response to decreased oxygen levels (GO:0036294),1/65,1,65,0.0989999438359977,1,0,0,9.61538461538461,22.2368845784698,NDNF,delta,1
positive regulation of endocytosis (GO:0045807),1/65,1,65,0.0989999438359977,1,0,0,9.61538461538461,22.2368845784698,TFR2,delta,1
positive regulation of cell adhesion (GO:0045785),1/65,1,65,0.0989999438359977,1,0,0,9.61538461538461,22.2368845784698,NDNF,delta,1
positive regulation of transcription factor import into nucleus (GO:0042993),3/33,3,33,3.87844054663919e-05,0.197916821094998,0,0,45.4545454545455,461.704196049828,SPHK1;DMAP1;CHERP,delta,2
positive regulation of smooth muscle contraction (GO:0045987),2/14,2,14,0.000349552730471839,0.891883791798897,0,0,71.4285714285714,568.489723831818,SPHK1;GPER1,delta,2
cellular nitrogen compound biosynthetic process (GO:0044271),2/23,2,23,0.000960837466747064,1,0,0,43.4782608695652,302.074143156235,GCHFR;SPHK1,delta,2
positive regulation of ERBB signaling pathway (GO:1901186),2/23,2,23,0.000960837466747064,1,0,0,43.4782608695652,302.074143156235,GPER1;NUP62,delta,2
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),2/30,2,30,0.00163748677237875,1,0,0,33.3333333333333,213.819755614138,GPER1;NUP62,delta,2
negative regulation of immune system process (GO:0002683),2/45,2,45,0.00365681807811671,1,0,0,22.2222222222222,124.692486383566,LRRC14;GPER1,delta,2
positive regulation of mitotic cell cycle (GO:0045931),2/53,2,53,0.00503893905931115,1,0,0,18.8679245283019,99.8218815691111,SPHK1;NUP62,delta,2
cellular response to nutrient levels (GO:0031669),2/55,2,55,0.00541654599467577,1,0,0,18.1818181818182,94.878126127794,CLEC16A;GAS2L1,delta,2
negative regulation of cell proliferation (GO:0008285),4/364,4,364,0.00588392375307082,1,0,0,5.4945054945055,28.2172056850359,GPER1;NUP62;ATF5;CHERP,delta,2
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),2/59,2,59,0.00620953355419871,1,0,0,16.9491525423729,86.129991489883,GPER1;NUP62,delta,2
positive regulation of neurogenesis (GO:0050769),2/70,2,70,0.00864405198097742,1,0,0,14.2857142857143,67.8697689546113,GPER1;ADRA2B,delta,2
vesicle-mediated transport (GO:0016192),4/411,4,411,0.00895992999358159,1,0,0,4.8661800486618,22.9440042104241,CLEC16A;SPIRE2;BVES;S100A10,delta,2
negative regulation of cell cycle (GO:0045786),2/73,2,73,0.00937105040814959,1,0,0,13.6986301369863,63.9743847354866,LATS2;GPER1,delta,2
adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189),2/79,2,79,0.0109038988021621,1,0,0,12.6582278481013,57.1979096889935,GPER1;ADRA2B,delta,2
cellular response to hormone stimulus (GO:0032870),2/81,2,81,0.0114378590207367,1,0,0,12.3456790123457,55.1953883837279,GPER1;GAS2L1,delta,2
gap junction assembly (GO:0016264),1/6,1,6,0.0119415311049954,1,0,0,83.3333333333333,368.977745499139,GJD3,delta,2
membrane raft assembly (GO:0001765),1/6,1,6,0.0119415311049954,1,0,0,83.3333333333333,368.977745499139,S100A10,delta,2
negative regulation of cell cycle phase transition (GO:1901988),1/6,1,6,0.0119415311049954,1,0,0,83.3333333333333,368.977745499139,ATF5,delta,2
protein retention in ER lumen (GO:0006621),1/6,1,6,0.0119415311049954,1,0,0,83.3333333333333,368.977745499139,GPAA1,delta,2
negative regulation of catecholamine secretion (GO:0033604),1/6,1,6,0.0119415311049954,1,0,0,83.3333333333333,368.977745499139,ADRA2B,delta,2
regulation of NFAT protein import into nucleus (GO:0051532),1/6,1,6,0.0119415311049954,1,0,0,83.3333333333333,368.977745499139,CHERP,delta,2
positive regulation of protein localization to centrosome (GO:1904781),1/6,1,6,0.0119415311049954,1,0,0,83.3333333333333,368.977745499139,NUP62,delta,2
positive regulation of cell cycle (GO:0045787),2/83,2,83,0.0119831657991769,1,0,0,12.0481927710843,53.3042465563629,GPER1;SPHK1,delta,2
positive regulation of inositol phosphate biosynthetic process (GO:0060732),1/7,1,7,0.0139182304660795,1,0,0,71.4285714285714,305.325410989014,GPER1,delta,2
cleavage furrow formation (GO:0036089),1/7,1,7,0.0139182304660795,1,0,0,71.4285714285714,305.325410989014,SPIRE2,delta,2
regulation of protein localization to centrosome (GO:1904779),1/7,1,7,0.0139182304660795,1,0,0,71.4285714285714,305.325410989014,NUP62,delta,2
regulation of norepinephrine secretion (GO:0014061),1/7,1,7,0.0139182304660795,1,0,0,71.4285714285714,305.325410989014,ADRA2B,delta,2
attachment of GPI anchor to protein (GO:0016255),1/7,1,7,0.0139182304660795,1,0,0,71.4285714285714,305.325410989014,GPAA1,delta,2
regulation of cell cycle process (GO:0010564),2/91,2,91,0.0142759771439225,1,0,0,10.989010989011,46.6942535645013,GPER1;ATF5,delta,2
positive regulation of TORC1 signaling (GO:1904263),1/8,1,8,0.0158910747267935,1,0,0,62.5,258.874854081412,CLEC16A,delta,2
TORC1 signaling (GO:0038202),1/8,1,8,0.0158910747267935,1,0,0,62.5,258.874854081412,CLEC16A,delta,2
telomeric D-loop disassembly (GO:0061820),1/8,1,8,0.0158910747267935,1,0,0,62.5,258.874854081412,RECQL4,delta,2
negative regulation of biosynthetic process (GO:0009890),1/8,1,8,0.0158910747267935,1,0,0,62.5,258.874854081412,GPER1,delta,2
diol biosynthetic process (GO:0034312),1/8,1,8,0.0158910747267935,1,0,0,62.5,258.874854081412,SPHK1,delta,2
negative regulation of protein complex disassembly (GO:0043242),1/8,1,8,0.0158910747267935,1,0,0,62.5,258.874854081412,CLEC16A,delta,2
sphingosine biosynthetic process (GO:0046512),1/8,1,8,0.0158910747267935,1,0,0,62.5,258.874854081412,SPHK1,delta,2
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),2/101,2,101,0.017386111170255,1,0,0,9.9009900990099,40.119639605008,RBMX2;NUP62,delta,2
maintenance of protein localization in endoplasmic reticulum (GO:0035437),1/9,1,9,0.0178600710727219,1,0,0,55.5555555555556,223.62154022811,GPAA1,delta,2
sphingoid biosynthetic process (GO:0046520),1/9,1,9,0.0178600710727219,1,0,0,55.5555555555556,223.62154022811,SPHK1,delta,2
regulation of organ growth (GO:0046620),1/9,1,9,0.0178600710727219,1,0,0,55.5555555555556,223.62154022811,LATS2,delta,2
regulation of organ morphogenesis (GO:2000027),1/9,1,9,0.0178600710727219,1,0,0,55.5555555555556,223.62154022811,AJAP1,delta,2
mesodermal cell differentiation (GO:0048333),1/9,1,9,0.0178600710727219,1,0,0,55.5555555555556,223.62154022811,ITGA2,delta,2
regulation of leukocyte activation (GO:0002694),1/9,1,9,0.0178600710727219,1,0,0,55.5555555555556,223.62154022811,GPER1,delta,2
regulation of morphogenesis of an epithelium (GO:1905330),1/9,1,9,0.0178600710727219,1,0,0,55.5555555555556,223.62154022811,AJAP1,delta,2
sphingosine metabolic process (GO:0006670),1/9,1,9,0.0178600710727219,1,0,0,55.5555555555556,223.62154022811,SPHK1,delta,2
mRNA transport (GO:0051028),2/105,2,105,0.0187037772704154,1,0,0,9.52380952380952,37.8955217376105,RBMX2;NUP62,delta,2
mRNA export from nucleus (GO:0006406),2/106,2,106,0.0190396264848466,1,0,0,9.43396226415094,37.3701213887156,RBMX2;NUP62,delta,2
negative regulation of response to external stimulus (GO:0032102),2/108,2,108,0.019718966776121,1,0,0,9.25925925925926,36.3534659805586,GPER1;AJAP1,delta,2
cellular response to starvation (GO:0009267),2/108,2,108,0.019718966776121,1,0,0,9.25925925925926,36.3534659805586,CLEC16A;GAS2L1,delta,2
positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),1/10,1,10,0.019825226718581,1,0,0,50,196.040003776631,ADRA2B,delta,2
membrane raft organization (GO:0031579),1/10,1,10,0.019825226718581,1,0,0,50,196.040003776631,S100A10,delta,2
cellular response to thyroid hormone stimulus (GO:0097067),1/10,1,10,0.019825226718581,1,0,0,50,196.040003776631,GAS2L1,delta,2
negative regulation of cell activation (GO:0050866),1/10,1,10,0.019825226718581,1,0,0,50,196.040003776631,GPER1,delta,2
positive regulation of receptor recycling (GO:0001921),1/10,1,10,0.019825226718581,1,0,0,50,196.040003776631,BVES,delta,2
telomeric loop disassembly (GO:0090657),1/10,1,10,0.019825226718581,1,0,0,50,196.040003776631,RECQL4,delta,2
negative regulation of hydrolase activity (GO:0051346),2/109,2,109,0.0200624358796557,1,0,0,9.1743119266055,35.8615236158407,GCHFR;ELFN2,delta,2
negative regulation of cellular process (GO:0048523),4/535,4,535,0.0216340758229304,1,0,0,3.73831775700935,14.3307873756118,GPER1;NUP62;ATF5;CHERP,delta,2
positive regulation of endothelial cell apoptotic process (GO:2000353),1/11,1,11,0.021786548882168,1,0,0,45.4545454545455,173.930114699016,GPER1,delta,2
L-phenylalanine metabolic process (GO:0006558),1/11,1,11,0.021786548882168,1,0,0,45.4545454545455,173.930114699016,IL4I1,delta,2
L-phenylalanine catabolic process (GO:0006559),1/11,1,11,0.021786548882168,1,0,0,45.4545454545455,173.930114699016,IL4I1,delta,2
negative regulation of leukocyte activation (GO:0002695),1/11,1,11,0.021786548882168,1,0,0,45.4545454545455,173.930114699016,GPER1,delta,2
nitric oxide biosynthetic process (GO:0006809),1/11,1,11,0.021786548882168,1,0,0,45.4545454545455,173.930114699016,GCHFR,delta,2
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),1/11,1,11,0.021786548882168,1,0,0,45.4545454545455,173.930114699016,IL4I1,delta,2
regulation of autophagosome maturation (GO:1901096),1/11,1,11,0.021786548882168,1,0,0,45.4545454545455,173.930114699016,CLEC16A,delta,2
sphingolipid catabolic process (GO:0030149),1/11,1,11,0.021786548882168,1,0,0,45.4545454545455,173.930114699016,SPHK1,delta,2
epithelial cell-cell adhesion (GO:0090136),1/11,1,11,0.021786548882168,1,0,0,45.4545454545455,173.930114699016,BVES,delta,2
response to thyroid hormone (GO:0097066),1/11,1,11,0.021786548882168,1,0,0,45.4545454545455,173.930114699016,GAS2L1,delta,2
regulation of apoptotic process (GO:0042981),5/816,5,816,0.0225500258718287,1,0,0,3.06372549019608,11.6177054709701,LATS2;GPER1;SPHK1;NUP62;ATF5,delta,2
vesicle budding from membrane (GO:0006900),1/12,1,12,0.0237440447903621,1,0,0,41.6666666666667,155.85098023385,S100A10,delta,2
negative regulation of vascular smooth muscle cell proliferation (GO:1904706),1/12,1,12,0.0237440447903621,1,0,0,41.6666666666667,155.85098023385,GPER1,delta,2
positive regulation of cardiocyte differentiation (GO:1905209),1/12,1,12,0.0237440447903621,1,0,0,41.6666666666667,155.85098023385,GPER1,delta,2
nitric oxide metabolic process (GO:0046209),1/12,1,12,0.0237440447903621,1,0,0,41.6666666666667,155.85098023385,GCHFR,delta,2
RNA export from nucleus (GO:0006405),2/120,2,120,0.0240044026011477,1,0,0,8.33333333333333,31.0793168645256,RBMX2;NUP62,delta,2
cellular calcium ion homeostasis (GO:0006874),2/124,2,124,0.0255105861711504,1,0,0,8.06451612903226,29.5859820080604,GPER1;CHERP,delta,2
negative regulation of hormone secretion (GO:0046888),1/13,1,13,0.0256977216686787,1,0,0,38.4615384615385,140.821267001341,ADRA2B,delta,2
positive regulation of muscle contraction (GO:0045933),1/13,1,13,0.0256977216686787,1,0,0,38.4615384615385,140.821267001341,SPHK1,delta,2
positive regulation of blood vessel diameter (GO:0097755),1/14,1,14,0.0276475867285055,1,0,0,35.7142857142857,128.150601217187,GPER1,delta,2
regulation of protein complex disassembly (GO:0043244),1/15,1,15,0.0295936471887674,1,0,0,33.3333333333333,117.339852089594,CLEC16A,delta,2
regulation of centriole replication (GO:0046599),1/15,1,15,0.0295936471887674,1,0,0,33.3333333333333,117.339852089594,NUP62,delta,2
substrate-dependent cell migration (GO:0006929),1/15,1,15,0.0295936471887674,1,0,0,33.3333333333333,117.339852089594,ITGA2,delta,2
positive regulation of NF-kappaB import into nucleus (GO:0042346),1/15,1,15,0.0295936471887674,1,0,0,33.3333333333333,117.339852089594,SPHK1,delta,2
cellular response to corticosteroid stimulus (GO:0071384),1/15,1,15,0.0295936471887674,1,0,0,33.3333333333333,117.339852089594,GPER1,delta,2
adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),2/135,2,135,0.0298451081435765,1,0,0,7.40740740740741,26.0128469174871,GPER1;ADRA2B,delta,2
positive regulation of epithelial cell apoptotic process (GO:1904037),1/16,1,16,0.0315359102498905,1,0,0,31.25,108.01963670416,GPER1,delta,2
DNA methylation or demethylation (GO:0044728),1/16,1,16,0.0315359102498905,1,0,0,31.25,108.01963670416,DMAP1,delta,2
DNA alkylation (GO:0006305),1/16,1,16,0.0315359102498905,1,0,0,31.25,108.01963670416,DMAP1,delta,2
negative regulation of response to wounding (GO:1903035),1/16,1,16,0.0315359102498905,1,0,0,31.25,108.01963670416,AJAP1,delta,2
histone H2A acetylation (GO:0043968),1/16,1,16,0.0315359102498905,1,0,0,31.25,108.01963670416,DMAP1,delta,2
negative regulation of lipid biosynthetic process (GO:0051055),1/17,1,17,0.0334743831049908,1,0,0,29.4117647058824,99.9110240030511,GPER1,delta,2
regulation of receptor recycling (GO:0001919),1/17,1,17,0.0334743831049908,1,0,0,29.4117647058824,99.9110240030511,BVES,delta,2
positive regulation of focal adhesion assembly (GO:0051894),1/17,1,17,0.0334743831049908,1,0,0,29.4117647058824,99.9110240030511,S100A10,delta,2
positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745),1/17,1,17,0.0334743831049908,1,0,0,29.4117647058824,99.9110240030511,GPER1,delta,2
negative regulation of gene expression (GO:0010629),4/619,4,619,0.034465622063664,1,0,0,3.23101777059774,10.8813987517475,BCL7A;GPER1;DMAP1;ATF5,delta,2
positive regulation of cyclic nucleotide biosynthetic process (GO:0030804),1/18,1,18,0.0354090729455741,1,0,0,27.7777777777778,92.7996442717647,GPER1,delta,2
regulation of epithelial cell differentiation (GO:0030856),1/18,1,18,0.0354090729455741,1,0,0,27.7777777777778,92.7996442717647,AJAP1,delta,2
DNA methylation (GO:0006306),1/18,1,18,0.0354090729455741,1,0,0,27.7777777777778,92.7996442717647,DMAP1,delta,2
regulation of spindle organization (GO:0090224),1/18,1,18,0.0354090729455741,1,0,0,27.7777777777778,92.7996442717647,NUP62,delta,2
striated muscle cell differentiation (GO:0051146),1/19,1,19,0.0373399869476018,1,0,0,26.3157894736842,86.5181708006318,BVES,delta,2
positive regulation of adherens junction organization (GO:1903393),1/19,1,19,0.0373399869476018,1,0,0,26.3157894736842,86.5181708006318,S100A10,delta,2
negative regulation of lipid metabolic process (GO:0045833),1/19,1,19,0.0373399869476018,1,0,0,26.3157894736842,86.5181708006318,GPER1,delta,2
protein heterotetramerization (GO:0051290),1/19,1,19,0.0373399869476018,1,0,0,26.3157894736842,86.5181708006318,S100A10,delta,2
regulation of transcription factor import into nucleus (GO:0042990),1/19,1,19,0.0373399869476018,1,0,0,26.3157894736842,86.5181708006318,DMAP1,delta,2
regulation of cAMP biosynthetic process (GO:0030817),1/19,1,19,0.0373399869476018,1,0,0,26.3157894736842,86.5181708006318,GPER1,delta,2
mesoderm formation (GO:0001707),1/20,1,20,0.039267132268101,1,0,0,25,80.9341859770283,ITGA2,delta,2
cellular response to estradiol stimulus (GO:0071392),1/20,1,20,0.039267132268101,1,0,0,25,80.9341859770283,GPER1,delta,2
cellular response to steroid hormone stimulus (GO:0071383),1/20,1,20,0.039267132268101,1,0,0,25,80.9341859770283,GPER1,delta,2
regulation of toll-like receptor signaling pathway (GO:0034121),1/20,1,20,0.039267132268101,1,0,0,25,80.9341859770283,LRRC14,delta,2
adrenergic receptor signaling pathway (GO:0071875),1/20,1,20,0.039267132268101,1,0,0,25,80.9341859770283,ADRA2B,delta,2
positive regulation of cAMP biosynthetic process (GO:0030819),1/20,1,20,0.039267132268101,1,0,0,25,80.9341859770283,GPER1,delta,2
adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),1/20,1,20,0.039267132268101,1,0,0,25,80.9341859770283,ADRA2B,delta,2
aromatic amino acid family catabolic process (GO:0009074),1/21,1,21,0.0411905160666275,1,0,0,23.8095238095238,75.9416009924432,IL4I1,delta,2
steroid hormone mediated signaling pathway (GO:0043401),1/21,1,21,0.0411905160666275,1,0,0,23.8095238095238,75.9416009924432,GPER1,delta,2
negative regulation of cell cycle arrest (GO:0071157),1/21,1,21,0.0411905160666275,1,0,0,23.8095238095238,75.9416009924432,GPER1,delta,2
negative regulation of cyclin-dependent protein kinase activity (GO:1904030),1/21,1,21,0.0411905160666275,1,0,0,23.8095238095238,75.9416009924432,LATS2,delta,2
negative regulation of macroautophagy (GO:0016242),1/21,1,21,0.0411905160666275,1,0,0,23.8095238095238,75.9416009924432,CLEC16A,delta,2
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),2/164,2,164,0.0425399773068657,1,0,0,6.09756097560976,19.2518963577086,SPHK1;NUP62,delta,2
cellular response to hexose stimulus (GO:0071331),1/22,1,22,0.0431101454791181,1,0,0,22.7272727272727,71.4544753551407,GPER1,delta,2
regulation of mitotic cell cycle (GO:0007346),2/166,2,166,0.0434789912113837,1,0,0,6.02409638554217,18.8884181819784,SPHK1;NUP62,delta,2
chromosome condensation (GO:0030261),1/23,1,23,0.0450260276423818,1,0,0,21.7391304347826,67.4024905296326,GPER1,delta,2
regulation of smooth muscle contraction (GO:0006940),1/23,1,23,0.0450260276423818,1,0,0,21.7391304347826,67.4024905296326,SPHK1,delta,2
apoptotic nuclear changes (GO:0030262),1/23,1,23,0.0450260276423818,1,0,0,21.7391304347826,67.4024905296326,GPER1,delta,2
neuronal action potential (GO:0019228),1/23,1,23,0.0450260276423818,1,0,0,21.7391304347826,67.4024905296326,GPER1,delta,2
regulation of microtubule cytoskeleton organization (GO:0070507),1/23,1,23,0.0450260276423818,1,0,0,21.7391304347826,67.4024905296326,ATF5,delta,2
positive regulation of cell junction assembly (GO:1901890),1/23,1,23,0.0450260276423818,1,0,0,21.7391304347826,67.4024905296326,S100A10,delta,2
membrane assembly (GO:0071709),1/23,1,23,0.0450260276423818,1,0,0,21.7391304347826,67.4024905296326,S100A10,delta,2
rRNA methylation (GO:0031167),1/23,1,23,0.0450260276423818,1,0,0,21.7391304347826,67.4024905296326,MRM1,delta,2
negative regulation of programmed cell death (GO:0043069),3/409,3,409,0.048057940377932,1,0,0,3.66748166259169,11.1320827804994,SPHK1;NUP62;ATF5,delta,2
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),1/25,1,25,0.048846578661385,1,0,0,20,60.3814188116814,LATS2,delta,2
DNA geometric change (GO:0032392),1/25,1,25,0.048846578661385,1,0,0,20,60.3814188116814,RECQL4,delta,2
positive regulation of purine nucleotide biosynthetic process (GO:1900373),1/25,1,25,0.048846578661385,1,0,0,20,60.3814188116814,GPER1,delta,2
negative regulation of sequestering of calcium ion (GO:0051283),1/25,1,25,0.048846578661385,1,0,0,20,60.3814188116814,CHERP,delta,2
positive regulation of protein phosphorylation (GO:0001934),3/413,3,413,0.0492181069798942,1,0,0,3.6319612590799,10.9376284327226,GPER1;SPHK1;ADRA2B,delta,2
positive regulation of cell motility (GO:2000147),2/180,2,180,0.050265784662639,1,0,0,5.55555555555556,16.6135036596086,GPER1;SPHK1,delta,2
positive regulation of nuclear division (GO:0051785),1/26,1,26,0.0507512617202017,1,0,0,19.2307692307692,57.3234384593745,NUP62,delta,2
negative regulation of wound healing (GO:0061045),1/26,1,26,0.0507512617202017,1,0,0,19.2307692307692,57.3234384593745,AJAP1,delta,2
regulation of vascular smooth muscle cell proliferation (GO:1904705),1/26,1,26,0.0507512617202017,1,0,0,19.2307692307692,57.3234384593745,GPER1,delta,2
positive regulation of calcium ion transmembrane transport (GO:1904427),1/26,1,26,0.0507512617202017,1,0,0,19.2307692307692,57.3234384593745,GPER1,delta,2
positive regulation of peptidyl-threonine phosphorylation (GO:0010800),1/26,1,26,0.0507512617202017,1,0,0,19.2307692307692,57.3234384593745,SPHK1,delta,2
neutral amino acid transport (GO:0015804),1/26,1,26,0.0507512617202017,1,0,0,19.2307692307692,57.3234384593745,SLC1A5,delta,2
regulation of NF-kappaB import into nucleus (GO:0042345),1/27,1,27,0.0526522259283912,1,0,0,18.5185185185185,54.5193845084009,SPHK1,delta,2
positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/27,1,27,0.0526522259283912,1,0,0,18.5185185185185,54.5193845084009,GPER1,delta,2
regulation of centrosome cycle (GO:0046605),1/27,1,27,0.0526522259283912,1,0,0,18.5185185185185,54.5193845084009,ATF5,delta,2
positive regulation of cAMP metabolic process (GO:0030816),1/27,1,27,0.0526522259283912,1,0,0,18.5185185185185,54.5193845084009,GPER1,delta,2
negative regulation of cell-matrix adhesion (GO:0001953),1/28,1,28,0.0545494783414528,1,0,0,17.8571428571429,51.9401273159268,AJAP1,delta,2
regulation of neurotransmitter secretion (GO:0046928),1/28,1,28,0.0545494783414528,1,0,0,17.8571428571429,51.9401273159268,GPER1,delta,2
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),1/28,1,28,0.0545494783414528,1,0,0,17.8571428571429,51.9401273159268,S100A10,delta,2
negative regulation of smooth muscle cell proliferation (GO:0048662),1/28,1,28,0.0545494783414528,1,0,0,17.8571428571429,51.9401273159268,GPER1,delta,2
release of sequestered calcium ion into cytosol (GO:0051209),1/28,1,28,0.0545494783414528,1,0,0,17.8571428571429,51.9401273159268,CHERP,delta,2
regulation of blood vessel diameter (GO:0097746),1/28,1,28,0.0545494783414528,1,0,0,17.8571428571429,51.9401273159268,GPER1,delta,2
cellular response to glucose stimulus (GO:0071333),1/28,1,28,0.0545494783414528,1,0,0,17.8571428571429,51.9401273159268,GPER1,delta,2
regulation of GTPase activity (GO:0043087),2/189,2,189,0.0548184387408492,1,0,0,5.29100529100529,15.3636437473517,BVES;S100A10,delta,2
regulation of TORC1 signaling (GO:1903432),1/29,1,29,0.0564430260228561,1,0,0,17.2413793103448,49.5607506650337,CLEC16A,delta,2
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),1/29,1,29,0.0564430260228561,1,0,0,17.2413793103448,49.5607506650337,GPER1,delta,2
regulation of lipid biosynthetic process (GO:0046890),1/29,1,29,0.0564430260228561,1,0,0,17.2413793103448,49.5607506650337,GPER1,delta,2
protein export from nucleus (GO:0006611),1/29,1,29,0.0564430260228561,1,0,0,17.2413793103448,49.5607506650337,NUP62,delta,2
positive regulation of fibroblast proliferation (GO:0048146),1/29,1,29,0.0564430260228561,1,0,0,17.2413793103448,49.5607506650337,SPHK1,delta,2
skeletal muscle organ development (GO:0060538),1/30,1,30,0.058332876023497,1,0,0,16.6666666666667,47.3598238892443,BVES,delta,2
striated muscle tissue development (GO:0014706),1/30,1,30,0.058332876023497,1,0,0,16.6666666666667,47.3598238892443,BVES,delta,2
negative regulation of nucleic acid-templated transcription (GO:1903507),3/445,3,445,0.0589923737777933,1,0,0,3.37078651685393,9.54049584753188,BCL7A;DMAP1;ATF5,delta,2
regulation of cell proliferation (GO:0042127),4/741,4,741,0.0596641625498308,1,0,0,2.69905533063428,7.60870102868767,GPER1;NUP62;ATF5;CHERP,delta,2
response to estradiol (GO:0032355),1/31,1,31,0.0602190353597648,1,0,0,16.1290322580645,45.3188189461165,GPER1,delta,2
regulation of developmental growth (GO:0048638),1/31,1,31,0.0602190353597648,1,0,0,16.1290322580645,45.3188189461165,LATS2,delta,2
activation of protein kinase B activity (GO:0032148),1/31,1,31,0.0602190353597648,1,0,0,16.1290322580645,45.3188189461165,ADRA2B,delta,2
smoothened signaling pathway (GO:0007224),1/31,1,31,0.0602190353597648,1,0,0,16.1290322580645,45.3188189461165,TCTN2,delta,2
hippo signaling (GO:0035329),1/31,1,31,0.0602190353597648,1,0,0,16.1290322580645,45.3188189461165,LATS2,delta,2
negative regulation of toll-like receptor signaling pathway (GO:0034122),1/32,1,32,0.0621015110607877,1,0,0,15.625,43.4216399630757,LRRC14,delta,2
positive regulation of insulin secretion (GO:0032024),1/32,1,32,0.0621015110607877,1,0,0,15.625,43.4216399630757,GPER1,delta,2
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1/32,1,32,0.0621015110607877,1,0,0,15.625,43.4216399630757,GPER1,delta,2
regulation of MAPK cascade (GO:0043408),2/204,2,204,0.0627162202828375,1,0,0,4.90196078431373,13.5741920005074,GPER1;ADRA2B,delta,2
positive regulation of TOR signaling (GO:0032008),1/33,1,33,0.0639803101343835,1,0,0,15.1515151515152,41.6542408652723,CLEC16A,delta,2
positive regulation of calcium ion transport into cytosol (GO:0010524),1/33,1,33,0.0639803101343835,1,0,0,15.1515151515152,41.6542408652723,GPER1,delta,2
GPI anchor biosynthetic process (GO:0006506),1/33,1,33,0.0639803101343835,1,0,0,15.1515151515152,41.6542408652723,GPAA1,delta,2
substrate adhesion-dependent cell spreading (GO:0034446),1/33,1,33,0.0639803101343835,1,0,0,15.1515151515152,41.6542408652723,BVES,delta,2
negative regulation of fat cell differentiation (GO:0045599),1/33,1,33,0.0639803101343835,1,0,0,15.1515151515152,41.6542408652723,GPER1,delta,2
positive regulation of cell-matrix adhesion (GO:0001954),1/34,1,34,0.0658554395562883,1,0,0,14.7058823529412,40.004312484496,S100A10,delta,2
positive regulation of locomotion (GO:0040017),1/34,1,34,0.0658554395562883,1,0,0,14.7058823529412,40.004312484496,BVES,delta,2
cellular glucose homeostasis (GO:0001678),1/34,1,34,0.0658554395562883,1,0,0,14.7058823529412,40.004312484496,GPER1,delta,2
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),1/34,1,34,0.0658554395562883,1,0,0,14.7058823529412,40.004312484496,NUP62,delta,2
tRNA export from nucleus (GO:0006409),1/34,1,34,0.0658554395562883,1,0,0,14.7058823529412,40.004312484496,NUP62,delta,2
regulation of wound healing (GO:0061041),1/35,1,35,0.0677269063272853,1,0,0,14.2857142857143,38.4610249049755,AJAP1,delta,2
positive regulation of cell development (GO:0010720),1/35,1,35,0.0677269063272853,1,0,0,14.2857142857143,38.4610249049755,GPER1,delta,2
negative regulation of cell-substrate adhesion (GO:0010812),1/36,1,36,0.0695947174016119,1,0,0,13.8888888888889,37.0148140822833,AJAP1,delta,2
regulation of mitotic spindle organization (GO:0060236),1/36,1,36,0.0695947174016119,1,0,0,13.8888888888889,37.0148140822833,NUP62,delta,2
negative regulation of protein kinase B signaling (GO:0051898),1/36,1,36,0.0695947174016119,1,0,0,13.8888888888889,37.0148140822833,GPER1,delta,2
regulation of endothelial cell apoptotic process (GO:2000351),1/36,1,36,0.0695947174016119,1,0,0,13.8888888888889,37.0148140822833,GPER1,delta,2
anatomical structure homeostasis (GO:0060249),1/36,1,36,0.0695947174016119,1,0,0,13.8888888888889,37.0148140822833,RECQL4,delta,2
tRNA transport (GO:0051031),1/36,1,36,0.0695947174016119,1,0,0,13.8888888888889,37.0148140822833,NUP62,delta,2
positive regulation of intracellular signal transduction (GO:1902533),3/480,3,480,0.0706573972756406,1,0,0,3.125,8.28097647565494,GPER1;NUP62;ADRA2B,delta,2
calcium ion transmembrane import into cytosol (GO:0097553),1/37,1,37,0.0714588797420939,1,0,0,13.5135135135135,35.6572040976039,CHERP,delta,2
muscle cell differentiation (GO:0042692),1/37,1,37,0.0714588797420939,1,0,0,13.5135135135135,35.6572040976039,BVES,delta,2
positive regulation of signaling (GO:0023056),1/37,1,37,0.0714588797420939,1,0,0,13.5135135135135,35.6572040976039,BVES,delta,2
positive regulation of cell migration (GO:0030335),2/222,2,222,0.0726702814141103,1,0,0,4.50450450450451,11.8100124408445,GPER1;SPHK1,delta,2
negative regulation of apoptotic process (GO:0043066),3/486,3,486,0.0727559040965478,1,0,0,3.08641975308642,8.08841117363336,SPHK1;NUP62;ATF5,delta,2
regulation of peptidyl-threonine phosphorylation (GO:0010799),1/38,1,38,0.0733194002791394,1,0,0,13.1578947368421,34.3806583624079,SPHK1,delta,2
positive regulation of stress fiber assembly (GO:0051496),1/38,1,38,0.0733194002791394,1,0,0,13.1578947368421,34.3806583624079,S100A10,delta,2
base-excision repair (GO:0006284),1/38,1,38,0.0733194002791394,1,0,0,13.1578947368421,34.3806583624079,RECQL4,delta,2
regulation of carbohydrate catabolic process (GO:0043470),1/38,1,38,0.0733194002791394,1,0,0,13.1578947368421,34.3806583624079,NUP62,delta,2
skeletal muscle tissue development (GO:0007519),1/40,1,40,0.0770295436931649,1,0,0,12.5,32.0445780798706,BVES,delta,2
positive regulation of peptide hormone secretion (GO:0090277),1/40,1,40,0.0770295436931649,1,0,0,12.5,32.0445780798706,GPER1,delta,2
regulation of coenzyme metabolic process (GO:0051196),1/40,1,40,0.0770295436931649,1,0,0,12.5,32.0445780798706,NUP62,delta,2
extracellular matrix organization (GO:0030198),2/230,2,230,0.0772497839873302,1,0,0,4.34782608695652,11.1335267803857,ITGA2;TNR,delta,2
positive regulation of mitotic nuclear division (GO:0045840),1/41,1,41,0.0788791803782377,1,0,0,12.1951219512195,30.9736336522459,NUP62,delta,2
response to peptide hormone (GO:0043434),1/41,1,41,0.0788791803782377,1,0,0,12.1951219512195,30.9736336522459,GPER1,delta,2
negative regulation of ERK1 and ERK2 cascade (GO:0070373),1/41,1,41,0.0788791803782377,1,0,0,12.1951219512195,30.9736336522459,GPER1,delta,2
regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,1,41,0.0788791803782377,1,0,0,12.1951219512195,30.9736336522459,GPER1,delta,2
cellular response to peptide (GO:1901653),1/42,1,42,0.0807252029061721,1,0,0,11.9047619047619,29.9607672475338,GPER1,delta,2
DNA duplex unwinding (GO:0032508),1/42,1,42,0.0807252029061721,1,0,0,11.9047619047619,29.9607672475338,RECQL4,delta,2
regulation of substrate adhesion-dependent cell spreading (GO:1900024),1/42,1,42,0.0807252029061721,1,0,0,11.9047619047619,29.9607672475338,S100A10,delta,2
telomere organization (GO:0032200),1/42,1,42,0.0807252029061721,1,0,0,11.9047619047619,29.9607672475338,RECQL4,delta,2
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",2/237,2,237,0.0813308465915815,1,0,0,4.21940928270042,10.5874680064056,RBMX2;CHERP,delta,2
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),3/513,3,513,0.0825442538420185,1,0,0,2.92397660818713,7.29362783406943,BCL7A;DMAP1;ATF5,delta,2
regulation of ATP metabolic process (GO:1903578),1/44,1,44,0.0844064330302912,1,0,0,11.3636363636364,28.0921779493958,NUP62,delta,2
mitotic metaphase plate congression (GO:0007080),1/44,1,44,0.0844064330302912,1,0,0,11.3636363636364,28.0921779493958,NUP62,delta,2
positive regulation of protein localization to plasma membrane (GO:1903078),1/44,1,44,0.0844064330302912,1,0,0,11.3636363636364,28.0921779493958,GPER1,delta,2
negative regulation of DNA metabolic process (GO:0051053),1/44,1,44,0.0844064330302912,1,0,0,11.3636363636364,28.0921779493958,GPER1,delta,2
metaphase plate congression (GO:0051310),1/45,1,45,0.0862416543351897,1,0,0,11.1111111111111,27.2289109898165,NUP62,delta,2
regulation of focal adhesion assembly (GO:0051893),1/45,1,45,0.0862416543351897,1,0,0,11.1111111111111,27.2289109898165,S100A10,delta,2
positive regulation of actin filament bundle assembly (GO:0032233),1/45,1,45,0.0862416543351897,1,0,0,11.1111111111111,27.2289109898165,S100A10,delta,2
mitotic nuclear envelope disassembly (GO:0007077),1/45,1,45,0.0862416543351897,1,0,0,11.1111111111111,27.2289109898165,NUP62,delta,2
regulation of fibroblast proliferation (GO:0048145),1/47,1,47,0.0899013436297567,1,0,0,10.6382978723404,25.6281105509602,SPHK1,delta,2
regulation of DNA metabolic process (GO:0051052),1/47,1,47,0.0899013436297567,1,0,0,10.6382978723404,25.6281105509602,GPER1,delta,2
positive regulation of protein localization to cell periphery (GO:1904377),1/47,1,47,0.0899013436297567,1,0,0,10.6382978723404,25.6281105509602,GPER1,delta,2
nuclear envelope disassembly (GO:0051081),1/47,1,47,0.0899013436297567,1,0,0,10.6382978723404,25.6281105509602,NUP62,delta,2
regulation of generation of precursor metabolites and energy (GO:0043467),1/47,1,47,0.0899013436297567,1,0,0,10.6382978723404,25.6281105509602,NUP62,delta,2
response to glucose (GO:0009749),1/48,1,48,0.0917258252694664,1,0,0,10.4166666666667,24.884909495491,GPER1,delta,2
positive regulation of organelle assembly (GO:1902117),1/48,1,48,0.0917258252694664,1,0,0,10.4166666666667,24.884909495491,NUP62,delta,2
histone H4 acetylation (GO:0043967),1/48,1,48,0.0917258252694664,1,0,0,10.4166666666667,24.884909495491,DMAP1,delta,2
endosome to lysosome transport (GO:0008333),1/49,1,49,0.0935467406593446,1,0,0,10.2040816326531,24.1764700764896,CLEC16A,delta,2
amino acid transport (GO:0006865),1/49,1,49,0.0935467406593446,1,0,0,10.2040816326531,24.1764700764896,SLC1A5,delta,2
regulation of cell cycle arrest (GO:0071156),1/49,1,49,0.0935467406593446,1,0,0,10.2040816326531,24.1764700764896,GPER1,delta,2
positive regulation of programmed cell death (GO:0043068),2/258,2,258,0.0939621249282672,1,0,0,3.87596899224806,9.16613761319292,LATS2;GPER1,delta,2
protein heterooligomerization (GO:0051291),1/50,1,50,0.0953640965755272,1,0,0,10,23.5005311753237,S100A10,delta,2
regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/50,1,50,0.0953640965755272,1,0,0,10,23.5005311753237,GPER1,delta,2
RNA methylation (GO:0001510),1/50,1,50,0.0953640965755272,1,0,0,10,23.5005311753237,MRM1,delta,2
"regulation of transcription, DNA-templated (GO:0006355)",6/1599,6,1599,0.0962963212620932,1,0,0,1.87617260787993,4.39085396194508,BCL7A;ZNF816;NUP62;DMAP1;ATF5;ETV4,delta,2
"mRNA splicing, via spliceosome (GO:0000398)",2/262,2,262,0.0964302304029554,1,0,0,3.81679389312977,8.92723485929051,RBMX2;CHERP,delta,2
carboxylic acid transport (GO:0046942),1/52,1,52,0.0989881570768418,1,0,0,9.61538461538461,22.2380294374009,SLC1A5,delta,2
telomere maintenance (GO:0000723),1/52,1,52,0.0989881570768418,1,0,0,9.61538461538461,22.2380294374009,RECQL4,delta,2
actin polymerization or depolymerization (GO:0008154),4/37,4,37,0.000424297259461064,1,0,0,11.2612612612613,87.4445525308791,DSTN;EVL;JAK2;CAP2,delta,3
carbohydrate biosynthetic process (GO:0016051),4/37,4,37,0.000424297259461064,1,0,0,11.2612612612613,87.4445525308791,GALNT11;GLT8D1;GLT8D2;ST6GALNAC5,delta,3
phosphatidylserine acyl-chain remodeling (GO:0036150),3/21,3,21,0.00101977125690145,1,0,0,14.8809523809524,102.502632957966,OSBPL8;LPCAT4;OSBPL10,delta,3
negative regulation of cytoplasmic translation (GO:2000766),2/6,2,6,0.00134076505731355,1,0,0,34.7222222222222,229.670655890586,CPEB3;CPEB2,delta,3
MAPK cascade (GO:0000165),9/279,9,279,0.001545821125696,1,0,0,3.36021505376344,21.7479839948648,PSMA5;CAMK2B;PSMA3;RIPK2;IRS2;JAK2;MARK3;SPTB;MAP3K5,delta,3
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),11/397,11,397,0.00163440577770471,1,0,0,2.88623005877414,18.5194258431624,SOCS2;CYFIP1;HNRNPM;ACTR2;CHN1;ATP6V1H;IRS2;PIK3C2A;JAK2;ARHGEF7;EPHA2,delta,3
store-operated calcium entry (GO:0002115),2/7,2,7,0.00186522161579136,1,0,0,29.7619047619048,187.034982264982,STIM2;ORAI1,delta,3
positive regulation of cell death (GO:0010942),4/58,4,58,0.0023306263756185,1,0,0,7.18390804597701,43.5461078792779,RIPK2;ZNF746;CLU;MAP3K5,delta,3
phosphatidylserine metabolic process (GO:0006658),3/28,3,28,0.00239096613000456,1,0,0,11.1607142857143,67.3667160293019,OSBPL8;LPCAT4;OSBPL10,delta,3
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),2/8,2,8,0.00247127371878236,1,0,0,26.0416666666667,156.32868712596,PIK3C2A;PIK3C2B,delta,3
activation of adenylate cyclase activity (GO:0007190),3/33,3,33,0.00384454257188928,1,0,0,9.46969696969697,52.661937974437,GNAL;ADCY9;CAP2,delta,3
protein deglycosylation (GO:0006517),2/10,2,10,0.00392179347750023,1,0,0,20.8333333333333,115.441796042491,MGEA5;NGLY1,delta,3
cellular response to growth hormone stimulus (GO:0071378),2/10,2,10,0.00392179347750023,1,0,0,20.8333333333333,115.441796042491,SOCS2;JAK2,delta,3
regulation of cytoplasmic translational elongation (GO:1900247),2/10,2,10,0.00392179347750023,1,0,0,20.8333333333333,115.441796042491,CPEB3;CPEB2,delta,3
glycoprotein catabolic process (GO:0006516),2/10,2,10,0.00392179347750023,1,0,0,20.8333333333333,115.441796042491,MGEA5;NGLY1,delta,3
regulation of cytoplasmic translation (GO:2000765),2/10,2,10,0.00392179347750023,1,0,0,20.8333333333333,115.441796042491,CPEB3;CPEB2,delta,3
sphingolipid biosynthetic process (GO:0030148),4/67,4,67,0.00393842175093076,1,0,0,6.21890547263682,34.4339254151242,CERS6;VAPA;SGMS2;ST6GALNAC5,delta,3
positive regulation of adenylate cyclase activity (GO:0045762),3/34,3,34,0.00418710927904084,1,0,0,9.19117647058824,50.3285357783271,GNAL;ADCY9;CAP2,delta,3
cell-substrate junction assembly (GO:0007044),2/11,2,11,0.00476313250903901,1,0,0,18.9393939393939,101.266093504752,CD151;LAMC1,delta,3
hemidesmosome assembly (GO:0031581),2/11,2,11,0.00476313250903901,1,0,0,18.9393939393939,101.266093504752,CD151;LAMC1,delta,3
carbohydrate derivative catabolic process (GO:1901136),2/11,2,11,0.00476313250903901,1,0,0,18.9393939393939,101.266093504752,MGEA5;NGLY1,delta,3
mitochondrial outer membrane permeabilization (GO:0097345),2/12,2,12,0.00567980926918814,1,0,0,17.3611111111111,89.7714865656452,MOAP1;RHOT1,delta,3
"alternative mRNA splicing, via spliceosome (GO:0000380)",2/12,2,12,0.00567980926918814,1,0,0,17.3611111111111,89.7714865656452,HNRNPM;SLU7,delta,3
positive regulation of neuron death (GO:1901216),3/39,3,39,0.0061745423104683,1,0,0,8.01282051282052,40.7637862097542,ZNF746;CLU;MAP3K5,delta,3
inositol lipid-mediated signaling (GO:0048017),3/40,3,40,0.00662863362066943,1,0,0,7.8125,39.1902858314115,IRS2;PIK3C2A;PIK3C2B,delta,3
protein catabolic process (GO:0030163),4/82,4,82,0.00804382019799472,1,0,0,5.08130081300813,24.5063575184679,PSMA5;MGEA5;PSMA3;NGLY1,delta,3
ephrin receptor signaling pathway (GO:0048013),4/83,4,83,0.00838901131533688,1,0,0,5.02008032128514,24.000163686188,ACTR2;CHN1;ARHGEF7;EPHA2,delta,3
anterograde synaptic vesicle transport (GO:0048490),2/15,2,15,0.00886688774487149,1,0,0,13.8888888888889,65.6309919241848,AP3M1;BLOC1S3,delta,3
synaptic vesicle transport along microtubule (GO:0099517),2/15,2,15,0.00886688774487149,1,0,0,13.8888888888889,65.6309919241848,AP3M1;BLOC1S3,delta,3
proteolysis involved in cellular protein catabolic process (GO:0051603),4/94,4,94,0.012838834292197,1,0,0,4.43262411347518,19.3053225711605,PSMA5;PSMA3;PDCD6IP;NGLY1,delta,3
cellular response to interleukin-7 (GO:0098761),2/19,2,19,0.0140819818168745,1,0,0,10.9649122807018,46.7418770188353,SOCS2;IRS2,delta,3
macromolecule biosynthetic process (GO:0009059),2/19,2,19,0.0140819818168745,1,0,0,10.9649122807018,46.7418770188353,GLT8D1;GLT8D2,delta,3
protein targeting to lysosome (GO:0006622),2/19,2,19,0.0140819818168745,1,0,0,10.9649122807018,46.7418770188353,AP3M1;CLU,delta,3
interleukin-7-mediated signaling pathway (GO:0038111),2/19,2,19,0.0140819818168745,1,0,0,10.9649122807018,46.7418770188353,SOCS2;IRS2,delta,3
positive regulation of cell-substrate adhesion (GO:0010811),3/53,3,53,0.0143545663373826,1,0,0,5.89622641509434,25.0217404229411,JAK2;UTRN;ARHGEF7,delta,3
regulation of calcium ion transport (GO:0051924),3/53,3,53,0.0143545663373826,1,0,0,5.89622641509434,25.0217404229411,CAMK2B;STIM2;ORAI1,delta,3
positive regulation of dendritic spine development (GO:0060999),2/20,2,20,0.0155488416827922,1,0,0,10.4166666666667,43.37259513525,CAMK2B;CPEB3,delta,3
growth hormone receptor signaling pathway (GO:0060396),2/20,2,20,0.0155488416827922,1,0,0,10.4166666666667,43.37259513525,SOCS2;JAK2,delta,3
regulation of axonogenesis (GO:0050770),3/56,3,56,0.0166354226846485,1,0,0,5.58035714285714,22.8583758955236,RUFY3;CHN1;ZSWIM8,delta,3
phosphatidylinositol-mediated signaling (GO:0048015),3/57,3,57,0.0174381655825471,1,0,0,5.48245614035088,22.1989805401346,IRS2;PIK3C2A;PIK3C2B,delta,3
protein import into nucleus (GO:0006606),4/104,4,104,0.0179898990131201,1,0,0,4.00641025641026,16.0975354348409,POM121;ZFYVE9;JAK2;GPN3,delta,3
STAT cascade (GO:0097696),2/22,2,22,0.0186687997674937,1,0,0,9.46969696969697,37.6979319146326,SOCS2;JAK2,delta,3
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),2/22,2,22,0.0186687997674937,1,0,0,9.46969696969697,37.6979319146326,TMTC3;CLU,delta,3
negative regulation of response to endoplasmic reticulum stress (GO:1903573),2/22,2,22,0.0186687997674937,1,0,0,9.46969696969697,37.6979319146326,USP25;CLU,delta,3
axon guidance (GO:0007411),5/159,5,159,0.0187874200502987,1,0,0,3.27568134171908,13.01941751633,CYFIP1;CHN1;IRS2;EVL;SPTB,delta,3
response to endoplasmic reticulum stress (GO:0034976),4/107,4,107,0.0197522031079235,1,0,0,3.89408099688474,15.2822828819624,UBA5;TMTC3;MAP3K5;TMCO1,delta,3
cell morphogenesis (GO:0000902),3/60,3,60,0.019974366247378,1,0,0,5.20833333333333,20.381799557934,CYFIP1;CLU;CAP2,delta,3
melanosome organization (GO:0032438),2/23,2,23,0.0203192724181344,1,0,0,9.05797101449275,35.291534991912,TRAPPC6A;BLOC1S3,delta,3
lamellipodium assembly (GO:0030032),2/23,2,23,0.0203192724181344,1,0,0,9.05797101449275,35.291534991912,CYFIP1;ARHGEF7,delta,3
membrane lipid biosynthetic process (GO:0046467),3/61,3,61,0.0208625160487296,1,0,0,5.12295081967213,19.8248013357194,CERS6;VAPA;SGMS2,delta,3
positive regulation of cellular amide metabolic process (GO:0034250),3/62,3,62,0.0217720686564369,1,0,0,5.04032258064516,19.2899565775557,CPEB3;CLU;LARP6,delta,3
cellular response to insulin stimulus (GO:0032869),4/111,4,111,0.0222624789759896,1,0,0,3.75375375375375,14.2824796348934,ATP6V1H;IRS2;PIK3C2A;CPEB2,delta,3
proteasomal ubiquitin-independent protein catabolic process (GO:0010499),2/25,2,25,0.0237947850127502,1,0,0,8.33333333333333,31.1524069952142,PSMA5;PSMA3,delta,3
cAMP metabolic process (GO:0046058),2/25,2,25,0.0237947850127502,1,0,0,8.33333333333333,31.1524069952142,ADCY9;EPHA2,delta,3
lamellipodium organization (GO:0097581),2/26,2,26,0.0256173135597135,1,0,0,8.01282051282052,29.3628753619029,CYFIP1;ARHGEF7,delta,3
cyclic nucleotide metabolic process (GO:0009187),2/26,2,26,0.0256173135597135,1,0,0,8.01282051282052,29.3628753619029,ADCY9;EPHA2,delta,3
"RNA splicing, via transesterification reactions (GO:0000375)",2/26,2,26,0.0256173135597135,1,0,0,8.01282051282052,29.3628753619029,SF3B3;SLU7,delta,3
positive regulation of cellular protein localization (GO:1903829),3/67,3,67,0.0266408622585276,1,0,0,4.66417910447761,16.9090907965107,RUFY3;SESN2;CEP290,delta,3
positive regulation of glucose import (GO:0046326),2/27,2,27,0.0274947135477811,1,0,0,7.71604938271605,27.7296414152407,OSBPL8;IRS2,delta,3
insulin receptor signaling pathway (GO:0008286),3/68,3,68,0.0276787340857232,1,0,0,4.59558823529412,16.4847926616534,ATP6V1H;IRS2;PIK3C2A,delta,3
positive regulation of autophagy (GO:0010508),3/68,3,68,0.0276787340857232,1,0,0,4.59558823529412,16.4847926616534,SCOC;SESN2;FBXO7,delta,3
calcium ion transport (GO:0006816),4/119,4,119,0.0278447102452449,1,0,0,3.50140056022409,12.5389085013422,MCUR1;STIM2;ORAI1;TMCO1,delta,3
plasma membrane bounded cell projection organization (GO:0120036),4/119,4,119,0.0278447102452449,1,0,0,3.50140056022409,12.5389085013422,CYFIP1;VAPA;BLOC1S3;FAM161B,delta,3
regulation of neuron projection development (GO:0010975),4/120,4,120,0.0285959026535494,1,0,0,3.47222222222222,12.3419855391718,CAMK2B;RUFY3;CHN1;FBXO7,delta,3
COPII-coated vesicle budding (GO:0090114),3/69,3,69,0.028737917100589,1,0,0,4.52898550724638,16.0758055925774,TRAPPC6A;VAPA;KLHL12,delta,3
actin filament organization (GO:0007015),4/121,4,121,0.0293590704758063,1,0,0,3.4435261707989,12.1492897220399,RUFY3;DSTN;EVL;CAP2,delta,3
phosphatidylinositol phosphorylation (GO:0046854),2/28,2,28,0.0294257752120217,1,0,0,7.44047619047619,26.2342580418862,PIK3C2A;PIK3C2B,delta,3
plasma membrane bounded cell projection assembly (GO:0120031),6/242,6,242,0.0296429841159304,1,0,0,2.58264462809917,9.08711209955293,CYFIP1;GALNT11;ACTR2;TTC8;ARHGEF7;CEP290,delta,3
ER to Golgi vesicle-mediated transport (GO:0006888),5/181,5,181,0.0306603776746085,1,0,0,2.87753222836096,10.0275785205459,TRAPPC6A;VAPA;COG4;KLHL12;SPTB,delta,3
regulation of neuron death (GO:1901214),3/73,3,73,0.0331869289797426,1,0,0,4.28082191780822,14.5787636387477,ZNF746;CLU;MAP3K5,delta,3
phosphatidylinositol 3-kinase signaling (GO:0014065),2/31,2,31,0.0355291007665049,1,0,0,6.72043010752688,22.4287848010919,PIK3C2A;PIK3C2B,delta,3
positive regulation of mitochondrion organization (GO:0010822),4/129,4,129,0.0358982731456108,1,0,0,3.22997416020672,10.7463374884961,MOAP1;HHAT;FBXO7;MARCH5,delta,3
regulation of GTPase activity (GO:0043087),5/189,5,189,0.0359270745115927,1,0,0,2.75573192239859,9.1662921711278,TBC1D2;DOCK9;CHN1;ARHGEF7;CPEB2,delta,3
regulation of dendritic spine development (GO:0060998),2/32,2,32,0.0376630673407751,1,0,0,6.51041666666667,21.3481465548721,CAMK2B;CPEB3,delta,3
renal water homeostasis (GO:0003091),2/32,2,32,0.0376630673407751,1,0,0,6.51041666666667,21.3481465548721,ADCY9;RAB11FIP2,delta,3
anterograde axonal transport (GO:0008089),2/32,2,32,0.0376630673407751,1,0,0,6.51041666666667,21.3481465548721,AP3M1;BLOC1S3,delta,3
cilium organization (GO:0044782),5/193,5,193,0.038757228127968,1,0,0,2.6986183074266,8.77169151620012,GALNT11;ACTR2;TTC8;FAM161B;CEP290,delta,3
protein modification by small protein conjugation (GO:0032446),8/399,8,399,0.0392360920481582,1,0,0,2.08855472013367,6.76307067725568,POM121;UBA5;RNF38;DCUN1D1;UBR3;WWP1;KLHL12;FBXO7,delta,3
cellular response to amino acid stimulus (GO:0071230),2/33,2,33,0.0398449116193616,1,0,0,6.31313131313131,20.3457106707451,SESN2;CPEB3,delta,3
ceramide biosynthetic process (GO:0046513),2/33,2,33,0.0398449116193616,1,0,0,6.31313131313131,20.3457106707451,CERS6;SGMS2,delta,3
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),2/33,2,33,0.0398449116193616,1,0,0,6.31313131313131,20.3457106707451,JAK2;CLU,delta,3
positive regulation of translation (GO:0045727),3/79,3,79,0.040490964463924,1,0,0,3.95569620253165,12.6846377745897,KHDRBS1;CPEB3;LARP6,delta,3
anaphase-promoting complex-dependent catabolic process (GO:0031145),3/80,3,80,0.0417809371629363,1,0,0,3.90625,12.403574578933,PSMA5;PSMA3;PTTG1,delta,3
oligosaccharide biosynthetic process (GO:0009312),2/34,2,34,0.0420735281835711,1,0,0,6.12745098039216,19.4138267175229,GALNT11;ST6GALNAC5,delta,3
positive regulation of calcium ion transport (GO:0051928),2/34,2,34,0.0420735281835711,1,0,0,6.12745098039216,19.4138267175229,STIM2;ORAI1,delta,3
regulation of intracellular protein transport (GO:0033157),2/34,2,34,0.0420735281835711,1,0,0,6.12745098039216,19.4138267175229,RUFY3;CEP290,delta,3
NIK/NF-kappaB signaling (GO:0038061),3/81,3,81,0.0430914331447489,1,0,0,3.85802469135803,12.1312927028256,PSMA5;PSMA3;RELB,delta,3
response to amino acid (GO:0043200),2/35,2,35,0.0443478282494987,1,0,0,5.95238095238095,18.5457829754153,SESN2;CPEB3,delta,3
regulation of JUN kinase activity (GO:0043506),2/35,2,35,0.0443478282494987,1,0,0,5.95238095238095,18.5457829754153,AIDA;MAP3K5,delta,3
regulation of interferon-beta production (GO:0032648),2/35,2,35,0.0443478282494987,1,0,0,5.95238095238095,18.5457829754153,RIPK2;RELB,delta,3
lipid phosphorylation (GO:0046834),2/36,2,36,0.0466667394012544,1,0,0,5.78703703703704,17.7356689030315,PIK3C2A;PIK3C2B,delta,3
apical junction assembly (GO:0043297),2/36,2,36,0.0466667394012544,1,0,0,5.78703703703704,17.7356689030315,PDCD6IP;CTNNA1,delta,3
positive regulation of protein ubiquitination (GO:0031398),3/84,3,84,0.0471450867123106,1,0,0,3.7202380952381,11.3635620565392,RIPK2;DCUN1D1;CLU,delta,3
Golgi vesicle transport (GO:0048193),6/272,6,272,0.0478034544304508,1,0,0,2.29779411764706,6.986804627014,TRAPPC6A;VAPA;COG4;SURF4;KLHL12;SPTB,delta,3
protein acylation (GO:0043543),2/37,2,37,0.0490292054373335,1,0,0,5.63063063063063,16.9782608620108,ING5;ZDHHC2,delta,3
regulation of cell morphogenesis involved in differentiation (GO:0010769),2/37,2,37,0.0490292054373335,1,0,0,5.63063063063063,16.9782608620108,RUFY3;CHN1,delta,3
axonal transport (GO:0098930),2/37,2,37,0.0490292054373335,1,0,0,5.63063063063063,16.9782608620108,AP3M1;BLOC1S3,delta,3
positive regulation of macromolecule biosynthetic process (GO:0010557),4/143,4,143,0.0492115159861187,1,0,0,2.91375291375291,8.77513874741913,IRS2;CPEB3;JAK2;LARP6,delta,3
cellular protein complex assembly (GO:0043623),4/145,4,145,0.0513076965019545,1,0,0,2.87356321839081,8.53423709419774,ZFYVE9;COG4;PIK3C2A;CLU,delta,3
regulation of dendrite development (GO:0050773),2/38,2,38,0.0514341861336844,1,0,0,5.48245614035088,16.2689266870877,CAMK2B;CPEB3,delta,3
regulation of metal ion transport (GO:0010959),2/38,2,38,0.0514341861336844,1,0,0,5.48245614035088,16.2689266870877,CAMK2B;ORAI1,delta,3
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),3/88,3,88,0.0528310547596772,1,0,0,3.55113636363636,10.4426708197444,PSMA5;PSMA3;CLU,delta,3
positive regulation of nucleobase-containing compound transport (GO:0032241),1/6,1,6,0.0562417808045898,1,0,0,17.3611111111111,49.9669334653394,KHDRBS1,delta,3
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),1/6,1,6,0.0562417808045898,1,0,0,17.3611111111111,49.9669334653394,MOAP1,delta,3
positive regulation of RNA binding (GO:1905216),1/6,1,6,0.0562417808045898,1,0,0,17.3611111111111,49.9669334653394,LARP6,delta,3
negative regulation of translation in response to stress (GO:0032055),1/6,1,6,0.0562417808045898,1,0,0,17.3611111111111,49.9669334653394,SESN2,delta,3
"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",1/6,1,6,0.0562417808045898,1,0,0,17.3611111111111,49.9669334653394,RHOT1,delta,3
mRNA 3'-splice site recognition (GO:0000389),1/6,1,6,0.0562417808045898,1,0,0,17.3611111111111,49.9669334653394,SLU7,delta,3
nucleobase metabolic process (GO:0009112),1/6,1,6,0.0562417808045898,1,0,0,17.3611111111111,49.9669334653394,UCK2,delta,3
positive regulation of fibroblast migration (GO:0010763),1/6,1,6,0.0562417808045898,1,0,0,17.3611111111111,49.9669334653394,ARHGEF7,delta,3
epithelial tube formation (GO:0072175),1/6,1,6,0.0562417808045898,1,0,0,17.3611111111111,49.9669334653394,CEP290,delta,3
platelet dense granule organization (GO:0060155),1/6,1,6,0.0562417808045898,1,0,0,17.3611111111111,49.9669334653394,BLOC1S3,delta,3
regulation of extracellular exosome assembly (GO:1903551),1/6,1,6,0.0562417808045898,1,0,0,17.3611111111111,49.9669334653394,PDCD6IP,delta,3
insulin secretion involved in cellular response to glucose stimulus (GO:0035773),1/6,1,6,0.0562417808045898,1,0,0,17.3611111111111,49.9669334653394,RAB11FIP2,delta,3
regulation of glial cell apoptotic process (GO:0034350),1/6,1,6,0.0562417808045898,1,0,0,17.3611111111111,49.9669334653394,PRKCH,delta,3
lens fiber cell development (GO:0070307),1/6,1,6,0.0562417808045898,1,0,0,17.3611111111111,49.9669334653394,EPHA2,delta,3
pronephros development (GO:0048793),1/6,1,6,0.0562417808045898,1,0,0,17.3611111111111,49.9669334653394,CEP290,delta,3
positive regulation of RNA export from nucleus (GO:0046833),1/6,1,6,0.0562417808045898,1,0,0,17.3611111111111,49.9669334653394,KHDRBS1,delta,3
cellular response to amino acid starvation (GO:0034198),2/40,2,40,0.0563676092230423,1,0,0,5.20833333333333,14.9784405729695,SESN2;MAP3K5,delta,3
mRNA processing (GO:0006397),6/284,6,284,0.0566461992310103,1,0,0,2.20070422535211,6.31806863091068,HNRNPM;LSM6;SF3B3;TRA2A;CMTR1;SLU7,delta,3
protein polyubiquitination (GO:0000209),6/284,6,284,0.0566461992310103,1,0,0,2.20070422535211,6.31806863091068,PSMA5;PSMA3;UBE2E2;WWP1;FBXO7;MARCH5,delta,3
negative regulation of kinase activity (GO:0033673),3/92,3,92,0.0588314410540291,1,0,0,3.39673913043478,9.62322980700324,SOCS2;LRRC4;IRS2,delta,3
regulation of release of cytochrome c from mitochondria (GO:0090199),2/41,2,41,0.0588940492064456,1,0,0,5.08130081300813,14.3903212681774,MOAP1;CLU,delta,3
cognition (GO:0050890),2/41,2,41,0.0588940492064456,1,0,0,5.08130081300813,14.3903212681774,CYFIP1;TTC8,delta,3
positive regulation of mitotic cell cycle phase transition (GO:1901992),2/41,2,41,0.0588940492064456,1,0,0,5.08130081300813,14.3903212681774,ESPL1;UBE2E2,delta,3
JAK-STAT cascade (GO:0007259),2/41,2,41,0.0588940492064456,1,0,0,5.08130081300813,14.3903212681774,SOCS2;JAK2,delta,3
cellular protein modification process (GO:0006464),15/1002,15,1002,0.0592769051674032,1,0,0,1.55938123752495,4.40608705461694,CAMK2B;MGEA5;USP25;PRKCH;NGLY1;DCUN1D1;UBE2E2;LAMC1;SOCS2;PSMA5;PSMA3;NEK10;JAK2;FBXO7;MAP3K5,delta,3
positive regulation of intracellular protein transport (GO:0090316),4/153,4,153,0.0601739030988892,1,0,0,2.72331154684096,7.65391210239055,HHAT;TMEM30B;RUFY3;CEP290,delta,3
peptide transport (GO:0015833),2/42,2,42,0.0614589986360119,1,0,0,4.96031746031746,13.8362351951926,ZFYVE9;CEP290,delta,3
negative regulation of STAT cascade (GO:1904893),2/42,2,42,0.0614589986360119,1,0,0,4.96031746031746,13.8362351951926,SOCS2;LRRC4,delta,3
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),6/292,6,292,0.0630544138264079,1,0,0,2.14041095890411,5.91557622826303,PSMA5;PSMA3;PTTG1;RNF38;UBR3;WWP1,delta,3
ceramide metabolic process (GO:0006672),2/43,2,43,0.0640614941012886,1,0,0,4.84496124031008,13.3135262190224,CERS6;SGMS2,delta,3
interleukin-1-mediated signaling pathway (GO:0070498),3/96,3,96,0.0651380306838086,1,0,0,3.25520833333333,8.89077705614591,PSMA5;PSMA3;RIPK2,delta,3
ATP hydrolysis coupled proton transport (GO:0015991),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,ATP6V1H,delta,3
positive regulation of dendritic spine morphogenesis (GO:0061003),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,CAMK2B,delta,3
ATP hydrolysis coupled cation transmembrane transport (GO:0099132),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,ATP6V1H,delta,3
positive regulation of lamellipodium morphogenesis (GO:2000394),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,ARHGEF7,delta,3
response to misfolded protein (GO:0051788),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,CLU,delta,3
"retrograde transport, vesicle recycling within Golgi (GO:0000301)",1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,COG4,delta,3
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,ESPL1,delta,3
negative regulation of glial cell apoptotic process (GO:0034351),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,PRKCH,delta,3
positive regulation of fatty acid beta-oxidation (GO:0032000),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,IRS2,delta,3
negative regulation of B cell apoptotic process (GO:0002903),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,IRS2,delta,3
positive regulation of mRNA binding (GO:1902416),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,LARP6,delta,3
regulation of establishment of protein localization (GO:0070201),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,CEP290,delta,3
nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,RIPK2,delta,3
vascular smooth muscle contraction (GO:0014829),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,PIK3C2A,delta,3
positive regulation of autophagy of mitochondrion (GO:1903599),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,FBXO7,delta,3
adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,GNAL,delta,3
negative regulation of calcium ion import (GO:0090281),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,SLC30A1,delta,3
negative regulation of RIG-I signaling pathway (GO:0039536),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,SEC14L1,delta,3
ER overload response (GO:0006983),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,TMCO1,delta,3
microglial cell activation (GO:0001774),1/7,1,7,0.0653045590248281,1,0,0,14.8809523809524,40.6055569720808,CLU,delta,3
positive regulation of protein localization to plasma membrane (GO:1903078),2/44,2,44,0.0667005870142831,1,0,0,4.73484848484849,12.8197988886622,PRKCH;EPHA2,delta,3
negative regulation of protein metabolic process (GO:0051248),2/44,2,44,0.0667005870142831,1,0,0,4.73484848484849,12.8197988886622,SF3B3;CLU,delta,3
cellular response to organonitrogen compound (GO:0071417),3/98,3,98,0.0684033878548077,1,0,0,3.18877551020408,8.55335754317333,SESN2;CTNNA1;CPEB3,delta,3
positive regulation of cellular biosynthetic process (GO:0031328),4/160,4,160,0.0685562536333636,1,0,0,2.60416666666667,6.97942877553736,IRS2;CPEB3;CLU;LARP6,delta,3
amide biosynthetic process (GO:0043604),2/45,2,45,0.069375343338714,1,0,0,4.62962962962963,12.3528877680615,CERS6;SGMS2,delta,3
positive regulation of macroautophagy (GO:0016239),2/45,2,45,0.069375343338714,1,0,0,4.62962962962963,12.3528877680615,SCOC;SESN2,delta,3
positive regulation of intracellular transport (GO:0032388),2/45,2,45,0.069375343338714,1,0,0,4.62962962962963,12.3528877680615,RUFY3;CEP290,delta,3
hexose metabolic process (GO:0019318),2/46,2,46,0.0720848434403006,1,0,0,4.52898550724638,11.9108309447322,GAA;IRS2,delta,3
transmembrane transport (GO:0055085),7/379,7,379,0.0736088299679439,1,0,0,1.92392260334213,5.01949538708502,PSMA5;PSMA3;SLC41A2;ABCA3;SLC12A1;ATP6V1H;WWP1,delta,3
protein insertion into mitochondrial membrane (GO:0051204),1/8,1,8,0.0742807590185367,1,0,0,13.0208333333333,33.8529078672733,MOAP1,delta,3
positive regulation of mRNA 3'-end processing (GO:0031442),1/8,1,8,0.0742807590185367,1,0,0,13.0208333333333,33.8529078672733,CPEB3,delta,3
positive regulation of mitotic sister chromatid separation (GO:1901970),1/8,1,8,0.0742807590185367,1,0,0,13.0208333333333,33.8529078672733,ESPL1,delta,3
positive regulation of mitochondrial calcium ion concentration (GO:0051561),1/8,1,8,0.0742807590185367,1,0,0,13.0208333333333,33.8529078672733,MCUR1,delta,3
myelin maintenance (GO:0043217),1/8,1,8,0.0742807590185367,1,0,0,13.0208333333333,33.8529078672733,CLU,delta,3
negative regulation of protein homooligomerization (GO:0032463),1/8,1,8,0.0742807590185367,1,0,0,13.0208333333333,33.8529078672733,CLU,delta,3
negative regulation of anion transmembrane transport (GO:1903960),1/8,1,8,0.0742807590185367,1,0,0,13.0208333333333,33.8529078672733,IRS2,delta,3
pyrimidine nucleobase metabolic process (GO:0006206),1/8,1,8,0.0742807590185367,1,0,0,13.0208333333333,33.8529078672733,UCK2,delta,3
SMAD protein complex assembly (GO:0007183),1/8,1,8,0.0742807590185367,1,0,0,13.0208333333333,33.8529078672733,ZFYVE9,delta,3
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),1/8,1,8,0.0742807590185367,1,0,0,13.0208333333333,33.8529078672733,RHOT1,delta,3
regulation of ERAD pathway (GO:1904292),1/8,1,8,0.0742807590185367,1,0,0,13.0208333333333,33.8529078672733,USP25,delta,3
regulation of amyloid fibril formation (GO:1905906),1/8,1,8,0.0742807590185367,1,0,0,13.0208333333333,33.8529078672733,CLU,delta,3
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),1/8,1,8,0.0742807590185367,1,0,0,13.0208333333333,33.8529078672733,SESN2,delta,3
central nervous system myelination (GO:0022010),1/8,1,8,0.0742807590185367,1,0,0,13.0208333333333,33.8529078672733,CLU,delta,3
negative regulation of hippo signaling (GO:0035331),1/8,1,8,0.0742807590185367,1,0,0,13.0208333333333,33.8529078672733,MARK3,delta,3
regulation of receptor binding (GO:1900120),1/8,1,8,0.0742807590185367,1,0,0,13.0208333333333,33.8529078672733,ADAM15,delta,3
angiogenesis involved in wound healing (GO:0060055),1/8,1,8,0.0742807590185367,1,0,0,13.0208333333333,33.8529078672733,ADIPOR2,delta,3
positive regulation of protein localization to cell periphery (GO:1904377),2/47,2,47,0.0748281818924619,1,0,0,4.43262411347518,11.4918470819635,PRKCH;EPHA2,delta,3
positive regulation of ion transport (GO:0043270),2/47,2,47,0.0748281818924619,1,0,0,4.43262411347518,11.4918470819635,STIM2;ORAI1,delta,3
intrinsic apoptotic signaling pathway (GO:0097193),3/102,3,102,0.0751523541279389,1,0,0,3.06372549019608,7.92965023760024,MOAP1;MAP3K5;EPHA2,delta,3
activation of protein kinase activity (GO:0032147),5/234,5,234,0.0754987165865883,1,0,0,2.22578347578348,5.75062237741447,OSBPL8;ADCY9;RIPK2;JAK2;MAP3K5,delta,3
positive regulation of tumor necrosis factor production (GO:0032760),2/48,2,48,0.0776044672911607,1,0,0,4.34027777777778,11.09431547424,JAK2;CLU,delta,3
negative regulation of JAK-STAT cascade (GO:0046426),2/48,2,48,0.0776044672911607,1,0,0,4.34027777777778,11.09431547424,SOCS2;LRRC4,delta,3
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",5/237,5,237,0.0787395655040412,1,0,0,2.19760900140647,5.58546394073375,HNRNPM;LSM6;SF3B3;TRA2A;SLU7,delta,3
peptide metabolic process (GO:0006518),3/105,3,105,0.0804002033784906,1,0,0,2.97619047619048,7.502198134575,SPCS1;RNPEP;GSR,delta,3
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),2/49,2,49,0.0804128220463635,1,0,0,4.25170068027211,10.7167586620915,MOAP1;EPHA2,delta,3
glycoprotein metabolic process (GO:0009100),2/49,2,49,0.0804128220463635,1,0,0,4.25170068027211,10.7167586620915,MGEA5;NGLY1,delta,3
cellular macromolecule catabolic process (GO:0044265),2/49,2,49,0.0804128220463635,1,0,0,4.25170068027211,10.7167586620915,MGEA5;NGLY1,delta,3
regulation of mitochondrion organization (GO:0010821),2/49,2,49,0.0804128220463635,1,0,0,4.25170068027211,10.7167586620915,RHOT1;MARCH5,delta,3
secretory granule organization (GO:0033363),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,BLOC1S3,delta,3
mitotic DNA replication checkpoint (GO:0033314),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,ORAOV1,delta,3
interleukin-23-mediated signaling pathway (GO:0038155),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,JAK2,delta,3
Notch signaling involved in heart development (GO:0061314),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,GALNT11,delta,3
negative regulation of lymphocyte apoptotic process (GO:0070229),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,IRS2,delta,3
short-chain fatty acid metabolic process (GO:0046459),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,OXSM,delta,3
positive regulation of mitotic metaphase/anaphase transition (GO:0045842),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,ESPL1,delta,3
negative regulation of interferon-beta production (GO:0032688),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,RELB,delta,3
sphingomyelin metabolic process (GO:0006684),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,SGMS2,delta,3
positive regulation of synapse maturation (GO:0090129),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,CAMK2B,delta,3
positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,JAK2,delta,3
mRNA methylation (GO:0080009),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,CMTR1,delta,3
cellular response to leucine (GO:0071233),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,SESN2,delta,3
endosome to melanosome transport (GO:0035646),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,BLOC1S3,delta,3
endosome to pigment granule transport (GO:0043485),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,BLOC1S3,delta,3
negative regulation of amyloid-beta formation (GO:1902430),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,CLU,delta,3
positive regulation of protein homooligomerization (GO:0032464),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,CLU,delta,3
response to leucine (GO:0043201),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,SESN2,delta,3
mitochondrial calcium uptake (GO:0036444),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,MCUR1,delta,3
tyrosine phosphorylation of STAT protein (GO:0007260),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,JAK2,delta,3
Golgi vesicle budding (GO:0048194),1/9,1,9,0.0831712032407706,1,0,0,11.5740740740741,28.7830336338095,VAPA,delta,3
glutathione metabolic process (GO:0006749),2/50,2,50,0.0832523822519886,1,0,0,4.16666666666667,10.3578272287146,GSR;GCLM,delta,3
positive regulation of cellular component organization (GO:0051130),3/107,3,107,0.0839850140442803,1,0,0,2.92056074766355,7.23457038635955,CAMK2B;CD151;SURF4,delta,3
RNA splicing (GO:0008380),3/107,3,107,0.0839850140442803,1,0,0,2.92056074766355,7.23457038635955,LSM6;SF3B3;SLU7,delta,3
viral life cycle (GO:0019058),3/108,3,108,0.0858028026037682,1,0,0,2.89351851851852,7.10562386759869,POM121;PDCD6IP;WWP1,delta,3
fatty acid oxidation (GO:0019395),2/51,2,51,0.0861222974600758,1,0,0,4.08496732026144,10.0162864763647,ACAD11;ADIPOR2,delta,3
regulation of cellular amine metabolic process (GO:0033238),2/52,2,52,0.0890217305236634,1,0,0,4.00641025641026,9.6910047110006,PSMA5;PSMA3,delta,3
regulation of cellular amino acid metabolic process (GO:0006521),2/52,2,52,0.0890217305236634,1,0,0,4.00641025641026,9.6910047110006,PSMA5;PSMA3,delta,3
cellular response to peptide hormone stimulus (GO:0071375),3/111,3,111,0.0913556997536093,1,0,0,2.81531531531532,6.73703435650074,ADCY9;IRS2;CPEB2,delta,3
regulation of cell-matrix adhesion (GO:0001952),2/53,2,53,0.0919498574236561,1,0,0,3.93081761006289,9.38094291870514,ADAM15;UTRN,delta,3
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,SEC14L1,delta,3
regulation of B cell apoptotic process (GO:0002902),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,IRS2,delta,3
regulation of synapse maturation (GO:0090128),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,CAMK2B,delta,3
positive regulation of protein exit from endoplasmic reticulum (GO:0070863),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,TMEM30B,delta,3
3'-UTR-mediated mRNA destabilization (GO:0061158),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,CPEB3,delta,3
regulation of sequestering of zinc ion (GO:0061088),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,SLC30A1,delta,3
negative regulation of oxidative stress-induced neuron death (GO:1903204),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,FBXO7,delta,3
maintenance of apical/basal cell polarity (GO:0035090),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,PDCD6IP,delta,3
chloride ion homeostasis (GO:0055064),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,SLC12A1,delta,3
"energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)",1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,ATP6V1H,delta,3
negative regulation by host of viral process (GO:0044793),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,VAPA,delta,3
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,CYFIP1,delta,3
establishment of spindle localization (GO:0051293),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,ESPL1,delta,3
positive regulation of amyloid-beta formation (GO:1902004),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,CLU,delta,3
positive regulation of glucose import in response to insulin stimulus (GO:2001275),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,OSBPL8,delta,3
regulation of protein exit from endoplasmic reticulum (GO:0070861),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,TMEM30B,delta,3
regulation of amyloid-beta clearance (GO:1900221),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,CLU,delta,3
chaperone-mediated protein transport (GO:0072321),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,CLU,delta,3
cellular response to leucine starvation (GO:1990253),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,SESN2,delta,3
actin filament depolymerization (GO:0030042),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,DSTN,delta,3
medium-chain fatty acid metabolic process (GO:0051791),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,OXSM,delta,3
maintenance of epithelial cell apical/basal polarity (GO:0045199),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,PDCD6IP,delta,3
endosomal vesicle fusion (GO:0034058),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,TGFBRAP1,delta,3
response to muramyl dipeptide (GO:0032495),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,RIPK2,delta,3
motor neuron axon guidance (GO:0008045),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,CHN1,delta,3
regulation of fatty acid beta-oxidation (GO:0031998),1/10,1,10,0.0919767065184695,1,0,0,10.4166666666667,24.8564575417473,IRS2,delta,3
neutrophil degranulation (GO:0043312),8/480,8,480,0.0921980291634886,1,0,0,1.73611111111111,4.13857035471389,PSMA5;CYFIP1;ACTR2;VAPA;GAA;SURF4;PLEKHO2;CEP290,delta,3
neutrophil activation involved in immune response (GO:0002283),8/484,8,484,0.0955471492105105,1,0,0,1.72176308539945,4.0429329275466,PSMA5;CYFIP1;ACTR2;VAPA;GAA;SURF4;PLEKHO2;CEP290,delta,3
protein transport (GO:0015031),6/327,6,327,0.0959124908882417,1,0,0,1.91131498470948,4.48073214158849,TBC1D2;ZFYVE9;ATP6V1H;CLU;CEP290;SLU7,delta,3
regulation of organelle organization (GO:0033043),3/114,3,114,0.0970543278204405,1,0,0,2.74122807017544,6.39387164649745,TBC1D2;RHOT1;SURF4,delta,3
sensory perception (GO:0007600),2/55,2,55,0.0978889612379316,1,0,0,3.78787878787879,8.80273292154901,TTC8;GNAL,delta,3
cell morphogenesis involved in differentiation (GO:0000904),2/55,2,55,0.0978889612379316,1,0,0,3.78787878787879,8.80273292154901,LAMC1;EPHA2,delta,3
cytoplasmic translation (GO:0002181),2/55,2,55,0.0978889612379316,1,0,0,3.78787878787879,8.80273292154901,MRPL2;RPL22L1,delta,3
neutrophil mediated immunity (GO:0002446),8/488,8,488,0.0989652315064731,1,0,0,1.70765027322404,3.94977234876355,PSMA5;CYFIP1;ACTR2;VAPA;GAA;SURF4;PLEKHO2;CEP290,delta,3
protein dephosphorylation (GO:0006470),7/126,7,126,4.649156418349e-05,0.237246452028349,0,0,7.40740740740741,73.8980716832411,PPP3CA;PPP3CB;FBXW11;DUSP18;DUSP16;DUSP14;CTTNBP2NL,delta,4
dephosphorylation (GO:0016311),6/125,6,125,0.00036279927547371,0.925682351371171,0,0,6.4,50.698629355301,PPP3CA;PPP3CB;FBXW11;DUSP18;DUSP16;CTTNBP2NL,delta,4
cellular senescence (GO:0090398),3/25,3,25,0.000842546408649779,1,0,0,16,113.265309004865,KAT6A;NSMCE2;SMC5,delta,4
cellular response to drug (GO:0035690),3/31,3,31,0.00159334598545051,1,0,0,12.9032258064516,83.121536522827,ACER2;PPP3CA;PPP3CB,delta,4
telomere maintenance via recombination (GO:0000722),2/10,2,10,0.00241710122513065,1,0,0,26.6666666666667,160.671634604091,NSMCE2;SMC5,delta,4
mRNA 3'-end processing (GO:0031124),4/75,4,75,0.00244510076417457,1,0,0,7.11111111111111,42.763868050227,LSM11;SRSF1;SRSF2;TUT1,delta,4
mitotic spindle organization (GO:0007052),4/75,4,75,0.00244510076417457,1,0,0,7.11111111111111,42.763868050227,TUBGCP2;PLK2;RCC1;WDR62,delta,4
calcineurin-NFAT signaling cascade (GO:0033173),2/11,2,11,0.00293973046573966,1,0,0,24.2424242424243,141.319694064342,PPP3CA;PPP3CB,delta,4
calcineurin-mediated signaling (GO:0097720),2/12,2,12,0.00351036654922718,1,0,0,22.2222222222222,125.600773710612,PPP3CA;PPP3CB,delta,4
positive regulation of mitotic cell cycle phase transition (GO:1901992),3/41,3,41,0.00357761589158158,1,0,0,9.75609756097561,54.9566697803541,ANKRD17;LSM11;NSMCE2,delta,4
positive regulation of protein complex disassembly (GO:0043243),2/13,2,13,0.00412826972233185,1,0,0,20.5128205128205,112.613270014877,SETX;SMCR8,delta,4
double-strand break repair (GO:0006302),5/142,5,142,0.00436989652573558,1,0,0,4.69483568075117,25.507117128997,SETX;PAXIP1;NSMCE2;SMC5;AP5S1,delta,4
microtubule cytoskeleton organization involved in mitosis (GO:1902850),3/45,3,45,0.00465955684205505,1,0,0,8.88888888888889,47.7229771878947,PLK2;RCC1;WDR62,delta,4
cell cycle G1/S phase transition (GO:0044843),4/93,4,93,0.00529545592653557,1,0,0,5.73476702508961,30.055376048916,WEE1;PLK2;RCC1;PIM2,delta,4
transport along microtubule (GO:0010970),2/15,2,15,0.00550295956466604,1,0,0,17.7777777777778,92.4883418453775,COPG2;DYNC1I1,delta,4
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),2/16,2,16,0.00625830772594311,1,0,0,16.6666666666667,84.5640910289203,ANKRD17;LSM11,delta,4
"positive regulation of DNA-templated transcription, initiation (GO:2000144)",2/16,2,16,0.00625830772594311,1,0,0,16.6666666666667,84.5640910289203,SETX;PAXIP1,delta,4
mRNA metabolic process (GO:0016071),4/98,4,98,0.00636613226457235,1,0,0,5.4421768707483,27.5197995843393,LSM11;SRSF1;SRSF2;DXO,delta,4
high-density lipoprotein particle remodeling (GO:0034375),2/17,2,17,0.00705804580284673,1,0,0,15.6862745098039,77.7033264981394,ABCA5;PLTP,delta,4
mitotic recombination (GO:0006312),2/18,2,18,0.00790147456562771,1,0,0,14.8148148148148,71.714161230369,NSMCE2;SMC5,delta,4
DNA conformation change (GO:0071103),2/18,2,18,0.00790147456562771,1,0,0,14.8148148148148,71.714161230369,KAT6A;TOP3A,delta,4
G1/S transition of mitotic cell cycle (GO:0000082),4/106,4,106,0.00836248199979553,1,0,0,5.0314465408805,24.0704402818663,WEE1;PLK2;RCC1;PIM2,delta,4
"DNA-templated transcription, termination (GO:0006353)",4/107,4,107,0.00863764411534499,1,0,0,4.98442367601246,23.6841141691363,SETX;LSM11;SRSF1;SRSF2,delta,4
NADP metabolic process (GO:0006739),2/19,2,19,0.00878790264945169,1,0,0,14.0350877192982,66.4474273991488,NUDT17;PGD,delta,4
acylglycerol biosynthetic process (GO:0046463),2/19,2,19,0.00878790264945169,1,0,0,14.0350877192982,66.4474273991488,DGAT1;LPIN2,delta,4
triglyceride biosynthetic process (GO:0019432),2/19,2,19,0.00878790264945169,1,0,0,14.0350877192982,66.4474273991488,DGAT1;LPIN2,delta,4
inositol phosphate-mediated signaling (GO:0048016),2/20,2,20,0.00971664648187495,1,0,0,13.3333333333333,61.7855297625728,PPP3CA;PPP3CB,delta,4
Arp2/3 complex-mediated actin nucleation (GO:0034314),2/20,2,20,0.00971664648187495,1,0,0,13.3333333333333,61.7855297625728,ARPC2;ARPC5L,delta,4
"positive regulation of transcription, DNA-templated (GO:0045893)",16/1121,16,1121,0.0100735973041438,1,0,0,1.90306274159976,8.7499730597439,FBXW11;WBP2;MKL1;FOXJ3;EIF2AK3;EBF4;SETX;PPP3CA;PPP3CB;KAT6A;NRIP1;ASXL2;SPIN1;PIM2;LPIN2;RNF111,delta,4
nuclear-transcribed mRNA catabolic process (GO:0000956),5/175,5,175,0.0103571655319387,1,0,0,3.80952380952381,17.4098159119565,EIF4A1;SMG1;RPL35;DXO;EIF4B,delta,4
positive regulation of histone acetylation (GO:0035066),2/21,2,21,0.010687030205642,1,0,0,12.6984126984127,57.6345955943142,PAXIP1;WBP2,delta,4
phosphate-containing compound metabolic process (GO:0006796),5/184,5,184,0.0126566268914697,1,0,0,3.6231884057971,15.8317910726073,PPP3CA;PPP3CB;SLC20A1;DUSP18;DUSP16,delta,4
positive regulation of cell cycle G1/S phase transition (GO:1902808),2/24,2,24,0.0138413762787296,1,0,0,11.1111111111111,47.556587684799,ANKRD17;LSM11,delta,4
mRNA splice site selection (GO:0006376),2/25,2,25,0.014971712638495,1,0,0,10.6666666666667,44.8169886121092,SETX;SRSF1,delta,4
actin nucleation (GO:0045010),2/25,2,25,0.014971712638495,1,0,0,10.6666666666667,44.8169886121092,ARPC2;ARPC5L,delta,4
termination of RNA polymerase II transcription (GO:0006369),3/69,3,69,0.0151037178508085,1,0,0,5.79710144927536,24.3061701459822,LSM11;SRSF1;SRSF2,delta,4
RNA processing (GO:0006396),5/194,5,194,0.0155919580328658,1,0,0,3.43642611683849,14.2989691008993,SETX;ATXN1;SRSF1;SRSF2;WDR62,delta,4
peptidyl-tyrosine dephosphorylation (GO:0035335),2/26,2,26,0.0161404226851224,1,0,0,10.2564102564103,42.3223428493739,DUSP18;DUSP14,delta,4
positive regulation of calcium ion transmembrane transport (GO:1904427),2/26,2,26,0.0161404226851224,1,0,0,10.2564102564103,42.3223428493739,TRPC1;AKAP6,delta,4
recombinational repair (GO:0000725),3/72,3,72,0.0169162851222554,1,0,0,5.55555555555556,22.6637694685119,NSMCE2;SMC5;AP5S1,delta,4
response to metal ion (GO:0010038),3/73,3,73,0.0175463420116464,1,0,0,5.47945205479452,22.1529303187952,PPP3CA;SLC30A8;TRPC1,delta,4
negative regulation of synaptic transmission (GO:0050805),2/28,2,28,0.0185904464668634,1,0,0,9.52380952380952,37.9534043907645,PLK2;CBLN1,delta,4
transition metal ion transport (GO:0000041),2/28,2,28,0.0185904464668634,1,0,0,9.52380952380952,37.9534043907645,SLC30A8;TRPC1,delta,4
double-strand break repair via homologous recombination (GO:0000724),3/77,3,77,0.0201964191724457,1,0,0,5.1948051948052,20.2714283583363,NSMCE2;SMC5;AP5S1,delta,4
regulation of vesicle-mediated transport (GO:0060627),4/139,4,139,0.0207682673918243,1,0,0,3.83693045563549,14.8655311783566,SLC30A8;TBC1D10A;TBC1D15;STXBP5L,delta,4
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),2/30,2,30,0.0211864844342245,1,0,0,8.88888888888889,34.2612606870955,EIF4A1;EIF4B,delta,4
regulation of cell cycle (GO:0051726),5/216,5,216,0.0235713518703732,1,0,0,3.08641975308642,11.5670469386615,ANKRD17;LIN54;WEE1;PIM2;MAP4K4,delta,4
positive regulation of insulin secretion (GO:0032024),2/32,2,32,0.0239236862966858,1,0,0,8.33333333333333,31.107385436501,PPP3CB;SLC30A8,delta,4
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),2/32,2,32,0.0239236862966858,1,0,0,8.33333333333333,31.107385436501,TRPC1;AKAP6,delta,4
organelle transport along microtubule (GO:0072384),2/32,2,32,0.0239236862966858,1,0,0,8.33333333333333,31.107385436501,COPG2;DYNC1I1,delta,4
positive regulation of TOR signaling (GO:0032008),2/33,2,33,0.0253437382853009,1,0,0,8.08080808080808,29.6987764840309,RHEB;SMCR8,delta,4
positive regulation of calcium ion transport into cytosol (GO:0010524),2/33,2,33,0.0253437382853009,1,0,0,8.08080808080808,29.6987764840309,TRPC1;AKAP6,delta,4
protein phosphorylation (GO:0006468),8/471,8,471,0.0258838239385153,1,0,0,2.26468506723284,8.27546964190334,SMG1;PPP3CB;PLK2;EIF2AK3;CRY1;STK19;PIM2;MAP4K4,delta,4
mitotic cell cycle phase transition (GO:0044772),5/222,5,222,0.0261321880877129,1,0,0,3.003003003003,10.9447071003856,WEE1;FBXW11;PLK2;RCC1;PIM2,delta,4
positive regulation of transcription from RNA polymerase II promoter (GO:0045944),12/849,12,849,0.0262680565718858,1,0,0,1.88457008244994,6.85870748082555,SETX;PPP3CA;PPP3CB;PAXIP1;WBP2;MKL1;NRIP1;FOXJ3;ASXL2;EBF4;LPIN2;RNF111,delta,4
phosphorylation (GO:0016310),7/387,7,387,0.0269458766339448,1,0,0,2.41171403962102,8.71575364599503,DGKE;PPP3CB;PLK2;EIF2AK3;STK19;PIM2;MAP4K4,delta,4
divalent metal ion transport (GO:0070838),3/89,3,89,0.0293963763243849,1,0,0,4.49438202247191,15.8511634449733,SLC30A8;TRPC1;NALCN,delta,4
lipid phosphorylation (GO:0046834),2/36,2,36,0.0298027316296627,1,0,0,7.40740740740741,26.0233720314583,DGKE;SMG1,delta,4
protein kinase B signaling (GO:0043491),2/36,2,36,0.0298027316296627,1,0,0,7.40740740740741,26.0233720314583,SETX;MKRN1,delta,4
regulation of cell cycle process (GO:0010564),3/91,3,91,0.0311114684591544,1,0,0,4.3956043956044,15.2535330418812,KLHL21;RCC1;MYO19,delta,4
"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",2/37,2,37,0.0313534455466075,1,0,0,7.20720720720721,24.9544584659424,PPP3CA;PPP3CB,delta,4
regulation of response to DNA damage stimulus (GO:2001020),2/37,2,37,0.0313534455466075,1,0,0,7.20720720720721,24.9544584659424,SMG1;CRY1,delta,4
nuclear export (GO:0051168),3/93,3,93,0.0328781308974969,1,0,0,4.3010752688172,14.6879464799705,ATXN1;SRSF1;SRSF2,delta,4
proteasomal protein catabolic process (GO:0010498),5/238,5,238,0.0338092335995353,1,0,0,2.80112044817927,9.48745470695449,RNF145;FBXW11;PPP2R5C;BUB3;RNF111,delta,4
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),4/164,4,164,0.0351702496238671,1,0,0,3.2520325203252,10.8863568614152,ANKRD17;SLC20A1;PLK2;PIM2,delta,4
positive regulation of nucleic acid-templated transcription (GO:1903508),8/503,8,503,0.0361162561169098,1,0,0,2.12060967528164,7.04257061800686,PPP3CB;FBXW11;WBP2;KAT6A;NRIP1;SPIN1;PIM2;RNF111,delta,4
regulation of cholesterol biosynthetic process (GO:0045540),2/41,2,41,0.0378634362846677,1,0,0,6.50406504065041,21.2928089390961,FDFT1;SOD1,delta,4
positive regulation of mitotic nuclear division (GO:0045840),2/41,2,41,0.0378634362846677,1,0,0,6.50406504065041,21.2928089390961,NSMCE2;SMC5,delta,4
regulation of insulin secretion (GO:0050796),3/99,3,99,0.0384852934905408,1,0,0,4.04040404040404,13.161531708779,PPP3CB;SLC30A8;BMP8A,delta,4
spliceosomal complex assembly (GO:0000245),2/42,2,42,0.0395650186577298,1,0,0,6.34920634920635,20.5067296403143,SETX;SRSF1,delta,4
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),3/101,3,101,0.0404558454987252,1,0,0,3.96039603960396,12.7031450859686,SMG1;SRSF1;SRSF2,delta,4
response to hydrogen peroxide (GO:0042542),2/44,2,44,0.0430533939162003,1,0,0,6.06060606060606,19.0625103915309,SETX;SOD1,delta,4
negative regulation of gene expression (GO:0010629),9/619,9,619,0.0438931430779457,1,0,0,1.93861066235864,6.06009143500774,ATXN1;FBXW11;KAT6A;EIF2AK3;CRY1;ZNF503;DXO;SMCR8;EIF4E2,delta,4
positive regulation of microtubule motor activity (GO:2000576),1/6,1,6,0.0441698345932514,1,0,0,22.2222222222222,69.3269599590344,DYNC1I1,delta,4
mRNA 5'-splice site recognition (GO:0000395),1/6,1,6,0.0441698345932514,1,0,0,22.2222222222222,69.3269599590344,SRSF1,delta,4
polyamine biosynthetic process (GO:0006596),1/6,1,6,0.0441698345932514,1,0,0,22.2222222222222,69.3269599590344,SAT1,delta,4
negative regulation of translation in response to stress (GO:0032055),1/6,1,6,0.0441698345932514,1,0,0,22.2222222222222,69.3269599590344,EIF2AK3,delta,4
regulation of translational initiation in response to stress (GO:0043558),1/6,1,6,0.0441698345932514,1,0,0,22.2222222222222,69.3269599590344,EIF2AK3,delta,4
negative regulation of erythrocyte differentiation (GO:0045647),1/6,1,6,0.0441698345932514,1,0,0,22.2222222222222,69.3269599590344,MAFB,delta,4
NADH metabolic process (GO:0006734),1/6,1,6,0.0441698345932514,1,0,0,22.2222222222222,69.3269599590344,NUDT17,delta,4
regulation of cell cycle checkpoint (GO:1901976),1/6,1,6,0.0441698345932514,1,0,0,22.2222222222222,69.3269599590344,CRY1,delta,4
ceramide transport (GO:0035627),1/6,1,6,0.0441698345932514,1,0,0,22.2222222222222,69.3269599590344,PLTP,delta,4
negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),1/6,1,6,0.0441698345932514,1,0,0,22.2222222222222,69.3269599590344,CRY1,delta,4
negative regulation of neurological system process (GO:0031645),1/6,1,6,0.0441698345932514,1,0,0,22.2222222222222,69.3269599590344,EIF2AK3,delta,4
positive regulation of autophagosome maturation (GO:1901098),1/6,1,6,0.0441698345932514,1,0,0,22.2222222222222,69.3269599590344,SMCR8,delta,4
positive regulation of oxidative stress-induced cell death (GO:1903209),1/6,1,6,0.0441698345932514,1,0,0,22.2222222222222,69.3269599590344,SOD1,delta,4
spermine metabolic process (GO:0008215),1/6,1,6,0.0441698345932514,1,0,0,22.2222222222222,69.3269599590344,SAT1,delta,4
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),1/6,1,6,0.0441698345932514,1,0,0,22.2222222222222,69.3269599590344,WBP2,delta,4
cellular response to cold (GO:0070417),1/6,1,6,0.0441698345932514,1,0,0,22.2222222222222,69.3269599590344,EIF2AK3,delta,4
chondrocyte development (GO:0002063),1/6,1,6,0.0441698345932514,1,0,0,22.2222222222222,69.3269599590344,EIF2AK3,delta,4
interphase microtubule nucleation by interphase microtubule organizing center (GO:0051415),1/6,1,6,0.0441698345932514,1,0,0,22.2222222222222,69.3269599590344,TUBGCP2,delta,4
mRNA transport (GO:0051028),3/105,3,105,0.0445473033540763,1,0,0,3.80952380952381,11.8522044101717,SMG1;SRSF1;SRSF2,delta,4
mRNA export from nucleus (GO:0006406),3/106,3,106,0.0456012316071113,1,0,0,3.77358490566038,11.6521530335798,SMG1;SRSF1;SRSF2,delta,4
regulation of G1/S transition of mitotic cell cycle (GO:2000045),2/47,2,47,0.0484913030809409,1,0,0,5.67375886524823,17.1708982413437,ANKRD17;LSM11,delta,4
regulation of DNA metabolic process (GO:0051052),2/47,2,47,0.0484913030809409,1,0,0,5.67375886524823,17.1708982413437,ANKRD17;SMG1,delta,4
inner ear receptor stereocilium organization (GO:0060122),1/7,1,7,0.0513406942793393,1,0,0,19.0476190476191,56.5575539136122,SOD1,delta,4
tRNA pseudouridine synthesis (GO:0031119),1/7,1,7,0.0513406942793393,1,0,0,19.0476190476191,56.5575539136122,RPUSD4,delta,4
progesterone receptor signaling pathway (GO:0050847),1/7,1,7,0.0513406942793393,1,0,0,19.0476190476191,56.5575539136122,WBP2,delta,4
positive regulation of RIG-I signaling pathway (GO:1900246),1/7,1,7,0.0513406942793393,1,0,0,19.0476190476191,56.5575539136122,ANKRD17,delta,4
positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),1/7,1,7,0.0513406942793393,1,0,0,19.0476190476191,56.5575539136122,AKAP6,delta,4
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),1/7,1,7,0.0513406942793393,1,0,0,19.0476190476191,56.5575539136122,NSMCE2,delta,4
regulation of mitochondrial fusion (GO:0010635),1/7,1,7,0.0513406942793393,1,0,0,19.0476190476191,56.5575539136122,OMA1,delta,4
regulation of glucocorticoid receptor signaling pathway (GO:2000322),1/7,1,7,0.0513406942793393,1,0,0,19.0476190476191,56.5575539136122,CRY1,delta,4
regulation of MDA-5 signaling pathway (GO:0039533),1/7,1,7,0.0513406942793393,1,0,0,19.0476190476191,56.5575539136122,ANKRD17,delta,4
negative regulation of transporter activity (GO:0032410),1/7,1,7,0.0513406942793393,1,0,0,19.0476190476191,56.5575539136122,CTTNBP2NL,delta,4
retrograde axonal transport (GO:0008090),1/7,1,7,0.0513406942793393,1,0,0,19.0476190476191,56.5575539136122,SOD1,delta,4
terpenoid metabolic process (GO:0006721),1/7,1,7,0.0513406942793393,1,0,0,19.0476190476191,56.5575539136122,FDFT1,delta,4
regulation of isotype switching (GO:0045191),1/7,1,7,0.0513406942793393,1,0,0,19.0476190476191,56.5575539136122,PAXIP1,delta,4
formation of translation preinitiation complex (GO:0001731),1/7,1,7,0.0513406942793393,1,0,0,19.0476190476191,56.5575539136122,EIF4B,delta,4
spermidine metabolic process (GO:0008216),1/7,1,7,0.0513406942793393,1,0,0,19.0476190476191,56.5575539136122,SAT1,delta,4
negative regulation of cell adhesion mediated by integrin (GO:0033629),1/7,1,7,0.0513406942793393,1,0,0,19.0476190476191,56.5575539136122,ACER2,delta,4
long term synaptic depression (GO:0060292),1/7,1,7,0.0513406942793393,1,0,0,19.0476190476191,56.5575539136122,PLK2,delta,4
ER overload response (GO:0006983),1/7,1,7,0.0513406942793393,1,0,0,19.0476190476191,56.5575539136122,EIF2AK3,delta,4
regulation of transcription from RNA polymerase II promoter (GO:0006357),17/1479,17,1479,0.0516353064738052,1,0,0,1.53256704980843,4.54183847737548,CBX7;GMEB2;WBP2;MKL1;FOXJ3;BMP8A;EBF4;SETX;PPP3CA;PPP3CB;NRIP1;ASXL2;CRY1;RCOR3;LPIN2;RNF111;JDP2,delta,4
regulation of release of sequestered calcium ion into cytosol (GO:0051279),2/50,2,50,0.0541636617411515,1,0,0,5.33333333333333,15.5506402291587,TRPC1;AKAP6,delta,4
telomere maintenance (GO:0000723),2/52,2,52,0.0580690304785809,1,0,0,5.12820512820513,14.5955015152516,NSMCE2;SMC5,delta,4
phosphate ion transmembrane transport (GO:0035435),1/8,1,8,0.0584581138777585,1,0,0,16.6666666666667,47.3240797214307,SLC20A1,delta,4
positive regulation of mitotic sister chromatid separation (GO:1901970),1/8,1,8,0.0584581138777585,1,0,0,16.6666666666667,47.3240797214307,NSMCE2,delta,4
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),1/8,1,8,0.0584581138777585,1,0,0,16.6666666666667,47.3240797214307,SESTD1,delta,4
positive regulation of isotype switching (GO:0045830),1/8,1,8,0.0584581138777585,1,0,0,16.6666666666667,47.3240797214307,PAXIP1,delta,4
microtubule nucleation by microtubule organizing center (GO:0051418),1/8,1,8,0.0584581138777585,1,0,0,16.6666666666667,47.3240797214307,TUBGCP2,delta,4
sulfur amino acid catabolic process (GO:0000098),1/8,1,8,0.0584581138777585,1,0,0,16.6666666666667,47.3240797214307,PCYOX1,delta,4
myelin maintenance (GO:0043217),1/8,1,8,0.0584581138777585,1,0,0,16.6666666666667,47.3240797214307,SOD1,delta,4
phenol-containing compound biosynthetic process (GO:0046189),1/8,1,8,0.0584581138777585,1,0,0,16.6666666666667,47.3240797214307,TRPC1,delta,4
positive regulation of DNA recombination (GO:0045911),1/8,1,8,0.0584581138777585,1,0,0,16.6666666666667,47.3240797214307,PAXIP1,delta,4
DNA damage induced protein phosphorylation (GO:0006975),1/8,1,8,0.0584581138777585,1,0,0,16.6666666666667,47.3240797214307,CRY1,delta,4
acylglycerol acyl-chain remodeling (GO:0036155),1/8,1,8,0.0584581138777585,1,0,0,16.6666666666667,47.3240797214307,DGAT1,delta,4
regulation of long term synaptic depression (GO:1900452),1/8,1,8,0.0584581138777585,1,0,0,16.6666666666667,47.3240797214307,CBLN1,delta,4
positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),1/8,1,8,0.0584581138777585,1,0,0,16.6666666666667,47.3240797214307,AKAP6,delta,4
negative regulation of calcium ion transmembrane transport (GO:1903170),1/8,1,8,0.0584581138777585,1,0,0,16.6666666666667,47.3240797214307,SESTD1,delta,4
regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),1/8,1,8,0.0584581138777585,1,0,0,16.6666666666667,47.3240797214307,ASXL2,delta,4
diol biosynthetic process (GO:0034312),1/8,1,8,0.0584581138777585,1,0,0,16.6666666666667,47.3240797214307,ACER2,delta,4
regulation of type B pancreatic cell development (GO:2000074),1/8,1,8,0.0584581138777585,1,0,0,16.6666666666667,47.3240797214307,RHEB,delta,4
sphingosine biosynthetic process (GO:0046512),1/8,1,8,0.0584581138777585,1,0,0,16.6666666666667,47.3240797214307,ACER2,delta,4
positive regulation of proteolysis (GO:0045862),2/53,2,53,0.0600574402043883,1,0,0,5.0314465408805,14.1507111344644,FBXW11;TBC1D10A,delta,4
triglyceride metabolic process (GO:0006641),2/53,2,53,0.0600574402043883,1,0,0,5.0314465408805,14.1507111344644,DGAT1;LPIN2,delta,4
RNA export from nucleus (GO:0006405),3/120,3,120,0.0616264262583872,1,0,0,3.33333333333333,9.28888167578259,SMG1;SRSF1;SRSF2,delta,4
protein polyubiquitination (GO:0000209),5/284,5,284,0.0630634007864865,1,0,0,2.34741784037559,6.48735844352767,RNF145;FBXW11;MKRN1;RNF111;RC3H2,delta,4
action potential (GO:0001508),2/55,2,55,0.0641034102600836,1,0,0,4.84848484848485,13.3200374025954,AKAP6;NALCN,delta,4
negative regulation of circadian rhythm (GO:0042754),1/9,1,9,0.0655224886726777,1,0,0,14.8148148148148,40.3757312111696,CRY1,delta,4
removal of superoxide radicals (GO:0019430),1/9,1,9,0.0655224886726777,1,0,0,14.8148148148148,40.3757312111696,SOD1,delta,4
RNA destabilization (GO:0050779),1/9,1,9,0.0655224886726777,1,0,0,14.8148148148148,40.3757312111696,DXO,delta,4
mitochondrial protein processing (GO:0034982),1/9,1,9,0.0655224886726777,1,0,0,14.8148148148148,40.3757312111696,OMA1,delta,4
manganese ion transport (GO:0006828),1/9,1,9,0.0655224886726777,1,0,0,14.8148148148148,40.3757312111696,TRPC1,delta,4
negative regulation of alcohol biosynthetic process (GO:1902931),1/9,1,9,0.0655224886726777,1,0,0,14.8148148148148,40.3757312111696,SOD1,delta,4
response to UV-C (GO:0010225),1/9,1,9,0.0655224886726777,1,0,0,14.8148148148148,40.3757312111696,ERCC5,delta,4
positive regulation of voltage-gated potassium channel activity (GO:1903818),1/9,1,9,0.0655224886726777,1,0,0,14.8148148148148,40.3757312111696,AKAP6,delta,4
regulation of organ growth (GO:0046620),1/9,1,9,0.0655224886726777,1,0,0,14.8148148148148,40.3757312111696,SOD1,delta,4
cellular response to superoxide (GO:0071451),1/9,1,9,0.0655224886726777,1,0,0,14.8148148148148,40.3757312111696,SOD1,delta,4
positive regulation of mitotic metaphase/anaphase transition (GO:0045842),1/9,1,9,0.0655224886726777,1,0,0,14.8148148148148,40.3757312111696,NSMCE2,delta,4
vasodilation (GO:0042311),1/9,1,9,0.0655224886726777,1,0,0,14.8148148148148,40.3757312111696,SOD1,delta,4
sphingoid biosynthetic process (GO:0046520),1/9,1,9,0.0655224886726777,1,0,0,14.8148148148148,40.3757312111696,ACER2,delta,4
"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",1/9,1,9,0.0655224886726777,1,0,0,14.8148148148148,40.3757312111696,RPL35,delta,4
nuclear RNA surveillance (GO:0071027),1/9,1,9,0.0655224886726777,1,0,0,14.8148148148148,40.3757312111696,DXO,delta,4
sphingosine metabolic process (GO:0006670),1/9,1,9,0.0655224886726777,1,0,0,14.8148148148148,40.3757312111696,ACER2,delta,4
DNA topological change (GO:0006265),1/9,1,9,0.0655224886726777,1,0,0,14.8148148148148,40.3757312111696,TOP3A,delta,4
positive regulation of immunoglobulin mediated immune response (GO:0002891),1/9,1,9,0.0655224886726777,1,0,0,14.8148148148148,40.3757312111696,PAXIP1,delta,4
positive regulation of gene expression (GO:0010628),10/772,10,772,0.0656108835718627,1,0,0,1.72711571675302,4.70468685437938,SETX;PPP3CB;FBXW11;WBP2;KAT6A;NRIP1;EIF2AK3;SPIN1;PIM2;RNF111,delta,4
regulation of autophagy (GO:0010506),4/204,4,204,0.0677716547267567,1,0,0,2.61437908496732,7.03689213942208,RHEB;PLK2;SMCR8;PIM2,delta,4
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),4/205,4,205,0.0687360455590669,1,0,0,2.60162601626016,6.96580562399662,ANKRD17;SLC20A1;PLK2;PIM2,delta,4
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),5/292,5,292,0.069258801270285,1,0,0,2.28310502283105,6.09567362519344,RNF145;FBXW11;PPP2R5C;BUB3;RNF111,delta,4
response to retinoic acid (GO:0032526),2/58,2,58,0.0703385051169791,1,0,0,4.59770114942529,12.2043030087755,ACER2;SETX,delta,4
regulation of DNA damage checkpoint (GO:2000001),1/10,1,10,0.072534211173127,1,0,0,13.3333333333333,34.9826260022801,CRY1,delta,4
regulation of sequestering of zinc ion (GO:0061088),1/10,1,10,0.072534211173127,1,0,0,13.3333333333333,34.9826260022801,SLC30A8,delta,4
actin filament-based transport (GO:0099515),1/10,1,10,0.072534211173127,1,0,0,13.3333333333333,34.9826260022801,MYO19,delta,4
positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),1/10,1,10,0.072534211173127,1,0,0,13.3333333333333,34.9826260022801,PPP3CB,delta,4
"regulation of DNA-templated transcription, initiation (GO:2000142)",1/10,1,10,0.072534211173127,1,0,0,13.3333333333333,34.9826260022801,SETX,delta,4
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),1/10,1,10,0.072534211173127,1,0,0,13.3333333333333,34.9826260022801,WBP2,delta,4
positive regulation of cardiac muscle cell differentiation (GO:2000727),1/10,1,10,0.072534211173127,1,0,0,13.3333333333333,34.9826260022801,AKAP6,delta,4
UV protection (GO:0009650),1/10,1,10,0.072534211173127,1,0,0,13.3333333333333,34.9826260022801,ERCC5,delta,4
DNA replication-dependent nucleosome organization (GO:0034723),1/10,1,10,0.072534211173127,1,0,0,13.3333333333333,34.9826260022801,ASF1B,delta,4
very-low-density lipoprotein particle assembly (GO:0034379),1/10,1,10,0.072534211173127,1,0,0,13.3333333333333,34.9826260022801,DGAT1,delta,4
negative regulation of autophagosome assembly (GO:1902902),1/10,1,10,0.072534211173127,1,0,0,13.3333333333333,34.9826260022801,SMCR8,delta,4
sequestering of actin monomers (GO:0042989),1/10,1,10,0.072534211173127,1,0,0,13.3333333333333,34.9826260022801,PFN4,delta,4
Rap protein signal transduction (GO:0032486),1/10,1,10,0.072534211173127,1,0,0,13.3333333333333,34.9826260022801,PLK2,delta,4
smooth muscle cell differentiation (GO:0051145),1/10,1,10,0.072534211173127,1,0,0,13.3333333333333,34.9826260022801,MKL1,delta,4
nuclear mRNA surveillance (GO:0071028),1/10,1,10,0.072534211173127,1,0,0,13.3333333333333,34.9826260022801,DXO,delta,4
insulin-like growth factor receptor signaling pathway (GO:0048009),1/10,1,10,0.072534211173127,1,0,0,13.3333333333333,34.9826260022801,EIF2AK3,delta,4
DNA replication-dependent nucleosome assembly (GO:0006335),1/10,1,10,0.072534211173127,1,0,0,13.3333333333333,34.9826260022801,ASF1B,delta,4
positive regulation of circadian rhythm (GO:0042753),1/10,1,10,0.072534211173127,1,0,0,13.3333333333333,34.9826260022801,FBXW11,delta,4
cellular protein modification process (GO:0006464),12/1002,12,1002,0.0740977625860566,1,0,0,1.59680638722555,4.15548094476026,PPP3CA;PPP3CB;FBXW11;APLP2;PLK2;KLHL21;EIF2AK3;STK19;PIM2;DUSP16;CTTNBP2NL;MAP4K4,delta,4
regulation of vesicle fusion (GO:0031338),2/62,2,62,0.078943788467923,1,0,0,4.3010752688172,10.9205127662771,TBC1D10A;TBC1D15,delta,4
RNA 3'-end processing (GO:0031123),2/62,2,62,0.078943788467923,1,0,0,4.3010752688172,10.9205127662771,SRSF1;SRSF2,delta,4
positive regulation of superoxide anion generation (GO:0032930),1/11,1,11,0.0794936710039838,1,0,0,12.1212121212121,30.6918529758022,SOD1,delta,4
heart process (GO:0003015),1/11,1,11,0.0794936710039838,1,0,0,12.1212121212121,30.6918529758022,SOD1,delta,4
calcium ion regulated exocytosis (GO:0017156),1/11,1,11,0.0794936710039838,1,0,0,12.1212121212121,30.6918529758022,PPP3CB,delta,4
regulation of autophagosome maturation (GO:1901096),1/11,1,11,0.0794936710039838,1,0,0,12.1212121212121,30.6918529758022,SMCR8,delta,4
T cell proliferation (GO:0042098),1/11,1,11,0.0794936710039838,1,0,0,12.1212121212121,30.6918529758022,PPP3CB,delta,4
positive regulation of chromosome segregation (GO:0051984),1/11,1,11,0.0794936710039838,1,0,0,12.1212121212121,30.6918529758022,SMC5,delta,4
regulation of translational initiation (GO:0006446),2/63,2,63,0.0811444019849837,1,0,0,4.23280423280423,10.6307935278315,EIF2AK3;EIF4B,delta,4
regulation of proteolysis (GO:0030162),2/64,2,64,0.0833639098616836,1,0,0,4.16666666666667,10.3522491614411,FBXW11;TBC1D10A,delta,4
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",2/64,2,64,0.0833639098616836,1,0,0,4.16666666666667,10.3522491614411,EIF4A1;EIF4B,delta,4
glucose metabolic process (GO:0006006),2/65,2,65,0.085601909476698,1,0,0,4.1025641025641,10.0842982117435,CRY1;OMA1,delta,4
cytoplasmic translational initiation (GO:0002183),1/12,1,12,0.0864012549894364,1,0,0,11.1111111111111,27.2083675326324,EIF4B,delta,4
activation of cysteine-type endopeptidase activity (GO:0097202),1/12,1,12,0.0864012549894364,1,0,0,11.1111111111111,27.2083675326324,TBC1D10A,delta,4
ribose phosphate metabolic process (GO:0019693),1/12,1,12,0.0864012549894364,1,0,0,11.1111111111111,27.2083675326324,PGD,delta,4
pentose-phosphate shunt (GO:0006098),1/12,1,12,0.0864012549894364,1,0,0,11.1111111111111,27.2083675326324,PGD,delta,4
cellular modified amino acid catabolic process (GO:0042219),1/12,1,12,0.0864012549894364,1,0,0,11.1111111111111,27.2083675326324,PCYOX1,delta,4
cell differentiation in hindbrain (GO:0021533),1/12,1,12,0.0864012549894364,1,0,0,11.1111111111111,27.2083675326324,CBLN1,delta,4
pre-mRNA cleavage required for polyadenylation (GO:0098789),1/12,1,12,0.0864012549894364,1,0,0,11.1111111111111,27.2083675326324,TUT1,delta,4
PERK-mediated unfolded protein response (GO:0036499),1/12,1,12,0.0864012549894364,1,0,0,11.1111111111111,27.2083675326324,EIF2AK3,delta,4
response to axon injury (GO:0048678),1/12,1,12,0.0864012549894364,1,0,0,11.1111111111111,27.2083675326324,SOD1,delta,4
regulation of T cell differentiation in thymus (GO:0033081),1/12,1,12,0.0864012549894364,1,0,0,11.1111111111111,27.2083675326324,SOD1,delta,4
"alternative mRNA splicing, via spliceosome (GO:0000380)",1/12,1,12,0.0864012549894364,1,0,0,11.1111111111111,27.2083675326324,SRSF1,delta,4
polyamine metabolic process (GO:0006595),1/12,1,12,0.0864012549894364,1,0,0,11.1111111111111,27.2083675326324,SAT1,delta,4
protein ubiquitination (GO:0016567),7/507,7,507,0.0877007346813106,1,0,0,1.84089414858646,4.48041420565526,RNF145;HERC3;FBXW11;MKRN1;KLHL21;RNF111;RC3H2,delta,4
regulation of cell division (GO:0051302),2/66,2,66,0.0878580031056413,1,0,0,4.04040404040404,9.82639744982846,KLHL21;MYO19,delta,4
inorganic cation transmembrane transport (GO:0098662),3/141,3,141,0.0898315215938953,1,0,0,2.83687943262411,6.83636693699438,SLC30A8;TRPC1;NALCN,delta,4
intracellular steroid hormone receptor signaling pathway (GO:0030518),2/67,2,67,0.0901317978763934,1,0,0,3.98009950248756,9.57803884187696,WBP2;NRIP1,delta,4
gene expression (GO:0010467),6/412,6,412,0.0903617620301041,1,0,0,1.94174757281553,4.66783317953522,SETX;SMG1;ATXN1;SRSF1;SRSF2;RPL35,delta,4
"regulation of transcription, DNA-templated (GO:0006355)",17/1599,17,1599,0.0910444052724118,1,0,0,1.41755263706483,3.39703436854505,GMEB2;FBXW11;WBP2;MKL1;FOXJ3;PPP3CB;ATXN1;MAFB;KAT6A;NRIP1;SPIN1;CRY1;PIM2;RCOR3;RNF111;JDP2;ZFP28,delta,4
positive regulation of autophagy (GO:0010508),2/68,2,68,0.0924229057215344,1,0,0,3.92156862745098,9.33874679857562,PLK2;PIM2,delta,4
regulation of TOR signaling (GO:0032006),2/68,2,68,0.0924229057215344,1,0,0,3.92156862745098,9.33874679857562,RHEB;SMCR8,delta,4
positive regulation of histone H3-K4 methylation (GO:0051571),1/13,1,13,0.0932573471587156,1,0,0,10.2564102564103,24.3322300887813,PAXIP1,delta,4
negative regulation of macrophage derived foam cell differentiation (GO:0010745),1/13,1,13,0.0932573471587156,1,0,0,10.2564102564103,24.3322300887813,ABCA5,delta,4
dicarboxylic acid catabolic process (GO:0043649),1/13,1,13,0.0932573471587156,1,0,0,10.2564102564103,24.3322300887813,PM20D2,delta,4
motile cilium assembly (GO:0044458),1/13,1,13,0.0932573471587156,1,0,0,10.2564102564103,24.3322300887813,SPATA6,delta,4
regulation of superoxide anion generation (GO:0032928),1/13,1,13,0.0932573471587156,1,0,0,10.2564102564103,24.3322300887813,SOD1,delta,4
positive regulation of lamellipodium assembly (GO:0010592),1/13,1,13,0.0932573471587156,1,0,0,10.2564102564103,24.3322300887813,ARPC2,delta,4
DNA replication-independent nucleosome organization (GO:0034724),1/13,1,13,0.0932573471587156,1,0,0,10.2564102564103,24.3322300887813,ASF1B,delta,4
diacylglycerol metabolic process (GO:0046339),1/13,1,13,0.0932573471587156,1,0,0,10.2564102564103,24.3322300887813,DGAT1,delta,4
mRNA cleavage involved in mRNA processing (GO:0098787),1/13,1,13,0.0932573471587156,1,0,0,10.2564102564103,24.3322300887813,TUT1,delta,4
myelination in peripheral nervous system (GO:0022011),1/13,1,13,0.0932573471587156,1,0,0,10.2564102564103,24.3322300887813,SOD1,delta,4
placenta development (GO:0001890),1/13,1,13,0.0932573471587156,1,0,0,10.2564102564103,24.3322300887813,SOD1,delta,4
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),1/13,1,13,0.0932573471587156,1,0,0,10.2564102564103,24.3322300887813,PAXIP1,delta,4
positive regulation of cholesterol efflux (GO:0010875),1/13,1,13,0.0932573471587156,1,0,0,10.2564102564103,24.3322300887813,PLTP,delta,4
phosphate ion transport (GO:0006817),1/13,1,13,0.0932573471587156,1,0,0,10.2564102564103,24.3322300887813,SLC20A1,delta,4
peptidyl-serine phosphorylation (GO:0018105),3/146,3,146,0.0972215725514347,1,0,0,2.73972602739726,6.38565110222238,SMG1;PLK2;EIF2AK3,delta,4
phospholipid metabolic process (GO:0006644),2/71,2,71,0.0993962980538967,1,0,0,3.75586854460094,8.67094989270117,DGKE;FDFT1,delta,4
stress-activated protein kinase signaling cascade (GO:0031098),2/71,2,71,0.0993962980538967,1,0,0,3.75586854460094,8.67094989270117,FBXW11;MAP4K4,delta,4
IRES-dependent viral translational initiation (GO:0075522),3/10,3,10,0.00419247239844105,0.822853332663257,0,0,8.62068965517242,47.1936607572818,PTBP1;DENR;EIF3F,delta,5
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),20/292,20,292,0.00322692794893164,0.823350666169908,0,0,1.96819398519918,11.2900029399535,FBXW4;RNF11;WFS1;FAF2;UBE3A;RNF6;RNF7;SIRT2;ABTB1;FOXRED2;UCHL1;CCNB1;FZR1;BTBD1;PSMB3;PSMC1;JKAMP;CTNNB1;RBCK1;NFE2L2,delta,5
mRNA transport (GO:0051028),10/105,10,105,0.00361158520789393,0.837723605267397,0,0,2.73672687465791,15.3902804796398,NUP205;NUP107;NCBP1;POLDIP3;SARNP;EIF4A3;SRSF5;THOC5;SRSF11;WDR33,delta,5
negative regulation of gene expression (GO:0010629),35/619,35,619,0.00348239471861405,0.846221916623214,0,0,1.62479341912243,9.19638775700689,SUV39H1;EIF4A3;ASCL1;PPM1D;HDAC9;GLI3;FAM129B;MECP2;FXR1;PTBP1;ZNF749;DIP2A;SUDS3;CIC;SMARCE1;HSPA8;SMAD4;RBFOX2;CBX5;CBX4;DIS3;MIF;CBFA2T2;SMARCA2;ZHX1;SIRT2;ZNF639;CNOT2;IRF1;ZNF417;LANCL2;CTNNB1;TRIB3;GAPDH;TRIM33,delta,5
"regulation of DNA-templated transcription, elongation (GO:0032784)",4/20,4,20,0.00451484132932371,0.853305011242182,0,0,5.74712643678161,31.0366967571129,SUPT16H;ZNF326;ERCC6;THOC5,delta,5
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),8/71,8,71,0.00318534235365626,0.855515896353048,0,0,3.23781771086288,18.6148470337075,RNF144A;DET1;NUB1;RNF14;TRIB3;SIRT2;HERPUD1;NFE2L2,delta,5
mitotic nuclear envelope reassembly (GO:0007084),3/10,3,10,0.00419247239844105,0.855767465969787,0,0,8.62068965517242,47.1936607572818,PPP2CA;REEP4;LMNA,delta,5
IRE1-mediated unfolded protein response (GO:0036498),7/58,7,58,0.00386228268150771,0.856922979292777,0,0,3.46809353943718,19.2704510078276,ACADVL;EXTL2;WFS1;LMNA;HDGF;SEC62;TLN1,delta,5
'de novo' posttranslational protein folding (GO:0051084),5/31,5,31,0.00403327296985795,0.857574665216046,0,0,4.6347793845013,25.5523594795628,CHCHD4;HSPA8;DNAJC7;HSPA6;DNAJB12,delta,5
RNA export from nucleus (GO:0006405),11/120,11,120,0.00313554071084479,0.888925791524497,0,0,2.63409961685824,15.1854621854477,NUP205;NUP107;NCBP1;POLDIP3;SARNP;EIF4A3;SRSF5;THOC5;HNRNPA1;SRSF11;WDR33,delta,5
positive regulation of chromosome segregation (GO:0051984),3/11,3,11,0.00561668420961305,0.895685610051731,0,0,7.83699059561129,40.6113933188363,CCNB1;SMC6;SIRT2,delta,5
"DNA-templated transcription, termination (GO:0006353)",11/107,11,107,0.00125436680958619,0.914433404188333,0,0,2.9541304114298,19.7369126777961,NCBP1;PABPN1;POLDIP3;SARNP;EIF4A3;POLR1C;POLR1E;SRSF5;THOC5;SRSF11;WDR33,delta,5
negative regulation of fatty acid biosynthetic process (GO:0045717),3/11,3,11,0.00561668420961305,0.924578694246948,0,0,7.83699059561129,40.6113933188363,ACADVL;TRIB3;PIBF1,delta,5
regulation of phosphorylation (GO:0042325),11/120,11,120,0.00313554071084479,0.941215543967115,0,0,2.63409961685824,15.1854621854477,PPP2CA;NUP205;CDKN1A;NUP107;SOCS1;MCM7;KCTD20;FZD7;MIF;BTBD10;SIRT2,delta,5
"regulation of transcription, DNA-templated (GO:0006355)",78/1599,78,1599,0.00147862693883755,0.943179158611004,0,0,1.40173815531259,9.13462484700819,ZNF132;ZNF131;CDKN1A;NUP107;SMARCB1;RNF14;SUV39H1;CHD7;YEATS4;CHD2;GLI3;MECP2;ZNF326;KAT7;CIC;ATXN7L3;MYBL1;BRD3;RBFOX2;USP3;BAZ1A;CBFA2T2;ZHX1;SIRT2;DNM2;PSRC1;ZNF639;IRF1;LANCL2;ATF7;TRIB3;TOX;ATF6;CREB5;DDX5;SRCAP;CEBPG;RNF6;ZNF23;ASCL1;HDAC9;FAM129B;ZNF7;PPP2CA;ZNF749;NSD1;ZNF623;BRD8;TP53BP1;SUDS3;ZNF621;PPARGC1A;ZBED5;SMARCE1;MAP3K2;HSPA8;SMAD4;CBX5;SMAD3;ZNF140;NFYA;CBX4;ZNF184;FZD7;SMARCA5;GRHL1;SMARCA2;YY1AP1;TADA2B;FAM200A;SP1;CNOT2;ZNF417;CTNNB1;ZNF655;ERCC6;TRIM33;NFE2L2,delta,5
mRNA processing (GO:0006397),19/284,19,284,0.00518410091444469,0.944802391657545,0,0,1.92245426582483,10.1162597355525,HSPA8;DDX5;RBM15;NCBP1;POLDIP3;EIF4A3;ELAVL4;THOC5;WDR33;PTBP1;PABPN1;SNRPD1;RSRC1;SARNP;SRSF5;HNRNPA1;PPARGC1A;SMNDC1;SRSF11,delta,5
negative regulation of MAP kinase activity (GO:0043407),7/62,7,62,0.00560838212559846,0.953985799564298,0,0,3.24434556915091,16.8170425219662,DUSP4;PPP2CA;UCHL1;SMPD1;SORL1;CDK5RAP3;HIPK3,delta,5
RNA metabolic process (GO:0016070),15/192,15,192,0.00301694411068709,0.962216612302263,0,0,2.24497126436782,13.0287150767195,FTO;DDX28;DDX5;RBFOX2;NCBP1;DIS3;EIF4A3;ELAVL4;DDX50;ISG20;PTBP1;PABPN1;DHX29;HNRNPA1;SKIV2L2,delta,5
regulation of fibroblast proliferation (GO:0048145),6/47,6,47,0.00554152919219254,0.975118050612363,0,0,3.66837857666911,19.0590050947907,CDKN1A;MED25;CDK6;FTH1;CTNNB1;MIF,delta,5
mRNA export from nucleus (GO:0006406),11/106,11,106,0.00116106428789819,0.987485176857406,0,0,2.98199956625461,20.1536001556767,NUP205;NUP107;NCBP1;PABPN1;POLDIP3;SARNP;EIF4A3;SRSF5;THOC5;SRSF11;WDR33,delta,5
RNA 3'-end processing (GO:0031123),9/62,9,62,0.000276903749471475,1,0,0,4.17130144605117,34.1706364863426,NCBP1;PABPN1;POLDIP3;SARNP;EIF4A3;SRSF5;THOC5;SRSF11;WDR33,delta,5
termination of RNA polymerase II transcription (GO:0006369),9/69,9,69,0.000623376773932416,1,0,0,3.74812593703148,27.6625166732061,NCBP1;PABPN1;POLDIP3;SARNP;EIF4A3;SRSF5;THOC5;SRSF11;WDR33,delta,5
positive regulation of histone acetylation (GO:0035066),5/21,5,21,0.000643604089999204,1,0,0,6.84181718664477,50.2765926928617,TADA2B;SMAD4;SMARCB1;KAT7;PPARGC1A,delta,5
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),32/513,32,513,0.00112082035047976,1,0,0,1.79247608164729,12.177534728784,SUV39H1;EIF4A3;ASCL1;HDAC9;GLI3;FAM129B;MECP2;FXR1;ZNF749;ENPP1;SUDS3;CIC;SMARCE1;HSPA8;SMAD4;RBFOX2;CBX5;CBX4;CBFA2T2;SMARCA2;ZHX1;SIRT2;ZNF639;CNOT2;IRF1;ZNF417;LANCL2;CTNNB1;TRIB3;GAPDH;TRIM33;ATR,delta,5
mRNA 3'-end processing (GO:0031124),9/75,9,75,0.00114872955494925,1,0,0,3.44827586206897,23.3417195934587,NCBP1;PABPN1;POLDIP3;SARNP;EIF4A3;SRSF5;THOC5;SRSF11;WDR33,delta,5
lung epithelium development (GO:0060428),3/8,3,8,0.00206122294502884,1,0,0,10.7758620689655,66.6428427768668,ERRFI1;WNT7B;ASCL1,delta,5
mRNA metabolic process (GO:0016071),10/98,10,98,0.00217595691628061,1,0,0,2.9322073657049,17.9752719613179,PTBP1;DDX5;NCBP1;DIS3;ELAVL4;SRSF5;PPARGC1A;SRSF11;HIPK3;WDR33,delta,5
regulation of G2/M transition of mitotic cell cycle (GO:0010389),13/150,13,150,0.0022809232411882,1,0,0,2.4904214559387,15.149669509429,DYNC1I2;CEP152;FHL1;HAUS3;CDC7;MECP2;CCNB1;CDK6;PSMB3;PSMC1;CNTRL;CEP250;CEP78,delta,5
purine ribonucleoside monophosphate metabolic process (GO:0009167),6/40,6,40,0.00243153442240018,1,0,0,4.31034482758621,25.9449688420804,HSPA8;BAD;IMPDH2;OLA1;ENPP1;PFAS,delta,5
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),10/101,10,101,0.00272090700080593,1,0,0,2.84511209741664,16.8054796804363,NUP205;NUP107;NCBP1;POLDIP3;SARNP;EIF4A3;SRSF5;THOC5;SRSF11;WDR33,delta,5
negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),3/9,3,9,0.00301218702310719,1,0,0,9.57854406130268,55.6042996006426,PPP2CA;SOCS1;PIBF1,delta,5
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),4/18,4,18,0.00301319322198454,1,0,0,6.38569604086846,37.0674003285837,DLX1;SMAD4;SMAD3;TRIM33,delta,5
RNA transport (GO:0050658),8/81,8,81,0.00712286287339026,1,0,0,2.83808712927487,14.0327672638429,NCBP1;POLDIP3;SARNP;EIF4A3;SRSF5;THOC5;HNRNPA1;SRSF11,delta,5
negative regulation of nucleic acid-templated transcription (GO:1903507),26/445,26,445,0.00728687484568683,1,0,0,1.67893581299238,8.26318567750182,SUV39H1;ASCL1;HDAC9;GLI3;FAM129B;MECP2;ZNF749;SUDS3;CIC;SMARCE1;HSPA8;SMAD4;RBFOX2;CBX5;CBX4;CBFA2T2;SMARCA2;ZHX1;SIRT2;ZNF639;IRF1;ZNF417;LANCL2;CTNNB1;TRIB3;TRIM33,delta,5
positive regulation of binding (GO:0051099),8/82,8,82,0.00765912447432389,1,0,0,2.80347631062518,13.6581373707691,MED25;RALB;NCBP1;CEBPG;TRIB3;MET;SIRT2;STK3,delta,5
fatty acid oxidation (GO:0019395),6/51,6,51,0.00827142632552053,1,0,0,3.38066260987154,16.2101024847348,ACADVL;ABCD3;ECI1;HADH;ACAD10;PPARGC1A,delta,5
fatty acid beta-oxidation (GO:0006635),6/51,6,51,0.00827142632552053,1,0,0,3.38066260987154,16.2101024847348,ACADVL;ABCD3;ECI1;ETFA;HADH;ACAD10,delta,5
protein deubiquitination (GO:0016579),17/258,17,258,0.00914250593394972,1,0,0,1.89343312839704,8.88932915676818,SMAD4;USP37;SMAD3;TNKS;USP3;UCHL5;TADA2B;UCHL1;PSMB3;ATXN7;TRAF3;OTUD6B;PSMC1;SUDS3;EIF3F;ATXN7L3;BAP1,delta,5
viral translation (GO:0019081),3/13,3,13,0.0092435590565645,1,0,0,6.63129973474801,31.0598692852067,PTBP1;DENR;EIF3F,delta,5
regulation of fatty acid oxidation (GO:0046320),3/13,3,13,0.0092435590565645,1,0,0,6.63129973474801,31.0598692852067,ACADVL;LONP2;PPARGC1A,delta,5
positive regulation of microtubule polymerization (GO:0031116),4/25,4,25,0.0102759148053594,1,0,0,4.59770114942529,21.0480574271779,MECP2;CLIP1;PSRC1;MET,delta,5
chaperone mediated protein folding requiring cofactor (GO:0051085),4/25,4,25,0.0102759148053594,1,0,0,4.59770114942529,21.0480574271779,HSPA8;DNAJC7;HSPA6;DNAJB12,delta,5
protein import into nucleus (GO:0006606),9/104,9,104,0.0103702141734683,1,0,0,2.4867374005305,11.3614496115089,PDIA3;NCKIPSD;NUP107;CTNNB1;PTTG1IP;KPNA2;GDF5;GPN1;IPO5,delta,5
pore complex assembly (GO:0046931),3/14,3,14,0.0114642297131265,1,0,0,6.1576354679803,27.5155391063767,NUP205;NUP107;BAD,delta,5
interleukin-6-mediated signaling pathway (GO:0070102),3/14,3,14,0.0114642297131265,1,0,0,6.1576354679803,27.5155391063767,SMAD4;IL6ST;IL6R,delta,5
protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),7/71,7,71,0.0116157549876859,1,0,0,2.83309049700502,12.6225313244537,RNF144A;ABTB1;CUL5;BTBD1;RNF14;UBE3A;RNF7,delta,5
"negative regulation of transcription, DNA-templated (GO:0045892)",41/814,41,814,0.0116360880508732,1,0,0,1.44737213702731,6.44608019225502,DLX1;DDX5;SUV39H1;GLIS3;VLDLR;ASCL1;IKZF2;HDAC9;GLI3;FAM129B;ZBTB2;MECP2;ZNF749;NSD1;SUDS3;CIC;NKX6-1;SMARCE1;HSPA8;SMAD4;RBFOX2;CBX5;SMAD3;ZNF140;CBX4;WFS1;CBFA2T2;SMARCA2;ZHX1;SIRT2;GATAD2B;MED25;ZNF639;CNOT2;IRF1;ZNF417;LANCL2;CTNNB1;TRIB3;HDGF;TRIM33,delta,5
"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",4/26,4,26,0.0118166691767638,1,0,0,4.42086648983201,19.6208846253407,DDX5;PTTG1IP;MIF;ATR,delta,5
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",5/40,5,40,0.0120927130559019,1,0,0,3.59195402298851,15.8590238310912,PTBP1;DDX5;RBFOX2;CELF6;HNRNPA1,delta,5
response to endoplasmic reticulum stress (GO:0034976),9/107,9,107,0.012357551004597,1,0,0,2.41701579116984,10.6191298389574,PDIA3;ERP44;WFS1;DNAJB12;TRIB3;CHAC1;ATF6;HERPUD1;NCK1,delta,5
RNA splicing (GO:0008380),9/107,9,107,0.012357551004597,1,0,0,2.41701579116984,10.6191298389574,PPP2CA;PTBP1;NCBP1;SNRPD1;RSRC1;EIF4A3;PPARGC1A;SMNDC1;SRSF11,delta,5
negative regulation of cellular process (GO:0048523),29/535,29,535,0.0127544043816629,1,0,0,1.55763239875389,6.79420346624595,CDKN1A;PPP1R13B;SMARCB1;CUL5;FHL1;CIB1;PPM1D;FAM129B;PPP2CA;FTH1;LMNA;WDR6;ENPP1;MYBL1;NCK1;SMAD4;SMAD3;BAD;FUZ;MIF;SMARCA2;SIRT2;DUS2;CDK6;PSRC1;IRF1;CDK10;CTNNB1;BAP1,delta,5
regulation of mitotic cell cycle phase transition (GO:1901990),13/185,13,185,0.012928669051218,1,0,0,2.0192606399503,8.78036724816446,DYNC1I2;CEP152;HAUS3;SIRT2;CCNB1;FZR1;CDK6;PSMB3;PSMC1;CNTRL;CEP250;TMEM14B;CEP78,delta,5
cellular response to starvation (GO:0009267),9/108,9,108,0.0130791386379755,1,0,0,2.39463601532567,10.3849061026995,HSPA8;RRAGA;CDKN1A;PRKAA1;NUAK2;RALB;SESN3;HNRNPA1;RNF152,delta,5
mitochondrial translational termination (GO:0070126),8/90,8,90,0.0131044349727082,1,0,0,2.55427841634738,11.0722977229485,MRPS27;MRPS14;MRPL15;MRPL34;CHCHD1;MRPS6;DAP3;C12ORF65,delta,5
phosphatidylethanolamine biosynthetic process (GO:0006646),3/15,3,15,0.0139651802632042,1,0,0,5.74712643678161,24.5470584566357,SLC27A1;PCYT2;ETNK1,delta,5
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),3/15,3,15,0.0139651802632042,1,0,0,5.74712643678161,24.5470584566357,ACADVL;ETFA;ACAD10,delta,5
ATP metabolic process (GO:0046034),6/57,6,57,0.0140019443453691,1,0,0,3.02480338777979,12.9115519576467,ATP5B;HSPA8;BAD;OLA1;ENPP1;UQCRH,delta,5
negative regulation of transcription from RNA polymerase II promoter (GO:0000122),30/566,30,566,0.0152048145331364,1,0,0,1.52309004508347,6.37587296771373,DLX1;DDX5;SUV39H1;GLIS3;VLDLR;ASCL1;IKZF2;HDAC9;GLI3;ZBTB2;MECP2;NSD1;SUDS3;CIC;NKX6-1;SMAD4;SMAD3;CBX5;ZNF140;CBX4;WFS1;SMARCA2;ZHX1;SIRT2;GATAD2B;MED25;CNOT2;TRIB3;HDGF;TRIM33,delta,5
regulation of cilium assembly (GO:1902017),4/28,4,28,0.0153240683772411,1,0,0,4.10509031198686,17.1524244255022,TCTEX1D2;CDK10;FUZ;EVI5L,delta,5
regulation of protein localization to cell surface (GO:2000008),4/28,4,28,0.0153240683772411,1,0,0,4.10509031198686,17.1524244255022,HSP90AB1;CTNNB1;STX3;RAB11FIP5,delta,5
nuclear export (GO:0051168),8/93,8,93,0.0157400661212701,1,0,0,2.47188233840069,10.2621328269896,NCBP1;POLDIP3;SARNP;EIF4A3;SRSF5;THOC5;HNRNPA1;SRSF11,delta,5
regulation of extent of cell growth (GO:0061387),2/6,2,6,0.0165257483170851,1,0,0,9.57854406130268,39.299191669838,CTTN;DNM2,delta,5
nucleus localization (GO:0051647),2/6,2,6,0.0165257483170851,1,0,0,9.57854406130268,39.299191669838,DCTN4;SYNE2,delta,5
type B pancreatic cell development (GO:0003323),2/6,2,6,0.0165257483170851,1,0,0,9.57854406130268,39.299191669838,CDK6;NKX6-1,delta,5
regulation of transforming growth factor beta2 production (GO:0032909),2/6,2,6,0.0165257483170851,1,0,0,9.57854406130268,39.299191669838,SMAD4;SMAD3,delta,5
insulin secretion involved in cellular response to glucose stimulus (GO:0035773),2/6,2,6,0.0165257483170851,1,0,0,9.57854406130268,39.299191669838,PTPRN;RAB11FIP5,delta,5
peptidyl-threonine dephosphorylation (GO:0035970),3/16,3,16,0.0167508290230844,1,0,0,5.38793103448276,22.0329069397649,DUSP4;PPP2CA;PPM1D,delta,5
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),3/16,3,16,0.0167508290230844,1,0,0,5.38793103448276,22.0329069397649,MECP2;CCNB1;CDC7,delta,5
ubiquitin-dependent protein catabolic process (GO:0006511),20/342,20,342,0.017010090104114,1,0,0,1.68044632654433,6.84605191816621,FBXW4;RNF11;CUL5;RNF14;UBE3A;RNF6;RNF7;FBXO11;SIRT2;RNF144A;ABTB1;NUB1;UCHL1;BTBD1;PSMB3;PSMC1;TTC3;CTNNB1;RBCK1;NFE2L2,delta,5
positive regulation of phosphate metabolic process (GO:0045937),4/29,4,29,0.0172983483989098,1,0,0,3.96353547364249,16.080635157776,KCTD20;FZD7;MIF;BTBD10,delta,5
response to unfolded protein (GO:0006986),5/44,5,44,0.0178261509126737,1,0,0,3.26541274817137,13.1501069338925,HSPA8;ERP44;HSP90AB1;HSPA6;HERPUD1,delta,5
nucleobase-containing compound catabolic process (GO:0034655),5/44,5,44,0.0178261509126737,1,0,0,3.26541274817137,13.1501069338925,ISG20;ENTPD2;DIS3;NUDT18;SKIV2L2,delta,5
ERAD pathway (GO:0036503),7/78,7,78,0.0187740064473797,1,0,0,2.57883878573534,10.2516114100822,FOXRED2;WFS1;PSMC1;JKAMP;FAF2;DNAJB12;HERPUD1,delta,5
"regulation of mRNA splicing, via spliceosome (GO:0048024)",6/61,6,61,0.0190847632856529,1,0,0,2.82645562464669,11.1895562352286,PTBP1;DDX5;RBFOX2;NCBP1;CELF6;HNRNPA1,delta,5
mitotic nuclear envelope disassembly (GO:0007077),5/45,5,45,0.0194973525440918,1,0,0,3.19284802043423,12.5717643346081,CTDNEP1;NUP205;CCNB1;NUP107;LMNA,delta,5
translational termination (GO:0006415),8/97,8,97,0.0198239237567303,1,0,0,2.36994904609551,9.29225216284181,MRPS27;MRPS14;MRPL15;MRPL34;CHCHD1;MRPS6;DAP3;C12ORF65,delta,5
ciliary basal body-plasma membrane docking (GO:0097711),8/97,8,97,0.0198239237567303,1,0,0,2.36994904609551,9.29225216284181,DYNC1I2;CEP152;CNTRL;SCLT1;CEP250;HAUS3;RPGRIP1L;CEP78,delta,5
positive regulation of cell cycle G2/M phase transition (GO:1902751),3/17,3,17,0.019824029102429,1,0,0,5.0709939148073,19.8826596655995,MECP2;CCNB1;CDC7,delta,5
negative regulation of lipid biosynthetic process (GO:0051055),3/17,3,17,0.019824029102429,1,0,0,5.0709939148073,19.8826596655995,SLC27A1;ACADVL;TRIB3,delta,5
positive regulation of signal transduction by p53 class mediator (GO:1901798),3/17,3,17,0.019824029102429,1,0,0,5.0709939148073,19.8826596655995,DDX5;CDK5RAP3;ATR,delta,5
positive regulation by host of viral transcription (GO:0043923),3/17,3,17,0.019824029102429,1,0,0,5.0709939148073,19.8826596655995,SMARCB1;SP1;ZNF639,delta,5
negative regulation of cell growth (GO:0030308),9/116,9,116,0.020022414516907,1,0,0,2.2294887039239,8.71931385358319,PPP2CA;SMAD4;CDKN1A;SMAD3;PSRC1;FHL1;ENPP1;RNF6;SMARCA2,delta,5
regulation of tyrosine phosphorylation of STAT protein (GO:0042509),6/62,6,62,0.0205286634922205,1,0,0,2.78086763070078,10.8062657127453,PPP2CA;SOCS1;ARL2BP;IL6ST;IL6R;PIBF1,delta,5
protein modification by small protein removal (GO:0070646),16/262,16,262,0.0215094876807452,1,0,0,1.75484776695622,6.73731886235094,SMAD4;USP37;SMAD3;TNKS;USP3;UCHL5;TADA2B;UCHL1;PSMB3;ATXN7;TRAF3;OTUD6B;PSMC1;SUDS3;EIF3F;BAP1,delta,5
ATP-dependent chromatin remodeling (GO:0043044),4/31,4,31,0.0217042589439275,1,0,0,3.70782350760104,14.2018790248276,SMARCE1;SMARCB1;SMARCA5;GATAD2B,delta,5
positive regulation of histone H4 acetylation (GO:0090240),2/7,2,7,0.0226071088811809,1,0,0,8.21018062397373,31.112404514782,SMARCB1;KAT7,delta,5
negative regulation of cardiac muscle cell differentiation (GO:2000726),2/7,2,7,0.0226071088811809,1,0,0,8.21018062397373,31.112404514782,SMAD4;FZD7,delta,5
regulation of response to biotic stimulus (GO:0002831),2/7,2,7,0.0226071088811809,1,0,0,8.21018062397373,31.112404514782,TRAF3;CD55,delta,5
positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),2/7,2,7,0.0226071088811809,1,0,0,8.21018062397373,31.112404514782,NFE2L2;HERPUD1,delta,5
regulation of histone H3-K9 acetylation (GO:2000615),2/7,2,7,0.0226071088811809,1,0,0,8.21018062397373,31.112404514782,SMAD4;SMARCB1,delta,5
peptidyl-lysine deacetylation (GO:0034983),2/7,2,7,0.0226071088811809,1,0,0,8.21018062397373,31.112404514782,HDAC9;SIRT2,delta,5
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),2/7,2,7,0.0226071088811809,1,0,0,8.21018062397373,31.112404514782,CASP7;CYCS,delta,5
regulation of skeletal muscle fiber development (GO:0048742),2/7,2,7,0.0226071088811809,1,0,0,8.21018062397373,31.112404514782,HDAC9;FAM129B,delta,5
negative regulation of MAPK cascade (GO:0043409),7/81,7,81,0.0226262370991529,1,0,0,2.48332623811551,9.40844181471815,DUSP4;UCHL1;SMAD4;SMPD1;RANBP9;SORL1;CDK5RAP3,delta,5
nucleocytoplasmic transport (GO:0006913),5/47,5,47,0.0231402943150488,1,0,0,3.05698214722426,11.5131445292563,NUP205;NCBP1;RSRC1;SNRPD1;HNRNPA1,delta,5
nuclear envelope disassembly (GO:0051081),5/47,5,47,0.0231402943150488,1,0,0,3.05698214722426,11.5131445292563,CTDNEP1;NUP205;CCNB1;NUP107;LMNA,delta,5
positive regulation of ion transport (GO:0043270),5/47,5,47,0.0231402943150488,1,0,0,3.05698214722426,11.5131445292563,RAB3B;WFS1;FHL1;PKP2;SCN3B,delta,5
nuclear envelope reassembly (GO:0031468),3/18,3,18,0.0231862034063877,1,0,0,4.78927203065134,18.027767518974,PPP2CA;REEP4;LMNA,delta,5
modulation by virus of host morphology or physiology (GO:0019048),3/18,3,18,0.0231862034063877,1,0,0,4.78927203065134,18.027767518974,RRAGA;SMAD3;KPNA2,delta,5
iron ion homeostasis (GO:0055072),6/64,6,64,0.0236347845439052,1,0,0,2.69396551724138,10.0889971194897,SLC25A37;SMAD4;CCDC115;FTH1;NEO1;NUBP1,delta,5
mitotic cell cycle phase transition (GO:0044772),14/222,14,222,0.0237773737357106,1,0,0,1.81215698457078,6.77569271954278,DYNC1I2;CDKN1A;USP37;CUL5;MCM7;CEP152;HAUS3;CDC7;DNM2;CCNB1;CDK6;CNTRL;CEP250;CEP78,delta,5
negative regulation of cell death (GO:0060548),7/82,7,82,0.0240231694524258,1,0,0,2.45304177179703,9.1467464407529,DUS2;WFS1;CTNNB1;PPARGC1A;BTBD10;SORL1;NCK1,delta,5
postreplication repair (GO:0006301),5/48,5,48,0.0251157970629268,1,0,0,2.99329501915709,11.0280719161718,POLD3;POLN;MSH2;REV1;WDR33,delta,5
positive regulation of organelle assembly (GO:1902117),5/48,5,48,0.0251157970629268,1,0,0,2.99329501915709,11.0280719161718,RALB;CNOT6L;CNOT2;PIP4K2B;FUZ,delta,5
"positive regulation of gene expression, epigenetic (GO:0045815)",5/48,5,48,0.0251157970629268,1,0,0,2.99329501915709,11.0280719161718,POLR1C;SMARCA5;POLR1E;SLC50A1;ERCC6,delta,5
positive regulation of protein polymerization (GO:0032273),6/65,6,65,0.0252997472414451,1,0,0,2.6525198938992,9.75321186672489,CLIP1;PSRC1;CTTN;PFN1;MET;NCK1,delta,5
DNA replication (GO:0006260),9/121,9,121,0.025526003074255,1,0,0,2.13736107153035,7.8399635608124,MCM7;POLN;REV1;REV3L;DONSON;KAT7;CDC7;BAZ1A;ATR,delta,5
negative regulation of growth (GO:0045926),9/121,9,121,0.025526003074255,1,0,0,2.13736107153035,7.8399635608124,PPP2CA;SMAD4;CDKN1A;SMAD3;PSRC1;FHL1;ENPP1;MT1X;SMARCA2,delta,5
intrinsic apoptotic signaling pathway (GO:0097193),8/102,8,102,0.0259234688468419,1,0,0,2.25377507324769,8.23215367925331,DDX5;CDKN1A;PPP1R13B;CUL5;BAD;CYCS;TRIB3;CHAC1,delta,5
microtubule bundle formation (GO:0001578),4/33,4,33,0.0267370687318156,1,0,0,3.48310693138279,12.6147834706237,CLIP1;PSRC1;NCKAP5L;KIF20A,delta,5
purine ribonucleoside triphosphate metabolic process (GO:0009205),4/33,4,33,0.0267370687318156,1,0,0,3.48310693138279,12.6147834706237,HSPA8;BAD;OLA1;ENPP1,delta,5
negative regulation of fat cell differentiation (GO:0045599),4/33,4,33,0.0267370687318156,1,0,0,3.48310693138279,12.6147834706237,SMAD3;ENPP1;TRIB3;SIRT2,delta,5
G2 DNA damage checkpoint (GO:0031572),4/33,4,33,0.0267370687318156,1,0,0,3.48310693138279,12.6147834706237,FZR1;DONSON;CDK5RAP3;STK3,delta,5
positive regulation of telomere maintenance via telomerase (GO:0032212),4/33,4,33,0.0267370687318156,1,0,0,3.48310693138279,12.6147834706237,TNKS;HNRNPA1;CCT5;ATR,delta,5
protein targeting to lysosome (GO:0006622),3/19,3,19,0.0268374710798967,1,0,0,4.53720508166969,16.4154092258544,AP4M1;HSPA8;SORL1,delta,5
sulfur compound transport (GO:0072348),3/19,3,19,0.0268374710798967,1,0,0,4.53720508166969,16.4154092258544,SLC6A6;SLC25A26;SLC25A10,delta,5
nucleosome disassembly (GO:0006337),3/19,3,19,0.0268374710798967,1,0,0,4.53720508166969,16.4154092258544,SMARCE1;SUPT16H;SMARCB1,delta,5
chromatin disassembly (GO:0031498),3/19,3,19,0.0268374710798967,1,0,0,4.53720508166969,16.4154092258544,SMARCE1;SUPT16H;SMARCB1,delta,5
histone deubiquitination (GO:0016578),3/19,3,19,0.0268374710798967,1,0,0,4.53720508166969,16.4154092258544,ATXN7;USP3;ATXN7L3,delta,5
regulation of cell cycle G2/M phase transition (GO:1902749),7/85,7,85,0.0285667198402693,1,0,0,2.36646382691007,8.41399261819928,DYNC1I2;CDK6;CEP152;CNTRL;CEP250;HAUS3;CEP78,delta,5
intracellular steroid hormone receptor signaling pathway (GO:0030518),6/67,6,67,0.0288598199826775,1,0,0,2.57334019557386,9.12327576753044,DDX5;RBFOX2;RNF14;CTNNB1;UBE3A;PPARGC1A,delta,5
protein autoubiquitination (GO:0051865),5/50,5,50,0.0293831791449978,1,0,0,2.87356321839081,10.136014098552,RNF11;RNF13;TRIM17;UBE3D;UBE3A,delta,5
positive regulation of cell aging (GO:0090343),2/8,2,8,0.0294557542974007,1,0,0,7.18390804597701,25.3223131887155,ARG2;LMNA,delta,5
regulation of histone H4 acetylation (GO:0090239),2/8,2,8,0.0294557542974007,1,0,0,7.18390804597701,25.3223131887155,SMARCB1;KAT7,delta,5
cardiolipin biosynthetic process (GO:0032049),2/8,2,8,0.0294557542974007,1,0,0,7.18390804597701,25.3223131887155,SLC27A1;CRLS1,delta,5
SMAD protein complex assembly (GO:0007183),2/8,2,8,0.0294557542974007,1,0,0,7.18390804597701,25.3223131887155,SMAD4;SMAD3,delta,5
positive regulation of protein localization to cell surface (GO:2000010),2/8,2,8,0.0294557542974007,1,0,0,7.18390804597701,25.3223131887155,HSP90AB1;STX3,delta,5
histone H4 deacetylation (GO:0070933),2/8,2,8,0.0294557542974007,1,0,0,7.18390804597701,25.3223131887155,HDAC9;SIRT2,delta,5
regulation of type B pancreatic cell development (GO:2000074),2/8,2,8,0.0294557542974007,1,0,0,7.18390804597701,25.3223131887155,BAD;NKX6-1,delta,5
regulation of cytoplasmic mRNA processing body assembly (GO:0010603),2/8,2,8,0.0294557542974007,1,0,0,7.18390804597701,25.3223131887155,CNOT6L;CNOT2,delta,5
negative regulation of cilium assembly (GO:1902018),2/8,2,8,0.0294557542974007,1,0,0,7.18390804597701,25.3223131887155,CDK10;EVI5L,delta,5
nose development (GO:0043584),2/8,2,8,0.0294557542974007,1,0,0,7.18390804597701,25.3223131887155,CHD7;GLI3,delta,5
cellular response to glucose starvation (GO:0042149),4/34,4,34,0.0294935529822856,1,0,0,3.38066260987154,11.9120472700937,PRKAA1;NUAK2;SESN3;HNRNPA1,delta,5
regulation of transcription from RNA polymerase II promoter (GO:0006357),65/1479,65,1479,0.0304124485394263,1,0,0,1.26289120483707,4.41115681013913,CDKN1A;SMARCB1;RNF14;PTPRN;SUV39H1;YEATS4;VLDLR;IKZF2;CHD2;GLI3;MECP2;KAT7;CIC;MYBL1;NCK1;BRD3;ABHD14B;ZHX1;SIRT2;CREB3;MED25;ZNF639;IRF1;TRIB3;ATF6;MET;DLX1;DDX5;SRCAP;TNKS;CEBPG;GLIS3;ASCL1;HDAC9;ZBTB2;NSD1;BRD8;TP53BP1;SUDS3;NKX6-1;PPARGC1A;ZBED5;SMARCE1;SMAD4;CBX5;SMAD3;ZNF140;CBX4;WFS1;SMARCA5;GRHL1;GDF5;SMARCA2;GATAD2B;TADA2B;FAM200A;SP1;CNOT2;CTNNB1;TAF4B;HDGF;PPIL4;TRIM33;SSBP4;NFE2L2,delta,5
negative regulation of cell proliferation (GO:0008285),20/364,20,364,0.0304744020066466,1,0,0,1.57888088922572,5.51166512920098,CDKN1A;SMARCB1;CUL5;CTNNBIP1;CIB1;FUZ;PPM1D;SMARCA2;GDF5;SIRT2;FAM129B;MED25;CDK6;FTH1;IRF1;LMNA;CDK10;CTNNB1;WDR6;BAP1,delta,5
negative regulation of protein serine/threonine kinase activity (GO:0071901),6/68,6,68,0.0307572542668489,1,0,0,2.53549695740365,8.82766075414611,UCHL1;SMPD1;PRKAR2A;SORL1;CDK5RAP3;IPO5,delta,5
extrinsic apoptotic signaling pathway (GO:0097191),6/68,6,68,0.0307572542668489,1,0,0,2.53549695740365,8.82766075414611,SMAD3;BAD;BLOC1S2;CIB1;IL6R;DEDD,delta,5
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),3/20,3,20,0.0307767658279035,1,0,0,4.31034482758621,15.004289784092,CREB3;HERPUD1;NCK1,delta,5
phosphatidylethanolamine metabolic process (GO:0046337),3/20,3,20,0.0307767658279035,1,0,0,4.31034482758621,15.004289784092,SLC27A1;PCYT2;ETNK1,delta,5
regulation of cell development (GO:0060284),3/20,3,20,0.0307767658279035,1,0,0,4.31034482758621,15.004289784092,CTNNB1;ASCL1;HDAC9,delta,5
organelle disassembly (GO:1903008),3/20,3,20,0.0307767658279035,1,0,0,4.31034482758621,15.004289784092,RB1CC1;DENR;KLC1,delta,5
translational elongation (GO:0006414),8/106,8,106,0.0316618156523573,1,0,0,2.16872695727608,7.48784185146398,MRPS27;MRPS14;MRPL15;MRPL34;CHCHD1;MRPS6;DAP3;C12ORF65,delta,5
neurogenesis (GO:0022008),5/51,5,51,0.0316779379738355,1,0,0,2.81721884155961,9.72541921164088,CDK6;BTBD1;CHAC1;DAGLB;ASCL1,delta,5
protein ubiquitination (GO:0016567),26/507,26,507,0.0322885233469821,1,0,0,1.47362216327734,5.05900888038247,DET1;RNF11;CUL5;RNF13;TNKS;RNF14;UBE3D;UBE3A;RNF6;RNF7;NUB1;BTBD1;PSMB3;RNF152;BRAP;FBXW4;ARRDC4;FBXO11;RNF144A;ABTB1;RRAGA;TRIM17;PSMC1;RBCK1;TRIM33;NFE2L2,delta,5
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),4/35,4,35,0.0324120122041142,1,0,0,3.28407224958949,11.2618265282529,TNKS;HNRNPA1;CCT5;ATR,delta,5
positive regulation of cell development (GO:0010720),4/35,4,35,0.0324120122041142,1,0,0,3.28407224958949,11.2618265282529,BAD;NUMB;NKX6-1;FAM129B,delta,5
peptidyl-threonine phosphorylation (GO:0018107),6/69,6,69,0.0327343810091463,1,0,0,2.49875062468766,8.54405134036138,TNKS;CDK10;OXSR1;CAMKK1;HIPK3;PSKH1,delta,5
G2/M transition of mitotic cell cycle (GO:0000086),9/127,9,127,0.0334492663320184,1,0,0,2.03638338311159,6.91907159772216,DYNC1I2;CCNB1;CDKN1A;CEP152;CNTRL;CEP250;HAUS3;CEP78;DNM2,delta,5
mitochondrial translational elongation (GO:0070125),7/88,7,88,0.0336586956132655,1,0,0,2.28578892371996,7.75221620285752,MRPS27;MRPS14;MRPL15;MRPL34;CHCHD1;MRPS6;DAP3,delta,5
regulation of telomere maintenance via telomerase (GO:0032210),5/52,5,52,0.0340817444461766,1,0,0,2.763041556145,9.33629915873692,CTC1;TNKS;HNRNPA1;CCT5;ATR,delta,5
transcription from RNA polymerase II promoter (GO:0006366),25/486,25,486,0.0341955742700158,1,0,0,1.47817037983066,4.98979922099964,CDKN1A;DDX5;POLDIP3;EIF4A3;GLIS3;PPM1D;CCNB1;PABPN1;PPARGC1A;SRSF11;SUPT16H;NFYA;NCBP1;THOC5;WDR33;MED25;SP1;SARNP;IRF1;TAF4B;SRSF5;ERCC6;INTS8;NFE2L2;CREB5,delta,5
regulation of osteoblast differentiation (GO:0045667),6/70,6,70,0.034792176663884,1,0,0,2.46305418719212,8.27182937434485,DDX5;CDK6;WNT7B;CTNNBIP1;IL6ST;IL6R,delta,5
mitochondrial translation (GO:0032543),8/108,8,108,0.034833169009455,1,0,0,2.12856534695615,7.14598810917076,MRPS27;MRPS14;MRPL15;MRPL34;CHCHD1;MRPS6;DAP3;C12ORF65,delta,5
cell cycle G2/M phase transition (GO:0044839),9/128,9,128,0.0349179410647425,1,0,0,2.02047413793103,6.77819472906748,DYNC1I2;CCNB1;CDKN1A;CEP152;CNTRL;CEP250;HAUS3;CEP78;DNM2,delta,5
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),3/21,3,21,0.0350019466115752,1,0,0,4.10509031198686,13.7617060819612,CREB3;SMAD4;NFE2L2,delta,5
negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744),3/21,3,21,0.0350019466115752,1,0,0,4.10509031198686,13.7617060819612,YWHAB;RPGRIP1L;MET,delta,5
non-motile cilium assembly (GO:1905515),3/21,3,21,0.0350019466115752,1,0,0,4.10509031198686,13.7617060819612,CEP250;FUZ;PIBF1,delta,5
protein-DNA complex disassembly (GO:0032986),3/21,3,21,0.0350019466115752,1,0,0,4.10509031198686,13.7617060819612,SMARCE1;SUPT16H;SMARCB1,delta,5
regulation of cellular macromolecule biosynthetic process (GO:2000112),31/632,31,632,0.0352441837136467,1,0,0,1.40950094572967,4.71542165427438,ZNF132;ZNF131;USP37;NUP107;RNF14;CHD7;NOLC1;RNF6;ZNF23;ZNF7;PPP2CA;ZNF623;KAT7;BRD8;ZNF621;PPARGC1A;SMARCE1;ZNF140;NFYA;ZNF184;FZD7;USP3;BAZ1A;SMARCA2;YY1AP1;DNM2;SP1;ZNF417;ATF7;ZNF655;TOX,delta,5
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),7/89,7,89,0.0354818015190969,1,0,0,2.26010590210513,7.54589546378955,RNF144A;DET1;NUB1;HSP90AB1;RNF14;TRIB3;SIRT2,delta,5
regulation of microtubule polymerization (GO:0031113),4/36,4,36,0.035493438600573,1,0,0,3.19284802043423,10.6590275470513,CLIP1;PSRC1;MAP2;MET,delta,5
positive regulation of osteoblast differentiation (GO:0045669),4/36,4,36,0.035493438600573,1,0,0,3.19284802043423,10.6590275470513,WNT7B;CTNNBIP1;IL6ST;IL6R,delta,5
regulation of amyloid precursor protein biosynthetic process (GO:0042984),2/9,2,9,0.0370110752518482,1,0,0,6.38569604086846,21.0506901660122,NECAB3;SOAT1,delta,5
regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),2/9,2,9,0.0370110752518482,1,0,0,6.38569604086846,21.0506901660122,NFE2L2;HERPUD1,delta,5
nuclear migration (GO:0007097),2/9,2,9,0.0370110752518482,1,0,0,6.38569604086846,21.0506901660122,DCTN4;SYNE2,delta,5
positive regulation of autophagosome assembly (GO:2000786),2/9,2,9,0.0370110752518482,1,0,0,6.38569604086846,21.0506901660122,RALB;PIP4K2B,delta,5
regulation of helicase activity (GO:0051095),2/9,2,9,0.0370110752518482,1,0,0,6.38569604086846,21.0506901660122,MSH2;IFIT1,delta,5
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",14/237,14,237,0.0383015247483166,1,0,0,1.69746350453465,5.53757675214333,HSPA8;DDX5;RBM15;NCBP1;EIF4A3;WDR33;PTBP1;PABPN1;SNRPD1;RSRC1;SRSF5;HNRNPA1;SMNDC1;SRSF11,delta,5
negative regulation of cell differentiation (GO:0045596),10/151,10,151,0.0385492794510155,1,0,0,1.90302199893431,6.19589303195389,PPP2CA;PTBP1;SMAD3;CDK6;PKP2;ENPP1;NPHP3;TRIB3;GDF5;SIRT2,delta,5
regulation of muscle cell differentiation (GO:0051147),4/37,4,37,0.0387384757563668,1,0,0,3.10655483069276,10.0991673415675,SPAG9;PTBP1;CTNNB1;HDAC9,delta,5
RNA processing (GO:0006396),12/194,12,194,0.0392254862498973,1,0,0,1.77746178457163,5.75618305014512,PPP2CA;PTBP1;NCBP1;PABPN1;SNRPD1;RSRC1;EIF4A3;ELAVL4;DHX29;SRSF5;PPARGC1A;SRSF11,delta,5
negative regulation of response to endoplasmic reticulum stress (GO:1903573),3/22,3,22,0.039509901114877,1,0,0,3.91849529780564,12.6614575914937,CREB3;HERPUD1;NCK1,delta,5
negative regulation of cell cycle G1/S phase transition (GO:1902807),3/22,3,22,0.039509901114877,1,0,0,3.91849529780564,12.6614575914937,CDKN1A;FHL1;ZNF655,delta,5
phosphatidylglycerol metabolic process (GO:0046471),3/22,3,22,0.039509901114877,1,0,0,3.91849529780564,12.6614575914937,SLC27A1;LPGAT1;CRLS1,delta,5
NLS-bearing protein import into nucleus (GO:0006607),3/22,3,22,0.039509901114877,1,0,0,3.91849529780564,12.6614575914937,NCKIPSD;KPNA2;IPO5,delta,5
positive regulation of cell differentiation (GO:0045597),12/195,12,195,0.0405376632952272,1,0,0,1.7683465959328,5.66847706296332,SPAG9;BLOC1S5;DLX1;SMAD4;SMAD3;HSP90AB1;WNT7B;CTNNBIP1;CTNNB1;IL6ST;GDF5;IL6R,delta,5
regulation of protein binding (GO:0043393),8/112,8,112,0.0418054231746277,1,0,0,2.05254515599343,6.51627505510522,PPP2CA;RALB;BTBD1;CTNNBIP1;TRIB3;IFIT1;SORL1;STK3,delta,5
cellular response to hypoxia (GO:0071456),9/133,9,133,0.042927245800153,1,0,0,1.94451646357273,6.12182114545432,EGLN3;PSMB3;BAD;SUV39H1;PSMC1;LMNA;FMN2;HIGD1A;SIRT2,delta,5
positive regulation of proteasomal protein catabolic process (GO:1901800),6/74,6,74,0.0438468753261762,1,0,0,2.32991612301957,7.28576845513264,RNF144A;DET1;NUB1;RNF14;TRIB3;SIRT2,delta,5
peroxisome organization (GO:0007031),3/23,3,23,0.04429664235107,1,0,0,3.74812593703148,11.6823328269606,PLA2G16;ABCD3;LONP2,delta,5
cellular response to interleukin-6 (GO:0071354),3/23,3,23,0.04429664235107,1,0,0,3.74812593703148,11.6823328269606,SMAD4;IL6ST;IL6R,delta,5
positive regulation of DNA biosynthetic process (GO:2000573),5/56,5,56,0.0448064414612845,1,0,0,2.56568144499179,7.96747579864268,HSP90AB1;TNKS;HNRNPA1;CCT5;ATR,delta,5
peptidyl-serine dephosphorylation (GO:0070262),2/10,2,10,0.0452157411507477,1,0,0,5.74712643678161,17.7948850415134,PPP2CA;NCK1,delta,5
ganglion development (GO:0061548),2/10,2,10,0.0452157411507477,1,0,0,5.74712643678161,17.7948850415134,CTNNB1;ASCL1,delta,5
regulation of attachment of spindle microtubules to kinetochore (GO:0051988),2/10,2,10,0.0452157411507477,1,0,0,5.74712643678161,17.7948850415134,CCNB1;SIRT2,delta,5
phosphatidylglycerol biosynthetic process (GO:0006655),2/10,2,10,0.0452157411507477,1,0,0,5.74712643678161,17.7948850415134,SLC27A1;CRLS1,delta,5
aspartate family amino acid metabolic process (GO:0009066),2/10,2,10,0.0452157411507477,1,0,0,5.74712643678161,17.7948850415134,MTHFD1;NIT2,delta,5
negative regulation of inclusion body assembly (GO:0090084),2/10,2,10,0.0452157411507477,1,0,0,5.74712643678161,17.7948850415134,SACS;SORL1,delta,5
regulation of transforming growth factor beta production (GO:0071634),2/10,2,10,0.0452157411507477,1,0,0,5.74712643678161,17.7948850415134,SMAD4;SMAD3,delta,5
nuclear pore complex assembly (GO:0051292),2/10,2,10,0.0452157411507477,1,0,0,5.74712643678161,17.7948850415134,NUP205;NUP107,delta,5
primary miRNA processing (GO:0031053),2/10,2,10,0.0452157411507477,1,0,0,5.74712643678161,17.7948850415134,SMAD3;NCBP1,delta,5
sympathetic ganglion development (GO:0061549),2/10,2,10,0.0452157411507477,1,0,0,5.74712643678161,17.7948850415134,CTNNB1;ASCL1,delta,5
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),2/10,2,10,0.0452157411507477,1,0,0,5.74712643678161,17.7948850415134,SIRT2;NCK1,delta,5
negative regulation of embryonic development (GO:0045992),2/10,2,10,0.0452157411507477,1,0,0,5.74712643678161,17.7948850415134,CTNNB1;FUZ,delta,5
negative regulation of protein autophosphorylation (GO:0031953),2/10,2,10,0.0452157411507477,1,0,0,5.74712643678161,17.7948850415134,ERRFI1;ENPP1,delta,5
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),2/10,2,10,0.0452157411507477,1,0,0,5.74712643678161,17.7948850415134,WFS1;NCK1,delta,5
positive regulation of vacuole organization (GO:0044090),2/10,2,10,0.0452157411507477,1,0,0,5.74712643678161,17.7948850415134,RALB;PIP4K2B,delta,5
DNA damage checkpoint (GO:0000077),4/39,4,39,0.0457202747681715,1,0,0,2.94724432655467,9.09287777857666,DONSON;TP53BP1;STK3;ATR,delta,5
"regulation of gene expression, epigenetic (GO:0040029)",6/75,6,75,0.0463199483718868,1,0,0,2.29885057471264,7.06248864440136,POLR1C;SMARCA5;POLR1E;SLC50A1;ERCC6;PPM1D,delta,5
cilium assembly (GO:0060271),16/289,16,289,0.0464146949544307,1,0,0,1.59090005170425,4.88428456156415,ACTR3;DYNC1I2;CEP152;SCLT1;HAUS3;FUZ;RPGRIP1L;CNTRL;TCTEX1D2;DZIP1L;HYLS1;CEP250;NPHP3;IFT27;PIBF1;CEP78,delta,5
negative regulation of cellular catabolic process (GO:0031330),5/57,5,57,0.047768415415042,1,0,0,2.5206694898165,7.66634055067068,RRAGA;WDR6;MET;CDK5RAP3;SIRT2,delta,5
negative regulation of cellular amide metabolic process (GO:0034249),6/76,6,76,0.0488779103326855,1,0,0,2.26860254083485,6.84761732305041,FXR1;ORMDL2;CNOT2;EIF4A3;GAPDH;SORL1,delta,5
regulation of androgen receptor signaling pathway (GO:0060765),3/24,3,24,0.0493573988470946,1,0,0,3.59195402298851,10.8069956837672,DDX5;RNF14;RNF6,delta,5
cellular response to amino acid starvation (GO:0034198),4/40,4,40,0.0494566747681929,1,0,0,2.87356321839081,8.63982255711769,CDKN1A;RRAGA;SESN3;RNF152,delta,5
regulation of cell growth (GO:0001558),12/202,12,202,0.0505899181687694,1,0,0,1.70706725844998,5.09389376616127,PPP2CA;CDKN1A;SMAD4;SMAD3;PSRC1;NCBP1;ZNF639;FHL1;ENPP1;CIB1;SMARCA2;BAP1,delta,5
regulation of neurogenesis (GO:0050767),5/58,5,58,0.0508435607390959,1,0,0,2.47720967102656,7.37961206146525,NUMB;CTNNB1;ASCL1;SORL1;CDK5RAP3,delta,5
chromatin remodeling (GO:0006338),8/117,8,117,0.0517443341863564,1,0,0,1.96482955103645,5.81872548806783,TADA2B;SMARCE1;SMARCB1;SMARCA5;BAZ1A;TOX;SMARCA2;GATAD2B,delta,5
protein localization to nucleus (GO:0034504),7/97,7,97,0.0524275542214381,1,0,0,2.07370541533357,6.11395333380561,PDIA3;CTDNEP1;NUP107;ARL2BP;LMNA;PTTG1IP;GPN1,delta,5
gene expression (GO:0010467),21/412,21,412,0.053127711354542,1,0,0,1.46468028121861,4.2989195493902,NUP205;NUP107;NCBP1;MRPS14;POLDIP3;DHPS;EIF4A3;ELAVL4;BAZ1A;MRPL34;THOC5;SORL1;MRPS6;WDR33;PABPN1;SARNP;RPL13;SRSF5;DHX29;SRSF11;NFKBIB,delta,5
androgen receptor signaling pathway (GO:0030521),4/41,4,41,0.0533559850998596,1,0,0,2.80347631062518,8.21634180533313,DDX5;RNF14;CTNNB1;PPARGC1A,delta,5
regulation of cholesterol biosynthetic process (GO:0045540),4/41,4,41,0.0533559850998596,1,0,0,2.80347631062518,8.21634180533313,PRKAA1;NFYA;SP1;HMGCR,delta,5
positive regulation of cellular biosynthetic process (GO:0031328),10/160,10,160,0.0533804650810383,1,0,0,1.79597701149425,5.26277015516848,CTDNEP1;FXR1;CTC1;LPGAT1;SMAD3;HSP90AB1;SP1;POLDIP3;EIF4A3;PPARGC1A,delta,5
regulation of autophagy (GO:0010506),12/204,12,204,0.0537483662426673,1,0,0,1.69033130493577,4.94158554415412,RRAGA;UCHL1;PRKAA1;DRAM1;BAD;RB1CC1;WDR6;PIP4K2B;RNF152;MET;GAPDH;SIRT2,delta,5
chromatin silencing at rDNA (GO:0000183),2/11,2,11,0.0540155458784734,1,0,0,5.22466039707419,15.2480845726796,SUV39H1;SIRT2,delta,5
rhodopsin mediated signaling pathway (GO:0016056),2/11,2,11,0.0540155458784734,1,0,0,5.22466039707419,15.2480845726796,CNGA1;RNF7,delta,5
negative regulation of T cell differentiation (GO:0045581),2/11,2,11,0.0540155458784734,1,0,0,5.22466039707419,15.2480845726796,IRF1;GLI3,delta,5
negative regulation of cardiac muscle hypertrophy (GO:0010614),2/11,2,11,0.0540155458784734,1,0,0,5.22466039707419,15.2480845726796,SMAD4;LMNA,delta,5
ubiquitin-dependent ERAD pathway (GO:0030433),5/59,5,59,0.0540320467517533,1,0,0,2.43522306643289,7.10641425598782,FOXRED2;WFS1;PSMC1;JKAMP;FAF2,delta,5
regulation of nucleic acid-templated transcription (GO:1903506),29/608,29,608,0.0544942157680174,1,0,0,1.37061403508772,3.98802181420277,ZNF132;ZNF131;NUP107;RNF14;CHD7;RNF6;ZNF23;ZNF7;PPP2CA;ZNF623;KAT7;BRD8;ZNF621;PPARGC1A;SMARCE1;ZNF140;NFYA;ZNF184;FZD7;USP3;BAZ1A;SMARCA2;YY1AP1;DNM2;SP1;ZNF417;ATF7;ZNF655;TOX,delta,5
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),3/25,3,25,0.0546866987528865,1,0,0,3.44827586206897,10.0211543667153,CDKN1A;FHL1;ZNF655,delta,5
"positive regulation of DNA-templated transcription, elongation (GO:0032786)",3/25,3,25,0.0546866987528865,1,0,0,3.44827586206897,10.0211543667153,SUPT16H;ERCC6;THOC5,delta,5
positive regulation of microtubule polymerization or depolymerization (GO:0031112),3/25,3,25,0.0546866987528865,1,0,0,3.44827586206897,10.0211543667153,CLIP1;PSRC1;MET,delta,5
limb development (GO:0060173),3/25,3,25,0.0546866987528865,1,0,0,3.44827586206897,10.0211543667153,CHD7;KREMEN1;GLI3,delta,5
regulation of primary metabolic process (GO:0080090),9/140,9,140,0.0560825660355874,1,0,0,1.84729064039409,5.32191554299001,SLC27A1;CHD9;PSMB3;OPA3;PSMC1;TRIB3;CACYBP;HMGCR;GRHL1,delta,5
regulation of cellular response to heat (GO:1900034),6/79,6,79,0.0570649769661235,1,0,0,2.18245307725884,6.24959562116861,HSPA8;NUP205;NUP107;HSP90AB1;DNAJC7;ATR,delta,5
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),6/79,6,79,0.0570649769661235,1,0,0,2.18245307725884,6.24959562116861,EGLN3;PSMB3;PSMC1;HIGD1A;SIRT2;NFE2L2,delta,5
dicarboxylic acid metabolic process (GO:0043648),5/60,5,60,0.0573338994395974,1,0,0,2.39463601532567,6.84593682217211,FH;MTHFD1;IDH2;DLST;NIT2,delta,5
histone modification (GO:0016570),7/99,7,99,0.0573384757630971,1,0,0,2.03181237663996,5.80851149692801,ATXN7;USP3;NSD1;SUDS3;ATXN7L3;HDAC9;SIRT2,delta,5
regulation of cholesterol metabolic process (GO:0090181),4/42,4,42,0.0574172698794504,1,0,0,2.73672687465791,7.81995115470345,ACADVL;NFYA;SP1;HMGCR,delta,5
gluconeogenesis (GO:0006094),4/42,4,42,0.0574172698794504,1,0,0,2.73672687465791,7.81995115470345,SLC25A10;ENO3;PPARGC1A;GAPDH,delta,5
small GTPase mediated signal transduction (GO:0007264),7/100,7,100,0.0598971143550987,1,0,0,2.01149425287356,5.66261167981444,BRAP;CNKSR2;RASSF1;CDKN1A;RRAS;SAMD3;RASGRP3,delta,5
negative regulation of insulin receptor signaling pathway (GO:0046627),3/26,3,26,0.0602784482087231,1,0,0,3.31564986737401,9.31293318504276,SOCS1;ENPP1;NCK1,delta,5
regulation of nervous system development (GO:0051960),3/26,3,26,0.0602784482087231,1,0,0,3.31564986737401,9.31293318504276,CTNNB1;ASCL1;SIRT2,delta,5
regulation of cellular protein localization (GO:1903827),3/26,3,26,0.0602784482087231,1,0,0,3.31564986737401,9.31293318504276,RALB;CTNNB1;RAB11FIP5,delta,5
positive regulation of protein localization to nucleus (GO:1900182),4/43,4,43,0.0616393135803711,1,0,0,2.67308206361935,7.44842396294276,KAT7;CDK5RAP3;CCT5;IPO5,delta,5
ceramide metabolic process (GO:0006672),4/43,4,43,0.0616393135803711,1,0,0,2.67308206361935,7.44842396294276,PPP2CA;ORMDL2;SMPD1;CLN8,delta,5
translesion synthesis (GO:0019985),4/43,4,43,0.0616393135803711,1,0,0,2.67308206361935,7.44842396294276,POLD3;POLN;REV3L;REV1,delta,5
nucleic acid metabolic process (GO:0090304),6/81,6,81,0.0629531206287581,1,0,0,2.12856534695615,5.88625999699217,PTBP1;RBFOX2;NCBP1;ENPP1;KPNA2;HNRNPA1,delta,5
regulation of protein serine/threonine kinase activity (GO:0071900),6/81,6,81,0.0629531206287581,1,0,0,2.12856534695615,5.88625999699217,PPP2CA;CDKN1A;RALB;CIB1;TRIB3;CDK5RAP3,delta,5
mitochondrial outer membrane permeabilization (GO:0097345),2/12,2,12,0.0633592603039789,1,0,0,4.78927203065134,13.2132864273917,BAD;BLOC1S2,delta,5
viral RNA genome replication (GO:0039694),2/12,2,12,0.0633592603039789,1,0,0,4.78927203065134,13.2132864273917,SMARCB1;ATG16L1,delta,5
entry of bacterium into host cell (GO:0035635),2/12,2,12,0.0633592603039789,1,0,0,4.78927203065134,13.2132864273917,CTNNB1;MET,delta,5
histone H3 deacetylation (GO:0070932),2/12,2,12,0.0633592603039789,1,0,0,4.78927203065134,13.2132864273917,HDAC9;SIRT2,delta,5
regulation of skeletal muscle tissue development (GO:0048641),2/12,2,12,0.0633592603039789,1,0,0,4.78927203065134,13.2132864273917,DDX5;HDAC9,delta,5
purine nucleoside monophosphate biosynthetic process (GO:0009127),2/12,2,12,0.0633592603039789,1,0,0,4.78927203065134,13.2132864273917,IMPDH2;PFAS,delta,5
"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",2/12,2,12,0.0633592603039789,1,0,0,4.78927203065134,13.2132864273917,MIF;PTTG1IP,delta,5
PERK-mediated unfolded protein response (GO:0036499),2/12,2,12,0.0633592603039789,1,0,0,4.78927203065134,13.2132864273917,HERPUD1;NFE2L2,delta,5
negative regulation of fatty acid metabolic process (GO:0045922),2/12,2,12,0.0633592603039789,1,0,0,4.78927203065134,13.2132864273917,ACADVL;TRIB3,delta,5
positive regulation of SMAD protein import into nucleus (GO:0060391),2/12,2,12,0.0633592603039789,1,0,0,4.78927203065134,13.2132864273917,SMAD4;SMAD3,delta,5
regulation of centrosome cycle (GO:0046605),3/27,3,27,0.0661260042243627,1,0,0,3.19284802043423,8.67239208863711,GEN1;CEP250;CTNNB1,delta,5
regulation of supramolecular fiber organization (GO:1902903),3/27,3,27,0.0661260042243627,1,0,0,3.19284802043423,8.67239208863711,HSPA8;MAP2;MAP1A,delta,5
negative regulation of cellular response to insulin stimulus (GO:1900077),3/27,3,27,0.0661260042243627,1,0,0,3.19284802043423,8.67239208863711,SOCS1;ENPP1;NCK1,delta,5
regulation of rhodopsin mediated signaling pathway (GO:0022400),3/27,3,27,0.0661260042243627,1,0,0,3.19284802043423,8.67239208863711,FNTA;CNGA1;RNF7,delta,5
negative regulation of telomere maintenance via telomere lengthening (GO:1904357),3/27,3,27,0.0661260042243627,1,0,0,3.19284802043423,8.67239208863711,CTC1;TNKS;HNRNPA1,delta,5
cellular protein complex assembly (GO:0043623),9/145,9,145,0.0669228747348544,1,0,0,1.78359096313912,4.82321244828109,NUP205;SMAD4;IMMP2L;NUP107;SMAD3;HSP90AB1;DNAAF2;PSMG2;NCK1,delta,5
cellular amide metabolic process (GO:0043603),5/63,5,63,0.0679178198495099,1,0,0,2.28060572888159,6.13359066843217,PPP2CA;SMPD1;ORMDL2;CLN8;NIT2,delta,5
hexose biosynthetic process (GO:0019319),4/45,4,45,0.0705594944861594,1,0,0,2.55427841634738,6.7721558917524,SLC25A10;ENO3;PPARGC1A;GAPDH,delta,5
microtubule cytoskeleton organization involved in mitosis (GO:1902850),4/45,4,45,0.0705594944861594,1,0,0,2.55427841634738,6.7721558917524,MECP2;CCNB1;TNKS;TBCE,delta,5
metaphase plate congression (GO:0051310),4/45,4,45,0.0705594944861594,1,0,0,2.55427841634738,6.7721558917524,CCNB1;PSRC1;PIBF1;GEM,delta,5
regulation of translation (GO:0006417),12/214,12,214,0.0715297328613786,1,0,0,1.61134386077989,4.25014835885648,FXR1;EIF5B;NUP205;NUP107;EIF5;NCBP1;POLDIP3;CNOT2;EIF4A3;NOLC1;GAPDH;C12ORF65,delta,5
carbohydrate homeostasis (GO:0033500),5/64,5,64,0.0716706222838336,1,0,0,2.24497126436782,5.91701316987161,PRKAA1;VGF;BAD;WFS1;SLC8B1,delta,5
regulation of proteolysis (GO:0030162),5/64,5,64,0.0716706222838336,1,0,0,2.24497126436782,5.91701316987161,ABTB1;BTBD1;TRAF3;BAD;CLN8,delta,5
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),3/28,3,28,0.0722222425855481,1,0,0,3.07881773399015,8.09115520774314,DDX5;RNF14;RNF6,delta,5
telomere maintenance via telomere lengthening (GO:0010833),3/28,3,28,0.0722222425855481,1,0,0,3.07881773399015,8.09115520774314,DCLRE1B;CTC1;HSP90AB1,delta,5
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),3/28,3,28,0.0722222425855481,1,0,0,3.07881773399015,8.09115520774314,PPP2CA;SOCS1;PIBF1,delta,5
modulation by host of viral transcription (GO:0043921),3/28,3,28,0.0722222425855481,1,0,0,3.07881773399015,8.09115520774314,SMARCB1;SP1;ZNF639,delta,5
negative regulation of organelle assembly (GO:1902116),3/28,3,28,0.0722222425855481,1,0,0,3.07881773399015,8.09115520774314,SMAD4;CDK10;EVI5L,delta,5
cellular response to topologically incorrect protein (GO:0035967),3/28,3,28,0.0722222425855481,1,0,0,3.07881773399015,8.09115520774314,HSPA8;HSPA6;DNAJB12,delta,5
cellular response to glucose stimulus (GO:0071333),3/28,3,28,0.0722222425855481,1,0,0,3.07881773399015,8.09115520774314,UNC13B;PTPRN;RAB11FIP5,delta,5
positive regulation of protein ubiquitination (GO:0031398),6/84,6,84,0.072431820685099,1,0,0,2.05254515599343,5.38815591938126,ARRDC4;WFS1;UBE3A;TRIB3;PTTG1IP;CDK5RAP3,delta,5
protein maturation (GO:0051604),6/84,6,84,0.072431820685099,1,0,0,2.05254515599343,5.38815591938126,LIPT2;ISCA1;MMP16;DDI2;LONP2;SORL1,delta,5
positive regulation of histone H3-K4 methylation (GO:0051571),2/13,2,13,0.0731984911685476,1,0,0,4.42086648983201,11.5587111877933,SMAD4;CTNNB1,delta,5
nucleotide-sugar metabolic process (GO:0009225),2/13,2,13,0.0731984911685476,1,0,0,4.42086648983201,11.5587111877933,EXTL2;UGP2,delta,5
cellular response to exogenous dsRNA (GO:0071360),2/13,2,13,0.0731984911685476,1,0,0,4.42086648983201,11.5587111877933,RALB;IFIT1,delta,5
positive regulation of sodium ion transport (GO:0010765),2/13,2,13,0.0731984911685476,1,0,0,4.42086648983201,11.5587111877933,PKP2;SCN3B,delta,5
regulation of cell aging (GO:0090342),2/13,2,13,0.0731984911685476,1,0,0,4.42086648983201,11.5587111877933,LMNA;MIF,delta,5
cardiolipin metabolic process (GO:0032048),2/13,2,13,0.0731984911685476,1,0,0,4.42086648983201,11.5587111877933,SLC27A1;CRLS1,delta,5
poly(A)+ mRNA export from nucleus (GO:0016973),2/13,2,13,0.0731984911685476,1,0,0,4.42086648983201,11.5587111877933,PABPN1;POLDIP3,delta,5
response to UV-B (GO:0010224),2/13,2,13,0.0731984911685476,1,0,0,4.42086648983201,11.5587111877933,CDKN1A;MSH2,delta,5
positive regulation of ERAD pathway (GO:1904294),2/13,2,13,0.0731984911685476,1,0,0,4.42086648983201,11.5587111877933,HERPUD1;NFE2L2,delta,5
regulation of cytolysis (GO:0042268),2/13,2,13,0.0731984911685476,1,0,0,4.42086648983201,11.5587111877933,RRAGA;BAD,delta,5
high-density lipoprotein particle assembly (GO:0034380),2/13,2,13,0.0731984911685476,1,0,0,4.42086648983201,11.5587111877933,BMP1;PRKACB,delta,5
ribonucleoprotein complex disassembly (GO:0032988),2/13,2,13,0.0731984911685476,1,0,0,4.42086648983201,11.5587111877933,DENR;KLC1,delta,5
proteasomal protein catabolic process (GO:0010498),13/238,13,238,0.0735344800033256,1,0,0,1.56959335458321,4.09664001641296,RNF11;DNAJB12;UBE3A;RNF6;SIRT2;ABTB1;UCHL1;BTBD1;PSMB3;PSMC1;CTNNB1;RBCK1;NFE2L2,delta,5
positive regulation of nucleic acid-templated transcription (GO:1903508),24/503,24,503,0.0746175783357141,1,0,0,1.37108384177692,3.55848243641993,MAP3K2;DDX5;SMAD4;SMAD3;NFYA;RNF14;FZD7;YEATS4;RNF6;SMARCA2;GLI3;FAM129B;DNM2;PSRC1;SP1;NSD1;IRF1;CTNNB1;TP53BP1;PPARGC1A;ATXN7L3;MYBL1;NFE2L2;CREB5,delta,5
"mRNA splicing, via spliceosome (GO:0000398)",14/262,14,262,0.0749529981714949,1,0,0,1.53549179608669,3.97829656282757,HSPA8;DDX5;RBM15;NCBP1;EIF4A3;WDR33;PTBP1;PABPN1;SNRPD1;RSRC1;SRSF5;HNRNPA1;SMNDC1;SRSF11,delta,5
positive regulation of blood vessel endothelial cell migration (GO:0043536),4/46,4,46,0.0752539184996509,1,0,0,2.49875062468766,6.46398626592665,ATP5B;SP1;CIB1;HDAC9,delta,5
nucleus organization (GO:0006997),4/46,4,46,0.0752539184996509,1,0,0,2.49875062468766,6.46398626592665,CTDNEP1;NUP205;ATXN7;REEP4,delta,5
regulation of cell cycle (GO:0051726),12/216,12,216,0.0754927023591095,1,0,0,1.59642401021711,4.12471150206583,MAP3K2;CCNB1;CDK6;PPP1R13B;IRF1;CDK10;OXSR1;YY1AP1;CDK5RAP3;BAP1;SIRT2;STK3,delta,5
glucose metabolic process (GO:0006006),5/65,5,65,0.0755348646710292,1,0,0,2.210433244916,5.7099048311101,SLC25A10;ENO3;GAPDH;PPARGC1A;GDPGP1,delta,5
cellular response to decreased oxygen levels (GO:0036294),5/65,5,65,0.0755348646710292,1,0,0,2.210433244916,5.7099048311101,BAD;SUV39H1;LMNA;FMN2;SIRT2,delta,5
negative regulation of neuron differentiation (GO:0045665),5/65,5,65,0.0755348646710292,1,0,0,2.210433244916,5.7099048311101,DLX1;CRMP1;CIB1;CBFA2T2;ASCL1,delta,5
positive regulation of supramolecular fiber organization (GO:1902905),6/85,6,85,0.0757633495127023,1,0,0,2.02839756592292,5.23355095117396,CLIP1;PSRC1;CTTN;PFN1;MET;NCK1,delta,5
negative regulation of canonical Wnt signaling pathway (GO:0090090),9/149,9,149,0.0764816930477779,1,0,0,1.73570932654478,4.46199468876364,INVS;PSMB3;PSMC1;KREMEN1;NPHP3;FUZ;GLI3;SCYL2;STK3,delta,5
regulation of TORC1 signaling (GO:1903432),3/29,3,29,0.0785596208308801,1,0,0,2.97265160523187,7.56212081283712,RRAGA;SESN3;RNF152,delta,5
negative regulation of response to DNA damage stimulus (GO:2001021),3/29,3,29,0.0785596208308801,1,0,0,2.97265160523187,7.56212081283712,PTTG1IP;MIF;THOC5,delta,5
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),3/29,3,29,0.0785596208308801,1,0,0,2.97265160523187,7.56212081283712,SMAD4;SMAD3;TRIM33,delta,5
regulation of fatty acid biosynthetic process (GO:0042304),3/29,3,29,0.0785596208308801,1,0,0,2.97265160523187,7.56212081283712,ACADVL;LPGAT1;TRIB3,delta,5
positive regulation of fibroblast proliferation (GO:0048146),3/29,3,29,0.0785596208308801,1,0,0,2.97265160523187,7.56212081283712,CDKN1A;CDK6;MIF,delta,5
fatty acid catabolic process (GO:0009062),5/66,5,66,0.0795097721959082,1,0,0,2.17694183211425,5.51174535042828,ACADVL;ABCD3;ECI1;HADH;ACAD10,delta,5
regulation of G1/S transition of mitotic cell cycle (GO:2000045),4/47,4,47,0.0801017012246235,1,0,0,2.44558571777941,6.17377888572761,CDKN1A;FHL1;ZNF655;TMEM14B,delta,5
RNA secondary structure unwinding (GO:0010501),4/47,4,47,0.0801017012246235,1,0,0,2.44558571777941,6.17377888572761,DDX28;DDX5;EIF4A3;DDX50,delta,5
negative regulation of autophagy (GO:0010507),4/47,4,47,0.0801017012246235,1,0,0,2.44558571777941,6.17377888572761,RRAGA;WDR6;MET;SIRT2,delta,5
"positive regulation of transcription, DNA-templated (GO:0045893)",48/1121,48,1121,0.0802733235026836,1,0,0,1.23042849672398,3.10353185105772,DLX1;DDX5;SMARCB1;TNKS;RNF14;PTPRN;CEBPG;GLIS3;YEATS4;RNF6;ASCL1;IKZF2;GLI3;FAM129B;NSD1;KAT7;TP53BP1;NKX6-1;PPARGC1A;ATXN7L3;MYBL1;NCK1;MAP3K2;SUPT16H;SMAD4;SMAD3;NFYA;FZD7;ABHD14B;THOC5;GRHL1;SMARCA2;SIRT2;DNM2;CREB3;MED25;PSRC1;SP1;ZNF639;IRF1;CTNNB1;TAF4B;ERCC6;ATF6;MET;SSBP4;NFE2L2;CREB5,delta,5
negative regulation of hydrogen peroxide-induced cell death (GO:1903206),2/14,2,14,0.0834875462829608,1,0,0,4.10509031198686,10.1931765376051,MET;NFE2L2,delta,5
ribonucleoside monophosphate biosynthetic process (GO:0009156),2/14,2,14,0.0834875462829608,1,0,0,4.10509031198686,10.1931765376051,IMPDH2;PFAS,delta,5
ubiquinone metabolic process (GO:0006743),2/14,2,14,0.0834875462829608,1,0,0,4.10509031198686,10.1931765376051,COQ2;COQ7,delta,5
regulation of phosphate metabolic process (GO:0019220),2/14,2,14,0.0834875462829608,1,0,0,4.10509031198686,10.1931765376051,MCM7;SIRT2,delta,5
neurotransmitter biosynthetic process (GO:0042136),2/14,2,14,0.0834875462829608,1,0,0,4.10509031198686,10.1931765376051,PAH;DAGLB,delta,5
"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",2/14,2,14,0.0834875462829608,1,0,0,4.10509031198686,10.1931765376051,CYCS;UQCRH,delta,5
regulation of monocyte differentiation (GO:0045655),2/14,2,14,0.0834875462829608,1,0,0,4.10509031198686,10.1931765376051,CDK6;CTNNBIP1,delta,5
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),2/14,2,14,0.0834875462829608,1,0,0,4.10509031198686,10.1931765376051,MIF;PTTG1IP,delta,5
pancreas development (GO:0031016),2/14,2,14,0.0834875462829608,1,0,0,4.10509031198686,10.1931765376051,NPHP3;NKX6-1,delta,5
quinone biosynthetic process (GO:1901663),2/14,2,14,0.0834875462829608,1,0,0,4.10509031198686,10.1931765376051,COQ2;COQ7,delta,5
"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",2/14,2,14,0.0834875462829608,1,0,0,4.10509031198686,10.1931765376051,DDX5;ATR,delta,5
Golgi to vacuole transport (GO:0006896),2/14,2,14,0.0834875462829608,1,0,0,4.10509031198686,10.1931765376051,AP4M1;VPS54,delta,5
metallo-sulfur cluster assembly (GO:0031163),2/14,2,14,0.0834875462829608,1,0,0,4.10509031198686,10.1931765376051,ISCA1;NUBP1,delta,5
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),2/14,2,14,0.0834875462829608,1,0,0,4.10509031198686,10.1931765376051,CREB3;HERPUD1,delta,5
regulation of response to interferon-gamma (GO:0060330),2/14,2,14,0.0834875462829608,1,0,0,4.10509031198686,10.1931765376051,HSP90AB1;SOCS1,delta,5
regulation of adaptive immune response (GO:0002819),2/14,2,14,0.0834875462829608,1,0,0,4.10509031198686,10.1931765376051,IRF1;IL6ST,delta,5
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),2/14,2,14,0.0834875462829608,1,0,0,4.10509031198686,10.1931765376051,GEN1;CCNB1,delta,5
purine ribonucleotide metabolic process (GO:0009150),5/67,5,67,0.0835944484440046,1,0,0,2.14445016297821,5.32204959527505,HSPA8;BAD;OLA1;ENPP1;ABHD14B,delta,5
positive regulation of cellular protein localization (GO:1903829),5/67,5,67,0.0835944484440046,1,0,0,2.14445016297821,5.32204959527505,HSP90AB1;CEP250;KAT7;STX3;CDK5RAP3,delta,5
lung development (GO:0030324),3/30,3,30,0.0851302367530836,1,0,0,2.87356321839081,7.07923275291108,ERRFI1;WNT7B;NPHP3,delta,5
coenzyme biosynthetic process (GO:0009108),3/30,3,30,0.0851302367530836,1,0,0,2.87356321839081,7.07923275291108,MAT2A;GPHN;PTS,delta,5
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),3/30,3,30,0.0851302367530836,1,0,0,2.87356321839081,7.07923275291108,CNOT6L;CNOT2;EIF4A3,delta,5
respiratory system development (GO:0060541),3/30,3,30,0.0851302367530836,1,0,0,2.87356321839081,7.07923275291108,WNT7B;CHD7;NPHP3,delta,5
negative regulation of Wnt signaling pathway (GO:0030178),10/175,10,175,0.0856323777795572,1,0,0,1.64203612479475,4.03561875576814,INVS;PSMB3;PSMC1;CTNNBIP1;KREMEN1;NPHP3;FUZ;GLI3;SCYL2;STK3,delta,5
regulation of MAP kinase activity (GO:0043405),6/88,6,88,0.0862699194225198,1,0,0,1.95924764890282,4.80069416126402,UCHL1;SMPD1;TRIB3;RASGRP1;SORL1;CDK5RAP3,delta,5
protein K48-linked ubiquitination (GO:0070936),4/49,4,49,0.0902474642360574,1,0,0,2.34576589256392,5.64203560701683,TTC3;UBE3A;RNF6;RNF152,delta,5
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),3/31,3,31,0.0919258826050826,1,0,0,2.78086763070078,6.63729880556227,PPP1R13B;YWHAB;BAD,delta,5
hippo signaling (GO:0035329),3/31,3,31,0.0919258826050826,1,0,0,2.78086763070078,6.63729880556227,MOB1A;YWHAB;STK3,delta,5
negative regulation of DNA biosynthetic process (GO:2000279),3/31,3,31,0.0919258826050826,1,0,0,2.78086763070078,6.63729880556227,CTC1;HNRNPA1;FAM129B,delta,5
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),3/31,3,31,0.0919258826050826,1,0,0,2.78086763070078,6.63729880556227,PPP1R13B;YWHAB;BAD,delta,5
nuclear envelope organization (GO:0006998),3/31,3,31,0.0919258826050826,1,0,0,2.78086763070078,6.63729880556227,CTDNEP1;TMEM43;REEP4,delta,5
negative regulation of cellular protein metabolic process (GO:0032269),6/90,6,90,0.0936965179896094,1,0,0,1.91570881226054,4.53581274270453,FXR1;CNOT2;EIF4A3;CLN8;GAPDH;CDK5RAP3,delta,5
peptidyl-threonine modification (GO:0018210),6/90,6,90,0.0936965179896094,1,0,0,1.91570881226054,4.53581274270453,TNKS;CDK10;OXSR1;CAMKK1;HIPK3;PSKH1,delta,5
positive regulation of peptidyl-lysine acetylation (GO:2000758),2/15,2,15,0.0941833055218086,1,0,0,3.83141762452107,9.05177140561609,TADA2B;PPARGC1A,delta,5
positive regulation of alpha-beta T cell activation (GO:0046635),2/15,2,15,0.0941833055218086,1,0,0,3.83141762452107,9.05177140561609,GLI3;CD55,delta,5
ubiquinone biosynthetic process (GO:0006744),2/15,2,15,0.0941833055218086,1,0,0,3.83141762452107,9.05177140561609,COQ2;COQ7,delta,5
nuclear pore organization (GO:0006999),2/15,2,15,0.0941833055218086,1,0,0,3.83141762452107,9.05177140561609,NUP205;NUP107,delta,5
"protein localization to chromosome, telomeric region (GO:0070198)",2/15,2,15,0.0941833055218086,1,0,0,3.83141762452107,9.05177140561609,TNKS;ATR,delta,5
"phototransduction, visible light (GO:0007603)",2/15,2,15,0.0941833055218086,1,0,0,3.83141762452107,9.05177140561609,CNGA1;RNF7,delta,5
negative regulation of TORC1 signaling (GO:1904262),2/15,2,15,0.0941833055218086,1,0,0,3.83141762452107,9.05177140561609,SESN3;RNF152,delta,5
transport along microtubule (GO:0010970),2/15,2,15,0.0941833055218086,1,0,0,3.83141762452107,9.05177140561609,HSPA8;DYNC1I2,delta,5
anterograde synaptic vesicle transport (GO:0048490),2/15,2,15,0.0941833055218086,1,0,0,3.83141762452107,9.05177140561609,BLOC1S5;BLOC1S2,delta,5
negative regulation of cell aging (GO:0090344),2/15,2,15,0.0941833055218086,1,0,0,3.83141762452107,9.05177140561609,CDK6;MIF,delta,5
negative regulation of signal transduction by p53 class mediator (GO:1901797),2/15,2,15,0.0941833055218086,1,0,0,3.83141762452107,9.05177140561609,MIF;PTTG1IP,delta,5
negative regulation of protein processing (GO:0010955),2/15,2,15,0.0941833055218086,1,0,0,3.83141762452107,9.05177140561609,CHAC1;CD55,delta,5
synaptic vesicle transport along microtubule (GO:0099517),2/15,2,15,0.0941833055218086,1,0,0,3.83141762452107,9.05177140561609,BLOC1S5;BLOC1S2,delta,5
embryonic cranial skeleton morphogenesis (GO:0048701),2/15,2,15,0.0941833055218086,1,0,0,3.83141762452107,9.05177140561609,MTHFD1;EIF4A3,delta,5
nucleobase-containing small molecule catabolic process (GO:0034656),2/15,2,15,0.0941833055218086,1,0,0,3.83141762452107,9.05177140561609,ENTPD2;NUDT18,delta,5
positive regulation of gene expression (GO:0010628),34/772,34,772,0.0950392378244391,1,0,0,1.26555893037937,2.97844920863165,PRKAA1;DDX5;RNF14;POLDIP3;EIF4A3;YEATS4;RNF6;GLI3;FAM129B;FXR1;NSD1;TP53BP1;PPARGC1A;ATXN7L3;MYBL1;MAP3K2;SMAD4;SMAD3;NFYA;FZD7;SMARCA5;SLC50A1;SMARCA2;DNM2;PSRC1;SP1;IRF1;POLR1C;POLR1E;CTNNB1;UBAP2;ERCC6;NFE2L2;CREB5,delta,5
positive regulation of multicellular organismal process (GO:0051240),11/203,11,203,0.09826261443131,1,0,0,1.55710322178812,3.61265331782942,SMAD4;SMAD3;BMP1;BAD;RBM19;CTNNB1;TP53BP1;PFN1;NKX6-1;PPARGC1A;FAM129B,delta,5
positive regulation of ubiquitin-protein transferase activity (GO:0051443),3/32,3,32,0.0989380952871054,1,0,0,2.69396551724138,6.23184516314509,ARRDC4;FZR1;TRIB3,delta,5
regulation of ubiquitin-protein transferase activity (GO:0051438),3/32,3,32,0.0989380952871054,1,0,0,2.69396551724138,6.23184516314509,ARRDC4;ZYG11B;TRIB3,delta,5
renal water homeostasis (GO:0003091),3/32,3,32,0.0989380952871054,1,0,0,2.69396551724138,6.23184516314509,WFS1;PRKAR2A;PRKACB,delta,5
anterograde axonal transport (GO:0008089),3/32,3,32,0.0989380952871054,1,0,0,2.69396551724138,6.23184516314509,FXR1;BLOC1S5;BLOC1S2,delta,5
cofactor biosynthetic process (GO:0051188),3/32,3,32,0.0989380952871054,1,0,0,2.69396551724138,6.23184516314509,ISCA1;NUBP1;GPHN,delta,5
liver development (GO:0001889),3/32,3,32,0.0989380952871054,1,0,0,2.69396551724138,6.23184516314509,CEBPG;NPHP3;MET,delta,5
regulation of gene expression (GO:0010468),49/1038,49,1038,0.000214940108122759,1,0,0,1.69806351450631,14.3404030177087,RB1;ZNF253;SETD2;CTCF;ZNF45;ETS1;UBE2L3;GLI4;SART3;VPS35;ZNF765;METTL16;ZNF841;HAVCR2;ZNF484;ZNF561;MBNL1;FOXD1;ZNF281;ZFP3;ZNF12;SUPT3H;HGS;NOS1AP;TLR9;PPIE;HKR1;ZNF470;PHB;HIF1A;ZFP36L1;NPAT;PCGF1;ZKSCAN5;MBNL3;APBB3;PPARGC1B;ZNF263;CDK11A;NONO;SSRP1;ZNF33A;ZNF37A;FUBP3;CDK4;ATM;TARDBP;HSPA1A;ZNF354B,delta,6
positive regulation of mRNA processing (GO:0050685),4/16,4,16,0.000823914039579831,1,0,0,8.99280575539568,63.8619096618244,NUDT21;LEO1;PRDX6;HSPA1A,delta,6
positive regulation of epithelial cell migration (GO:0010634),8/75,8,75,0.00111561250542587,1,0,0,3.83693045563549,26.0848026577544,BCAS3;ANGPT1;CAPN7;PLCG1;ETS1;DOCK1;HIF1A;CLASP1,delta,6
glycine transport (GO:0015816),3/9,3,9,0.00158379821404064,1,0,0,11.9904076738609,77.3133019643953,SLC36A1;SLC6A9;SLC6A17,delta,6
regulation of mRNA 3'-end processing (GO:0031440),3/10,3,10,0.00221603726288781,1,0,0,10.7913669064748,65.9572089372938,NUDT21;LEO1;ZFP36L1,delta,6
negative regulation of protein tyrosine kinase activity (GO:0061099),4/21,4,21,0.00242674044785869,1,0,0,6.85166152792052,41.2552675681157,ZGPAT;SH3BP5;CBL;CHMP6,delta,6
RNA processing (GO:0006396),13/194,13,194,0.0031220775445882,1,0,0,2.41044277979678,13.9064629622671,MBNL1;SF3B2;ZCCHC6;NUFIP1;NONO;USB1;ZCRB1;NUDT21;HNRNPK;NOVA1;XRN2;TARDBP;RBM6,delta,6
"regulation of transcription, DNA-templated (GO:0006355)",63/1599,63,1599,0.00312371070148251,1,0,0,1.4172526894057,8.17575328907186,RB1;FOXA1;ZNF253;CITED4;CTCF;ZNF45;AATF;ETS1;UBE2L3;GLI4;ZNF609;NKRF;KAT8;ZNF765;ZNF841;SOX7;ZNF484;ZNF561;BATF3;FOXD1;ZGPAT;KLF13;ZNF281;ZFP3;TCF12;ARID5A;ZNF12;POU3F2;SUPT3H;MED7;EID2;PAX8;RFX7;PPIE;ANKRA2;PPARD;ENY2;HKR1;ZNF470;CBFB;PHB;TYMS;HIF1A;NPAS1;NPAT;CREG1;DVL2;PCGF1;TASP1;ZKSCAN5;APBB3;PPARGC1B;ZNF263;CDK11A;SMURF2;NONO;FOXJ1;SSRP1;ZNF33A;ZNF37A;FUBP3;MDM2;ZNF354B,delta,6
regulation of nucleic acid-templated transcription (GO:1903506),29/608,29,608,0.003543443025373,1,0,0,1.71573267701628,9.68129000235095,RB1;ZNF253;HKR1;ZNF470;ZNF45;PHB;HIF1A;UBE2L3;GLI4;PCGF1;ZKSCAN5;ZNF765;ZNF841;APBB3;PPARGC1B;ZNF484;ZNF561;ZNF263;CDK11A;ZFP3;NONO;ZNF12;SSRP1;SUPT3H;ZNF33A;ZNF37A;PPIE;ZNF653;ZNF354B,delta,6
macroautophagy (GO:0016236),9/111,9,111,0.00381851727081741,1,0,0,2.9165856503986,16.2392370621631,GABARAPL1;HGS;ATG10;PLAA;PRKAG2;PIK3C3;CHMP6;ATG12;UBXN6,delta,6
activation of cysteine-type endopeptidase activity (GO:0097202),3/12,3,12,0.00389769347892266,1,0,0,8.99280575539568,49.8864237091962,CYFIP2;PERP;FADD,delta,6
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),4/25,4,25,0.00469829120221342,1,0,0,5.75539568345324,30.8521232251644,BAG6;CASP4;DNAJC10;ITPR1,delta,6
negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),3/13,3,13,0.0049632385665299,1,0,0,8.30105146651909,44.0428623230388,ZGPAT;CBL;CHMP6,delta,6
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),5/41,5,41,0.00535037684839834,1,0,0,4.38673451482716,22.9452021477539,ZGPAT;HGS;PTPRJ;CBL;CHMP6,delta,6
L-amino acid transport (GO:0015807),4/26,4,26,0.00543234554308528,1,0,0,5.53403431101273,28.8621155409609,SLC36A1;SLC6A17;SLC6A9;SLC1A2,delta,6
positive regulation of receptor-mediated endocytosis (GO:0048260),5/42,5,42,0.00593739303404484,1,0,0,4.28228845495033,21.9530880657007,HNRNPK;ANXA2;ANGPT1;SGIP1;CBL,delta,6
regulation of cellular macromolecule biosynthetic process (GO:2000112),29/632,29,632,0.00603004336380235,1,0,0,1.65057827155997,8.43610732349237,RB1;CYFIP2;ZNF253;HKR1;ZNF470;ZNF45;PHB;HIF1A;UBE2L3;GLI4;PCGF1;ZKSCAN5;ZNF765;ZNF841;APBB3;PPARGC1B;ZNF484;ZNF561;ZNF263;CDK11A;ZFP3;NONO;ZNF12;SSRP1;SUPT3H;ZNF33A;ZNF37A;PPIE;ZNF354B,delta,6
regulation of synapse organization (GO:0050807),3/14,3,14,0.00618767846589325,1,0,0,7.70811921891059,39.1972916895989,NEDD4;VPS35;CTNNA2,delta,6
T cell receptor signaling pathway (GO:0050852),11/164,11,164,0.00625243695028019,1,0,0,2.41270398315494,12.2439515202304,ITK;DENND1B;PSMB7;PSMD6;PSMD14;BTN2A2;PTPRJ;PLCG1;ERMAP;TNFRSF21;MALT1,delta,6
regulation of lipid metabolic process (GO:0019216),8/101,8,101,0.00715654592174026,1,0,0,2.84920578388774,14.0743010971523,RB1;LACTB;RXRA;ACSL1;ME1;PRKAG2;TNFRSF21;PPARD,delta,6
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),6/63,6,63,0.00799423091949332,1,0,0,3.42583076396026,16.5434571171929,PSMB7;PSMD6;PSMD14;ZFYVE19;PINX1;ATM,delta,6
"positive regulation of transcription, DNA-templated (GO:0045893)",45/1121,45,1121,0.00866451349221139,1,0,0,1.44398308293597,6.85678183233759,RB1;FOXA1;ENY2;GTF2A2;NUFIP1;CITED4;CTCF;PHB;AATF;HIF1A;NPAS1;ETS1;SLC9A1;PAGR1;NPAT;ZNF609;RXRA;NKRF;LEO1;DVL2;KAT8;TASP1;RIPK1;FADD;IER5;PPARGC1B;ZBED3;UTP15;BCAS3;PPP1R12A;ZNF382;ZNF281;TCF12;FOXJ1;KLF15;ELL3;SUPT3H;SENP1;HNRNPK;PAX8;FUBP3;NFIB;TLR9;PFKM;PPARD,delta,6
hexose metabolic process (GO:0019318),5/46,5,46,0.00874033353654363,1,0,0,3.90991554582421,18.5322447918631,SLC35A2;FPGT;ALDOC;MAN2C1;PPARD,delta,6
regulation of actin nucleation (GO:0051125),3/16,3,16,0.00913499917450624,1,0,0,6.74460431654676,31.6702485129376,WIPF3;WHAMM;CORO1A,delta,6
regulation of G2/M transition of mitotic cell cycle (GO:0010389),10/150,10,150,0.00928555177768242,1,0,0,2.39808153477218,11.221332515971,PSMB7;NEDD1;PSMD6;PSMD14;CDK4;PINX1;DCTN3;CSNK1E;CKAP5;CLASP1,delta,6
aminoglycan biosynthetic process (GO:0006023),5/47,5,47,0.00956267284546856,1,0,0,3.82672585335987,17.793846642621,B3GNT9;XYLT2;XYLT1;GPC2;GPC5,delta,6
response to endoplasmic reticulum stress (GO:0034976),8/107,8,107,0.010002903964718,1,0,0,2.68943723525852,12.3845352831929,BAG6;ERLEC1;DNAJC10;CASP4;ATG10;ITPR1;PDIA5;UBXN6,delta,6
replication fork processing (GO:0031297),4/31,4,31,0.0102519341865576,1,0,0,4.64144813181713,21.2591733120073,RTEL1;FANCM;EME2;RFWD3,delta,6
aminoglycan metabolic process (GO:0006022),4/31,4,31,0.0102519341865576,1,0,0,4.64144813181713,21.2591733120073,XYLT2;XYLT1;GPC2;GPC5,delta,6
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),2/6,2,6,0.0107435258712302,1,0,0,11.9904076738609,54.3579370547635,NONO;HIF1A,delta,6
positive regulation of hormone metabolic process (GO:0032352),2/6,2,6,0.0107435258712302,1,0,0,11.9904076738609,54.3579370547635,PAX8;HIF1A,delta,6
COPI coating of Golgi vesicle (GO:0048205),2/6,2,6,0.0107435258712302,1,0,0,11.9904076738609,54.3579370547635,GBF1;ARFGAP2,delta,6
astral microtubule organization (GO:0030953),2/6,2,6,0.0107435258712302,1,0,0,11.9904076738609,54.3579370547635,KPNB1;CLASP1,delta,6
Golgi transport vesicle coating (GO:0048200),2/6,2,6,0.0107435258712302,1,0,0,11.9904076738609,54.3579370547635,GBF1;ARFGAP2,delta,6
COPI-coated vesicle budding (GO:0035964),2/6,2,6,0.0107435258712302,1,0,0,11.9904076738609,54.3579370547635,GBF1;ARFGAP2,delta,6
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),2/6,2,6,0.0107435258712302,1,0,0,11.9904076738609,54.3579370547635,FOXA1;PAGR1,delta,6
peptidyl-serine autophosphorylation (GO:0036289),2/6,2,6,0.0107435258712302,1,0,0,11.9904076738609,54.3579370547635,ATM;RIPK1,delta,6
regulation of telomere maintenance via telomere lengthening (GO:1904356),3/17,3,17,0.0108666688785318,1,0,0,6.34786288616166,28.7053855844164,RTEL1;PINX1;ATM,delta,6
negative regulation of telomere maintenance (GO:0032205),3/17,3,17,0.0108666688785318,1,0,0,6.34786288616166,28.7053855844164,RTEL1;PINX1;ATM,delta,6
negative regulation of B cell activation (GO:0050869),3/17,3,17,0.0108666688785318,1,0,0,6.34786288616166,28.7053855844164,FOXJ1;ATM;TNFRSF21,delta,6
positive chemotaxis (GO:0050918),3/17,3,17,0.0108666688785318,1,0,0,6.34786288616166,28.7053855844164,ANGPT1;PTPRJ;CORO1A,delta,6
regulation of epithelial cell migration (GO:0010632),5/49,5,49,0.0113638277109753,1,0,0,3.67053296138599,16.4341505507787,CAPN7;PLCG1;DOCK1;HIF1A;CLASP1,delta,6
endosomal transport (GO:0016197),13/230,13,230,0.0124705246111951,1,0,0,2.03315608382859,8.9141440184632,DENND1B;STX16;GBF1;ARFRP1;SNX1;SNX27;BLOC1S1;HGS;MYO5B;VPS35;PIK3C3;CHMP6;RAB9B,delta,6
regulation of erythrocyte differentiation (GO:0045646),4/33,4,33,0.012765458809106,1,0,0,4.36014824504033,19.0146600662406,ETS1;HIF1A;ZFP36L1;HSPA1A,delta,6
anion transmembrane transport (GO:0098656),3/18,3,18,0.0127749179758181,1,0,0,5.99520383693046,26.140716808109,SLC35A2;ABCC1;SLC35A3,delta,6
cellular response to gamma radiation (GO:0071480),3/18,3,18,0.0127749179758181,1,0,0,5.99520383693046,26.140716808109,MDM2;ATM;TSPYL5,delta,6
establishment of mitotic spindle localization (GO:0040001),3/18,3,18,0.0127749179758181,1,0,0,5.99520383693046,26.140716808109,DYNLT1;KPNB1;CLASP1,delta,6
positive regulation of cytokine-mediated signaling pathway (GO:0001961),4/34,4,34,0.0141569811072685,1,0,0,4.23190859077444,18.0175514688356,CASP4;FADD;HIF1A;HSPA1A,delta,6
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),2/7,2,7,0.014765757740343,1,0,0,10.2774922918808,43.3241977910206,SLC25A5;HSPA1A,delta,6
progesterone receptor signaling pathway (GO:0050847),2/7,2,7,0.014765757740343,1,0,0,10.2774922918808,43.3241977910206,NEDD4;PHB,delta,6
regulation of low-density lipoprotein particle clearance (GO:0010988),2/7,2,7,0.014765757740343,1,0,0,10.2774922918808,43.3241977910206,HNRNPK;ANXA2,delta,6
death-inducing signaling complex assembly (GO:0071550),2/7,2,7,0.014765757740343,1,0,0,10.2774922918808,43.3241977910206,RIPK1;FADD,delta,6
positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),2/7,2,7,0.014765757740343,1,0,0,10.2774922918808,43.3241977910206,CASP4;HSPA1A,delta,6
membrane invagination (GO:0010324),2/7,2,7,0.014765757740343,1,0,0,10.2774922918808,43.3241977910206,SNX3;HGS,delta,6
protein targeting to lysosome (GO:0006622),3/19,3,19,0.014862287262011,1,0,0,5.67966679288148,23.9053104741173,SCARB2;HGS;NEDD4,delta,6
positive regulation of cellular metabolic process (GO:0031325),7/93,7,93,0.0149995520421478,1,0,0,2.70751141022666,11.3708302758872,ANXA2;PAX8;ANGPT1;FASN;RIPK1;HIF1A;TGFBR2,delta,6
regulation of interleukin-8 production (GO:0032677),4/35,4,35,0.0156409728597492,1,0,0,4.11099691675231,17.0929551592631,TLR9;RIPK1;FADD;HSPA1A,delta,6
regulation of primary metabolic process (GO:0080090),9/140,9,140,0.0164435200949699,1,0,0,2.31243576567318,9.49907866165883,LACTB;PSMB7;PSMD6;RXRA;PSMD14;ACSL1;ME1;TNFRSF21;PPARD,delta,6
protein modification by small protein conjugation (GO:0032446),19/399,19,399,0.0165987254824642,1,0,0,1.71291538198013,7.02026270080857,TOP2A;UBE2D4;DCUN1D5;SMURF2;KLHL26;ATG10;AAAS;CBL;HIF1A;UBE2L3;SENP1;CNOT4;INCENP;RFWD3;NEDD4;UBE2T;PEX5;LEO1;MDM2,delta,6
DNA-dependent DNA replication maintenance of fidelity (GO:0045005),4/36,4,36,0.017219212768013,1,0,0,3.99680255795364,16.2339308440081,RTEL1;FANCM;EME2;RFWD3,delta,6
zymogen activation (GO:0031638),4/37,4,37,0.0188933244317284,1,0,0,3.88878086719813,15.4343636942581,CYFIP2;PERP;F11;FADD,delta,6
positive regulation of macrophage differentiation (GO:0045651),2/8,2,8,0.0193283346548018,1,0,0,8.99280575539568,35.4872584790655,RIPK1;FADD,delta,6
amyloid fibril formation (GO:1990000),2/8,2,8,0.0193283346548018,1,0,0,8.99280575539568,35.4872584790655,MDM2;RIPK1,delta,6
protein K6-linked ubiquitination (GO:0085020),2/8,2,8,0.0193283346548018,1,0,0,8.99280575539568,35.4872584790655,UBE2D4;UBE2T,delta,6
positive regulation of mRNA 3'-end processing (GO:0031442),2/8,2,8,0.0193283346548018,1,0,0,8.99280575539568,35.4872584790655,NUDT21;LEO1,delta,6
negative regulation of vascular permeability (GO:0043116),2/8,2,8,0.0193283346548018,1,0,0,8.99280575539568,35.4872584790655,ANGPT1;PTPRJ,delta,6
peptidyl-lysine acetylation (GO:0018394),2/8,2,8,0.0193283346548018,1,0,0,8.99280575539568,35.4872584790655,BAG6;BLOC1S1,delta,6
autophagosome organization (GO:1905037),5/57,5,57,0.0208522445423332,1,0,0,3.15537044048971,12.2122102884668,STX12;GABARAPL1;ATG16L2;PIK3C3;ATG12,delta,6
glycosaminoglycan biosynthetic process (GO:0006024),7/100,7,100,0.02151980651112,1,0,0,2.51798561151079,9.66599667048041,ANGPT1;CHST12;XYLT2;XYLT1;GPC2;GPC5;B4GALT6,delta,6
positive regulation of transcription from RNA polymerase II promoter (GO:0045944),34/849,34,849,0.0215286360700276,1,0,0,1.4405436781317,5.52934153908917,FOXA1;GTF2A2;NUFIP1;CITED4;AATF;HIF1A;NPAS1;ETS1;SLC9A1;PAGR1;ZNF609;RXRA;NKRF;LEO1;RIPK1;FADD;IER5;PPARGC1B;ZBED3;BCAS3;PPP1R12A;ZNF382;TCF12;FOXJ1;KLF15;ELL3;SENP1;HNRNPK;PAX8;FUBP3;NFIB;TLR9;PFKM;PPARD,delta,6
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),3/22,3,22,0.0222149747394002,1,0,0,4.90516677567037,18.6739143869758,HGS;NEDD4;HIF1A,delta,6
positive regulation of erythrocyte differentiation (GO:0045648),3/22,3,22,0.0222149747394002,1,0,0,4.90516677567037,18.6739143869758,ETS1;HIF1A;HSPA1A,delta,6
regulation of protein ubiquitination (GO:0031396),7/102,7,102,0.0236951991623082,1,0,0,2.46861334461842,9.23874302738825,ANGPT1;PINX1;N4BP1;MALT1;UBE2L3;TSPYL5;HSPA1A,delta,6
autophagosome assembly (GO:0000045),5/59,5,59,0.0238426680173767,1,0,0,3.0484087306426,11.3897040896423,STX12;GABARAPL1;ATG16L2;PIK3C3;ATG12,delta,6
negative regulation of mitotic cell cycle phase transition (GO:1901991),6/80,6,80,0.0239101152223555,1,0,0,2.69784172661871,10.0722671183114,RB1;PSMB7;PSMD6;PSMD14;PINX1;ZFP36L1,delta,6
regulation of transcription from RNA polymerase II promoter (GO:0006357),54/1479,54,1479,0.0241273455470324,1,0,0,1.31335094196448,4.89145660916439,RB1;FOXA1;CITED4;CTCF;AATF;ETS1;PAGR1;ZNF609;NKRF;IER5;BCAS3;BATF3;PPP1R12A;FOXD1;ZGPAT;KLF13;ZNF281;TCF12;ARID5A;POU3F2;KLF15;SUPT3H;MED7;SENP1;PAX8;RFX7;TLR9;ANKRA2;PPARD;ENY2;GTF2A2;NUFIP1;CBFB;PHB;HIF1A;NPAS1;SLC9A1;RXRA;CREG1;LEO1;RIPK1;FADD;PPARGC1B;ZBED3;ZNF263;ZNF382;SMURF2;FOXJ1;ELL3;HNRNPK;FUBP3;NFIB;MDM2;PFKM,delta,6
alanine transport (GO:0032328),2/9,2,9,0.0243982155459043,1,0,0,7.99360511590728,29.6822164885846,SLC36A1;SLC6A17,delta,6
negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),2/9,2,9,0.0243982155459043,1,0,0,7.99360511590728,29.6822164885846,NFIB;PPARD,delta,6
oligosaccharide catabolic process (GO:0009313),2/9,2,9,0.0243982155459043,1,0,0,7.99360511590728,29.6822164885846,NEU3;MAN2C1,delta,6
positive regulation of ribosome biogenesis (GO:0090070),2/9,2,9,0.0243982155459043,1,0,0,7.99360511590728,29.6822164885846,UTP15;DIMT1,delta,6
positive regulation of rRNA processing (GO:2000234),2/9,2,9,0.0243982155459043,1,0,0,7.99360511590728,29.6822164885846,UTP15;DIMT1,delta,6
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),2/9,2,9,0.0243982155459043,1,0,0,7.99360511590728,29.6822164885846,HGS;NEDD4,delta,6
toll-like receptor 3 signaling pathway (GO:0034138),2/9,2,9,0.0243982155459043,1,0,0,7.99360511590728,29.6822164885846,RIPK1;FADD,delta,6
proline transport (GO:0015824),2/9,2,9,0.0243982155459043,1,0,0,7.99360511590728,29.6822164885846,SLC36A1;SLC6A17,delta,6
lipoprotein biosynthetic process (GO:0042158),2/9,2,9,0.0243982155459043,1,0,0,7.99360511590728,29.6822164885846,ATG10;PIK3C3,delta,6
Golgi inheritance (GO:0048313),2/9,2,9,0.0243982155459043,1,0,0,7.99360511590728,29.6822164885846,GBF1;YWHAZ,delta,6
mitotic DNA damage checkpoint (GO:0044773),4/40,4,40,0.0245048090703241,1,0,0,3.59712230215827,13.341316158665,EME2;RFWD3;TAOK1;RAD9A,delta,6
DNA biosynthetic process (GO:0071897),4/40,4,40,0.0245048090703241,1,0,0,3.59712230215827,13.341316158665,POLD4;RMI1;ATM;TYMS,delta,6
regulation of telomere capping (GO:1904353),3/23,3,23,0.025031802333087,1,0,0,4.69189865498905,17.3018838092695,PKIB;RTEL1;ATM,delta,6
"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",6/81,6,81,0.0252390575085348,1,0,0,2.66453503863576,9.80379052275399,PITPNB;GBF1;TMED3;KIF15;SCYL1;ARFGAP2,delta,6
"retrograde transport, endosome to Golgi (GO:0042147)",6/83,6,83,0.0280425187691721,1,0,0,2.60032937505417,9.29366401958949,ARFRP1;SNX1;STX16;GBF1;VPS35;RAB9B,delta,6
cellular response to peptide (GO:1901653),4/42,4,42,0.0287480041648731,1,0,0,3.42583076396026,12.1589137872584,CASP4;MDM2;ZFP36L1;IGF1R,delta,6
cellular macromolecule biosynthetic process (GO:0034645),17/368,17,368,0.0291340095473673,1,0,0,1.66171410697529,5.8755702868169,GTF3C1;ACHE;RMI1;RPS5;TYMS;PWP1;HARS2;MRPS5;RPS4X;MRPS9;ORC6;FUBP3;PAX8;RPLP2;ATM;HARS;RAD9A,delta,6
RNA splicing (GO:0008380),7/107,7,107,0.0297843422597531,1,0,0,2.35325758085121,8.26881165789309,MBNL1;SF3B2;NOVA1;NONO;USB1;ZCRB1;TARDBP,delta,6
negative regulation of oxidative stress-induced neuron death (GO:1903204),2/10,2,10,0.0299437730845845,1,0,0,7.19424460431655,25.2405315568453,NONO;HIF1A,delta,6
establishment of spindle localization (GO:0051293),2/10,2,10,0.0299437730845845,1,0,0,7.19424460431655,25.2405315568453,KPNB1;CLASP1,delta,6
regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),2/10,2,10,0.0299437730845845,1,0,0,7.19424460431655,25.2405315568453,HGS;PTPRJ,delta,6
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),2/10,2,10,0.0299437730845845,1,0,0,7.19424460431655,25.2405315568453,FOXA1;PAGR1,delta,6
negative regulation of B cell proliferation (GO:0030889),2/10,2,10,0.0299437730845845,1,0,0,7.19424460431655,25.2405315568453,ATM;TNFRSF21,delta,6
myeloid dendritic cell differentiation (GO:0043011),2/10,2,10,0.0299437730845845,1,0,0,7.19424460431655,25.2405315568453,BATF3;TGFBR2,delta,6
negative regulation of cytoskeleton organization (GO:0051494),3/25,3,25,0.0312133056218609,1,0,0,4.31654676258993,14.9650826453385,TWF2;CORO1A;CLASP1,delta,6
regulation of epidermal growth factor-activated receptor activity (GO:0007176),3/25,3,25,0.0312133056218609,1,0,0,4.31654676258993,14.9650826453385,ZGPAT;CBL;CHMP6,delta,6
transcription from RNA polymerase II promoter (GO:0006366),21/486,21,486,0.0315226539104565,1,0,0,1.55431210587086,5.37333283131069,SETD2;BATF3;GTF2A2;KLF13;CBFB;ZNF45;SSRP1;HIF1A;ETS1;ELL3;GTF2E2;MED7;NUDT21;RXRA;SNAPC1;CDK4;LEO1;DVL2;TARDBP;IRF9;PPARD,delta,6
DNA repair (GO:0006281),14/289,14,289,0.0320608254625561,1,0,0,1.74255059620124,5.99458382736954,SETD2;FANCM;RMI1;H2AFX;CSNK1E;POLD4;NEIL2;EME2;TDP1;RFWD3;UBE2T;ATM;ASCC3;RAD9A,delta,6
cilium assembly (GO:0060271),14/289,14,289,0.0320608254625561,1,0,0,1.74255059620124,5.99458382736954,ABCC4;LRGUK;RAB3IP;CCDC113;DCTN3;FOXJ1;CSNK1E;CKAP5;NEDD1;IFT74;KIAA0586;WDR5B;DYNLRB1;CLASP1,delta,6
cellular response to hypoxia (GO:0071456),8/133,8,133,0.0324822635451249,1,0,0,2.16368258776438,7.41507237667162,BNIP3L;PSMB7;PSMD6;CPEB1;PSMD14;MDM2;HIF1A;ZFP36L1,delta,6
cellular response to decreased oxygen levels (GO:0036294),5/65,5,65,0.0344176875589534,1,0,0,2.76701715550636,9.3225917916966,BNIP3L;CPEB1;MDM2;HIF1A;ZFP36L1,delta,6
neutral amino acid transport (GO:0015804),3/26,3,26,0.034576045138291,1,0,0,4.15052573325955,13.9648347000749,SLC36A1;SLC6A17;SLC6A9,delta,6
regulation of cellular protein localization (GO:1903827),3/26,3,26,0.034576045138291,1,0,0,4.15052573325955,13.9648347000749,SETD2;GBF1;CSNK1E,delta,6
regulation of focal adhesion assembly (GO:0051893),4/45,4,45,0.0358818920674866,1,0,0,3.19744204636291,10.639560383611,BCAS3;PTPRJ;CLASP1;SLC9A1,delta,6
sprouting angiogenesis (GO:0002040),4/45,4,45,0.0358818920674866,1,0,0,3.19744204636291,10.639560383611,EFNB2;EGR3;ANGPT1;NRARP,delta,6
positive regulation of interleukin-8 production (GO:0032757),4/45,4,45,0.0358818920674866,1,0,0,3.19744204636291,10.639560383611,TLR9;RIPK1;FADD;HSPA1A,delta,6
positive regulation of cell cycle phase transition (GO:1901989),2/11,2,11,0.0359347408598855,1,0,0,6.5402223675605,21.7531114417577,PAGR1;STXBP4,delta,6
regulation of trophoblast cell migration (GO:1901163),2/11,2,11,0.0359347408598855,1,0,0,6.5402223675605,21.7531114417577,SMURF2;TIMP1,delta,6
T cell differentiation in thymus (GO:0033077),2/11,2,11,0.0359347408598855,1,0,0,6.5402223675605,21.7531114417577,FADD;ZFP36L1,delta,6
positive regulation of receptor biosynthetic process (GO:0010870),2/11,2,11,0.0359347408598855,1,0,0,6.5402223675605,21.7531114417577,HNRNPK;HIF1A,delta,6
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296),2/11,2,11,0.0359347408598855,1,0,0,6.5402223675605,21.7531114417577,RIPK1;FADD,delta,6
internal protein amino acid acetylation (GO:0006475),2/11,2,11,0.0359347408598855,1,0,0,6.5402223675605,21.7531114417577,BAG6;NAA10,delta,6
synaptonemal complex assembly (GO:0007130),2/11,2,11,0.0359347408598855,1,0,0,6.5402223675605,21.7531114417577,BAG6;STAG3,delta,6
negative regulation of cell division (GO:0051782),2/11,2,11,0.0359347408598855,1,0,0,6.5402223675605,21.7531114417577,ORC6;ZFYVE19,delta,6
establishment of synaptic vesicle localization (GO:0097480),2/11,2,11,0.0359347408598855,1,0,0,6.5402223675605,21.7531114417577,KIF5C;SPG11,delta,6
icosanoid secretion (GO:0032309),2/11,2,11,0.0359347408598855,1,0,0,6.5402223675605,21.7531114417577,ABCC4;PNPLA8,delta,6
protein carboxylation (GO:0018214),2/11,2,11,0.0359347408598855,1,0,0,6.5402223675605,21.7531114417577,VKORC1L1;PROS1,delta,6
peptidyl-glutamic acid carboxylation (GO:0017187),2/11,2,11,0.0359347408598855,1,0,0,6.5402223675605,21.7531114417577,VKORC1L1;PROS1,delta,6
synaptonemal complex organization (GO:0070193),2/11,2,11,0.0359347408598855,1,0,0,6.5402223675605,21.7531114417577,BAG6;STAG3,delta,6
fatty acid catabolic process (GO:0009062),5/66,5,66,0.0364212772291299,1,0,0,2.72509265315021,9.02714774322585,ALDH3A2;ABHD3;ECHDC2;AIG1;PPARD,delta,6
response to gamma radiation (GO:0010332),3/27,3,27,0.0381181545506956,1,0,0,3.99680255795364,13.0578122020173,MDM2;ATM;TSPYL5,delta,6
regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),3/27,3,27,0.0381181545506956,1,0,0,3.99680255795364,13.0578122020173,NFIB;HIF1A;PPARD,delta,6
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),3/27,3,27,0.0381181545506956,1,0,0,3.99680255795364,13.0578122020173,RB1;NPAT;TYMS,delta,6
internal peptidyl-lysine acetylation (GO:0018393),3/27,3,27,0.0381181545506956,1,0,0,3.99680255795364,13.0578122020173,BAG6;KAT8;CPA4,delta,6
strand displacement (GO:0000732),3/27,3,27,0.0381181545506956,1,0,0,3.99680255795364,13.0578122020173,RTEL1;RMI1;ATM,delta,6
positive regulation of blood vessel endothelial cell migration (GO:0043536),4/46,4,46,0.0384668058434285,1,0,0,3.12793243665937,10.1906774959944,ANGPT1;PLCG1;ETS1;HIF1A,delta,6
protein complex assembly (GO:0006461),10/190,10,190,0.0401407764685279,1,0,0,1.89322226429383,6.08739604655788,PYGO1;FARP2;CNIH1;NUFIP1;LEO1;RIPK1;FADD;PFKM;MALT1;SLC9A1,delta,6
gene expression (GO:0010467),18/412,18,412,0.0403509240735175,1,0,0,1.5715582873507,5.04492366552062,GTF3C1;NXT1;NUFIP1;RPS5;AAAS;PWP1;HARS2;MRPS5;RPS4X;MRPS9;HNRNPK;PAX8;FUBP3;NOVA1;XRN2;RPLP2;HARS;RBM6,delta,6
negative regulation of gene expression (GO:0010629),25/619,25,619,0.0407006422015262,1,0,0,1.45279576016085,4.65114219928696,RB1;ZNF253;CTCF;PHB;TYMS;HIF1A;NKRF;KAT8;METTL16;SOX7;HAVCR2;ZNF263;FOXD1;ZGPAT;SMURF2;ZNF281;NONO;ARID5A;ZNF12;EID2;AEBP2;MDM2;TARDBP;PPARD;HSPA1A,delta,6
cellular response to ionizing radiation (GO:0071479),4/47,4,47,0.0411555658287486,1,0,0,3.06138068268789,9.7670170026871,MDM2;ATM;TSPYL5;RAD9A,delta,6
peptidyl-glutamic acid modification (GO:0018200),3/28,3,28,0.0418377160120638,1,0,0,3.85405960945529,12.2326196659967,VKORC1L1;NAA10;PROS1,delta,6
protein targeting to vacuole (GO:0006623),3/28,3,28,0.0418377160120638,1,0,0,3.85405960945529,12.2326196659967,SCARB2;HGS;NEDD4,delta,6
protein localization to chromosome (GO:0034502),3/28,3,28,0.0418377160120638,1,0,0,3.85405960945529,12.2326196659967,RB1;PINX1;CTCF,delta,6
"transcription, DNA-templated (GO:0006351)",16/357,16,357,0.0423208912044669,1,0,0,1.61215565362836,5.09840103653087,GTF3C1;BATF3;GTF2A2;KLF13;CBFB;SSRP1;PWP1;HIF1A;ELL3;GTF2E2;FUBP3;PAX8;LEO1;DVL2;TARDBP;IRF9,delta,6
vesicle budding from membrane (GO:0006900),2/12,2,12,0.0423421623893153,1,0,0,5.99520383693046,18.9566663223011,SNX3;ANXA2,delta,6
regulation of rRNA processing (GO:2000232),2/12,2,12,0.0423421623893153,1,0,0,5.99520383693046,18.9566663223011,UTP15;DIMT1,delta,6
protein hydroxylation (GO:0018126),2/12,2,12,0.0423421623893153,1,0,0,5.99520383693046,18.9566663223011,OGFOD1;PLOD2,delta,6
plasma membrane tubulation (GO:0097320),2/12,2,12,0.0423421623893153,1,0,0,5.99520383693046,18.9566663223011,PACSIN3;WHAMM,delta,6
regulation of sister chromatid cohesion (GO:0007063),2/12,2,12,0.0423421623893153,1,0,0,5.99520383693046,18.9566663223011,RB1;CTCF,delta,6
positive regulation of neuron migration (GO:2001224),2/12,2,12,0.0423421623893153,1,0,0,5.99520383693046,18.9566663223011,ZNF609;PLAA,delta,6
regulation of catabolic process (GO:0009894),2/12,2,12,0.0423421623893153,1,0,0,5.99520383693046,18.9566663223011,HGS;MDM2,delta,6
positive regulation of cellular protein metabolic process (GO:0032270),6/92,6,92,0.0431663767597496,1,0,0,2.34594932749453,7.37259947417164,CYFIP2;RPS4X;PERP;ATG10;VPS35;FADD,delta,6
regulation of protein catabolic process (GO:0042176),6/92,6,92,0.0431663767597496,1,0,0,2.34594932749453,7.37259947417164,SNX3;SMURF2;HGS;NEDD4;MDM2;PHB,delta,6
peptidyl-lysine modification (GO:0018205),7/116,7,116,0.0432351144396861,1,0,0,2.17067725130241,6.81831926245242,TOP2A;BLOC1S1;INCENP;MDM2;PLOD2;AAAS;SENP1,delta,6
cellular response to oxidative stress (GO:0034599),7/116,7,116,0.0432351144396861,1,0,0,2.17067725130241,6.81831926245242,VKORC1L1;PXN;LONP1;HIF1A;PRDX6;TXN2;HSPA1A,delta,6
positive regulation of Wnt signaling pathway (GO:0030177),8/141,8,141,0.0434888005627315,1,0,0,2.04092045512526,6.39879959663982,PSMB7;PSMD6;PSMD14;SMURF2;NRARP;CSNK1E;ATP6V0C;ZBED3,delta,6
negative regulation of nucleic acid-templated transcription (GO:1903507),19/445,19,445,0.0435312547217837,1,0,0,1.53584997170803,4.81377785879327,RB1;ZNF253;ZNF263;FOXD1;ZGPAT;SMURF2;ZNF281;NONO;ARID5A;ZNF12;CTCF;PHB;EID2;NKRF;MDM2;KAT8;ZNF653;SOX7;PPARD,delta,6
positive regulation of tumor necrosis factor production (GO:0032760),4/48,4,48,0.043948194514453,1,0,0,2.99760191846523,9.36673781816406,TLR9;RIPK1;FADD;HAVCR2,delta,6
modification-dependent protein catabolic process (GO:0019941),8/142,8,142,0.0450179606163523,1,0,0,2.02654777586382,6.28370401060514,BAG6;PSMD14;SMURF2;NEDD4;LONP1;MDM2;CBL;UBE2L3,delta,6
regulation of mRNA processing (GO:0050684),3/29,3,29,0.0457324859335044,1,0,0,3.7211610022327,11.4795821694899,CDK11A;METTL16;ZFP36L1,delta,6
protein K11-linked ubiquitination (GO:0070979),3/29,3,29,0.0457324859335044,1,0,0,3.7211610022327,11.4795821694899,UBE2D4;UBE2T;UBE2L3,delta,6
positive regulation of macromolecule metabolic process (GO:0010604),13/277,13,277,0.0467785338903901,1,0,0,1.68818014180713,5.16976614353523,FOXD1;ANXA2;ANGPT1;CTCF;PHB;HIF1A;ETS1;FUBP3;HGS;NOS1AP;TLR9;VPS35;HSPA1A,delta,6
positive regulation of endothelial cell migration (GO:0010595),5/71,5,71,0.0475009474967813,1,0,0,2.53318471982977,7.71862807994687,BCAS3;ANGPT1;PLCG1;ETS1;HIF1A,delta,6
neutrophil degranulation (GO:0043312),20/480,20,480,0.048159130905006,1,0,0,1.49880095923261,4.54622980236331,ANXA2;PSMD14;DYNLT1;PTPRJ;AMPD3;PRDX6;UNC13D;PSMB7;PSMD6;ALOX5;DNAJC5;CREG1;COTL1;MLEC;PPIE;ALDOC;ATP6V0C;KPNB1;RAB9B;HSPA1A,delta,6
cytosolic transport (GO:0016482),7/119,7,119,0.0484668018034547,1,0,0,2.11595429538722,6.40473172728073,ARFRP1;SNX1;STX16;GBF1;VPS35;PIK3C3;RAB9B,delta,6
serine family amino acid biosynthetic process (GO:0009070),2/13,2,13,0.0491383418964417,1,0,0,5.53403431101273,16.6746854172637,PSAT1;SEPHS1,delta,6
positive regulation of actin nucleation (GO:0051127),2/13,2,13,0.0491383418964417,1,0,0,5.53403431101273,16.6746854172637,WIPF3;WHAMM,delta,6
regulation of macrophage differentiation (GO:0045649),2/13,2,13,0.0491383418964417,1,0,0,5.53403431101273,16.6746854172637,RIPK1;FADD,delta,6
alpha-linolenic acid metabolic process (GO:0036109),2/13,2,13,0.0491383418964417,1,0,0,5.53403431101273,16.6746854172637,SCP2;ACSL1,delta,6
synaptic vesicle localization (GO:0097479),2/13,2,13,0.0491383418964417,1,0,0,5.53403431101273,16.6746854172637,KIF5C;SPG11,delta,6
toll-like receptor 9 signaling pathway (GO:0034162),2/13,2,13,0.0491383418964417,1,0,0,5.53403431101273,16.6746854172637,TLR9;PIK3C3,delta,6
regulation of fatty acid oxidation (GO:0046320),2/13,2,13,0.0491383418964417,1,0,0,5.53403431101273,16.6746854172637,PRKAG2;PPARGC1B,delta,6
positive regulation of myeloid cell differentiation (GO:0045639),3/30,3,30,0.0497999226179035,1,0,0,3.59712230215827,10.7904383050723,ETS1;HIF1A;HSPA1A,delta,6
organic hydroxy compound biosynthetic process (GO:1901617),4/50,4,50,0.0498445100661685,1,0,0,2.87769784172662,8.62977530274177,SCP2;PSAT1;OSBPL2;PRKAG2,delta,6
transcription elongation from RNA polymerase II promoter (GO:0006368),6/96,6,96,0.0512593880286349,1,0,0,2.24820143884892,6.67908385047816,SETD2;GTF2A2;LEO1;SSRP1;GTF2E2;ELL3,delta,6
neutrophil activation involved in immune response (GO:0002283),20/484,20,484,0.0516095947750422,1,0,0,1.48641417444557,4.40580248309582,ANXA2;PSMD14;DYNLT1;PTPRJ;AMPD3;PRDX6;UNC13D;PSMB7;PSMD6;ALOX5;DNAJC5;CREG1;COTL1;MLEC;PPIE;ALDOC;ATP6V0C;KPNB1;RAB9B;HSPA1A,delta,6
positive regulation of JUN kinase activity (GO:0043507),4/51,4,51,0.0529476153202558,1,0,0,2.82127239384963,8.29017419775298,TAOK1;TLR9;DVL2;RIPK1,delta,6
regulation of blood vessel endothelial cell migration (GO:0043535),4/51,4,51,0.0529476153202558,1,0,0,2.82127239384963,8.29017419775298,ANGPT1;PLCG1;ETS1;HIF1A,delta,6
negative regulation of protein ubiquitination (GO:0031397),4/51,4,51,0.0529476153202558,1,0,0,2.82127239384963,8.29017419775298,PDCL3;PINX1;N4BP1;HSPA1A,delta,6
protein localization to nucleus (GO:0034504),6/97,6,97,0.053417851758844,1,0,0,2.2250241044278,6.51845350355836,IPO11;IPO9;NXT1;PINX1;MDM2;KPNB1,delta,6
ciliary basal body-plasma membrane docking (GO:0097711),6/97,6,97,0.053417851758844,1,0,0,2.2250241044278,6.51845350355836,NEDD1;RAB3IP;DCTN3;CSNK1E;CKAP5;CLASP1,delta,6
regulation of intracellular estrogen receptor signaling pathway (GO:0033146),3/31,3,31,0.0540372123385403,1,0,0,3.48108609886285,10.1580959121716,FOXA1;PAGR1;CBFB,delta,6
protein localization to lysosome (GO:0061462),3/31,3,31,0.0540372123385403,1,0,0,3.48108609886285,10.1580959121716,SCARB2;HGS;NEDD4,delta,6
Golgi organization (GO:0007030),7/122,7,122,0.0540845282730832,1,0,0,2.06392263238589,6.02088979397569,BCAS3;GORASP2;STX16;GBF1;TMED3;YWHAZ;CLASP1,delta,6
neutrophil mediated immunity (GO:0002446),20/488,20,488,0.0552325860832512,1,0,0,1.47423045170421,4.26966943666521,ANXA2;PSMD14;DYNLT1;PTPRJ;AMPD3;PRDX6;UNC13D;PSMB7;PSMD6;ALOX5;DNAJC5;CREG1;COTL1;MLEC;PPIE;ALDOC;ATP6V0C;KPNB1;RAB9B;HSPA1A,delta,6
positive regulation of developmental growth (GO:0048639),4/52,4,52,0.0561534338324593,1,0,0,2.76701715550636,7.96808922257284,SYT4;TWF2;ISLR2;PLAA,delta,6
branching involved in blood vessel morphogenesis (GO:0001569),2/14,2,14,0.0562967968008115,1,0,0,5.13874614594039,14.7847771872813,NRARP;TGFBR2,delta,6
myeloid dendritic cell activation (GO:0001773),2/14,2,14,0.0562967968008115,1,0,0,5.13874614594039,14.7847771872813,BATF3;TGFBR2,delta,6
gliogenesis (GO:0042063),2/14,2,14,0.0562967968008115,1,0,0,5.13874614594039,14.7847771872813,CDH2;NFIB,delta,6
regulation of nucleocytoplasmic transport (GO:0046822),2/14,2,14,0.0562967968008115,1,0,0,5.13874614594039,14.7847771872813,NEDD4;AAAS,delta,6
"retrograde transport, endosome to plasma membrane (GO:1990126)",2/14,2,14,0.0562967968008115,1,0,0,5.13874614594039,14.7847771872813,SNX27;VPS35,delta,6
regulation of lymphocyte differentiation (GO:0045619),2/14,2,14,0.0562967968008115,1,0,0,5.13874614594039,14.7847771872813,TLR9;ZFP36L1,delta,6
cell migration involved in sprouting angiogenesis (GO:0002042),2/14,2,14,0.0562967968008115,1,0,0,5.13874614594039,14.7847771872813,EFNB2;EGR3,delta,6
necroptotic process (GO:0070266),2/14,2,14,0.0562967968008115,1,0,0,5.13874614594039,14.7847771872813,MLKL;RIPK1,delta,6
regulation of response to interferon-gamma (GO:0060330),2/14,2,14,0.0562967968008115,1,0,0,5.13874614594039,14.7847771872813,IFNGR1;CDC37,delta,6
positive regulation of multicellular organismal process (GO:0051240),10/203,10,203,0.0579313681262358,1,0,0,1.77198142963462,5.04748250569863,FOXD1;SMURF2;CAPN7;SGIP1;FOXJ1;PLCG1;HIF1A;DOCK1;CLASP1;TGFBR2,delta,6
DNA metabolic process (GO:0006259),14/315,14,315,0.0580990956278539,1,0,0,1.59872102318146,4.54932882658844,TOP2A;ACHE;RTEL1;RMI1;IGFBP4;CSNK1E;TYMS;POLD4;ORC6;TDP1;UBE2T;LONP1;ATM;RAD9A,delta,6
proton transport (GO:0015992),3/32,3,32,0.0584412940255136,1,0,0,3.37230215827338,9.57643620573281,SLC36A1;ATP6V0C;SLC9A1,delta,6
positive regulation of proteolysis (GO:0045862),4/53,4,53,0.0594613847808972,1,0,0,2.71480928464775,7.662354207678,CYFIP2;PERP;PACSIN3;FADD,delta,6
negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),4/54,4,54,0.0628707785970875,1,0,0,2.66453503863576,7.37189926039207,EID2;SMURF2;TGFBR2;HSPA1A,delta,6
organelle assembly (GO:0070925),16/377,16,377,0.0629000051333827,1,0,0,1.52663015476213,4.22297812516678,FARP2;STX12;ABCC4;GABARAPL1;CCDC113;FOXJ1;CORO1A;ATG12;IFT74;ATG16L2;HGS;KIAA0586;OGFOD1;WDR5B;PIK3C3;CHMP6,delta,6
negative regulation of receptor activity (GO:2000272),3/33,3,33,0.0630088825732349,1,0,0,3.27011118378025,9.04015555691061,ZGPAT;CBL;CHMP6,delta,6
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),3/33,3,33,0.0630088825732349,1,0,0,3.27011118378025,9.04015555691061,TLR9;RIPK1;FADD,delta,6
positive regulation of telomere maintenance (GO:0032206),3/33,3,33,0.0630088825732349,1,0,0,3.27011118378025,9.04015555691061,PKIB;RTEL1;ATM,delta,6
positive regulation of myeloid leukocyte differentiation (GO:0002763),3/33,3,33,0.0630088825732349,1,0,0,3.27011118378025,9.04015555691061,RIPK1;FADD;ZFP36L1,delta,6
intracellular protein transport (GO:0006886),15/348,15,348,0.0631486970579482,1,0,0,1.55048375093029,4.28284399481111,STX12;IPO11;NXT1;STX16;SNX1;IPO9;XPO4;SNX27;CDC37;TMED3;SCG5;VPS35;TBC1D22B;RAB9B;KPNB1,delta,6
transforming growth factor beta receptor signaling pathway (GO:0007179),5/77,5,77,0.0631594888927201,1,0,0,2.33579370270018,6.45167752473519,EID2;TWSG1;PXN;CBL;TGFBR2,delta,6
regulation of hematopoietic stem cell differentiation (GO:1902036),5/77,5,77,0.0631594888927201,1,0,0,2.33579370270018,6.45167752473519,PSMB7;PSMD6;PSMD14;CBFB;TCF12,delta,6
positive regulation of JNK cascade (GO:0046330),5/77,5,77,0.0631594888927201,1,0,0,2.33579370270018,6.45167752473519,TAOK1;TLR9;DVL2;RIPK1;ANKRD6,delta,6
regulation of B cell differentiation (GO:0045577),2/15,2,15,0.0637922118749996,1,0,0,4.79616306954437,13.1996362926016,TLR9;ZFP36L1,delta,6
negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),2/15,2,15,0.0637922118749996,1,0,0,4.79616306954437,13.1996362926016,HGS;PTPRJ,delta,6
"protein localization to chromosome, centromeric region (GO:0071459)",2/15,2,15,0.0637922118749996,1,0,0,4.79616306954437,13.1996362926016,RB1;CTCF,delta,6
positive regulation of cytokine production involved in immune response (GO:0002720),2/15,2,15,0.0637922118749996,1,0,0,4.79616306954437,13.1996362926016,RAET1G;MALT1,delta,6
anterograde synaptic vesicle transport (GO:0048490),2/15,2,15,0.0637922118749996,1,0,0,4.79616306954437,13.1996362926016,BLOC1S1;AP3S1,delta,6
glycerophospholipid catabolic process (GO:0046475),2/15,2,15,0.0637922118749996,1,0,0,4.79616306954437,13.1996362926016,PNPLA8;PRDX6,delta,6
regulation of cell-substrate junction assembly (GO:0090109),2/15,2,15,0.0637922118749996,1,0,0,4.79616306954437,13.1996362926016,CLASP1;SLC9A1,delta,6
intra-S DNA damage checkpoint (GO:0031573),2/15,2,15,0.0637922118749996,1,0,0,4.79616306954437,13.1996362926016,EME2;RAD9A,delta,6
regulation of protein complex disassembly (GO:0043244),2/15,2,15,0.0637922118749996,1,0,0,4.79616306954437,13.1996362926016,OGFOD1;IGF1R,delta,6
synaptic vesicle transport along microtubule (GO:0099517),2/15,2,15,0.0637922118749996,1,0,0,4.79616306954437,13.1996362926016,BLOC1S1;AP3S1,delta,6
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),2/15,2,15,0.0637922118749996,1,0,0,4.79616306954437,13.1996362926016,RIPK1;FADD,delta,6
cellular response to corticosteroid stimulus (GO:0071384),2/15,2,15,0.0637922118749996,1,0,0,4.79616306954437,13.1996362926016,ZFP36L1;UBE2L3,delta,6
G2/M transition of mitotic cell cycle (GO:0000086),7/127,7,127,0.0643177116677804,1,0,0,1.98266583583527,5.44027690034019,NEDD1;PPP1R12A;DCTN3;CSNK1E;PHLDA1;CKAP5;CLASP1,delta,6
ERAD pathway (GO:0036503),5/78,5,78,0.0660200991557065,1,0,0,2.30584762958864,6.26682358110623,BAG6;ERLEC1;DNAJC10;UBXN4;UBXN6,delta,6
regulation of hematopoietic progenitor cell differentiation (GO:1901532),5/78,5,78,0.0660200991557065,1,0,0,2.30584762958864,6.26682358110623,PSMB7;PSMD6;PSMD14;CBFB;TCF12,delta,6
non-canonical Wnt signaling pathway (GO:0035567),7/128,7,128,0.0664958872661753,1,0,0,1.96717625899281,5.33225782710766,GNAO1;PSMB7;PSMD6;PSMD14;SMURF2;GNB1;DVL2,delta,6
cell cycle G2/M phase transition (GO:0044839),7/128,7,128,0.0664958872661753,1,0,0,1.96717625899281,5.33225782710766,NEDD1;PPP1R12A;DCTN3;CSNK1E;PHLDA1;CKAP5;CLASP1,delta,6
stem cell differentiation (GO:0048863),3/34,3,34,0.0677364908542692,1,0,0,3.17393144308083,8.5446368051931,SETD2;ZNF281;ELL3,delta,6
regulation of mRNA stability (GO:0043488),7/129,7,129,0.0687180508752861,1,0,0,1.95192683062852,5.22675911966151,PSMB7;PSMD6;PSMD14;METTL16;YWHAZ;ZFP36L1;HSPA1A,delta,6
regulation of cellular response to heat (GO:1900034),5/79,5,79,0.0689519422006564,1,0,0,2.2766596849103,6.08857459906241,HSPA1L;ATM;AAAS;IER5;HSPA1A,delta,6
regulation of cellular catabolic process (GO:0031329),4/56,4,56,0.0699906175823287,1,0,0,2.5693730729702,6.8329755407358,DAPK2;ITPR1;KAT8;ATM,delta,6
positive regulation of cysteine-type endopeptidase activity (GO:2001056),4/56,4,56,0.0699906175823287,1,0,0,2.5693730729702,6.8329755407358,CYFIP2;PERP;FADD;SOX7,delta,6
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),4/56,4,56,0.0699906175823287,1,0,0,2.5693730729702,6.8329755407358,EID2;SMURF2;TGFBR2;HSPA1A,delta,6
long-chain fatty acid metabolic process (GO:0001676),4/56,4,56,0.0699906175823287,1,0,0,2.5693730729702,6.8329755407358,SCP2;ACSL1;PNPLA8;AIG1,delta,6
regulation of macromolecule metabolic process (GO:0060255),7/130,7,130,0.0709842236227019,1,0,0,1.93691200885446,5.12370874485343,NPAT;MFAP4;CDK11A;SART3;CDK4;HIF1A;ZFP36L1,delta,6
glucose transmembrane transport (GO:1904659),2/16,2,16,0.0716003949978957,1,0,0,4.49640287769784,11.8554617279693,SLC45A1;PPARD,delta,6
positive regulation of regulated secretory pathway (GO:1903307),2/16,2,16,0.0716003949978957,1,0,0,4.49640287769784,11.8554617279693,SYT4;UNC13D,delta,6
positive regulation of nitric-oxide synthase activity (GO:0051000),2/16,2,16,0.0716003949978957,1,0,0,4.49640287769784,11.8554617279693,NOS1AP;HIF1A,delta,6
myoblast differentiation (GO:0045445),2/16,2,16,0.0716003949978957,1,0,0,4.49640287769784,11.8554617279693,RB1;MBNL1,delta,6
linoleic acid metabolic process (GO:0043651),2/16,2,16,0.0716003949978957,1,0,0,4.49640287769784,11.8554617279693,PNPLA8;ACSL1,delta,6
regulation of interferon-alpha production (GO:0032647),2/16,2,16,0.0716003949978957,1,0,0,4.49640287769784,11.8554617279693,SETD2;HAVCR2,delta,6
programmed necrotic cell death (GO:0097300),2/16,2,16,0.0716003949978957,1,0,0,4.49640287769784,11.8554617279693,MLKL;RIPK1,delta,6
positive regulation of exocytosis (GO:0045921),3/35,3,35,0.0726204504406418,1,0,0,3.08324768756423,8.08584391667225,HGS;CLASP1;UNC13D,delta,6
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),3/35,3,35,0.0726204504406418,1,0,0,3.08324768756423,8.08584391667225,PKIB;RTEL1;ATM,delta,6
protein import (GO:0017038),4/57,4,57,0.0736991770908787,1,0,0,2.52429635239177,6.58276825825799,IPO11;NXT1;IPO9;KPNB1,delta,6
phosphatidylinositol-mediated signaling (GO:0048015),4/57,4,57,0.0736991770908787,1,0,0,2.52429635239177,6.58276825825799,PITPNM2;PIK3C3;IGF1R;ZFP36L1,delta,6
regulation of programmed cell death (GO:0043067),12/269,12,269,0.073732820921683,1,0,0,1.60466422401113,4.18385266115051,BNIP3L;PAX8;DAPK2;PERP;TAOK1;NOS1AP;ATM;RIPK1;PHB;TARDBP;TNFRSF21;MALT1,delta,6
regulation of mitotic cell cycle phase transition (GO:1901990),9/185,9,185,0.0740408919651211,1,0,0,1.74995139023916,4.5553645145844,PSMB7;NEDD1;PSMD6;PSMD14;DCTN3;CSNK1E;CKAP5;CLASP1;ZFP36L1,delta,6
protein ubiquitination (GO:0016567),20/507,20,507,0.0748967937906054,1,0,0,1.41898315666993,3.67749946207649,UBE2D4;CBFB;PSMD14;SMURF2;KLHL26;CBL;HIF1A;UBE2L3;CNOT4;RNF167;PSMB7;MARCH1;PSMD6;RFWD3;NEDD4;UBE2T;PEX5;LEO1;MDM2;TRIM69,delta,6
RNA transport (GO:0050658),5/81,5,81,0.0750281348320158,1,0,0,2.2204458655298,5.7507152160413,NXT1;KIF5C;CKAP5;TGFBR2;ZFP36L1,delta,6
regulation of canonical Wnt signaling pathway (GO:0060828),10/214,10,214,0.0764941672004117,1,0,0,1.68089827203658,4.32081756673629,PSMB7;PSMD6;PSMD14;SMURF2;IGFBP4;DVL2;NRARP;SOX7;ZBED3;ANKRD6,delta,6
tRNA modification (GO:0006400),4/58,4,58,0.0775054165163336,1,0,0,2.48077400148846,6.34434992441511,RPUSD3;NSUN6;THUMPD1;SEPHS1,delta,6
positive regulation of RNA metabolic process (GO:0051254),3/36,3,36,0.0776569312279764,1,0,0,2.99760191846523,7.6602352246325,UTP15;DIMT1;HSPA1A,delta,6
carbohydrate catabolic process (GO:0016052),3/36,3,36,0.0776569312279764,1,0,0,2.99760191846523,7.6602352246325,NEU3;MAN2C1;PFKM,delta,6
"DNA-templated transcription, initiation (GO:0006352)",9/187,9,187,0.0779892158180765,1,0,0,1.73123533258954,4.41670112825453,GTF3C1;GTF2A2;RXRA;CBFB;CDK4;ZNF45;GTF2E2;MED7;PPARD,delta,6
fatty acid metabolic process (GO:0006631),6/107,6,107,0.0780034765808263,1,0,0,2.01707792644389,5.14556958596808,SCARB2;ACSL1;PNPLA8;FASN;ALOX5;PPARD,delta,6
high-density lipoprotein particle remodeling (GO:0034375),2/17,2,17,0.079698234456526,1,0,0,4.23190859077444,10.704645983056,APOM;LIPG,delta,6
positive regulation of cholesterol transport (GO:0032376),2/17,2,17,0.079698234456526,1,0,0,4.23190859077444,10.704645983056,SCP2;LIPG,delta,6
reverse cholesterol transport (GO:0043691),2/17,2,17,0.079698234456526,1,0,0,4.23190859077444,10.704645983056,APOM;LIPG,delta,6
positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745),2/17,2,17,0.079698234456526,1,0,0,4.23190859077444,10.704645983056,VPS35;PHB,delta,6
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),2/17,2,17,0.079698234456526,1,0,0,4.23190859077444,10.704645983056,SLC25A5;HSPA1A,delta,6
positive regulation of dendrite extension (GO:1903861),2/17,2,17,0.079698234456526,1,0,0,4.23190859077444,10.704645983056,SYT4;PLAA,delta,6
negative regulation of intracellular transport (GO:0032387),2/17,2,17,0.079698234456526,1,0,0,4.23190859077444,10.704645983056,SLC25A5;HSPA1A,delta,6
phospholipid catabolic process (GO:0009395),2/17,2,17,0.079698234456526,1,0,0,4.23190859077444,10.704645983056,LIPG;PRDX6,delta,6
chaperone-mediated protein complex assembly (GO:0051131),2/17,2,17,0.079698234456526,1,0,0,4.23190859077444,10.704645983056,LONP1;HSPA1A,delta,6
synaptic vesicle transport (GO:0048489),2/17,2,17,0.079698234456526,1,0,0,4.23190859077444,10.704645983056,KIF5C;SPG11,delta,6
positive regulation of telomere capping (GO:1904355),2/17,2,17,0.079698234456526,1,0,0,4.23190859077444,10.704645983056,PKIB;RTEL1,delta,6
nucleobase-containing compound biosynthetic process (GO:0034654),2/17,2,17,0.079698234456526,1,0,0,4.23190859077444,10.704645983056,AMPD3;TYMS,delta,6
cellular response to glucocorticoid stimulus (GO:0071385),2/17,2,17,0.079698234456526,1,0,0,4.23190859077444,10.704645983056,ZFP36L1;UBE2L3,delta,6
mitotic G2 DNA damage checkpoint (GO:0007095),2/17,2,17,0.079698234456526,1,0,0,4.23190859077444,10.704645983056,TAOK1;ATM,delta,6
mitochondrial translation (GO:0032543),6/108,6,108,0.0807614769878021,1,0,0,1.99840127897682,5.02848760411464,MRPS9;MRPS34;ERAL1;HARS;HARS2;MRPS5,delta,6
transcription initiation from RNA polymerase II promoter (GO:0006367),8/161,8,161,0.0808855566799889,1,0,0,1.78738996380535,4.49478529668073,GTF2A2;RXRA;CBFB;CDK4;ZNF45;GTF2E2;MED7;PPARD,delta,6
ubiquitin-dependent ERAD pathway (GO:0030433),4/59,4,59,0.0814081648068525,1,0,0,2.43872698451408,6.1170094043442,BAG6;ERLEC1;DNAJC10;UBXN4,delta,6
regulation of receptor-mediated endocytosis (GO:0048259),3/37,3,37,0.0828419598480756,1,0,0,2.9165856503986,7.26469157447294,HNRNPK;SGIP1;CBL,delta,6
regulation of muscle cell differentiation (GO:0051147),3/37,3,37,0.0828419598480756,1,0,0,2.9165856503986,7.26469157447294,CDH2;CTNNA2;ZFP36L1,delta,6
regulation of nitric-oxide synthase activity (GO:0050999),3/37,3,37,0.0828419598480756,1,0,0,2.9165856503986,7.26469157447294,NOS1AP;NOSTRIN;HIF1A,delta,6
axonal transport (GO:0098930),3/37,3,37,0.0828419598480756,1,0,0,2.9165856503986,7.26469157447294,BLOC1S1;AP3S1;HIF1A,delta,6
"DNA-templated transcription, elongation (GO:0006354)",6/109,6,109,0.0835734025051155,1,0,0,1.98006732228896,4.91458641944137,SETD2;GTF2A2;LEO1;SSRP1;GTF2E2;ELL3,delta,6
positive regulation of protein ubiquitination (GO:0031398),5/84,5,84,0.0846678965939492,1,0,0,2.14114422747516,5.2865252955572,DCUN1D5;ANGPT1;MALT1;UBE2L3;TSPYL5,delta,6
positive regulation of homeostatic process (GO:0032846),5/84,5,84,0.0846678965939492,1,0,0,2.14114422747516,5.2865252955572,RTEL1;SGIP1;ETS1;HIF1A;HSPA1A,delta,6
mitochondrial transport (GO:0006839),7/136,7,136,0.0855041632233544,1,0,0,1.85146000846382,4.55309232989802,TIMM9;TOMM20L;VPS35;SPG7;ATP5G2;SLC25A5;SLC25A11,delta,6
activation of GTPase activity (GO:0090630),5/85,5,85,0.0880193916366466,1,0,0,2.11595429538722,5.14218817027544,SYDE2;BCAS3;ARHGEF10;FOXJ1;TBC1D22B,delta,6
regulation of cell cycle G2/M phase transition (GO:1902749),5/85,5,85,0.0880193916366466,1,0,0,2.11595429538722,5.14218817027544,NEDD1;DCTN3;CSNK1E;CKAP5;CLASP1,delta,6
regulation of adherens junction organization (GO:1903391),2/18,2,18,0.0880636577596755,1,0,0,3.99680255795364,9.71101255950074,CLASP1;SLC9A1,delta,6
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),2/18,2,18,0.0880636577596755,1,0,0,3.99680255795364,9.71101255950074,EID2;SMURF2,delta,6
regulation of keratinocyte proliferation (GO:0010837),2/18,2,18,0.0880636577596755,1,0,0,3.99680255795364,9.71101255950074,STXBP4;ZFP36L1,delta,6
regulation of chemokine production (GO:0032642),2/18,2,18,0.0880636577596755,1,0,0,3.99680255795364,9.71101255950074,TLR9;HIF1A,delta,6
establishment or maintenance of apical/basal cell polarity (GO:0035088),2/18,2,18,0.0880636577596755,1,0,0,3.99680255795364,9.71101255950074,CLIC4;FOXJ1,delta,6
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),2/18,2,18,0.0880636577596755,1,0,0,3.99680255795364,9.71101255950074,NEDD4;PLAA,delta,6
modulation by virus of host morphology or physiology (GO:0019048),2/18,2,18,0.0880636577596755,1,0,0,3.99680255795364,9.71101255950074,RXRA;KPNB1,delta,6
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),2/18,2,18,0.0880636577596755,1,0,0,3.99680255795364,9.71101255950074,NONO;HIF1A,delta,6
DNA conformation change (GO:0071103),2/18,2,18,0.0880636577596755,1,0,0,3.99680255795364,9.71101255950074,TOP2A;NAA10,delta,6
blood vessel endothelial cell migration (GO:0043534),2/18,2,18,0.0880636577596755,1,0,0,3.99680255795364,9.71101255950074,EFNB2;EGR3,delta,6
regulation of dendrite extension (GO:1903859),2/18,2,18,0.0880636577596755,1,0,0,3.99680255795364,9.71101255950074,SYT4;PLAA,delta,6
mRNA destabilization (GO:0061157),2/18,2,18,0.0880636577596755,1,0,0,3.99680255795364,9.71101255950074,METTL16;ZFP36L1,delta,6
DNA ligation (GO:0006266),2/18,2,18,0.0880636577596755,1,0,0,3.99680255795364,9.71101255950074,TOP2A;POLD4,delta,6
myelination (GO:0042552),3/38,3,38,0.0881714370504011,1,0,0,2.83983339644074,6.89645648821608,ARHGEF10;SBF2;TNFRSF21,delta,6
protein K63-linked ubiquitination (GO:0070534),3/38,3,38,0.0881714370504011,1,0,0,2.83983339644074,6.89645648821608,UBE2D4;UBE2T;NEDD4,delta,6
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),6/111,6,111,0.0893580964518529,1,0,0,1.94439043359907,4.69590399856903,PSMB7;HSPA1L;NMT1;YWHAZ;UBE2L3;ZBED3,delta,6
"regulation of mRNA splicing, via spliceosome (GO:0048024)",4/61,4,61,0.0894980888466476,1,0,0,2.35876872272674,5.69297796343452,MBNL1;METTL16;MBNL3;PRDX6,delta,6
regulation of stress fiber assembly (GO:0051492),4/61,4,61,0.0894980888466476,1,0,0,2.35876872272674,5.69297796343452,ARHGEF10;PXN;CLASP1;SLC9A1,delta,6
muscle organ development (GO:0007517),4/61,4,61,0.0894980888466476,1,0,0,2.35876872272674,5.69297796343452,COPRS;ACHE;EGR3;TCF12,delta,6
mitotic cell cycle phase transition (GO:0044772),10/222,10,222,0.0920802868695508,1,0,0,1.62032536133256,3.86462894409091,RB1;NEDD1;ORC6;PPP1R12A;CDK4;DCTN3;CSNK1E;PHLDA1;CKAP5;CLASP1,delta,6
DNA damage checkpoint (GO:0000077),3/39,3,39,0.0936411539733499,1,0,0,2.76701715550636,6.55308609000197,TAOK1;H2AFX;RAD9A,delta,6
glycosaminoglycan metabolic process (GO:0030203),4/62,4,62,0.0936825200571711,1,0,0,2.32072406590856,5.495111764583,XYLT2;XYLT1;GPC2;GPC5,delta,6
regulation of cellular ketone metabolic process (GO:0010565),4/62,4,62,0.0936825200571711,1,0,0,2.32072406590856,5.495111764583,PSMB7;PSMD6;PSMD14;PRKAG2,delta,6
regulation of tumor necrosis factor production (GO:0032680),4/62,4,62,0.0936825200571711,1,0,0,2.32072406590856,5.495111764583,TLR9;RIPK1;FADD;HAVCR2,delta,6
ribosomal small subunit assembly (GO:0000028),2/19,2,19,0.0966755918831144,1,0,0,3.78644452858766,8.84662748620425,RPS5;ERAL1,delta,6
osteoclast differentiation (GO:0030316),2/19,2,19,0.0966755918831144,1,0,0,3.78644452858766,8.84662748620425,FARP2;ANXA2,delta,6
leukotriene metabolic process (GO:0006691),2/19,2,19,0.0966755918831144,1,0,0,3.78644452858766,8.84662748620425,ABCC1;ALOX5,delta,6
histone deubiquitination (GO:0016578),2/19,2,19,0.0966755918831144,1,0,0,3.78644452858766,8.84662748620425,ENY2;SUPT3H,delta,6
regulation of neuron migration (GO:2001222),2/19,2,19,0.0966755918831144,1,0,0,3.78644452858766,8.84662748620425,ZNF609;PLAA,delta,6
hexose transmembrane transport (GO:0035428),2/19,2,19,0.0966755918831144,1,0,0,3.78644452858766,8.84662748620425,SLC45A1;PPARD,delta,6
protein heterotetramerization (GO:0051290),2/19,2,19,0.0966755918831144,1,0,0,3.78644452858766,8.84662748620425,NUDT21;ANXA2,delta,6
positive regulation of axon extension (GO:0045773),2/19,2,19,0.0966755918831144,1,0,0,3.78644452858766,8.84662748620425,TWF2;ISLR2,delta,6
diterpenoid metabolic process (GO:0016101),4/63,4,63,0.0979579791546024,1,0,0,2.28388717597351,5.30596477424342,ALDH3A2;APOM;GPC2;GPC5,delta,6
cellular protein catabolic process (GO:0044257),4/63,4,63,0.0979579791546024,1,0,0,2.28388717597351,5.30596477424342,BNIP3L;LONP1;MDM2;RIPK1,delta,6
establishment of protein localization to organelle (GO:0072594),4/63,4,63,0.0979579791546024,1,0,0,2.28388717597351,5.30596477424342,IPO11;NXT1;IPO9;KPNB1,delta,6
positive regulation of canonical Wnt signaling pathway (GO:0090263),6/114,6,114,0.0984330087046097,1,0,0,1.89322226429383,4.38920688538624,PSMB7;PSMD6;PSMD14;SMURF2;NRARP;ZBED3,delta,6
negative regulation of protein catabolic process (GO:0042177),3/40,3,40,0.0992468075953296,1,0,0,2.69784172661871,6.23240699249596,SNX3;PHB;TIMP1,delta,6
inositol lipid-mediated signaling (GO:0048017),3/40,3,40,0.0992468075953296,1,0,0,2.69784172661871,6.23240699249596,PITPNM2;PIK3C3;IGF1R,delta,6
regulation of coenzyme metabolic process (GO:0051196),3/40,3,40,0.0992468075953296,1,0,0,2.69784172661871,6.23240699249596,ME1;PRKAG2;AAAS,delta,6
protein polyubiquitination (GO:0000209),12/284,12,284,0.0999278026273452,1,0,0,1.51991083189786,3.50082175621005,RNF167;PSMB7;MARCH1;PSMD6;UBE2D4;CBFB;PSMD14;SMURF2;NEDD4;UBE2T;TRIM69;UBE2L3,delta,6
cell morphogenesis involved in neuron differentiation (GO:0048667),6/98,6,98,0.000532048966555888,1,0,0,5.9441252229047,44.8114228083613,MEF2A;APP;SDC2;BTBD3;SLIT3;LLGL1,delta,7
negative regulation of translational initiation (GO:0045947),3/16,3,16,0.000546230422660575,1,0,0,18.2038834951456,136.756122300723,RBM4;AGO2;EIF4EBP2,delta,7
polyamine biosynthetic process (GO:0006596),2/6,2,6,0.0015410807881311,1,0,0,32.3624595469256,209.55570544452,AMD1;PAOX,delta,7
spermine metabolic process (GO:0008215),2/6,2,6,0.0015410807881311,1,0,0,32.3624595469256,209.55570544452,AMD1;PAOX,delta,7
neuron projection morphogenesis (GO:0048812),7/164,7,164,0.00158233812090672,1,0,0,4.14397347856974,26.7238704221579,MEF2A;APP;SDC2;BTBD3;SLIT3;ZNF335;LLGL1,delta,7
positive regulation of neuroblast proliferation (GO:0002052),2/7,2,7,0.00214289278458326,1,0,0,27.7392510402219,170.474302198836,FZD3;ZNF335,delta,7
spermidine metabolic process (GO:0008216),2/7,2,7,0.00214289278458326,1,0,0,27.7392510402219,170.474302198836,AMD1;PAOX,delta,7
positive regulation of extracellular matrix assembly (GO:1901203),2/8,2,8,0.00283784368876394,1,0,0,24.2718446601942,142.347349022234,PHLDB1;DAG1,delta,7
positive regulation of cell activation (GO:0050867),2/9,2,9,0.00362396980871384,1,0,0,21.5749730312837,121.255344590398,APP;RPS6KA1,delta,7
regulation of translational initiation (GO:0006446),4/63,4,63,0.00405241014822621,1,0,0,6.1642780089382,33.9555769858963,EIF2B5;RBM4;AGO2;EIF4EBP2,delta,7
gene silencing by miRNA (GO:0035195),3/32,3,32,0.00428640942117815,1,0,0,9.10194174757282,49.6265703390757,RBM4;AGO2;PUM1,delta,7
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",4/64,4,64,0.00428829306652311,1,0,0,6.06796116504854,33.0817142707005,PDE12;CNOT11;EXOSC8;EXOSC1,delta,7
negative regulation of inclusion body assembly (GO:0090084),2/10,2,10,0.00449933766623237,1,0,0,19.4174757281553,104.928642297483,DNAJB2;DNAJA4,delta,7
astrocyte development (GO:0014002),2/10,2,10,0.00449933766623237,1,0,0,19.4174757281553,104.928642297483,EIF2B5;APP,delta,7
regulation of neuroblast proliferation (GO:1902692),2/10,2,10,0.00449933766623237,1,0,0,19.4174757281553,104.928642297483,FZD3;ZNF335,delta,7
positive regulation of reproductive process (GO:2000243),2/10,2,10,0.00449933766623237,1,0,0,19.4174757281553,104.928642297483,AGO2;INHBA,delta,7
dendrite morphogenesis (GO:0048813),3/33,3,33,0.0046796587641058,1,0,0,8.8261253309797,47.3480148752296,MEF2A;SDC2;BTBD3,delta,7
cellular macromolecule biosynthetic process (GO:0034645),10/368,10,368,0.00497833842691577,1,0,0,2.63824398480371,13.9897084551302,MEF2A;DBF4;AGO2;ZNF219;KCTD13;EIF4EBP2;CLSPN;INHBA;EEF2;ILF2,delta,7
"negative regulation of translation, ncRNA-mediated (GO:0040033)",2/11,2,11,0.00546204359419755,1,0,0,17.6522506619594,91.9670304430853,RBM4;AGO2,delta,7
miRNA mediated inhibition of translation (GO:0035278),2/11,2,11,0.00546204359419755,1,0,0,17.6522506619594,91.9670304430853,RBM4;AGO2,delta,7
regulation of inclusion body assembly (GO:0090083),2/12,2,12,0.00651021333415759,1,0,0,16.1812297734628,81.4625089494287,DNAJB2;DNAJA4,delta,7
regulation of histone methylation (GO:0031060),2/12,2,12,0.00651021333415759,1,0,0,16.1812297734628,81.4625089494287,ZNF335;PRDM10,delta,7
pre-mRNA cleavage required for polyadenylation (GO:0098789),2/12,2,12,0.00651021333415759,1,0,0,16.1812297734628,81.4625089494287,CPSF7;FIP1L1,delta,7
polyamine metabolic process (GO:0006595),2/12,2,12,0.00651021333415759,1,0,0,16.1812297734628,81.4625089494287,AMD1;PAOX,delta,7
positive regulation of multi-organism process (GO:0043902),3/38,3,38,0.00696852012461081,1,0,0,7.66479305058763,38.0660633428877,AGO2;INHBA;PUM1,delta,7
chemical homeostasis (GO:0048878),3/39,3,39,0.00749273730942893,1,0,0,7.46825989544436,36.5483277546297,FBXW7;EIF5A2;ABHD5,delta,7
mRNA cleavage involved in mRNA processing (GO:0098787),2/13,2,13,0.00764200163651857,1,0,0,14.9365197908887,72.8020271218747,CPSF7;FIP1L1,delta,7
toll-like receptor 9 signaling pathway (GO:0034162),2/13,2,13,0.00764200163651857,1,0,0,14.9365197908887,72.8020271218747,IRAK1;PIK3R4,delta,7
cellular protein modification process (GO:0006464),19/1002,19,1002,0.00776626372039784,1,0,0,1.84097823769936,8.94340985102108,APP;UBE2I;FBXW7;SDC2;ALG5;PIK3R4;RABGGTB;FUT4;CKAP4;KLHL9;CDK8;PSMA1;SDHAF2;IRAK1;RPS6KA1;CALU;WDR5;MAN2B1;MAP3K6,delta,7
positive regulation of neural precursor cell proliferation (GO:2000179),2/14,2,14,0.00885559187552966,1,0,0,13.869625520111,65.5576445097552,FZD3;ZNF335,delta,7
regulation of gastrulation (GO:0010470),2/14,2,14,0.00885559187552966,1,0,0,13.869625520111,65.5576445097552,PHLDB1;DAG1,delta,7
regulation of histone modification (GO:0031056),2/14,2,14,0.00885559187552966,1,0,0,13.869625520111,65.5576445097552,ZNF335;PRDM10,delta,7
mRNA processing (GO:0006397),8/284,8,284,0.0094156738580071,1,0,0,2.73485573635991,12.7591400153812,SF3B5;CPSF7;SFPQ;FIP1L1;RNMT;HNRNPF;BUD31;WDR83,delta,7
NIK/NF-kappaB signaling (GO:0038061),4/81,4,81,0.00981168453451324,1,0,0,4.79443845139638,22.1703526505573,PSMA1;IRAK1;REL;NFKB1,delta,7
regulation of mRNA stability (GO:0043488),5/129,5,129,0.0108626742728409,1,0,0,3.76307669150297,17.0182236207935,PSMA1;PDE12;EXOSC8;PUM1;EXOSC1,delta,7
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",7/237,7,237,0.0116237943361631,1,0,0,2.86755970668961,12.7741212245867,SF3B5;CPSF7;SFPQ;FIP1L1;HNRNPF;BUD31;WDR83,delta,7
regulation of type I interferon production (GO:0032479),4/86,4,86,0.0120380222143184,1,0,0,4.51569202980357,19.9579368729224,IRAK1;TRAF3IP1;POLR3E;NFKB1,delta,7
post-translational protein modification (GO:0043687),9/358,9,358,0.0121697113226232,1,0,0,2.44074415577372,10.760765263887,KLHL9;APP;PSMA1;FBXW7;SDC2;CALU;WDR5;RABGGTB;CKAP4,delta,7
positive regulation of nitrogen compound metabolic process (GO:0051173),2/17,2,17,0.0129694290892031,1,0,0,11.4220445459737,49.6306144993406,APP;NFKB1,delta,7
negative regulation of cell development (GO:0010721),2/17,2,17,0.0129694290892031,1,0,0,11.4220445459737,49.6306144993406,FBXW7;HOOK3,delta,7
positive regulation of telomere capping (GO:1904355),2/17,2,17,0.0129694290892031,1,0,0,11.4220445459737,49.6306144993406,TNKS2;MAP3K4,delta,7
positive regulation of stem cell proliferation (GO:2000648),2/17,2,17,0.0129694290892031,1,0,0,11.4220445459737,49.6306144993406,FZD3;ZNF335,delta,7
negative regulation of translation (GO:0017148),4/89,4,89,0.0135171725345203,1,0,0,4.3634776917203,18.7795106896502,RBM4;AGO2;EIF4EBP2;PUM1,delta,7
actin filament polymerization (GO:0030041),2/18,2,18,0.0144926196806803,1,0,0,10.7874865156419,45.6754665229021,ANG;WASF3,delta,7
regulation of cellular protein metabolic process (GO:0032268),3/51,3,51,0.015606764461564,1,0,0,5.71102227298687,23.7581430004644,APP;INHBA;NFKB1,delta,7
positive regulation of JUN kinase activity (GO:0043507),3/51,3,51,0.015606764461564,1,0,0,5.71102227298687,23.7581430004644,MAP3K6;MAPK8IP3;MAP3K4,delta,7
production of small RNA involved in gene silencing by RNA (GO:0070918),2/19,2,19,0.0160889449273848,1,0,0,10.2197240674502,42.2036064723263,AGO2;PUM1,delta,7
morphogenesis of an epithelium (GO:0002009),2/19,2,19,0.0160889449273848,1,0,0,10.2197240674502,42.2036064723263,TRAF3IP1;MPP5,delta,7
protein heterotetramerization (GO:0051290),2/19,2,19,0.0160889449273848,1,0,0,10.2197240674502,42.2036064723263,CPSF7;FARSA,delta,7
axon development (GO:0061564),4/95,4,95,0.0168105502855943,1,0,0,4.08788962698007,16.7020893060317,APP;MTR;SLIT3;LLGL1,delta,7
covalent chromatin modification (GO:0016569),2/20,2,20,0.0177567519284482,1,0,0,9.70873786407767,39.1358198549094,ZNF335;PRDM10,delta,7
positive regulation of gene silencing by miRNA (GO:2000637),2/20,2,20,0.0177567519284482,1,0,0,9.70873786407767,39.1358198549094,AGO2;PUM1,delta,7
glial cell development (GO:0021782),2/20,2,20,0.0177567519284482,1,0,0,9.70873786407767,39.1358198549094,EIF2B5;APP,delta,7
negative regulation of cellular component organization (GO:0051129),3/55,3,55,0.0190835443190821,1,0,0,5.29567519858782,20.9652014258883,DNAJB2;TRAF3IP1;DNAJA4,delta,7
"mRNA splicing, via spliceosome (GO:0000398)",7/262,7,262,0.019140171699381,1,0,0,2.59393759727266,10.2615287393523,SF3B5;CPSF7;SFPQ;FIP1L1;HNRNPF;BUD31;WDR83,delta,7
regulation of telomere capping (GO:1904353),2/23,2,23,0.0231729223110425,1,0,0,8.44238075137189,31.7836287354636,TNKS2;MAP3K4,delta,7
TOR signaling (GO:0031929),2/23,2,23,0.0231729223110425,1,0,0,8.44238075137189,31.7836287354636,EIF4EBP2;RHEBL1,delta,7
histone H3-K4 methylation (GO:0051568),2/23,2,23,0.0231729223110425,1,0,0,8.44238075137189,31.7836287354636,WDR5;ZNF335,delta,7
autophagosome maturation (GO:0097352),2/23,2,23,0.0231729223110425,1,0,0,8.44238075137189,31.7836287354636,VPS33A;SNAP29,delta,7
vesicle-mediated transport between endosomal compartments (GO:0098927),2/23,2,23,0.0231729223110425,1,0,0,8.44238075137189,31.7836287354636,MYO1D;HOOK3,delta,7
regulation of microtubule cytoskeleton organization (GO:0070507),2/23,2,23,0.0231729223110425,1,0,0,8.44238075137189,31.7836287354636,PHLDB1;TRAF3IP1,delta,7
regulation of translation (GO:0006417),6/214,6,214,0.0237157853573943,1,0,0,2.72207603665729,10.1849589067723,APP;RBM4;RPS6KA1;AGO2;PUM1;EEF2,delta,7
regulation of cell cycle (GO:0051726),6/216,6,216,0.0246807400582015,1,0,0,2.69687162891046,9.98309626279325,RBL2;CDK8;INHBA;PUM1;MAP3K4;PAK4,delta,7
macromolecule modification (GO:0043412),2/25,2,25,0.0271119618777632,1,0,0,7.76699029126214,28.0215941808183,ZNF335;PRDM10,delta,7
receptor catabolic process (GO:0032801),2/25,2,25,0.0271119618777632,1,0,0,7.76699029126214,28.0215941808183,SH3GLB1;PIK3R4,delta,7
regulation of epidermal growth factor-activated receptor activity (GO:0007176),2/25,2,25,0.0271119618777632,1,0,0,7.76699029126214,28.0215941808183,APP;FBXW7,delta,7
positive regulation of type I interferon production (GO:0032481),3/63,3,63,0.0272190172603605,1,0,0,4.62320850670365,16.6613009061378,IRAK1;POLR3E;NFKB1,delta,7
regulation of mitotic cell cycle (GO:0007346),5/166,5,166,0.0288745574654569,1,0,0,2.92431863375833,10.3661084224156,RBL2;APP;CDK8;MAP3K4;PAK4,delta,7
regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),2/26,2,26,0.0291753798046064,1,0,0,7.46825989544436,26.3960424401905,TRIM39;FBXW7,delta,7
positive regulation of embryonic development (GO:0040019),2/26,2,26,0.0291753798046064,1,0,0,7.46825989544436,26.3960424401905,PHLDB1;DAG1,delta,7
cellular protein metabolic process (GO:0044267),10/485,10,485,0.0291847366382666,1,0,0,2.00180162145931,7.07458597585846,APP;IMMP1L;UBE2I;SDC2;AGO2;CALU;EIF4EBP2;MAN2B1;RABGGTB;CKAP4,delta,7
regulation of cell division (GO:0051302),3/66,3,66,0.0306757690602357,1,0,0,4.41306266548985,15.3763557699078,SH3GLB1;KLHL9;PIK3R4,delta,7
regulation of microtubule-based process (GO:0032886),2/27,2,27,0.031299417552219,1,0,0,7.19165767709457,24.913022582988,PHLDB1;TRAF3IP1,delta,7
JNK cascade (GO:0007254),3/67,3,67,0.0318769259560554,1,0,0,4.34719605854224,14.9798848942681,IRAK1;MAP3K6;MAPK8IP3,delta,7
mRNA polyadenylation (GO:0006378),2/28,2,28,0.0334826205059918,1,0,0,6.93481276005548,23.5556779863771,APP;FIP1L1,delta,7
phosphatidylinositol phosphorylation (GO:0046854),2/28,2,28,0.0334826205059918,1,0,0,6.93481276005548,23.5556779863771,EFR3A;PI4KA,delta,7
regulation of epithelial to mesenchymal transition (GO:0010717),3/69,3,69,0.0343522162043019,1,0,0,4.22119037568594,14.2300073620714,PHLDB1;SDHAF2;DAG1,delta,7
regulation of signal transduction (GO:0009966),6/234,6,234,0.034560840175737,1,0,0,2.48941996514812,8.37698288449401,APP;EPHA6;INTU;HOMER1;IRAK1;LLGL1,delta,7
activation of protein kinase activity (GO:0032147),6/234,6,234,0.034560840175737,1,0,0,2.48941996514812,8.37698288449401,IRAK1;ANG;CLSPN;MAP3K6;MAP3K4;PAK4,delta,7
positive regulation of neurogenesis (GO:0050769),3/70,3,70,0.0356261977709822,1,0,0,4.16088765603329,13.8752039638706,FZD3;ZEB1;ZNF335,delta,7
RNA polyadenylation (GO:0043631),2/29,2,29,0.0357235573329591,1,0,0,6.69568128557081,22.3096413695613,APP;FIP1L1,delta,7
positive regulation of cell communication (GO:0010647),2/29,2,29,0.0357235573329591,1,0,0,6.69568128557081,22.3096413695613,HOMER1;KCTD13,delta,7
RNA phosphodiester bond hydrolysis (GO:0090501),2/29,2,29,0.0357235573329591,1,0,0,6.69568128557081,22.3096413695613,PDE12;RNASE4,delta,7
production of miRNAs involved in gene silencing by miRNA (GO:0035196),2/29,2,29,0.0357235573329591,1,0,0,6.69568128557081,22.3096413695613,AGO2;PUM1,delta,7
positive regulation of phosphate metabolic process (GO:0045937),2/29,2,29,0.0357235573329591,1,0,0,6.69568128557081,22.3096413695613,APP;ANG,delta,7
stress-activated protein kinase signaling cascade (GO:0031098),3/71,3,71,0.0369242914981636,1,0,0,4.10228360453986,13.5329644674176,MAP3K4;NFKB1;PAK4,delta,7
regulation of embryonic development (GO:0045995),2/30,2,30,0.0380208196340836,1,0,0,6.47249190938511,21.162597955874,PHLDB1;DAG1,delta,7
lysosomal transport (GO:0007041),3/73,3,73,0.0395924413043137,1,0,0,3.98989227290863,12.8838291864393,AP1G1;VPS33A;HOOK3,delta,7
activation of JUN kinase activity (GO:0007257),2/31,2,31,0.0403730216760329,1,0,0,6.26370184779205,20.1039367201743,MAP3K6;MAPK8IP3,delta,7
negative regulation of macromolecule metabolic process (GO:0010605),4/125,4,125,0.0404647169835294,1,0,0,3.10679611650485,9.96450445099564,RBL2;APP;REL;NFKB1,delta,7
mRNA 3'-end processing (GO:0031124),3/75,3,75,0.0423558574984876,1,0,0,3.88349514563107,12.2782468186239,APP;CPSF7;FIP1L1,delta,7
"regulation of gene expression, epigenetic (GO:0040029)",3/75,3,75,0.0423558574984876,1,0,0,3.88349514563107,12.2782468186239,TAF1D;ZNF335;ACTB,delta,7
cytoskeleton organization (GO:0007010),4/127,4,127,0.042484416535141,1,0,0,3.05787019341029,9.65864365125892,FMNL3;DAG1;WASF3;PAK4,delta,7
lysosome organization (GO:0007040),2/32,2,32,0.0427788000292463,1,0,0,6.06796116504854,19.1244698151002,VPS33A;HOOK3,delta,7
nucleobase-containing small molecule interconversion (GO:0015949),2/32,2,32,0.0427788000292463,1,0,0,6.06796116504854,19.1244698151002,DTYMK;TXNRD1,delta,7
negative regulation of phosphorylation (GO:0042326),3/76,3,76,0.0437730127351685,1,0,0,3.83239652529382,11.9905638698093,TRAF3IP1;PDE12;INHBA,delta,7
positive regulation of NF-kappaB transcription factor activity (GO:0051092),4/129,4,129,0.0445601758210739,1,0,0,3.01046135320238,9.36528859081987,APP;IRAK1;RHEBL1;NFKB1,delta,7
nucleic acid-templated transcription (GO:0097659),3/77,3,77,0.0452136403316866,1,0,0,3.78262514184844,11.712355795309,MEF2A;ZNF219;ILF2,delta,7
hemopoiesis (GO:0030097),3/77,3,77,0.0452136403316866,1,0,0,3.78262514184844,11.712355795309,CD164;ZNF160;INHBA,delta,7
positive regulation of telomere maintenance via telomerase (GO:0032212),2/33,2,33,0.0452368132866658,1,0,0,5.88408355398647,18.216205180266,TNKS2;MAP3K4,delta,7
positive regulation of telomere maintenance (GO:0032206),2/33,2,33,0.0452368132866658,1,0,0,5.88408355398647,18.216205180266,TNKS2;MAP3K4,delta,7
regulation of macromolecule metabolic process (GO:0060255),4/130,4,130,0.0456190643105035,1,0,0,2.98730395817774,9.22309058356058,APP;TOB2;ZNF335;PRDM10,delta,7
regulation of cytokinesis (GO:0032465),3/78,3,78,0.0466776144311646,1,0,0,3.73412994772218,11.4432060403305,SH3GLB1;KLHL9;PIK3R4,delta,7
protein glycosylation (GO:0006486),4/131,4,131,0.0466919469324811,1,0,0,2.96450011116875,9.08377253905434,TNKS2;ALG5;DAG1;FUT4,delta,7
activation of MAPKK activity (GO:0000186),2/34,2,34,0.0477457417463254,1,0,0,5.71102227298687,17.372161017244,MAP3K6;MAP3K4,delta,7
cellular response to glucose starvation (GO:0042149),2/34,2,34,0.0477457417463254,1,0,0,5.71102227298687,17.372161017244,SH3GLB1;PIK3R4,delta,7
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay (GO:0043928),2/34,2,34,0.0477457417463254,1,0,0,5.71102227298687,17.372161017244,EXOSC8;EXOSC1,delta,7
cilium organization (GO:0044782),5/193,5,193,0.0497748625977528,1,0,0,2.51521706323256,7.54626789451867,INTU;TRAF3IP1;TMEM138;WDR5;SNAP29,delta,7
positive regulation of muscle cell differentiation (GO:0051149),2/35,2,35,0.0503042871367639,1,0,0,5.54785020804438,16.5862134488834,MEF2A;RBM4,delta,7
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),2/35,2,35,0.0503042871367639,1,0,0,5.54785020804438,16.5862134488834,TNKS2;MAP3K4,delta,7
macromolecule catabolic process (GO:0009057),2/35,2,35,0.0503042871367639,1,0,0,5.54785020804438,16.5862134488834,SH3GLB1;PIK3R4,delta,7
positive regulation of cell differentiation (GO:0045597),5/195,5,195,0.0516016912650686,1,0,0,2.48941996514812,7.37914072834687,MEF2A;RBM4;CEBPB;RPS6KA1;NFKB1,delta,7
cellular response to organic cyclic compound (GO:0071407),4/136,4,136,0.0522657895968395,1,0,0,2.85551113649343,8.42779337677741,PDE12;ACTB;NFKB1;CCDC62,delta,7
positive regulation of protein targeting to mitochondrion (GO:1903955),3/82,3,82,0.0527642868214816,1,0,0,3.55197726734549,10.4496354596693,SH3GLB1;FBXW7;ARIH2,delta,7
lipid phosphorylation (GO:0046834),2/36,2,36,0.0529111722651811,1,0,0,5.39374325782093,15.8529706929744,EFR3A;PI4KA,delta,7
positive regulation of NIK/NF-kappaB signaling (GO:1901224),2/36,2,36,0.0529111722651811,1,0,0,5.39374325782093,15.8529706929744,APP;IRAK1,delta,7
"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",2/36,2,36,0.0529111722651811,1,0,0,5.39374325782093,15.8529706929744,EXOSC8;EXOSC1,delta,7
membrane protein proteolysis (GO:0033619),2/36,2,36,0.0529111722651811,1,0,0,5.39374325782093,15.8529706929744,DAG1;NFKB1,delta,7
modulation of chemical synaptic transmission (GO:0050804),3/83,3,83,0.0543429358557901,1,0,0,3.50918236051,10.2202853512114,APP;KCTD13;EIF4EBP2,delta,7
ephrin receptor signaling pathway (GO:0048013),3/83,3,83,0.0543429358557901,1,0,0,3.50918236051,10.2202853512114,EPHA6;SDC2;ACTB,delta,7
positive regulation of transferase activity (GO:0051347),4/138,4,138,0.0545927127289412,1,0,0,2.81412691712396,8.18307266537676,EPHA6;UBE2I;FBXW7;MAP3K4,delta,7
actin polymerization or depolymerization (GO:0008154),2/37,2,37,0.0555651407903089,1,0,0,5.24796641301496,15.1676685308471,ANG;WASF3,delta,7
"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",2/37,2,37,0.0555651407903089,1,0,0,5.24796641301496,15.1676685308471,FZD3;AGO2,delta,7
regulation of muscle cell differentiation (GO:0051147),2/37,2,37,0.0555651407903089,1,0,0,5.24796641301496,15.1676685308471,MEF2A;RBM4,delta,7
positive regulation of signaling (GO:0023056),2/37,2,37,0.0555651407903089,1,0,0,5.24796641301496,15.1676685308471,HOMER1;KCTD13,delta,7
glutamate receptor signaling pathway (GO:0007215),2/37,2,37,0.0555651407903089,1,0,0,5.24796641301496,15.1676685308471,APP;HOMER1,delta,7
positive regulation of transcription from RNA polymerase II promoter (GO:0045944),14/849,14,849,0.0566579212403758,1,0,0,1.6009697302366,4.59594138505313,MEF2A;APP;CEBPB;INHBA;SMAD5;NFKB1;FOSL2;CDK8;SFPQ;RPS6KA1;AGO2;REL;E2F5;CCDC62,delta,7
protein modification process (GO:0036211),3/85,3,85,0.0575675514988584,1,0,0,3.42661336379212,9.78228285111619,UBE2I;MAN2B1;RABGGTB,delta,7
positive regulation of receptor activity (GO:2000273),2/38,2,38,0.0582649568695348,1,0,0,5.10986203372509,14.5260830311892,FBXW7;BUD31,delta,7
regulation of hyaluronan biosynthetic process (GO:1900125),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,NFKB1,delta,7
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,FBXW7,delta,7
neuron projection maintenance (GO:1990535),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,APP,delta,7
nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,EXOSC8,delta,7
protein geranylgeranylation (GO:0018344),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,RABGGTB,delta,7
negative regulation of translation in response to stress (GO:0032055),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,RBM4,delta,7
folic acid-containing compound biosynthetic process (GO:0009396),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,ST20-MTHFS,delta,7
mitochondrial ribosome assembly (GO:0061668),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,FASTKD2,delta,7
NADH metabolic process (GO:0006734),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,MDH1B,delta,7
positive regulation of microglial cell activation (GO:1903980),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,APP,delta,7
ventricular cardiac muscle cell development (GO:0055015),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,MEF2A,delta,7
negative regulation of lymphocyte differentiation (GO:0045620),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,INHBA,delta,7
establishment of endothelial intestinal barrier (GO:0090557),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,TJP1,delta,7
nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,EXOSC8,delta,7
negative regulation of sterol transport (GO:0032372),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,NFKB1,delta,7
3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,SLC35B2,delta,7
positive regulation of oxidative stress-induced cell death (GO:1903209),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,SFPQ,delta,7
positive regulation of trophoblast cell migration (GO:1901165),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,AGO2,delta,7
astrocyte differentiation (GO:0048708),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,EIF2B5,delta,7
tRNA catabolic process (GO:0016078),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,EXOSC8,delta,7
negative regulation of cAMP-mediated signaling (GO:0043951),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,PDE3B,delta,7
astrocyte activation (GO:0048143),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,APP,delta,7
single strand break repair (GO:0000012),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,APTX,delta,7
regulation of chemokine-mediated signaling pathway (GO:0070099),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,SLIT3,delta,7
pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,DTYMK,delta,7
regulation of osteoclast development (GO:2001204),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,FBXW7,delta,7
neuron remodeling (GO:0016322),1/6,1,6,0.0602374163024787,1,0,0,16.1812297734628,45.4605434704757,APP,delta,7
neutrophil degranulation (GO:0043312),9/480,9,480,0.0611761094572161,1,0,0,1.82038834951456,5.08616237989725,CMTM6;PDAP1;MAN2B1;EEF2;ILF2;SNAP29;NFKB1;CKAP4;CPPED1,delta,7
neutrophil activation involved in immune response (GO:0002283),9/484,9,484,0.0637476853622719,1,0,0,1.80534381770039,4.96979090764863,CMTM6;PDAP1;MAN2B1;EEF2;ILF2;SNAP29;NFKB1;CKAP4;CPPED1,delta,7
gene expression (GO:0010467),8/412,8,412,0.0639554629761024,1,0,0,1.88519181826751,5.18346371734451,MEF2A;RBM4;FIP1L1;HNRNPF;AGO2;ZNF219;EIF4EBP2;ILF2,delta,7
regulation of protein targeting to mitochondrion (GO:1903214),3/89,3,89,0.0642815059442974,1,0,0,3.27260826879023,8.98161877551411,SH3GLB1;FBXW7;ARIH2,delta,7
neutrophil mediated immunity (GO:0002446),9/488,9,488,0.0663872248842987,1,0,0,1.79054591755531,4.85640930605998,CMTM6;PDAP1;MAN2B1;EEF2;ILF2;SNAP29;NFKB1;CKAP4;CPPED1,delta,7
regulation of cell cycle process (GO:0010564),3/91,3,91,0.0677681153621209,1,0,0,3.2006828123333,8.61516100355706,SH3GLB1;KLHL9;PIK3R4,delta,7
inositol phosphate dephosphorylation (GO:0046855),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,IMPA2,delta,7
axon regeneration (GO:0031103),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,MTR,delta,7
modification by symbiont of host morphology or physiology (GO:0044003),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,DAG1,delta,7
regulation of vitamin D biosynthetic process (GO:0060556),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,NFKB1,delta,7
"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,EXOSC8,delta,7
positive regulation of triglyceride catabolic process (GO:0010898),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,ABHD5,delta,7
cellular response to interferon-alpha (GO:0035457),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,PDE12,delta,7
purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,SLC35B2,delta,7
positive regulation of RIG-I signaling pathway (GO:1900246),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,PUM1,delta,7
exonucleolytic trimming involved in rRNA processing (GO:0000459),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,EXOSC8,delta,7
regulation of DNA endoreduplication (GO:0032875),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,FBXW7,delta,7
oxaloacetate metabolic process (GO:0006107),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,MDH1B,delta,7
purine ribonucleotide transport (GO:0015868),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,SLC35B2,delta,7
sulfur amino acid biosynthetic process (GO:0000097),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,MTR,delta,7
mannose metabolic process (GO:0006013),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,MAN2B1,delta,7
pteridine-containing compound biosynthetic process (GO:0042559),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,ST20-MTHFS,delta,7
miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,AGO2,delta,7
forebrain neuron differentiation (GO:0021879),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,INHBA,delta,7
tetrahydrofolate interconversion (GO:0035999),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,ST20-MTHFS,delta,7
regulation of calcidiol 1-monooxygenase activity (GO:0060558),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,NFKB1,delta,7
negative regulation of glycoprotein biosynthetic process (GO:0010561),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,ITM2C,delta,7
regulation of microglial cell activation (GO:1903978),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,APP,delta,7
box C/D snoRNP assembly (GO:0000492),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,PIH1D2,delta,7
phosphorylated carbohydrate dephosphorylation (GO:0046838),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,IMPA2,delta,7
negative regulation of cell adhesion mediated by integrin (GO:0033629),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,PDE3B,delta,7
regulation of transcription involved in cell fate commitment (GO:0060850),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,CEBPB,delta,7
malate metabolic process (GO:0006108),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,MDH1B,delta,7
adenine nucleotide transport (GO:0051503),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,SLC35B2,delta,7
morphogenesis of a polarized epithelium (GO:0001738),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,TRAF3IP1,delta,7
cAMP catabolic process (GO:0006198),1/7,1,7,0.0699198555965909,1,0,0,13.869625520111,36.8988295825678,PDE3B,delta,7
positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),5/216,5,216,0.0731256478026482,1,0,0,2.24739302409205,5.87822751400063,APP;IRAK1;BUD31;RHEBL1;NFKB1,delta,7
male gonad development (GO:0008584),2/44,2,44,0.0753599609450519,1,0,0,4.41306266548985,11.4098815841096,INHBA;MEA1,delta,7
histone H3 acetylation (GO:0043966),2/44,2,44,0.0753599609450519,1,0,0,4.41306266548985,11.4098815841096,WDR5;ELP4,delta,7
development of primary male sexual characteristics (GO:0046546),2/44,2,44,0.0753599609450519,1,0,0,4.41306266548985,11.4098815841096,INHBA;MEA1,delta,7
regulation of multicellular organismal development (GO:2000026),2/44,2,44,0.0753599609450519,1,0,0,4.41306266548985,11.4098815841096,PHLDB1;DAG1,delta,7
interleukin-1-mediated signaling pathway (GO:0070498),3/96,3,96,0.0768511069202488,1,0,0,3.03398058252427,7.78484649713157,PSMA1;IRAK1;NFKB1,delta,7
"transcription, DNA-templated (GO:0006351)",7/357,7,357,0.0769450502499621,1,0,0,1.90367409099562,4.8822839234783,MEF2A;CEBPB;RNMT;ZNF219;NELFA;ILF2;NFKB1,delta,7
negative regulation of type I interferon production (GO:0032480),2/45,2,45,0.0783477719371147,1,0,0,4.31499460625674,10.9885555464507,TRAF3IP1;REL,delta,7
posttranscriptional regulation of gene expression (GO:0010608),2/45,2,45,0.0783477719371147,1,0,0,4.31499460625674,10.9885555464507,APP;PUM1,delta,7
positive regulation of cytokine production (GO:0001819),5/221,5,221,0.0788755774357422,1,0,0,2.19654702807187,5.57897385505133,CEBPB;IRAK1;POLR3E;PUM1;NFKB1,delta,7
Golgi to lysosome transport (GO:0090160),1/8,1,8,0.0795030167662016,1,0,0,12.1359223300971,30.7276736807905,AP1G1,delta,7
neuron projection extension involved in neuron projection guidance (GO:1902284),1/8,1,8,0.0795030167662016,1,0,0,12.1359223300971,30.7276736807905,SLIT3,delta,7
cellular response to nitric oxide (GO:0071732),1/8,1,8,0.0795030167662016,1,0,0,12.1359223300971,30.7276736807905,MTR,delta,7
late endosome to vacuole transport (GO:0045324),1/8,1,8,0.0795030167662016,1,0,0,12.1359223300971,30.7276736807905,PIK3R4,delta,7
mRNA cleavage (GO:0006379),1/8,1,8,0.0795030167662016,1,0,0,12.1359223300971,30.7276736807905,RNASE4,delta,7
cellular response to angiotensin (GO:1904385),1/8,1,8,0.0795030167662016,1,0,0,12.1359223300971,30.7276736807905,NFKB1,delta,7
amyloid fibril formation (GO:1990000),1/8,1,8,0.0795030167662016,1,0,0,12.1359223300971,30.7276736807905,APP,delta,7
negative regulation of monooxygenase activity (GO:0032769),1/8,1,8,0.0795030167662016,1,0,0,12.1359223300971,30.7276736807905,NFKB1,delta,7
peptidyl-diphthamide metabolic process (GO:0017182),1/8,1,8,0.0795030167662016,1,0,0,12.1359223300971,30.7276736807905,EEF2,delta,7
negative regulation of execution phase of apoptosis (GO:1900118),1/8,1,8,0.0795030167662016,1,0,0,12.1359223300971,30.7276736807905,FZD3,delta,7
axon extension involved in axon guidance (GO:0048846),1/8,1,8,0.0795030167662016,1,0,0,12.1359223300971,30.7276736807905,SLIT3,delta,7
regulation of amyloid fibril formation (GO:1905906),1/8,1,8,0.0795030167662016,1,0,0,12.1359223300971,30.7276736807905,APP,delta,7
peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),1/8,1,8,0.0795030167662016,1,0,0,12.1359223300971,30.7276736807905,EEF2,delta,7
U4 snRNA 3'-end processing (GO:0034475),1/8,1,8,0.0795030167662016,1,0,0,12.1359223300971,30.7276736807905,EXOSC8,delta,7
regulation of store-operated calcium entry (GO:2001256),1/8,1,8,0.0795030167662016,1,0,0,12.1359223300971,30.7276736807905,HOMER1,delta,7
inositol phosphate catabolic process (GO:0071545),1/8,1,8,0.0795030167662016,1,0,0,12.1359223300971,30.7276736807905,IMPA2,delta,7
mitochondrial respiratory chain complex assembly (GO:0033108),3/98,3,98,0.0806268895561394,1,0,0,2.97206261145235,7.48342500827901,CHCHD5;IMMP1L;SDHAF2,delta,7
protein polymerization (GO:0051258),2/46,2,46,0.0813722493056931,1,0,0,4.22119037568594,10.5897888633168,ANG;WASF3,delta,7
positive regulation of cellular biosynthetic process (GO:0031328),4/160,4,160,0.0837761008341892,1,0,0,2.42718446601942,6.01846481815235,DBF4;EEF2;NFKB1;PAOX,delta,7
protein complex disassembly (GO:0043241),2/47,2,47,0.0844323295230606,1,0,0,4.13137781450114,10.2119599235882,VPS33A;SNAP29,delta,7
regulation of lipid metabolic process (GO:0019216),3/101,3,101,0.0864383838159673,1,0,0,2.88378352398347,7.06043481119636,RBL2;CPT1A;TXNRD1,delta,7
"positive regulation of gene expression, epigenetic (GO:0045815)",2/48,2,48,0.0875269668825969,1,0,0,4.0453074433657,9.8535936090465,TAF1D;ACTB,delta,7
histone H4 acetylation (GO:0043967),2/48,2,48,0.0875269668825969,1,0,0,4.0453074433657,9.8535936090465,WDR5;ELP4,delta,7
negative regulation of cellular biosynthetic process (GO:0031327),2/48,2,48,0.0875269668825969,1,0,0,4.0453074433657,9.8535936090465,FBXW7;NFKB1,delta,7
negative regulation of circadian rhythm (GO:0042754),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,SFPQ,delta,7
inositol metabolic process (GO:0006020),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,IMPA2,delta,7
production of siRNA involved in RNA interference (GO:0030422),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,AGO2,delta,7
small RNA loading onto RISC (GO:0070922),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,AGO2,delta,7
mitotic DNA replication checkpoint (GO:0033314),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,CLSPN,delta,7
RNA destabilization (GO:0050779),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,PUM1,delta,7
mitochondrial protein processing (GO:0034982),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,IMMP1L,delta,7
L-fucose metabolic process (GO:0042354),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,FUT4,delta,7
negative regulation of alcohol biosynthetic process (GO:1902931),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,NFKB1,delta,7
response to UV-C (GO:0010225),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,MAP3K4,delta,7
positive regulation of protein sumoylation (GO:0033235),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,UBE2I,delta,7
neuron maturation (GO:0042551),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,APP,delta,7
microtubule anchoring at centrosome (GO:0034454),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,HOOK3,delta,7
regulation of amyloid precursor protein biosynthetic process (GO:0042984),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,ITM2C,delta,7
oligosaccharide catabolic process (GO:0009313),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,MAN2B1,delta,7
cellular response to reactive nitrogen species (GO:1902170),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,MTR,delta,7
negative regulation of interferon-beta production (GO:0032688),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,REL,delta,7
fucose catabolic process (GO:0019317),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,FUT4,delta,7
regulation of endothelial cell differentiation (GO:0045601),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,ZEB1,delta,7
ionotropic glutamate receptor signaling pathway (GO:0035235),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,APP,delta,7
L-fucose catabolic process (GO:0042355),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,FUT4,delta,7
positive regulation of long-term synaptic potentiation (GO:1900273),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,APP,delta,7
nuclear migration (GO:0007097),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,HOOK3,delta,7
small nucleolar ribonucleoprotein complex assembly (GO:0000491),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,PIH1D2,delta,7
regulation of oxidative phosphorylation (GO:0002082),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,PDE12,delta,7
endosome to melanosome transport (GO:0035646),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,AP1G1,delta,7
endosome to pigment granule transport (GO:0043485),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,AP1G1,delta,7
L-ascorbic acid metabolic process (GO:0019852),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,SLC2A1,delta,7
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,HLA-A,delta,7
neuron projection organization (GO:0106027),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,APP,delta,7
nuclear RNA surveillance (GO:0071027),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,EXOSC8,delta,7
positive regulation of astrocyte differentiation (GO:0048711),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,APP,delta,7
cytoskeletal anchoring at plasma membrane (GO:0007016),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,DAG1,delta,7
positive regulation of autophagosome assembly (GO:2000786),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,SH3GLB1,delta,7
protein localization to vacuole (GO:0072665),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,SH3GLB1,delta,7
"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,EXOSC8,delta,7
histone H3-K4 trimethylation (GO:0080182),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,ZNF335,delta,7
cyclic nucleotide catabolic process (GO:0009214),1/9,1,9,0.0889879124800912,1,0,0,10.7874865156419,26.0976778134207,PDE3B,delta,7
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),4/164,4,164,0.0897652349104197,1,0,0,2.36798484489699,5.70816366969891,APP;SLC35B2;IRAK1;REL,delta,7
endosome to lysosome transport (GO:0008333),2/49,2,49,0.0906551332970877,1,0,0,3.96275014860313,9.5133454160007,VPS33A;HOOK3,delta,7
cytoplasmic microtubule organization (GO:0031122),2/49,2,49,0.0906551332970877,1,0,0,3.96275014860313,9.5133454160007,KATNA1;HOOK3,delta,7
glycerophospholipid biosynthetic process (GO:0046474),4/165,4,165,0.0912940035586929,1,0,0,2.35363342159459,5.63382211703498,PIK3R4;PI4KA;ABHD5;CEPT1,delta,7
translation (GO:0006412),5/233,5,233,0.0936331327130419,1,0,0,2.08342014250594,4.93431179665504,AGO2;EIF4EBP2;FARSA;EEF2;ZC3H15,delta,7
protein heterooligomerization (GO:0051291),2/50,2,50,0.0938158179234975,1,0,0,3.88349514563107,9.18998758294487,CPSF7;FARSA,delta,7
gonad development (GO:0008406),2/50,2,50,0.0938158179234975,1,0,0,3.88349514563107,9.18998758294487,INHBA;MEA1,delta,7
lipid homeostasis (GO:0055088),2/50,2,50,0.0938158179234975,1,0,0,3.88349514563107,9.18998758294487,FBXW7;ABHD5,delta,7
positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,FBXW7,delta,7
cardiovascular system development (GO:0072358),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,FBXW7,delta,7
protein-cofactor linkage (GO:0018065),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,SDHAF2,delta,7
protein deglycosylation (GO:0006517),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,MAN2B1,delta,7
ganglion development (GO:0061548),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,FZD3,delta,7
negative regulation of cholesterol transport (GO:0032375),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,NFKB1,delta,7
regulation of myeloid leukocyte differentiation (GO:0002761),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,CEBPB,delta,7
neuron projection regeneration (GO:0031102),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,MTR,delta,7
regulation of cytoplasmic translational elongation (GO:1900247),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,EEF2,delta,7
establishment of spindle localization (GO:0051293),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,LLGL1,delta,7
cellular biogenic amine metabolic process (GO:0006576),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,AMD1,delta,7
positive regulation of amyloid-beta formation (GO:1902004),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,APP,delta,7
contractile actin filament bundle assembly (GO:0030038),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,KCTD13,delta,7
regulation of triglyceride catabolic process (GO:0010896),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,ABHD5,delta,7
negative regulation of embryonic development (GO:0045992),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,FZD3,delta,7
cellular copper ion homeostasis (GO:0006878),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,APP,delta,7
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,BUD31,delta,7
stress fiber assembly (GO:0043149),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,KCTD13,delta,7
positive regulation of lipid localization (GO:1905954),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,NFKB1,delta,7
positive regulation of natural killer cell activation (GO:0032816),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,AP1G1,delta,7
positive regulation of vacuole organization (GO:0044090),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,SH3GLB1,delta,7
regulation of lysosomal lumen pH (GO:0035751),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,VPS33A,delta,7
nucleoside metabolic process (GO:0009116),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,ERH,delta,7
sympathetic ganglion development (GO:0061549),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,FZD3,delta,7
protein prenylation (GO:0018342),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,RABGGTB,delta,7
nuclear mRNA surveillance (GO:0071028),1/10,1,10,0.0983755452548137,1,0,0,9.70873786407767,22.5142041713038,EXOSC8,delta,7
"DNA-templated transcription, termination (GO:0006353)",3/107,3,107,0.0985730915071942,1,0,0,2.72207603665729,6.30693301939645,CPSF7;TAF1D;FIP1L1,delta,7
positive regulation of cellular catabolic process (GO:0031331),3/107,3,107,0.0985730915071942,1,0,0,2.72207603665729,6.30693301939645,SH3GLB1;ABHD5;TRIM65,delta,7
intracellular protein transport (GO:0006886),11/348,11,348,7.37045543192305e-05,0.376114340691033,0,0,4.15910465819722,39.5757356391114,RANBP2;RANBP1;RAB4A;NLGN1;TBC1D9B;SYNRG;CLTC;RUNDC1;TBC1D9;TNPO1;RAB5A,delta,8
regulation of filopodium assembly (GO:0051489),4/37,4,37,0.000174223341600734,0.444530856094273,0,0,14.2247510668563,123.117674387007,DOCK11;NLGN1;PRKCD;RAB5A,delta,8
gene expression (GO:0010467),11/412,11,412,0.000320021901251972,0.544357254029604,0,0,3.513030148186,28.269779111555,MRPL41;NCOA1;RANBP2;CPSF4;RPL30;RPL32;YTHDC2;BUD13;MRPL13;MRRF;SMG6,delta,8
negative regulation of dendritic spine development (GO:0061000),2/6,2,6,0.000843649642294248,0.615020589232507,0,0,43.859649122807,310.428651987624,NLGN1;NGEF,delta,8
regulation of dendritic spine morphogenesis (GO:0061001),3/23,3,23,0.000681670980288799,0.695713402482748,0,0,17.162471395881,125.130951661158,EPHA4;NLGN1;NGEF,delta,8
positive regulation of centrosome cycle (GO:0046607),2/6,2,6,0.000843649642294248,0.717524020771258,0,0,43.859649122807,310.428651987624,RANBP2;RANBP1,delta,8
positive regulation of protein localization to nucleus (GO:1900182),3/43,3,43,0.00425137011168704,0.723158055997966,0,0,9.17992656058752,50.1271172164475,DTX3L;PRKCD;PARP9,delta,8
glycerol-3-phosphate metabolic process (GO:0006072),2/8,2,8,0.00155915007461018,0.723303893703251,0,0,32.8947368421053,212.618895728915,GNPAT;GPD2,delta,8
regulation of telomerase activity (GO:0051972),3/43,3,43,0.00425137011168704,0.748094540687551,0,0,9.17992656058752,50.1271172164475,NEK7;MAPKAPK5;SMG6,delta,8
negative regulation of dendrite morphogenesis (GO:0050774),2/7,2,7,0.00117521983016495,0.749643349166467,0,0,37.593984962406,253.620302984323,NLGN1;NGEF,delta,8
translation (GO:0006412),7/233,7,233,0.00206411350271609,0.752369371740016,0,0,3.95301558617574,24.4417105764296,MRPL41;PTCD3;RPL30;RPL32;IARS;MRPL13;MRRF,delta,8
RNA export from nucleus (GO:0006405),5/120,5,120,0.00224429083750616,0.763507742919594,0,0,5.48245614035088,33.4395048957682,RANBP2;CPSF4;RANBP1;BUD13;SMG6,delta,8
mitochondrial translational termination (GO:0070126),4/90,4,90,0.00494045490386414,0.763973981042991,0,0,5.84795321637427,31.0543734866637,MRPL41;PTCD3;MRRF;MRPL13,delta,8
"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",2/13,2,13,0.00423636119497933,0.772076827784982,0,0,20.2429149797571,110.608311476549,CPSF4;CSTF2,delta,8
positive regulation of telomere maintenance (GO:0032206),3/33,3,33,0.00198655030492107,0.77979740046248,0,0,11.9617224880383,74.4181298999618,NEK7;ATRX;MAPKAPK5,delta,8
"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",2/14,2,14,0.00491787201689144,0.784246903193656,0,0,18.796992481203,99.9037473483518,CPSF4;CSTF2,delta,8
negative regulation of cAMP-dependent protein kinase activity (GO:2000480),2/8,2,8,0.00155915007461018,0.795634283073576,0,0,32.8947368421053,212.618895728915,PRKAR1B;PKIA,delta,8
mRNA cleavage involved in mRNA processing (GO:0098787),2/13,2,13,0.00423636119497933,0.800672265851093,0,0,20.2429149797571,110.608311476549,CPSF4;CSTF2,delta,8
monocarboxylic acid biosynthetic process (GO:0072330),4/69,4,69,0.00188960639791849,0.803555120714839,0,0,7.627765064836,47.8366645817564,SRR;OSBPL6;ACSM3;OSBP,delta,8
regulation of phosphate metabolic process (GO:0019220),2/14,2,14,0.00491787201689144,0.809545190393452,0,0,18.796992481203,99.9037473483518,BARD1;SMG6,delta,8
cellular protein localization (GO:0034613),8/328,8,328,0.00366403215064395,0.812937220205916,0,0,3.20924261874198,18.0012549982981,RAB4A;TBC1D9B;SYNRG;CLTC;RUNDC1;TBC1D9;WIPI2;RAB5A,delta,8
positive regulation of double-strand break repair (GO:2000781),2/15,2,15,0.00564629878421816,0.823230362739007,0,0,17.5438596491228,90.8202637004089,DTX3L;PARP9,delta,8
synaptic vesicle cycle (GO:0099504),2/13,2,13,0.00423636119497933,0.831467352999212,0,0,20.2429149797571,110.608311476549,NLGN1;RAB5A,delta,8
cell cycle G1/S phase transition (GO:0044843),4/93,4,93,0.00554753763890396,0.832620134450792,0,0,5.65930956423316,29.3967239294839,RANBP2;ORC4;RANBP1;CCNE2,delta,8
pre-mRNA cleavage required for polyadenylation (GO:0098789),2/12,2,12,0.00360251775531864,0.835620368426864,0,0,21.9298245614035,123.379875032729,CPSF4;CSTF2,delta,8
regulation of chromatin binding (GO:0035561),2/11,2,11,0.00301710175481558,0.855348347490217,0,0,23.9234449760766,138.838722301977,DTX3L;PARP9,delta,8
regulation of cAMP-dependent protein kinase activity (GO:2000479),2/13,2,13,0.00423636119497933,0.86472604711918,0,0,20.2429149797571,110.608311476549,PRKAR1B;PKIA,delta,8
regulation of telomere capping (GO:1904353),3/23,3,23,0.000681670980288799,0.869641753103436,0,0,17.162471395881,125.130951661158,NEK7;MAPKAPK5;SMG6,delta,8
nucleosome organization (GO:0034728),4/80,4,80,0.0032416381207535,0.87063575422132,0,0,6.57894736842105,37.7083979218535,CHAF1B;HIST3H2A;ATRX;HIST3H2BB,delta,8
regulation of double-strand break repair via nonhomologous end joining (GO:2001032),2/12,2,12,0.00360251775531864,0.875411814542429,0,0,21.9298245614035,123.379875032729,DTX3L;PARP9,delta,8
clathrin-dependent endocytosis (GO:0072583),3/40,3,40,0.00346051325846288,0.882949957896803,0,0,9.86842105263158,55.9178127662928,GAK;NLGN1;CLTC,delta,8
positive regulation of chromatin binding (GO:0035563),2/8,2,8,0.00155915007461018,0.884038092303973,0,0,32.8947368421053,212.618895728915,DTX3L;PARP9,delta,8
regulation of vesicle-mediated transport (GO:0060627),5/139,5,139,0.0042222951138855,0.897765498589904,0,0,4.73305566073457,25.8773969752272,RAB4A;TBC1D9B;RUNDC1;TBC1D9;RAB5A,delta,8
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),4/101,4,101,0.00740497807194816,0.899704835741701,0,0,5.21104742053153,25.5633287780936,RANBP2;CPSF4;BUD13;SMG6,delta,8
regulation of telomere maintenance via telomerase (GO:0032210),3/52,3,52,0.00724440258865456,0.901663083168396,0,0,7.59109311740891,37.4053099573038,NEK7;MAPKAPK5;SMG6,delta,8
transcytosis (GO:0045056),2/11,2,11,0.00301710175481558,0.905662956166112,0,0,23.9234449760766,138.838722301977,CLTC;RAB5A,delta,8
translational termination (GO:0006415),4/97,4,97,0.00643180386574774,0.911708197969742,0,0,5.42593597395551,27.3819872006499,MRPL41;PTCD3;MRPL13;MRRF,delta,8
positive regulation of telomere capping (GO:1904355),2/17,2,17,0.00724093700202408,0.923762538033222,0,0,15.4798761609907,76.2849018698066,NEK7;MAPKAPK5,delta,8
regulation of synaptic vesicle exocytosis (GO:2000300),2/17,2,17,0.00724093700202408,0.947448756957151,0,0,15.4798761609907,76.2849018698066,NLGN1;RAB5A,delta,8
phosphatidylinositol biosynthetic process (GO:0006661),4/99,4,99,0.00690705215359414,0.952613165940294,0,0,5.31632110579479,26.4498263587037,PI4K2B;RAB4A;PIK3R1;RAB5A,delta,8
regulation of mitotic centrosome separation (GO:0046602),2/11,2,11,0.00301710175481558,0.962266890926494,0,0,23.9234449760766,138.838722301977,RANBP2;RANBP1,delta,8
cellular macromolecule biosynthetic process (GO:0034645),8/368,8,368,0.00721693507791427,0.969158413226224,0,0,2.8604118993135,14.1056204824054,BARD1;MRPL41;NCOA1;ORC4;RPL30;RPL32;MRPL13;MRRF,delta,8
mRNA export from nucleus (GO:0006406),4/106,4,106,0.00875184177286565,0.970883664498552,0,0,4.96524329692155,23.5277612335386,RANBP2;CPSF4;BUD13;SMG6,delta,8
G1/S transition of mitotic cell cycle (GO:0000082),4/106,4,106,0.00875184177286565,0.992458857042964,0,0,4.96524329692155,23.5277612335386,RANBP2;ORC4;RANBP1;CCNE2,delta,8
glycerophospholipid biosynthetic process (GO:0046474),5/165,5,165,0.00861165174976236,0.998755883614484,0,0,3.98724082934609,18.9578913001854,PI4K2B;GNPAT;RAB4A;PIK3R1;RAB5A,delta,8
mRNA transport (GO:0051028),4/105,4,105,0.00847059626045975,1,0,0,5.0125313283208,23.9155607821926,RANBP2;CPSF4;BUD13;SMG6,delta,8
mitochondrial translation (GO:0032543),4/108,4,108,0.00933249768076252,1,0,0,4.87329434697856,22.7790087509137,MRPL41;PTCD3;MRPL13;MRRF,delta,8
regulation of vacuole organization (GO:0044088),2/20,2,20,0.00996646428845589,1,0,0,13.1578947368421,60.6385446442877,LAPTM4B;RAB5A,delta,8
phosphatidylinositol metabolic process (GO:0046488),4/113,4,113,0.0108923634016421,1,0,0,4.65766185374942,21.0512032633423,PI4K2B;RAB4A;PIK3R1;RAB5A,delta,8
peptide biosynthetic process (GO:0043043),5/175,5,175,0.0109240526880979,1,0,0,3.7593984962406,16.9804069632769,MRPL41;RPL30;RPL32;MRPL13;MRRF,delta,8
positive regulation of defense response to virus by host (GO:0002230),2/21,2,21,0.0109610786653184,1,0,0,12.531328320802,56.5589546859219,DTX3L;PARP9,delta,8
regulation of organelle organization (GO:0033043),4/114,4,114,0.0112232636740727,1,0,0,4.61680517082179,20.728377382931,ZEB2;TBC1D9B;RUNDC1;TBC1D9,delta,8
nucleosome assembly (GO:0006334),3/61,3,61,0.011227806515887,1,0,0,6.47109577221743,29.0510905063686,CHAF1B;ATRX;HIST3H2BB,delta,8
regulation of vesicle fusion (GO:0031338),3/62,3,62,0.0117341179117001,1,0,0,6.36672325976231,28.3017059834929,TBC1D9B;RUNDC1;TBC1D9,delta,8
peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),2/22,2,22,0.0119975832364343,1,0,0,11.9617224880383,52.9072972062325,ZDHHC9;ZDHHC4,delta,8
peptidyl-L-cysteine S-palmitoylation (GO:0018230),2/22,2,22,0.0119975832364343,1,0,0,11.9617224880383,52.9072972062325,ZDHHC9;ZDHHC4,delta,8
NLS-bearing protein import into nucleus (GO:0006607),2/22,2,22,0.0119975832364343,1,0,0,11.9617224880383,52.9072972062325,RANBP2;TNPO1,delta,8
tRNA processing (GO:0008033),3/63,3,63,0.0122533965505827,1,0,0,6.265664160401,27.58115357762,CPSF4;PTCD1;CSTF2,delta,8
protein transport (GO:0015031),7/327,7,327,0.0126509177317567,1,0,0,2.81667471430871,12.3089403787727,RAB4A;TBC1D9B;SYNRG;CLTC;RUNDC1;TBC1D9;RAB5A,delta,8
membrane assembly (GO:0071709),2/23,2,23,0.0130752925229749,1,0,0,11.441647597254,49.6227791371551,GAK;NLGN1,delta,8
chromatin assembly (GO:0031497),3/66,3,66,0.0138895209930745,1,0,0,5.98086124401914,25.5778744530521,CHAF1B;ATRX;HIST3H2BB,delta,8
protein deubiquitination (GO:0016579),6/258,6,258,0.0141447576843792,1,0,0,3.05997552019584,13.0306340428626,BARD1;MBD5;USP42;PSMD1;NEDD8;FOXK1,delta,8
negative regulation of protein serine/threonine kinase activity (GO:0071901),3/68,3,68,0.0150459354771031,1,0,0,5.80495356037152,24.3613432211421,PRKAR1B;PKIA;PRKCD,delta,8
protein modification by small protein removal (GO:0070646),6/262,6,262,0.015152418391937,1,0,0,3.0132583366814,12.6243324525977,BARD1;MBD5;USP42;PSMD1;NEDD8;FOXK1,delta,8
regulation of epidermal growth factor-activated receptor activity (GO:0007176),2/25,2,25,0.0153516226286872,1,0,0,10.5263157894737,43.9635168613309,GPRC5A;NCK2,delta,8
cellular senescence (GO:0090398),2/25,2,25,0.0153516226286872,1,0,0,10.5263157894737,43.9635168613309,PRKCD;MAPKAPK5,delta,8
regulation of telomere maintenance (GO:0032204),2/26,2,26,0.0165489115664886,1,0,0,10.1214574898785,41.5124994503753,ATRX;SMG6,delta,8
positive regulation of filopodium assembly (GO:0051491),2/26,2,26,0.0165489115664886,1,0,0,10.1214574898785,41.5124994503753,DOCK11;NLGN1,delta,8
regulation of mRNA stability (GO:0043488),4/129,4,129,0.016979292401442,1,0,0,4.07996736026112,16.6289709157009,PRKCD;PSMD1;IGF2BP2;TNPO1,delta,8
bile acid biosynthetic process (GO:0006699),2/27,2,27,0.0177847413009564,1,0,0,9.74658869395711,39.2730450253356,OSBPL6;OSBP,delta,8
phosphatidylinositol phosphorylation (GO:0046854),2/28,2,28,0.01905846496125,1,0,0,9.3984962406015,37.2203376051182,PI4K2B;PIK3R1,delta,8
regulation of protein localization to nucleus (GO:1900180),2/28,2,28,0.01905846496125,1,0,0,9.3984962406015,37.2203376051182,DTX3L;PARP9,delta,8
regulation of mRNA processing (GO:0050684),2/29,2,29,0.0203694431745012,1,0,0,9.07441016333938,35.3332067575681,CPSF4;SLTM,delta,8
positive regulation of transferase activity (GO:0051347),4/138,4,138,0.0211786968399454,1,0,0,3.813882532418,14.7015998038171,EPHA4;DTX3L;NEK7;MAPKAPK5,delta,8
synaptic vesicle endocytosis (GO:0048488),2/30,2,30,0.0217170439806355,1,0,0,8.7719298245614,33.5934902617037,GAK;NLGN1,delta,8
synaptic vesicle recycling (GO:0036465),2/30,2,30,0.0217170439806355,1,0,0,8.7719298245614,33.5934902617037,NLGN1;RAB5A,delta,8
regulation of small GTPase mediated signal transduction (GO:0051056),4/141,4,141,0.0227077269818927,1,0,0,3.73273609555804,14.1285928209711,ARHGAP32;DEPDC1B;ARHGEF12;NGEF,delta,8
regulation of defense response to virus by host (GO:0050691),2/31,2,31,0.0231006427672299,1,0,0,8.48896434634975,31.9855249271672,DTX3L;PARP9,delta,8
replication fork processing (GO:0031297),2/31,2,31,0.0231006427672299,1,0,0,8.48896434634975,31.9855249271672,ETAA1;ATRX,delta,8
protein palmitoylation (GO:0018345),2/31,2,31,0.0231006427672299,1,0,0,8.48896434634975,31.9855249271672,ZDHHC9;ZDHHC4,delta,8
bile acid metabolic process (GO:0008206),2/31,2,31,0.0231006427672299,1,0,0,8.48896434634975,31.9855249271672,OSBPL6;OSBP,delta,8
modification-dependent protein catabolic process (GO:0019941),4/142,4,142,0.0232319770490837,1,0,0,3.70644922164566,13.9444982514502,RANBP2;RANBP1;DTX3L;NEDD8,delta,8
regulation of dendritic spine development (GO:0060998),2/32,2,32,0.0245196221844043,1,0,0,8.22368421052632,30.4957366488423,EPHA4;NLGN1,delta,8
regulation of protein tyrosine kinase activity (GO:0061097),2/32,2,32,0.0245196221844043,1,0,0,8.22368421052632,30.4957366488423,EPHA4;NCK2,delta,8
ephrin receptor signaling pathway (GO:0048013),3/83,3,83,0.0254153197199432,1,0,0,4.75586556753329,17.465455682588,EPHA4;NCK2;NGEF,delta,8
positive regulation of telomere maintenance via telomerase (GO:0032212),2/33,2,33,0.0259733720779601,1,0,0,7.97448165869219,29.1123079474416,NEK7;MAPKAPK5,delta,8
viral process (GO:0016032),5/221,5,221,0.0270032215990903,1,0,0,2.97689926172898,10.7519620790988,RANBP2;RANBP1;RPL30;RPL32;AP1M1,delta,8
activation of GTPase activity (GO:0090630),3/85,3,85,0.0270251062174218,1,0,0,4.64396284829721,16.7692986925319,TBC1D9B;RUNDC1;TBC1D9,delta,8
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),2/35,2,35,0.0289827782444761,1,0,0,7.5187969924812,26.624462248386,NEK7;MAPKAPK5,delta,8
mitochondrial translational elongation (GO:0070125),3/88,3,88,0.0295397725521759,1,0,0,4.48564593301435,15.7985243790254,MRPL41;PTCD3;MRPL13,delta,8
lipid phosphorylation (GO:0046834),2/36,2,36,0.0305372495345787,1,0,0,7.30994152046784,25.5029827801801,PI4K2B;PIK3R1,delta,8
positive regulation of telomerase activity (GO:0051973),2/36,2,36,0.0305372495345787,1,0,0,7.30994152046784,25.5029827801801,NEK7;MAPKAPK5,delta,8
DNA-dependent DNA replication maintenance of fidelity (GO:0045005),2/36,2,36,0.0305372495345787,1,0,0,7.30994152046784,25.5029827801801,ETAA1;ATRX,delta,8
endosome organization (GO:0007032),2/37,2,37,0.0321241212058392,1,0,0,7.11237553342817,24.453400367007,PI4K2B;LAPTM4B,delta,8
organic hydroxy compound transport (GO:0015850),2/37,2,37,0.0321241212058392,1,0,0,7.11237553342817,24.453400367007,NCOA1;OSBP,delta,8
regulation of response to DNA damage stimulus (GO:2001020),2/37,2,37,0.0321241212058392,1,0,0,7.11237553342817,24.453400367007,ETAA1;PRKCD,delta,8
protein-DNA complex assembly (GO:0065004),3/92,3,92,0.0330784926078709,1,0,0,4.29061784897025,14.6261669534305,CHAF1B;ATRX;HIST3H2BB,delta,8
positive regulation of mitotic nuclear division (GO:0045840),2/41,2,41,0.0387842078881282,1,0,0,6.41848523748395,20.8584218767512,RANBP2;RANBP1,delta,8
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),2/42,2,42,0.0405245871075195,1,0,0,6.265664160401,20.086756892225,NLGN1;CDH24,delta,8
negative regulation of cell projection organization (GO:0031345),2/42,2,42,0.0405245871075195,1,0,0,6.265664160401,20.086756892225,GAK;EPHA4,delta,8
regulation of intracellular signal transduction (GO:1902531),7/423,7,423,0.0430560920317996,1,0,0,2.17742938907553,6.84856315558175,BARD1;ARHGAP32;DEPDC1B;NLGN1;ARHGEF12;MAPKAPK5;NGEF,delta,8
regulation of protein localization to early endosome (GO:1902965),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,DTX3L,delta,8
regulation of hyaluronan biosynthetic process (GO:1900125),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,CLTC,delta,8
regulation of glial cell differentiation (GO:0045685),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,EPHA4,delta,8
polyamine biosynthetic process (GO:0006596),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,SMS,delta,8
negative regulation of transforming growth factor beta production (GO:0071635),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,LAPTM4B,delta,8
positive regulation of protein localization to endosome (GO:1905668),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,DTX3L,delta,8
positive regulation of aspartic-type peptidase activity (GO:1905247),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,EPHA4,delta,8
positive regulation of protein localization to early endosome (GO:1902966),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,DTX3L,delta,8
regulation of nuclear cell cycle DNA replication (GO:0033262),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,ATRX,delta,8
regulation of cell cycle checkpoint (GO:1901976),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,ETAA1,delta,8
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,ATF3,delta,8
positive regulation of phospholipid transport (GO:2001140),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,PRKCD,delta,8
positive regulation of sodium ion transmembrane transport (GO:1902307),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,GLRX,delta,8
positive regulation of clathrin-dependent endocytosis (GO:2000370),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,NLGN1,delta,8
retinal ganglion cell axon guidance (GO:0031290),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,ALCAM,delta,8
azole transport (GO:0045117),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,SLC15A4,delta,8
spermine metabolic process (GO:0008215),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,SMS,delta,8
regulation of lysosomal protein catabolic process (GO:1905165),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,LAPTM4B,delta,8
intermediate filament bundle assembly (GO:0045110),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,NEFM,delta,8
regulation of glial cell apoptotic process (GO:0034350),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,PRKCD,delta,8
forebrain regionalization (GO:0021871),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,WNT2B,delta,8
signal complex assembly (GO:0007172),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,NCK2,delta,8
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),1/6,1,6,0.0447475921851276,1,0,0,21.9298245614035,68.1297728427149,EPHA4,delta,8
protein import into nucleus (GO:0006606),3/104,3,104,0.0449506773597289,1,0,0,3.79554655870445,11.7745044875864,RANBP2;RANBP1;TNPO1,delta,8
posttranscriptional regulation of gene expression (GO:0010608),2/45,2,45,0.0459178830409848,1,0,0,5.84795321637427,18.0169627430255,MAPKAPK5;PARP9,delta,8
translational elongation (GO:0006414),3/106,3,106,0.0471092096285982,1,0,0,3.72393247269116,11.3776815921974,MRPL41;PTCD3;MRPL13,delta,8
"DNA-templated transcription, termination (GO:0006353)",3/107,3,107,0.0482073865463088,1,0,0,3.68912936546975,11.1863367750299,CPSF4;POLR1A;CSTF2,delta,8
polyol metabolic process (GO:0019751),2/48,2,48,0.0515583670832979,1,0,0,5.48245614035088,16.2557059848451,PLCB3;ITPK1,delta,8
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),2/48,2,48,0.0515583670832979,1,0,0,5.48245614035088,16.2557059848451,NLGN1;ALCAM,delta,8
inositol phosphate metabolic process (GO:0043647),2/48,2,48,0.0515583670832979,1,0,0,5.48245614035088,16.2557059848451,PLCB3;ITPK1,delta,8
ATP hydrolysis coupled proton transport (GO:0015991),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,ATP1A1,delta,8
histone H3-K4 demethylation (GO:0034720),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,KDM1A,delta,8
cellular lipid biosynthetic process (GO:0097384),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,GNPAT,delta,8
cellular divalent inorganic anion homeostasis (GO:0072501),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,GPCPD1,delta,8
zinc II ion transmembrane import (GO:0071578),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,SLC39A10,delta,8
ATP hydrolysis coupled cation transmembrane transport (GO:0099132),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,ATP1A1,delta,8
regulation of alpha-beta T cell differentiation (GO:0046637),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,NKAP,delta,8
positive regulation of sphingolipid biosynthetic process (GO:0090154),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,PRKCD,delta,8
cellular trivalent inorganic anion homeostasis (GO:0072502),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,GPCPD1,delta,8
negative regulation of glial cell apoptotic process (GO:0034351),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,PRKCD,delta,8
pri-miRNA transcription from RNA polymerase II promoter (GO:0061614),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,FOSL1,delta,8
negative regulation of axon regeneration (GO:0048681),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,EPHA4,delta,8
ribosomal protein import into nucleus (GO:0006610),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,TNPO1,delta,8
positive regulation of ceramide biosynthetic process (GO:2000304),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,PRKCD,delta,8
negative regulation of telomere capping (GO:1904354),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,SMG6,delta,8
tRNA 3'-end processing (GO:0042780),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,PTCD1,delta,8
glyoxylate metabolic process (GO:0046487),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,GRHPR,delta,8
marginal zone B cell differentiation (GO:0002315),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,DOCK11,delta,8
cellular phosphate ion homeostasis (GO:0030643),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,GPCPD1,delta,8
negative regulation of nitrogen compound metabolic process (GO:0051172),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,CLTC,delta,8
cellular response to hydroxyurea (GO:0072711),1/7,1,7,0.052009671210746,1,0,0,18.796992481203,55.5700299411975,ATRX,delta,8
viral gene expression (GO:0019080),3/111,3,111,0.0527248892976129,1,0,0,3.55618776671408,10.4646787063942,RANBP2;RPL30;RPL32,delta,8
cellular response to peptide hormone stimulus (GO:0071375),3/111,3,111,0.0527248892976129,1,0,0,3.55618776671408,10.4646787063942,PRKAR1B;PRKCD;PIK3R1,delta,8
regulation of protein binding (GO:0043393),3/112,3,112,0.0538851766459245,1,0,0,3.52443609022556,10.2945248639681,KDM1A;DTX3L;PRKCD,delta,8
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",3/113,3,113,0.0550577093043364,1,0,0,3.49324639031206,10.1282256069845,RPL30;RPL32;SMG6,delta,8
organic hydroxy compound biosynthetic process (GO:1901617),2/50,2,50,0.0554491879134877,1,0,0,5.26315789473684,15.2225695298761,OSBPL6;OSBP,delta,8
viral transcription (GO:0019083),3/114,3,114,0.0562424254286023,1,0,0,3.46260387811634,9.96566449450146,RANBP2;RPL30;RPL32,delta,8
receptor internalization (GO:0031623),2/51,2,51,0.05743225250948,1,0,0,5.15995872033024,14.7427721519549,CLTC;RAB5A,delta,8
Golgi to lysosome transport (GO:0090160),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,GAK,delta,8
neuron projection extension involved in neuron projection guidance (GO:1902284),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,ALCAM,delta,8
stress-induced premature senescence (GO:0090400),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,MAPKAPK5,delta,8
positive regulation of membrane potential (GO:0045838),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,GLRX,delta,8
cellular response to angiotensin (GO:1904385),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,PRKCD,delta,8
negative regulation of platelet aggregation (GO:0090331),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,PRKCD,delta,8
positive regulation of behavior (GO:0048520),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,NLGN1,delta,8
negative regulation of neuron projection regeneration (GO:0070571),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,EPHA4,delta,8
positive regulation of alpha-beta T cell differentiation (GO:0046638),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,NKAP,delta,8
response to hydroperoxide (GO:0033194),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,PRKCD,delta,8
protein K6-linked ubiquitination (GO:0085020),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,BARD1,delta,8
regulation of endodeoxyribonuclease activity (GO:0032071),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,PRKCD,delta,8
axon extension involved in axon guidance (GO:0048846),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,ALCAM,delta,8
excitatory synapse assembly (GO:1904861),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,NLGN1,delta,8
ribosome disassembly (GO:0032790),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,MRRF,delta,8
nose development (GO:0043584),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,SMCHD1,delta,8
response to hydroxyurea (GO:0072710),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,ATRX,delta,8
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,EPHA4,delta,8
cellular monovalent inorganic anion homeostasis (GO:0030320),1/8,1,8,0.0592169038679493,1,0,0,16.4473684210526,46.4892802556008,GPCPD1,delta,8
negative regulation of neuron projection development (GO:0010977),2/52,2,52,0.0594397692871531,1,0,0,5.06072874493927,14.2853834009163,GAK;EPHA4,delta,8
positive regulation of GTPase activity (GO:0043547),4/193,4,193,0.059932311755036,1,0,0,2.72702481592583,7.67531903736601,DOCK11;TBC1D9B;RUNDC1;TBC1D9,delta,8
cytosolic transport (GO:0016482),3/119,3,119,0.0623465125917783,1,0,0,3.3171163202123,9.20515548824829,GAK;CLTC;RAB5A,delta,8
positive regulation of protein import into nucleus (GO:0042307),2/54,2,54,0.0635262427463539,1,0,0,4.87329434697856,13.4322718657922,PRKCD;PIK3R1,delta,8
cytoplasmic translation (GO:0002181),2/55,2,55,0.0656042555663192,1,0,0,4.78468899521531,13.0340416923367,RPL30;RPL32,delta,8
inositol metabolic process (GO:0006020),1/9,1,9,0.0663697013463757,1,0,0,14.6198830409357,39.6566466617402,ITPK1,delta,8
galactose catabolic process (GO:0019388),1/9,1,9,0.0663697013463757,1,0,0,14.6198830409357,39.6566466617402,PGM2L1,delta,8
postsynaptic membrane assembly (GO:0097104),1/9,1,9,0.0663697013463757,1,0,0,14.6198830409357,39.6566466617402,NLGN1,delta,8
postsynaptic density organization (GO:0097106),1/9,1,9,0.0663697013463757,1,0,0,14.6198830409357,39.6566466617402,NLGN1,delta,8
mature B cell differentiation involved in immune response (GO:0002313),1/9,1,9,0.0663697013463757,1,0,0,14.6198830409357,39.6566466617402,DOCK11,delta,8
negative regulation of mRNA 3'-end processing (GO:0031441),1/9,1,9,0.0663697013463757,1,0,0,14.6198830409357,39.6566466617402,BARD1,delta,8
granulocyte activation (GO:0036230),1/9,1,9,0.0663697013463757,1,0,0,14.6198830409357,39.6566466617402,PRKCD,delta,8
ether lipid metabolic process (GO:0046485),1/9,1,9,0.0663697013463757,1,0,0,14.6198830409357,39.6566466617402,GNPAT,delta,8
potassium ion import across plasma membrane (GO:1990573),1/9,1,9,0.0663697013463757,1,0,0,14.6198830409357,39.6566466617402,ATP1A1,delta,8
hexose catabolic process (GO:0019320),1/9,1,9,0.0663697013463757,1,0,0,14.6198830409357,39.6566466617402,PGM2L1,delta,8
B cell homeostasis (GO:0001782),1/9,1,9,0.0663697013463757,1,0,0,14.6198830409357,39.6566466617402,DOCK11,delta,8
regulation of endoplasmic reticulum unfolded protein response (GO:1900101),1/9,1,9,0.0663697013463757,1,0,0,14.6198830409357,39.6566466617402,PIK3R1,delta,8
endosome to melanosome transport (GO:0035646),1/9,1,9,0.0663697013463757,1,0,0,14.6198830409357,39.6566466617402,AP1M1,delta,8
endosome to pigment granule transport (GO:0043485),1/9,1,9,0.0663697013463757,1,0,0,14.6198830409357,39.6566466617402,AP1M1,delta,8
lipoprotein biosynthetic process (GO:0042158),1/9,1,9,0.0663697013463757,1,0,0,14.6198830409357,39.6566466617402,WIPI2,delta,8
histone phosphorylation (GO:0016572),1/9,1,9,0.0663697013463757,1,0,0,14.6198830409357,39.6566466617402,PRKCD,delta,8
negative regulation of transcription from RNA polymerase II promoter (GO:0000122),8/566,8,566,0.0675664719989907,1,0,0,1.85977310768086,5.01142532139941,ZEB2;RIPPLY2;KDM1A;NFIL3;ATRX;TCEAL1;PARP9;ATF3,delta,8
DNA recombination (GO:0006310),2/56,2,56,0.067704832725444,1,0,0,4.69924812030075,12.6531847612244,BARD1;ATRX,delta,8
positive regulation of DNA biosynthetic process (GO:2000573),2/56,2,56,0.067704832725444,1,0,0,4.69924812030075,12.6531847612244,NEK7;MAPKAPK5,delta,8
protein import (GO:0017038),2/57,2,57,0.0698275164931172,1,0,0,4.61680517082179,12.2886755669374,RANBP2;RANBP1,delta,8
epidermal growth factor receptor signaling pathway (GO:0007173),2/58,2,58,0.0719718546757665,1,0,0,4.53720508166969,11.9395650801782,NCK2;PIK3R1,delta,8
positive regulation of signal transduction (GO:0009967),4/207,4,207,0.0734273530073838,1,0,0,2.54258835494533,6.63986462243735,DEPDC1B;NLGN1;MBD5;PIK3R1,delta,8
low-density lipoprotein particle receptor catabolic process (GO:0032802),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,CLTC,delta,8
negative regulation of cellular protein catabolic process (GO:1903363),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,EPHA4,delta,8
cellular response to growth hormone stimulus (GO:0071378),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,PIK3R1,delta,8
regulation of DNA damage checkpoint (GO:2000001),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,ETAA1,delta,8
"energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)",1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,ATP1A1,delta,8
presynaptic membrane assembly (GO:0097105),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,NLGN1,delta,8
neuron projection fasciculation (GO:0106030),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,EPHA4,delta,8
N-acetylneuraminate metabolic process (GO:0006054),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,NANP,delta,8
cellular biogenic amine metabolic process (GO:0006576),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,SMS,delta,8
positive regulation of amyloid-beta formation (GO:1902004),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,EPHA4,delta,8
galactose metabolic process (GO:0006012),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,PGM2L1,delta,8
aspartate family amino acid metabolic process (GO:0009066),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,SMS,delta,8
positive regulation of glucose import in response to insulin stimulus (GO:2001275),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,PIK3R1,delta,8
"regulation of DNA-templated transcription, initiation (GO:2000142)",1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,FOSL1,delta,8
regulation of astrocyte differentiation (GO:0048710),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,EPHA4,delta,8
regulation of mRNA 3'-end processing (GO:0031440),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,BARD1,delta,8
DNA replication-dependent nucleosome organization (GO:0034723),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,CHAF1B,delta,8
negative regulation of homotypic cell-cell adhesion (GO:0034111),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,PRKCD,delta,8
regulation of phospholipid metabolic process (GO:1903725),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,PIK3R1,delta,8
histone H2B ubiquitination (GO:0033523),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,DTX3L,delta,8
protein localization to synapse (GO:0035418),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,NLGN1,delta,8
central nervous system projection neuron axonogenesis (GO:0021952),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,EPHA4,delta,8
motor neuron axon guidance (GO:0008045),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,EPHA4,delta,8
regulation of axon regeneration (GO:0048679),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,EPHA4,delta,8
insulin-like growth factor receptor signaling pathway (GO:0048009),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,PIK3R1,delta,8
DNA replication-dependent nucleosome assembly (GO:0006335),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,CHAF1B,delta,8
positive regulation of circadian rhythm (GO:0042753),1/10,1,10,0.0734684718687947,1,0,0,13.1578947368421,34.3539331441653,NLGN1,delta,8
non-canonical Wnt signaling pathway (GO:0035567),3/128,3,128,0.0740704573849832,1,0,0,3.08388157894737,8.02653735178589,PLCB3;CLTC;PSMD1,delta,8
regulation of protein metabolic process (GO:0051246),2/60,2,60,0.076323713214089,1,0,0,4.3859649122807,11.2840859640403,NEDD8;IGF2BP2,delta,8
methionine metabolic process (GO:0006555),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,SMS,delta,8
regulation of histone H3-K9 methylation (GO:0051570),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,ATRX,delta,8
phosphate ion homeostasis (GO:0055062),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,GPCPD1,delta,8
postsynapse assembly (GO:0099068),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,NLGN1,delta,8
regulation of lipid kinase activity (GO:0043550),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,PIK3R1,delta,8
negative regulation of protein localization to nucleus (GO:1900181),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,POLR1A,delta,8
positive regulation by host of viral process (GO:0044794),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,YTHDC2,delta,8
positive regulation of superoxide anion generation (GO:0032930),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,PRKCD,delta,8
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,KDM1A,delta,8
UV-damage excision repair (GO:0070914),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,HIST3H2A,delta,8
protein localization to pre-autophagosomal structure (GO:0034497),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,WIPI2,delta,8
regulation of synaptic vesicle cycle (GO:0098693),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,RAB5A,delta,8
modulation by host of viral genome replication (GO:0044827),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,YTHDC2,delta,8
intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,PRKCD,delta,8
carbohydrate phosphorylation (GO:0046835),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,ITPK1,delta,8
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,ATF3,delta,8
positive regulation of sodium ion transmembrane transporter activity (GO:2000651),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,GLRX,delta,8
"regulation of synaptic transmission, GABAergic (GO:0032228)",1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,NLGN1,delta,8
low-density lipoprotein receptor particle metabolic process (GO:0032799),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,CLTC,delta,8
relaxation of cardiac muscle (GO:0055119),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,ATP1A1,delta,8
presynaptic membrane organization (GO:0097090),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,NLGN1,delta,8
regulation of ceramide biosynthetic process (GO:2000303),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,PRKCD,delta,8
cardiac muscle cell membrane repolarization (GO:0099622),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,ATP1A1,delta,8
relaxation of muscle (GO:0090075),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,ATP1A1,delta,8
negative regulation of nucleocytoplasmic transport (GO:0046823),1/11,1,11,0.0805136206673202,1,0,0,11.9617224880383,30.1355132539975,BARD1,delta,8
RNA 3'-end processing (GO:0031123),2/62,2,62,0.0807569002590761,1,0,0,4.24448217317487,10.6804408675951,CPSF4;CSTF2,delta,8
protein targeting to membrane (GO:0006612),2/62,2,62,0.0807569002590761,1,0,0,4.24448217317487,10.6804408675951,ZDHHC9;ZDHHC4,delta,8
positive regulation of cellular amide metabolic process (GO:0034250),2/62,2,62,0.0807569002590761,1,0,0,4.24448217317487,10.6804408675951,EPHA4;PRKCD,delta,8
protein targeting (GO:0006605),3/134,3,134,0.0823905768740515,1,0,0,2.94579732914375,7.35354734956031,NLGN1;ZDHHC9;ZDHHC4,delta,8
establishment of protein localization to organelle (GO:0072594),2/63,2,63,0.0830029191555978,1,0,0,4.17710944026734,10.3963220603786,RANBP2;RANBP1,delta,8
regulation of systemic arterial blood pressure (GO:0003073),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,PLCB3,delta,8
axonal fasciculation (GO:0007413),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,EPHA4,delta,8
histone H3-K9 demethylation (GO:0033169),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,KDM1A,delta,8
import across plasma membrane (GO:0098739),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,ATP1A1,delta,8
protein localization to kinetochore (GO:0034501),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,MTBP,delta,8
modification-dependent macromolecule catabolic process (GO:0043632),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,NEDD8,delta,8
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,KDM1A,delta,8
amino sugar biosynthetic process (GO:0046349),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,NANP,delta,8
regulation of cytokine biosynthetic process (GO:0042035),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,IGF2BP2,delta,8
viral RNA genome replication (GO:0039694),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,RAB5A,delta,8
regulation of long-term neuronal synaptic plasticity (GO:0048169),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,RAB5A,delta,8
positive regulation of DNA-dependent DNA replication (GO:2000105),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,ATRX,delta,8
cellular response to arsenic-containing substance (GO:0071243),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,ATF3,delta,8
positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,PIK3R1,delta,8
"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,KDM1A,delta,8
L-serine metabolic process (GO:0006563),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,SRR,delta,8
PERK-mediated unfolded protein response (GO:0036499),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,ATF3,delta,8
positive regulation of amyloid precursor protein catabolic process (GO:1902993),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,EPHA4,delta,8
negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,AP1AR,delta,8
polyamine metabolic process (GO:0006595),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,SMS,delta,8
endosome transport via multivesicular body sorting pathway (GO:0032509),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,LAPTM4B,delta,8
positive regulation of ruffle assembly (GO:1900029),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,NLGN1,delta,8
membrane repolarization during action potential (GO:0086011),1/12,1,12,0.0875055499955368,1,0,0,10.9649122807018,26.7111081042725,ATP1A1,delta,8
negative regulation of neuron differentiation (GO:0045665),2/65,2,65,0.0875517079901073,1,0,0,4.04858299595142,9.86042798259708,GAK;EPHA4,delta,8
mitotic cell cycle phase transition (GO:0044772),4/222,4,222,0.0894488461386782,1,0,0,2.37079184447606,5.72330101617428,RANBP2;ORC4;RANBP1;CCNE2,delta,8
Ras protein signal transduction (GO:0007265),4/224,4,224,0.0917030579409787,1,0,0,2.34962406015038,5.61372075433707,RAB4A;MAPKAPK5;RAB5A;CTNNAL1,delta,8
purine ribonucleotide metabolic process (GO:0009150),2/67,2,67,0.092173425573212,1,0,0,3.92772977219167,9.36403541182924,GMPR2;BPNT1,delta,8
positive regulation of cellular protein localization (GO:1903829),2/67,2,67,0.092173425573212,1,0,0,3.92772977219167,9.36403541182924,DTX3L;PARP9,delta,8
positive regulation of Wnt signaling pathway (GO:0030177),3/141,3,141,0.0925809380308074,1,0,0,2.79955207166853,6.66201570918157,DEPDC1B;WNT2B;PSMD1,delta,8
double-strand break repair (GO:0006302),3/142,3,142,0.0940776793184967,1,0,0,2.77983691623425,6.57051833462901,BARD1;DTX3L;PARP9,delta,8
protein neddylation (GO:0045116),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,NEDD8,delta,8
sodium ion export from cell (GO:0036376),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,ATP1A1,delta,8
regulation of superoxide anion generation (GO:0032928),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,PRKCD,delta,8
glycerolipid catabolic process (GO:0046503),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,GPCPD1,delta,8
regulation of NMDA receptor activity (GO:2000310),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,NLGN1,delta,8
DNA replication-independent nucleosome organization (GO:0034724),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,ATRX,delta,8
muscle cell development (GO:0055001),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,KDM1A,delta,8
chromatin assembly or disassembly (GO:0006333),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,CHAF1B,delta,8
regulation of glucose import in response to insulin stimulus (GO:2001273),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,PIK3R1,delta,8
negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,GPRC5A,delta,8
regulation of macromolecule biosynthetic process (GO:0010556),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,IGF2BP2,delta,8
multivesicular body sorting pathway (GO:0071985),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,LAPTM4B,delta,8
serine family amino acid biosynthetic process (GO:0009070),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,SRR,delta,8
sodium ion export (GO:0071436),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,ATP1A1,delta,8
cellular potassium ion homeostasis (GO:0030007),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,ATP1A1,delta,8
negative regulation of ubiquitin-protein transferase activity (GO:0051444),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,DTX3L,delta,8
synaptic vesicle localization (GO:0097479),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,NLGN1,delta,8
regulation of synaptic vesicle transport (GO:1902803),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,RAB5A,delta,8
ribonucleoprotein complex disassembly (GO:0032988),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,MRRF,delta,8
protein kinase C-activating G-protein coupled receptor signaling pathway (GO:0007205),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,PRKD3,delta,8
membrane repolarization (GO:0086009),1/13,1,13,0.0944446591214453,1,0,0,10.1214574898785,23.8840205848784,ATP1A1,delta,8
negative regulation of protein binding (GO:0032091),2/68,2,68,0.0945106244191517,1,0,0,3.86996904024768,9.12942346395539,KDM1A;PRKCD,delta,8
cellular response to UV (GO:0034644),2/68,2,68,0.0945106244191517,1,0,0,3.86996904024768,9.12942346395539,HIST3H2A;KDM1A,delta,8
regulation of protein localization to plasma membrane (GO:1903076),2/68,2,68,0.0945106244191517,1,0,0,3.86996904024768,9.12942346395539,CLTC;PIK3R1,delta,8
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),3/143,3,143,0.095584411756884,1,0,0,2.7603974972396,6.48071088283871,NLGN1;ALCAM;CDH24,delta,8
regulation of transcription from RNA polymerase II promoter (GO:0006357),16/1479,16,1479,0.0967763239530323,1,0,0,1.42343688836696,3.32422746788799,NCOA1;KDM1A;ATRX;FOXK1;PIK3R1;PARP9;FOSL1;FAM83G;ZEB2;RIPPLY2;SLTM;NFIL3;TCEAL1;NCK2;ATF3;BRWD3,delta,8
regulation of actin filament polymerization (GO:0030833),2/69,2,69,0.0968648555986775,1,0,0,3.813882532418,8.9032742684688,PRKCD;NCK2,delta,8
termination of RNA polymerase II transcription (GO:0006369),2/69,2,69,0.0968648555986775,1,0,0,3.813882532418,8.9032742684688,CPSF4;CSTF2,delta,8
endosomal transport (GO:0016197),4/230,4,230,0.0986272560188591,1,0,0,2.2883295194508,5.30070394819631,LAPTM4B;DTX3L;CLTC;RAB5A,delta,8
cellular protein complex assembly (GO:0043623),3/145,3,145,0.0986275081232991,1,0,0,2.72232304900182,6.30600291079351,CLTC;NCK2;PTGES3L,delta,8
regulation of endocytosis (GO:0030100),2/70,2,70,0.099235729469658,1,0,0,3.7593984962406,8.68517726854786,RAB4A;RAB5A,delta,8
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),2/70,2,70,0.099235729469658,1,0,0,3.7593984962406,8.68517726854786,DOCK11;NLGN1,delta,8
MyD88-independent toll-like receptor signaling pathway (GO:0002756),5/31,5,31,4.11937135336627e-05,0.0420423040324561,0,0,12.7000254000508,128.235012666819,TBK1;UBB;IKBKG;TANK;BIRC2,delta,9
regulation of necrotic cell death (GO:0010939),4/13,4,13,1.65992453066397e-05,0.0423529743998913,0,0,24.2277407631738,266.654229608497,HEBP2;UBB;TANK;BIRC2,delta,9
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),5/30,5,30,3.49093850446443e-05,0.044535647970705,0,0,13.1233595800525,134.681822210661,TBK1;UBB;IKBKG;TANK;BIRC2,delta,9
activation of protein kinase activity (GO:0032147),13/234,13,234,9.88839901529522e-06,0.0504605001750515,0,0,4.37445319335083,50.4118473515946,DUSP5;GADD45B;STK39;TANK;STK10;PAK1;SLK;KARS;UBB;PEA15;IKBKG;PAK2;CRK,delta,9
stress-activated protein kinase signaling cascade (GO:0031098),7/71,7,71,3.26488391787714e-05,0.0555356754430902,0,0,7.76311411777753,80.1906496556504,STK10;PAK1;SLK;UBB;STK39;IKBKG;PAK2,delta,9
positive regulation of MAP kinase activity (GO:0043406),10/178,10,178,9.62750201542151e-05,0.0701844896924228,0,0,4.42360435282668,40.9108275189032,DUSP5;PAK1;KARS;UBB;GADD45B;PEA15;STK39;IKBKG;CRK;TANK,delta,9
I-kappaB kinase/NF-kappaB signaling (GO:0007249),6/58,6,58,9.21014352226588e-05,0.0783322706568713,0,0,8.14553353244638,75.6933480710007,TBK1;UBB;IKBKG;TANK;BIRC2;NFKB2,delta,9
positive regulation of protein kinase activity (GO:0045860),9/173,9,173,0.000379051122816402,0.241787234966512,0,0,4.09630877065222,32.2700629281908,STK10;XRCC6;PAK1;SLK;RPLP1;STK39;RAPGEF2;MAPRE3;PAK2,delta,9
positive regulation of cytokine production involved in immune response (GO:0002720),3/15,3,15,0.000822621457130128,0.381621572339549,0,0,15.748031496063,111.858494771391,KARS;TANK;B2M,delta,9
regulation of programmed cell death (GO:0043067),11/269,11,269,0.000684785217638662,0.388273218401121,0,0,3.21985774083072,23.4611885716654,STK10;PAK1;SLK;UBB;CASP6;STK39;TMEM219;FYN;TANK;PAK2;BIRC2,delta,9
regulation of cytokine-mediated signaling pathway (GO:0001959),6/91,6,91,0.00107105185550828,0.390398401332769,0,0,5.19165873496582,35.506346305341,UBB;TNFAIP3;IKBKG;ABCE1;TANK;BIRC2,delta,9
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),5/57,5,57,0.000776202143830665,0.396095953996789,0,0,6.90703135792237,49.4619255220109,UBB;TNFAIP3;IKBKG;TANK;BIRC2,delta,9
protein polyubiquitination (GO:0000209),11/284,11,284,0.00106569932104432,0.418327971945319,0,0,3.04979483198403,20.8731741749459,FBXL20;PSMD12;UBE2H;ANKIB1;UBB;TNFAIP3;UBE2G1;TANK;ANAPC10;BIRC2;RNF41,delta,9
regulation of necroptotic process (GO:0060544),3/16,3,16,0.00100299609230652,0.426524088253347,0,0,14.7637795275591,101.940408454952,UBB;TANK;BIRC2,delta,9
ubiquitin-dependent protein catabolic process (GO:0006511),12/342,12,342,0.00149343865081424,0.508067829007004,0,0,2.76281254316895,17.9767205376746,ATE1;PSMD12;UBE2H;ANKIB1;WDR81;UBB;FAF1;HECTD4;TNFAIP3;UBE2G1;ANAPC10;BIRC2,delta,9
positive regulation of protein ubiquitination (GO:0031398),5/84,5,84,0.00434056880465919,0.598646557031779,0,0,4.68691413573303,25.4956406002821,UBB;COMMD1;BMI1;HSPBP1;BIRC2,delta,9
microvillus assembly (GO:0030033),2/8,2,8,0.00427701639265198,0.606267073658418,0,0,19.6850393700787,107.372039704711,RAPGEF2;EZR,delta,9
"fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",2/7,2,7,0.00323479338323943,0.611375949432253,0,0,22.4971878515186,128.994155730881,ELOVL4;ELOVL5,delta,9
regulation of type I interferon production (GO:0032479),5/86,5,86,0.00479771943330422,0.612069056703786,0,0,4.57791613257645,24.4443077826143,XRCC6;TBK1;UBB;TNFAIP3;NFKB2,delta,9
regulation of p38MAPK cascade (GO:1900744),3/27,3,27,0.00472662242823395,0.618460365417381,0,0,8.74890638670166,46.8464077508309,GADD45B;KARS;EZR,delta,9
microvillus organization (GO:0032528),2/8,2,8,0.00427701639265198,0.623588990048659,0,0,19.6850393700787,107.372039704711,RAPGEF2;EZR,delta,9
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),3/29,3,29,0.00579564770990515,0.629259367311617,0,0,8.14553353244638,41.9547763070392,UBB;TNFAIP3;IKBKG,delta,9
stimulatory C-type lectin receptor signaling pathway (GO:0002223),6/122,6,122,0.00469533368740312,0.630533889653109,0,0,3.87246676132697,20.7610149577314,PSMD12;PAK1;UBB;FYN;IKBKG;PAK2,delta,9
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",2/9,2,9,0.00545311559934562,0.632437475078652,0,0,17.4978127734033,91.1910439902555,HLA-B;B2M,delta,9
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",3/22,3,22,0.00260747225456056,0.633615757858216,0,0,10.7372942018611,63.8801790813318,UBB;XPA;CHD1L,delta,9
"fatty acid elongation, saturated fatty acid (GO:0019367)",2/7,2,7,0.00323479338323943,0.634890409025801,0,0,22.4971878515186,128.994155730881,ELOVL4;ELOVL5,delta,9
positive regulation of mRNA 3'-end processing (GO:0031442),2/8,2,8,0.00427701639265198,0.641929842697149,0,0,19.6850393700787,107.372039704711,NCBP2;PAF1,delta,9
regulation of defense response to virus by virus (GO:0050690),3/29,3,29,0.00579564770990515,0.642938918774913,0,0,8.14553353244638,41.9547763070392,FYN;PAK2;B2M,delta,9
negative regulation of microtubule polymerization (GO:0031115),2/9,2,9,0.00545311559934562,0.647145323336296,0,0,17.4978127734033,91.1910439902555,STMN1;TBCD,delta,9
DNA metabolic process (GO:0006259),11/315,11,315,0.00241320784235512,0.648136822080957,0,0,2.74965629296338,16.5716240414739,SMARCAL1;XRCC6;UBB;XPA;NABP2;TERF2IP;CHD1L;RBPJ;INIP;PTMS;POLG,delta,9
"negative regulation of gene expression, epigenetic (GO:0045814)",3/26,3,26,0.00424080259511017,0.655782292207491,0,0,9.08540278619019,49.6335802818174,CREBZF;SUZ12;BMI1,delta,9
activation of MAPK activity (GO:0000187),6/118,6,118,0.00399075138736346,0.656929171926315,0,0,4.00373682103296,22.115744354097,DUSP5;KARS;UBB;PEA15;STK39;IKBKG,delta,9
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),3/29,3,29,0.00579564770990515,0.657226450303244,0,0,8.14553353244638,41.9547763070392,SEC23A;HLA-B;B2M,delta,9
innate immune response activating cell surface receptor signaling pathway (GO:0002220),6/125,6,125,0.00528090672323785,0.657279683138604,0,0,3.77952755905512,19.8185479110106,PSMD12;PAK1;UBB;FYN;IKBKG;PAK2,delta,9
"fatty acid elongation, monounsaturated fatty acid (GO:0034625)",2/7,2,7,0.00323479338323943,0.660286025386833,0,0,22.4971878515186,128.994155730881,ELOVL4;ELOVL5,delta,9
Notch signaling involved in heart development (GO:0061314),2/9,2,9,0.00545311559934562,0.662553545320493,0,0,17.4978127734033,91.1910439902555,SNAI1;RBPJ,delta,9
very long-chain fatty acid metabolic process (GO:0000038),3/30,3,30,0.00637995398972025,0.664426636929438,0,0,7.8740157480315,39.799955852709,ELOVL4;ELOVL5;ACOX1,delta,9
regulation of calcium ion transport into cytosol (GO:0010522),3/22,3,22,0.00260747225456056,0.665296545751127,0,0,10.7372942018611,63.8801790813318,P2RX4;GPRIN1;FYN,delta,9
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),3/25,3,25,0.00378664664413715,0.666319235345927,0,0,9.44881889763779,52.6892073260887,UBB;TNFAIP3;IKBKG,delta,9
regulation of neuron death (GO:1901214),5/73,5,73,0.00236298329123492,0.669905763065099,0,0,5.39316147125445,32.6169256380057,TBK1;UBB;FYN;IKBKG;TANK,delta,9
"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",3/26,3,26,0.00424080259511017,0.676275488838975,0,0,9.08540278619019,49.6335802818174,UBB;TNFAIP3;IKBKG,delta,9
regulation of mRNA 3'-end processing (GO:0031440),2/10,2,10,0.00675954960968691,0.676352581533966,0,0,15.748031496063,78.6897482981547,NCBP2;PAF1,delta,9
fatty acid oxidation (GO:0019395),4/51,4,51,0.00397632507773755,0.676372895723157,0,0,6.17569862590706,34.1355394999884,HADHB;HADHA;ACOX1;HACL1,delta,9
NIK/NF-kappaB signaling (GO:0038061),5/81,5,81,0.00371432417128105,0.676935580215972,0,0,4.86050354816759,27.1972321194864,PSMD12;UBB;TANK;BIRC2;NFKB2,delta,9
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",3/30,3,30,0.00637995398972025,0.678268858532134,0,0,7.8740157480315,39.799955852709,UBB;XPA;CHD1L,delta,9
RNA secondary structure unwinding (GO:0010501),4/47,4,47,0.00295239029242612,0.684820348284113,0,0,6.70128999832468,39.0359535473398,EIF4A2;DDX17;DDX18;DDX46,delta,9
"fatty acid elongation, unsaturated fatty acid (GO:0019368)",2/7,2,7,0.00323479338323943,0.687797943111285,0,0,22.4971878515186,128.994155730881,ELOVL4;ELOVL5,delta,9
negative regulation of sodium ion transmembrane transport (GO:1902306),2/10,2,10,0.00675954960968691,0.689879633164646,0,0,15.748031496063,78.6897482981547,STK39;COMMD1,delta,9
MAPK cascade (GO:0000165),10/279,10,279,0.003120826690987,0.692416461048115,0,0,2.82222786667796,16.283287746445,DUSP5;PSMD12;KARS;UBB;GPRIN1;PEA15;RAPGEF2;FYN;IKBKG;RASAL2,delta,9
cardiolipin acyl-chain remodeling (GO:0035965),2/6,2,6,0.00233005684573131,0.699428240221581,0,0,26.246719160105,159.104005627101,HADHB;HADHA,delta,9
ceramide transport (GO:0035627),2/6,2,6,0.00233005684573131,0.74314250523543,0,0,26.246719160105,159.104005627101,PSAP;PLEKHA8,delta,9
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),3/32,3,32,0.00765062894022117,0.750791528499012,0,0,7.38188976377953,35.9717083177789,PEA15;TNFAIP3;TANK,delta,9
global genome nucleotide-excision repair (GO:0070911),3/33,3,33,0.00833788133100161,0.773603789674568,0,0,7.15819613457409,34.2658992980281,UBB;XPA;CHD1L,delta,9
hepatocyte growth factor receptor signaling pathway (GO:0048012),2/11,2,11,0.00819284475794367,0.774223829625677,0,0,14.3163922691482,68.7830221350795,PAK1;STMN1,delta,9
calcineurin-NFAT signaling cascade (GO:0033173),2/11,2,11,0.00819284475794367,0.788831826411067,0,0,14.3163922691482,68.7830221350795,NFAT5;NFATC3,delta,9
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),4/66,4,66,0.0098956374435338,0.814474804425048,0,0,4.77213075638273,22.0265391612076,UBB;COMMD1;TANK;HSPBP1,delta,9
calcineurin-mediated signaling (GO:0097720),2/12,2,12,0.00974959397276834,0.815609476115358,0,0,13.1233595800525,60.7681054942013,NFAT5;NFATC3,delta,9
regulation of cysteine-type endopeptidase activity (GO:2000116),3/37,3,37,0.0114417416971468,0.822355040570985,0,0,6.38433709299851,28.5410963504874,GPRIN1;FYN;BIRC2,delta,9
positive regulation of T cell cytokine production (GO:0002726),2/12,2,12,0.00974959397276834,0.829202967383947,0,0,13.1233595800525,60.7681054942013,TANK;B2M,delta,9
cardiolipin metabolic process (GO:0032048),2/13,2,13,0.0114264556600935,0.832988617620817,0,0,12.1138703815869,54.1710955813933,HADHB;HADHA,delta,9
peptidyl-methionine modification (GO:0018206),2/12,2,12,0.00974959397276834,0.843257254966726,0,0,13.1233595800525,60.7681054942013,METAP1D;NAA16,delta,9
regulation of G2/M transition of mitotic cell cycle (GO:0010389),6/150,6,150,0.012415522578523,0.844752156242707,0,0,3.1496062992126,13.8230165933762,PLK4;RINT1;PSMD12;UBB;TUBA4A;SDCCAG8,delta,9
alpha-linolenic acid metabolic process (GO:0036109),2/13,2,13,0.0114264556600935,0.845060916426915,0,0,12.1138703815869,54.1710955813933,ELOVL5;ACOX1,delta,9
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",3/38,3,38,0.0123079783781735,0.848751535997559,0,0,6.21632822213013,27.3363504657275,UBB;XPA;CHD1L,delta,9
negative regulation of cation transmembrane transport (GO:1904063),2/14,2,14,0.0132201526041539,0.853954920746801,0,0,11.2485939257593,48.661562443133,STK39;COMMD1,delta,9
regulation of T cell cytokine production (GO:0002724),2/13,2,13,0.0114264556600935,0.857488282844958,0,0,12.1138703815869,54.1710955813933,TANK;B2M,delta,9
positive regulation of peptidase activity (GO:0010952),2/12,2,12,0.00974959397276834,0.857796173155808,0,0,13.1233595800525,60.7681054942013,KARS;TANK,delta,9
regulation of microtubule polymerization (GO:0031113),3/36,3,36,0.0106118949332832,0.859563489595938,0,0,6.56167979002625,29.8279510728457,PAK1;STMN1;TBCD,delta,9
negative regulation of G0 to G1 transition (GO:0070317),3/38,3,38,0.0123079783781735,0.860378269367389,0,0,6.21632822213013,27.3363504657275,SUZ12;MGA;BMI1,delta,9
positive regulation of kinase activity (GO:0033674),5/114,5,114,0.0152237702995039,0.863187775981871,0,0,3.45351567896118,14.4526082233514,XRCC6;RYK;RPLP1;RAPGEF2;MAPRE3,delta,9
regulation of defense response to virus (GO:0050688),2/14,2,14,0.0132201526041539,0.864903060756376,0,0,11.2485939257593,48.661562443133,ELMOD2;TNFAIP3,delta,9
regulation of cell junction assembly (GO:1901888),2/15,2,15,0.0151274708769575,0.867364987473195,0,0,10.498687664042,44.0025503899407,SNAI1;RAPGEF2,delta,9
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),3/40,3,40,0.0141505434139627,0.870002687246407,0,0,5.90551181102362,25.1456825894686,PEA15;TNFAIP3;TANK,delta,9
regulation of mitotic cell cycle phase transition (GO:1901990),7/185,7,185,0.00954836993092523,0.870095209955562,0,0,2.97935731006597,13.8581373860127,PLK4;PSMD12;UBB;MAD2L1BP;TUBA4A;ANAPC10;SDCCAG8,delta,9
very long-chain fatty acid biosynthetic process (GO:0042761),2/13,2,13,0.0114264556600935,0.870286615424734,0,0,12.1138703815869,54.1710955813933,ELOVL4;ELOVL5,delta,9
epithelial to mesenchymal transition (GO:0001837),3/38,3,38,0.0123079783781735,0.872327967553047,0,0,6.21632822213013,27.3363504657275,DDX17;SNAI1;RBPJ,delta,9
fatty acid elongation (GO:0030497),2/12,2,12,0.00974959397276834,0.872845228825208,0,0,13.1233595800525,60.7681054942013,ELOVL4;ELOVL5,delta,9
protein complex assembly (GO:0006461),7/190,7,190,0.0109506018613752,0.873139395290588,0,0,2.90095317032739,13.0959494480094,ANKRD28;SEC23A;TNFAIP3;HACL1;STX2;CRK;TANK,delta,9
macroautophagy (GO:0016236),5/111,5,111,0.0136997821563678,0.873874854299312,0,0,3.54685394055473,15.2173347069218,PLEKHF2;VMP1;UBB;C6ORF106;DYNLL2,delta,9
cell surface receptor signaling pathway involved in heart development (GO:0061311),2/14,2,14,0.0132201526041539,0.876135568038926,0,0,11.2485939257593,48.661562443133,SNAI1;RBPJ,delta,9
DNA duplex unwinding (GO:0032508),3/42,3,42,0.0161411594907315,0.876258902991519,0,0,5.62429696287964,23.208002132431,UBB;XPA;CHD1L,delta,9
regulation of cell-substrate junction assembly (GO:0090109),2/15,2,15,0.0151274708769575,0.87722140778539,0,0,10.498687664042,44.0025503899407,SLK;CORO1C,delta,9
regulation of phosphatase activity (GO:0010921),4/73,4,73,0.0139553718258193,0.879188425026613,0,0,4.31452917700356,18.4311973582926,PLEKHF2;PPP1R2;WDR81;TIPRL,delta,9
regulation of G0 to G1 transition (GO:0070316),3/40,3,40,0.0141505434139627,0.880612476115265,0,0,5.90551181102362,25.1456825894686,SUZ12;MGA;BMI1,delta,9
response to iron ion (GO:0010039),2/13,2,13,0.0114264556600935,0.883472776264502,0,0,12.1138703815869,54.1710955813933,ACO1;B2M,delta,9
mesenchymal cell differentiation (GO:0048762),3/42,3,42,0.0161411594907315,0.885681041733364,0,0,5.62429696287964,23.208002132431,DDX17;SNAI1;RBPJ,delta,9
negative regulation of interleukin-2 production (GO:0032703),2/15,2,15,0.0151274708769575,0.887304412472578,0,0,10.498687664042,44.0025503899407,TNFAIP3;EZR,delta,9
protein ubiquitination (GO:0016567),13/507,13,507,0.0132169454786583,0.887448326020965,0,0,2.01897839693115,8.73461644317995,PSMD12;UBE2H;ANKIB1;MSL2;UBE2G1;COMMD1;TANK;RNF41;FBXL20;UBB;HECTD4;PAF1;BIRC2,delta,9
proteasomal protein catabolic process (GO:0010498),8/238,8,238,0.0113329367488054,0.88972271121775,0,0,2.6467279825316,11.8574526206546,ATE1;PSMD12;UBB;FAF1;HECTD4;ANAPC10;BIRC2;RNF41,delta,9
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),7/205,7,205,0.0160510601966155,0.890310436775317,0,0,2.68868830420588,11.1096073094168,TBK1;UBB;TNFAIP3;TERF2IP;IKBKG;TANK;BIRC2,delta,9
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",4/76,4,76,0.0159751325803033,0.895836280849317,0,0,4.14421881475342,17.1434810589161,PSMD12;HLA-B;IKBKG;B2M,delta,9
"protein localization to chromosome, telomeric region (GO:0070198)",2/15,2,15,0.0151274708769575,0.897621905640864,0,0,10.498687664042,44.0025503899407,NABP2;TERF2IP,delta,9
"nucleotide-excision repair, DNA incision (GO:0033683)",3/41,3,41,0.0151272637036721,0.908169725645161,0,0,5.76147493758402,24.1478199725695,UBB;XPA;CHD1L,delta,9
intraciliary transport involved in cilium assembly (GO:0035735),3/41,3,41,0.0151272637036721,0.91898126999808,0,0,5.76147493758402,24.1478199725695,IFT140;DYNLL2;SSX2IP,delta,9
positive regulation of mRNA processing (GO:0050685),2/16,2,16,0.0171452587784693,0.920971111016093,0,0,9.84251968503937,40.0200157446569,NCBP2;PAF1,delta,9
protein deubiquitination (GO:0016579),8/258,8,258,0.0176294047149566,0.937113044379411,0,0,2.44155527070744,9.8594568726155,PSMD12;UBB;TNFAIP3;RCE1;IKBKG;JOSD1;TANK;BIRC2,delta,9
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),4/79,4,79,0.018169555381375,0.955868465063473,0,0,3.98684341672481,15.9792997779459,PSMD12;HLA-B;IKBKG;B2M,delta,9
T cell receptor signaling pathway (GO:0050852),6/164,6,164,0.018512403173644,0.963967279541891,0,0,2.88073746879201,11.4921672644276,PSMD12;PAK1;UBB;FYN;IKBKG;PAK2,delta,9
negative regulation of type I interferon production (GO:0032480),3/45,3,45,0.0194070851402204,0.980538172975691,0,0,5.249343832021,20.6935279064232,TBK1;UBB;TNFAIP3,delta,9
N-terminal protein amino acid modification (GO:0031365),2/17,2,17,0.0192704257773996,0.9833698274207,0,0,9.26354793886058,36.5834525377462,METAP1D;NAA16,delta,9
protein modification by small protein removal (GO:0070646),8/262,8,262,0.0191411300885117,0.986638250926014,0,0,2.40427961771954,9.51112785096686,PSMD12;UBB;TNFAIP3;RCE1;IKBKG;JOSD1;TANK;BIRC2,delta,9
positive regulation of p38MAPK cascade (GO:1900745),2/18,2,18,0.0214999414862093,0.988416228866,0,0,8.74890638670166,33.5932201699378,GADD45B;KARS,delta,9
intraciliary transport (GO:0042073),3/47,3,47,0.0217720024560413,0.991986861903382,0,0,5.02596749874351,19.2350331325324,IFT140;DYNLL2;SSX2IP,delta,9
regulation of telomerase RNA localization to Cajal body (GO:1904872),2/18,2,18,0.0214999414862093,0.9974018309466,0,0,8.74890638670166,33.5932201699378,EXOSC10;CCT4,delta,9
regulation of cell cycle (GO:0051726),7/216,7,216,0.0207304872096347,0.997996945573263,0,0,2.55176436278799,9.89102105250279,STK10;PAK1;SLK;GADD45B;STK39;PAK2;BIRC2,delta,9
neuron projection development (GO:0031175),6/168,6,168,0.0205740960222534,0.999901066681517,0,0,2.81214848143982,10.9216042438671,PAK1;UBB;RYK;GPRIN1;STMN1;RAPGEF2,delta,9
protein catabolic process (GO:0030163),4/82,4,82,0.0205426045375368,1,0,0,3.84098329172268,14.9231967710001,ATE1;UBE2G1;IDE;RNF41,delta,9
positive regulation of protein catabolic process (GO:0045732),4/82,4,82,0.0205426045375368,1,0,0,3.84098329172268,14.9231967710001,TNFAIP3;IDE;EZR;RNF41,delta,9
nicotinamide nucleotide metabolic process (GO:0046496),3/46,3,46,0.0205707483097165,1,0,0,5.13522766175967,19.9446347002014,G6PD;PKM;NMNAT3,delta,9
tumor necrosis factor-mediated signaling pathway (GO:0033209),5/124,5,124,0.0211104212901901,1,0,0,3.1750063500127,12.2491378601079,PSMD12;KARS;UBB;TANK;BIRC2,delta,9
ephrin receptor signaling pathway (GO:0048013),4/83,4,83,0.0213739253579069,1,0,0,3.79470638459349,14.5928604158112,PAK1;GPRIN1;FYN;CRK,delta,9
regulation of adherens junction organization (GO:1903391),2/18,2,18,0.0214999414862093,1,0,0,8.74890638670166,33.5932201699378,SLK;CORO1C,delta,9
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),3/48,3,48,0.0230108629949353,1,0,0,4.92125984251969,18.5619531024894,FAF1;TNFAIP3;TANK,delta,9
endothelial cell development (GO:0001885),2/19,2,19,0.0238308346377418,1,0,0,8.28843762950684,30.9720262231321,RAPGEF2;EZR,delta,9
telomere capping (GO:0016233),2/19,2,19,0.0238308346377418,1,0,0,8.28843762950684,30.9720262231321,TEN1;TERF2IP,delta,9
protein heterotetramerization (GO:0051290),2/19,2,19,0.0238308346377418,1,0,0,8.28843762950684,30.9720262231321,XRCC6;GPRIN1,delta,9
protein K48-linked ubiquitination (GO:0070936),3/49,3,49,0.0242873244958993,1,0,0,4.82082596818255,17.922870112869,UBE2H;TNFAIP3;UBE2G1,delta,9
positive regulation of NF-kappaB transcription factor activity (GO:0051092),5/129,5,129,0.0245417684610718,1,0,0,3.0519440883843,11.3147127445142,UBB;TERF2IP;IKBKG;TANK;NFKB2,delta,9
calcium ion transmembrane transport (GO:0070588),4/87,4,87,0.0249037436578097,1,0,0,3.62023712553172,13.3685840858335,P2RX4;GPRIN1;ATP2A2;MICU3,delta,9
protein autophosphorylation (GO:0046777),6/176,6,176,0.0251535862185677,1,0,0,2.68432355046528,9.88570543866739,STK10;PAK1;SLK;STK39;FYN;PAK2,delta,9
inositol phosphate-mediated signaling (GO:0048016),2/20,2,20,0.026260192065929,1,0,0,7.8740157480315,28.6590637490018,NFAT5;NFATC3,delta,9
negative regulation of telomere maintenance via telomerase (GO:0032211),2/20,2,20,0.026260192065929,1,0,0,7.8740157480315,28.6590637490018,EXOSC10;TEN1,delta,9
positive regulation of protein complex assembly (GO:0031334),4/89,4,89,0.0267927331448754,1,0,0,3.53888348226135,12.8094296365358,FAF1;XPA;IDE;CHD1L,delta,9
fatty acid beta-oxidation (GO:0006635),3/51,3,51,0.026952928649876,1,0,0,4.63177396943029,16.7376716895649,HADHB;HADHA;ACOX1,delta,9
regulation of telomere maintenance via telomerase (GO:0032210),3/52,3,52,0.0283419624519336,1,0,0,4.54270139309509,16.187515749853,EXOSC10;TEN1;CCT4,delta,9
telomere maintenance (GO:0000723),3/52,3,52,0.0283419624519336,1,0,0,4.54270139309509,16.187515749853,XRCC6;TEN1;TERF2IP,delta,9
regulation of interleukin-2 production (GO:0032663),2/21,2,21,0.0287851577645116,1,0,0,7.49906261717285,26.605889614401,TNFAIP3;TANK,delta,9
"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",2/21,2,21,0.0287851577645116,1,0,0,7.49906261717285,26.605889614401,XPA;CHD1L,delta,9
cellular protein complex localization (GO:0034629),2/21,2,21,0.0287851577645116,1,0,0,7.49906261717285,26.605889614401,MIOS;EZR,delta,9
positive regulation of T cell mediated immunity (GO:0002711),2/21,2,21,0.0287851577645116,1,0,0,7.49906261717285,26.605889614401,TANK;B2M,delta,9
establishment of endothelial barrier (GO:0061028),2/21,2,21,0.0287851577645116,1,0,0,7.49906261717285,26.605889614401,RAPGEF2;EZR,delta,9
Fc-epsilon receptor signaling pathway (GO:0038095),6/183,6,183,0.0296803918935093,1,0,0,2.58164450755131,9.08033730943829,PSMD12;PAK1;UBB;NFATC3;IKBKG;PAK2,delta,9
regulation of protein catabolic process (GO:0042176),4/92,4,92,0.0297831500407247,1,0,0,3.42348510783978,12.0294846979267,FAF1;TNFAIP3;IDE;RNF41,delta,9
Fc receptor signaling pathway (GO:0038093),6/184,6,184,0.0303678944040277,1,0,0,2.56761383087984,8.97219103159691,PSMD12;PAK1;UBB;NFATC3;IKBKG;PAK2,delta,9
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),10/397,10,397,0.0309766824416488,1,0,0,1.98337928162002,6.89129204630681,PAK1;UBB;NCBP2;GPRIN1;STMN1;RAPGEF2;FYN;IDE;PAK2;CRK,delta,9
negative regulation of protein polymerization (GO:0032272),2/22,2,22,0.0314029318525778,1,0,0,7.15819613457409,24.7734718634613,STMN1;TBCD,delta,9
protein complex localization (GO:0031503),2/22,2,22,0.0314029318525778,1,0,0,7.15819613457409,24.7734718634613,MIOS;EZR,delta,9
"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",2/22,2,22,0.0314029318525778,1,0,0,7.15819613457409,24.7734718634613,XPA;CHD1L,delta,9
proteolysis involved in cellular protein catabolic process (GO:0051603),4/94,4,94,0.0318821353680802,1,0,0,3.35064499916234,11.5453491233721,ATE1;TNFAIP3;IDE;RNF41,delta,9
positive regulation of ERBB signaling pathway (GO:1901186),2/23,2,23,0.0341107696750497,1,0,0,6.84697021567956,23.130038468384,UBB;RBPJ,delta,9
"nucleotide-excision repair, DNA damage recognition (GO:0000715)",2/23,2,23,0.0341107696750497,1,0,0,6.84697021567956,23.130038468384,UBB;XPA,delta,9
Notch signaling pathway (GO:0007219),3/56,3,56,0.0342708652958872,1,0,0,4.21822272215973,14.2300043337108,UBB;SNAI1;RBPJ,delta,9
regulation of cell death (GO:0010941),4/97,4,97,0.0351896626050026,1,0,0,3.24701680331196,10.8677747073742,TBK1;UBB;FAF1;ADNP2,delta,9
RNA metabolic process (GO:0016070),6/192,6,192,0.0362447864360621,1,0,0,2.46062992125984,8.16304067538965,EIF4A2;DDX17;DDX18;DDX46;NCBP2;THOC1,delta,9
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),4/98,4,98,0.0363347292385496,1,0,0,3.21388397878837,10.6539651831897,DYNC1LI1;SEC23A;DYNLL2;ACTR10,delta,9
antigen processing and presentation of exogenous peptide antigen (GO:0002478),4/98,4,98,0.0363347292385496,1,0,0,3.21388397878837,10.6539651831897,DYNC1LI1;SEC23A;DYNLL2;ACTR10,delta,9
positive regulation of cell death (GO:0010942),3/58,3,58,0.0374571828669355,1,0,0,4.07276676622319,13.3772337302194,HEBP2;FAF1;FYN,delta,9
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),4/99,4,99,0.037501117920844,1,0,0,3.18142050425515,10.4458268837274,DYNC1LI1;SEC23A;DYNLL2;ACTR10,delta,9
neuron development (GO:0048666),5/145,5,145,0.0378475164651888,1,0,0,2.71517784414879,8.89000791864786,RYK;GPRIN1;STMN1;TBCD;RAPGEF2,delta,9
histone mRNA metabolic process (GO:0008334),2/25,2,25,0.0397859282293627,1,0,0,6.2992125984252,20.3101857718795,EXOSC10;NCBP2,delta,9
"positive regulation of DNA-templated transcription, elongation (GO:0032786)",2/25,2,25,0.0397859282293627,1,0,0,6.2992125984252,20.3101857718795,THOC1;PAF1,delta,9
positive regulation of endopeptidase activity (GO:0010950),2/25,2,25,0.0397859282293627,1,0,0,6.2992125984252,20.3101857718795,GPRIN1;FYN,delta,9
transition metal ion homeostasis (GO:0055076),2/25,2,25,0.0397859282293627,1,0,0,6.2992125984252,20.3101857718795,COMMD1;B2M,delta,9
negative regulation of endothelial cell apoptotic process (GO:2000352),2/25,2,25,0.0397859282293627,1,0,0,6.2992125984252,20.3101857718795,KRIT1;TNFAIP3,delta,9
regulation of protein kinase activity (GO:0045859),5/148,5,148,0.0407502672836896,1,0,0,2.66014045541605,8.51322855982079,XRCC6;RPLP1;RAPGEF2;MAPRE3;PAK2,delta,9
regulation of protein ubiquitination (GO:0031396),4/102,4,102,0.0411283623464109,1,0,0,3.08784931295353,9.85350413480147,UBB;TNFAIP3;COMMD1;HSPBP1,delta,9
positive regulation of protein binding (GO:0032092),3/61,3,61,0.0425102450249332,1,0,0,3.87246676132697,12.2292894256811,RAPGEF2;B2M;TANK,delta,9
regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),2/27,2,27,0.045789744766555,1,0,0,5.83260425780111,17.9859733235832,NFATC3;TEAD1,delta,9
negative regulation of telomere maintenance via telomere lengthening (GO:1904357),2/27,2,27,0.045789744766555,1,0,0,5.83260425780111,17.9859733235832,EXOSC10;TEN1,delta,9
positive regulation of type I interferon production (GO:0032481),3/63,3,63,0.0460589517178675,1,0,0,3.74953130858643,11.5404317356763,XRCC6;TBK1;NFKB2,delta,9
positive regulation of catabolic process (GO:0009896),3/63,3,63,0.0460589517178675,1,0,0,3.74953130858643,11.5404317356763,TNFAIP3;IDE;RNF41,delta,9
transcription from RNA polymerase II promoter (GO:0006366),11/486,11,486,0.0468824611127754,1,0,0,1.78218463432812,5.45368393870443,NFAT5;NCBP2;ECD;NFATC3;THOC1;NABP2;PAF1;RBPJ;ZNF148;ELL2;TEAD1,delta,9
negative regulation of protein modification process (GO:0031400),3/64,3,64,0.0478866132230734,1,0,0,3.69094488188976,11.2164835890041,G6PD;TERF2IP;CORO1C,delta,9
iron ion homeostasis (GO:0055072),3/64,3,64,0.0478866132230734,1,0,0,3.69094488188976,11.2164835890041,UBB;ACO1;B2M,delta,9
negative regulation of microtubule polymerization or depolymerization (GO:0031111),2/28,2,28,0.0489085982916489,1,0,0,5.62429696287964,16.973014981852,STMN1;TBCD,delta,9
fatty acid catabolic process (GO:0009062),3/66,3,66,0.0516472829418262,1,0,0,3.57909806728704,10.606004617009,HADHB;HADHA;HACL1,delta,9
negative regulation of homeostatic process (GO:0032845),2/29,2,29,0.0521021551217032,1,0,0,5.43035568829758,16.0442517837549,TNFAIP3;TERF2IP,delta,9
negative regulation of response to DNA damage stimulus (GO:2001021),2/29,2,29,0.0521021551217032,1,0,0,5.43035568829758,16.0442517837549,THOC1;SNAI1,delta,9
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),2/29,2,29,0.0521021551217032,1,0,0,5.43035568829758,16.0442517837549,TANK;PAK2,delta,9
protein K11-linked ubiquitination (GO:0070979),2/29,2,29,0.0521021551217032,1,0,0,5.43035568829758,16.0442517837549,UBE2H;ANAPC10,delta,9
negative regulation of epithelial cell apoptotic process (GO:1904036),2/30,2,30,0.0553680314638165,1,0,0,5.249343832021,15.1903039431788,KRIT1;TNFAIP3,delta,9
positive regulation of autophagy (GO:0010508),3/68,3,68,0.055546596456953,1,0,0,3.47383047707272,10.0412217508409,TBK1;IKBKG;SVIP,delta,9
regulation of apoptotic process (GO:0042981),16/816,16,816,0.0573806305188537,1,0,0,1.54392465647676,4.41261151769575,GADD45B;RYK;FAF1;STK39;TANK;STK10;PAK1;SLK;PNMA1;UBB;CASP6;TMEM219;FYN;NAA16;PAK2;BIRC2,delta,9
negative regulation of phosphatase activity (GO:0010923),3/69,3,69,0.0575475250313379,1,0,0,3.42348510783978,9.77454347920625,PLEKHF2;WDR81;TIPRL,delta,9
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),5/164,5,164,0.0584667451183522,1,0,0,2.40061455732668,6.81605806100932,TBK1;UBB;TERF2IP;IKBKG;BIRC2,delta,9
replication fork processing (GO:0031297),2/31,2,31,0.0587038916013589,1,0,0,5.08001016002032,14.4030950363219,SMARCAL1;THOC1,delta,9
cellular response to cAMP (GO:0071320),2/31,2,31,0.0587038916013589,1,0,0,5.08001016002032,14.4030950363219,RAPGEF2;EZR,delta,9
negative regulation of DNA biosynthetic process (GO:2000279),2/31,2,31,0.0587038916013589,1,0,0,5.08001016002032,14.4030950363219,EXOSC10;TEN1,delta,9
negative regulation of cell morphogenesis involved in differentiation (GO:0010771),2/31,2,31,0.0587038916013589,1,0,0,5.08001016002032,14.4030950363219,RAPGEF2;CORO1C,delta,9
positive regulation of reactive oxygen species biosynthetic process (GO:1903428),2/31,2,31,0.0587038916013589,1,0,0,5.08001016002032,14.4030950363219,P2RX4;GPRIN1,delta,9
Golgi vesicle transport (GO:0048193),7/272,7,272,0.059324738764971,1,0,0,2.02640111162575,5.72403374272877,GOLGA3;DYNC1LI1;RINT1;SEC23A;EXOC5;DYNLL2;ACTR10,delta,9
regulation of innate immune response (GO:0045088),3/70,3,70,0.0595822321621084,1,0,0,3.37457817772778,9.51765309598074,TNFAIP3;ABCE1;BIRC2,delta,9
cellular response to DNA damage stimulus (GO:0006974),8/330,8,330,0.0605223701983513,1,0,0,1.90885230255309,5.3538386579687,SMARCAL1;TIPRL;XPA;NABP2;IKBKG;CHD1L;TANK;INIP,delta,9
regulation of mitotic cell cycle (GO:0007346),5/166,5,166,0.0609473164787497,1,0,0,2.37169149037093,6.63538908135968,STK10;PAK1;SLK;STK39;PAK2,delta,9
snRNA transcription (GO:0009301),3/71,3,71,0.0616504048035397,1,0,0,3.32704890761894,9.27007480282903,NCBP2;NABP2;ELL2,delta,9
snRNA transcription from RNA polymerase II promoter (GO:0042795),3/71,3,71,0.0616504048035397,1,0,0,3.32704890761894,9.27007480282903,NCBP2;NABP2;ELL2,delta,9
vascular endothelial growth factor receptor signaling pathway (GO:0048010),3/71,3,71,0.0616504048035397,1,0,0,3.32704890761894,9.27007480282903,FYN;CRK;PAK2,delta,9
positive regulation of ubiquitin-protein transferase activity (GO:0051443),2/32,2,32,0.0621074470746489,1,0,0,4.92125984251969,13.6756366955996,BMI1;ANAPC10,delta,9
vesicle-mediated transport to the plasma membrane (GO:0098876),2/32,2,32,0.0621074470746489,1,0,0,4.92125984251969,13.6756366955996,COMMD1;EXOC5,delta,9
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),3/72,3,72,0.0637517215393039,1,0,0,3.28083989501312,9.03136184635865,PSMD12;UBB;ANAPC10,delta,9
plasma membrane bounded cell projection organization (GO:0120036),4/119,4,119,0.0652940883313381,1,0,0,2.6467279825316,7.2225336537063,RYK;GPRIN1;STMN1;RAPGEF2,delta,9
positive regulation of calcium ion transport into cytosol (GO:0010524),2/33,2,33,0.065576455835037,1,0,0,4.77213075638273,13.0018542228948,P2RX4;GPRIN1,delta,9
central nervous system neuron differentiation (GO:0021953),2/33,2,33,0.065576455835037,1,0,0,4.77213075638273,13.0018542228948,RYK;MDGA1,delta,9
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),3/73,3,73,0.0658858530251047,1,0,0,3.23589688275267,8.80109438211558,FBXL20;PSMD12;UBB,delta,9
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),3/73,3,73,0.0658858530251047,1,0,0,3.23589688275267,8.80109438211558,PSMD12;UBB;ANAPC10,delta,9
nucleic acid phosphodiester bond hydrolysis (GO:0090305),3/74,3,74,0.0680524623123307,1,0,0,3.19216854649926,8.57887752714285,UBB;XPA;CHD1L,delta,9
regulation of DNA recombination (GO:0000018),2/34,2,34,0.0691087214779624,1,0,0,4.63177396943029,12.3764443763891,THOC1;TERF2IP,delta,9
positive regulation of calcium ion transport (GO:0051928),2/34,2,34,0.0691087214779624,1,0,0,4.63177396943029,12.3764443763891,P2RX4;GPRIN1,delta,9
regulation of cell-substrate adhesion (GO:0010810),2/34,2,34,0.0691087214779624,1,0,0,4.63177396943029,12.3764443763891,TBCD;CORO1C,delta,9
mRNA 3'-end processing (GO:0031124),3/75,3,75,0.0702512052785667,1,0,0,3.1496062992126,8.36433957141792,NCBP2;THOC1;PAF1,delta,9
"regulation of gene expression, epigenetic (GO:0040029)",3/75,3,75,0.0702512052785667,1,0,0,3.1496062992126,8.36433957141792,CREBZF;SUZ12;BMI1,delta,9
regulation of defense response (GO:0031347),3/76,3,76,0.0724817309500014,1,0,0,3.10816411106506,8.15713034326173,ELMOD2;TNFAIP3;BIRC2,delta,9
regulation of wound healing (GO:0061041),2/35,2,35,0.0727020924320846,1,0,0,4.49943757030371,11.7947586642184,TNFAIP3;CRK,delta,9
regulation of JUN kinase activity (GO:0043506),2/35,2,35,0.0727020924320846,1,0,0,4.49943757030371,11.7947586642184,PAK1;TANK,delta,9
sphingosine-1-phosphate signaling pathway (GO:0003376),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,EZR,delta,9
regulation of protein localization to early endosome (GO:1902965),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,EZR,delta,9
positive regulation of nucleobase-containing compound transport (GO:0032241),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,NCBP2,delta,9
negative regulation of membrane potential (GO:0045837),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,HEBP2,delta,9
positive regulation of microtubule motor activity (GO:2000576),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,DYNLL2,delta,9
epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,RBPJ,delta,9
negative regulation of chromosome organization (GO:2001251),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,TERF2IP,delta,9
nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,EXOSC10,delta,9
positive regulation of protein localization to endosome (GO:1905668),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,EZR,delta,9
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,UBB,delta,9
cellular response to iron ion (GO:0071281),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,B2M,delta,9
positive regulation of icosanoid secretion (GO:0032305),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,P2RX4,delta,9
N-terminal peptidyl-methionine acetylation (GO:0017196),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,NAA16,delta,9
positive regulation of protein localization to early endosome (GO:1902966),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,EZR,delta,9
"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,UBB,delta,9
negative regulation of necroptotic process (GO:0060546),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,BIRC2,delta,9
astral microtubule organization (GO:0030953),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,EZR,delta,9
establishment of endothelial intestinal barrier (GO:0090557),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,RAPGEF2,delta,9
positive regulation of receptor binding (GO:1900122),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,B2M,delta,9
negative regulation of bone resorption (GO:0045779),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,TNFAIP3,delta,9
nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,EXOSC10,delta,9
aggrephagy (GO:0035973),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,WDR81,delta,9
protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,TNFAIP3,delta,9
positive regulation of protein acetylation (GO:1901985),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,TERF2IP,delta,9
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,PAK1,delta,9
regulation of extracellular exosome assembly (GO:1903551),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,SDC4,delta,9
citrate metabolic process (GO:0006101),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,ACO1,delta,9
antigen processing and presentation of endogenous peptide antigen (GO:0002483),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,B2M,delta,9
regulation of protein K63-linked ubiquitination (GO:1900044),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,BIRC2,delta,9
establishment of protein localization to telomere (GO:0070200),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,NABP2,delta,9
negative regulation of amino acid transport (GO:0051956),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,STK39,delta,9
dendritic spine maintenance (GO:0097062),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,FYN,delta,9
positive regulation of RNA export from nucleus (GO:0046833),1/6,1,6,0.0738298867665755,1,0,0,13.1233595800525,34.199365611772,NCBP2,delta,9
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),3/77,3,77,0.0747436818794105,1,0,0,3.06779834338889,7.95691970641991,PEA15;TNFAIP3;TANK,delta,9
positive regulation of JNK cascade (GO:0046330),3/77,3,77,0.0747436818794105,1,0,0,3.06779834338889,7.95691970641991,PAK1;GADD45B;TANK,delta,9
positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),3/77,3,77,0.0747436818794105,1,0,0,3.06779834338889,7.95691970641991,PSMD12;UBB;ANAPC10,delta,9
positive regulation of NIK/NF-kappaB signaling (GO:1901224),2/36,2,36,0.0763544611899679,1,0,0,4.37445319335083,11.2527069914507,TERF2IP;TANK,delta,9
negative regulation of cell-substrate adhesion (GO:0010812),2/36,2,36,0.0763544611899679,1,0,0,4.37445319335083,11.2527069914507,TBCD;CORO1C,delta,9
regulation of endothelial cell apoptotic process (GO:2000351),2/36,2,36,0.0763544611899679,1,0,0,4.37445319335083,11.2527069914507,KRIT1;TNFAIP3,delta,9
anatomical structure homeostasis (GO:0060249),2/36,2,36,0.0763544611899679,1,0,0,4.37445319335083,11.2527069914507,XRCC6;TERF2IP,delta,9
regulation of mitochondrial membrane potential (GO:0051881),2/36,2,36,0.0763544611899679,1,0,0,4.37445319335083,11.2527069914507,HEBP2;UBB,delta,9
negative regulation of epithelial cell migration (GO:0010633),2/36,2,36,0.0763544611899679,1,0,0,4.37445319335083,11.2527069914507,KRIT1;CORO1C,delta,9
positive regulation of ATPase activity (GO:0032781),2/36,2,36,0.0763544611899679,1,0,0,4.37445319335083,11.2527069914507,DNAJB1;DYNLL2,delta,9
regulation of phosphoprotein phosphatase activity (GO:0043666),2/36,2,36,0.0763544611899679,1,0,0,4.37445319335083,11.2527069914507,PPP1R2;TIPRL,delta,9
regulation of cardiac muscle contraction (GO:0055117),2/36,2,36,0.0763544611899679,1,0,0,4.37445319335083,11.2527069914507,P2RX4;ATP2A2,delta,9
actin filament bundle organization (GO:0061572),2/36,2,36,0.0763544611899679,1,0,0,4.37445319335083,11.2527069914507,FSCN3;EZR,delta,9
DNA-dependent DNA replication maintenance of fidelity (GO:0045005),2/36,2,36,0.0763544611899679,1,0,0,4.37445319335083,11.2527069914507,SMARCAL1;THOC1,delta,9
cilium assembly (GO:0060271),7/289,7,289,0.0764637557289833,1,0,0,1.907201046236,4.9032964668228,PLK4;IFT140;RAB23;DYNLL2;SSX2IP;TUBA4A;SDCCAG8,delta,9
response to ionizing radiation (GO:0010212),3/78,3,78,0.0770366944907149,1,0,0,3.02846759539673,7.76339618054436,NABP2;TANK;INIP,delta,9
negative regulation of ubiquitin protein ligase activity (GO:1904667),3/78,3,78,0.0770366944907149,1,0,0,3.02846759539673,7.76339618054436,PSMD12;UBB;ANAPC10,delta,9
translation (GO:0006412),6/233,6,233,0.0773972663115052,1,0,0,2.02764354026562,5.18834203234021,HBS1L;KARS;RPLP1;GTPBP2;ABCE1;RSL24D1,delta,9
G2/M transition of mitotic cell cycle (GO:0000086),4/127,4,127,0.0787435840812318,1,0,0,2.48000496000992,6.3030776280731,PLK4;UBB;TUBA4A;SDCCAG8,delta,9
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),3/79,3,79,0.0793603994129383,1,0,0,2.99013256254361,7.57626567255972,PSMD12;UBB;RBPJ,delta,9
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),7/292,7,292,0.0797609154921706,1,0,0,1.88760651493906,4.77323150877905,FBXL20;PSMD12;UBB;FAF1;HECTD4;ANAPC10;BIRC2,delta,9
centromere complex assembly (GO:0034508),2/37,2,37,0.080063763526113,1,0,0,4.25622472866567,10.7466776663239,POGZ;OIP5,delta,9
regulation of cell morphogenesis involved in differentiation (GO:0010769),2/37,2,37,0.080063763526113,1,0,0,4.25622472866567,10.7466776663239,PAK1;CORO1C,delta,9
cell cycle G2/M phase transition (GO:0044839),4/128,4,128,0.0805150356841906,1,0,0,2.46062992125984,6.19909284771897,PLK4;UBB;TUBA4A;SDCCAG8,delta,9
cation transport (GO:0006812),3/80,3,80,0.0817144217825179,1,0,0,2.95275590551181,7.39525030951289,P2RX4;GPRIN1;SLC1A4,delta,9
anaphase-promoting complex-dependent catabolic process (GO:0031145),3/80,3,80,0.0817144217825179,1,0,0,2.95275590551181,7.39525030951289,PSMD12;UBB;ANAPC10,delta,9
positive regulation of protein phosphorylation (GO:0001934),9/413,9,413,0.0818039155438093,1,0,0,1.71588720901413,4.29560380605093,XRCC6;PAK1;TBK1;RYK;RPLP1;RAPGEF2;TERF2IP;MAPRE3;PAK2,delta,9
base-excision repair (GO:0006284),2/38,2,38,0.0838279777958919,1,0,0,4.14421881475342,10.2734706311706,XPA;POLG,delta,9
negative regulation of Ras protein signal transduction (GO:0046580),2/38,2,38,0.0838279777958919,1,0,0,4.14421881475342,10.2734706311706,STMN1;RASAL2,delta,9
actin filament bundle assembly (GO:0051017),2/38,2,38,0.0838279777958919,1,0,0,4.14421881475342,10.2734706311706,FSCN3;EZR,delta,9
protein K63-linked ubiquitination (GO:0070534),2/38,2,38,0.0838279777958919,1,0,0,4.14421881475342,10.2734706311706,UBE2G1;TANK,delta,9
nucleic acid metabolic process (GO:0090304),3/81,3,81,0.0840983816335655,1,0,0,2.91630212890055,7.22008735942464,SMARCAL1;NCBP2;POLG,delta,9
adherens junction assembly (GO:0034333),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,TBCD,delta,9
regulation of vitamin D biosynthetic process (GO:0060556),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,SNAI1,delta,9
negative regulation of muscle hypertrophy (GO:0014741),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,P2RX4,delta,9
regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901213),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,RBPJ,delta,9
erythrocyte development (GO:0048821),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,G6PD,delta,9
positive regulation of lamellipodium morphogenesis (GO:2000394),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,CORO1C,delta,9
rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,ABCE1,delta,9
mitochondrial DNA metabolic process (GO:0032042),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,POLG,delta,9
regulation of dendritic spine maintenance (GO:1902950),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,FYN,delta,9
protection from non-homologous end joining at telomere (GO:0031848),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,TERF2IP,delta,9
regulation of cardiac muscle cell membrane potential (GO:0086036),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,ATP2A2,delta,9
regulation of ER to Golgi vesicle-mediated transport (GO:0060628),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,RINT1,delta,9
dorsal aorta development (GO:0035907),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,RBPJ,delta,9
regulation of lymphocyte migration (GO:2000401),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,STK10,delta,9
regulation of toll-like receptor 3 signaling pathway (GO:0034139),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,TNFAIP3,delta,9
cytoplasmic sequestering of NF-kappaB (GO:0007253),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,FAF1,delta,9
death-inducing signaling complex assembly (GO:0071550),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,TANK,delta,9
dorsal aorta morphogenesis (GO:0035912),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,RBPJ,delta,9
pentose metabolic process (GO:0019321),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,G6PD,delta,9
positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,DYNC1LI1,delta,9
cell differentiation in spinal cord (GO:0021515),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,MDGA1,delta,9
forebrain neuron differentiation (GO:0021879),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,RAPGEF2,delta,9
regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,RBPJ,delta,9
L-alanine transport (GO:0015808),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,SLC1A4,delta,9
negative regulation of dendrite morphogenesis (GO:0050774),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,RAPGEF2,delta,9
activation of MAPKKK activity (GO:0000185),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,GADD45B,delta,9
regulation of protein deubiquitination (GO:0090085),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,TANK,delta,9
positive regulation of macrophage chemotaxis (GO:0010759),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,KARS,delta,9
regulation of response to biotic stimulus (GO:0002831),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,ELMOD2,delta,9
positive regulation of protein deubiquitination (GO:1903003),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,TANK,delta,9
excitatory chemical synaptic transmission (GO:0098976),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,GPRIN1,delta,9
negative regulation of necrotic cell death (GO:0060547),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,BIRC2,delta,9
negative regulation of dendrite development (GO:2000171),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,RAPGEF2,delta,9
negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,CORO1C,delta,9
positive regulation of macrophage migration (GO:1905523),1/7,1,7,0.0855957551577063,1,0,0,11.2485939257593,27.6503890477296,KARS,delta,9
generation of neurons (GO:0048699),4/131,4,131,0.0859470763959134,1,0,0,2.40427961771954,5.9001588336946,RYK;ADNP2;RAPGEF2;MDGA1,delta,9
"transcription, DNA-templated (GO:0006351)",8/357,8,357,0.0862167103833721,1,0,0,1.76448532168773,4.32456166063572,CREBZF;NFAT5;NCBP2;ECD;NFATC3;UBTF;PAF1;ZNF148,delta,9
positive regulation of binding (GO:0051099),3/82,3,82,0.0865118941230977,1,0,0,2.88073746879201,7.05052824135938,STMN1;RAPGEF2;B2M,delta,9
negative regulation of cell death (GO:0060548),3/82,3,82,0.0865118941230977,1,0,0,2.88073746879201,7.05052824135938,ADNP2;IKBKG;TANK,delta,9
negative regulation of cell cycle process (GO:0010948),3/82,3,82,0.0865118941230977,1,0,0,2.88073746879201,7.05052824135938,SUZ12;MGA;BMI1,delta,9
positive regulation of intracellular signal transduction (GO:1902533),10/480,10,480,0.086808858873594,1,0,0,1.64041994750656,4.00926279817583,TBK1;P2RX4;MIOS;UBB;RYK;RAPGEF2;TERF2IP;FYN;IKBKG;BIRC2,delta,9
neutrophil degranulation (GO:0043312),10/480,10,480,0.086808858873594,1,0,0,1.64041994750656,4.00926279817583,DYNC1LI1;STK10;HEBP2;XRCC6;PSMD12;PKM;PSAP;B2M;SVIP;ACTR10,delta,9
positive regulation of ubiquitin protein ligase activity (GO:1904668),3/83,3,83,0.0889545698895145,1,0,0,2.84602978844512,6.8863376062629,PSMD12;UBB;ANAPC10,delta,9
neutrophil activation involved in immune response (GO:0002283),10/484,10,484,0.0904694520915838,1,0,0,1.62686275785775,3.90893315417301,DYNC1LI1;STK10;HEBP2;XRCC6;PSMD12;PKM;PSAP;B2M;SVIP;ACTR10,delta,9
positive regulation of peptidyl-serine phosphorylation (GO:0033138),3/84,3,84,0.0914260153194251,1,0,0,2.81214848143982,6.72729249020905,PAK1;TBK1;TERF2IP,delta,9
positive regulation of reactive oxygen species metabolic process (GO:2000379),2/40,2,40,0.0915132636992401,1,0,0,3.93700787401575,9.41445416828537,GPRIN1;RNF41,delta,9
regulation of proteasomal protein catabolic process (GO:0061136),2/40,2,40,0.0915132636992401,1,0,0,3.93700787401575,9.41445416828537,UBB;COMMD1,delta,9
Golgi to plasma membrane transport (GO:0006893),2/40,2,40,0.0915132636992401,1,0,0,3.93700787401575,9.41445416828537,COMMD1;EXOC5,delta,9
DNA replication-independent nucleosome assembly (GO:0006336),2/40,2,40,0.0915132636992401,1,0,0,3.93700787401575,9.41445416828537,UBN1;OIP5,delta,9
regulation of intracellular signal transduction (GO:1902531),9/423,9,423,0.0915156538952623,1,0,0,1.67532249958117,4.00610695344409,RINT1;PAK1;ARHGAP20;UBB;ARAP2;IKBKG;PAK2;BIRC2;RNF41,delta,9
regulation of cell cycle G2/M phase transition (GO:1902749),3/85,3,85,0.0939258328639428,1,0,0,2.77906438165818,6.57318152912935,PLK4;TUBA4A;SDCCAG8,delta,9
neutrophil mediated immunity (GO:0002446),10/488,10,488,0.0942217926212502,1,0,0,1.61352781721957,3.81132015615904,DYNC1LI1;STK10;HEBP2;XRCC6;PSMD12;PKM;PSAP;B2M;SVIP;ACTR10,delta,9
cellular response to organic cyclic compound (GO:0071407),4/136,4,136,0.0953852266139799,1,0,0,2.31588698471515,5.44194434880809,P2RX4;CASP6;RAPGEF2;EZR,delta,9
neuron migration (GO:0001764),2/41,2,41,0.0954304981082789,1,0,0,3.84098329172268,9.02384123275284,RAPGEF2;MDGA1,delta,9
regulation of protein dephosphorylation (GO:0035304),2/41,2,41,0.0954304981082789,1,0,0,3.84098329172268,9.02384123275284,PPP1R2;TIPRL,delta,9
regulation of ATPase activity (GO:0043462),2/41,2,41,0.0954304981082789,1,0,0,3.84098329172268,9.02384123275284,DNAJB1;PAM16,delta,9
response to cAMP (GO:0051591),2/41,2,41,0.0954304981082789,1,0,0,3.84098329172268,9.02384123275284,RAPGEF2;EZR,delta,9
positive regulation of vasculogenesis (GO:2001214),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,RAPGEF2,delta,9
fatty acid alpha-oxidation (GO:0001561),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,HACL1,delta,9
histone H2A-K119 monoubiquitination (GO:0036353),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,BMI1,delta,9
positive regulation of protein localization to Cajal body (GO:1904871),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,CCT4,delta,9
cellular response to interleukin-21 (GO:0098757),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,STAT4,delta,9
establishment of integrated proviral latency (GO:0075713),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,XRCC6,delta,9
ventricular trabecula myocardium morphogenesis (GO:0003222),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,RBPJ,delta,9
negative regulation of anion transmembrane transport (GO:1903960),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,STK39,delta,9
endodermal cell fate commitment (GO:0001711),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,PAF1,delta,9
translocation of molecules into host (GO:0044417),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,THOC1,delta,9
negative regulation of potassium ion transmembrane transporter activity (GO:1901017),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,STK39,delta,9
response to hydroperoxide (GO:0033194),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,STX2,delta,9
interleukin-21-mediated signaling pathway (GO:0038114),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,STAT4,delta,9
actin filament network formation (GO:0051639),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,COBLL1,delta,9
negative regulation of execution phase of apoptosis (GO:1900118),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,PAK2,delta,9
negative regulation of glucose import (GO:0046325),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,PEA15,delta,9
negative regulation of bone remodeling (GO:0046851),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,TNFAIP3,delta,9
regulation of protein localization to Cajal body (GO:1904869),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,CCT4,delta,9
positive regulation of early endosome to late endosome transport (GO:2000643),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,EZR,delta,9
plasma membrane to endosome transport (GO:0048227),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,COMMD1,delta,9
positive regulation of cAMP-mediated signaling (GO:0043950),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,RAPGEF2,delta,9
positive regulation of spindle checkpoint (GO:0090232),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,DYNC1LI1,delta,9
positive regulation of protein homodimerization activity (GO:0090073),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,TANK,delta,9
insulin metabolic process (GO:1901142),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,IDE,delta,9
"negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,SVIP,delta,9
regulation of toll-like receptor 2 signaling pathway (GO:0034135),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,TNFAIP3,delta,9
histone H3-K36 demethylation (GO:0070544),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,KDM4C,delta,9
viral mRNA export from host cell nucleus (GO:0046784),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,THOC1,delta,9
kinetochore assembly (GO:0051382),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,POGZ,delta,9
arginine catabolic process (GO:0006527),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,OAT,delta,9
regulation of receptor binding (GO:1900120),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,B2M,delta,9
regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),1/8,1,8,0.097212734850973,1,0,0,9.84251968503937,22.9414720385079,ATP2A2,delta,9
toll-like receptor signaling pathway (GO:0002224),3/87,3,87,0.0990089758295366,1,0,0,2.71517784414879,6.27897031770989,UBB;IKBKG;BIRC2,delta,9
regulation of peptidyl-serine phosphorylation (GO:0033135),3/87,3,87,0.0990089758295366,1,0,0,2.71517784414879,6.27897031770989,PAK1;TBK1;TERF2IP,delta,9
telomere organization (GO:0032200),2/42,2,42,0.0993949685795838,1,0,0,3.74953130858643,8.65636964571568,XRCC6;TERF2IP,delta,9
regulation of substrate adhesion-dependent cell spreading (GO:1900024),2/42,2,42,0.0993949685795838,1,0,0,3.74953130858643,8.65636964571568,CRK;CORO1C,delta,9
carboxylic acid transport (GO:0046942),6/52,6,52,1.88933093895083e-05,0.0482062789073304,0,0,10.78360891445,117.290108186126,SLC6A19;SLC7A8;SLC17A5;SLC16A2;SLC7A2;SLC38A4,alpha,1
regulation of insulin secretion (GO:0050796),8/99,8,99,1.12012787305344e-05,0.057160125361917,0,0,7.55215708486737,86.090683385717,NEUROD1;G6PC2;SLC30A8;NLGN2;HNF4A;KCNA5;GCG;GCK,alpha,1
protein exit from endoplasmic reticulum (GO:0032527),4/19,4,19,4.35454184401629e-05,0.074070756766717,0,0,19.6753566158387,197.574147810967,CTAGE5;SYVN1;DERL2;AUP1,alpha,1
amino acid transport (GO:0006865),5/49,5,49,0.000174022338133351,0.148005998582415,0,0,9.53652489032996,82.5512768158786,SLC6A19;SLC7A8;SLC38A10;SLC7A2;SLC38A4,alpha,1
regulation of protein secretion (GO:0050708),7/108,7,108,0.000162711803102056,0.166063666245958,0,0,6.05745932848737,52.8424281830039,NEUROD1;G6PC2;RSAD2;HNF4A;KCNA5;GCG;GCK,alpha,1
regulation of peptide hormone secretion (GO:0090276),6/74,6,74,0.000141416060888281,0.180411539678224,0,0,7.577671129073,67.1669933783985,NEUROD1;G6PC2;HNF4A;KCNA5;GCG;GCK,alpha,1
positive regulation of insulin secretion (GO:0032024),4/32,4,32,0.00036230267213708,0.23110381698944,0,0,11.6822429906542,92.5587685117824,NLGN2;SLC30A8;GCG;GCK,alpha,1
atrial cardiac muscle cell action potential (GO:0086014),3/13,3,13,0.000319174518721365,0.232678224147875,0,0,21.5672178289001,173.611197501271,KCNA5;ANK2;KCNJ3,alpha,1
endoplasmic reticulum to cytosol transport (GO:1903513),3/16,3,16,0.000610319743426038,0.311446165070307,0,0,17.5233644859813,129.699665337177,SYVN1;DERL2;AUP1,alpha,1
regulation of heart rate by cardiac conduction (GO:0086091),4/36,4,36,0.000573968759589923,0.325440286687486,0,0,10.3842159916926,77.4967350875117,KCNH6;KCNA5;ANK2;KCNJ3,alpha,1
"retrograde protein transport, ER to cytosol (GO:0030970)",3/18,3,18,0.000875399162980659,0.406105629880937,0,0,15.5763239875389,109.670258401314,SYVN1;DERL2;AUP1,alpha,1
protein import into mitochondrial matrix (GO:0030150),3/19,3,19,0.00103137262088693,0.438591207032167,0,0,14.756517461879,101.478574357327,DNAJC19;TOMM40;TIMM44,alpha,1
response to glucose (GO:0009749),4/48,4,48,0.00171555417503669,0.625319496800874,0,0,7.78816199376947,49.595164458167,NEUROD1;SLC30A8;HNF4A;GCK,alpha,1
regulation of mitotic spindle checkpoint (GO:1903504),2/6,2,6,0.00166162330360499,0.652251055253557,0,0,31.1526479750779,199.375709056148,ANAPC15;CDK5RAP2,alpha,1
atrial cardiac muscle cell to AV node cell signaling (GO:0086026),2/8,2,8,0.00305818790274756,0.743139660367658,0,0,23.3644859813084,135.278802034472,KCNA5;ANK2,alpha,1
response to hexose (GO:0009746),3/28,3,28,0.00324860361757383,0.75352837547633,0,0,10.0133511348465,57.3717960390547,NEUROD1;SLC30A8;HNF4A,alpha,1
mitochondrial transport (GO:0006839),6/136,6,136,0.00347370144675273,0.770708629686051,0,0,4.12314458493678,23.3474486841279,DNAJC19;ATP5B;TOMM40;SLC25A43;TIMM44;SLC25A34,alpha,1
mast cell degranulation (GO:0043303),2/8,2,8,0.00305818790274756,0.780296643386041,0,0,23.3644859813084,135.278802034472,CHGA;KIT,alpha,1
SA node cell action potential (GO:0086015),2/7,2,7,0.00230989251851847,0.785825434799984,0,0,26.7022696929239,162.097577685202,KCNA5;ANK2,alpha,1
amino acid transmembrane transport (GO:0003333),3/30,3,30,0.00396339528224076,0.809008245010985,0,0,9.34579439252336,51.6883572576001,SLC7A8;SLC38A10;SLC38A4,alpha,1
positive regulation of cellular component biogenesis (GO:0044089),5/88,5,88,0.00255406292718551,0.814586444839229,0,0,5.31011045029737,31.7017304747057,CHGA;NLGN2;SRPX2;EPHB1;SPIDR,alpha,1
Golgi vesicle transport (GO:0048193),9/272,9,272,0.00271789266037631,0.815847426229429,0,0,3.09235843870258,18.26933964593,LMAN1;EHD3;TFG;CTAGE5;DCTN4;ANK2;KIF22;RAB8A;DNAJC28,alpha,1
mast cell activation involved in immune response (GO:0002279),2/8,2,8,0.00305818790274756,0.82136488777478,0,0,23.3644859813084,135.278802034472,CHGA;KIT,alpha,1
positive regulation of synapse assembly (GO:0051965),3/27,3,27,0.00292339235554542,0.828781732797127,0,0,10.3842159916926,60.5920100875559,NLGN2;SRPX2;EPHB1,alpha,1
mast cell mediated immunity (GO:0002448),2/9,2,9,0.00390431488588977,0.830154952612313,0,0,20.7684319833853,115.174931597872,CHGA;KIT,alpha,1
negative regulation of secretion by cell (GO:1903531),3/31,3,31,0.00435379513834436,0.854516022729664,0,0,9.04431715405487,49.1713057158088,CHGA;GRM7;RSAD2,alpha,1
carbohydrate homeostasis (GO:0033500),4/64,4,64,0.00490582878282227,0.927201639953408,0,0,5.8411214953271,31.0591777646138,NEUROD1;G6PC2;HNF4A;GCK,alpha,1
positive regulation of cellular component organization (GO:0051130),5/107,5,107,0.00589034719215243,1,0,0,4.36719364136606,22.4230951918064,LMAN1;NLGN2;SRPX2;EPHB1;SPIDR,alpha,1
regulation of synapse assembly (GO:0051963),3/36,3,36,0.00665040597318811,1,0,0,7.78816199376947,39.0426587038789,NLGN2;SRPX2;EPHB1,alpha,1
carboxylic acid transmembrane transport (GO:1905039),3/36,3,36,0.00665040597318811,1,0,0,7.78816199376947,39.0426587038789,SLC7A8;SLC38A10;SLC38A4,alpha,1
regulation of cholesterol homeostasis (GO:2000188),2/12,2,12,0.00700826351567012,1,0,0,15.5763239875389,77.2689302793319,HNF4A;RALY,alpha,1
epithelial cell migration (GO:0010631),3/37,3,37,0.00718089730604772,1,0,0,7.577671129073,37.4058923774438,PXN;KIT;PRSS3,alpha,1
protein localization to endoplasmic reticulum (GO:0070972),2/13,2,13,0.00822446617086265,1,0,0,14.3781452192667,69.0243262066944,CTAGE5;ANK2,alpha,1
glucose homeostasis (GO:0042593),4/75,4,75,0.00857026802314173,1,0,0,4.98442367601246,23.723146528511,NEUROD1;G6PC2;HNF4A;GCK,alpha,1
nitrogen compound transport (GO:0071705),4/75,4,75,0.00857026802314173,1,0,0,4.98442367601246,23.723146528511,SLC6A19;SLC7A8;SLC7A2;SLC38A4,alpha,1
positive regulation of peptide hormone secretion (GO:0090277),3/40,3,40,0.00891967051311453,1,0,0,7.00934579439252,33.0805813392343,NLGN2;SLC30A8;GCK,alpha,1
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),2/14,2,14,0.00952804457493119,1,0,0,13.351134846462,62.1297165371263,ANAPC15;CDK5RAP2,alpha,1
cellular response to retinoic acid (GO:0071300),3/43,3,43,0.0108841081810345,1,0,0,6.52032166920235,29.4747979916646,FZD4;HTRA2;RORB,alpha,1
membrane repolarization during cardiac muscle cell action potential (GO:0086013),2/15,2,15,0.0109170075997138,1,0,0,12.4610591900312,56.2920046797323,KCNA5;KCNJ3,alpha,1
protein transmembrane import into intracellular organelle (GO:0044743),3/44,3,44,0.0115899676114563,1,0,0,6.37213254035684,28.4045162457049,DNAJC19;TOMM40;TIMM44,alpha,1
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),3/44,3,44,0.0115899676114563,1,0,0,6.37213254035684,28.4045162457049,ZNF385B;KRCC1;TP73,alpha,1
protein N-linked glycosylation via asparagine (GO:0018279),3/45,3,45,0.0123216209085005,1,0,0,6.23052959501558,27.3918988304209,LMAN1;SYVN1;ST3GAL6,alpha,1
glucose 6-phosphate metabolic process (GO:0051156),2/16,2,16,0.0123893963748976,1,0,0,11.6822429906542,51.2957278418333,G6PC2;GCK,alpha,1
peptidyl-asparagine modification (GO:0018196),3/46,3,46,0.0130792085545921,1,0,0,6.09508329947176,26.4327393915632,LMAN1;SYVN1;ST3GAL6,alpha,1
positive regulation of cation transmembrane transport (GO:1904064),2/17,2,17,0.0139432838318642,1,0,0,10.9950522264981,46.9791900207969,ANK2;PDZK1,alpha,1
regulation of cardiac muscle cell membrane repolarization (GO:0099623),2/18,2,18,0.0155767742432303,1,0,0,10.3842159916926,43.2188401318621,KCNA5;ANK2,alpha,1
plasma membrane bounded cell projection assembly (GO:0120031),7/242,7,242,0.015629714295243,1,0,0,2.70332895651502,11.2420135544127,SPAG16;EHD3;KIT;DNAH6;RAB8A;CDC14A;SEPT2,alpha,1
establishment of protein localization to mitochondrion (GO:0072655),3/50,3,50,0.0163712299817739,1,0,0,5.60747663551402,23.059232265917,DNAJC19;TOMM40;TIMM44,alpha,1
neurogenesis (GO:0022008),3/51,3,51,0.0172601193280751,1,0,0,5.49752611324904,22.3164193501322,NEUROD1;EPHB1;CDK5RAP2,alpha,1
insulin secretion (GO:0030073),2/19,2,19,0.017288002791931,1,0,0,9.83767830791933,39.9187653544737,NEUROD1;SLC30A8,alpha,1
cilium organization (GO:0044782),6/193,6,193,0.0178565310184553,1,0,0,2.90542830855649,11.6954703044559,SPAG16;EHD3;DNAH6;RAB8A;CDC14A;SEPT2,alpha,1
cellular polysaccharide catabolic process (GO:0044247),2/20,2,20,0.0190751351249388,1,0,0,9.34579439252336,37.0034543734625,MANBA;GYG2,alpha,1
endoplasmic reticulum mannose trimming (GO:1904380),2/20,2,20,0.0190751351249388,1,0,0,9.34579439252336,37.0034543734625,SYVN1;DERL2,alpha,1
positive regulation of nervous system development (GO:0051962),3/53,3,53,0.0191174354366414,1,0,0,5.29007229765474,20.9336334521489,NLGN2;SRPX2;EPHB1,alpha,1
protein targeting to mitochondrion (GO:0006626),3/55,3,55,0.0210810766266494,1,0,0,5.09770603228547,19.6739820726052,DNAJC19;TOMM40;TIMM44,alpha,1
regulation of secretion by cell (GO:1903530),3/57,3,57,0.023151216218109,1,0,0,4.91883915395967,18.5229117728012,MCTP1;RAB3A;RAB8A,alpha,1
intrinsic apoptotic signaling pathway (GO:0097193),4/102,4,102,0.0240174399764612,1,0,0,3.66501740883269,13.6667584637786,HTRA2;ZNF385B;KRCC1;TP73,alpha,1
response to retinoic acid (GO:0032526),3/58,3,58,0.0242262301973165,1,0,0,4.83403158233967,17.9841411876686,FZD4;HTRA2;RORB,alpha,1
positive regulation of ion transmembrane transporter activity (GO:0032414),2/23,2,23,0.0248740592098288,1,0,0,8.12677773262901,30.0197465856408,ANK2;PDZK1,alpha,1
ubiquitin-dependent ERAD pathway (GO:0030433),3/59,3,59,0.0253278570472872,1,0,0,4.75209884365595,17.468004529944,SYVN1;DERL2;AUP1,alpha,1
potassium ion transport (GO:0006813),3/62,3,62,0.0287921204066694,1,0,0,4.52215857702744,16.0430518221226,KCNK16;KCNA5;KCNJ3,alpha,1
regulation of neuronal synaptic plasticity (GO:0048168),2/25,2,25,0.029087229614044,1,0,0,7.47663551401869,26.4482695028299,RAB3A;MCTP1,alpha,1
"protein alpha-1,2-demannosylation (GO:0036508)",2/25,2,25,0.029087229614044,1,0,0,7.47663551401869,26.4482695028299,SYVN1;DERL2,alpha,1
oligosaccharide metabolic process (GO:0009311),3/64,3,64,0.0312339926527041,1,0,0,4.38084112149533,15.1850829548062,MANBA;ST3GAL6;GALNT8,alpha,1
peptide hormone secretion (GO:0030072),2/26,2,26,0.0312929153935775,1,0,0,7.18907260963336,24.9055611237175,NEUROD1;SLC30A8,alpha,1
neutral amino acid transport (GO:0015804),2/26,2,26,0.0312929153935775,1,0,0,7.18907260963336,24.9055611237175,SLC6A19;SLC7A8,alpha,1
negative regulation of cell growth (GO:0030308),4/116,4,116,0.0361155130318738,1,0,0,3.22268772155978,10.7026515696859,HNF4A;DACT3;APBB1;ESR2,alpha,1
cilium assembly (GO:0060271),7/289,7,289,0.0363683747509566,1,0,0,2.26368722310255,7.50198556174105,SPAG16;EHD3;DNAH6;RAB8A;CDC14A;SEPT2;CDK5RAP2,alpha,1
cardiac muscle cell action potential involved in contraction (GO:0086002),2/29,2,29,0.0382868603554037,1,0,0,6.44537544311956,21.028994607274,KCNA5;ANK2,alpha,1
keratan sulfate biosynthetic process (GO:0018146),2/30,2,30,0.0407385408512294,1,0,0,6.23052959501558,19.9413126787907,ST3GAL6;CHST2,alpha,1
synaptic vesicle recycling (GO:0036465),2/30,2,30,0.0407385408512294,1,0,0,6.23052959501558,19.9413126787907,RAB3A;NLGN2,alpha,1
lysosome localization (GO:0032418),2/30,2,30,0.0407385408512294,1,0,0,6.23052959501558,19.9413126787907,CHGA;KIT,alpha,1
negative regulation of growth (GO:0045926),4/121,4,121,0.0411500689251983,1,0,0,3.08951880744574,9.85720144245314,HNF4A;DACT3;APBB1;ESR2,alpha,1
negative regulation of DNA biosynthetic process (GO:2000279),2/31,2,31,0.0432478380134877,1,0,0,6.02954476936991,18.9376426589156,CTC1;DACH1,alpha,1
sulfur compound biosynthetic process (GO:0044272),4/123,4,123,0.0432698038661732,1,0,0,3.03928272927589,9.54426033749927,B3GAT2;ESD;ST3GAL6;CHST2,alpha,1
regulation of neuron death (GO:1901214),3/73,3,73,0.0435150339429199,1,0,0,3.84073742158494,12.0393629216986,CHGA;HTRA2;EPHB1,alpha,1
protein N-linked glycosylation (GO:0006487),3/74,3,74,0.0450080531684149,1,0,0,3.7888355645365,11.7488526620044,LMAN1;SYVN1;ST3GAL6,alpha,1
ER to Golgi vesicle-mediated transport (GO:0006888),5/181,5,181,0.0453981903262397,1,0,0,2.58171115815563,7.9833816166283,LMAN1;TFG;CTAGE5;DCTN4;ANK2,alpha,1
microtubule bundle formation (GO:0001578),2/33,2,33,0.0484333036733835,1,0,0,5.66411781365053,17.1484996287812,SPAG16;CDK5RAP2,alpha,1
positive regulation of organelle organization (GO:0010638),2/34,2,34,0.051106545601199,1,0,0,5.49752611324904,16.3487778780587,LMAN1;HTRA2,alpha,1
ERAD pathway (GO:0036503),3/78,3,78,0.0512308774556886,1,0,0,3.59453630481668,10.6808513781707,SYVN1;DERL2;AUP1,alpha,1
keratan sulfate metabolic process (GO:0042339),2/35,2,35,0.0538315503529527,1,0,0,5.34045393858478,15.604248576313,ST3GAL6;CHST2,alpha,1
endothelial cell migration (GO:0043542),2/36,2,36,0.0566069158042542,1,0,0,5.19210799584631,14.9097825227568,PXN;PRSS3,alpha,1
regulation of cardiac muscle contraction (GO:0055117),2/36,2,36,0.0566069158042542,1,0,0,5.19210799584631,14.9097825227568,CHGA;ANK2,alpha,1
carbohydrate catabolic process (GO:0016052),2/36,2,36,0.0566069158042542,1,0,0,5.19210799584631,14.9097825227568,MANBA;GCK,alpha,1
sensory perception of sound (GO:0007605),3/82,3,82,0.0578472865739276,1,0,0,3.41919307043538,9.74452495197888,GRM7;KIT;TSPEAR,alpha,1
protein catabolic process (GO:0030163),3/82,3,82,0.0578472865739276,1,0,0,3.41919307043538,9.74452495197888,BACE1;MANBA;HTRA2,alpha,1
regulation of potassium ion transport (GO:0043266),2/37,2,37,0.0594312636651613,1,0,0,5.05178075271533,14.2608480259878,KCNA5;ANK2,alpha,1
plasma membrane organization (GO:0007009),2/37,2,37,0.0594312636651613,1,0,0,5.05178075271533,14.2608480259878,TMEM256-PLSCR3;ANK2,alpha,1
positive regulation of protein secretion (GO:0050714),3/83,3,83,0.0595616016620201,1,0,0,3.37799797320122,9.52846812281063,SLC30A8;NLGN2;GCK,alpha,1
modulation of chemical synaptic transmission (GO:0050804),3/83,3,83,0.0595616016620201,1,0,0,3.37799797320122,9.52846812281063,MCTP1;NLGN2;GRM7,alpha,1
negative regulation of neuron death (GO:1901215),3/84,3,84,0.0612996357806806,1,0,0,3.33778371161549,9.31902996543797,CHGA;HTRA2;TP73,alpha,1
positive regulation of homeostatic process (GO:0032846),3/84,3,84,0.0612996357806806,1,0,0,3.33778371161549,9.31902996543797,PRMT1;HNF4A;GCG,alpha,1
regulation of metal ion transport (GO:0010959),2/38,2,38,0.0623032391157661,1,0,0,4.91883915395967,13.6534277536296,KCNA5;ANK2,alpha,1
regulation of vesicle-mediated transport (GO:0060627),4/139,4,139,0.0623947578683824,1,0,0,2.68943723525852,7.46123583851323,RAB3A;SLC30A8;RAB8A;TBC1D10B,alpha,1
response to lead ion (GO:0010288),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,PPP1CA,alpha,1
cellular response to lipoteichoic acid (GO:0071223),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,CD14,alpha,1
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway (GO:0007196),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,GRM7,alpha,1
hormone transport (GO:0009914),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,SLC16A2,alpha,1
regulation of translational initiation in response to stress (GO:0043558),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,PPP1CA,alpha,1
regulation of skeletal muscle satellite cell proliferation (GO:0014842),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,EPHB1,alpha,1
NADH metabolic process (GO:0006734),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,NUDT12,alpha,1
positive regulation of cardiac muscle contraction (GO:0060452),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,CHGA,alpha,1
negative regulation of catecholamine secretion (GO:0033604),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,CHGA,alpha,1
aldehyde catabolic process (GO:0046185),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,HOGA1,alpha,1
regulation of respiratory system process (GO:0044065),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,NLGN2,alpha,1
indolalkylamine metabolic process (GO:0006586),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,DDC,alpha,1
regulation of digestive system process (GO:0044058),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,NEUROD1,alpha,1
response to lipoteichoic acid (GO:0070391),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,CD14,alpha,1
cellular response to bacterial lipopeptide (GO:0071221),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,CD14,alpha,1
nucleobase metabolic process (GO:0009112),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,TTR,alpha,1
protein localization to endoplasmic reticulum exit site (GO:0070973),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,CTAGE5,alpha,1
retinal ganglion cell axon guidance (GO:0031290),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,EPHB1,alpha,1
choline catabolic process (GO:0042426),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,DMGDH,alpha,1
nucleus localization (GO:0051647),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,DCTN4,alpha,1
regulation of relaxation of cardiac muscle (GO:1901897),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,CHGA,alpha,1
glutamate catabolic process (GO:0006538),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,ADHFE1,alpha,1
signal complex assembly (GO:0007172),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,PXN,alpha,1
alpha-beta T cell activation (GO:0046631),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,RSAD2,alpha,1
pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,CMPK2,alpha,1
negative regulation of amino acid transport (GO:0051956),1/6,1,6,0.0625143004036104,1,0,0,15.5763239875389,43.1831766659536,GRM7,alpha,1
T cell differentiation (GO:0030217),2/39,2,39,0.0652215105124061,1,0,0,4.79271507308891,13.0839489509961,CD8A;KIT,alpha,1
chemical homeostasis (GO:0048878),2/39,2,39,0.0652215105124061,1,0,0,4.79271507308891,13.0839489509961,HNF4A;KLHL3,alpha,1
regulation of cell growth (GO:0001558),5/202,5,202,0.0663743766448582,1,0,0,2.3133154436939,6.27473903691751,HNF4A;DERL2;DACT3;APBB1;ESR2,alpha,1
signal transduction by p53 class mediator (GO:0072331),2/40,2,40,0.0681847689694663,1,0,0,4.67289719626168,12.5492246166719,ZNF385B;KRCC1,alpha,1
purine ribonucleoside monophosphate biosynthetic process (GO:0009168),2/40,2,40,0.0681847689694663,1,0,0,4.67289719626168,12.5492246166719,ATP5B;PFAS,alpha,1
alpha-amino acid catabolic process (GO:1901606),2/40,2,40,0.0681847689694663,1,0,0,4.67289719626168,12.5492246166719,HOGA1;DDO,alpha,1
cellular protein complex assembly (GO:0043623),4/145,4,145,0.0705447824593027,1,0,0,2.57815017724783,6.83598468227417,PXN;MIS12;DNAJC28;SEPT2,alpha,1
regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,KCNA5,alpha,1
cardiac atrium development (GO:0003230),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,ANK2,alpha,1
regulation of alpha-beta T cell differentiation (GO:0046637),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,ZNF683,alpha,1
regulation of RNA biosynthetic process (GO:2001141),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,RALY,alpha,1
"retrograde transport, vesicle recycling within Golgi (GO:0000301)",1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,DNAJC28,alpha,1
negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,CD14,alpha,1
postsynaptic density assembly (GO:0097107),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,NLGN2,alpha,1
ion homeostasis (GO:0050801),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,KLHL3,alpha,1
positive regulation of striated muscle contraction (GO:0045989),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,CHGA,alpha,1
regulation of cardiac muscle cell membrane potential (GO:0086036),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,EHD3,alpha,1
ornithine transport (GO:0015822),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,SLC7A2,alpha,1
bone cell development (GO:0098751),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,KIT,alpha,1
melanocyte differentiation (GO:0030318),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,KIT,alpha,1
nucleoside diphosphate metabolic process (GO:0009132),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,CMPK2,alpha,1
regulation of establishment of protein localization (GO:0070201),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,SPIDR,alpha,1
cellular response to leptin stimulus (GO:0044320),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,GCK,alpha,1
regulation of anion transport (GO:0044070),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,PDZK1,alpha,1
regulation of toll-like receptor 9 signaling pathway (GO:0034163),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,RSAD2,alpha,1
central nervous system neuron axonogenesis (GO:0021955),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,EPHB1,alpha,1
carnitine transport (GO:0015879),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,PDZK1,alpha,1
amino-acid betaine transport (GO:0015838),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,PDZK1,alpha,1
amino acid import across plasma membrane (GO:0089718),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,SLC7A2,alpha,1
glyoxylate metabolic process (GO:0046487),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,HOGA1,alpha,1
regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,ENPEP,alpha,1
L-methionine salvage (GO:0071267),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,BHMT2,alpha,1
cAMP catabolic process (GO:0006198),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,PDE3A,alpha,1
chondroitin sulfate proteoglycan metabolic process (GO:0050654),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,B3GAT2,alpha,1
cellular response to hydroxyurea (GO:0072711),1/7,1,7,0.0725483872640994,1,0,0,13.351134846462,35.0267226862693,SPIDR,alpha,1
cellular response to oxygen-containing compound (GO:1901701),6/275,6,275,0.0757773998207717,1,0,0,2.03908241291419,5.26074124626629,FZD4;PXN;PDE3A;HTRA2;CD14;RORB,alpha,1
cellular response to acid chemical (GO:0071229),3/92,3,92,0.0760341175168263,1,0,0,3.04754164973588,7.85221391121327,FZD4;HTRA2;RORB,alpha,1
regulation of ion transmembrane transporter activity (GO:0032412),2/43,2,43,0.0773317133188167,1,0,0,4.34688111280157,11.1264992161136,ANK2;PDZK1,alpha,1
mitotic metaphase plate congression (GO:0007080),2/44,2,44,0.0804622760657886,1,0,0,4.24808836023789,10.7050417361733,MIS12;KIF22,alpha,1
axon development (GO:0061564),3/95,3,95,0.0819262807764968,1,0,0,2.9513034923758,7.38397083422017,RAB3A;APBB1;RAB8A,alpha,1
Golgi to lysosome transport (GO:0090160),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,EHD3,alpha,1
barbed-end actin filament capping (GO:0051016),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,ADD2,alpha,1
phospholipid homeostasis (GO:0055091),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,HNF4A,alpha,1
4-hydroxyproline metabolic process (GO:0019471),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,HOGA1,alpha,1
phospholipid scrambling (GO:0017121),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,TMEM256-PLSCR3,alpha,1
cGMP-mediated signaling (GO:0019934),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,PDE3A,alpha,1
nucleoside diphosphate phosphorylation (GO:0006165),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,CMPK2,alpha,1
positive regulation of protein localization to Cajal body (GO:1904871),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,CCT6A,alpha,1
cellular biogenic amine catabolic process (GO:0042402),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,DMGDH,alpha,1
"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)",1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,PRMT1,alpha,1
regulation of response to oxidative stress (GO:1902882),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,MCTP1,alpha,1
negative regulation of vascular permeability (GO:0043116),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,PDE3A,alpha,1
nucleotide phosphorylation (GO:0046939),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,CMPK2,alpha,1
regulation of protein localization to Cajal body (GO:1904869),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,CCT6A,alpha,1
regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,CD14,alpha,1
"negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,DERL2,alpha,1
response to leptin (GO:0044321),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,GCK,alpha,1
response to hydroxyurea (GO:0072710),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,SPIDR,alpha,1
regulation of T-helper 2 cell cytokine production (GO:2000551),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,RSAD2,alpha,1
kinetochore assembly (GO:0051382),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,MIS12,alpha,1
negative regulation of centriole replication (GO:0046600),1/8,1,8,0.0824755753211491,1,0,0,11.6822429906542,29.1501528760314,CDK5RAP2,alpha,1
"regulation of synaptic transmission, glutamatergic (GO:0051966)",2/46,2,46,0.0868385429002981,1,0,0,4.06338886631451,9.92972252435361,NLGN2;GRM7,alpha,1
positive regulation of blood vessel endothelial cell migration (GO:0043536),2/46,2,46,0.0868385429002981,1,0,0,4.06338886631451,9.92972252435361,ATP5B;SRPX2,alpha,1
cell morphogenesis involved in neuron differentiation (GO:0048667),3/98,3,98,0.0880092292174304,1,0,0,2.86095746709899,6.95302381994771,RAB3A;APBB1;RAB8A,alpha,1
negative regulation of cell motility (GO:2000146),3/98,3,98,0.0880092292174304,1,0,0,2.86095746709899,6.95302381994771,DACH1;MCTP1;CX3CL1,alpha,1
protein complex disassembly (GO:0043241),2/47,2,47,0.0900819099087513,1,0,0,3.9769337840525,9.57262243966482,SNX14;PPP1CA,alpha,1
pyruvate metabolic process (GO:0006090),2/47,2,47,0.0900819099087513,1,0,0,3.9769337840525,9.57262243966482,HOGA1;GCK,alpha,1
glycosaminoglycan biosynthetic process (GO:0006024),3/100,3,100,0.0921674450838924,1,0,0,2.80373831775701,6.68452794663646,B3GAT2;ST3GAL6;CHST2,alpha,1
nucleoside triphosphate biosynthetic process (GO:0009142),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,CMPK2,alpha,1
positive regulation of establishment of protein localization to telomere (GO:1904851),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,CCT6A,alpha,1
peptidyl-arginine methylation (GO:0018216),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,PRMT1,alpha,1
ornithine metabolic process (GO:0006591),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,HNF4A,alpha,1
megakaryocyte differentiation (GO:0030219),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,KIT,alpha,1
integrin activation (GO:0033622),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,CX3CL1,alpha,1
regulation of sequestering of calcium ion (GO:0051282),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,ANK2,alpha,1
regulation of natural killer cell activation (GO:0032814),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,ZNF683,alpha,1
ventricular cardiac muscle cell membrane repolarization (GO:0099625),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,KCNJ3,alpha,1
postsynaptic membrane assembly (GO:0097104),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,NLGN2,alpha,1
sarcoplasmic reticulum calcium ion transport (GO:0070296),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,ANK2,alpha,1
oligosaccharide catabolic process (GO:0009313),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,MANBA,alpha,1
postsynaptic density organization (GO:0097106),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,NLGN2,alpha,1
negative regulation of catenin import into nucleus (GO:0035414),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,DACT3,alpha,1
potassium ion export (GO:0071435),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,KCNA5,alpha,1
protein autoprocessing (GO:0016540),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,HTRA2,alpha,1
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,HTRA2,alpha,1
nuclear migration (GO:0007097),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,DCTN4,alpha,1
ether lipid metabolic process (GO:0046485),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,TMEM86B,alpha,1
positive regulation of ion transmembrane transport (GO:0034767),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,PDZK1,alpha,1
potassium ion import across plasma membrane (GO:1990573),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,KCNJ3,alpha,1
peptidyl-arginine omega-N-methylation (GO:0035247),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,PRMT1,alpha,1
negative regulation of protein exit from endoplasmic reticulum (GO:0070862),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,DERL2,alpha,1
T cell mediated immunity (GO:0002456),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,CD8A,alpha,1
negative regulation of transcription by competitive promoter binding (GO:0010944),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,DACH1,alpha,1
detection of mechanical stimulus involved in sensory perception (GO:0050974),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,KIT,alpha,1
nucleoside phosphate biosynthetic process (GO:1901293),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,CMPK2,alpha,1
cell junction maintenance (GO:0034331),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,NLGN2,alpha,1
early endosome to Golgi transport (GO:0034498),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,EHD3,alpha,1
receptor recycling (GO:0001881),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,EHD3,alpha,1
cyclic nucleotide catabolic process (GO:0009214),1/9,1,9,0.0922969977803603,1,0,0,10.3842159916926,24.7429248676947,PDE3A,alpha,1
protein localization to membrane (GO:0072657),4/161,4,161,0.0947741984285737,1,0,0,2.32193649503686,5.47108161662665,EHD3;NLGN2;ANK2;RAB8A,alpha,1
transcription initiation from RNA polymerase II promoter (GO:0006367),4/161,4,161,0.0947741984285737,1,0,0,2.32193649503686,5.47108161662665,HNF4A;RORB;NR0B2;ESR2,alpha,1
metal ion transport (GO:0030001),3/102,3,102,0.0964057924087694,1,0,0,2.74876305662452,6.4298762835154,KCNK16;KCNA5;KCNJ3,alpha,1
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),2/49,2,49,0.0966734208409908,1,0,0,3.81460995613199,8.91251869670687,HTRA2;TP73,alpha,1
protein K48-linked ubiquitination (GO:0070936),2/49,2,49,0.0966734208409908,1,0,0,3.81460995613199,8.91251869670687,SYVN1;KLHL3,alpha,1
regulation of cell cycle arrest (GO:0071156),2/49,2,49,0.0966734208409908,1,0,0,3.81460995613199,8.91251869670687,NEUROD1;TP73,alpha,1
cellular macromolecule catabolic process (GO:0044265),2/49,2,49,0.0966734208409908,1,0,0,3.81460995613199,8.91251869670687,MANBA;HTRA2,alpha,1
neuron projection morphogenesis (GO:0048812),4/164,4,164,0.0997047832807279,1,0,0,2.27946204695692,5.25539463512127,RAB3A;APBB1;EPHB1;RAB8A,alpha,1
protein ubiquitination (GO:0016567),61/507,61,507,3.13186910025116e-07,0.000799096400929084,0,0,1.96915845914965,29.4910340583135,UBE2D4;RNF13;UBE3C;CCNF;KLHDC7A;PSMD9;MAEA;PSMD2;ARIH2;PSMD1;FBXW11;UBE4B;RBX1;RNF167;TRAF7;GAN;HECW2;WAC;NHLRC1;UBE2V1;DTL;THOP1;PCNA;PSMD11;HIST1H2BO;CBFB;EPAS1;PSMD13;PELI3;CTR9;CUL1;RTF1;PSMA7;PSMB10;RNF135;DCAF15;RNF213;ZNRF3;BTBD1;RNF138;PSMB3;LEO1;RBBP6;KLHL29;AMFR;SIAH1;MIB2;KLHL21;KLHL22;FBXL15;FBXO31;SPSB1;PSMC3;RNF181;TRIM36;STUB1;UBA1;BLMH;UBE2K;RNF187;ASB1,alpha,2
protein polyubiquitination (GO:0000209),41/284,41,284,2.58528336276629e-07,0.00131927010001964,0,0,2.36278555127821,35.8393468204675,PSMD11;UBE2D4;UBE3C;CBFB;PSMD13;PELI3;CCNF;CUL1;PSMA7;PSMB10;PSMD9;RNF213;RNF138;PSMB3;PSMD2;ARIH2;PSMD1;RBBP6;FBXW11;AMFR;SIAH1;MIB2;UBE4B;FBXL15;RBX1;FBXO31;RNF167;SPSB1;PSMC3;HECW2;TTC3;RNF181;TRIM36;NHLRC1;BLMH;STUB1;UBE2V1;UBE2K;THOP1;DTL;RNF187,alpha,2
ubiquitin-dependent protein catabolic process (GO:0006511),45/342,45,342,9.95213405870119e-07,0.00169285800338507,0,0,2.15350159359118,29.7620566899035,TSG101;PSMD11;UBE3C;PSMD13;VPS4A;CUL1;PSMA7;PSMB10;CDC20;PSMD9;RNF213;MAEA;ZNRF3;BTBD1;PSMB3;PSMD2;ARIH2;PSMD1;RBBP6;RANBP1;FBXW11;AMFR;SIAH1;ADRM1;AXIN1;UBE4B;NTAN1;KCTD6;RBX1;COPS3;SPSB1;PSMC3;UBXN11;RFWD2;HECW2;TOLLIP;TTC3;RNF181;NHLRC1;UBA1;STUB1;UBE2K;DTL;VPS28;RNF187,alpha,2
cellular protein modification process (GO:0006464),98/1002,98,1002,2.33278572775558e-06,0.00297605139218418,0,0,1.60072653383903,20.758937877046,MAML1;GMFG;CCNF;PSMD9;NRBP2;AKT2;PSMD2;PSMD1;MACROD2;CHGB;RAB2A;FBXW11;DAPK1;PRPF4B;PRKCA;PASK;PHKA2;NRBP1;KCTD6;RBX1;CTDNEP1;ILF3;PHPT1;PSMD11;EPAS1;PSMD13;DCUN1D3;CUL1;DCUN1D1;PRKCZ;NUAK2;BTBD1;MAN2A2;CDK17;FN3K;KLHL21;KLHL22;B3GALT6;FBXO31;SSH1;ICK;COPS3;COPS5;CDK10;STT3B;CDK12;CDK13;BAP1;UBE2M;FBN1;BMPR1A;PIGU;DYRK3;MAST2;DSTYK;WDR5;TLK2;QSOX1;DSP;KSR1;WIPI2;B3GNT9;GAN;B3GNT4;ATG4B;VWA1;B3GNT2;DTL;B4GALT7;PIGH;ROCK2;WDR45B;STYXL1;PSMA7;PSMB10;DCAF17;PDF;PSMB3;MAPK1;MAP4K5;ZNF862;MBTPS1;USP25;FEM1B;FBXL15;PTPN12;CDC42BPA;HIPK3;RAB11A;SPSB1;PSMC3;RPS6KB1;RFWD2;PTPN9;P4HB;PNPLA2;ENGASE;ASB1,alpha,2
post-translational protein modification (GO:0043687),44/358,44,358,7.93436323090825e-06,0.00809781111346496,0,0,2.0115389187064,23.6241315197077,PSMD11;EPAS1;PSMD13;DCUN1D3;CCNF;DCUN1D1;CUL1;PSMA7;PSMB10;PSMD9;DCAF17;BTBD1;PSMB3;PSMD2;WDR5;PSMD1;QSOX1;CHGB;RAB2A;FN3K;MBTPS1;FBXW11;FEM1B;KLHL21;KLHL22;FBXL15;RAB11A;KCTD6;RBX1;FBXO31;COPS3;SPSB1;COPS5;PSMC3;GAN;RFWD2;VWA1;STT3B;P4HB;DTL;PNPLA2;UBE2M;FBN1;ASB1,alpha,2
interleukin-1-mediated signaling pathway (GO:0070498),18/96,18,96,1.79513740618077e-05,0.0152676436395675,0,0,3.06873977086743,33.5347091751905,MAP3K3;PSMD11;FBXW11;PSMD13;PELI3;CUL1;PSMB10;PSMA7;RBX1;PSMD9;PSMC3;PSMB3;PSMD2;TOLLIP;PSMD1;TAB2;UBE2V1;PLCB1,alpha,2
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),15/73,15,73,2.87977485957193e-05,0.0209935587262794,0,0,3.36300248862184,35.1609085071784,PSMD11;FBXW11;PSMD13;CCNF;CUL1;FBXL15;PSMB10;PSMA7;RBX1;FBXO31;PSMD9;PSMC3;PSMB3;PSMD2;PSMD1,alpha,2
mRNA processing (GO:0006397),35/284,35,284,6.15032504328455e-05,0.0348723429954234,0,0,2.0170120559692,19.5577971127547,ZCCHC8;ISY1;SF3B2;DBR1;DDX46;RNMT;PDCD7;POLDIP3;PRPF8;PTBP1;ALKBH5;DHX32;SNRPD2;RAVER1;PUF60;U2AF2;RAVER2;SNRPD3;PPARGC1A;SRSF11;POLR2L;RBM15;PRPF40B;GTF2H1;PRPF4B;GTF2H4;LSM2;HNRNPM;DDX39A;HNRNPH1;SNRPA1;SNRPF;PPIL3;SNRPA;SF1,alpha,2
snRNA metabolic process (GO:0016073),7/18,7,18,5.47193780825465e-05,0.0349041232944044,0,0,6.36479359883615,62.4595822432767,INTS1;SNAPC2;INTS10;TUT1;INTS7;RPAP2;INTS8,alpha,2
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),35/292,35,292,0.000107907564523749,0.0500593001604266,0,0,1.96175145169607,17.9190999118616,PSMD11;PSMD13;CCNF;CUL1;PSMA7;PSMB10;UBE2J1;CDC20;PSMD9;MAEA;BTBD1;PSMB3;PSMD2;PSMD1;HSPA5;FBXW11;AMFR;SIAH1;AXIN1;UBE4B;FBXL15;RBX1;FBXO31;SPSB1;PSMC3;UBXN11;RFWD2;HECW2;RNF181;NHLRC1;STUB1;STT3B;MAN1B1;UBE2K;RNF187,alpha,2
endoplasmic reticulum tubular network organization (GO:0071786),6/14,6,14,0.000100812474610995,0.0514446057939907,0,0,7.01426233341127,64.5469847130421,RAB10;RTN3;ARL6IP1;ATL1;ATL2;RTN4,alpha,2
"mRNA splicing, via spliceosome (GO:0000398)",32/262,32,262,0.000147598239342825,0.0537995582404598,0,0,1.99897552504342,17.6329962383093,ZCCHC8;ISY1;SF3B2;DBR1;DDX46;PDCD7;PRPF8;PTBP1;DHX32;SNRPD2;RAVER1;PUF60;U2AF2;TGS1;RAVER2;SNRPD3;SRSF11;POLR2L;PRMT7;RBM15;PRPF40B;PRPF4B;LSM2;HNRNPM;DDX39A;HNRNPH1;SNRPA1;SNRPF;CDK13;PPIL3;SNRPA;SF1,alpha,2
endoplasmic reticulum membrane organization (GO:0090158),4/6,4,6,0.000188317482787145,0.056528477333106,0,0,10.911074740862,93.5884482402611,ARL6IP1;ATL1;ATL2;RTN4,alpha,2
ncRNA processing (GO:0034470),29/228,29,228,0.00014678947369695,0.0576205141750412,0,0,2.08171820713814,18.374308965248,RPL5;POP7;RPL31;INTS10;NOLC1;RPL8;RRP9;EXOSC6;RPL7A;RPS15A;PDCD11;RPL35;RPL13;DGCR8;RPS2;NOP14;SSB;INTS1;RCL1;BOP1;AGO3;RPL27A;AGO1;XRN2;TUT1;INTS7;RPP25;INTS8;RPS24,alpha,2
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),16/94,16,94,0.000171018825273131,0.0581806043579192,0,0,2.78580631681582,24.1633510971326,PSMD11;PSMD13;EPAS1;ARNT;PSMB10;PSMA7;RBX1;PSMD9;MAPK7;PSMC3;PSMB3;PSMD2;HSF1;HSF4;PSMD1;ATF3,alpha,2
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),4/6,4,6,0.000188317482787145,0.0600615071664251,0,0,10.911074740862,93.5884482402611,GTF2H1;CDK12;CDK13;GTF2H4,alpha,2
modification-dependent protein catabolic process (GO:0019941),21/142,21,142,0.000146624021191441,0.0623518650116604,0,0,2.42041446716304,21.3665449688442,RANBP1;PSMD11;PSMD13;AMFR;SIAH1;ADRM1;UBE4B;NTAN1;KCTD6;PSMD9;COPS3;RNF213;ZNRF3;TOLLIP;TTC3;ARIH2;UBA1;RBBP6;STUB1;UBE2K;DTL,alpha,2
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",29/237,29,237,0.000286274135119431,0.0768872058691818,0,0,2.00266561699365,16.3388689816687,ZCCHC8;ISY1;SF3B2;DBR1;DDX46;PDCD7;PRPF8;PTBP1;DHX32;SNRPD2;RAVER1;PUF60;U2AF2;RAVER2;SNRPD3;SRSF11;POLR2L;RBM15;PRPF40B;PRPF4B;LSM2;HNRNPM;DDX39A;HNRNPH1;SNRPA1;SNRPF;PPIL3;SNRPA;SF1,alpha,2
negative regulation of mitotic cell cycle phase transition (GO:1901991),14/80,14,80,0.000318317043706044,0.0773510416205687,0,0,2.86415711947627,23.063518311561,CDKN1A;PSMD11;PSMD13;DCUN1D3;CUL1;PSMB10;ZFP36L2;PSMA7;RBX1;PSMD9;PSMC3;PSMB3;PSMD2;PSMD1,alpha,2
proteasomal protein catabolic process (GO:0010498),29/238,29,238,0.000307416635995406,0.078437354674228,0,0,1.99425105557771,16.1281197436267,PSMD11;PSMD13;CUL1;PSMA7;PSMB10;CDC20;PSMD9;MAEA;BTBD1;PSMB3;PSMD2;PSMD1;FBXW11;AMFR;SIAH1;DNAJB12;AXIN1;UBE4B;RBX1;SPSB1;PSMC3;UBXN11;RFWD2;HECW2;RNF181;NHLRC1;STUB1;UBE2K;RNF187,alpha,2
proteasome assembly (GO:0043248),5/11,5,11,0.000286008871486789,0.0810835150665047,0,0,7.4393691414968,60.7014412173853,PSMD9;PSMD11;PSMD13;ADRM1;PSMG2,alpha,2
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),12/63,12,63,0.000375519089450732,0.0871033597030494,0,0,3.11744992596056,24.5879549548236,PSMD9;PSMD11;PSMC3;PSMD13;PSMB3;PSMD2;VPS4A;CUL1;PSMD1;PSMB10;PSMA7;RBX1,alpha,2
DNA ligation (GO:0006266),6/18,6,18,0.000504288215048706,0.111886207017111,0,0,5.45553737043099,41.4204178837122,PARP3;XRCC6;PCNA;LIG1;POLD1;LIG3,alpha,2
histone H4 acetylation (GO:0043967),10/48,10,48,0.000542108061021214,0.115265726474636,0,0,3.40971085651937,25.6411797661594,MORF4L1;PER1;NAA40;KMT2A;HAT1;WDR5;EP400;BEND3;KAT8;KAT7,alpha,2
endosomal transport (GO:0016197),27/230,27,230,0.00086833944786778,0.164116155647011,0,0,1.92129794349961,13.5430905835795,TSG101;VPS4A;ARHGAP1;VPS26A;AP2A1;SNX1;VPS51;BLOC1S3;TOM1;STX5;TBC1D17;RAB11FIP3;RILP;TBC1D10A;SPAG9;VPS18;VPS33A;AKTIP;DENND2A;VPS13A;ARL4C;MYO1D;RAB10;EHD4;HOOK2;VPS28;RAB7A,alpha,2
mRNA metabolic process (GO:0016071),15/98,15,98,0.000865359383612568,0.169843420560574,0,0,2.50509369050402,17.6668367303501,ZNF473;SF3B2;SSB;PRPF8;ZFP36L2;HIPK3;PTBP1;ALKBH5;AGO3;U2AF2;HSF1;SNRPD3;SNRPF;PPARGC1A;SRSF11,alpha,2
organelle disassembly (GO:1903008),6/20,6,20,0.000947524527530729,0.172686345142475,0,0,4.90998363338789,34.1816255389531,PLK3;DYRK3;STX5;DENR;PELO;MRRF,alpha,2
regulation of mRNA stability (GO:0043488),18/129,18,129,0.000859888965779896,0.175520535694992,0,0,2.28371331785483,16.120063837271,PSMD11;YTHDF3;PSMD13;SAMD4B;PRKCA;ZFP36L2;PSMB10;PSMA7;PSMD9;EXOSC6;FXR2;XRN1;PSMC3;PDE12;PSMB3;PSMD2;E2F1;PSMD1,alpha,2
negative regulation of cell cycle G2/M phase transition (GO:1902750),12/70,12,70,0.00100980543432946,0.177690935564939,0,0,2.80570493336451,19.3537459133899,PSMD9;PSMD11;PSMC3;PSMD13;PSMB3;PSMD2;CUL1;PSMD1;DTL;PSMB10;PSMA7;RBX1,alpha,2
Ras protein signal transduction (GO:0007265),26/224,26,224,0.0012639772965343,0.215002538140484,0,0,1.89969604863222,12.6776062785361,CDKN1A;ARHGAP1;RHOBTB1;CRKL;RAP1B;GNA13;RHOT1;TRIM28;RRAS;PLCE1;RALGDS;HRAS;FARP2;RAB2A;KSR1;RHOF;MAPK14;RAB11A;RAB10;CDC42EP3;ARHGEF3;CDC42EP2;GRB2;TAX1BP3;MAPKAPK5;RAB7A,alpha,2
protein modification by small protein conjugation (GO:0032446),40/399,40,399,0.00145444844838582,0.239420981681059,0,0,1.64076311892661,10.7193163325654,PCNA;HIST1H2BO;UBE2D4;UBE3C;EPAS1;DCUN1D3;CCNF;CTR9;CUL1;DCUN1D1;KLHDC7A;RTF1;RNF135;DCAF15;RNF213;ZNRF3;TRIM28;RNF138;LEO1;ARIH2;KLHL29;NUP210;NUP133;FBXW11;MIB2;KLHL21;KLHL22;FBXL15;RBX1;TRAF7;GAN;HECW2;WAC;RNF181;STUB1;UBA1;TOP1;UBE2K;UBE2M;ASB1,alpha,2
transcription-coupled nucleotide-excision repair (GO:0006283),12/74,12,74,0.00166419339333864,0.265386840193971,0,0,2.6540452072367,16.9816819251861,ISY1;COPS3;PCNA;COPS5;LIG1;POLD1;XPA;LIG3;GTF2H1;GTF2H4;RBX1;POLR2L,alpha,2
cellular response to interleukin-1 (GO:0071347),19/151,19,151,0.00217570817636019,0.317218252113315,0,0,2.0593750338713,12.6247949093443,MAP3K3;PSMD11;FBXW11;PSMD13;PELI3;CUL1;PSMB10;PSMA7;RBX1;PSMD9;PSMC3;PSMB3;PSMD2;TOLLIP;HYAL3;PSMD1;TAB2;UBE2V1;PLCB1,alpha,2
protein localization to nucleus (GO:0034504),14/97,14,97,0.00225018805147808,0.318964156297018,0,0,2.36219143874331,14.4016705467681,IPO13;PDIA3;RANBP1;NUP133;XPA;ARL2;IPO7;CTDNEP1;IPO9;DVL1;LMNA;TAF8;HEATR3;CALR,alpha,2
transcription from RNA polymerase II promoter (GO:0006366),46/486,46,486,0.00216499727235693,0.32494062002463,0,0,1.54910320394954,9.50426892973305,ZNF473;CDKN1A;CBFB;KMT2A;MAML1;RNMT;EPAS1;POLDIP3;CTR9;INTS10;RTF1;MED15;RPAP2;TRIM28;U2AF2;SNAPC2;MED31;DVL1;LEO1;NELFA;SNRPD3;ZNF148;PPARGC1A;TEAD1;SRSF11;POLR2L;KLF11;INTS1;NR1H2;ADRM1;SSU72;ARNT;GTF2H1;GTF2H4;NRBP1;DDX39A;NCOR1;COPS5;MAFF;TAF8;NABP1;INTS7;CDK12;SNRPF;CDK13;INTS8,alpha,2
RNA splicing (GO:0008380),15/107,15,107,0.0021408179234115,0.331048298883906,0,0,2.2943848754149,14.1025910850207,DBR1;SF3B2;PDCD7;PRPF4B;PRPF8;CCAR2;PTBP1;SNRPD2;RRAGC;SNRPA1;SNRPD3;SNRPF;CDK12;PPARGC1A;SRSF11,alpha,2
regulation of ubiquitin-protein transferase activity (GO:0051438),7/32,7,32,0.00272780124945112,0.376215399349974,0,0,3.58019639934534,21.1384082354729,BAG5;FEM1B;DCUN1D3;DCUN1D1;AXIN1;PIN1;RPS2,alpha,2
response to light stimulus (GO:0009416),10/59,10,59,0.00283278726800033,0.380413511279097,0,0,2.77400205276152,16.273666819245,MSH6;COPS3;PER1;TP53I13;POLD1;CRY2;USP1;UBE4B;DTL;CCAR2,alpha,2
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),12/79,12,79,0.00293575998023124,0.384132902028719,0,0,2.48606766247488,14.4957357861337,PSMD9;PSMD11;PSMC3;PSMD13;EPAS1;PSMB3;PSMD2;PSMD1;ARNT;PSMB10;PSMA7;RBX1,alpha,2
histone mRNA metabolic process (GO:0008334),6/25,6,25,0.00333009174072747,0.386214958021188,0,0,3.92798690671031,22.4082046177464,ZNF473;SSB;XRN1;PAPD5;SNRPD3;SNRPF,alpha,2
cellular response to hypoxia (GO:0071456),17/133,17,133,0.0030727351330109,0.392004184593865,0,0,2.09197297663143,12.1024552687747,PLK3;PSMD11;EPAS1;PSMD13;ARNT;PSMB10;PSMA7;RBX1;PSMD9;TBL2;PSMC3;PSMB3;PSMD2;LMNA;PSMD1;STUB1;P4HB,alpha,2
positive regulation of glucose metabolic process (GO:0010907),4/11,4,11,0.0032343754861378,0.392976621565742,0,0,5.95149531319744,34.1253945470792,AKT2;IRS2;PPARGC1A;ARPP19,alpha,2
regulation of establishment of planar polarity (GO:0090175),13/90,13,90,0.00315806729093573,0.393063838674269,0,0,2.36406619385343,13.6118086413467,PSMD11;PSMD13;AP2A1;PSMB10;PSMA7;PSMD9;SAPCD2;PSMC3;PSMB3;PSMD2;DVL1;PSMD1;AP2M1,alpha,2
regulation of cell cycle process (GO:0010564),13/91,13,91,0.00348324229132993,0.394999675836814,0,0,2.33808744447042,13.2330879729747,PLK3;NUMA1;KLHL21;TXLNG;RAB11A;FLCN;AKT2;PIN1;E4F1;CALM3;KIF20B;CDK13;RAB11FIP3,alpha,2
cellular senescence (GO:0090398),6/25,6,25,0.00333009174072747,0.395196701230983,0,0,3.92798690671031,22.4082046177464,CDKN1A;OPA1;MAPKAPK5;CALR;MAPK14;HRAS,alpha,2
NIK/NF-kappaB signaling (GO:0038061),12/81,12,81,0.00362599199698155,0.402248633926019,0,0,2.42468327574711,13.6258165091163,PSMD9;PSMD11;PSMC3;FBXW11;PSMD13;PSMB3;PSMD2;CUL1;PSMD1;PSMB10;PSMA7;UBE2M,alpha,2
negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),3/6,3,6,0.00395704414564371,0.412097883167752,0,0,8.18330605564648,45.2721600679172,PER1;CRY2;PHB,alpha,2
histone acetylation (GO:0016573),11/72,11,72,0.00412279045947564,0.412521563033415,0,0,2.5004546281142,13.7305590875209,NAA50;MORF4L1;PER1;NAA40;TEX30;HAT1;WDR5;EP400;BEND3;KAT8;KAT7,alpha,2
regulation of cellular amino acid metabolic process (GO:0006521),9/52,9,52,0.00391989501147413,0.416733838407344,0,0,2.83268286541609,15.6978514651047,PSMD9;PSMD11;PSMC3;PSMD13;PSMB3;PSMD2;PSMD1;PSMB10;PSMA7,alpha,2
positive regulation of cellular amide metabolic process (GO:0034250),10/62,10,62,0.00410948903196856,0.419414450602711,0,0,2.63977614698274,14.5041354240134,RPL5;EPHA4;PLK3;FXR2;YTHDF3;RPS6KB1;ROCK2;POLDIP3;RPS27L;PASK,alpha,2
vesicle-mediated transport (GO:0016192),39/411,39,411,0.00431768814597091,0.423714665555569,0,0,1.55303618574313,8.45633665377598,STX12;WIPF2;VPS4A;ASAP3;VPS26A;AP2A1;DOC2B;WASL;CYTH2;SNX1;VPS51;CUX1;TOM1;STX5;KIF1B;TBC1D17;RILP;RAB11FIP3;TBC1D10A;SPAG9;VPS18;VPS33A;CACFD1;AKTIP;DENND2A;MYO5A;SYT14;HSPA2;ARAP1;VRK3;MAPK8IP3;RAB11A;ARL4C;RAB10;EHD4;ACAP1;HOOK2;SPIRE1;RAB7A,alpha,2
regulation of cellular amine metabolic process (GO:0033238),9/52,9,52,0.00391989501147413,0.425600515820266,0,0,2.83268286541609,15.6978514651047,PSMD9;PSMD11;PSMC3;PSMD13;PSMB3;PSMD2;PSMD1;PSMB10;PSMA7,alpha,2
viral process (GO:0016032),24/221,24,221,0.00452500426533775,0.435681071056954,0,0,1.77736964104539,9.5944843940392,RPL5;RANBP1;TSG101;SSB;NUP210;NUP133;RPL31;VPS4A;AP2A1;RPL8;PTBP1;RPL7A;RPS15A;NFIA;RPL27A;RPL35;RPL13;DENR;AP1S3;RPS2;VPS28;RPS24;AP2M1;RAB7A,alpha,2
vesicle budding from membrane (GO:0006900),4/12,4,12,0.00461873775499236,0.436470717846778,0,0,5.45553737043099,29.3378822936341,VPS4A;MYO18A;WASL;RILP,alpha,2
regulation of macroautophagy (GO:0016241),15/117,15,117,0.00508800439333149,0.472074298530375,0,0,2.09828360401192,11.0807620745215,ATP6V1A;ATP6V0E1;GBA;VPS26A;NRBP2;RRAGC;RHEB;SESN2;RRAGD;WAC;TBC1D14;QSOX1;SMCR8;ATP6V0D1;GAPDH,alpha,2
protein modification by small protein removal (GO:0070646),27/262,27,262,0.00554553759046962,0.505337112931544,0,0,1.68663559925538,8.76167003376369,USP37;PSMD11;PSMD13;USP32;PSMA7;PSMB10;CDC20;RNF135;PSMD9;RHOT1;PSMB3;PSMD2;USP1;PSMD1;USP25;USP42;USP4;USP43;ACTR5;USP2;ADRM1;AXIN1;UCHL5;COPS3;COPS5;PSMC3;BAP1,alpha,2
small GTPase mediated signal transduction (GO:0007264),13/100,13,100,0.00780420377373839,0.510575023812654,0,0,2.12765957446809,10.3257292449243,CDKN1A;KSR1;ARHGAP1;MAPK14;CRKL;TRIM28;RRAGC;RRAS;PLCE1;MAPKAPK5;GRB2;RALGDS;HRAS,alpha,2
regulation of TOR signaling (GO:0032006),10/68,10,68,0.007994652944538,0.51641410096174,0,0,2.40685472224897,11.6226589551888,FLCN;DYRK3;WDR59;RRAGC;RHEB;DGKQ;RRAGD;AKT1S1;MAPKAPK5;SMCR8,alpha,2
regulation of stem cell differentiation (GO:2000736),12/89,12,89,0.0077952717280189,0.516613917247798,0,0,2.20673421725298,10.7120129119155,PSMD9;PSMD11;CBFB;KMT2A;PSMC3;PSMD13;PSMB3;PSMD2;PSMD1;PSMB10;ZFP36L2;PSMA7,alpha,2
regulation of cytokinesis (GO:0032465),11/78,11,78,0.00761427312196412,0.518075143218439,0,0,2.30811196441311,11.2583487047445,FLCN;PLK3;CSPP1;VPS4A;KLHL21;PIN1;CALM3;CDC6;KIF20B;RAB11FIP3;RAB11A,alpha,2
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",12/89,12,89,0.0077952717280189,0.523411468790532,0,0,2.20673421725298,10.7120129119155,PSMD9;PSMD11;PSMC3;PSMD13;PSMB3;PSMD2;DVL1;PSMD1;AP2A1;AP2M1;PSMB10;PSMA7,alpha,2
regulation of hematopoietic progenitor cell differentiation (GO:1901532),11/78,11,78,0.00761427312196412,0.525076158667337,0,0,2.30811196441311,11.2583487047445,PSMD9;PSMD11;CBFB;KMT2A;PSMC3;PSMD13;PSMB3;PSMD2;PSMD1;PSMB10;PSMA7,alpha,2
ribonucleoprotein complex disassembly (GO:0032988),4/13,4,13,0.00635207873595071,0.53138783261568,0,0,5.0358806496286,25.4763850417016,DYRK3;DENR;PELO;MRRF,alpha,2
negative regulation of ubiquitin protein ligase activity (GO:1904667),11/78,11,78,0.00761427312196412,0.53226898275867,0,0,2.30811196441311,11.2583487047445,CDC20;RPL5;PSMD9;PSMD11;PSMC3;PSMD13;PSMB3;PSMD2;PSMD1;PSMB10;PSMA7,alpha,2
mitochondrial respiratory chain complex IV assembly (GO:0033617),5/20,5,20,0.00605344310990211,0.532598623962595,0,0,4.09165302782324,20.89659598914,COA4;SCO1;SCO2;COX18;COA5,alpha,2
cytosolic transport (GO:0016482),15/119,15,119,0.00595717569998645,0.533323992930366,0,0,2.06301833335626,10.5691705003384,SPAG9;AKTIP;DENND2A;VPS13A;VPS26A;AP2A1;MYO1D;SNX1;HOOK2;VPS51;STX5;TBC1D17;RILP;TBC1D10A;RAB7A,alpha,2
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),11/79,11,79,0.00837109273266351,0.533971077684774,0,0,2.27889535726864,10.8998900629174,PDIA3;PSMD9;PSMD11;PSMC3;PSMD13;PSMB3;PSMD2;PSMD1;CALR;PSMB10;PSMA7,alpha,2
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),12/88,12,88,0.00712957521345788,0.535032681092288,0,0,2.23181074244904,11.0329644926779,CDC20;PSMD9;PSMD11;PSMC3;PSMD13;PSMB3;PSMD2;AXIN1;CUL1;PSMD1;PSMB10;PSMA7,alpha,2
protein deubiquitination (GO:0016579),26/258,26,258,0.00849365543793766,0.535100292590072,0,0,1.6493485073396,7.86481249094744,USP37;PSMD11;PSMD13;USP32;PSMA7;PSMB10;CDC20;RNF135;PSMD9;RHOT1;PSMB3;PSMD2;USP1;PSMD1;USP25;USP42;USP4;USP43;ACTR5;USP2;ADRM1;AXIN1;UCHL5;COPS5;PSMC3;BAP1,alpha,2
negative regulation of macroautophagy (GO:0016242),5/21,5,21,0.00755185794194209,0.535237931635145,0,0,3.89681240745071,19.0396760227952,NRBP2;SCFD1;FEZ1;QSOX1;SMCR8,alpha,2
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),6/30,6,30,0.00860367635766366,0.535421468940947,0,0,3.27332242225859,15.5664997827117,MAPK7;HSPA5;HSF1;SESN2;HSF4;ATF3,alpha,2
malate metabolic process (GO:0006108),3/7,3,7,0.00661127273637839,0.535513091646649,0,0,7.01426233341127,35.2044360290825,FH;MDH2;MDH1B,alpha,2
regulation of TORC1 signaling (GO:1903432),6/29,6,29,0.00725009427738227,0.536191755035967,0,0,3.38619560923303,16.6829080865395,DYRK3;RRAGC;DGKQ;SESN2;RRAGD;SMCR8,alpha,2
cellular response to ionizing radiation (GO:0071479),8/47,8,47,0.00708904512437481,0.539931302532607,0,0,2.78580631681582,13.7875255123359,CDKN1A;XRCC6;HSF1;TLK2;INTS7;GRB2;MAPK14;HRAS,alpha,2
protein neddylation (GO:0045116),4/13,4,13,0.00635207873595071,0.540244296492608,0,0,5.0358806496286,25.4763850417016,DCUN1D3;DCUN1D1;RBX1;UBE2M,alpha,2
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",11/76,11,76,0.00626095939587316,0.541519928765097,0,0,2.3688517529503,12.0181842368741,PDIA3;PSMD9;PSMD11;PSMC3;PSMD13;PSMB3;PSMD2;PSMD1;CALR;PSMB10;PSMA7,alpha,2
spliceosomal snRNP assembly (GO:0000387),7/38,7,38,0.00743569146021614,0.542061907449757,0,0,3.01490223102765,14.7774338525494,PRMT7;SNRPD2;USP4;TGS1;SNRPD3;SNRPF;PRPF8,alpha,2
positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),11/77,11,77,0.00691177938610136,0.542627849342696,0,0,2.33808744447042,11.630881845943,CDC20;PSMD9;PSMD11;PSMC3;PSMD13;PSMB3;PSMD2;CUL1;PSMD1;PSMB10;PSMA7,alpha,2
mitochondrial respiratory chain complex IV biogenesis (GO:0097034),5/21,5,21,0.00755185794194209,0.542776494052542,0,0,3.89681240745071,19.0396760227952,COA4;SCO1;SCO2;COX18;COA5,alpha,2
regulation of glucocorticoid receptor signaling pathway (GO:2000322),3/7,3,7,0.00661127273637839,0.544150399576434,0,0,7.01426233341127,35.2044360290825,PER1;CRY2;PHB,alpha,2
RNA secondary structure unwinding (GO:0010501),8/47,8,47,0.00708904512437481,0.548112079843707,0,0,2.78580631681582,13.7875255123359,DDX3Y;DDX6;EIF4A1;DDX39A;DDX46;AGO3;DDX55;AGO1,alpha,2
regulation of hematopoietic stem cell differentiation (GO:1902036),11/77,11,77,0.00691177938610136,0.551106409488676,0,0,2.33808744447042,11.630881845943,PSMD9;PSMD11;CBFB;KMT2A;PSMC3;PSMD13;PSMB3;PSMD2;PSMD1;PSMB10;PSMA7,alpha,2
anaphase-promoting complex-dependent catabolic process (GO:0031145),11/80,11,80,0.00918492178871506,0.56470669744353,0,0,2.25040916530278,10.5548512336485,CDC20;PSMD9;PSMD11;PSMC3;PSMD13;PSMB3;PSMD2;PSMD1;PSMB10;PSMA7;FBXO31,alpha,2
regulation of G2/M transition of mitotic cell cycle (GO:0010389),17/150,17,150,0.010241630133149,0.580700428549549,0,0,1.85488270594654,8.49776390059513,PSMD11;PSMD13;NDE1;CEP164;CUL1;TUBG1;PSMB10;PSMA7;RAB11A;RBX1;PSMD9;PSMC3;PSMB3;PSMD2;CNTRL;PSMD1;DTL,alpha,2
regulation of intracellular estrogen receptor signaling pathway (GO:0033146),6/31,6,31,0.0101290700768473,0.580771287664626,0,0,3.16773137637928,14.5473177673761,CBFB;WBP2;CNOT2;CARM1;AXIN1;KCTD6,alpha,2
desmosome organization (GO:0002934),3/8,3,8,0.0101006338981812,0.585721986163848,0,0,6.13747954173486,28.2026826610571,DSP;PERP;PRKCA,alpha,2
ribosome disassembly (GO:0032790),3/8,3,8,0.0101006338981812,0.592454422786421,0,0,6.13747954173486,28.2026826610571,DENR;PELO;MRRF,alpha,2
lagging strand elongation (GO:0006273),3/8,3,8,0.0101006338981812,0.599343427702542,0,0,6.13747954173486,28.2026826610571,PARP3;LIG1;LIG3,alpha,2
nuclear-transcribed mRNA catabolic process (GO:0000956),19/175,19,175,0.0107476531266589,0.602695317641101,0,0,1.77694645779752,8.05501888041055,RPL5;EIF4A1;RPL31;SAMD4B;RPL8;RPL7A;EXOSC6;RPS15A;XRN1;PDE12;CNOT2;RPL27A;AGO1;PAPD5;RPL35;RPL13;RPS2;PELO;RPS24,alpha,2
endodermal cell fate commitment (GO:0001711),3/8,3,8,0.0101006338981812,0.606394526851983,0,0,6.13747954173486,28.2026826610571,CTR9;LEO1;RTF1,alpha,2
nuclear import (GO:0051170),10/72,10,72,0.0118477246639497,0.610696353132682,0,0,2.27314057101291,10.0827865096349,IPO13;PDIA3;RANBP1;IPO9;SNRPD2;NUP133;HEATR3;SNRPD3;SNRPF;IPO7,alpha,2
positive regulation of ubiquitin protein ligase activity (GO:1904668),11/83,11,83,0.0119956457107279,0.612137800618447,0,0,2.16906907499063,9.59425139063037,CDC20;PSMD9;PSMD11;PSMC3;PSMD13;PSMB3;PSMD2;CUL1;PSMD1;PSMB10;PSMA7,alpha,2
stress-induced premature senescence (GO:0090400),3/8,3,8,0.0101006338981812,0.613613509314507,0,0,6.13747954173486,28.2026826610571,CDKN1A;MAPKAPK5;MAPK14,alpha,2
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),10/72,10,72,0.0118477246639497,0.616927948572812,0,0,2.27314057101291,10.0827865096349,CDC20;PSMD9;PSMD11;PSMC3;PSMD13;PSMB3;PSMD2;PSMD1;PSMB10;PSMA7,alpha,2
rRNA metabolic process (GO:0016072),21/201,21,201,0.0115262916887946,0.619143857767566,0,0,1.70994454894106,7.63169561394956,RPL5;NOP14;RPL31;NOLC1;SIRT7;RPL8;RRP9;RCL1;EXOSC6;BOP1;RPL7A;RPS15A;XRN1;PDCD11;RPL27A;XRN2;RPL35;RPL13;RPS2;RPP25;RPS24,alpha,2
vesicle-mediated transport between endosomal compartments (GO:0098927),5/23,5,23,0.0112851822064849,0.619228868813897,0,0,3.5579591546289,15.9548307227734,MYO1D;HOOK2;AKTIP;RILP;RAB7A,alpha,2
negative regulation of cell growth (GO:0030308),14/116,14,116,0.0111847483421842,0.620388812936587,0,0,1.9752807720526,8.87533982931333,EPHA4;CDKN1A;DCUN1D3;NAIF1;OSGIN1;PHB;CCAR2;RTN4;ST7L;FLCN;SERTAD3;GNG4;CCDC85B;SESN2,alpha,2
non-canonical Wnt signaling pathway (GO:0035567),15/128,15,128,0.0114557332077028,0.621900069775609,0,0,1.91796235679214,8.57188195095539,PSMD11;PSMD13;AP2A1;PSMB10;PSMA7;PSMD9;AGO3;PSMC3;PSMB3;PSMD2;AGO1;DVL1;PSMD1;PLCB1;AP2M1,alpha,2
positive regulation of ubiquitin-protein transferase activity (GO:0051443),6/32,6,32,0.011837058721578,0.622726913981573,0,0,3.06873977086743,13.6145256725848,CDC20;DCUN1D3;DCUN1D1;AXIN1;PIN1;RPS2,alpha,2
regulation of translation (GO:0006417),22/214,22,214,0.0118019884926544,0.627349450812662,0,0,1.68254890863759,7.46965441962658,ZNF540;RPL5;DDX6;NUP210;YTHDF3;NUP133;DAPK1;POLDIP3;NOLC1;RPS27L;SAMD4B;PASK;ILF3;FXR2;RPS6KB1;AGO1;CNOT2;MAPKAPK5;CALR;GAPDH;EIF4G2;POLR2L,alpha,2
regulation of cellular ketone metabolic process (GO:0010565),9/62,9,62,0.0125580157045301,0.634490635051654,0,0,2.37579853228446,10.3998112669819,PSMD9;PSMD11;PSMC3;PSMD13;PSMB3;PSMD2;PSMD1;PSMB10;PSMA7,alpha,2
gluconeogenesis (GO:0006094),7/42,7,42,0.0128680923985002,0.637532771937345,0,0,2.72776868521549,11.8739893320912,CRTC2;MDH2;SLC25A10;ALDOA;PPARGC1A;SLC25A11;GAPDH,alpha,2
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),10/73,10,73,0.0129993316749882,0.637842207091007,0,0,2.24200165908123,9.73669334452484,CDC20;PSMD9;PSMD11;PSMC3;PSMD13;PSMB3;PSMD2;PSMD1;PSMB10;PSMA7,alpha,2
regulation of autophagy (GO:0010506),21/204,21,204,0.0134714821546783,0.642476387246012,0,0,1.68479830557428,7.25673000529694,ATP6V1A;ATP6V0E1;DAPK1;GBA;VPS26A;MID2;FLCN;DRAM1;RRAGC;RHEB;RRAGD;EEF1A2;TLK2;KAT8;TBC1D14;PIP4K2B;TAB2;SMCR8;ATP6V0D1;GAPDH;EIF4G2,alpha,2
regulation of cholesterol metabolic process (GO:0090181),7/42,7,42,0.0128680923985002,0.643783093230848,0,0,2.72776868521549,11.8739893320912,FDPS;MBTPS1;NFYC;FASN;DGKQ;PMVK;LDLRAP1,alpha,2
phosphorylation (GO:0016310),35/387,35,387,0.0133221143728152,0.64745475851882,0,0,1.48018455786887,6.39192521862024,DGKE;DYRK3;MAML1;ROCK2;GMFG;MAST2;PNKP;PRKCZ;NRBP2;DSTYK;NUAK2;TLK2;MAPK1;MAP4K5;NADK;CDK17;KSR1;DAPK1;PRKCA;PRPF4B;PASK;CDC42BPA;PHKA2;HIPK3;NRBP1;ICK;ILF3;RPS6KB1;TOLLIP;DGKQ;CDK10;CDK12;TOP1;CDK13;BMPR1A,alpha,2
"DNA-templated transcription, termination (GO:0006353)",13/107,13,107,0.0134579816937256,0.647887552670585,0,0,1.98846689202625,8.56667909021506,ZNF473;POLDIP3;SSU72;GTF2H1;GTF2H4;DDX39A;TAF1B;U2AF2;TWISTNB;SNRPD3;SNRPF;SRSF11;POLR2L,alpha,2
positive regulation of TOR signaling (GO:0032008),6/33,6,33,0.0137380689051359,0.649123755767674,0,0,2.97574765659872,12.7587696698203,FLCN;WDR59;RRAGC;RHEB;RRAGD;SMCR8,alpha,2
DNA strand elongation involved in DNA replication (GO:0006271),4/16,4,16,0.0139656995284903,0.653825364164093,0,0,4.09165302782324,17.4760678776184,PARP3;PCNA;LIG1;LIG3,alpha,2
poly-N-acetyllactosamine biosynthetic process (GO:0030311),3/9,3,9,0.0144694386463912,0.659263798326198,0,0,5.45553737043099,23.1081098385015,B3GNT9;B3GNT4;B3GNT2,alpha,2
histone H3-K4 trimethylation (GO:0080182),3/9,3,9,0.0144694386463912,0.665203111824632,0,0,5.45553737043099,23.1081098385015,KMT2A;CTR9;BEND3,alpha,2
ATF6-mediated unfolded protein response (GO:0036500),3/9,3,9,0.0144694386463912,0.67125041284122,0,0,5.45553737043099,23.1081098385015,MBTPS1;HSPA5;CALR,alpha,2
positive regulation of protein metabolic process (GO:0051247),12/97,12,97,0.0150278590099664,0.678647473697863,0,0,2.02473551892284,8.49953505283668,MAPK7;ROCK2;HECW2;NR1H2;GBA;AXIN1;STX5;IDE;DTL;RILP;VPS28;RAB7A,alpha,2
RNA processing (GO:0006396),20/194,20,194,0.0153852424314328,0.688692036207031,0,0,1.68727959910237,7.04328971043429,SF3B2;PDCD7;PRPF4B;PRPF8;TSEN54;CCAR2;PTBP1;ALKBH5;DHX32;SNRPD2;RRAGC;HNRNPH1;U2AF2;XRN2;SNRPA1;SNRPD3;CDK12;SNRPF;PPARGC1A;SRSF11,alpha,2
nucleotide-excision repair (GO:0006289),13/109,13,109,0.0155434317796317,0.689722890186614,0,0,1.95198126097989,8.12827859297875,ISY1;PCNA;LIG1;PNKP;XPA;LIG3;GTF2H1;GTF2H4;RBX1;COPS3;COPS5;POLD1;POLR2L,alpha,2
negative regulation of growth (GO:0045926),14/121,14,121,0.0158144239217791,0.695698321317576,0,0,1.89365759965373,7.85268153891387,CDKN1A;DCUN1D3;NAIF1;OSGIN1;MT1X;PHB;CCAR2;RTN4;ST7L;FLCN;SERTAD3;GNG4;CCDC85B;SESN2,alpha,2
stimulatory C-type lectin receptor signaling pathway (GO:0002223),14/122,14,122,0.016894650006568,0.730622025284038,0,0,1.87813581605001,7.66421827260055,PSMD11;FBXW11;PSMD13;CUL1;PSMB10;PSMA7;PSMD9;PSMC3;PSMB3;PSMD2;PSMD1;TAB2;UBE2V1;HRAS,alpha,2
glucose metabolic process (GO:0006006),9/65,9,65,0.0168299779733287,0.734045962375182,0,0,2.26614629233287,9.25628659599424,CRTC2;MDH2;DCXR;IRS2;SLC25A10;ALDOA;SLC25A11;GAPDH;PPARGC1A,alpha,2
positive regulation of acrosome reaction (GO:2000344),3/10,3,10,0.0197439660040121,0.735426704514407,0,0,4.90998363338789,19.2712308662827,HYAL3;PLCB1;CACNA1H,alpha,2
histone H2B ubiquitination (GO:0033523),3/10,3,10,0.0197439660040121,0.740834253812307,0,0,4.90998363338789,19.2712308662827,CTR9;LEO1;WAC,alpha,2
ERAD pathway (GO:0036503),10/78,10,78,0.0200543680114347,0.741575651901094,0,0,2.09828360401192,8.20283749428179,SDF2L1;HSPA5;PSMC3;AMFR;DNAJB12;UBE4B;MAN1B1;STT3B;GET4;UBE2J1,alpha,2
N-terminal protein amino acid modification (GO:0031365),4/17,4,17,0.0173966664587359,0.746009991083438,0,0,3.85096755559834,15.6021052236344,NAA50;NAA40;PDF;NTMT1,alpha,2
poly-N-acetyllactosamine metabolic process (GO:0030309),3/10,3,10,0.0197439660040121,0.746321914951658,0,0,4.90998363338789,19.2712308662827,B3GNT9;B3GNT4;B3GNT2,alpha,2
innate immune response activating cell surface receptor signaling pathway (GO:0002220),14/125,14,125,0.0204741810865206,0.751652849528882,0,0,1.83306055646481,7.12802213308551,PSMD11;FBXW11;PSMD13;CUL1;PSMB10;PSMA7;PSMD9;PSMC3;PSMB3;PSMD2;PSMD1;TAB2;UBE2V1;HRAS,alpha,2
mitotic G1/S transition checkpoint (GO:0044819),3/10,3,10,0.0197439660040121,0.751891481481148,0,0,4.90998363338789,19.2712308662827,PLK3;RPS27L;FBXO31,alpha,2
nucleus organization (GO:0006997),7/46,7,46,0.0206901861309629,0.754157284473596,0,0,2.49057140824023,9.65867449569363,CTDNEP1;NUMA1;NUP133;VPS4A;WDR73;LEMD3;LEMD2,alpha,2
negative regulation of locomotion (GO:0040013),5/26,5,26,0.0189661536032653,0.756127201855179,0,0,3.14742540601788,12.4798542039478,FRMD5;TRIM28;PIN1;TRIM26;MID2,alpha,2
neuron projection fasciculation (GO:0106030),3/10,3,10,0.0197439660040121,0.75754480089078,0,0,4.90998363338789,19.2712308662827,EPHA4;CNTN4;RTN4,alpha,2
regulation of viral release from host cell (GO:1902186),5/26,5,26,0.0189661536032653,0.762080959350102,0,0,3.14742540601788,12.4798542039478,TSG101;TRIM28;VPS4A;TRIM26;MID2,alpha,2
positive regulation of cellular biosynthetic process (GO:0031328),17/160,17,160,0.018525142461926,0.762369370832328,0,0,1.73895253682488,6.93603202729249,RPL5;PCNA;YTHDF3;POLDIP3;NR1H2;ARNT;RPS27L;IRS2;PASK;ARPP19;CTDNEP1;FXR2;RPS6KB1;AKT2;CALR;PPARGC1A;HRAS,alpha,2
IRES-dependent viral translational initiation (GO:0075522),3/10,3,10,0.0197439660040121,0.763283776655105,0,0,4.90998363338789,19.2712308662827,PTBP1;SSB;DENR,alpha,2
protein phosphorylation (GO:0006468),40/471,40,471,0.0222013741197863,0.765497379278847,0,0,1.3899458268614,5.29235925197535,DDR1;DYRK3;MAML1;ROCK2;GMFG;MAST2;PRKCZ;NRBP2;DSTYK;NUAK2;AKT2;TLK2;MAPK1;MAP4K5;CDK17;EPHA4;MAP3K3;KSR1;DAPK1;PRKCA;GTF2H1;PRPF4B;PASK;VRK3;CDC42BPA;MAPK14;PHKA2;GTF2H4;HIPK3;NRBP1;ICK;ILF3;RPS6KB1;DGKQ;CDK10;MAPKAPK5;CDK12;TOP1;CDK13;BMPR1A,alpha,2
endoplasmic reticulum organization (GO:0007029),6/35,6,35,0.0181586597445088,0.765815212200236,0,0,2.80570493336451,11.2469704310901,RAB10;RTN3;ATL1;ATL2;RTN4;GET4,alpha,2
regulation of mitotic cell cycle phase transition (GO:1901990),19/185,19,185,0.018511759742704,0.768012276154621,0,0,1.68089529791657,6.70567812221625,PSMD11;PSMD13;NDE1;CEP164;CUL1;CDC6;TUBG1;ZFP36L2;PSMB10;PSMA7;CDC20;PSMD9;PSMC3;PSMB3;PSMD2;HECW2;CNTRL;E2F1;PSMD1,alpha,2
cellular response to epidermal growth factor stimulus (GO:0071364),5/26,5,26,0.0189661536032653,0.768129220932246,0,0,3.14742540601788,12.4798542039478,INPP5K;IQGAP1;PTPN12;PDE8A;ZFP36L2,alpha,2
autophagosome organization (GO:1905037),8/57,8,57,0.0218325943281582,0.768356750735114,0,0,2.29706836649726,8.78479633191984,STX12;MAP1LC3B;GABARAPL1;WDR45B;ATG4B;WIPI2;EMC6;RAB7A,alpha,2
snRNA processing (GO:0016180),5/27,5,27,0.0221371241900081,0.768474454024567,0,0,3.03085409468388,11.5490672612856,INTS1;INTS10;TUT1;INTS7;INTS8,alpha,2
MAPK cascade (GO:0000165),26/279,26,279,0.0213915076584546,0.768738475923195,0,0,1.52520399603447,5.86404525906428,PSMD11;PSMD13;CUL1;IRS2;PSMA7;ZFP36L2;PSMB10;PSMD9;PSMB3;PSMD2;HSF1;PSMD1;MAPK1;NCAM1;MAP4K5;HRAS;SPTBN1;FGF22;MAP3K3;KSR1;FBXW11;RBX1;PSMC3;PTPRA;GRB2;MAPKAPK5,alpha,2
G1 DNA damage checkpoint (GO:0044783),3/10,3,10,0.0197439660040121,0.769110370370029,0,0,4.90998363338789,19.2712308662827,WAC;RPS27L;FBXO31,alpha,2
cellular response to gamma radiation (GO:0071480),4/18,4,18,0.0213089071030046,0.771201084727892,0,0,3.63702491362066,13.997563629122,XRCC6;HSF1;TLK2;HRAS,alpha,2
positive regulation of muscle cell differentiation (GO:0051149),6/35,6,35,0.0181586597445088,0.772197005635238,0,0,2.80570493336451,11.2469704310901,SPAG9;BOC;CTNNA1;CDH15;MAPK14;PLCB1,alpha,2
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),11/89,11,89,0.0195251494146694,0.772378584984947,0,0,2.02283969914857,7.96200210354434,BAG5;RNF138;RFWD2;DVL1;GLMN;TLK2;ARIH2;WAC;STUB1;CCAR2;RBX1,alpha,2
hexose biosynthetic process (GO:0019319),7/45,7,45,0.0184862471319117,0.77324032060775,0,0,2.54591743953446,10.1600645758912,CRTC2;MDH2;SLC25A10;ALDOA;PPARGC1A;SLC25A11;GAPDH,alpha,2
positive regulation of canonical Wnt signaling pathway (GO:0090263),13/114,13,114,0.0218298792583114,0.77359634621641,0,0,1.86636804777902,7.13787913294827,PSMD11;PSMD13;AXIN1;CCAR2;PSMB10;PSMA7;PSMD9;PSMC3;PSMB3;PSMD2;PSMD1;FAM53B;PIN1,alpha,2
response to gamma radiation (GO:0010332),5/27,5,27,0.0221371241900081,0.77373797768227,0,0,3.03085409468388,11.5490672612856,XRCC6;DCUN1D3;HSF1;TLK2;HRAS,alpha,2
respiratory chain complex IV assembly (GO:0008535),5/26,5,26,0.0189661536032653,0.774274254699704,0,0,3.14742540601788,12.4798542039478,COA4;SCO1;SCO2;COX18;COA5,alpha,2
negative regulation of autophagosome assembly (GO:1902902),3/10,3,10,0.0197439660040121,0.77502660398826,0,0,4.90998363338789,19.2712308662827,SCFD1;FEZ1;SMCR8,alpha,2
positive regulation of translation (GO:0045727),10/79,10,79,0.0217475983448381,0.776069890585377,0,0,2.0717230520624,7.93107781075072,EIF5A;EIF2B5;RPL5;KHDRBS1;FXR2;YTHDF3;RPS6KB1;POLDIP3;RPS27L;PASK,alpha,2
negative regulation of autophagy (GO:0010507),7/47,7,47,0.0230703891253435,0.784854638044185,0,0,2.43758052721385,9.18774153931905,NRBP2;TLK2;TBC1D14;QSOX1;TAB2;SMCR8;EIF4G2,alpha,2
protein complex disassembly (GO:0043241),7/47,7,47,0.0230703891253435,0.790122118836428,0,0,2.43758052721385,9.18774153931905,MAP1LC3B;GABARAPL1;TSG101;VPS33A;VPS4A;DVL1;AXIN1,alpha,2
regulation of muscle cell differentiation (GO:0051147),6/37,6,37,0.0234645865100499,0.792978708349567,0,0,2.6540452072367,9.95867550259545,SPAG9;PTBP1;BOC;CTNNA1;CDH15;MAPK14,alpha,2
regulation of protein catabolic process (GO:0042176),11/92,11,92,0.0243898636051661,0.802977251465564,0,0,1.9568775350459,7.2670362643483,HECW2;EEF1A2;AXIN1;STX5;PIN1;IDE;PHB;DTL;RILP;VPS28;RAB7A,alpha,2
regulation of cell cycle (GO:0051726),21/216,21,216,0.023980479718981,0.805081500039211,0,0,1.59119839970904,5.9359896963876,LIN54;MAP3K3;TP53I13;GMNN;TXLNG;IQGAP1;RNF167;BOP1;RPS15A;MAEA;MADD;ID4;CDK10;E4F1;CALR;NF2;MAP4K5;ZNF268;DTL;BAP1;LIN52,alpha,2
regulation of primary metabolic process (GO:0080090),15/140,15,140,0.0241907880051123,0.806833929346981,0,0,1.75356558335282,6.52639124252111,PSMD11;PSMD13;ROCK2;IRS2;GRHL1;PSMB10;PSMA7;PSMD9;NCOR1;PSMC3;PSMB3;PSMD2;TGS1;CARM1;PSMD1,alpha,2
positive regulation of cellular protein metabolic process (GO:0032270),11/92,11,92,0.0243898636051661,0.808191389462094,0,0,1.9568775350459,7.2670362643483,RPL5;FXR2;YTHDF3;RPS6KB1;FBXW11;POLDIP3;PERP;NR1H2;RPS27L;PASK;TBC1D10A,alpha,2
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",6/38,6,38,0.0264700085529858,0.823636912474918,0,0,2.58420191230942,9.38515704959049,PCNA;POLD1;XPA;GTF2H1;GTF2H4;RBX1,alpha,2
regulation of peptidyl-threonine phosphorylation (GO:0010799),6/38,6,38,0.0264700085529858,0.828689899668016,0,0,2.58420191230942,9.38515704959049,DGKQ;AXIN1;INPP5K;MAPK1;CALM3;UBE2K,alpha,2
positive regulation of fatty acid oxidation (GO:0046321),3/11,3,11,0.0259350758435838,0.832369132262943,0,0,4.46362148489808,16.3018551412492,AKT2;IRS2;PPARGC1A,alpha,2
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),5/28,5,28,0.0256327524742875,0.833146088384006,0,0,2.92260930558803,10.7081025008659,CBFB;CARM1;AXIN1;CALR;KCTD6,alpha,2
RNA metabolic process (GO:0016070),19/192,19,192,0.0261351065257342,0.833546553755136,0,0,1.6196126568467,5.90263911842504,DDX3Y;EIF4A1;DDX6;PARP3;PCNA;LIG1;DDX46;DDX55;LIG3;ADAT3;HNRNPM;PTBP1;DDX39A;DHX32;AGO3;HNRNPH1;AGO1;XRN2;POLR2L,alpha,2
protein monoubiquitination (GO:0006513),6/38,6,38,0.0264700085529858,0.833805269419053,0,0,2.58420191230942,9.38515704959049,CTR9;LEO1;WAC;KLHL22;DTL;RBX1,alpha,2
autophagosome assembly (GO:0000045),8/59,8,59,0.0263479082868662,0.835114136570673,0,0,2.21920164220922,8.06983026225035,STX12;MAP1LC3B;GABARAPL1;WDR45B;ATG4B;WIPI2;EMC6;RAB7A,alpha,2
histone mRNA catabolic process (GO:0071044),3/11,3,11,0.0259350758435838,0.837637291327898,0,0,4.46362148489808,16.3018551412492,SSB;XRN1;PAPD5,alpha,2
cellular response to topologically incorrect protein (GO:0035967),5/28,5,28,0.0256327524742875,0.83848676843775,0,0,2.92260930558803,10.7081025008659,HSPA5;HSF1;DNAJB12;STUB1;HSPA2,alpha,2
snRNA transcription from RNA polymerase II promoter (GO:0042795),9/71,9,71,0.0284022262366324,0.86271762193771,0,0,2.07464097185404,7.38839347512977,INTS1;SNAPC2;INTS10;TAF8;NABP1;INTS7;RPAP2;INTS8;POLR2L,alpha,2
snRNA transcription (GO:0009301),9/71,9,71,0.0284022262366324,0.867883595721769,0,0,2.07464097185404,7.38839347512977,INTS1;SNAPC2;INTS10;TAF8;NABP1;INTS7;RPAP2;INTS8;POLR2L,alpha,2
cotranslational protein targeting to membrane (GO:0006613),11/94,11,94,0.02808792021862,0.868682768943138,0,0,1.91524184281088,6.84203999126101,RPL5;RPL7A;RPS15A;ARL6IP1;RPL31;RPL27A;RPL35;RPL13;RPS2;RPL8;RPS24,alpha,2
"retrograde transport, endosome to Golgi (GO:0042147)",10/83,10,83,0.0295646697269406,0.872072309922415,0,0,1.97188097726421,6.94333843561694,SPAG9;SNX1;VPS51;DENND2A;TBC1D14;STX5;VPS26A;TBC1D17;TBC1D10A;RAB7A,alpha,2
cytoplasmic microtubule organization (GO:0031122),7/49,7,49,0.0283828692966666,0.872516759161985,0,0,2.33808744447042,8.32819618795623,PLK3;NUMA1;HOOK2;VPS4A;AXIN1;WDR73;RAB11A,alpha,2
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",10/83,10,83,0.0295646697269406,0.877142497770801,0,0,1.97188097726421,6.94333843561694,PLK3;CDKN1A;PCNA;PLAGL1;CNOT2;CARM1;SESN2;E2F1;RPS27L;ARID3A,alpha,2
negative regulation of proteasomal protein catabolic process (GO:1901799),5/29,5,29,0.0294624785295703,0.879222385592967,0,0,2.82182967436086,9.94592736457387,USP25;BAG5;TLK2;WAC;CCAR2,alpha,2
transcription elongation from RNA polymerase I promoter (GO:0006362),5/29,5,29,0.0294624785295703,0.884394281978808,0,0,2.82182967436086,9.94592736457387,TAF1B;TWISTNB;GTF2H1;GTF2H4;POLR2L,alpha,2
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),5/29,5,29,0.0294624785295703,0.889627384239038,0,0,2.82182967436086,9.94592736457387,PER1;CNOT2;CRY2;PHB;CALR,alpha,2
melanosome localization (GO:0032400),4/20,4,20,0.0306334398439078,0.893271105848353,0,0,3.27332242225859,11.4096990551373,VPS33A;BLOC1S3;MYO5A;RAB11A,alpha,2
regulation of glycogen biosynthetic process (GO:0005979),4/20,4,20,0.0306334398439078,0.898404847835987,0,0,3.27332242225859,11.4096990551373,AKT2;INPP5K;IRS2;PASK,alpha,2
cell-cell junction organization (GO:0045216),9/73,9,73,0.0332657605307694,0.912662236497398,0,0,2.01780149317311,6.86703576201612,DSP;TJP1;FLCN;PARD6B;CADM1;PERP;CTNNA1;CDH15;PVR,alpha,2
macromolecular complex assembly (GO:0065003),13/121,13,121,0.0335760856195657,0.916250079768147,0,0,1.75839634253561,5.96789379801529,KMT2A;DNAJB12;AXIN1;WASL;PARD6B;CAPZA1;HSF1;CAPZA2;TSPAN4;REPS2;APBA1;PPARGC1A;TEAD1,alpha,2
Rho protein signal transduction (GO:0007266),9/73,9,73,0.0332657605307694,0.91759554588387,0,0,2.01780149317311,6.86703576201612,GNA13;RHOT1;CDC42EP3;ARHGAP1;ARHGEF3;CDC42EP2;TAX1BP3;RHOF;RHOBTB1,alpha,2
regulation of DNA replication (GO:0006275),8/62,8,62,0.034276751936399,0.920601395428653,0,0,2.11182091758619,7.12378003425777,USP37;PCNA;GMNN;RBBP6;CDC6;NF2;CALR;HRAS,alpha,2
cellular response to amino acid starvation (GO:0034198),6/40,6,40,0.0332207941272421,0.921335393648459,0,0,2.45499181669394,8.35821424710669,CDKN1A;WDR59;RRAGC;SESN2;RRAGD;MAPK1,alpha,2
regulation of actomyosin structure organization (GO:0110020),3/12,3,12,0.0330405351558773,0.921343447543398,0,0,4.09165302782324,13.9526192031455,AKAP13;ROCK2;ASAP3,alpha,2
"DNA-templated transcription, elongation (GO:0006354)",12/109,12,109,0.0341325644583838,0.921579240376363,0,0,1.80182885628913,6.08568305397709,TAF1B;CTR9;TWISTNB;ADRM1;LEO1;GTF2H1;RTF1;CDK12;NELFA;CDK13;GTF2H4;POLR2L,alpha,2
axon guidance (GO:0007411),16/159,16,159,0.0340844508353051,0.925175279854054,0,0,1.64695467786596,5.56491819521916,EPHA4;SIAH1;NRXN3;IRS2;PRKCA;GAB2;ALCAM;MAPK7;PTPRA;FEZ1;MAPK1;GRB2;NCAM1;CNTN4;HRAS;SPTBN1,alpha,2
regulation of inclusion body assembly (GO:0090083),3/12,3,12,0.0330405351558773,0.926405774178252,0,0,4.09165302782324,13.9526192031455,BAG5;DNAJA4;HSPA2,alpha,2
histone H3-K9 demethylation (GO:0033169),3/12,3,12,0.0330405351558773,0.931524038123989,0,0,4.09165302782324,13.9526192031455,KDM4B;KDM3A;KDM3B,alpha,2
tRNA 5'-leader removal (GO:0001682),3/12,3,12,0.0330405351558773,0.936699171669122,0,0,4.09165302782324,13.9526192031455,SSB;POP7;RPP25,alpha,2
regulation of protein localization to cell periphery (GO:1904375),3/12,3,12,0.0330405351558773,0.94193212793543,0,0,4.09165302782324,13.9526192031455,VPS4A;LDLRAP1;SPTBN1,alpha,2
negative regulation of cyclin-dependent protein kinase activity (GO:1904030),4/21,4,21,0.0360644082929908,0.943777823175037,0,0,3.11744992596056,10.3575678274296,HEXIM1;CDKN1A;NR2F2;IPO7,alpha,2
positive regulation of catabolic process (GO:0009896),8/63,8,63,0.0372434912083224,0.945539978288902,0,0,2.07829995064038,6.83818477559366,HECW2;AXIN1;STX5;IDE;DTL;RILP;VPS28;RAB7A,alpha,2
histone H3 deacetylation (GO:0070932),3/12,3,12,0.0330405351558773,0.947223881463157,0,0,4.09165302782324,13.9526192031455,ELK4;PER1;SIRT7,alpha,2
"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",4/21,4,21,0.0360644082929908,0.948642657315115,0,0,3.11744992596056,10.3575678274296,XPA;GTF2H1;GTF2H4;RBX1,alpha,2
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),11/98,11,98,0.0366616246336241,0.949666347743064,0,0,1.83706870636962,6.07339455799425,DYNC1LI1;KLC2;CAPZA1;CAPZA2;AP2A1;AP1S3;RILP;SEC24C;ACTR10;AP2M1;RAB7A,alpha,2
establishment of protein localization to organelle (GO:0072594),8/63,8,63,0.0372434912083224,0.950267678180347,0,0,2.07829995064038,6.83818477559366,IPO13;PDIA3;RANBP1;IPO9;NUP133;HEATR3;IPO7;RAB11A,alpha,2
DNA ligation involved in DNA repair (GO:0051103),3/12,3,12,0.0330405351558773,0.952575428816056,0,0,4.09165302782324,13.9526192031455,PARP3;LIG1;LIG3,alpha,2
"nucleotide-excision repair, DNA incision (GO:0033683)",6/41,6,41,0.0369779792927737,0.953023375409214,0,0,2.39511396750629,7.89772711132137,PCNA;POLD1;XPA;GTF2H1;GTF2H4;RBX1,alpha,2
positive regulation of translational initiation (GO:0045948),4/21,4,21,0.0360644082929908,0.953557904244209,0,0,3.11744992596056,10.3575678274296,EIF2B5;KHDRBS1;YTHDF3;RPS6KB1,alpha,2
protein N-linked glycosylation (GO:0006487),9/74,9,74,0.0359010696111449,0.954183115758711,0,0,1.99053390542752,6.62248279465318,OST4;KRTCAP2;MGAT2;STT3B;NUDT14;ST6GALNAC4;B4GALT7;UBE2J1;ST3GAL3,alpha,2
antigen processing and presentation of exogenous peptide antigen (GO:0002478),11/98,11,98,0.0366616246336241,0.95451158421114,0,0,1.83706870636962,6.07339455799425,DYNC1LI1;KLC2;CAPZA1;CAPZA2;AP2A1;AP1S3;RILP;SEC24C;ACTR10;AP2M1;RAB7A,alpha,2
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",8/63,8,63,0.0372434912083224,0.955042892643565,0,0,2.07829995064038,6.83818477559366,PLK3;CDKN1A;PCNA;PLAGL1;CNOT2;CARM1;E2F1;ARID3A,alpha,2
organelle assembly (GO:0070925),32/377,32,377,0.0378070654060832,0.955096310728924,0,0,1.38920845506996,4.55001788198608,STX12;GALNT11;DDX6;TSG101;TRAF3IP1;WDR45B;CEP164;VPS4A;NOXO1;MAP1LC3B;WDR5;EMC6;RILP;FARP2;GABARAPL1;STARD9;RFX2;TUBG2;WIPI2;TUBG1;RAB11A;TMEM231;ICK;TRAPPC6A;NCOR1;RILPL1;ATG4B;B9D1;ATP6V0D1;LSM14A;VPS28;RAB7A,alpha,2
axonal fasciculation (GO:0007413),3/12,3,12,0.0330405351558773,0.957987789207056,0,0,4.09165302782324,13.9526192031455,EPHA4;CNTN4;RTN4,alpha,2
regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),9/75,9,75,0.0386759401213248,0.95807438077243,0,0,1.96399345335516,6.38796250325648,RGS2;GRK4;GNG4;DGKQ;GNG7;NMT1;PLCE1;PHB;PLCB1,alpha,2
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),11/99,11,99,0.0390631757952231,0.95836243309146,0,0,1.81851245681033,5.89666312289044,DYNC1LI1;KLC2;CAPZA1;CAPZA2;AP2A1;AP1S3;RILP;SEC24C;ACTR10;AP2M1;RAB7A,alpha,2
cellular response to insulin stimulus (GO:0032869),12/111,12,111,0.0385011065674358,0.958395838115244,0,0,1.76936347149113,5.76293766725372,ATP6V1A;RAB10;ATP6V0E1;PKM;RPS6KB1;AKT2;INPP5K;MYO5A;IRS2;GRB2;IDE;ATP6V0D1,alpha,2
nucleic acid phosphodiester bond hydrolysis (GO:0090305),9/74,9,74,0.0359010696111449,0.959178838877866,0,0,1.99053390542752,6.62248279465318,PCNA;PDE12;ERI2;POLD1;XRN2;XPA;GTF2H1;GTF2H4;RBX1,alpha,2
ribosome biogenesis (GO:0042254),21/227,21,227,0.0382992799441194,0.962764657905622,0,0,1.51409186932666,4.93945852117385,RPL5;NOP14;RPL31;WDR74;NOLC1;RPL8;RRP9;RCL1;EXOSC6;BOP1;RPL7A;RPS15A;PDCD11;RPL27A;XRN2;RPL35;RPL13;HEATR3;RPS2;RPP25;RPS24,alpha,2
response to UV (GO:0009411),11/99,11,99,0.0390631757952231,0.962992203299631,0,0,1.81851245681033,5.89666312289044,MSH6;PCNA;TP53I13;DCUN1D3;POLD1;XPA;USP1;SDF4;UBE4B;DTL;CCAR2,alpha,2
viral gene expression (GO:0019080),12/111,12,111,0.0385011065674358,0.963093856929535,0,0,1.76936347149113,5.76293766725372,RPL5;RPL7A;RPS15A;NUP210;NUP133;RPL31;RPL27A;RPL35;RPL13;RPS2;RPL8;RPS24,alpha,2
signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),8/64,8,64,0.0403778421613917,0.985876213155895,0,0,2.04582651391162,6.56602722141298,PLK3;CDKN1A;PCNA;PLAGL1;CNOT2;CARM1;E2F1;ARID3A,alpha,2
viral translation (GO:0019081),3/13,3,13,0.04104708506598,0.988034316470265,0,0,3.77691048722145,12.059809095908,PTBP1;SSB;DENR,alpha,2
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),4/23,4,23,0.0484835526375293,0.989646276437248,0,0,2.84636732370312,8.61461797318401,CTR9;AXIN1;LEO1;RTF1,alpha,2
establishment of mitotic spindle orientation (GO:0000132),3/14,3,14,0.0499322735699017,0.991456778315986,0,0,3.50713116670563,10.511179753422,NUMA1;SAPCD2;NDE1,alpha,2
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",4/22,4,22,0.0420142643753517,0.992586995867683,0,0,2.97574765659872,9.43236450044557,XPA;GTF2H1;GTF2H4;RBX1,alpha,2
DNA replication-independent nucleosome organization (GO:0034724),3/13,3,13,0.04104708506598,0.992716943562541,0,0,3.77691048722145,12.059809095908,HAT1;CABIN1;ASF1B,alpha,2
positive regulation of protein dephosphorylation (GO:0035307),5/32,5,32,0.043028077584267,0.993539728110924,0,0,2.55728314238953,8.04496319891276,PPP1R7;GBA;ITGA1;PIN1;CALM3,alpha,2
autophagosome maturation (GO:0097352),4/23,4,23,0.0484835526375293,0.993620759475149,0,0,2.84636732370312,8.61461797318401,GABARAPL1;MAP1LC3B;TSG101;VPS33A,alpha,2
positive regulation of myoblast differentiation (GO:0045663),3/14,3,14,0.0499322735699017,0.995329656356283,0,0,3.50713116670563,10.511179753422,BOC;MAPK14;PLCB1,alpha,2
negative regulation of cellular amide metabolic process (GO:0034249),9/76,9,76,0.0415930389468993,0.996475482375714,0,0,1.93815143423206,6.162977458979,ZNF540;PRNP;ILF3;FXR2;DAPK1;CNOT2;SAMD4B;CALR;GAPDH,alpha,2
early endosome to late endosome transport (GO:0045022),4/22,4,22,0.0420142643753517,0.997203679569394,0,0,2.97574765659872,9.43236450044557,HOOK2;AKTIP;RILP;RAB7A,alpha,2
negative regulation of viral release from host cell (GO:1902187),3/13,3,13,0.04104708506598,0.997444167103315,0,0,3.77691048722145,12.059809095908,TRIM28;TRIM26;MID2,alpha,2
histone H3-K4 methylation (GO:0051568),4/23,4,23,0.0484835526375293,0.997627294795613,0,0,2.84636732370312,8.61461797318401,KMT2A;CTR9;WDR5;BEND3,alpha,2
termination of RNA polymerase I transcription (GO:0006363),5/32,5,32,0.043028077584267,0.998055817784156,0,0,2.55728314238953,8.04496319891276,TAF1B;TWISTNB;GTF2H1;GTF2H4;POLR2L,alpha,2
ncRNA transcription (GO:0098781),3/14,3,14,0.0499322735699017,0.999232909910621,0,0,3.50713116670563,10.511179753422,SNAPC2;SIRT7;RPAP2,alpha,2
"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",4/22,4,22,0.0420142643753517,1,0,0,2.97574765659872,9.43236450044557,XPA;GTF2H1;GTF2H4;RBX1,alpha,2
rRNA processing (GO:0006364),19/203,19,203,0.0426079472670296,1,0,0,1.53185039465304,4.83408248315361,RPL5;NOP14;RPL31;NOLC1;RPL8;RRP9;RCL1;EXOSC6;BOP1;RPL7A;RPS15A;PDCD11;RPL27A;XRN2;RPL35;RPL13;RPS2;RPP25;RPS24,alpha,2
positive regulation of transferase activity (GO:0051347),14/138,14,138,0.0428082147498232,1,0,0,1.66038093882682,5.23190228179727,DDR1;EPHA4;VAC14;DCUN1D3;PNKP;DCUN1D1;AXIN1;DSTYK;PIN1;MAPK1;MAPKAPK5;ROR1;RPS2;CCT4,alpha,2
lysosome organization (GO:0007040),5/32,5,32,0.043028077584267,1,0,0,2.55728314238953,8.04496319891276,MBTPS1;VPS18;HOOK2;AKTIP;VPS33A,alpha,2
negative regulation of translation (GO:0017148),10/89,10,89,0.0447250803778099,1,0,0,1.83894518104415,5.71400881302119,ZNF540;ILF3;FXR2;YTHDF3;DAPK1;CNOT2;SAMD4B;CALR;PAIP2;GAPDH,alpha,2
viral transcription (GO:0019083),12/114,12,114,0.0457683866527792,1,0,0,1.72280127487294,5.31339766379287,RPL5;RPL7A;RPS15A;NUP210;NUP133;RPL31;RPL27A;RPL35;RPL13;RPS2;RPL8;RPS24,alpha,2
regulation of cell division (GO:0051302),8/66,8,66,0.0471610945369293,1,0,0,1.98383177106581,6.05899121077601,FLCN;PLK3;CSPP1;KLHL21;PIN1;CALM3;RAB11FIP3;RAB11A,alpha,2
neuron projection maintenance (GO:1990535),2/6,2,6,0.0474561603813105,1,0,0,5.45553737043099,16.6281993096188,PRNP;ATP1A3,alpha,2
positive regulation of aspartic-type peptidase activity (GO:1905247),2/6,2,6,0.0474561603813105,1,0,0,5.45553737043099,16.6281993096188,EPHA4;ROCK2,alpha,2
viral release from host cell (GO:0019076),2/6,2,6,0.0474561603813105,1,0,0,5.45553737043099,16.6281993096188,VPS4A;RAB7A,alpha,2
mRNA 3'-splice site recognition (GO:0000389),2/6,2,6,0.0474561603813105,1,0,0,5.45553737043099,16.6281993096188,ISY1;SF1,alpha,2
astral microtubule organization (GO:0030953),2/6,2,6,0.0474561603813105,1,0,0,5.45553737043099,16.6281993096188,NUMA1;RAB11A,alpha,2
positive regulation of vesicle fusion (GO:0031340),2/6,2,6,0.0474561603813105,1,0,0,5.45553737043099,16.6281993096188,AKT2;DOC2B,alpha,2
azole transport (GO:0045117),2/6,2,6,0.0474561603813105,1,0,0,5.45553737043099,16.6281993096188,SLC25A19;SLC15A4,alpha,2
centromeric sister chromatid cohesion (GO:0070601),2/6,2,6,0.0474561603813105,1,0,0,5.45553737043099,16.6281993096188,NAA50;BOD1,alpha,2
regulation of protein localization to cell cortex (GO:1904776),2/6,2,6,0.0474561603813105,1,0,0,5.45553737043099,16.6281993096188,SAPCD2;NUMA1,alpha,2
Golgi disassembly (GO:0090166),2/6,2,6,0.0474561603813105,1,0,0,5.45553737043099,16.6281993096188,PLK3;STX5,alpha,2
definitive hemopoiesis (GO:0060216),2/6,2,6,0.0474561603813105,1,0,0,5.45553737043099,16.6281993096188,HIPK1;ZFP36L2,alpha,2
positive regulation of transcription from RNA polymerase II promoter in response to heat stress (GO:0061408),2/6,2,6,0.0474561603813105,1,0,0,5.45553737043099,16.6281993096188,HSF1;HSF4,alpha,2
ventricular compact myocardium morphogenesis (GO:0003223),2/6,2,6,0.0474561603813105,1,0,0,5.45553737043099,16.6281993096188,DSP;BMPR1A,alpha,2
monoubiquitinated protein deubiquitination (GO:0035520),2/6,2,6,0.0474561603813105,1,0,0,5.45553737043099,16.6281993096188,USP1;BAP1,alpha,2
negative regulation of glycogen biosynthetic process (GO:0045719),2/6,2,6,0.0474561603813105,1,0,0,5.45553737043099,16.6281993096188,INPP5K;PASK,alpha,2
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),2/6,2,6,0.0474561603813105,1,0,0,5.45553737043099,16.6281993096188,EPHA4;ROCK2,alpha,2
SCF complex assembly (GO:0010265),2/6,2,6,0.0474561603813105,1,0,0,5.45553737043099,16.6281993096188,CUL1;RBX1,alpha,2
protein stabilization (GO:0050821),15/153,15,153,0.0475902731815403,1,0,0,1.60456981483264,4.88611867968238,RPL5;EPHA4;STX12;CDKN1A;USP2;PHB;RTN4;DVL1;ZNF207;PIN1;CALR;ZSWIM7;PPARGC1A;GAPDH;CCT4,alpha,2
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),10/90,10,90,0.047683331573773,1,0,0,1.81851245681033,5.53404870895632,RPL5;RPL7A;RPS15A;RPL31;RPL27A;RPL35;RPL13;RPS2;RPL8;RPS24,alpha,2
cyclic-nucleotide-mediated signaling (GO:0019935),5/33,5,33,0.048258441866602,1,0,0,2.47978971383227,7.51670015755389,RIMS2;MAPK7;KSR1;DGKQ;PDE2A,alpha,2
"nucleotide-excision repair, DNA gap filling (GO:0006297)",4/23,4,23,0.0484835526375293,1,0,0,2.84636732370312,8.61461797318401,PCNA;LIG1;POLD1;LIG3,alpha,2
"nucleotide-excision repair, DNA damage recognition (GO:0000715)",4/23,4,23,0.0484835526375293,1,0,0,2.84636732370312,8.61461797318401,COPS3;COPS5;XPA;RBX1,alpha,2
positive regulation of ATP metabolic process (GO:1903580),4/23,4,23,0.0484835526375293,1,0,0,2.84636732370312,8.61461797318401,PFKFB4;BEND3;ARNT;PPARGC1A,alpha,2
positive regulation of Wnt signaling pathway (GO:0030177),14/141,14,141,0.0497606340045498,1,0,0,1.62505368480923,4.87602410318713,PSMD11;PSMD13;AXIN1;CCAR2;PSMB10;PSMA7;PSMD9;PSMC3;PSMB3;PSMD2;DVL1;PSMD1;FAM53B;PIN1,alpha,2
regulation of histone modification (GO:0031056),3/14,3,14,0.0499322735699017,1,0,0,3.50713116670563,10.511179753422,FLCN;ZNHIT1;MTHFR,alpha,2
histone H4-K16 acetylation (GO:0043984),3/14,3,14,0.0499322735699017,1,0,0,3.50713116670563,10.511179753422,KMT2A;WDR5;KAT8,alpha,2
positive regulation of calcium ion-dependent exocytosis (GO:0045956),3/14,3,14,0.0499322735699017,1,0,0,3.50713116670563,10.511179753422,HYAL3;DOC2B;CACNA1H,alpha,2
regulation of cellular catabolic process (GO:0031329),7/56,7,56,0.0532697093258883,1,0,0,2.04582651391162,5.99915592202833,DRAM1;RRAGC;DAPK1;RRAGD;KAT8;PIP4K2B;SMCR8,alpha,2
protein acetylation (GO:0006473),5/34,5,34,0.0538474718166978,1,0,0,2.40685472224897,7.03186633557331,NAA50;NAT6;NAA40;MDH2;HAT1,alpha,2
regulation of autophagosome assembly (GO:2000785),5/34,5,34,0.0538474718166978,1,0,0,2.40685472224897,7.03186633557331,SCFD1;FEZ1;TBC1D14;PIP4K2B;SMCR8,alpha,2
transcription initiation from RNA polymerase I promoter (GO:0006361),5/34,5,34,0.0538474718166978,1,0,0,2.40685472224897,7.03186633557331,TAF1B;TWISTNB;GTF2H1;GTF2H4;POLR2L,alpha,2
transcription from RNA polymerase I promoter (GO:0006360),5/34,5,34,0.0538474718166978,1,0,0,2.40685472224897,7.03186633557331,TAF1B;TWISTNB;GTF2H1;GTF2H4;POLR2L,alpha,2
negative regulation of protein serine/threonine kinase activity (GO:0071901),8/68,8,68,0.0546468909013433,1,0,0,1.92548377779917,5.59711746814039,HEXIM1;RGS2;PRKAR2A;GBA;SPRY4;INPP5K;NR2F2;IPO7,alpha,2
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),8/68,8,68,0.0546468909013433,1,0,0,1.92548377779917,5.59711746814039,HEXIM1;CDKN1A;CCND3;SERTAD1;GTF2H1;CDC6;NR2F2;IPO7,alpha,2
regulation of dendrite morphogenesis (GO:0048814),6/45,6,45,0.054653757655182,1,0,0,2.1822149481724,6.34312560428933,EPHA4;FXR2;CUX1;SS18L1;HECW2;LZTS3,alpha,2
protein N-linked glycosylation via asparagine (GO:0018279),6/45,6,45,0.054653757655182,1,0,0,2.1822149481724,6.34312560428933,OST4;STT3B;NUDT14;ST6GALNAC4;UBE2J1;ST3GAL3,alpha,2
mitotic nuclear envelope disassembly (GO:0007077),6/45,6,45,0.054653757655182,1,0,0,2.1822149481724,6.34312560428933,CTDNEP1;NUP210;NUP133;LMNA;BANF1;PRKCA,alpha,2
regulation of steroid biosynthetic process (GO:0050810),6/45,6,45,0.054653757655182,1,0,0,2.1822149481724,6.34312560428933,MBTPS1;FDPS;NFYC;FASN;DGKQ;PMVK,alpha,2
Fc-epsilon receptor signaling pathway (GO:0038095),17/183,17,183,0.0560426623511595,1,0,0,1.52039566061191,4.38123606915558,PSMD11;FBXW11;PSMD13;CUL1;GAB2;PSMB10;PSMA7;PSMD9;PSMC3;PSMB3;PSMD2;PSMD1;MAPK1;TAB2;GRB2;UBE2V1;HRAS,alpha,2
ribonucleoprotein complex assembly (GO:0022618),15/157,15,157,0.0572204597120788,1,0,0,1.56368905521907,4.47347007194605,ISY1;RPL5;DDX6;PRMT7;RPS27L;BOP1;SNRPD2;TGS1;LUC7L;DENR;SNRPD3;SNRPF;LSM14A;LUC7L2;SF1,alpha,2
protein import (GO:0017038),7/57,7,57,0.0576709088811788,1,0,0,2.0099348206851,5.73434889026125,IPO13;PDIA3;RANBP1;IPO9;NUP133;HEATR3;IPO7,alpha,2
ERBB signaling pathway (GO:0038127),9/81,9,81,0.0583910658822237,1,0,0,1.81851245681033,5.1656526319687,REPS2;PLCE1;MAPK1;PRKCA;GRB2;STUB1;IQGAP1;PTPN12;HRAS,alpha,2
Fc receptor signaling pathway (GO:0038093),17/184,17,184,0.0583986672194651,1,0,0,1.51213264071728,4.29515562396631,PSMD11;FBXW11;PSMD13;CUL1;GAB2;PSMB10;PSMA7;PSMD9;PSMC3;PSMB3;PSMD2;PSMD1;MAPK1;TAB2;GRB2;UBE2V1;HRAS,alpha,2
termination of RNA polymerase II transcription (GO:0006369),8/69,8,69,0.0586582357415491,1,0,0,1.89757821580208,5.3815836085108,ZNF473;DDX39A;POLDIP3;U2AF2;SSU72;SNRPD3;SNRPF;SRSF11,alpha,2
G1/S transition of mitotic cell cycle (GO:0000082),11/106,11,106,0.0589733232847037,1,0,0,1.69842201154927,4.80767237987091,PLK3;KLF11;RANBP1;USP37;CDKN1A;PCNA;RPS6KB1;CUL1;SPDYA;E2F1;CDC6,alpha,2
histone H4-K8 acetylation (GO:0043982),3/15,3,15,0.0596660766880831,1,0,0,3.27332242225859,9.22746857534402,WDR5;KAT8;KAT7,alpha,2
mitotic sister chromatid cohesion (GO:0007064),3/15,3,15,0.0596660766880831,1,0,0,3.27332242225859,9.22746857534402,NAA50;CHTF8;BOD1,alpha,2
L-alpha-amino acid transmembrane transport (GO:1902475),3/15,3,15,0.0596660766880831,1,0,0,3.27332242225859,9.22746857534402,SLC7A5;SLC7A1;SLC25A22,alpha,2
regulation of establishment of cell polarity (GO:2000114),3/15,3,15,0.0596660766880831,1,0,0,3.27332242225859,9.22746857534402,RAP1B;ROCK2;KIF20B,alpha,2
positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),3/15,3,15,0.0596660766880831,1,0,0,3.27332242225859,9.22746857534402,CTR9;LEO1;RTF1,alpha,2
unsaturated fatty acid biosynthetic process (GO:0006636),3/15,3,15,0.0596660766880831,1,0,0,3.27332242225859,9.22746857534402,FADS3;DEGS1;DECR2,alpha,2
negative regulation of RNA metabolic process (GO:0051253),3/15,3,15,0.0596660766880831,1,0,0,3.27332242225859,9.22746857534402,ZC3H10;PTBP1;NCOR1,alpha,2
positive regulation of exosomal secretion (GO:1903543),3/15,3,15,0.0596660766880831,1,0,0,3.27332242225859,9.22746857534402,TSG101;VPS4A;RAB7A,alpha,2
histone H4-K5 acetylation (GO:0043981),3/15,3,15,0.0596660766880831,1,0,0,3.27332242225859,9.22746857534402,WDR5;KAT8;KAT7,alpha,2
regulation of cell junction assembly (GO:1901888),3/15,3,15,0.0596660766880831,1,0,0,3.27332242225859,9.22746857534402,TJP1;RAP1B;CBFB,alpha,2
nucleobase-containing small molecule catabolic process (GO:0034656),3/15,3,15,0.0596660766880831,1,0,0,3.27332242225859,9.22746857534402,ENTPD4;NUDT18;ADPRM,alpha,2
negative regulation of peptidyl-threonine phosphorylation (GO:0010801),3/15,3,15,0.0596660766880831,1,0,0,3.27332242225859,9.22746857534402,DGKQ;INPP5K;CALM3,alpha,2
peptidyl-asparagine modification (GO:0018196),6/46,6,46,0.0597482975930244,1,0,0,2.13477549277734,6.01497455506308,OST4;STT3B;NUDT14;ST6GALNAC4;UBE2J1;ST3GAL3,alpha,2
regulation of alcohol biosynthetic process (GO:1902930),5/35,5,35,0.059795612576091,1,0,0,2.33808744447042,6.58597846389976,MBTPS1;FDPS;NFYC;FASN;PMVK,alpha,2
positive regulation of protein catabolic process (GO:0045732),9/82,9,82,0.0622059770153938,1,0,0,1.79633547562972,4.98897004375624,PLK3;HECW2;AXIN1;STX5;IDE;DTL;RILP;VPS28;RAB7A,alpha,2
response to endoplasmic reticulum stress (GO:0034976),11/107,11,107,0.0622784115042403,1,0,0,1.68254890863759,4.67099206427225,PDIA3;EIF2B5;MBTPS1;HSPA5;TMEM259;AMFR;DNAJB12;TXNDC11;P4HB;ATF3;BBC3,alpha,2
positive regulation of dephosphorylation (GO:0035306),4/25,4,25,0.062966921438536,1,0,0,2.61865793780687,7.24097085960649,PPP1R7;GBA;PIN1;CALM3,alpha,2
mRNA splice site selection (GO:0006376),4/25,4,25,0.062966921438536,1,0,0,2.61865793780687,7.24097085960649,ISY1;LUC7L;LUC7L2;SF1,alpha,2
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),4/25,4,25,0.062966921438536,1,0,0,2.61865793780687,7.24097085960649,BAG5;TLK2;WAC;CCAR2,alpha,2
regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),2/7,2,7,0.0637941408806344,1,0,0,4.67617488894085,12.8692725208103,MAPK7;CALM3,alpha,2
AV node cell action potential (GO:0086016),2/7,2,7,0.0637941408806344,1,0,0,4.67617488894085,12.8692725208103,CACNB2;CACNA1C,alpha,2
response to misfolded protein (GO:0051788),2/7,2,7,0.0637941408806344,1,0,0,4.67617488894085,12.8692725208103,DNAJB12;STUB1,alpha,2
miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),2/7,2,7,0.0637941408806344,1,0,0,4.67617488894085,12.8692725208103,AGO3;AGO1,alpha,2
exit from host cell (GO:0035891),2/7,2,7,0.0637941408806344,1,0,0,4.67617488894085,12.8692725208103,VPS4A;RAB7A,alpha,2
morphogenesis of a polarized epithelium (GO:0001738),2/7,2,7,0.0637941408806344,1,0,0,4.67617488894085,12.8692725208103,RAB10;TRAF3IP1,alpha,2
positive regulation of fatty acid beta-oxidation (GO:0032000),2/7,2,7,0.0637941408806344,1,0,0,4.67617488894085,12.8692725208103,AKT2;IRS2,alpha,2
negative regulation of glycogen metabolic process (GO:0070874),2/7,2,7,0.0637941408806344,1,0,0,4.67617488894085,12.8692725208103,INPP5K;PASK,alpha,2
response to increased oxygen levels (GO:0036296),2/7,2,7,0.0637941408806344,1,0,0,4.67617488894085,12.8692725208103,ATP6V1A;ATP6V0D1,alpha,2
negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),2/7,2,7,0.0637941408806344,1,0,0,4.67617488894085,12.8692725208103,ZC3H10;NCOR1,alpha,2
regulation of hormone biosynthetic process (GO:0046885),2/7,2,7,0.0637941408806344,1,0,0,4.67617488894085,12.8692725208103,DGKQ;ARNT,alpha,2
progesterone receptor signaling pathway (GO:0050847),2/7,2,7,0.0637941408806344,1,0,0,4.67617488894085,12.8692725208103,WBP2;PHB,alpha,2
regulation of lymphocyte migration (GO:2000401),2/7,2,7,0.0637941408806344,1,0,0,4.67617488894085,12.8692725208103,WASL;SLC8B1,alpha,2
vesicle transport along actin filament (GO:0030050),2/7,2,7,0.0637941408806344,1,0,0,4.67617488894085,12.8692725208103,MYO5A;WASL,alpha,2
cellular response to fibroblast growth factor stimulus (GO:0044344),10/95,10,95,0.064434266883651,1,0,0,1.72280127487294,4.72411007479932,PTBP1;HNRNPM;FIBP;DSTYK;HNRNPH1;MAPK1;GRB2;ZFP36L2;FGF22;POLR2L,alpha,2
nuclear envelope disassembly (GO:0051081),6/47,6,47,0.0651158005248396,1,0,0,2.08935473761187,5.70725642850345,CTDNEP1;NUP210;NUP133;LMNA;BANF1;PRKCA,alpha,2
cellular response to starvation (GO:0009267),11/108,11,108,0.0657022891645149,1,0,0,1.66696975207613,4.53852770587542,GABARAPL1;CDKN1A;MAP1LC3B;NUAK2;WDR59;TBL2;RRAGC;HSPA5;SESN2;RRAGD;MAPK1,alpha,2
mitotic sister chromatid segregation (GO:0000070),9/83,9,83,0.0661758682028575,1,0,0,1.77469287953779,4.81907098779065,NAA50;CHTF8;BOD1;VPS4A;ZNF207;KLHL22;TUBG2;TUBG1;RAB11A,alpha,2
ubiquitin-dependent ERAD pathway (GO:0030433),7/59,7,59,0.0671286055533103,1,0,0,1.94180143693306,5.24508726873395,HSPA5;PSMC3;AMFR;UBE4B;MAN1B1;STT3B;UBE2J1,alpha,2
post-Golgi vesicle-mediated transport (GO:0006892),7/59,7,59,0.0671286055533103,1,0,0,1.94180143693306,5.24508726873395,RAB10;SCFD1;RABIF;VPS13A;MYO5A;AP2A1;CCDC93,alpha,2
protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),8/71,8,71,0.0672249517171188,1,0,0,1.8441253083147,4.97860500229229,SPSB1;MAEA;UBE3C;BTBD1;HECW2;ARIH2;CUL1;RBX1,alpha,2
gene expression (GO:0010467),33/412,33,412,0.068080261832551,1,0,0,1.31091796037055,3.52252563477915,RPL5;GTF3C2;RPL31;POLDIP3;RPL8;MRPL41;RPL7A;ALKBH5;RPS15A;DHX32;TAF1B;U2AF2;E2F1;RPL35;RPL13;RPS2;PELO;SRSF11;POLR2L;EIF5A;NUP210;NUP133;ARNT;DDX39A;COPS5;RRAGC;HNRNPH1;RPL27A;XRN2;EEF1A2;STUB1;MRRF;RPS24,alpha,2
transcription elongation from RNA polymerase II promoter (GO:0006368),10/96,10,96,0.068185638467839,1,0,0,1.70485542825968,4.5784255932184,CTR9;ADRM1;LEO1;GTF2H1;NELFA;RTF1;CDK12;CDK13;GTF2H4;POLR2L,alpha,2
negative regulation of Wnt signaling pathway (GO:0030178),16/175,16,175,0.0698408124663069,1,0,0,1.49637596446107,3.98265959768681,WWOX;PSMD11;PSMD13;AXIN1;PSMB10;PSMA7;RBX1;PSMD9;RNF213;ZNRF3;PSMC3;PSMB3;PSMD2;DVL1;PSMD1;TAX1BP3,alpha,2
regulation of exosomal secretion (GO:1903541),3/16,3,16,0.0702123288667336,1,0,0,3.06873977086743,8.15128281041849,TSG101;VPS4A;RAB7A,alpha,2
regulation of bicellular tight junction assembly (GO:2000810),3/16,3,16,0.0702123288667336,1,0,0,3.06873977086743,8.15128281041849,TJP1;CBFB;ROCK2,alpha,2
regulation of energy homeostasis (GO:2000505),3/16,3,16,0.0702123288667336,1,0,0,3.06873977086743,8.15128281041849,FLCN;PASK;PPARGC1A,alpha,2
negative regulation of DNA replication (GO:0008156),3/16,3,16,0.0702123288667336,1,0,0,3.06873977086743,8.15128281041849,GMNN;CDC6;NF2,alpha,2
rRNA transcription (GO:0009303),3/16,3,16,0.0702123288667336,1,0,0,3.06873977086743,8.15128281041849,GTF3C2;TAF1B;SIRT7,alpha,2
positive regulation of triglyceride metabolic process (GO:0090208),3/16,3,16,0.0702123288667336,1,0,0,3.06873977086743,8.15128281041849,CTDNEP1;NR1H2;PNPLA2,alpha,2
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),3/16,3,16,0.0702123288667336,1,0,0,3.06873977086743,8.15128281041849,CDK10;CDC6;PLCB1,alpha,2
histone H2A acetylation (GO:0043968),3/16,3,16,0.0702123288667336,1,0,0,3.06873977086743,8.15128281041849,MORF4L1;NAA40;EP400,alpha,2
organophosphate ester transport (GO:0015748),4/26,4,26,0.0709670681764288,1,0,0,2.5179403248143,6.66131018014236,PRELID2;SLC25A19;STARD10;PITPNC1,alpha,2
regulation of glucose metabolic process (GO:0010906),4/26,4,26,0.0709670681764288,1,0,0,2.5179403248143,6.66131018014236,AKT2;DGKQ;IRS2;PASK,alpha,2
peptidyl-tyrosine dephosphorylation (GO:0035335),4/26,4,26,0.0709670681764288,1,0,0,2.5179403248143,6.66131018014236,PTPN9;DUSP18;PTPN12;DUSP14,alpha,2
positive regulation of peptidyl-threonine phosphorylation (GO:0010800),4/26,4,26,0.0709670681764288,1,0,0,2.5179403248143,6.66131018014236,AXIN1;MAPK1;CALM3;UBE2K,alpha,2
mRNA catabolic process (GO:0006402),5/37,5,37,0.0727639777072197,1,0,0,2.21170433936391,5.79584698976695,XRN1;AGO3;PDE12;AGO1;ZFP36L2,alpha,2
histone deacetylation (GO:0016575),5/37,5,37,0.0727639777072197,1,0,0,2.21170433936391,5.79584698976695,ELK4;MORF4L1;PER1;PHB;SIRT7,alpha,2
cellular response to DNA damage stimulus (GO:0006974),27/330,27,330,0.0753400127804798,1,0,0,1.33908644546942,3.46253461742716,CDKN1A;PNKP;XPA;ENDOV;TRIM28;CHCHD6;POLD1;TLK2;E2F1;RBBP6;MACROD2;PLK3;PARP3;LIG1;GTF2H1;MAPK14;GTF2H4;FBXO31;MSH6;DDX39A;SPDYA;WAC;NABP1;INTS7;GRB2;UBA1;DTL,alpha,2
mitochondrial respiratory chain complex assembly (GO:0033108),10/98,10,98,0.076097047876847,1,0,0,1.67006246033602,4.30165638055654,COA4;NDUFA6;SCO1;SCO2;COX18;NDUFB4;SDHAF1;NDUFB3;TTC19;COA5,alpha,2
protein targeting to ER (GO:0045047),10/98,10,98,0.076097047876847,1,0,0,1.67006246033602,4.30165638055654,RPL5;RPL7A;RPS15A;RPL31;RPL27A;RPL35;RPL13;RPS2;RPL8;RPS24,alpha,2
lysosomal transport (GO:0007041),8/73,8,73,0.0765226637573142,1,0,0,1.79360132726498,4.6098573167902,VPS18;VPS51;HOOK2;AKTIP;VPS33A;VPS4A;RILP;RAB7A,alpha,2
endosome to lysosome transport (GO:0008333),6/49,6,49,0.0766688049375826,1,0,0,2.00407495240322,5.14698627601278,VPS18;HOOK2;AKTIP;VPS33A;RILP;RAB7A,alpha,2
protein K48-linked ubiquitination (GO:0070936),6/49,6,49,0.0766688049375826,1,0,0,2.00407495240322,5.14698627601278,UBE2D4;AMFR;TTC3;ARIH2;UBE2K;RNF187,alpha,2
T cell receptor signaling pathway (GO:0050852),15/164,15,164,0.0771208928831675,1,0,0,1.49694622969143,3.83574665318495,EIF2B5;PSMD11;FBXW11;PSMD13;CUL1;PSMB10;PSMA7;PSMD9;PSMC3;PSMB3;PSMD2;PSMD1;TAB2;UBE2V1;CD276,alpha,2
nucleosome assembly (GO:0006334),7/61,7,61,0.0774640784738649,1,0,0,1.87813581605001,4.80416052036649,BRD2;HIST1H2BO;HAT1;ANP32B;CABIN1;ASF1B;NAP1L4,alpha,2
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),4/27,4,27,0.0794592391701503,1,0,0,2.42468327574711,6.14053731865412,KLF11;PCNA;E2F1;CDC6,alpha,2
internal peptidyl-lysine acetylation (GO:0018393),4/27,4,27,0.0794592391701503,1,0,0,2.42468327574711,6.14053731865412,NAA50;MORF4L1;TEX30;KAT8,alpha,2
protein K63-linked ubiquitination (GO:0070534),5/38,5,38,0.0797782204107499,1,0,0,2.15350159359118,5.44513898475614,UBE2D4;PELI3;ARIH2;STUB1;UBE2V1,alpha,2
pigment granule transport (GO:0051904),3/17,3,17,0.0815299813414918,1,0,0,2.88822566669876,7.24015921005638,BLOC1S3;MYO5A;RAB11A,alpha,2
negative regulation of phosphoprotein phosphatase activity (GO:0032515),3/17,3,17,0.0815299813414918,1,0,0,2.88822566669876,7.24015921005638,ROCK2;BOD1;CRY2,alpha,2
peptidyl-lysine trimethylation (GO:0018023),3/17,3,17,0.0815299813414918,1,0,0,2.88822566669876,7.24015921005638,KMT2A;CTR9;BEND3,alpha,2
rRNA catabolic process (GO:0016075),3/17,3,17,0.0815299813414918,1,0,0,2.88822566669876,7.24015921005638,EXOSC6;XRN1;PELO,alpha,2
regulation of protein localization to membrane (GO:1905475),3/17,3,17,0.0815299813414918,1,0,0,2.88822566669876,7.24015921005638,VPS4A;LDLRAP1;SPTBN1,alpha,2
nucleotide catabolic process (GO:0009166),3/17,3,17,0.0815299813414918,1,0,0,2.88822566669876,7.24015921005638,PNP;SAMHD1;DNPH1,alpha,2
regulation of establishment or maintenance of cell polarity (GO:0032878),3/17,3,17,0.0815299813414918,1,0,0,2.88822566669876,7.24015921005638,RAP1B;ROCK2;KIF20B,alpha,2
positive regulation of telomere capping (GO:1904355),3/17,3,17,0.0815299813414918,1,0,0,2.88822566669876,7.24015921005638,PNKP;MAPK1;MAPKAPK5,alpha,2
melanosome transport (GO:0032402),3/17,3,17,0.0815299813414918,1,0,0,2.88822566669876,7.24015921005638,BLOC1S3;MYO5A;RAB11A,alpha,2
microtubule nucleation (GO:0007020),3/17,3,17,0.0815299813414918,1,0,0,2.88822566669876,7.24015921005638,NDE1;TUBG2;TUBG1,alpha,2
phosphate ion transmembrane transport (GO:0035435),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,SLC20A1;SLC25A10,alpha,2
protein localization to microtubule (GO:0035372),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,KIF20B;MID2,alpha,2
regulation of ATP biosynthetic process (GO:2001169),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,FLCN;PPARGC1A,alpha,2
cellular response to UV-B (GO:0071493),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,CDKN1A;HYAL3,alpha,2
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,SESN2;ARNT,alpha,2
insulin metabolic process (GO:1901142),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,CPD;IDE,alpha,2
regulation of metaphase/anaphase transition of cell cycle (GO:1902099),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,HECW2;CDC6,alpha,2
protein localization to microtubule cytoskeleton (GO:0072698),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,KIF20B;MID2,alpha,2
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,EPHA4;ROCK2,alpha,2
positive regulation of mRNA 3'-end processing (GO:0031442),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,HSF1;LEO1,alpha,2
fatty acid alpha-oxidation (GO:0001561),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,ALDH3A2;HACL1,alpha,2
regulation of lipid transport (GO:0032368),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,NCOR1;NR1H2,alpha,2
regulation of ERAD pathway (GO:1904292),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,USP25;TMEM259,alpha,2
aldehyde biosynthetic process (GO:0046184),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,KDM3A;CACNA1H,alpha,2
regulation of stress-activated protein kinase signaling cascade (GO:0070302),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,NBR1;MAPK1,alpha,2
4-hydroxyproline metabolic process (GO:0019471),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,ALDH4A1;P4HB,alpha,2
regulation of chaperone-mediated autophagy (GO:1904714),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,PLK3;EEF1A2,alpha,2
regulation of amyloid precursor protein catabolic process (GO:1902991),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,PRNP;ROCK2,alpha,2
establishment of integrated proviral latency (GO:0075713),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,XRCC6;BANF1,alpha,2
negative regulation of anion transmembrane transport (GO:1903960),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,AKT2;IRS2,alpha,2
"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)",2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,PRMT7;CARM1,alpha,2
regulation of protein deacetylation (GO:0090311),2/8,2,8,0.0816919986322545,1,0,0,4.09165302782324,10.2487693038868,ZNHIT1;CCAR2,alpha,2
protein autoubiquitination (GO:0051865),6/50,6,50,0.0828519376848317,1,0,0,1.96399345335516,4.89171878399105,RNF213;RNF13;AMFR;RNF181;STUB1;RNF187,alpha,2
regulation of vesicle fusion (GO:0031338),7/62,7,62,0.0829606504421433,1,0,0,1.84784330288792,4.60000056032555,VPS18;TBC1D2;AKT2;TBC1D14;DOC2B;TBC1D17;TBC1D10A,alpha,2
negative regulation of viral life cycle (GO:1903901),7/62,7,62,0.0829606504421433,1,0,0,1.84784330288792,4.60000056032555,ILF3;TRIM28;IFIT5;BANF1;TRIM26;IFIT1;MID2,alpha,2
regulation of mitotic cell cycle (GO:0007346),15/166,15,166,0.0835438099298,1,0,0,1.47891073294816,3.67122451082333,MAP3K3;PARP3;NUMA1;USP2;PRKCA;IQGAP1;MAEA;RPS6KB1;HSF1;CDK10;PIN1;KIF20B;CDK13;MAP4K5;ZNF268,alpha,2
mRNA 3'-end processing (GO:0031124),8/75,8,75,0.0865534306849719,1,0,0,1.74577195853792,4.27189239054629,ZNF473;DDX39A;POLDIP3;U2AF2;SSU72;LEO1;TUT1;SRSF11,alpha,2
mitochondrion disassembly (GO:0061726),5/39,5,39,0.0871397308096487,1,0,0,2.09828360401192,5.12032050750871,MAP1LC3B;GABARAPL1;WDR45B;ATG4B;WIPI2,alpha,2
G2/M transition of mitotic cell cycle (GO:0000086),12/127,12,127,0.0879814452922913,1,0,0,1.54645153807493,3.75885047466309,KHDRBS1;PLK3;CDKN1A;FBXW11;NDE1;CEP164;CNTRL;CUL1;FBXL15;TUBG1;PLCB1;ARPP19,alpha,2
regulation of protein localization to nucleus (GO:1900180),4/28,4,28,0.0884303267541974,1,0,0,2.33808744447042,5.6711253339744,FLCN;SESN2;PIN1;KAT7,alpha,2
phagosome acidification (GO:0090383),4/28,4,28,0.0884303267541974,1,0,0,2.33808744447042,5.6711253339744,ATP6V1A;ATP6V0E1;ATP6V0D1;RAB7A,alpha,2
microtubule polymerization (GO:0046785),4/28,4,28,0.0884303267541974,1,0,0,2.33808744447042,5.6711253339744,NDE1;ZNF207;TUBG2;TUBG1,alpha,2
regulation of protein targeting to membrane (GO:0090313),4/28,4,28,0.0884303267541974,1,0,0,2.33808744447042,5.6711253339744,PRNP;AKT2;INPP5K;MIEF2,alpha,2
negative regulation of organelle assembly (GO:1902116),4/28,4,28,0.0884303267541974,1,0,0,2.33808744447042,5.6711253339744,SCFD1;FEZ1;CDK10;SMCR8,alpha,2
endocytic recycling (GO:0032456),4/28,4,28,0.0884303267541974,1,0,0,2.33808744447042,5.6711253339744,ARL4C;EHD4;VPS51;RAB11FIP3,alpha,2
stress-activated MAPK cascade (GO:0051403),7/63,7,63,0.0886752983861892,1,0,0,1.81851245681033,4.40584454152863,FBXW11;CUL1;MAPK1;TAB2;UBE2V1;MAPK14;CRKL,alpha,2
positive regulation of kinase activity (GO:0033674),11/114,11,114,0.088779595239544,1,0,0,1.57923450196686,3.82427180434632,DDR1;EPHA4;VAC14;XRCC6;CDKN1A;DSTYK;EEF1A2;SPDYA;ROR1;TAB2;IQGAP1,alpha,2
regulation of cellular protein metabolic process (GO:0032268),6/51,6,51,0.0893033342085106,1,0,0,1.92548377779917,4.65142284516285,DDX6;NR1H2;GBA;NOLC1;MAPKAPK5;SSH1,alpha,2
positive regulation of phosphorylation (GO:0042327),18/209,18,209,0.0894135613553002,1,0,0,1.4095646794415,3.40336983651419,DDR1;EPHA4;VAC14;PFKFB4;ROCK2;AKTIP;GLMN;AXIN1;ARNT;FLCN;DSTYK;CCND3;KCTD20;AKT2;PIN1;ROR1;HRAS;PDE8A,alpha,2
cell cycle G2/M phase transition (GO:0044839),12/128,12,128,0.0919836206040808,1,0,0,1.53436988543372,3.66122865389072,KHDRBS1;PLK3;CDKN1A;FBXW11;NDE1;CEP164;CNTRL;CUL1;FBXL15;TUBG1;PLCB1;ARPP19,alpha,2
establishment of melanosome localization (GO:0032401),3/18,3,18,0.0935742059253579,1,0,0,2.72776868521549,6.46208540970443,BLOC1S3;MYO5A;RAB11A,alpha,2
regulation of amyloid-beta formation (GO:1902003),3/18,3,18,0.0935742059253579,1,0,0,2.72776868521549,6.46208540970443,PRNP;EPHA4;ROCK2,alpha,2
nuclear envelope reassembly (GO:0031468),3/18,3,18,0.0935742059253579,1,0,0,2.72776868521549,6.46208540970443,VPS4A;LMNA;BANF1,alpha,2
establishment of mitotic spindle localization (GO:0040001),3/18,3,18,0.0935742059253579,1,0,0,2.72776868521549,6.46208540970443,NUMA1;SAPCD2;NDE1,alpha,2
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),3/18,3,18,0.0935742059253579,1,0,0,2.72776868521549,6.46208540970443,TSG101;VPS4A;VPS28,alpha,2
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),3/18,3,18,0.0935742059253579,1,0,0,2.72776868521549,6.46208540970443,BAG5;MAPK7;P4HB,alpha,2
negative regulation of protein dephosphorylation (GO:0035308),3/18,3,18,0.0935742059253579,1,0,0,2.72776868521549,6.46208540970443,BOD1;CRY2;ARPP19,alpha,2
tRNA metabolic process (GO:0006399),3/18,3,18,0.0935742059253579,1,0,0,2.72776868521549,6.46208540970443,SSB;POP7;DTD2,alpha,2
DNA conformation change (GO:0071103),3/18,3,18,0.0935742059253579,1,0,0,2.72776868521549,6.46208540970443,TOP3A;HAT1;TOP1,alpha,2
positive regulation of lipid catabolic process (GO:0050996),3/18,3,18,0.0935742059253579,1,0,0,2.72776868521549,6.46208540970443,AKT2;IRS2;PNPLA2,alpha,2
maintenance of protein localization in organelle (GO:0072595),3/18,3,18,0.0935742059253579,1,0,0,2.72776868521549,6.46208540970443,HSPA5;TAF8;ARL2,alpha,2
regulation of cellular macromolecule biosynthetic process (GO:2000112),47/632,47,632,0.0942112658892983,1,0,0,1.21713729308666,2.87514059046128,DDX6;ZNF571;USP37;KDM3A;KDM3B;ZNF250;CTR9;NOLC1;PRDM2;PHB;SBNO1;SERTAD3;GPBP1;ZNF207;ZNF548;E2F1;HSF4;ZNF668;ZNF701;RBBP6;KAT7;ZNF324;PPARGC1A;ZNF268;ZNF565;ZNF146;ZNF584;ZNF540;ARNT2;ZNF19;ZNF263;PRMT7;NUP133;ZNF260;DENND4A;NFYC;TOX3;NFIA;CARM1;ZNF813;MAPKAPK5;ZNF678;CALR;UBE2V1;ZNF510;ZNF256;ZNF354B,alpha,2
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",7/64,7,64,0.0946065678753339,1,0,0,1.79009819967267,4.22110235329802,EIF4A1;DDX6;EXOSC6;PDE12;CNOT2;SAMD4B;LSM2,alpha,2
ERBB2 signaling pathway (GO:0038128),5/40,5,40,0.0948424405908797,1,0,0,2.04582651391162,4.81902267664615,PRKCA;GRB2;STUB1;PTPN12;HRAS,alpha,2
DNA replication-independent nucleosome assembly (GO:0006336),5/40,5,40,0.0948424405908797,1,0,0,2.04582651391162,4.81902267664615,HAT1;CENPN;CENPO;CABIN1;ASF1B,alpha,2
regulation of telomere maintenance via telomerase (GO:0032210),6/52,6,52,0.0960199783247952,1,0,0,1.88845524361073,4.42502644142463,XRN1;PAPD5;PNKP;MAPK1;MAPKAPK5;CCT4,alpha,2
hemopoiesis (GO:0030097),8/77,8,77,0.0973139723940129,1,0,0,1.70042723234213,3.9616769595138,FLCN;KMT2A;RRAS;KAT8;PRRC2C;HIPK1;CDK13;ZFP36L2,alpha,2
lytic vacuole organization (GO:0080171),4/29,4,29,0.0978651885743576,1,0,0,2.25746373948868,5.24671679924824,MBTPS1;VPS18;HOOK2;AKTIP,alpha,2
positive regulation of macromolecule biosynthetic process (GO:0010557),13/143,13,143,0.0983425826919489,1,0,0,1.48787382829936,3.45082302404382,RPL5;PCNA;YTHDF3;POLDIP3;GBA;RPS27L;IRS2;PASK;FXR2;RPS6KB1;AKT2;CALR;HRAS,alpha,2
negative regulation of gene expression (GO:0010629),37/619,37,619,4.15702935446908e-05,0.0707110693195191,0,0,2.02623148325621,20.4408759618286,NAB1;ZBTB21;ZBTB4;GIGYF2;FOXO1;ARNTL;NIPBL;HEY1;ZNF706;BAHD1;STC2;UIMC1;EPC1;JARID2;ZBTB7A;YAF2;HSPA8;NDFIP1;SMARCC2;POU2F1;DAPK3;H3F3A;DNMT3A;RFX3;MIF;PROX1;GATAD2A;PTBP3;PER2;NCL;BHLHE40;ERP29;MDM2;CPEB3;EIF4E2;CLOCK;LIMS1,alpha,3
"regulation of transcription, DNA-templated (GO:0006355)",75/1599,75,1599,4.10737579732591e-05,0.104799693468771,0,0,1.58997678633892,16.0589899394534,NAB1;CHD7;ZBTB21;CHD4;NR3C1;ETS1;NIPBL;HEY1;POFUT1;UIMC1;UBTF;EPC1;EPC2;JARID2;YAF2;FADS1;GTF2I;BRD3;PCID2;SMARCC2;KLF13;USP3;BUD31;DAPK3;TFEB;RFX3;RFX1;SOX12;PROX1;GLRX2;ARID1A;SLTM;CTDSP1;ZNF436;CLOCK;ATF4;DDX5;DHX9;HTATSF1;ZBTB4;FOXO1;ARNTL;HIRA;CDC45;POLR2A;ZNF706;NFIL3;BAHD1;UBN1;DVL3;TASP1;ZBTB7A;RREB1;ZNF860;ESRRA;MLXIP;RNF20;EGR1;HSPA8;ZFHX3;JUND;POU2F1;TAF15;NFATC3;ZNF34;ACVR2B;GATAD2A;PER2;RYBP;TEF;BHLHE40;MDM2;MMS19;RAN;LIMS1,alpha,3
transcription from RNA polymerase II promoter (GO:0006366),32/486,32,486,2.17847207862406e-05,0.111167430172186,0,0,2.2319871660738,23.9588236652388,DDX5;ZBTB1;DDX21;ARRB2;NR3C1;ETS1;GTF2E2;MNT;POLR2A;PAPOLA;POLR2I;RREB1;GTF2I;ESRRA;EGR1;SUPT16H;PCID2;CPSF7;ZFHX3;POU2F1;KLF13;TAF15;LMO4;NFATC3;ELL2;CDC40;CDK9;MAF;NFX1;SRSF4;SRSF5;ATF4,alpha,3
"negative regulation of transcription, DNA-templated (GO:0045892)",43/814,43,814,0.000172256511870597,0.175804996015131,0,0,1.79069670595094,15.5191192809273,DDX5;NAB1;ZBTB21;ZBTB1;VLDLR;NR3C1;ZBTB4;FOXO1;ZBTB2;ARNTL;NIPBL;MNT;HEY1;ZNF706;NFIL3;BAHD1;TPR;ORC2;UIMC1;EPC1;JARID2;ZBTB7A;RREB1;YAF2;HSPA8;ZFHX3;JUND;SMARCC2;POU2F1;USP9X;RFX3;DICER1;PROX1;ACVR2B;GATAD2A;PER2;NFX1;BHLHE40;MDM2;CPEB3;CLOCK;LIMS1;CC2D1B,alpha,3
ubiquitin-dependent protein catabolic process (GO:0006511),23/342,23,342,0.000225690807043213,0.191950031390252,0,0,2.27971057587472,19.141235596617,RNF20;RNF44;VCP;RNF34;RNF38;KLHL24;ARRB2;CBL;ARNTL;DDB1;SPSB3;CUL4A;ZNRF2;WDR81;PSMA1;RNF19A;TRIM13;MDM2;TRIP12;ANAPC5;RBCK1;ARIH1;CLOCK,alpha,3
"transcription, DNA-templated (GO:0006351)",24/357,24,357,0.000167030393971214,0.213089025108776,0,0,2.27887765275602,19.8201618282976,EGR1;SUPT16H;DDX5;ZFHX3;KLF13;TAF15;LMO4;NFATC3;DDX21;ARRB2;NR3C1;GTF2E2;CDK9;MNT;MAF;POLR2A;NFX1;UBTF;EPC1;MMS19;POLR2I;RREB1;ATF4;GTF2I,alpha,3
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),30/513,30,513,0.000316946202351885,0.231053781514524,0,0,1.98235702249975,15.9714114523903,NAB1;ZBTB21;ZBTB4;GIGYF2;FOXO1;ARNTL;NIPBL;HEY1;ZNF706;BAHD1;UIMC1;EPC1;JARID2;ZBTB7A;YAF2;HSPA8;SMARCC2;POU2F1;DAPK3;RFX3;PROX1;GATAD2A;PER2;NCL;BHLHE40;MDM2;CPEB3;EIF4E2;CLOCK;LIMS1,alpha,3
nucleotide-excision repair (GO:0006289),11/109,11,109,0.00037733995593022,0.240695724388989,0,0,3.42092987093765,26.9650145876803,DDB1;POLD3;CUL4A;POLR2A;RFC2;ERCC1;LIG4;MMS19;CHD1L;POLR2I;RAD23B,alpha,3
DNA replication-independent nucleosome organization (GO:0034724),4/13,4,13,0.000433433068612018,0.245756549903014,0,0,10.4302477183833,80.7694724519395,HIRA;SUPT16H;H3F3A;UBN1,alpha,3
regulation of translation (GO:0006417),16/214,16,214,0.000641741597998179,0.327480737458471,0,0,2.53445271661651,18.6315851877136,NUP214;NDC1;DHX9;DAPK3;H3F3A;GIGYF2;EIF5;POLR2A;NCL;TPR;CPEB3;EIF4E2;POLR2I;EIF4B;RAN;EIF3B,alpha,3
regulation of gene silencing by miRNA (GO:0060964),8/68,8,68,0.000852219992190708,0.362406551679099,0,0,3.98803589232303,28.186105115326,NUP214;NDC1;POLR2A;DHX9;TPR;H3F3A;POLR2I;RAN,alpha,3
DNA duplex unwinding (GO:0032508),6/42,6,42,0.00136534088983059,0.366701818989764,0,0,4.84261501210654,31.943589081765,CUL4A;DDB1;PURA;DHX9;CHD1L;RAD23B,alpha,3
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",6/38,6,38,0.000793759888223521,0.368232428145875,0,0,5.35236396074933,38.2090787701902,POLD3;CUL4A;DDB1;RFC2;ERCC1;CHD1L,alpha,3
nucleic acid phosphodiester bond hydrolysis (GO:0090305),8/74,8,74,0.00148966399595256,0.380087768567297,0,0,3.66468163078333,23.8541628603837,DDB1;POLD3;CUL4A;RFC2;ERCC1;DICER1;CHD1L;PNRC2,alpha,3
regulation of protein secretion (GO:0050708),10/108,10,108,0.00134284122196163,0.380695486426122,0,0,3.13873195229127,20.7563326893214,PER2;SNAP25;GOLPH3;ERP29;RFX3;ARFIP1;ANG;CLOCK;LLGL2;ARNTL,alpha,3
regulation of hair cycle (GO:0042634),3/9,3,9,0.0018784390450109,0.383426977867625,0,0,11.2994350282486,70.9301033020704,NIPBL;CLOCK;ARNTL,alpha,3
proteasomal protein catabolic process (GO:0010498),16/238,16,238,0.00195648610212531,0.383998022274825,0,0,2.27887765275602,14.2124602644094,RNF44;VCP;RNF34;RNF38;ARRB2;ARNTL;RNF41;DDB1;SPSB3;CUL4A;ZNRF2;PSMA1;TRIM13;ANAPC5;RBCK1;CLOCK,alpha,3
regulation of type B pancreatic cell development (GO:2000074),3/8,3,8,0.00128026791978505,0.384306305568418,0,0,12.7118644067797,84.6697361519659,RFX3;CLOCK;ARNTL,alpha,3
intracellular estrogen receptor signaling pathway (GO:0030520),4/19,4,19,0.00204124748935052,0.385795775487249,0,0,7.13648528099911,44.204775333718,DDX5;EGLN2;DDX54;ARID1A,alpha,3
negative regulation of MAPK cascade (GO:0043409),8/81,8,81,0.00265776257624022,0.387501783615824,0,0,3.34798074911069,19.8544319628185,DUSP1;CAMK2N1;SMPD1;DAG1;RANBP9;PTPRJ;FOXO1;PTPN2,alpha,3
negative regulation of nucleic acid-templated transcription (GO:1903507),25/445,25,445,0.00169701754426959,0.393630933109441,0,0,1.90439916206437,12.1479393532292,NAB1;ZBTB21;ZBTB4;FOXO1;ARNTL;NIPBL;HEY1;ZNF706;BAHD1;UIMC1;EPC1;JARID2;ZBTB7A;YAF2;HSPA8;SMARCC2;POU2F1;RFX3;PROX1;GATAD2A;PER2;BHLHE40;MDM2;CLOCK;LIMS1,alpha,3
regulation of posttranscriptional gene silencing (GO:0060147),7/56,7,56,0.00124277855595334,0.396368685689369,0,0,4.23728813559322,28.3491764204161,NUP214;NDC1;POLR2A;TPR;H3F3A;POLR2I;RAN,alpha,3
nucleic acid metabolic process (GO:0090304),8/81,8,81,0.00265776257624022,0.398898894898642,0,0,3.34798074911069,19.8544319628185,HNRNPL;DDX24;POLR2A;DDX54;HNRNPR;MMS19;POLR2I;RAN,alpha,3
sphingomyelin metabolic process (GO:0006684),3/9,3,9,0.0018784390450109,0.399403101945443,0,0,11.2994350282486,70.9301033020704,SGMS1;SMPD1;SGMS2,alpha,3
actin filament polymerization (GO:0030041),4/18,4,18,0.00164964651135252,0.400864102258663,0,0,7.53295668549906,48.2651167575539,COBL;ANG;RAC1;WASF1,alpha,3
photoperiodism (GO:0009648),4/21,4,21,0.00300810628845888,0.403957010263306,0,0,6.45682001614205,37.4911673172551,PPP1CB;PER2;BHLHE40;CLOCK,alpha,3
global genome nucleotide-excision repair (GO:0070911),5/33,5,33,0.00263049385153,0.406770003768412,0,0,5.13610683102209,30.5114723891786,CUL4A;DDB1;ERCC1;CHD1L;RAD23B,alpha,3
"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",4/21,4,21,0.00300810628845888,0.41487476729745,0,0,6.45682001614205,37.4911673172551,CUL4A;DDB1;ERCC1;CHD1L,alpha,3
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",16/237,16,237,0.00187460373787635,0.415917516277522,0,0,2.2884931702782,14.3702678548396,HSPA8;DDX5;CPSF7;DHX9;BUD31;HNRNPR;HTATSF1;CRNKL1;CDC40;HNRNPL;POLR2A;RSRC1;PAPOLA;SRSF4;SRSF5;POLR2I,alpha,3
regulation of cytoplasmic translation (GO:2000765),3/10,3,10,0.0026249348974996,0.41859508693564,0,0,10.1694915254237,60.4342289918505,DHX9;CPEB3;CPEB2,alpha,3
regulation of transcription from RNA polymerase II promoter (GO:0006357),62/1479,62,1479,0.00321741957079727,0.420986976148165,0,0,1.42102428347142,8.15550791776655,CHD4;VLDLR;NR3C1;ETS1;PAGR1;NIPBL;HEY1;EPC1;EPC2;GTF2I;NCK1;BRD3;SMARCC2;KLF13;BUD31;TFEB;RFX3;DICER1;RFX1;SOX12;PROX1;ARID1A;METTL23;CREB3;SLTM;CTDSP1;NFX1;CLOCK;ATF4;DDX5;DHX9;ZBTB1;HTATSF1;ZBTB4;FOXO1;ZBTB2;ARNTL;HIRA;MNT;NFIL3;UBN1;TPR;ORC2;RREB1;ESRRA;MLXIP;EGR1;ZFHX3;JUND;POU2F1;USP9X;NFATC3;ACVR2B;GATAD2A;CDK9;PER2;TEF;ASXL2;BHLHE40;MDM2;CPEB3;CC2D1B,alpha,3
regulation of gene silencing by RNA (GO:0060966),7/56,7,56,0.00124277855595334,0.422793264735327,0,0,4.23728813559322,28.3491764204161,NUP214;NDC1;POLR2A;TPR;H3F3A;POLR2I;RAN,alpha,3
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),4/20,4,20,0.00249263587172743,0.423997361780836,0,0,6.77966101694915,40.6400986127889,CREB3;BCL2L11;TMBIM6;NCK1,alpha,3
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",4/22,4,22,0.00359184989436464,0.426260697928902,0,0,6.1633281972265,34.6939162914598,CUL4A;DDB1;CHD1L;RAD23B,alpha,3
positive regulation of leukocyte cell-cell adhesion (GO:1903039),4/21,4,21,0.00300810628845888,0.426399066389046,0,0,6.45682001614205,37.4911673172551,FAM49B;SIRPA;CD47;ETS1,alpha,3
antigen processing and presentation of exogenous peptide antigen (GO:0002478),9/98,9,98,0.00243768658809247,0.428948781346065,0,0,3.11310965063992,18.730664919249,ACTR1A;HLA-DMA;ACTR1B;SEC24A;SAR1B;AP1G1;KLC1;DYNLL1;SEC31A,alpha,3
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),9/99,9,99,0.00261308948781799,0.430148246978555,0,0,3.08166409861325,18.3273406652522,ACTR1A;HLA-DMA;ACTR1B;SEC24A;SAR1B;AP1G1;KLC1;DYNLL1;SEC31A,alpha,3
"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",4/22,4,22,0.00359184989436464,0.436409762165304,0,0,6.1633281972265,34.6939162914598,CUL4A;DDB1;ERCC1;CHD1L,alpha,3
ncRNA metabolic process (GO:0034660),5/35,5,35,0.0034282614801573,0.437360458331067,0,0,4.84261501210654,27.4852397258923,EXD1;TDRKH;ZCCHC11;DICER1;RAN,alpha,3
regulation of mRNA polyadenylation (GO:1900363),3/11,3,11,0.00353065521296508,0.439437403701483,0,0,9.24499229583975,52.199739406991,CDK9;RNF20;CPEB3,alpha,3
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),9/98,9,98,0.00243768658809247,0.444268380679853,0,0,3.11310965063992,18.730664919249,ACTR1A;HLA-DMA;ACTR1B;SEC24A;SAR1B;AP1G1;KLC1;DYNLL1;SEC31A,alpha,3
regulation of protein transport (GO:0051223),5/28,5,28,0.00122959698234772,0.448188100065743,0,0,6.05326876513317,40.5633705806104,HSPA8;NDFIP1;ARFIP1;NDEL1;LLGL2,alpha,3
"nucleotide-excision repair, DNA incision (GO:0033683)",6/41,6,41,0.00119976205975707,0.470952753149256,0,0,4.96072757337743,33.3640282367163,POLD3;CUL4A;DDB1;RFC2;ERCC1;CHD1L,alpha,3
lamellipodium assembly (GO:0030032),4/23,4,23,0.00424793794765967,0.492664257884256,0,0,5.89535740604274,32.1964427565155,GOLPH3;RAC1;ARHGEF7;VCL,alpha,3
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),8/89,8,89,0.0047586766400074,0.527902758564299,0,0,3.04703865930299,16.2949096665711,SDCBP;VCP;RYBP;RNF19A;GNA12;MDM2;ARIH1;RAD23B,alpha,3
mRNA processing (GO:0006397),17/284,17,284,0.0047569864613719,0.539442264719574,0,0,2.02912389591788,10.8520405143052,HSPA8;DDX5;CPSF7;DHX9;BUD31;FAM103A1;HNRNPR;HTATSF1;CRNKL1;CDC40;HNRNPL;POLR2A;RSRC1;PAPOLA;SRSF4;SRSF5;POLR2I,alpha,3
"mRNA splicing, via spliceosome (GO:0000398)",16/262,16,262,0.0050210613210266,0.545159062153165,0,0,2.07012550135852,10.9594802931154,HSPA8;DDX5;CPSF7;DHX9;BUD31;HNRNPR;HTATSF1;CRNKL1;CDC40;HNRNPL;POLR2A;RSRC1;PAPOLA;SRSF4;SRSF5;POLR2I,alpha,3
prostanoid biosynthetic process (GO:0046457),3/13,3,13,0.00585665667701922,0.574740750439021,0,0,7.82268578878748,40.2099846503854,FAM213B;PTGES3;MIF,alpha,3
DNA repair (GO:0006281),17/289,17,289,0.00564559928834991,0.576189863368991,0,0,1.99401794616152,10.3227894802225,VCP;ERCC6L2;RFC2;USP3;RAD21L1;ZBTB1;LIG4;CHD1L;RAD23B;DDB1;POLD3;NIPBL;APEX1;ERCC1;UIMC1;MMS19;TMEM189-UBE2V1,alpha,3
in utero embryonic development (GO:0001701),4/26,4,26,0.00668889228847968,0.578532497425624,0,0,5.21512385919166,26.1137261838813,MBNL1;CHD7;LIG4;ADAM10,alpha,3
DNA metabolic process (GO:0006259),18/315,18,315,0.00601304258219961,0.578953892395559,0,0,1.93704600484262,9.90571313367588,VCP;RFC2;PTGES3;USP3;ZBTB1;LIG4;CHD1L;GLRX2;DDB1;POLD3;PURA;CDC45;APEX1;ERCC1;THAP9;ORC2;MMS19;RAN,alpha,3
transcription-coupled nucleotide-excision repair (GO:0006283),7/74,7,74,0.0061273508928408,0.579034659373455,0,0,3.20659642693541,16.3375856338354,DDB1;POLD3;CUL4A;POLR2A;RFC2;ERCC1;POLR2I,alpha,3
protein oligomerization (GO:0051259),14/218,14,218,0.00545048744572193,0.579454946573312,0,0,2.17695537241487,11.3464007597796,FIS1;CPSF7;NLGN1;ATL3;ZBTB1;TYSND1;TOR1B;EHD1;ALAD;SPAST;TRIM4;MAT2A;TMCC1;STX2,alpha,3
regulation of viral transcription (GO:0046782),5/41,5,41,0.00684900399872219,0.582507790091322,0,0,4.13393964448119,20.6021167380167,CDK9;POLR2A;DHX9;TRIM13;POLR2I,alpha,3
negative regulation of transcription from RNA polymerase II promoter (GO:0000122),28/566,28,566,0.00560387493181639,0.583603546470592,0,0,1.67694795472241,8.69379619786456,DDX5;ZBTB1;VLDLR;NR3C1;ZBTB4;ZBTB2;NIPBL;MNT;HEY1;NFIL3;TPR;ORC2;EPC1;RREB1;ZFHX3;JUND;USP9X;NFATC3;DICER1;PROX1;ACVR2B;GATAD2A;PER2;NFX1;BHLHE40;MDM2;CPEB3;CC2D1B,alpha,3
regulation of cell aging (GO:0090342),3/13,3,13,0.00585665667701922,0.586010176918217,0,0,7.82268578878748,40.2099846503854,MIF;MARCH5;ARNTL,alpha,3
"negative regulation of gene expression, epigenetic (GO:0045814)",4/26,4,26,0.00668889228847968,0.5885071956571,0,0,5.21512385919166,26.1137261838813,H3F3A;DNMT3A;EPC1;JARID2,alpha,3
Golgi vesicle transport (GO:0048193),16/272,16,272,0.00712339627602356,0.595912970435217,0,0,1.99401794616152,9.85916383296014,SEC24A;SAR1B;USO1;DYNLL1;KLC1;YIF1A;BET1L;ACTR1A;GOLPH3;SPAST;RER1;SNX8;ATP9B;ARF5;SEC31A;TMED4,alpha,3
lamellipodium organization (GO:0097581),4/26,4,26,0.00668889228847968,0.598831883300207,0,0,5.21512385919166,26.1137261838813,GOLPH3;RAC1;ARHGEF7;VCL,alpha,3
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),3/14,3,14,0.0072922843978562,0.600202052939681,0,0,7.26392251815981,35.7453154109536,PCID2;DUSP1;TPR,alpha,3
mitotic spindle organization (GO:0007052),7/75,7,75,0.00659079279693312,0.60058599362053,0,0,3.1638418079096,15.8890718385318,SUN2;SPAST;SPICE1;MAP4;PCNT;RHOA;RAN,alpha,3
positive regulation of protein transport (GO:0051222),6/57,6,57,0.00651619384962978,0.604584312993832,0,0,3.56824264049955,17.9606238676009,GOLPH3;RUFY3;TPR;ANG;ACSL3;PCNT,alpha,3
negative regulation of signal transduction by p53 class mediator (GO:1901797),3/15,3,15,0.008917991891245,0.669242832662107,0,0,6.77966101694915,31.9978608951484,RNF34;MDM2;MIF,alpha,3
positive regulation of viral process (GO:0048524),5/45,5,45,0.0101444897227677,0.67230300071797,0,0,3.76647834274953,17.2912414514721,CDK9;DDB1;POLR2A;DHX9;POLR2I,alpha,3
ceramide metabolic process (GO:0006672),5/43,5,43,0.00838507575602494,0.67919113623802,0,0,3.94166338194718,18.8462824163972,FUT5;ASAH1;SGMS1;SMPD1;SGMS2,alpha,3
mitotic chromosome condensation (GO:0007076),3/15,3,15,0.008917991891245,0.679231531657063,0,0,6.77966101694915,31.9978608951484,NIPBL;PHF13;NCAPD3,alpha,3
regulation of phosphorylation (GO:0042325),9/120,9,120,0.0091976113865709,0.680223346459005,0,0,2.54237288135593,11.920707103047,NUP214;NDC1;SDCBP;CDKN2C;PTGES3;TPR;ANG;MIF;DYNLL1,alpha,3
"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",6/64,6,64,0.0113358425720759,0.680550642885922,0,0,3.17796610169492,14.2366069834377,SEC24A;SAR1B;PPP6R3;USO1;TRAPPC9;SEC31A,alpha,3
positive regulation of intracellular transport (GO:0032388),5/45,5,45,0.0101444897227677,0.68114909283268,0,0,3.76647834274953,17.2912414514721,EHD1;CAPN10;RUFY3;TPR;PCNT,alpha,3
positive regulation of cell adhesion (GO:0045785),6/65,6,65,0.0121863827662983,0.683374848971652,0,0,3.12907431551499,13.7911951519721,SIRPA;PTPRJ;RAC1;CD47;STX3;LIMS1,alpha,3
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),4/29,4,29,0.00991331346089662,0.683616737715614,0,0,4.67562828755114,21.5727720922841,SEC24A;SAR1B;HLA-C;SEC31A,alpha,3
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),4/28,4,28,0.00874597578188521,0.686626375614772,0,0,4.84261501210654,22.9499350849668,RAC1;ARHGEF7;RREB1;LIMS1,alpha,3
RNA secondary structure unwinding (GO:0010501),5/47,5,47,0.0121414686978242,0.688421275166635,0,0,3.60620266858998,15.9074234425419,DDX5;DDX24;DHX9;DDX21;DDX54,alpha,3
COPII vesicle coating (GO:0048208),6/64,6,64,0.0113358425720759,0.688652436253612,0,0,3.17796610169492,14.2366069834377,SEC24A;SAR1B;PPP6R3;USO1;TRAPPC9;SEC31A,alpha,3
negative regulation of cell aging (GO:0090344),3/15,3,15,0.008917991891245,0.689522918500352,0,0,6.77966101694915,31.9978608951484,AKT3;MIF;MARCH5,alpha,3
regulation of focal adhesion assembly (GO:0051893),5/45,5,45,0.0101444897227677,0.690231080737115,0,0,3.76647834274953,17.2912414514721,DAPK3;PTPRJ;RAC1;RHOA;LIMS1,alpha,3
peptidyl-proline hydroxylation (GO:0019511),2/6,2,6,0.0120435409682678,0.690541455742365,0,0,11.2994350282486,49.9347658981472,EGLN3;EGLN2,alpha,3
positive regulation of focal adhesion assembly (GO:0051894),3/17,3,17,0.0127584169388343,0.692619166370972,0,0,5.98205383848455,26.0911111053846,PTPRJ;RAC1;LIMS1,alpha,3
cellular response to DNA damage stimulus (GO:0006974),18/330,18,330,0.00950402223362075,0.692843220830953,0,0,1.84899845916795,8.60901111303876,VCP;RFC2;USP3;MCM9;ZBTB1;CHD1L;ZBTB4;FOXO1;DDB1;CASP9;CUL4A;NIPBL;BCL2L11;APEX1;ERCC1;MMS19;TRIP12;CLOCK,alpha,3
positive regulation of phosphate metabolic process (GO:0045937),4/29,4,29,0.00991331346089662,0.692981350561034,0,0,4.67562828755114,21.5727720922841,SDCBP;PTGES3;ANG;MIF,alpha,3
vesicle-mediated transport (GO:0016192),21/411,21,411,0.0108647151657964,0.69303301863824,0,0,1.73203018681183,7.83264732639444,SNAP25;HSPA8;APLP2;USO1;AGAP1;VPS26B;SNX11;SNX30;BET1L;EHD1;ACAP3;ACTR1A;HEATR5A;VPS54;STX3;KIF1A;RAC1;STX2;ATP9B;SNX8;APPL1,alpha,3
negative regulation of cell cycle process (GO:0010948),7/82,7,82,0.0105963191688808,0.693243804087162,0,0,2.89375775113683,13.1586358432049,CDK9;RYBP;NME6;MDM2;EPC1;MIF;YAF2,alpha,3
miRNA metabolic process (GO:0010586),3/16,3,16,0.0107387128795603,0.693666478789825,0,0,6.35593220338983,28.817161275633,ZCCHC11;DICER1;RAN,alpha,3
regulation of ARF protein signal transduction (GO:0032012),4/31,4,31,0.0125401849835254,0.69557134751011,0,0,4.37397484964461,19.1528353959928,ACAP3;APLP2;AGAP1;APPL1,alpha,3
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",4/30,4,30,0.0111771395825097,0.695572479140816,0,0,4.51977401129944,20.3113432555336,CUL4A;DDB1;CHD1L;RAD23B,alpha,3
vesicle coating (GO:0006901),6/64,6,64,0.0113358425720759,0.696949453557872,0,0,3.17796610169492,14.2366069834377,SEC24A;SAR1B;PPP6R3;USO1;TRAPPC9;SEC31A,alpha,3
negative regulation of intracellular signal transduction (GO:1902532),11/162,11,162,0.00874191271052416,0.6970309462782,0,0,2.3017367650136,10.9093720326976,MAPKBP1;RNF34;PLEKHA1;DUSP1;PDE3B;DAG1;MDM2;PTPRJ;ARRB2;MARK3;ARNTL,alpha,3
negative regulation of cytoplasmic translation (GO:2000766),2/6,2,6,0.0120435409682678,0.698388517739437,0,0,11.2994350282486,49.9347658981472,CPEB3;CPEB2,alpha,3
RNA processing (GO:0006396),12/194,12,194,0.0127581321485415,0.70005105756997,0,0,2.09680237637603,9.14538471806477,HNRNPL;MAPKBP1;MBNL1;ZCCHC11;DHX9;RSRC1;DDX54;HNRNPR;SRSF4;DICER1;SRSF5;CDC40,alpha,3
protein polymerization (GO:0051258),5/46,5,46,0.0111124268306899,0.700082890333463,0,0,3.68459837877671,16.579555131093,GPX4;COBL;ANG;RAC1;WASF1,alpha,3
RNA 3'-end processing (GO:0031123),6/62,6,62,0.00976200245350267,0.701626739721467,0,0,3.28048113723346,15.1861926632649,ZCCHC11;CPSF7;PAPOLA;SRSF4;SRSF5;CDC40,alpha,3
RNA metabolic process (GO:0016070),12/192,12,192,0.0118270985281799,0.701787020805835,0,0,2.11864406779661,9.40119045543235,HNRNPL;DDX5;DDX24;POLR2A;DHX9;PAPOLA;LIG4;DDX54;DDX21;HNRNPR;DICER1;POLR2I,alpha,3
regulation of mRNA processing (GO:0050684),4/29,4,29,0.00991331346089662,0.702606091541048,0,0,4.67562828755114,21.5727720922841,SLTM;DHX9;PAPOLA;JMJD6,alpha,3
negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),2/6,2,6,0.0120435409682678,0.706415971966328,0,0,11.2994350282486,49.9347658981472,CLOCK;ARNTL,alpha,3
postreplication repair (GO:0006301),5/48,5,48,0.0132332587832615,0.710834942852458,0,0,3.53107344632768,15.2719703865807,POLD3;VCP;RFC2;ZBTB1;TMEM189-UBE2V1,alpha,3
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),16/292,16,292,0.0134269321895063,0.713725364198444,0,0,1.85744137450662,8.00648753046284,RNF44;VCP;RNF34;RNF38;ARRB2;ARNTL;DDB1;SPSB3;CUL4A;ZNRF2;PSMA1;TRIM13;MDM2;ANAPC5;RBCK1;CLOCK,alpha,3
mitochondrial calcium ion homeostasis (GO:0051560),3/19,3,19,0.0174062318315731,0.728065582266539,0,0,5.35236396074933,21.6820356055807,SLC8A3;FIS1;MCU,alpha,3
positive regulation of adherens junction organization (GO:1903393),3/19,3,19,0.0174062318315731,0.734082653194362,0,0,5.35236396074933,21.6820356055807,PTPRJ;RAC1;LIMS1,alpha,3
snRNA transcription from RNA polymerase II promoter (GO:0042795),6/71,6,71,0.0182480479403115,0.739045941582616,0,0,2.86464550011936,11.4691730728552,CDK9;POU2F1;POLR2A;POLR2I;ELL2;GTF2E2,alpha,3
positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),2/7,2,7,0.0165337442473666,0.740102604336069,0,0,9.68523002421307,39.7322216034561,PCID2;TPR,alpha,3
chromatin disassembly (GO:0031498),3/19,3,19,0.0174062318315731,0.740200008637648,0,0,5.35236396074933,21.6820356055807,SUPT16H;SMARCC2;ARID1A,alpha,3
snRNA transcription (GO:0009301),6/71,6,71,0.0182480479403115,0.744958309115277,0,0,2.86464550011936,11.4691730728552,CDK9;POU2F1;POLR2A;POLR2I;ELL2;GTF2E2,alpha,3
regulation of intracellular protein transport (GO:0033157),4/34,4,34,0.0172490257086413,0.745947272806749,0,0,3.98803589232303,16.191424198438,RUFY3;TPR;PCNT;NDEL1,alpha,3
nucleosome disassembly (GO:0006337),3/19,3,19,0.0174062318315731,0.74642017677746,0,0,5.35236396074933,21.6820356055807,SUPT16H;SMARCC2;ARID1A,alpha,3
regulation of glucocorticoid receptor signaling pathway (GO:2000322),2/7,2,7,0.0165337442473666,0.746652184905415,0,0,9.68523002421307,39.7322216034561,CLOCK;ARNTL,alpha,3
protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),6/71,6,71,0.0182480479403115,0.750966037414594,0,0,2.86464550011936,11.4691730728552,CUL4A;SPSB3;RNF19A;TRIP12;ARIH1;KLHL24,alpha,3
tRNA export from nucleus (GO:0006409),4/34,4,34,0.0172490257086413,0.752322890523046,0,0,3.98803589232303,16.191424198438,NUP214;NDC1;TPR;RAN,alpha,3
chromatin-mediated maintenance of transcription (GO:0048096),2/7,2,7,0.0165337442473666,0.753318722270641,0,0,9.68523002421307,39.7322216034561,ARID1A;ARID1B,alpha,3
cellular protein localization (GO:0034613),17/328,17,328,0.0181598462173861,0.753412156482287,0,0,1.75692434890451,7.04270570058472,CEP68;SYNRG;USO1;VPS26B;EHD1;NIPBL;RAB40C;ERP29;ARFIP1;STX3;LAMTOR1;TBC1D12;STX2;SNX8;VCL;SEC31A;TMED4,alpha,3
regulation of receptor-mediated endocytosis (GO:0048259),4/37,4,37,0.0229303746621806,0.754927109039405,0,0,3.66468163078333,13.8352463320466,HIP1;TNK2;RAC1;CBL,alpha,3
regulation of establishment of planar polarity (GO:0090175),7/90,7,90,0.0170621958096554,0.757116393188446,0,0,2.63653483992467,10.7330434046742,FZD3;PSMA1;DAAM1;DVL3;ARRB2;RAC1;RHOA,alpha,3
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),4/34,4,34,0.0172490257086413,0.758808432682727,0,0,3.98803589232303,16.191424198438,NUP214;NDC1;TPR;RAN,alpha,3
regulation of protein catabolic process (GO:0042176),7/92,7,92,0.0190368633387052,0.758946200136037,0,0,2.5792188651437,10.2172608793775,DDB1;VCP;EGLN2;MDM2;FOXO1;AZIN1;RNF41,alpha,3
actin polymerization or depolymerization (GO:0008154),4/37,4,37,0.0229303746621806,0.759829233124077,0,0,3.66468163078333,13.8352463320466,COBL;ANG;RAC1;WASF1,alpha,3
lymphatic endothelial cell differentiation (GO:0060836),2/7,2,7,0.0165337442473666,0.760105377426233,0,0,9.68523002421307,39.7322216034561,PROX1;ACVR2B,alpha,3
mitotic nuclear division (GO:0140014),6/75,6,75,0.0232746887353644,0.76135087574721,0,0,2.71186440677966,10.1976646217078,HIRA;SPAST;SPICE1;RHOA;RAN;NDEL1,alpha,3
transcription elongation from RNA polymerase II promoter (GO:0006368),7/96,7,96,0.023455657270218,0.762383560827532,0,0,2.47175141242938,9.27560203210456,CDK9;SUPT16H;PCID2;TAF15;POLR2A;POLR2I;GTF2E2,alpha,3
hepaticobiliary system development (GO:0061008),3/21,3,21,0.0228763785107096,0.762994506798372,0,0,4.84261501210654,18.2937065708137,NIPBL;COBL;PROX1,alpha,3
endoplasmic reticulum organization (GO:0007029),4/35,4,35,0.0190323536171162,0.764740948883022,0,0,3.87409200968523,15.347660730343,ATL3;TMCC1;TOR1B;SEC31A,alpha,3
pri-miRNA transcription from RNA polymerase II promoter (GO:0061614),2/7,2,7,0.0165337442473666,0.767015426311926,0,0,9.68523002421307,39.7322216034561,DDX5;ETS1,alpha,3
negative regulation of cell cycle arrest (GO:0071157),3/21,3,21,0.0228763785107096,0.768014207500993,0,0,4.84261501210654,18.2937065708137,CDK9;MDM2;MIF,alpha,3
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),20/397,20,397,0.0146404091999439,0.770206269559937,0,0,1.70772317807283,7.21337116513469,TNK2;NEDD9;PTPRJ;CBL;FRS3;GIGYF2;FOXO1;RHOA;SOCS2;SDCBP;POLR2A;CHN1;ELMO2;RAC1;POLR2I;ARHGEF7;PTPN2;APPL1;NCK1;EPHB3,alpha,3
nose development (GO:0043584),2/8,2,8,0.021618250804291,0.771454082897181,0,0,8.47457627118644,32.4933675967262,CHD7;PROX1,alpha,3
prostaglandin biosynthetic process (GO:0001516),3/18,3,18,0.0149801767550589,0.772160020010765,0,0,5.64971751412429,23.7346186528788,FAM213B;PTGES3;MIF,alpha,3
protein-DNA complex disassembly (GO:0032986),3/21,3,21,0.0228763785107096,0.773100394305635,0,0,4.84261501210654,18.2937065708137,SUPT16H;SMARCC2;ARID1A,alpha,3
positive regulation of lamellipodium morphogenesis (GO:2000394),2/7,2,7,0.0165337442473666,0.77405226508543,0,0,9.68523002421307,39.7322216034561,ARHGEF7;RREB1,alpha,3
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",7/89,7,89,0.0161311532004989,0.77657806398251,0,0,2.66615882689012,11.0032451977967,FZD3;PSMA1;DAAM1;DVL3;ARRB2;RAC1;RHOA,alpha,3
actin filament network formation (GO:0051639),2/8,2,8,0.021618250804291,0.776886858128852,0,0,8.47457627118644,32.4933675967262,ACTN1;COBL,alpha,3
protein modification by small protein removal (GO:0070646),14/262,14,262,0.0240709487371098,0.77743070509792,0,0,1.81135981368871,6.75048448324374,USP14;VCP;USP48;USP9X;USP3;USP11;USP34;ARRB2;RAD23B;RHOA;PSMA1;UIMC1;ASXL2;MDM2,alpha,3
regulation of peptide hormone secretion (GO:0090276),6/74,6,74,0.0219399752937529,0.777497874472367,0,0,2.74851122308749,10.4977873116392,PER2;SNAP25;CHD7;RFX3;CLOCK;ARNTL,alpha,3
vesicle docking (GO:0048278),3/21,3,21,0.0228763785107096,0.77825439693434,0,0,4.84261501210654,18.2937065708137,USO1;STX3;STX2,alpha,3
negative regulation of RNA splicing (GO:0033119),3/18,3,18,0.0149801767550589,0.780039203888426,0,0,5.64971751412429,23.7346186528788,SRSF4;TMBIM6;PTBP3,alpha,3
protein autoubiquitination (GO:0051865),5/50,5,50,0.0156113570025835,0.781027007688076,0,0,3.38983050847458,14.1008698868252,TRIM13;MDM2;KLHL24;MARCH5;RNF41,alpha,3
regulation of hormone biosynthetic process (GO:0046885),2/7,2,7,0.0165337442473666,0.781219415688072,0,0,9.68523002421307,39.7322216034561,EGR1;STC2,alpha,3
cytoskeletal anchoring at plasma membrane (GO:0007016),2/9,2,9,0.0272582110797002,0.781453096290505,0,0,7.53295668549906,27.136726773907,DAG1;TLN1,alpha,3
nuclear export (GO:0051168),7/93,7,93,0.0200818781153985,0.782273465823501,0,0,2.55148532895936,9.9710450877432,NUP214;CSE1L;TPR;SRSF4;SRSF5;CDC40;RAN,alpha,3
negative regulation of mRNA polyadenylation (GO:1900364),2/8,2,8,0.021618250804291,0.782396694002106,0,0,8.47457627118644,32.4933675967262,CDK9;RNF20,alpha,3
positive regulation of lamellipodium organization (GO:1902745),3/21,3,21,0.0228763785107096,0.783477580806382,0,0,4.84261501210654,18.2937065708137,RAC1;ARHGEF7;RREB1,alpha,3
negative regulation of translation (GO:0017148),7/89,7,89,0.0161311532004989,0.783974045544248,0,0,2.66615882689012,11.0032451977967,NCL;DAPK3;TPR;EIF4E2;CPEB3;CPEB2;GIGYF2,alpha,3
protein hexamerization (GO:0034214),2/9,2,9,0.0272582110797002,0.785868085535084,0,0,7.53295668549906,27.136726773907,SPAST;MAT2A,alpha,3
entrainment of circadian clock by photoperiod (GO:0043153),3/20,3,20,0.0200380487936654,0.786570484569805,0,0,5.08474576271186,19.8819781682612,PPP1CB;PER2;BHLHE40,alpha,3
positive regulation of dendrite development (GO:1900006),4/33,4,33,0.015573885552314,0.786866712608496,0,0,4.10888546481767,17.1018377832243,NLGN1;COBL;VLDLR;CPEB3,alpha,3
"DNA-templated transcription, elongation (GO:0006354)",8/109,8,109,0.0154198395898947,0.786874414272328,0,0,2.48794899704556,10.3799727908733,CDK9;SUPT16H;PCID2;TAF15;POLR2A;UBTF;POLR2I;GTF2E2,alpha,3
positive regulation of spindle checkpoint (GO:0090232),2/8,2,8,0.021618250804291,0.787985241816407,0,0,8.47457627118644,32.4933675967262,PCID2;TPR,alpha,3
venous blood vessel development (GO:0060841),2/7,2,7,0.0165337442473666,0.78852053172254,0,0,9.68523002421307,39.7322216034561,PROX1;ACVR2B,alpha,3
establishment of spindle orientation (GO:0051294),3/21,3,21,0.0228763785107096,0.788771348244263,0,0,4.84261501210654,18.2937065708137,MAP4;NDEL1;LLGL2,alpha,3
Golgi vesicle budding (GO:0048194),2/9,2,9,0.0272582110797002,0.790333245111988,0,0,7.53295668549906,27.136726773907,GOLPH3;SEC31A,alpha,3
protein ubiquitination (GO:0016567),24/507,24,507,0.016125291242055,0.79122462700199,0,0,1.60465349513589,6.62299284716175,RNF20;RNF44;VCP;RNF34;USP9X;RNF38;KLHL23;ARRB2;KLHL24;FBXL13;CBL;MARCH5;RNF41;DDB1;SPSB3;CUL4A;ZNRF2;PSMA1;RNF19A;MDM2;TRIM13;TRIP12;RBCK1;ARIH1,alpha,3
regulation of cell development (GO:0060284),3/20,3,20,0.0200380487936654,0.792667930186625,0,0,5.08474576271186,19.8819781682612,PER2;CLOCK;ARNTL,alpha,3
negative regulation of execution phase of apoptosis (GO:1900118),2/8,2,8,0.021618250804291,0.793654200390625,0,0,8.47457627118644,32.4933675967262,FZD3;RNF34,alpha,3
phospholipid biosynthetic process (GO:0008654),4/38,4,38,0.0250479805930874,0.793912080537424,0,0,3.56824264049955,13.1559752711766,IDI1;SGMS1;SGMS2;FADS1,alpha,3
mRNA transcription (GO:0009299),3/21,3,21,0.0228763785107096,0.794137139728918,0,0,4.84261501210654,18.2937065708137,DDX5;ZBTB1;ATF4,alpha,3
cytosolic transport (GO:0016482),8/119,8,119,0.0247511847664684,0.794372929957789,0,0,2.27887765275602,8.4292993516841,DOPEY1;WDR81;HEATR5A;AP1G1;VPS13C;VPS54;VPS26B;BET1L,alpha,3
COPII-coated vesicle budding (GO:0090114),6/69,6,69,0.016038046299479,0.794583983167393,0,0,2.94767870302137,12.1821414465448,SEC24A;SAR1B;PPP6R3;USO1;TRAPPC9;SEC31A,alpha,3
regulation of skeletal muscle cell differentiation (GO:2001014),2/9,2,9,0.0272582110797002,0.794849435084056,0,0,7.53295668549906,27.136726773907,DDX5;ARNTL,alpha,3
chromatin remodeling (GO:0006338),8/117,8,117,0.022630224202885,0.796427821429807,0,0,2.3178328263074,8.78103760580723,SMARCC2;BAHD1;ZBTB1;UBTF;CHD4;CHD1L;ARID1A;ARID1B,alpha,3
gene expression (GO:0010467),20/412,20,412,0.0209260283730253,0.796906886474239,0,0,1.64554879052164,6.36294473942721,NUP214;NDC1;ZBTB25;DHX9;DDX54;NR3C1;CDC40;MRPL55;HNRNPL;TSPAN14;GOLPH3;POLR2A;TPR;NHP2;EPC1;RPL27;MMS19;SRSF4;SRSF5;POLR2I,alpha,3
regulation of DNA repair (GO:0006282),4/38,4,38,0.0250479805930874,0.798874031040783,0,0,3.56824264049955,13.1559752711766,CDK9;DHX9;UIMC1;TRIP12,alpha,3
cytoskeletal anchoring at nuclear membrane (GO:0090286),2/8,2,8,0.021618250804291,0.79940531778476,0,0,8.47457627118644,32.4933675967262,SUN2;SPAG4,alpha,3
negative regulation of protein exit from endoplasmic reticulum (GO:0070862),2/9,2,9,0.0272582110797002,0.799417535285689,0,0,7.53295668549906,27.136726773907,INSIG1;UBAC2,alpha,3
positive regulation of transcription from RNA polymerase I promoter (GO:0045943),3/21,3,21,0.0228763785107096,0.799576435206513,0,0,4.84261501210654,18.2937065708137,NCL;UBTF;ATF4,alpha,3
neutrophil degranulation (GO:0043312),22/480,22,480,0.028310773854645,0.802610438779187,0,0,1.55367231638418,5.53808492898902,SNAP25;HSPA8;ASAH1;VCP;ADAM10;PDAP1;PTPRJ;MIF;DYNLL1;APEH;RHOA;ALAD;SDCBP;TSPAN14;ACTR1B;SIRPA;CYSTM1;LTA4H;LAMTOR1;RAC1;CD47;VCL,alpha,3
tRNA transport (GO:0051031),4/36,4,36,0.0209256187566814,0.802882951243198,0,0,3.76647834274953,14.5641472423051,NUP214;NDC1;TPR;RAN,alpha,3
chordate embryonic development (GO:0043009),5/57,5,57,0.026122841254399,0.803041318802398,0,0,2.97353553374963,10.8383740812426,MBNL1;CHD7;LIG4;ADAM10;PROX1,alpha,3
cellular protein complex assembly (GO:0043623),9/145,9,145,0.0281980924951727,0.803881932976908,0,0,2.10403272939801,7.50824278388531,NDC1;HIP1;GPX4;DNAAF2;PTGES3;POGZ;CLTB;EIF4B;NCK1,alpha,3
maintenance of protein localization in endoplasmic reticulum (GO:0035437),2/9,2,9,0.0272582110797002,0.804038445894277,0,0,7.53295668549906,27.136726773907,RER1;INSIG1,alpha,3
positive regulation of cell junction assembly (GO:1901890),3/23,3,23,0.0291723218804736,0.804683019221929,0,0,4.42151805453206,15.6280098748859,PTPRJ;RAC1;LIMS1,alpha,3
4-hydroxyproline metabolic process (GO:0019471),2/8,2,8,0.021618250804291,0.805240393097058,0,0,8.47457627118644,32.4933675967262,EGLN3;EGLN2,alpha,3
DNA-dependent DNA replication (GO:0006261),5/57,5,57,0.026122841254399,0.807908235886049,0,0,2.97353553374963,10.8383740812426,PURA;CDC45;RFC2;ORC2;CDK2AP1,alpha,3
intracellular protein transport (GO:0006886),17/348,17,348,0.0299280929013654,0.808058508336867,0,0,1.65595168517436,5.81066437972355,NUP214;NLGN1;SYNRG;CSE1L;USO1;VPS26B;EHD1;RAB40C;ERP29;ARFIP1;STX3;TBC1D12;STX2;SNX8;RAN;SEC31A;TMED4,alpha,3
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),5/59,5,59,0.0297901230228317,0.808611690348459,0,0,2.87273771904625,10.0935891485112,RAC1;ARHGEF7;RREB1;RHOA;LIMS1,alpha,3
regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),2/9,2,9,0.0272582110797002,0.808713088021569,0,0,7.53295668549906,27.136726773907,HIP1;PTPN2,alpha,3
negative regulation of protein kinase B signaling (GO:0051898),4/36,4,36,0.0209256187566814,0.808965397843525,0,0,3.76647834274953,14.5641472423051,PLEKHA1;DAG1;PTPRJ;ARRB2,alpha,3
maturation of LSU-rRNA (GO:0000470),3/23,3,23,0.0291723218804736,0.80905629650031,0,0,4.42151805453206,15.6280098748859,WDR37;RPL7L1;NHP2,alpha,3
protein deubiquitination (GO:0016579),14/258,14,258,0.02143693032859,0.810315966420702,0,0,1.83944291157535,7.06831714518926,USP14;VCP;USP48;USP9X;USP3;USP11;USP34;ARRB2;RAD23B;RHOA;PSMA1;UIMC1;ASXL2;MDM2,alpha,3
positive regulation of mitochondrial calcium ion concentration (GO:0051561),2/8,2,8,0.021618250804291,0.811161278340419,0,0,8.47457627118644,32.4933675967262,FIS1;MCU,alpha,3
positive regulation of nucleic acid-templated transcription (GO:1903508),23/503,23,503,0.0259619728272234,0.8127849529897,0,0,1.5500219024834,5.65931968112765,RNF20;EGR1;PCID2;DDX5;ZFHX3;SMARCC2;TAF15;RFX3;PROX1;ARID1A;ETS1;FOXO1;ARNTL;RYBP;DVL3;EPC1;TASP1;MMS19;CLOCK;RREB1;YAF2;RAN;ATF4,alpha,3
regulation of proteasomal protein catabolic process (GO:0061136),4/40,4,40,0.0296262222755436,0.81280974339838,0,0,3.38983050847458,11.9291370241754,ALAD;USP14;GNA12;RAD23B,alpha,3
chromosome organization (GO:0051276),5/57,5,57,0.026122841254399,0.812834505617061,0,0,2.97353553374963,10.8383740812426,DDB1;CUL4A;H3F3A;LIG4;RAD23B,alpha,3
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),5/59,5,59,0.0297901230228317,0.812935817034814,0,0,2.87273771904625,10.0935891485112,HIP1;PTPRJ;ARHGEF7;CBL;PTPN2,alpha,3
negative regulation of mRNA 3'-end processing (GO:0031441),2/9,2,9,0.0272582110797002,0.813442404325789,0,0,7.53295668549906,27.136726773907,CDK9;RNF20,alpha,3
"nucleotide-excision repair, DNA damage recognition (GO:0000715)",3/23,3,23,0.0291723218804736,0.813477369158781,0,0,4.42151805453206,15.6280098748859,CUL4A;DDB1;RAD23B,alpha,3
protein homooligomerization (GO:0051260),11/191,11,191,0.0266221932493807,0.813491330249039,0,0,1.95225840802201,7.0789086630763,EHD1;ALAD;FIS1;NLGN1;SPAST;ATL3;ZBTB1;TYSND1;MIF;TMCC1;TOR1B,alpha,3
negative regulation of response to endoplasmic reticulum stress (GO:1903573),3/22,3,22,0.0259213100704717,0.816521267219858,0,0,4.62249614791988,16.8845448348214,CREB3;TMBIM6;NCK1,alpha,3
"nucleotide-excision repair, DNA gap filling (GO:0006297)",3/23,3,23,0.0291723218804736,0.81794702503328,0,0,4.42151805453206,15.6280098748859,POLD3;RFC2;LIG4,alpha,3
small RNA loading onto RISC (GO:0070922),2/9,2,9,0.0272582110797002,0.818227359645352,0,0,7.53295668549906,27.136726773907,DHX9;DICER1,alpha,3
actin filament organization (GO:0007015),8/121,8,121,0.0270074086165918,0.820350036728977,0,0,2.24121025353691,8.09445369359212,HIP1;ACTN1;RUFY3;COBL;NEDD9;RAC1;PROX1;RHOA,alpha,3
regulation of insulin secretion (GO:0050796),7/99,7,99,0.027200750736324,0.821333911286754,0,0,2.39684985447697,8.63947095984472,PER2;SNAP25;CAPN10;RFX3;CLOCK;MCU;ARNTL,alpha,3
chromosome condensation (GO:0030261),3/23,3,23,0.0291723218804736,0.82246606937048,0,0,4.42151805453206,15.6280098748859,NIPBL;PHF13;NCAPD3,alpha,3
neutrophil activation involved in immune response (GO:0002283),22/484,22,484,0.0306456299967368,0.823077104596568,0,0,1.54083204930663,5.37020832721002,SNAP25;HSPA8;ASAH1;VCP;ADAM10;PDAP1;PTPRJ;MIF;DYNLL1;APEH;RHOA;ALAD;SDCBP;TSPAN14;ACTR1B;SIRPA;CYSTM1;LTA4H;LAMTOR1;RAC1;CD47;VCL,alpha,3
protein-cofactor linkage (GO:0018065),2/10,2,10,0.0334165437154324,0.848381206864932,0,0,6.77966101694915,23.042062242773,LIPT2;SDHAF2,alpha,3
regulation of cellular metabolic process (GO:0031323),4/42,4,42,0.0346674301562603,0.850518731189405,0,0,3.22841000807103,10.8537680226412,RNF34;CACYBP;LAMTOR1;RNF41,alpha,3
positive regulation of circadian rhythm (GO:0042753),2/10,2,10,0.0334165437154324,0.852623112899257,0,0,6.77966101694915,23.042062242773,NLGN1;ARNTL,alpha,3
regulation of protein dephosphorylation (GO:0035304),4/41,4,41,0.032088627913052,0.852855563751585,0,0,3.30715171558495,11.3741333848243,PPP1R14C;SMPD1;PPP6R3;CALM2,alpha,3
"regulation of mRNA splicing, via spliceosome (GO:0048024)",5/61,5,61,0.0337662385061509,0.853015421271722,0,0,2.77854959711031,9.41454247416446,HNRNPL;MBNL1;DDX5;SRSF4;JMJD6,alpha,3
positive regulation of viral transcription (GO:0050434),4/42,4,42,0.0346674301562603,0.854627517330417,0,0,3.22841000807103,10.8537680226412,CDK9;POLR2A;DHX9;POLR2I,alpha,3
protein transport (GO:0015031),16/327,16,327,0.0340222954892074,0.85525011764249,0,0,1.65863266469704,5.6074045004398,NDC1;SYNRG;USO1;VPS26B;VLDLR;EHD1;GOLPH3;RAB40C;ERP29;ARFIP1;STX3;TBC1D12;STX2;SNX8;SEC31A;TMED4,alpha,3
positive regulation of natural killer cell activation (GO:0032816),2/10,2,10,0.0334165437154324,0.856907651155032,0,0,6.77966101694915,23.042062242773,AP1G1;ZBTB1,alpha,3
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),3/25,3,25,0.0362877333837205,0.857297701190396,0,0,4.06779661016949,13.4899343110526,USP14;SDCBP;RYBP,alpha,3
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),4/41,4,41,0.032088627913052,0.857320776127248,0,0,3.30715171558495,11.3741333848243,PTPRJ;CBL;ARHGEF7;PTPN2,alpha,3
regulation of substrate adhesion-dependent cell spreading (GO:1900024),4/42,4,42,0.0346674301562603,0.858776194599011,0,0,3.22841000807103,10.8537680226412,RAC1;ARHGEF7;RREB1;LIMS1,alpha,3
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),2/10,2,10,0.0334165437154324,0.861235467575007,0,0,6.77966101694915,23.042062242773,PAGR1;BUD31,alpha,3
DNA replication initiation (GO:0006270),3/25,3,25,0.0362877333837205,0.861285132358723,0,0,4.06779661016949,13.4899343110526,PURA;CDC45;ORC2,alpha,3
telomere organization (GO:0032200),4/42,4,42,0.0346674301562603,0.862965346767787,0,0,3.22841000807103,10.8537680226412,POLD3;PTGES3;APEX1;H3F3A,alpha,3
ephrin receptor signaling pathway (GO:0048013),6/83,6,83,0.0359365663693502,0.865020274447142,0,0,2.45047988564427,8.1502959527458,SDCBP;CHN1;RAC1;ARHGEF7;RHOA;EPHB3,alpha,3
regulation of chemotaxis (GO:0050920),3/25,3,25,0.0362877333837205,0.865309829238904,0,0,4.06779661016949,13.4899343110526,USP14;STX3;PTPN2,alpha,3
establishment of spindle localization (GO:0051293),2/10,2,10,0.0334165437154324,0.86560722121752,0,0,6.77966101694915,23.042062242773,MAP4;LLGL2,alpha,3
regulation of cholesterol metabolic process (GO:0090181),4/42,4,42,0.0346674301562603,0.867195569055864,0,0,3.22841000807103,10.8537680226412,IDI1;ARV1;SCD;RAN,alpha,3
negative regulation of ERBB signaling pathway (GO:1901185),4/44,4,44,0.0401757738338275,0.868715990991617,0,0,3.08166409861325,9.90598183657249,PTPRJ;CBL;ARHGEF7;PTPN2,alpha,3
mitotic sister chromatid segregation (GO:0000070),6/83,6,83,0.0359365663693502,0.86911989660092,0,0,2.45047988564427,8.1502959527458,HIRA;NIPBL;POGZ;PHF13;NCAPD3;RAN,alpha,3
histone monoubiquitination (GO:0010390),3/25,3,25,0.0362877333837205,0.86937231670012,0,0,4.06779661016949,13.4899343110526,RNF20;DDB1;RYBP,alpha,3
regulation of cytoplasmic translational elongation (GO:1900247),2/10,2,10,0.0334165437154324,0.870023584591079,0,0,6.77966101694915,23.042062242773,CPEB3;CPEB2,alpha,3
actin cytoskeleton reorganization (GO:0031532),5/62,5,62,0.035871875858922,0.871686583371806,0,0,2.73373428102788,9.09732556797772,CAPN10;NEDD9;RAC1;CDC42BPB;RHOA,alpha,3
peptidyl-tyrosine dephosphorylation (GO:0035335),3/26,3,26,0.0401484576665248,0.871819487116069,0,0,3.91134289439374,12.5756372370686,DUSP1;PTPRJ;PTPN2,alpha,3
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),2/10,2,10,0.0334165437154324,0.874485243999238,0,0,6.77966101694915,23.042062242773,ARFIP1;WASF1,alpha,3
regulation of translational initiation (GO:0006446),5/63,5,63,0.0380566876942823,0.874789537405057,0,0,2.69034167339252,8.79386184941569,EIF5;TPR;EIF4B;NCK1;EIF3B,alpha,3
negative regulation of locomotion (GO:0040013),3/26,3,26,0.0401484576665248,0.875545211419984,0,0,3.91134289439374,12.5756372370686,TRIM8;TRIM13;PTPN2,alpha,3
regulation of cellular response to stress (GO:0080135),7/105,7,105,0.0358661570771618,0.875717701266779,0,0,2.25988700564972,7.52081610826965,NUP214;CASP9;NDC1;HSPA8;PTGES3;TPR;ARNTL,alpha,3
neutrophil mediated immunity (GO:0002446),22/488,22,488,0.0331230850256678,0.875788097854834,0,0,1.52820227841067,5.20738717363434,SNAP25;HSPA8;ASAH1;VCP;ADAM10;PDAP1;PTPRJ;MIF;DYNLL1;APEH;RHOA;ALAD;SDCBP;TSPAN14;ACTR1B;SIRPA;CYSTM1;LTA4H;LAMTOR1;RAC1;CD47;VCL,alpha,3
protein maturation (GO:0051604),6/84,6,84,0.0377770875961038,0.876256718195081,0,0,2.42130750605327,7.9323305287892,LIPT2;TSPAN14;TYSND1;MMS19;PCSK7;PCSK4,alpha,3
mRNA export from nucleus (GO:0006406),7/106,7,106,0.0374685733374676,0.87707398963806,0,0,2.23856731691717,7.35202084805503,NUP214;NDC1;PCID2;TPR;SRSF4;SRSF5;CDC40,alpha,3
translesion synthesis (GO:0019985),4/43,4,43,0.0373630599104027,0.878634537893019,0,0,3.15333070555775,10.3652274831439,POLD3;VCP;RFC2;ZBTB1,alpha,3
positive regulation of catabolic process (GO:0009896),5/63,5,63,0.0380566876942823,0.878747861103723,0,0,2.69034167339252,8.79386184941569,DDB1;VCP;EGLN2;FOXO1;RNF41,alpha,3
regulation of chromatin organization (GO:1902275),2/10,2,10,0.0334165437154324,0.878992899896141,0,0,6.77966101694915,23.042062242773,CDK9;HIRA,alpha,3
negative regulation of insulin receptor signaling pathway (GO:0046627),3/26,3,26,0.0401484576665248,0.879302916190027,0,0,3.91134289439374,12.5756372370686,SOCS2;PTPN2;NCK1,alpha,3
regulation of cell growth (GO:0001558),11/202,11,202,0.0377454845642727,0.879521496490792,0,0,1.84594730659507,6.04896520741097,SOCS2;DNAJB2;SDCBP;EGLN2;CDKN2C;NME6;SERTAD2;H3F3A;ADAM10;PTPRJ;LAMTOR1,alpha,3
regulation of viral release from host cell (GO:1902186),3/26,3,26,0.0401484576665248,0.883093014966708,0,0,3.91134289439374,12.5756372370686,TRIM8;DDB1;TRIM13,alpha,3
"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",3/26,3,26,0.0401484576665248,0.886915928451412,0,0,3.91134289439374,12.5756372370686,DDX5;MDM2;MIF,alpha,3
prostaglandin metabolic process (GO:0006693),3/26,3,26,0.0401484576665248,0.89077208466207,0,0,3.91134289439374,12.5756372370686,FAM213B;PTGES3;MIF,alpha,3
regulation of chromatin silencing (GO:0031935),2/11,2,11,0.0400578653271666,0.892643173644242,0,0,6.1633281972265,19.8300785026488,HIRA;CDC45,alpha,3
"DNA-templated transcription, termination (GO:0006353)",7/107,7,107,0.0391173578818619,0.895138463099287,0,0,2.21764612703944,7.18781017719787,CPSF7;POLR2A;PAPOLA;UBTF;SRSF4;SRSF5;CDC40,alpha,3
negative regulation of cardiac muscle hypertrophy (GO:0010614),2/11,2,11,0.0400578653271666,0.896558275283032,0,0,6.1633281972265,19.8300785026488,P2RX4;FOXO1,alpha,3
icosanoid biosynthetic process (GO:0046456),2/11,2,11,0.0400578653271666,0.900507871209389,0,0,6.1633281972265,19.8300785026488,LTA4H;FADS1,alpha,3
UV-damage excision repair (GO:0070914),2/11,2,11,0.0400578653271666,0.904492419312086,0,0,6.1633281972265,19.8300785026488,DDB1;ERCC1,alpha,3
regulation of lamellipodium morphogenesis (GO:2000392),2/11,2,11,0.0400578653271666,0.908512385620139,0,0,6.1633281972265,19.8300785026488,ARHGEF7;RREB1,alpha,3
regulation of hippo signaling (GO:0035330),2/11,2,11,0.0400578653271666,0.912568244484515,0,0,6.1633281972265,19.8300785026488,NEK8;MARK3,alpha,3
regulation of steroid biosynthetic process (GO:0050810),4/45,4,45,0.0431056588449289,0.916534071190301,0,0,3.01318267419962,9.47375064341983,IDI1;EGR1;SCD;RAN,alpha,3
ER to Golgi vesicle-mediated transport (GO:0006888),10/181,10,181,0.0425819840966853,0.916860189221034,0,0,1.87283453506883,5.91127263542721,ACTR1A;SPAST;SEC24A;SAR1B;USO1;DYNLL1;BET1L;YIF1A;SEC31A;TMED4,alpha,3
mitotic nuclear envelope disassembly (GO:0007077),4/45,4,45,0.0431056588449289,0.920368941781056,0,0,3.01318267419962,9.47375064341983,NUP214;NDC1;TPR;EMD,alpha,3
microtubule cytoskeleton organization involved in mitosis (GO:1902850),4/45,4,45,0.0431056588449289,0.924236038175094,0,0,3.01318267419962,9.47375064341983,SUN2;MAP4;PCNT;RAN,alpha,3
negative regulation of cellular response to insulin stimulus (GO:1900077),3/27,3,27,0.0442079950735508,0.928367896544566,0,0,3.76647834274953,11.7470795564559,SOCS2;PTPN2;NCK1,alpha,3
response to gamma radiation (GO:0010332),3/27,3,27,0.0442079950735508,0.932204127522023,0,0,3.76647834274953,11.7470795564559,MDM2;TRIM13;LIG4,alpha,3
cytoskeleton-dependent intracellular transport (GO:0030705),3/27,3,27,0.0442079950735508,0.936072194441202,0,0,3.76647834274953,11.7470795564559,TUBA1B;KIF1A;DYNLL1,alpha,3
"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",2/12,2,12,0.0471484228948795,0.943523145225764,0,0,5.64971751412429,17.2568063228197,MDM2;MIF,alpha,3
cargo loading into COPII-coated vesicle (GO:0090110),2/12,2,12,0.0471484228948795,0.947237803277834,0,0,5.64971751412429,17.2568063228197,SEC24A;SEC31A,alpha,3
intracellular steroid hormone receptor signaling pathway (GO:0030518),5/67,5,67,0.0475964246324734,0.948767792576218,0,0,2.52972426005565,7.7030043848445,DDX5;EGLN2;DDX54;ARID1A;RAN,alpha,3
positive regulation of ruffle assembly (GO:1900029),2/12,2,12,0.0471484228948795,0.950981826215691,0,0,5.64971751412429,17.2568063228197,NLGN1;NDEL1,alpha,3
"alternative mRNA splicing, via spliceosome (GO:0000380)",2/12,2,12,0.0471484228948795,0.954755563621309,0,0,5.64971751412429,17.2568063228197,DDX5;DHX9,alpha,3
positive regulation of cellular component biogenesis (GO:0044089),6/88,6,88,0.0457343635463051,0.956485480232765,0,0,2.31124807395994,7.12998149327305,SDCBP;NLGN1;VCP;ERCC1;TPR;EPHB3,alpha,3
positive regulation of phosphorylation (GO:0042327),11/209,11,209,0.0463169958683918,0.956905384276936,0,0,1.78412132024978,5.48126013177001,SDCBP;VCP;LMO4;PTGES3;ERP29;DVL3;CDK2AP1;ANG;MIF;RAC1;EPHB3,alpha,3
nucleus organization (GO:0006997),4/46,4,46,0.0461526369334883,0.957385797851996,0,0,2.94767870302137,9.06647363697912,NDC1;SUN2;TPR;SPAG4,alpha,3
regulation of histone methylation (GO:0031060),2/12,2,12,0.0471484228948795,0.958559370647689,0,0,5.64971751412429,17.2568063228197,JARID2;PRDM10,alpha,3
positive regulation of blood vessel endothelial cell migration (GO:0043536),4/46,4,46,0.0461526369334883,0.961293494986085,0,0,2.94767870302137,9.06647363697912,P2RX4;AKT3;PLCG1;ETS1,alpha,3
negative regulation of ERAD pathway (GO:1904293),2/12,2,12,0.0471484228948795,0.962393608130279,0,0,5.64971751412429,17.2568063228197,USP14;UBAC2,alpha,3
negative regulation of cellular process (GO:0048523),23/535,23,535,0.0468181923888542,0.963359821614205,0,0,1.45731031205449,4.46153136592525,CDKN2C;PPP1R13B;VPS13C;ACTN1;PDE3B;ADAM10;PARP16;PTPRJ;MIF;PROX1;MARCH5;ETS1;RNF41;DNAJB2;CUL4A;MNT;NME6;CAMK2N1;SERTAD2;BHLHE40;TMBIM6;PTPN2;NCK1,alpha,3
regulation of IRE1-mediated unfolded protein response (GO:1903894),2/12,2,12,0.0471484228948795,0.966258642701084,0,0,5.64971751412429,17.2568063228197,BCL2L11;FICD,alpha,3
regulation of cellular component movement (GO:0051270),4/47,4,47,0.0493164701252957,0.971667749225421,0,0,2.88496213487198,8.68228539229733,ACTN1;DAPK3;ETS1;RHOA,alpha,3
regulation of fibroblast proliferation (GO:0048145),4/47,4,47,0.0493164701252957,0.975433903292186,0,0,2.88496213487198,8.68228539229733,DHX9;LIG4;MIF;EMD,alpha,3
cellular response to UV (GO:0034644),5/68,5,68,0.0501830006308174,0.97741928327886,0,0,2.49252243270189,7.45782388456069,CASP9;DDB1;ERCC1;ZBTB1;ATF4,alpha,3
nuclear envelope disassembly (GO:0051081),4/47,4,47,0.0493164701252957,0.97922936595091,0,0,2.88496213487198,8.68228539229733,NUP214;NDC1;TPR;EMD,alpha,3
protein modification by small protein conjugation (GO:0032446),18/399,18,399,0.0501084321654126,0.979706242682376,0,0,1.52924684592838,4.57790133048315,NUP214;NDC1;RNF20;RNF44;VCP;RNF34;USP9X;RNF38;KLHL23;ARRB2;KLHL24;CBL;DDB1;CUL4A;TPR;MDM2;TRIP12;ARIH1,alpha,3
negative regulation of cellular protein metabolic process (GO:0032269),6/90,6,90,0.0500752273089167,0.982822634451546,0,0,2.25988700564972,6.76661888829667,CAMK2N1;NCL;DAPK3;EIF4E2;CPEB3;GIGYF2,alpha,3
positive regulation of fibroblast proliferation (GO:0048146),3/29,3,29,0.0529115405961718,0.989038797297672,0,0,3.50672121566336,10.3067228703445,DHX9;LIG4;MIF,alpha,3
protein export from nucleus (GO:0006611),3/29,3,29,0.0529115405961718,0.99267496934656,0,0,3.50672121566336,10.3067228703445,NUP214;CSE1L;RAN,alpha,3
pre-miRNA processing (GO:0031054),2/13,2,13,0.0546560286169915,0.99610612154467,0,0,5.21512385919166,15.1587783949541,ZCCHC11;DICER1,alpha,3
negative regulation of proteasomal protein catabolic process (GO:1901799),3/29,3,29,0.0529115405961718,0.996337976613522,0,0,3.50672121566336,10.3067228703445,ALAD;SDCBP;RYBP,alpha,3
endothelial cell differentiation (GO:0045446),2/13,2,13,0.0546560286169915,0.999676394381748,0,0,5.21512385919166,15.1587783949541,PROX1;ACVR2B,alpha,3
positive regulation of gene expression (GO:0010628),31/772,31,772,0.0517315445500075,1,0,0,1.36120136998331,4.03145313350234,DDX5;DDX21;ETS1;FOXO1;ARNTL;POLR2A;CAMK2N1;DVL3;EPC1;TASP1;RREB1;YAF2;RNF20;EGR1;PCID2;ZFHX3;SMARCC2;TAF15;H3F3A;RFX3;BRAF;PROX1;ARID1A;RYBP;ERP29;MMS19;CPEB3;CLOCK;RAN;ATF4;LIMS1,alpha,3
positive regulation of canonical Wnt signaling pathway (GO:0090263),7/114,7,114,0.0519867704318398,1,0,0,2.08147487362474,6.15443415188631,VCP;PSMA1;WNK1;DAPK3;USP34;TMEM198;ARNTL,alpha,3
cell-matrix adhesion (GO:0007160),6/91,6,91,0.0523372078146432,1,0,0,2.23505308251071,6.59351327331196,ACTN1;PPFIA1;RAC1;ARHGEF7;VCL;TMEM8B,alpha,3
"positive regulation of gene expression, epigenetic (GO:0045815)",4/48,4,48,0.0525967656113311,1,0,0,2.82485875706215,8.31949336555919,H3F3A;DDX21;ARID1A;ARID1B,alpha,3
fatty acid biosynthetic process (GO:0006633),4/48,4,48,0.0525967656113311,1,0,0,2.82485875706215,8.31949336555919,ABCD3;SCD;TECR;FADS1,alpha,3
termination of RNA polymerase II transcription (GO:0006369),5/69,5,69,0.0528505777457801,1,0,0,2.45639891918448,7.22251691211693,CPSF7;PAPOLA;SRSF4;SRSF5;CDC40,alpha,3
positive regulation of T cell activation (GO:0050870),5/69,5,69,0.0528505777457801,1,0,0,2.45639891918448,7.22251691211693,FAM49B;ZBTB1;SIRPA;CD47;NCK1,alpha,3
RNA phosphodiester bond hydrolysis (GO:0090501),3/29,3,29,0.0529115405961718,1,0,0,3.50672121566336,10.3067228703445,NHP2;RNASE4;DICER1,alpha,3
regulation of GTPase activity (GO:0043087),10/189,10,189,0.0541456681408188,1,0,0,1.79356111559501,5.23016286635202,FGD6;FICD;CHN1;DVL3;ARHGEF7;CPEB2;RGS7;EPHB3;NDEL1;LIMS1,alpha,3
alpha-linolenic acid metabolic process (GO:0036109),2/13,2,13,0.0546560286169915,1,0,0,5.21512385919166,15.1587783949541,FADS2;FADS1,alpha,3
negative regulation of viral release from host cell (GO:1902187),2/13,2,13,0.0546560286169915,1,0,0,5.21512385919166,15.1587783949541,TRIM8;TRIM13,alpha,3
establishment of chromosome localization (GO:0051303),2/13,2,13,0.0546560286169915,1,0,0,5.21512385919166,15.1587783949541,SPICE1;NDEL1,alpha,3
RNA interference (GO:0016246),2/13,2,13,0.0546560286169915,1,0,0,5.21512385919166,15.1587783949541,DHX9;DICER1,alpha,3
plasma membrane bounded cell projection assembly (GO:0120031),12/242,12,242,0.0559481517875775,1,0,0,1.68090769015268,4.84661136527314,EHD1;SDCBP;GOLPH3;FGD6;TMEM138;IFT172;RFX3;RAC1;DYNLL1;ARHGEF7;PCNT;VCL,alpha,3
regulation of cellular macromolecule biosynthetic process (GO:2000112),26/632,26,632,0.0560231107837522,1,0,0,1.39455052563828,4.01908203717913,NAB1;CHD7;NR3C1;ARNTL;POLR2A;NFIL3;POFUT1;UBTF;RREB1;FADS1;ZNF860;ESRRA;RNF20;ZFHX3;ESCO1;USP3;DAPK3;TFEB;RFX3;ZNF34;GLRX2;ACVR2B;BHLHE40;ZNF436;CLOCK;ATF4,alpha,3
regulation of striated muscle contraction (GO:0006942),3/30,3,30,0.0575487017605141,1,0,0,3.38983050847458,9.6783854323073,SLC8A3;P2RX4;CALM2,alpha,3
regulation of embryonic development (GO:0045995),3/30,3,30,0.0575487017605141,1,0,0,3.38983050847458,9.6783854323073,NIPBL;DAG1;TRIP12,alpha,3
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),3/30,3,30,0.0575487017605141,1,0,0,3.38983050847458,9.6783854323073,ZCCHC11;CNOT11;EIF4B,alpha,3
sphingolipid metabolic process (GO:0006665),7/117,7,117,0.0582289881818588,1,0,0,2.02810372301898,5.76665327730865,FUT5;ARV1;ASAH1;SGMS1;SMPD1;SGMS2;SGPP1,alpha,3
positive regulation of endothelial cell migration (GO:0010595),5/71,5,71,0.0584288338939811,1,0,0,2.3872045834328,6.77953158255362,P2RX4;AKT3;PROX1;PLCG1;ETS1,alpha,3
non-recombinational repair (GO:0000726),4/50,4,50,0.059504430120127,1,0,0,2.71186440677966,7.65208003634385,KDM2A;ERCC1;UIMC1;LIG4,alpha,3
double-strand break repair (GO:0006302),8/142,8,142,0.0596596966018909,1,0,0,1.90976366674624,5.38381205129851,VCP;NIPBL;KDM2A;RAD21L1;MCM9;ERCC1;UIMC1;LIG4,alpha,3
modification-dependent protein catabolic process (GO:0019941),8/142,8,142,0.0596596966018909,1,0,0,1.90976366674624,5.38381205129851,DDB1;RNF20;RNF34;WDR81;MDM2;TRIP12;ARIH1;CBL,alpha,3
regulation of nucleic acid-templated transcription (GO:1903506),25/608,25,608,0.0603391927374966,1,0,0,1.39384478144514,3.91360033438882,NAB1;CHD7;NR3C1;ARNTL;POLR2A;NFIL3;POFUT1;UBTF;RREB1;FADS1;ZNF860;ESRRA;RNF20;ZFHX3;USP3;DAPK3;TFEB;RFX3;ZNF34;GLRX2;ACVR2B;BHLHE40;ZNF436;CLOCK;ATF4,alpha,3
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),3/31,3,31,0.0623710482108274,1,0,0,3.28048113723346,9.1022003791851,PPP1R13B;BCL2L11;DYNLL1,alpha,3
fatty-acyl-CoA biosynthetic process (GO:0046949),3/31,3,31,0.0623710482108274,1,0,0,3.28048113723346,9.1022003791851,SCD;TECR;ACSL3,alpha,3
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),3/31,3,31,0.0623710482108274,1,0,0,3.28048113723346,9.1022003791851,PPP1R13B;BCL2L11;DYNLL1,alpha,3
nuclear envelope organization (GO:0006998),3/31,3,31,0.0623710482108274,1,0,0,3.28048113723346,9.1022003791851,SUN2;SPAST;SPAG4,alpha,3
regulation of fibroblast migration (GO:0010762),2/14,2,14,0.0625499972271803,1,0,0,4.84261501210654,13.4227074401882,GNA12;ARHGEF7,alpha,3
positive regulation of neural precursor cell proliferation (GO:2000179),2/14,2,14,0.0625499972271803,1,0,0,4.84261501210654,13.4227074401882,FZD3;PROX1,alpha,3
clathrin coat assembly (GO:0048268),2/14,2,14,0.0625499972271803,1,0,0,4.84261501210654,13.4227074401882,HIP1;CLTB,alpha,3
negative regulation of receptor-mediated endocytosis (GO:0048261),2/14,2,14,0.0625499972271803,1,0,0,4.84261501210654,13.4227074401882,SDCBP;RAC1,alpha,3
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),2/14,2,14,0.0625499972271803,1,0,0,4.84261501210654,13.4227074401882,MDM2;MIF,alpha,3
thymus development (GO:0048538),2/14,2,14,0.0625499972271803,1,0,0,4.84261501210654,13.4227074401882,ZBTB1;EPHB3,alpha,3
positive regulation of mitochondrial fission (GO:0090141),2/14,2,14,0.0625499972271803,1,0,0,4.84261501210654,13.4227074401882,FIS1;MARCH5,alpha,3
Golgi to vacuole transport (GO:0006896),2/14,2,14,0.0625499972271803,1,0,0,4.84261501210654,13.4227074401882,AP1G1;VPS54,alpha,3
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),2/14,2,14,0.0625499972271803,1,0,0,4.84261501210654,13.4227074401882,CREB3;TMBIM6,alpha,3
regulation of histone modification (GO:0031056),2/14,2,14,0.0625499972271803,1,0,0,4.84261501210654,13.4227074401882,CDK9;PRDM10,alpha,3
regulation of protein modification by small protein conjugation or removal (GO:1903320),2/14,2,14,0.0625499972271803,1,0,0,4.84261501210654,13.4227074401882,DNAJB2;EGR1,alpha,3
negative regulation of T cell receptor signaling pathway (GO:0050860),2/14,2,14,0.0625499972271803,1,0,0,4.84261501210654,13.4227074401882,PTPRJ;PTPN2,alpha,3
plasma membrane bounded cell projection organization (GO:0120036),7/119,7,119,0.0626366918677556,1,0,0,1.99401794616152,5.52423537489855,EHD1;NLGN1;PLEKHA1;MAP4;RAC1;STX3;NPTX2,alpha,3
regulation of blood vessel endothelial cell migration (GO:0043535),4/51,4,51,0.0631302876886042,1,0,0,2.65869059488202,7.34477801138108,P2RX4;AKT3;PLCG1;ETS1,alpha,3
fatty acid beta-oxidation (GO:0006635),4/51,4,51,0.0631302876886042,1,0,0,2.65869059488202,7.34477801138108,ABCD3;ACAA2;ECHDC2;CRAT,alpha,3
double-strand break repair via nonhomologous end joining (GO:0006303),4/51,4,51,0.0631302876886042,1,0,0,2.65869059488202,7.34477801138108,KDM2A;ERCC1;UIMC1;LIG4,alpha,3
viral process (GO:0016032),11/221,11,221,0.0639294974319421,1,0,0,1.68724595444436,4.63988319043542,NUP214;NDC1;VCP;AP1G1;TPR;DAG1;RPL27;RAC1;HTATSF1;RAN;EIF3B,alpha,3
RNA export from nucleus (GO:0006405),7/120,7,120,0.0649147620680211,1,0,0,1.9774011299435,5.40755976192989,NUP214;NDC1;TPR;SRSF4;SRSF5;CDC40;RAN,alpha,3
"positive regulation of transcription, DNA-templated (GO:0045893)",42/1121,42,1121,0.0665217908829297,1,0,0,1.27005246526255,3.44212883493702,DDX5;DHX9;NR3C1;ETS1;FOXO1;ARNTL;PAGR1;HEY1;UBTF;DVL3;EPC1;TASP1;RREB1;YAF2;NCK1;ESRRA;MLXIP;RNF20;EGR1;SUPT16H;PCID2;ZFHX3;JUND;SMARCC2;POU2F1;TAF15;NFATC3;TFEB;RFX3;SOX12;PROX1;ARID1A;ARID1B;CDK9;METTL23;CREB3;RYBP;ASXL2;MMS19;CLOCK;RAN;ATF4,alpha,3
protein localization to organelle (GO:0033365),6/98,6,98,0.069893109630533,1,0,0,2.07540643375995,5.52221696839501,EHD1;CEP68;DHX9;MDM2;MARCH5;UBAC2,alpha,3
"regulation of gene expression, epigenetic (GO:0040029)",5/75,5,75,0.0705544508588312,1,0,0,2.25988700564972,5.99179777325913,DNMT3A;H3F3A;EPC1;DDX21;JARID2,alpha,3
mRNA 3'-end processing (GO:0031124),5/75,5,75,0.0705544508588312,1,0,0,2.25988700564972,5.99179777325913,CPSF7;PAPOLA;SRSF4;SRSF5;CDC40,alpha,3
positive regulation of nervous system development (GO:0051962),4/53,4,53,0.0707212686450706,1,0,0,2.55836264790534,6.77712547957256,NLGN1;LIG4;DICER1;EPHB3,alpha,3
positive regulation of cell-substrate adhesion (GO:0010811),4/53,4,53,0.0707212686450706,1,0,0,2.55836264790534,6.77712547957256,RAC1;ARHGEF7;RREB1;LIMS1,alpha,3
pseudouridine synthesis (GO:0001522),2/15,2,15,0.0708010855551668,1,0,0,4.51977401129944,11.9678234833894,NHP2;PUSL1,alpha,3
regulation of mRNA metabolic process (GO:1903311),2/15,2,15,0.0708010855551668,1,0,0,4.51977401129944,11.9678234833894,SLTM;DHX9,alpha,3
nuclear pore organization (GO:0006999),2/15,2,15,0.0708010855551668,1,0,0,4.51977401129944,11.9678234833894,NDC1;TPR,alpha,3
digestive tract morphogenesis (GO:0048546),2/15,2,15,0.0708010855551668,1,0,0,4.51977401129944,11.9678234833894,NIPBL;EPHB3,alpha,3
embryonic axis specification (GO:0000578),2/15,2,15,0.0708010855551668,1,0,0,4.51977401129944,11.9678234833894,COBL;CXXC4,alpha,3
negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),2/15,2,15,0.0708010855551668,1,0,0,4.51977401129944,11.9678234833894,PTPRJ;PTPN2,alpha,3
mitotic sister chromatid cohesion (GO:0007064),2/15,2,15,0.0708010855551668,1,0,0,4.51977401129944,11.9678234833894,NIPBL;POGZ,alpha,3
response to X-ray (GO:0010165),2/15,2,15,0.0708010855551668,1,0,0,4.51977401129944,11.9678234833894,NIPBL;LIG4,alpha,3
transport along microtubule (GO:0010970),2/15,2,15,0.0708010855551668,1,0,0,4.51977401129944,11.9678234833894,HSPA8;DYNLL1,alpha,3
positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),2/15,2,15,0.0708010855551668,1,0,0,4.51977401129944,11.9678234833894,CDK9;SUPT16H,alpha,3
unsaturated fatty acid biosynthetic process (GO:0006636),2/15,2,15,0.0708010855551668,1,0,0,4.51977401129944,11.9678234833894,SCD;FADS1,alpha,3
regulation of cell-substrate junction assembly (GO:0090109),2/15,2,15,0.0708010855551668,1,0,0,4.51977401129944,11.9678234833894,DAPK3;RHOA,alpha,3
negative regulation of mRNA processing (GO:0050686),2/15,2,15,0.0708010855551668,1,0,0,4.51977401129944,11.9678234833894,SRSF4;TMBIM6,alpha,3
regulation of RNA export from nucleus (GO:0046831),2/15,2,15,0.0708010855551668,1,0,0,4.51977401129944,11.9678234833894,DHX9;TPR,alpha,3
positive regulation of protein export from nucleus (GO:0046827),2/15,2,15,0.0708010855551668,1,0,0,4.51977401129944,11.9678234833894,TPR;EMD,alpha,3
regulation of peptide secretion (GO:0002791),2/15,2,15,0.0708010855551668,1,0,0,4.51977401129944,11.9678234833894,ARFIP1;LLGL2,alpha,3
cellular response to corticosteroid stimulus (GO:0071384),2/15,2,15,0.0708010855551668,1,0,0,4.51977401129944,11.9678234833894,BCL2L11;NR3C1,alpha,3
positive regulation of hydrolase activity (GO:0051345),9/173,9,173,0.0711906060295002,1,0,0,1.76349564024689,4.65985101665722,DNAJB2;VCP;DVL3;ARHGEF7;CALM2;RHOA;RGS7;NDEL1;LIMS1,alpha,3
7-methylguanosine mRNA capping (GO:0006370),3/33,3,33,0.0725544995683721,1,0,0,3.08166409861325,8.0844908515737,POLR2A;FAM103A1;POLR2I,alpha,3
ceramide biosynthetic process (GO:0046513),3/33,3,33,0.0725544995683721,1,0,0,3.08166409861325,8.0844908515737,SGMS1;SMPD1;SGMS2,alpha,3
7-methylguanosine RNA capping (GO:0009452),3/33,3,33,0.0725544995683721,1,0,0,3.08166409861325,8.0844908515737,POLR2A;FAM103A1;POLR2I,alpha,3
regulation of cell-cell adhesion (GO:0022407),3/33,3,33,0.0725544995683721,1,0,0,3.08166409861325,8.0844908515737,SIRPA;CD47;EPHB3,alpha,3
negative regulation of fat cell differentiation (GO:0045599),3/33,3,33,0.0725544995683721,1,0,0,3.08166409861325,8.0844908515737,TRIO;FOXO1;ARNTL,alpha,3
regulation of gene expression (GO:0010468),39/1038,39,1038,0.0725625108383446,1,0,0,1.27363574017831,3.34113738728903,DHX9;NAB1;CHD7;NR3C1;PRDM10;ETS1;ARNTL;POLR2A;NFIL3;POFUT1;CAMK2N1;STC2;UBTF;RREB1;FADS1;ZNF860;ESRRA;RNF20;EGR1;MBNL1;ZFHX3;NDFIP1;USP3;DAPK3;TFEB;RFX3;BRAF;ZNF34;MIF;PROX1;GLRX2;ACVR2B;SLTM;BHLHE40;ERP29;ZNF436;CLOCK;ATF4;LIMS1,alpha,3
negative regulation of cellular amide metabolic process (GO:0034249),5/76,5,76,0.0737862579138707,1,0,0,2.23015165031222,5.81307487030226,NCL;DAPK3;EIF4E2;CPEB3;GIGYF2,alpha,3
nucleic acid-templated transcription (GO:0097659),5/77,5,77,0.0770974474057991,1,0,0,2.20118864186661,5.6409533491924,POLR2A;EPC1;MMS19;NR3C1;POLR2I,alpha,3
regulation of intracellular signal transduction (GO:1902531),18/423,18,423,0.0778425131999545,1,0,0,1.44248106743599,3.68275161180547,NEK8;SUPT16H;NLGN1;TRIO;PPP1R13B;PLEKHG2;TAF15;SGMS1;RFC2;CHD4;RHOA;RNF41;CHN1;GNA12;MDM2;ANKRD54;RAC1;ARHGEF7,alpha,3
protein acetylation (GO:0006473),3/34,3,34,0.0779066471226972,1,0,0,2.99102691924227,7.63383051095094,ESCO1;CLOCK;FOXO1,alpha,3
neural tube closure (GO:0001843),3/34,3,34,0.0779066471226972,1,0,0,2.99102691924227,7.63383051095094,LMO4;DVL3;COBL,alpha,3
regulation of cell-substrate adhesion (GO:0010810),3/34,3,34,0.0779066471226972,1,0,0,2.99102691924227,7.63383051095094,RAC1;RHOA;LIMS1,alpha,3
positive regulation of cell-matrix adhesion (GO:0001954),3/34,3,34,0.0779066471226972,1,0,0,2.99102691924227,7.63383051095094,PTPRJ;RAC1;LIMS1,alpha,3
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),3/34,3,34,0.0779066471226972,1,0,0,2.99102691924227,7.63383051095094,FIS1;BCL2L11;NCK1,alpha,3
positive regulation of nucleocytoplasmic transport (GO:0046824),3/34,3,34,0.0779066471226972,1,0,0,2.99102691924227,7.63383051095094,DHX9;TPR;EMD,alpha,3
positive regulation of organelle organization (GO:0010638),3/34,3,34,0.0779066471226972,1,0,0,2.99102691924227,7.63383051095094,ATL3;KATNBL1;LIG4,alpha,3
cellular response to transforming growth factor beta stimulus (GO:0071560),6/101,6,101,0.0783401308027795,1,0,0,2.01376069810371,5.12843486705534,USP9X;ARRB2;NR3C1;CBL;RHOA;LIMS1,alpha,3
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),6/101,6,101,0.0783401308027795,1,0,0,2.01376069810371,5.12843486705534,NUP214;NDC1;TPR;SRSF4;SRSF5;CDC40,alpha,3
cell morphogenesis involved in differentiation (GO:0000904),4/55,4,55,0.0787567640802435,1,0,0,2.4653312788906,6.26537100001858,ACTN1;RAC1;PROX1;EPHB3,alpha,3
intracellular transport of virus (GO:0075733),4/55,4,55,0.0787567640802435,1,0,0,2.4653312788906,6.26537100001858,NUP214;NDC1;TPR;RAN,alpha,3
transport of virus (GO:0046794),4/55,4,55,0.0787567640802435,1,0,0,2.4653312788906,6.26537100001858,NUP214;NDC1;TPR;RAN,alpha,3
protein polyubiquitination (GO:0000209),13/284,13,284,0.0791482285087759,1,0,0,1.55168297923132,3.93573971908968,RNF20;RNF34;FBXL13;MARCH5;RNF41;ZNRF2;PSMA1;RNF19A;TRIP12;ANAPC5;RBCK1;ARIH1;TMEM189-UBE2V1,alpha,3
DNA alkylation (GO:0006305),2/16,2,16,0.0793814344588962,1,0,0,4.23728813559322,10.7351303432445,DNMT3A;GATAD2A,alpha,3
cardiac ventricle development (GO:0003231),2/16,2,16,0.0793814344588962,1,0,0,4.23728813559322,10.7351303432445,TMEM65;HEY1,alpha,3
DNA methylation or demethylation (GO:0044728),2/16,2,16,0.0793814344588962,1,0,0,4.23728813559322,10.7351303432445,DNMT3A;GATAD2A,alpha,3
negative regulation of transcription regulatory region DNA binding (GO:2000678),2/16,2,16,0.0793814344588962,1,0,0,4.23728813559322,10.7351303432445,PER2;HEY1,alpha,3
negative regulation of translational initiation (GO:0045947),2/16,2,16,0.0793814344588962,1,0,0,4.23728813559322,10.7351303432445,TPR;ATF4,alpha,3
regulation of steroid metabolic process (GO:0019218),2/16,2,16,0.0793814344588962,1,0,0,4.23728813559322,10.7351303432445,ARV1;LAMTOR1,alpha,3
mRNA transcription from RNA polymerase II promoter (GO:0042789),2/16,2,16,0.0793814344588962,1,0,0,4.23728813559322,10.7351303432445,ZBTB1;ATF4,alpha,3
aorta morphogenesis (GO:0035909),2/16,2,16,0.0793814344588962,1,0,0,4.23728813559322,10.7351303432445,HEY1;PROX1,alpha,3
ruffle organization (GO:0031529),2/16,2,16,0.0793814344588962,1,0,0,4.23728813559322,10.7351303432445,PLEKHA1;RAC1,alpha,3
myoblast differentiation (GO:0045445),2/16,2,16,0.0793814344588962,1,0,0,4.23728813559322,10.7351303432445,MBNL1;DDX5,alpha,3
linoleic acid metabolic process (GO:0043651),2/16,2,16,0.0793814344588962,1,0,0,4.23728813559322,10.7351303432445,FADS2;FADS1,alpha,3
neurotransmitter transport (GO:0006836),2/16,2,16,0.0793814344588962,1,0,0,4.23728813559322,10.7351303432445,SNAP25;GLUL,alpha,3
regulation of glucose transport (GO:0010827),2/16,2,16,0.0793814344588962,1,0,0,4.23728813559322,10.7351303432445,BRAF;APPL1,alpha,3
positive regulation of response to endoplasmic reticulum stress (GO:1905898),2/16,2,16,0.0793814344588962,1,0,0,4.23728813559322,10.7351303432445,BCL2L11;NCK1,alpha,3
protein dephosphorylation (GO:0006470),7/126,7,126,0.0796248420604677,1,0,0,1.88323917137476,4.76540329309564,PPP1CB;SDHAF2;DUSP1;CTDSP1;PTPRJ;PTPN2;NCK1,alpha,3
intrinsic apoptotic signaling pathway (GO:0097193),6/102,6,102,0.0812780853896613,1,0,0,1.99401794616152,5.00474347191793,CASP9;CUL4A;DDX5;BCL2L11;PPP1R13B;ATF4,alpha,3
cytoskeleton organization (GO:0007010),7/127,7,127,0.0822499333228752,1,0,0,1.86841051648205,4.66727583077748,SUN2;FGD6;SPAG4;DAG1;NEDD9;CDC42BPB;TLN1,alpha,3
regulation of axonogenesis (GO:0050770),4/56,4,56,0.0829378292132375,1,0,0,2.42130750605327,6.02824212465866,RUFY3;CHN1;RHOA;EPHB3,alpha,3
regulation of RNA splicing (GO:0043484),4/56,4,56,0.0829378292132375,1,0,0,2.42130750605327,6.02824212465866,MBNL1;POLR2A;JMJD6;PTBP3,alpha,3
response to amino acid (GO:0043200),3/35,3,35,0.0834261169137432,1,0,0,2.90556900726392,7.21683447805268,TMBIM6;LAMTOR1;CPEB3,alpha,3
regulation of alcohol biosynthetic process (GO:1902930),3/35,3,35,0.0834261169137432,1,0,0,2.90556900726392,7.21683447805268,IDI1;SCD;RAN,alpha,3
regulation of insulin receptor signaling pathway (GO:0046626),3/35,3,35,0.0834261169137432,1,0,0,2.90556900726392,7.21683447805268,SOCS2;PTPN2;NCK1,alpha,3
positive regulation of cell development (GO:0010720),3/35,3,35,0.0834261169137432,1,0,0,2.90556900726392,7.21683447805268,RFX3;LIG4;PROX1,alpha,3
regulation of cellular response to heat (GO:1900034),5/79,5,79,0.0839559073474967,1,0,0,2.14546234713581,5.31530472105436,NUP214;NDC1;HSPA8;PTGES3;TPR,alpha,3
vesicle organization (GO:0016050),7/128,7,128,0.0849243654374277,1,0,0,1.85381355932203,4.57149355375764,SNAP25;SNX11;STX3;LAMTOR1;SNX30;STX2;SNX8,alpha,3
non-canonical Wnt signaling pathway (GO:0035567),7/128,7,128,0.0849243654374277,1,0,0,1.85381355932203,4.57149355375764,FZD3;DAAM1;PSMA1;DVL3;ARRB2;RAC1;RHOA,alpha,3
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),5/80,5,80,0.0875019927708188,1,0,0,2.11864406779661,5.16121549015733,IFI27L1;CASP9;VCP;EGLN3;HIP1,alpha,3
negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),2/17,2,17,0.088264512763101,1,0,0,3.98803589232303,9.6806267043504,PTPRJ;PTPN2,alpha,3
microtubule nucleation (GO:0007020),2/17,2,17,0.088264512763101,1,0,0,3.98803589232303,9.6806267043504,RANBP9;NDEL1,alpha,3
histone H2A ubiquitination (GO:0033522),2/17,2,17,0.088264512763101,1,0,0,3.98803589232303,9.6806267043504,DDB1;RYBP,alpha,3
histone H2A monoubiquitination (GO:0035518),2/17,2,17,0.088264512763101,1,0,0,3.98803589232303,9.6806267043504,DDB1;RYBP,alpha,3
negative regulation of intracellular transport (GO:0032387),2/17,2,17,0.088264512763101,1,0,0,3.98803589232303,9.6806267043504,ACAA2;INSIG1,alpha,3
response to purine-containing compound (GO:0014074),2/17,2,17,0.088264512763101,1,0,0,3.98803589232303,9.6806267043504,JUND;P2RX4,alpha,3
regulation of transcription from RNA polymerase I promoter (GO:0006356),2/17,2,17,0.088264512763101,1,0,0,3.98803589232303,9.6806267043504,UBTF;ATF4,alpha,3
nucleotide catabolic process (GO:0009166),2/17,2,17,0.088264512763101,1,0,0,3.98803589232303,9.6806267043504,VCP;NUDT3,alpha,3
regulation of establishment or maintenance of cell polarity (GO:0032878),2/17,2,17,0.088264512763101,1,0,0,3.98803589232303,9.6806267043504,RUFY3;LLGL2,alpha,3
cellular response to glucocorticoid stimulus (GO:0071385),2/17,2,17,0.088264512763101,1,0,0,3.98803589232303,9.6806267043504,BCL2L11;NR3C1,alpha,3
anatomical structure homeostasis (GO:0060249),3/36,3,36,0.0891079849722146,1,0,0,2.82485875706215,6.830243871261,POLD3;PTGES3;APEX1,alpha,3
apical junction assembly (GO:0043297),3/36,3,36,0.0891079849722146,1,0,0,2.82485875706215,6.830243871261,OCLN;RHOA;VCL,alpha,3
cholesterol biosynthetic process (GO:0006695),3/36,3,36,0.0891079849722146,1,0,0,2.82485875706215,6.830243871261,IDI1;ARV1;ACAA2,alpha,3
regulation of sodium ion transport (GO:0002028),3/36,3,36,0.0891079849722146,1,0,0,2.82485875706215,6.830243871261,P2RX4;WNK1;SCN3B,alpha,3
positive regulation of ATPase activity (GO:0032781),3/36,3,36,0.0891079849722146,1,0,0,2.82485875706215,6.830243871261,DNAJB2;DHX9;DYNLL1,alpha,3
protein kinase B signaling (GO:0043491),3/36,3,36,0.0891079849722146,1,0,0,2.82485875706215,6.830243871261,CASP9;MDM2;FOXO1,alpha,3
peptide metabolic process (GO:0006518),6/105,6,105,0.0904554083779856,1,0,0,1.93704600484262,4.65452450326449,HSPA8;SPCS1;GSR;LTA4H;GLRX2;APEH,alpha,3
mRNA transport (GO:0051028),6/105,6,105,0.0904554083779856,1,0,0,1.93704600484262,4.65452450326449,NUP214;NDC1;TPR;SRSF4;SRSF5;CDC40,alpha,3
RNA transport (GO:0050658),5/81,5,81,0.0911250939136984,1,0,0,2.09248796819418,5.01260108401516,NUP214;TPR;SRSF4;SRSF5;CDC40,alpha,3
"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",5/81,5,81,0.0911250939136984,1,0,0,2.09248796819418,5.01260108401516,GOLPH3;RER1;KLC1;ATP9B;ARF5,alpha,3
regulation of neurogenesis (GO:0050767),4/58,4,58,0.0916189059124818,1,0,0,2.33781414377557,5.58765080578467,PER2;NLGN1;LIG4;ARNTL,alpha,3
protein localization to plasma membrane (GO:0072659),7/131,7,131,0.0932422684634415,1,0,0,1.81135981368871,4.29754921741766,TSPAN14;GOLPH3;RAB40C;KCNB2;MAP7;SCN3B;EFR3B,alpha,3
protein catabolic process (GO:0030163),5/82,5,82,0.0948244740887062,1,0,0,2.0669698222406,4.86921814292571,DDB1;HSPA8;VCP;PSMA1;RNF41,alpha,3
positive regulation of protein catabolic process (GO:0045732),5/82,5,82,0.0948244740887062,1,0,0,2.0669698222406,4.86921814292571,DDB1;VCP;EGLN2;FOXO1;RNF41,alpha,3
protein acylation (GO:0043543),3/37,3,37,0.0949471903021149,1,0,0,2.74851122308749,6.4711894645074,ZDHHC5;CLOCK;FOXO1,alpha,3
regulation of cell morphogenesis involved in differentiation (GO:0010769),3/37,3,37,0.0949471903021149,1,0,0,2.74851122308749,6.4711894645074,RUFY3;CHN1;EPHB3,alpha,3
secondary alcohol biosynthetic process (GO:1902653),3/37,3,37,0.0949471903021149,1,0,0,2.74851122308749,6.4711894645074,IDI1;ARV1;ACAA2,alpha,3
phospholipid transport (GO:0015914),4/59,4,59,0.096115547530641,1,0,0,2.298190175237,5.38283066055372,STARD7;PITPNA;ATP10D;ATP9B,alpha,3
response to endoplasmic reticulum stress (GO:0034976),6/107,6,107,0.0968732710643103,1,0,0,1.90083953746238,4.43722788888828,TMX4;VCP;BCL2L11;FICD;ATF4;NCK1,alpha,3
regulation of adherens junction organization (GO:1903391),2/18,2,18,0.0974250634233934,1,0,0,3.76647834274953,8.77089181454036,DAPK3;RHOA,alpha,3
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),2/18,2,18,0.0974250634233934,1,0,0,3.76647834274953,8.77089181454036,TECR;ACSL3,alpha,3
membrane protein ectodomain proteolysis (GO:0006509),2/18,2,18,0.0974250634233934,1,0,0,3.76647834274953,8.77089181454036,DAG1;ADAM10,alpha,3
nuclear envelope reassembly (GO:0031468),2/18,2,18,0.0974250634233934,1,0,0,3.76647834274953,8.77089181454036,SPAST;EMD,alpha,3
regulation of lipid catabolic process (GO:0050994),2/18,2,18,0.0974250634233934,1,0,0,3.76647834274953,8.77089181454036,PDE3B;TYSND1,alpha,3
negative regulation of protein transport (GO:0051224),2/18,2,18,0.0974250634233934,1,0,0,3.76647834274953,8.77089181454036,NDFIP1;ERP29,alpha,3
regulation of epithelial cell differentiation (GO:0030856),2/18,2,18,0.0974250634233934,1,0,0,3.76647834274953,8.77089181454036,CLOCK;ARNTL,alpha,3
DNA methylation (GO:0006306),2/18,2,18,0.0974250634233934,1,0,0,3.76647834274953,8.77089181454036,DNMT3A;GATAD2A,alpha,3
establishment of epithelial cell polarity (GO:0090162),2/18,2,18,0.0974250634233934,1,0,0,3.76647834274953,8.77089181454036,GOLPH3;RHOA,alpha,3
cell-substrate adherens junction assembly (GO:0007045),2/18,2,18,0.0974250634233934,1,0,0,3.76647834274953,8.77089181454036,ACTN1;ARHGEF7,alpha,3
piRNA metabolic process (GO:0034587),2/18,2,18,0.0974250634233934,1,0,0,3.76647834274953,8.77089181454036,TDRKH;EXD1,alpha,3
response to organophosphorus (GO:0046683),2/18,2,18,0.0974250634233934,1,0,0,3.76647834274953,8.77089181454036,JUND;P2RX4,alpha,3
mRNA destabilization (GO:0061157),2/18,2,18,0.0974250634233934,1,0,0,3.76647834274953,8.77089181454036,CPEB3;GIGYF2,alpha,3
DNA ligation (GO:0006266),2/18,2,18,0.0974250634233934,1,0,0,3.76647834274953,8.77089181454036,POLD3;LIG4,alpha,3
focal adhesion assembly (GO:0048041),2/18,2,18,0.0974250634233934,1,0,0,3.76647834274953,8.77089181454036,ACTN1;ARHGEF7,alpha,3
positive regulation of protein secretion (GO:0050714),5/83,5,83,0.0985993420410861,1,0,0,2.04206657137023,4.73083661508497,GOLPH3;CAPN10;ANG;MIF;MCU,alpha,3
"retrograde transport, endosome to Golgi (GO:0042147)",5/83,5,83,0.0985993420410861,1,0,0,2.04206657137023,4.73083661508497,HEATR5A;VPS54;VPS26B;SNX8;BET1L,alpha,3
cellular response to hypoxia (GO:0071456),7/133,7,133,0.0990311890486265,1,0,0,1.78412132024978,4.1254601919131,SLC8A3;EGLN3;ACAA2;EGLN2;PSMA1;MDM2;CPEB2,alpha,3
manganese ion transport (GO:0006828),3/9,3,9,0.000135890985978469,0.693451701448128,0,0,27.7777777777778,247.32382131522,TRPC6;TRPC3;TRPC4,alpha,4
positive regulation of response to DNA damage stimulus (GO:2001022),5/50,5,50,0.000325601699711809,0.830772736814682,0,0,8.33333333333333,66.9152975300367,EYA4;HMGA2;PLA2R1;EGFR;FGF10,alpha,4
regulation of delayed rectifier potassium channel activity (GO:1902259),3/15,3,15,0.000697869383077695,1,0,0,16.6666666666667,121.124643382902,AKAP6;ANK3;KCNRG,alpha,4
regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),2/6,2,6,0.00208370427795829,1,0,0,27.7777777777778,171.489112953655,MLIP;TRPC3,alpha,4
negative regulation of delayed rectifier potassium channel activity (GO:1902260),2/6,2,6,0.00208370427795829,1,0,0,27.7777777777778,171.489112953655,ANK3;KCNRG,alpha,4
anterograde trans-synaptic signaling (GO:0098916),9/241,9,241,0.00260797936591962,1,0,0,3.11203319502075,18.5140442327479,KCND2;HTR1E;MTNR1B;HTR1F;NPY;SYT10;NPY2R;PDE7B;GABRG2,alpha,4
positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031659),2/7,2,7,0.00289413521301584,1,0,0,23.8095238095238,139.168307857631,EGFR;FGF10,alpha,4
positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),2/8,2,8,0.00382838377587361,1,0,0,20.8333333333333,115.944011572629,GSTM2;AKAP6,alpha,4
negative regulation of voltage-gated potassium channel activity (GO:1903817),2/8,2,8,0.00382838377587361,1,0,0,20.8333333333333,115.944011572629,ANK3;KCNRG,alpha,4
transition metal ion transport (GO:0000041),3/28,3,28,0.00447941471284085,1,0,0,8.92857142857143,48.2880614780816,TRPC6;TRPC3;TRPC4,alpha,4
positive regulation of cation channel activity (GO:2001259),3/31,3,31,0.0059861731102851,1,0,0,8.06451612903226,41.2766366998184,GSTM2;AKAP6;ANK3,alpha,4
extracellular matrix organization (GO:0030198),8/230,8,230,0.0067562048756876,1,0,0,2.89855072463768,14.4849100159368,ADAM19;ADAMTS5;LOX;ITGA4;COL14A1;TGFBI;KLKB1;HAPLN1,alpha,4
chemical synaptic transmission (GO:0007268),9/290,9,290,0.0085819653671572,1,0,0,2.58620689655172,12.3054111929538,KCND2;HTR1E;MTNR1B;HTR1F;NPY;SYT10;NPY2R;PDE7B;GABRG2,alpha,4
regulation of hormone secretion (GO:0046883),2/12,2,12,0.00874311035663077,1,0,0,13.8888888888889,65.8262399524839,CCKAR;FFAR2,alpha,4
plasminogen activation (GO:0031639),2/12,2,12,0.00874311035663077,1,0,0,13.8888888888889,65.8262399524839,F11;KLKB1,alpha,4
positive regulation of DNA replication (GO:0045740),3/36,3,36,0.00910054784367748,1,0,0,6.94444444444444,32.6348657268716,KITLG;EGFR;FGF10,alpha,4
secretion (GO:0046903),2/13,2,13,0.0102515875077502,1,0,0,12.8205128205128,58.7220859818629,RIMS1;SLC22A16,alpha,4
regulation of fibrinolysis (GO:0051917),2/13,2,13,0.0102515875077502,1,0,0,12.8205128205128,58.7220859818629,F11;KLKB1,alpha,4
catecholamine biosynthetic process (GO:0042423),2/13,2,13,0.0102515875077502,1,0,0,12.8205128205128,58.7220859818629,MOXD1;PAH,alpha,4
regulation of DNA repair (GO:0006282),3/38,3,38,0.0105657921194543,1,0,0,6.57894736842105,29.9350898349514,EYA4;EGFR;FGF10,alpha,4
positive regulation of DNA repair (GO:0045739),3/39,3,39,0.0113466003518201,1,0,0,6.41025641025641,28.7104942845919,EYA4;EGFR;FGF10,alpha,4
neurotransmitter biosynthetic process (GO:0042136),2/14,2,14,0.0118663124313473,1,0,0,11.9047619047619,52.7863307324854,MOXD1;PAH,alpha,4
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031657),2/14,2,14,0.0118663124313473,1,0,0,11.9047619047619,52.7863307324854,EGFR;FGF10,alpha,4
positive regulation of acute inflammatory response (GO:0002675),2/15,2,15,0.0135845398773753,1,0,0,11.1111111111111,47.7646989619985,FFAR2;KLKB1,alpha,4
cellular biogenic amine biosynthetic process (GO:0042401),2/15,2,15,0.0135845398773753,1,0,0,11.1111111111111,47.7646989619985,MOXD1;TPH2,alpha,4
calcium ion transport (GO:0006816),5/119,5,119,0.0144381189451495,1,0,0,3.50140056022409,14.8385273843114,TRPC6;TRPC3;TRPC4;NPY;TRPM6,alpha,4
positive regulation of cardiac muscle hypertrophy (GO:0010613),2/16,2,16,0.0154035746948121,1,0,0,10.4166666666667,43.4703715985332,TRPC3;AKAP6,alpha,4
positive regulation of calcium ion transmembrane transporter activity (GO:1901021),2/17,2,17,0.0173207710477776,1,0,0,9.80392156862745,39.7632241085163,GSTM2;AKAP6,alpha,4
chaperone-mediated protein complex assembly (GO:0051131),2/17,2,17,0.0173207710477776,1,0,0,9.80392156862745,39.7632241085163,BBS10;HOPX,alpha,4
positive regulation of cation transmembrane transport (GO:1904064),2/17,2,17,0.0173207710477776,1,0,0,9.80392156862745,39.7632241085163,AKAP6;ANK3,alpha,4
positive regulation of DNA metabolic process (GO:0051054),4/83,4,83,0.0177642381904514,1,0,0,4.01606425702811,16.1870198113961,KITLG;EYA4;EGFR;FGF10,alpha,4
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),4/86,4,86,0.0199702664675888,1,0,0,3.87596899224806,15.168646466081,GHR;BANK1;EGFR;FGF10,alpha,4
calcium ion transmembrane transport (GO:0070588),4/87,4,87,0.0207414161607161,1,0,0,3.83141762452107,14.8491294900223,TRPC6;TRPC3;TRPC4;TRPM6,alpha,4
regulation of protein kinase A signaling (GO:0010738),2/19,2,19,0.0214393067951571,1,0,0,8.7719298245614,33.706397154541,SPHKAP;AKAP6,alpha,4
positive regulation of developmental growth (GO:0048639),3/52,3,52,0.0245016574925074,1,0,0,4.80769230769231,17.8318005334827,GHR;RIMS1;BDNF,alpha,4
regulation of cytosolic calcium ion concentration (GO:0051480),5/138,5,138,0.0255809554957013,1,0,0,3.01932367149758,11.0685601760145,CALB1;TRPC6;TRPC3;TRPC4;P2RY1,alpha,4
activation of phospholipase C activity (GO:0007202),2/22,2,22,0.028289924528737,1,0,0,7.57575757575758,27.0094663745756,AVPR1A;EGFR,alpha,4
action potential (GO:0001508),3/55,3,55,0.028339767699275,1,0,0,4.54545454545455,16.1976783712438,KCND2;AKAP6;ANK3,alpha,4
positive regulation of response to stimulus (GO:0048584),3/55,3,55,0.028339767699275,1,0,0,4.54545454545455,16.1976783712438,RFX6;HMGA2;EGFR,alpha,4
fat cell differentiation (GO:0045444),3/56,3,56,0.0296859286941961,1,0,0,4.46428571428571,15.7012594945693,C1QTNF3;HMGA2;FFAR2,alpha,4
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),2/23,2,23,0.0307431908141116,1,0,0,7.2463768115942,25.2325126535496,GSTM2;AKAP6,alpha,4
positive regulation of ion transmembrane transporter activity (GO:0032414),2/23,2,23,0.0307431908141116,1,0,0,7.2463768115942,25.2325126535496,TRPC6;ANK3,alpha,4
positive regulation of cell growth (GO:0030307),4/99,4,99,0.0314288149440741,1,0,0,3.36700336700337,11.6499331094093,RIMS1;BDNF;AKAP6;EGFR,alpha,4
regulated exocytosis (GO:0045055),5/149,5,149,0.0340148922149603,1,0,0,2.79642058165548,9.45457730408384,RIMS1;PCDH7;F13A1;STEAP2;F5,alpha,4
regulation of DNA replication (GO:0006275),3/62,3,62,0.0384577127602839,1,0,0,4.03225806451613,13.1378871419411,KITLG;EGFR;FGF10,alpha,4
glial cell differentiation (GO:0010001),2/26,2,26,0.0385796565098171,1,0,0,6.41025641025641,20.8655780440174,PTPRZ1;FGF10,alpha,4
regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),2/26,2,26,0.0385796565098171,1,0,0,6.41025641025641,20.8655780440174,GSTM2;AKAP6,alpha,4
positive regulation of synapse assembly (GO:0051965),2/27,2,27,0.0413432462148689,1,0,0,6.17283950617284,19.6657173025939,BDNF;VSTM5,alpha,4
carbohydrate homeostasis (GO:0033500),3/64,3,64,0.041643197915566,1,0,0,3.90625,12.4164735900752,RFX6;MTNR1B;FFAR2,alpha,4
positive regulation of cell communication (GO:0010647),2/29,2,29,0.0470845968558047,1,0,0,5.74712643678161,17.5621227707372,RIMS1;ANK3,alpha,4
positive regulation of calcium-mediated signaling (GO:0050850),2/29,2,29,0.0470845968558047,1,0,0,5.74712643678161,17.5621227707372,GSTM2;AKAP6,alpha,4
cellular amino acid biosynthetic process (GO:0008652),2/29,2,29,0.0470845968558047,1,0,0,5.74712643678161,17.5621227707372,PAH;GADL1,alpha,4
neuron projection morphogenesis (GO:0048812),5/164,5,164,0.0480156488817211,1,0,0,2.54065040650407,7.71399467184323,CNTNAP2;BDNF;SLITRK1;LRRN1;ANK3,alpha,4
collagen fibril organization (GO:0030199),2/30,2,30,0.0500581730621326,1,0,0,5.55555555555556,16.6364971589326,LOX;COL14A1,alpha,4
protein O-linked glycosylation (GO:0006493),4/116,4,116,0.051220557413639,1,0,0,2.8735632183908,8.53912159636755,ADAMTS5;GALNT6;ST8SIA6;ISPD,alpha,4
positive regulation of phospholipase C activity (GO:0010863),2/31,2,31,0.053097625958834,1,0,0,5.37634408602151,15.7829196806822,AVPR1A;EGFR,alpha,4
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),2/31,2,31,0.053097625958834,1,0,0,5.37634408602151,15.7829196806822,EGFR;FGF10,alpha,4
CENP-A containing nucleosome assembly (GO:0034080),2/31,2,31,0.053097625958834,1,0,0,5.37634408602151,15.7829196806822,CENPL;CENPC,alpha,4
CENP-A containing chromatin organization (GO:0061641),2/31,2,31,0.053097625958834,1,0,0,5.37634408602151,15.7829196806822,CENPL;CENPC,alpha,4
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),2/32,2,32,0.0562009610965825,1,0,0,5.20833333333333,14.9938615670106,GSTM2;AKAP6,alpha,4
positive regulation of calcium ion transport into cytosol (GO:0010524),2/33,2,33,0.0593662220541837,1,0,0,5.05050505050505,14.2627771042628,TRPC3;AKAP6,alpha,4
endodermal cell differentiation (GO:0035987),2/33,2,33,0.0593662220541837,1,0,0,5.05050505050505,14.2627771042628,ITGA4;HMGA2,alpha,4
chromatin remodeling at centromere (GO:0031055),2/33,2,33,0.0593662220541837,1,0,0,5.05050505050505,14.2627771042628,CENPL;CENPC,alpha,4
regulation of peptide hormone secretion (GO:0090276),3/74,3,74,0.0594667623194448,1,0,0,3.37837837837838,9.53492479390131,RFX6;MTNR1B;FFAR2,alpha,4
chloride transport (GO:0006821),3/74,3,74,0.0594667623194448,1,0,0,3.37837837837838,9.53492479390131,SLC26A4;ANO5;GABRG2,alpha,4
glucose homeostasis (GO:0042593),3/75,3,75,0.0614175398944778,1,0,0,3.33333333333333,9.30019939529991,RFX6;MTNR1B;FFAR2,alpha,4
cellular calcium ion homeostasis (GO:0006874),4/124,4,124,0.0624282902609308,1,0,0,2.68817204301075,7.45628155048787,CALB1;TRPC6;TRPC3;TRPC4,alpha,4
positive regulation of calcium ion transport (GO:0051928),2/34,2,34,0.0625914898065732,1,0,0,4.90196078431373,13.5839507632324,TRPC6;TRPC3,alpha,4
"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",4/126,4,126,0.0654164819729893,1,0,0,2.64550264550265,7.2142355405676,HTR1E;MTNR1B;HTR1F;NPY,alpha,4
response to peptide (GO:1901652),2/35,2,35,0.0658748821361863,1,0,0,4.76190476190476,12.952371720601,CCKAR;AVPR1A,alpha,4
positive regulation of protein kinase B signaling (GO:0051897),4/128,4,128,0.0684781878234949,1,0,0,2.60416666666667,6.98239586030375,F7;KITLG;EGFR;FGF10,alpha,4
regulation of sodium ion transport (GO:0002028),2/36,2,36,0.069214553019615,1,0,0,4.62962962962963,12.3636302533222,NKAIN3;ANK3,alpha,4
positive regulation of action potential (GO:0045760),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,ANK3,alpha,4
positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,TOMM7,alpha,4
vocal learning (GO:0042297),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,CNTNAP2,alpha,4
regulation of cellular carbohydrate catabolic process (GO:0043471),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,PGAM2,alpha,4
histone-serine phosphorylation (GO:0035404),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,HMGA2,alpha,4
B cell chemotaxis (GO:0035754),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,CYP7B1,alpha,4
SCF complex assembly (GO:0010265),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,FBXL7,alpha,4
dopamine catabolic process (GO:0042420),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,MOXD1,alpha,4
monoterpenoid metabolic process (GO:0016098),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,CYP2E1,alpha,4
positive regulation of icosanoid secretion (GO:0032305),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,PLA2R1,alpha,4
positive regulation of cholesterol storage (GO:0010886),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,APOB,alpha,4
regulation of nuclease activity (GO:0032069),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,OAS3,alpha,4
cellular triglyceride homeostasis (GO:0035356),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,C1QTNF3,alpha,4
indolalkylamine metabolic process (GO:0006586),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,TPH2,alpha,4
N-acetylneuraminate catabolic process (GO:0019262),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,AMDHD2,alpha,4
regulation of digestive system process (GO:0044058),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,FGF10,alpha,4
positive regulation of receptor binding (GO:1900122),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,BDNF,alpha,4
SREBP signaling pathway (GO:0032933),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,ARHGEF10L,alpha,4
regulation of adiponectin secretion (GO:0070163),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,C1QTNF3,alpha,4
negative regulation of phospholipase activity (GO:0010519),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,PLA2R1,alpha,4
positive regulation of sodium ion transmembrane transport (GO:1902307),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,ANK3,alpha,4
positive regulation of keratinocyte migration (GO:0051549),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,FGF10,alpha,4
amino sugar catabolic process (GO:0046348),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,AMDHD2,alpha,4
imitative learning (GO:0098596),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,CNTNAP2,alpha,4
cellular response to magnesium ion (GO:0071286),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,ANK3,alpha,4
regulation of saliva secretion (GO:0046877),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,FGF10,alpha,4
iron ion import across plasma membrane (GO:0098711),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,STEAP2,alpha,4
citrate metabolic process (GO:0006101),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,GHR,alpha,4
equilibrioception (GO:0050957),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,PCDH15,alpha,4
regulation of cytokine production involved in immune response (GO:0002718),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,FFAR2,alpha,4
negative regulation of interleukin-6 secretion (GO:1900165),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,C1QTNF3,alpha,4
response to UV-A (GO:0070141),1/6,1,6,0.0698824514752293,1,0,0,13.8888888888889,36.9575099044123,EGFR,alpha,4
peptidyl-tyrosine phosphorylation (GO:0018108),3/80,3,80,0.0716099102888651,1,0,0,3.125,8.23913063355599,GHR;GRAP2;EGFR,alpha,4
centromere complex assembly (GO:0034508),2/37,2,37,0.0726086920336459,1,0,0,4.50450450450451,11.813831708723,CENPL;CENPC,alpha,4
histone exchange (GO:0043486),2/37,2,37,0.0726086920336459,1,0,0,4.50450450450451,11.813831708723,CENPL;CENPC,alpha,4
carbohydrate biosynthetic process (GO:0016051),2/37,2,37,0.0726086920336459,1,0,0,4.50450450450451,11.813831708723,GALNT6;ST8SIA6,alpha,4
regulation of nitric-oxide synthase activity (GO:0050999),2/37,2,37,0.0726086920336459,1,0,0,4.50450450450451,11.813831708723,NPR3;EGFR,alpha,4
endoderm formation (GO:0001706),2/37,2,37,0.0726086920336459,1,0,0,4.50450450450451,11.813831708723,ITGA4;HMGA2,alpha,4
negative regulation of blood coagulation (GO:0030195),2/37,2,37,0.0726086920336459,1,0,0,4.50450450450451,11.813831708723,F11;KLKB1,alpha,4
zymogen activation (GO:0031638),2/37,2,37,0.0726086920336459,1,0,0,4.50450450450451,11.813831708723,F11;KLKB1,alpha,4
cellular response to hormone stimulus (GO:0032870),3/81,3,81,0.0737340646705422,1,0,0,3.08641975308642,8.04719252892907,GHR;CCKAR;AVPR1A,alpha,4
sodium-independent organic anion transport (GO:0043252),2/38,2,38,0.0760555237708104,1,0,0,4.3859649122807,11.2995246908104,SLC22A16;SLCO4C1,alpha,4
base-excision repair (GO:0006284),2/38,2,38,0.0760555237708104,1,0,0,4.3859649122807,11.2995246908104,HMGA2;APEX2,alpha,4
positive regulation of receptor activity (GO:2000273),2/38,2,38,0.0760555237708104,1,0,0,4.3859649122807,11.2995246908104,GSTM2;AKAP6,alpha,4
regulation of metal ion transport (GO:0010959),2/38,2,38,0.0760555237708104,1,0,0,4.3859649122807,11.2995246908104,NKAIN3;ANK3,alpha,4
positive regulation of axonogenesis (GO:0050772),2/38,2,38,0.0760555237708104,1,0,0,4.3859649122807,11.2995246908104,SLITRK1;BDNF,alpha,4
cellular response to organic substance (GO:0071310),4/134,4,134,0.0780982515475026,1,0,0,2.48756218905473,6.34275524811696,GHR;CCKAR;AKAP6;AVPR1A,alpha,4
positive regulation of multicellular organism growth (GO:0040018),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,GHR,alpha,4
cellular response to caffeine (GO:0071313),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,GSTM2,alpha,4
protein localization to basolateral plasma membrane (GO:1903361),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,LIN7A,alpha,4
positive regulation of urine volume (GO:0035810),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,NPR3,alpha,4
positive regulation of keratinocyte proliferation (GO:0010838),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,FGF10,alpha,4
regulation of collateral sprouting (GO:0048670),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,BDNF,alpha,4
negative regulation of muscle hypertrophy (GO:0014741),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,MLIP,alpha,4
positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,FGF10,alpha,4
negative regulation of cardiocyte differentiation (GO:1905208),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,EGFR,alpha,4
regulation of monocyte chemotactic protein-1 production (GO:0071637),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,C1QTNF3,alpha,4
positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,AKAP6,alpha,4
positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,CASP4,alpha,4
oxaloacetate metabolic process (GO:0006107),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,GHR,alpha,4
radial glial cell differentiation (GO:0060019),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,FGF10,alpha,4
elastic fiber assembly (GO:0048251),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,LOX,alpha,4
positive regulation of cellular senescence (GO:2000774),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,HMGA2,alpha,4
cellular response to histamine (GO:0071420),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,GABRG2,alpha,4
regulation of NADP metabolic process (GO:1902031),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,PGAM2,alpha,4
cellular response to sterol depletion (GO:0071501),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,ARHGEF10L,alpha,4
valine metabolic process (GO:0006573),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,GHR,alpha,4
xenobiotic catabolic process (GO:0042178),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,GSTM2,alpha,4
terpenoid metabolic process (GO:0006721),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,CYP2E1,alpha,4
positive regulation of membrane depolarization (GO:1904181),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,ANK3,alpha,4
response to caffeine (GO:0031000),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,GSTM2,alpha,4
regulation of microtubule binding (GO:1904526),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,GTSE1,alpha,4
outer mitochondrial membrane organization (GO:0007008),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,TOMM7,alpha,4
carnitine transport (GO:0015879),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,SLC22A16,alpha,4
amino-acid betaine transport (GO:0015838),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,SLC22A16,alpha,4
norepinephrine biosynthetic process (GO:0042421),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,MOXD1,alpha,4
chylomicron remnant clearance (GO:0034382),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,APOB,alpha,4
response to type I interferon (GO:0034340),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,TRIM56,alpha,4
neuron fate specification (GO:0048665),1/7,1,7,0.081047190165139,1,0,0,11.9047619047619,29.9133773728657,MYT1L,alpha,4
Golgi to plasma membrane transport (GO:0006893),2/40,2,40,0.0831003354951034,1,0,0,4.16666666666667,10.3654439161807,ANK3;STEAP2,alpha,4
DNA replication-independent nucleosome assembly (GO:0006336),2/40,2,40,0.0831003354951034,1,0,0,4.16666666666667,10.3654439161807,CENPL;CENPC,alpha,4
ameboidal-type cell migration (GO:0001667),2/41,2,41,0.0866949346656979,1,0,0,4.0650406504065,9.94048707559652,ITGA4;SEMA3D,alpha,4
inorganic cation transmembrane transport (GO:0098662),4/141,4,141,0.0901258713065576,1,0,0,2.36406619385343,5.68923880772393,TRPC6;TRPC3;TRPC4;TRPM6,alpha,4
divalent metal ion transport (GO:0070838),3/89,3,89,0.0917038872762312,1,0,0,2.80898876404494,6.71120929602079,TRPC3;TRPC4;NPY,alpha,4
exocrine system development (GO:0035272),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,FGF10,alpha,4
catecholamine catabolic process (GO:0042424),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,MOXD1,alpha,4
positive regulation of cell aging (GO:0090343),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,HMGA2,alpha,4
stress-induced premature senescence (GO:0090400),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,PLA2R1,alpha,4
ketone body biosynthetic process (GO:0046951),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,ACSS3,alpha,4
positive regulation of membrane potential (GO:0045838),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,ANK3,alpha,4
protein lipoylation (GO:0009249),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,NDUFAB1,alpha,4
response to magnesium ion (GO:0032026),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,ANK3,alpha,4
cellular response to purine-containing compound (GO:0071415),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,GSTM2,alpha,4
phenol-containing compound biosynthetic process (GO:0046189),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,MOXD1,alpha,4
"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)",1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,PRMT8,alpha,4
norepinephrine metabolic process (GO:0042415),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,MOXD1,alpha,4
positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,EGFR,alpha,4
benzene-containing compound metabolic process (GO:0042537),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,CYP2E1,alpha,4
acid secretion (GO:0046717),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,SLC22A16,alpha,4
regulation of cilium movement (GO:0003352),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,ARMC4,alpha,4
copper ion import (GO:0015677),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,STEAP2,alpha,4
positive regulation of catenin import into nucleus (GO:0035413),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,EGFR,alpha,4
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,HMGA2,alpha,4
regulation of positive chemotaxis (GO:0050926),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,F7,alpha,4
lung epithelium development (GO:0060428),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,FGF10,alpha,4
kinetochore assembly (GO:0051382),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,CENPC,alpha,4
regulation of keratinocyte migration (GO:0051547),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,FGF10,alpha,4
regulation of receptor binding (GO:1900120),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,BDNF,alpha,4
succinate metabolic process (GO:0006105),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,GHR,alpha,4
protein localization to endosome (GO:0036010),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,TMEM30A,alpha,4
tRNA aminoacylation for mitochondrial protein translation (GO:0070127),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,DARS2,alpha,4
negative regulation of mRNA polyadenylation (GO:1900364),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,SUPT5H,alpha,4
heterochromatin assembly (GO:0031507),1/8,1,8,0.0920784651859131,1,0,0,10.4166666666667,24.8449394059906,HMGA2,alpha,4
glycolipid biosynthetic process (GO:0009247),2/43,2,43,0.0940203142307906,1,0,0,3.87596899224806,9.16373802799258,NDUFAB1;ST8SIA6,alpha,4
cellular protein complex assembly (GO:0043623),4/145,4,145,0.0973748428183362,1,0,0,2.29885057471264,5.35445376777386,BBS10;HOPX;FBXL7;CENPC,alpha,4
nervous system development (GO:0007399),9/456,9,456,0.0995521438624313,1,0,0,1.64473684210526,3.79452913350263,PTPRZ1;MYT1L;BDNF;SLITRK1;PCDH15;LSAMP;GFRA1;TAGLN3;HAPLN1,alpha,4
gene expression (GO:0010467),45/412,45,412,3.68071906323484e-07,0.00187827093796874,0,0,2.24277825402205,33.2267318440179,SLBP;SMG1;GTF3C4;DHX8;YTHDC2;SRSF1;ELAVL4;DDX20;BAZ2A;MRPL34;MRPL13;RPL6;MRPL10;LMF2;SMG6;RPS15;MRPL42;DHX30;NUP85;DHX34;MAGOH;RAE1;RPL19;UPF1;RPS9;COA1;NCBP1;RPS8;RPL23;MRPL27;TDRD9;MRPS18A;RPL23A;BAZ1A;THOC5;MRPS7;ILF2;RPS28;FUBP3;NUP50;BCL3;DRG1;RNPS1;NUP54;RPL26,alpha,5
ribosome biogenesis (GO:0042254),29/227,29,227,2.05329242189634e-06,0.00523897561446851,0,0,2.62327112863979,34.3545318199994,DDX49;DDX27;NIP7;RPL6;RPS15;RRP7A;FBL;EXOSC10;NOB1;SURF6;RRP36;EXOSC1;RPL19;NOM1;RPS9;RPS8;RPL23;WDR18;DDX31;CSNK1D;RPL23A;RRP1B;DDX52;SENP3;DIEXF;RPS28;EBNA1BP2;PIH1D2;RPL26,alpha,5
rRNA processing (GO:0006364),26/203,26,203,6.52158608360309e-06,0.0110932179282089,0,0,2.62995518960965,31.4026983976076,DDX49;DDX27;RPL6;RPS15;RRP7A;FBL;SART1;EXOSC10;NOB1;RRP36;EXOSC1;RPL19;RPS9;RPS8;RPL23;WDR18;CSNK1D;RPL23A;RRP1B;DDX52;SENP3;DIEXF;RPS28;EBNA1BP2;PIH1D2;RPL26,alpha,5
rRNA metabolic process (GO:0016072),25/201,25,201,1.62875814763803e-05,0.0207788820684921,0,0,2.55396528650383,28.1577421239253,DDX49;DDX27;RPL6;RPS15;RRP7A;FBL;EXOSC10;NOB1;RRP36;EXOSC1;RPL19;RPS9;RPS8;RPL23;WDR18;CSNK1D;RPL23A;RRP1B;DDX52;SENP3;DIEXF;RPS28;EBNA1BP2;PIH1D2;RPL26,alpha,5
cellular macromolecule biosynthetic process (GO:0034645),37/368,37,368,2.56381868544143e-05,0.0261663335036152,0,0,2.06454780823141,21.8252177721293,FEN1;GTF3C4;BAZ2A;BRCA1;MRPL34;MRPL13;RPL6;MRPL10;RPS15;EFTUD2;MRPL42;ORC6;RPL19;RFC5;UPF1;RPS9;COA1;NCOA6;RPS8;RPL23;MRPL27;MRPS18A;RPL23A;BAZ1A;INHBA;MRPS7;EEF2;ILF2;CDC25A;RPS28;FUBP3;BCL3;CDK2;KCTD13;DRG1;RNPS1;RPL26,alpha,5
ncRNA processing (GO:0034470),26/228,26,228,5.0735142522253e-05,0.0431502387151762,0,0,2.34158291004719,23.1556599002353,DDX49;DDX27;RPL6;RPS15;RRP7A;FBL;EXOSC10;NOB1;RRP36;EXOSC1;RPL19;RPS9;NCBP1;RPS8;RPL23;WDR18;CSNK1D;RPL23A;RRP1B;DDX52;SENP3;DIEXF;RPS28;EBNA1BP2;PIH1D2;RPL26,alpha,5
"regulation of transcription, DNA-templated (GO:0006355)",111/1599,111,1599,8.40381537447769e-05,0.0612638140799424,0,0,1.42542888073013,13.376566222223,FOXA1;SMARCB1;EHMT1;IKZF4;RPL6;UBE2L3;ZNF607;ZNF83;ZNF84;ATXN7L3;JUNB;TLE2;MAP2K2;ZFP3;MYT1;POU3F2;ILF2;HIC1;PIAS1;NPAS4;EID2;THAP7;RFX5;MZF1;ZNF674;ZNF28;ZNF274;CRABP2;BAZ2A;NPAS1;PHF21B;HMGXB4;NUP85;ZNHIT3;ZKSCAN3;PATZ1;ZNF267;ZBED4;ABCA2;ZNF781;SMURF2;FZD7;SNF8;INHBA;SMAD5;BMP2;TADA2A;FUBP3;COPS2;ZNF417;BCL3;SP6;TCF4;NFKBID;RNF10;NKAP;CBY1;RSF1;BRCA1;YBX1;MED16;ZMYM1;NKRF;CHMP1A;MLX;ANKRD1;EID2B;YWHAH;TCF19;BATF2;BATF3;RING1;NCOA6;VEZF1;BAZ1A;ETV2;MED26;ETV4;MED24;HAND1;RARA;PPARD;CREB5;YAP1;HDAC5;SMARCD2;CEBPB;ZNF197;CEBPG;FOXK2;LIN9;ACVR1B;PPM1F;ATOH8;ZNF623;ZNF468;ZNF500;SUZ12;SPEN;CDK11A;PCGF6;USP21;CDC5L;KLF4;TBX3;KLF2;MAD2L2;CENPF;TFAP4;WT1;ZNF699,alpha,5
protein import into nucleus (GO:0006606),15/104,15,104,0.00015176070719953,0.0968043611049002,0,0,2.96161743800348,26.0421109590567,RPL23;NUTF2;GDF5;GPN1;NUP85;NUP50;BCL3;KPNA6;KPNA7;NUP54;NUP62CL;TNPO2;RAE1;TNPO3;RBM22,alpha,5
"mRNA splicing, via spliceosome (GO:0000398)",27/262,27,262,0.000204539948303347,0.115974150687998,0,0,2.11608696333683,17.9756239238502,SF3B3;DHX8;SRSF1;DDX20;WDR83;CWC25;YBX1;EFTUD2;SART1;MAGOH;CTNNBL1;SRRM2;SPEN;SF3A2;USP49;NCBP1;CDC5L;CHERP;GEMIN4;RNPS1;SNRNP25;GEMIN7;CACTIN;SNRPC;SUGP1;SNRPB;RBM22,alpha,5
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",25/237,25,237,0.000242313350974752,0.123652503002416,0,0,2.16602119235135,18.0327303794212,SF3B3;DHX8;SRSF1;WDR83;CWC25;YBX1;EFTUD2;SART1;MAGOH;CTNNBL1;SRRM2;SPEN;SF3A2;USP49;NCBP1;CDC5L;CHERP;RNPS1;SNRNP25;GEMIN7;CACTIN;SNRPC;SUGP1;SNRPB;RBM22,alpha,5
negative regulation of G0 to G1 transition (GO:0070317),8/38,8,38,0.000407754867261721,0.173397757303047,0,0,4.32292229547174,33.7397357815069,SUZ12;PCGF6;RAD51;RING1;PCGF2;EHMT1;BRCA1;E2F6,alpha,5
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",15/113,15,113,0.000383346064972207,0.177837724504834,0,0,2.72573640311824,21.4422027934864,UPF1;RPS9;SMG1;NCBP1;RPS8;RPL23;RPL23A;RPL6;SMG6;RPS15;RPS28;MAGOH;RNPS1;RPL26;RPL19,alpha,5
translation (GO:0006412),24/233,24,233,0.000453553498693649,0.178037192602591,0,0,2.11507786130377,16.2827097536745,RPS9;NDUFA7;COA1;RPS8;RPL23;MRPS34;MRPL27;MRPS18A;RPL23A;MRPL34;MRPS7;EEF2;MRPL13;FTSJ1;RPL6;MRPL10;RPS15;EFTUD2;MRPL42;RPS28;LARS;RARS;RPL26;RPL19,alpha,5
RNA export from nucleus (GO:0006405),15/120,15,120,0.000730720665221256,0.207159308590226,0,0,2.56673511293635,18.5356244819402,SLBP;UPF1;SMG1;NCBP1;SRSF1;THOC5;SMG6;XPOT;NUP85;NUP50;MAGOH;RNPS1;NUP54;NUP62CL;RAE1,alpha,5
ribonucleoprotein complex assembly (GO:0022618),18/157,18,157,0.000650790848748347,0.207561606322676,0,0,2.3542029061327,17.27354535067,SF3A2;NCBP1;WDR18;SRSF1;DDX20;RPL23A;MRPS7;RPL6;RPS15;RRP7A;MRPL20;SART1;RPS28;GEMIN4;GEMIN7;SNRPC;SNRPB;RBM22,alpha,5
mRNA export from nucleus (GO:0006406),14/106,14,106,0.000624219801973857,0.212359576631506,0,0,2.71202200612142,20.0120320925432,SLBP;UPF1;SMG1;NCBP1;ZC3H3;SRSF1;THOC5;SMG6;NUP85;NUP50;MAGOH;RNPS1;NUP54;RAE1,alpha,5
cellular response to DNA damage stimulus (GO:0006974),30/330,30,330,0.000796922763366196,0.214036676918826,0,0,1.86671644577189,13.3185603753441,YAP1;PPP1R15A;RTEL1;FEN1;SMG1;SMARCB1;BRAT1;DOT1L;BOD1L1;CIB1;BRCA1;SLX4;RFC5;UPF1;NCOA6;FANCL;DDX11;H2AFX;FANCC;UBE2A;ZDHHC16;HIC1;RAD51B;RAD51D;EID3;RNF169;RAD51;TAOK1;BCL3;FAN1,alpha,5
regulation of G0 to G1 transition (GO:0070316),8/40,8,40,0.000588265517465864,0.214422781116308,0,0,4.10677618069815,30.5475653046088,SUZ12;PCGF6;RAD51;RING1;PCGF2;EHMT1;BRCA1;E2F6,alpha,5
mRNA processing (GO:0006397),27/284,27,284,0.000729500483237044,0.218978880350508,0,0,1.95216473378257,14.1007797267435,SF3B3;DHX8;SRSF1;ELAVL4;WDR83;CWC25;YBX1;EFTUD2;SART1;MAGOH;CTNNBL1;SRRM2;SPEN;SF3A2;USP49;NCBP1;CDC5L;THOC5;CHERP;RNPS1;SNRNP25;GEMIN7;CACTIN;SNRPC;SUGP1;SNRPB;RBM22,alpha,5
histone mRNA metabolic process (GO:0008334),6/25,6,25,0.00104753900161456,0.267279576261955,0,0,4.92813141683778,33.8134456204494,LSM10;SLBP;UPF1;EXOSC10;NCBP1;SNRPB,alpha,5
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),13/101,13,101,0.00122829542519222,0.29847578832171,0,0,2.64297476975624,17.7135549537656,SLBP;UPF1;SMG1;NCBP1;SRSF1;THOC5;SMG6;NUP85;NUP50;MAGOH;RNPS1;NUP54;RAE1,alpha,5
ribosomal small subunit biogenesis (GO:0042274),8/45,8,45,0.0013298558399225,0.308466106869296,0,0,3.65046771617614,24.1758968146345,RPS15;RRP7A;NOM1;RPS28;NOB1;SURF6;RRP36;MRPS7,alpha,5
DNA-dependent DNA replication maintenance of fidelity (GO:0045005),7/36,7,36,0.00153542770273023,0.340664676827494,0,0,3.99269906456765,25.8684828435864,RTEL1;RAD51;EME1;EME2;DDX11;BOD1L1;ZNF830,alpha,5
spliceosomal snRNP assembly (GO:0000387),7/38,7,38,0.00213309782394549,0.351135425664317,0,0,3.78255700853777,23.2634063810813,SART1;DDX20;GEMIN4;GEMIN7;SNRPC;SNRPB;RBM22,alpha,5
RNA splicing (GO:0008380),13/107,13,107,0.00208698139859512,0.35499553590103,0,0,2.49477057705963,15.3978152201895,SF3B3;SF3A2;DHX8;NCBP1;WDR83;PPP1R9B;EFTUD2;WT1;MAGOH;RNPS1;SNRNP25;TARDBP;SNRPB,alpha,5
nuclear-transcribed mRNA catabolic process (GO:0000956),18/175,18,175,0.0022599341568567,0.360388875076242,0,0,2.11205632150191,12.867533329964,UPF1;RPS9;SMG1;NBAS;NCBP1;RPS8;RPL23;RPL23A;RPL6;SMG6;RPS15;RPS28;EXOSC10;DHX34;MAGOH;RNPS1;RPL26;RPL19,alpha,5
glucocorticoid receptor signaling pathway (GO:0042921),3/6,3,6,0.00206121519374453,0.362702797713046,0,0,10.2669404517454,63.4954781337495,NCOA6;NEDD4;YWHAH,alpha,5
mRNA transport (GO:0051028),13/105,13,105,0.00175831837943704,0.373862445427801,0,0,2.54229001662267,16.126755863465,SLBP;UPF1;SMG1;NCBP1;SRSF1;THOC5;SMG6;NUP85;NUP50;MAGOH;RNPS1;NUP54;RAE1,alpha,5
intracellular protein transport (GO:0006886),30/348,30,348,0.00183414699710128,0.374386085048314,0,0,1.77016214685265,11.1541028061824,RAB3B;KDELR1;RAB3D;AP4E1;HID1;GGA2;GGA3;NUP85;TMED2;TLK1;VPS35;STX4;CCHCR1;TMED6;RAE1;TNPO2;TNPO3;YWHAH;RAB4A;COG7;HPS4;NUTF2;SNF8;APPBP2;CDC37;NUP50;BCL3;TBC1D25;NUP62CL;RBM22,alpha,5
corticosteroid receptor signaling pathway (GO:0031958),3/6,3,6,0.00206121519374453,0.37565646905994,0,0,10.2669404517454,63.4954781337495,NCOA6;NEDD4;YWHAH,alpha,5
translational elongation (GO:0006414),13/106,13,106,0.00191684868536165,0.376218416976943,0,0,2.51830614854132,15.7572247809009,MRPS23;MRPS34;MRPL27;MRPS18A;EEF2;MRPL34;MRPS7;MRPL13;MRPL10;EFTUD2;MRPL20;MRPL42;ZNF598,alpha,5
DNA repair (GO:0006281),26/289,26,289,0.00199480457080504,0.377018063882152,0,0,1.84733876640401,11.485291560952,FEN1;SMG1;SMARCB1;DOT1L;CIB1;BRCA1;SLX4;EME1;EME2;ORAOV1;RFC5;UPF1;NCOA6;FANCL;H2AFX;FANCC;UBE2A;FANCE;RAD51B;MAD2L2;RAD51D;EID3;HIST3H2A;RAD51;TRIP13;FAN1,alpha,5
nuclear import (GO:0051170),10/72,10,72,0.00247252570636274,0.382342384229365,0,0,2.85192790326261,17.11874029663,NUP85;NUP50;GEMIN4;DDX20;NUTF2;GEMIN7;NUP62CL;RAE1;TNPO3;SNRPB,alpha,5
viral process (GO:0016032),21/221,21,221,0.0027164603000356,0.407708732678873,0,0,1.95118325327288,11.5284210965332,RPS9;RPS8;RPL23;RPL23A;AP2A2;RPL6;RPS15;RPS28;RXRA;TBC1D20;NUP85;NEDD4;NUP50;MVB12B;EIF3G;NUP54;RPL26;B2M;RAE1;RPL19;AP1M1,alpha,5
viral gene expression (GO:0019080),13/111,13,111,0.0028964525690885,0.422302784573103,0,0,2.40486893464306,14.0546998643194,RPS9;RPS8;RPL23;RPL23A;RPL6;RPS15;RPS28;NUP85;NUP50;NUP54;RPL26;RAE1;RPL19,alpha,5
RNA processing (GO:0006396),19/194,19,194,0.00302472482230647,0.428754743561942,0,0,2.01105019157899,11.6659717637889,SF3B3;SF3A2;DHX8;NCBP1;YTHDC2;SRSF1;TDRD9;ELAVL4;DDX20;PPP1R9B;EFTUD2;DHX30;DHX34;WT1;MAGOH;RNPS1;SNRNP25;TARDBP;SNRPB,alpha,5
strand invasion (GO:0042148),3/7,3,7,0.00347675779486659,0.454920385312928,0,0,8.80023467292461,49.823893408126,RAD51B;RAD51D;RAD51,alpha,5
replication fork processing (GO:0031297),6/31,6,31,0.00339493444260981,0.45590395949047,0,0,3.97429952970789,22.5957640384459,RTEL1;RAD51;EME1;EME2;DDX11;BOD1L1,alpha,5
negative regulation of nucleic acid-templated transcription (GO:1903507),35/445,35,445,0.00373629444654083,0.46503196489507,0,0,1.61502434072399,9.02743848807202,HDAC5;NKAP;CBY1;EHMT1;RSF1;BRCA1;PPM1F;IKZF4;NKRF;CHMP1A;ATOH8;ZKSCAN3;MLX;PATZ1;EID2B;SPEN;PCGF6;TLE2;RING1;SMURF2;KLF4;TBX3;EID2;CENPF;BMP2;TFAP4;WT1;THAP7;COPS2;ZNF417;BCL3;HAND1;RARA;ZNF674;PPARD,alpha,5
viral transcription (GO:0019083),13/114,13,114,0.0036582436642321,0.466700435464411,0,0,2.34158291004719,13.1380881081399,RPS9;RPS8;RPL23;RPL23A;RPL6;RPS15;RPS28;NUP85;NUP50;NUP54;RPL26;RAE1;RPL19,alpha,5
ribosomal large subunit assembly (GO:0000027),6/31,6,31,0.00339493444260981,0.468225688125348,0,0,3.97429952970789,22.5957640384459,DDX28;DHX30;MRPL20;WDR18;RPL23A;RPL6,alpha,5
double-strand break repair (GO:0006302),15/142,15,142,0.00393610647682063,0.478236936933706,0,0,2.16907192642508,12.011372982301,FEN1;PAXIP1;H2AFX;CIB1;BRCA1;RAD51B;MAD2L2;RAD51D;SLX4;RAD51;EME1;EME2;TRIP13;ORAOV1;FAN1,alpha,5
double-strand break repair via synthesis-dependent strand annealing (GO:0045003),3/8,3,8,0.00536227302221477,0.55844243331351,0,0,7.70020533880904,40.2595019698423,RAD51B;RAD51D;RAD51,alpha,5
DNA repair complex assembly (GO:0090735),3/8,3,8,0.00536227302221477,0.570076650674208,0,0,7.70020533880904,40.2595019698423,RAD51B;RAD51D;RAD51,alpha,5
regulation of cellular response to heat (GO:1900034),10/79,10,79,0.00489770660278035,0.58123248358112,0,0,2.59922543082162,13.8252494572284,YWHAE;DNAJB1;HSPA1L;NUP85;NUP50;NUP54;IER5;CRYAB;RAE1;HSPA1A,alpha,5
DNA recombinase assembly (GO:0000730),3/8,3,8,0.00536227302221477,0.582205941114085,0,0,7.70020533880904,40.2595019698423,RAD51B;RAD51D;RAD51,alpha,5
protein-DNA complex assembly (GO:0065004),11/92,11,92,0.00504585289400262,0.585204257229441,0,0,2.45513793411303,12.985687528788,RAD51B;HIST1H2BN;NAA60;RAD51D;CENPV;CHAF1A;RAD51;H2AFX;RSF1;HIST3H2BB;TCF4,alpha,5
cotranslational protein targeting to membrane (GO:0006613),11/94,11,94,0.00593817935688689,0.594167240356741,0,0,2.40290095679147,12.3181178032703,RPS15;RPS9;RPS28;RPS8;RPL23;SSR2;RPL23A;RPL26;SRP68;RPL6;RPL19,alpha,5
histone H2A-K119 monoubiquitination (GO:0036353),3/8,3,8,0.00536227302221477,0.594862592007869,0,0,7.70020533880904,40.2595019698423,PCGF6;PCGF2;TRIM37,alpha,5
"negative regulation of transcription, DNA-templated (GO:0045892)",56/814,56,814,0.00585541583129176,0.597603739741637,0,0,1.41265028328683,7.26157093576806,NKAP;CBY1;EHMT1;RSF1;BRCA1;IKZF4;NKRF;CHMP1A;MLX;ZNF567;JUNB;EID2B;BATF3;TLE2;RING1;RPL23;HIC1;EID2;MED25;THAP7;HAND1;RARA;MZF1;ZNF674;PPARD;HDAC5;CEBPB;DDX20;LRP8;PPM1F;RELB;RXRA;ATOH8;ZKSCAN3;ZNF500;PATZ1;E2F6;SPEN;CBX7;PCGF6;SMURF2;PCGF2;KLF4;TBX3;KLF2;THAP11;MAD2L2;CENPF;BMP2;TFAP4;WT1;COPS2;DNAJA3;ZNF417;BCL3;TRIM37,alpha,5
ribosome assembly (GO:0042255),8/57,8,57,0.00610472870672653,0.599085203662029,0,0,2.88194819698116,14.6941650932368,RPS15;RRP7A;MRPL20;RPS28;WDR18;RPL23A;MRPS7;RPL6,alpha,5
peptide biosynthetic process (GO:0043043),17/175,17,175,0.00528523512368924,0.599345663026359,0,0,1.99471985919625,10.4579934197965,RPS9;COA1;RPS8;RPL23;MRPL27;MRPS18A;RPL23A;MRPL34;MRPS7;MRPL13;RPL6;MRPL10;RPS15;MRPL42;RPS28;RPL26;RPL19,alpha,5
negative regulation of cell cycle process (GO:0010948),10/82,10,82,0.00638445079192924,0.614714196060659,0,0,2.50413181749887,12.6556062717402,SUZ12;PCGF6;TFAP4;RAD51;RING1;RPL23;PCGF2;EHMT1;BRCA1;E2F6,alpha,5
Golgi organization (GO:0007030),13/122,13,122,0.0065055362196327,0.61477317275529,0,0,2.18803648971623,11.016986333263,COG7;FBXW8;COG4;COG2;COG1;CSNK1D;CDC42;NSFL1C;NPLOC4;TBC1D20;PLEKHM2;TMED2;TMED6,alpha,5
protein targeting to ER (GO:0045047),11/98,11,98,0.00809191122995928,0.645203484476284,0,0,2.30482336671835,11.1020813871251,RPS15;RPS9;RPS28;RPS8;RPL23;PMM2;RPL23A;RPL26;SRP68;RPL6;RPL19,alpha,5
mRNA catabolic process (GO:0006402),6/37,6,37,0.00836982960979735,0.647140007557514,0,0,3.32981852489039,15.9269274164172,UPF1;NBAS;EXOSC10;DHX34;METTL16;HSPA1A,alpha,5
regulation of protein metabolic process (GO:0051246),8/60,8,60,0.00832149027485474,0.65330099803975,0,0,2.7378507871321,13.111331747064,HGS;LTBP4;SPOP;KLHL11;VPS35;SNF8;KLF4;KLF2,alpha,5
mRNA metabolic process (GO:0016071),11/98,11,98,0.00809191122995928,0.655444809626701,0,0,2.30482336671835,11.1020813871251,EFTUD2;LSM10;SLBP;SF3B3;SF3A2;NCBP1;SRSF1;ELAVL4;METTL16;SNRPB;HSPA1A,alpha,5
positive regulation of signal transduction by p53 class mediator (GO:1901798),4/17,4,17,0.00799816454203912,0.658300542871381,0,0,4.83150138905665,23.3291131579708,RPL23;ANKRD1;CHD5;HIC1,alpha,5
histone H2A monoubiquitination (GO:0035518),4/17,4,17,0.00799816454203912,0.669092355049601,0,0,4.83150138905665,23.3291131579708,PCGF6;RING1;PCGF2;TRIM37,alpha,5
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),12/111,12,111,0.00781707110528359,0.676110404241732,0,0,2.2198790165936,10.7696216960951,YWHAE;LRRC46;NBPF3;HSPA1L;CSNK2A2;VPS11;HPS4;NKAP;BMF;ZDHHC8;UBE2L3;YWHAH,alpha,5
"transcription, DNA-templated (GO:0006351)",28/357,28,357,0.00917802115362991,0.67877452097063,0,0,1.61050046301888,7.55476693351536,CEBPB;GTF3C4;HSF2BP;BAZ2A;RSF1;YBX1;MED16;TRIM29;BATF3;NCBP1;NCOA6;VEZF1;BAZ1A;POLRMT;KLF4;ILF2;TADA2A;FUBP3;COPS2;BCL3;HAND1;DRG1;RNPS1;TCF4;TRIP13;TARDBP;POLR3K;CREB5,alpha,5
"mRNA cis splicing, via spliceosome (GO:0045292)",4/17,4,17,0.00799816454203912,0.680243894300427,0,0,4.83150138905665,23.3291131579708,SART1;SRSF1;SNRPC;RBM22,alpha,5
strand displacement (GO:0000732),5/27,5,27,0.00894855095899525,0.681559037966459,0,0,3.80257053768347,17.9339252560123,RAD51B;RTEL1;RAD51D;RAD51;BRCA1,alpha,5
tRNA wobble uridine modification (GO:0002098),3/9,3,9,0.0077541923857478,0.682235236973638,0,0,6.84462696783025,33.261612791783,CTU2;TRMU;URM1,alpha,5
interstrand cross-link repair (GO:0036297),7/49,7,49,0.00914433540720738,0.686228582102636,0,0,2.93341155764154,13.7712545397011,SLX4;RAD51;EME1;FANCL;FANCC;FANCE;FAN1,alpha,5
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),3/9,3,9,0.0077541923857478,0.69420427621879,0,0,6.84462696783025,33.261612791783,PTPN1;HGS;NEDD4,alpha,5
ATP synthesis coupled electron transport (GO:0042773),3/9,3,9,0.0077541923857478,0.706600781151268,0,0,6.84462696783025,33.261612791783,NDUFB6;NDUFA12;COA6,alpha,5
positive regulation of protein sumoylation (GO:0033235),3/9,3,9,0.0077541923857478,0.719448068081291,0,0,6.84462696783025,33.261612791783,RASD2;MUL1;PIAS1,alpha,5
myeloid dendritic cell differentiation (GO:0043011),3/10,3,10,0.0106801464937328,0.726677167433581,0,0,6.16016427104723,27.9632570568943,BATF2;BATF3;TGFBR2,alpha,5
positive regulation of reproductive process (GO:2000243),3/10,3,10,0.0106801464937328,0.736497129155656,0,0,6.16016427104723,27.9632570568943,SMURF2;INHBA;ACVR1B,alpha,5
protein targeting to vacuole (GO:0006623),5/28,5,28,0.010466262745965,0.741796372120266,0,0,3.66676444705192,16.7189728169204,LARS;TMEM50A;HGS;NEDD4;NAGPA,alpha,5
positive regulation of mitochondrion organization (GO:0010822),13/129,13,129,0.0102377568239782,0.746332472468012,0,0,2.06930582748356,9.48088210780165,LRRC46;NBPF3;HSPA1L;CSNK2A2;HPS4;NKAP;MUL1;ZDHHC8;UBE2L3;VPS11;VPS35;BMF;FBXO7,alpha,5
regulation of attachment of spindle microtubules to kinetochore (GO:0051988),3/10,3,10,0.0106801464937328,0.746586130924912,0,0,6.16016427104723,27.9632570568943,CDC42;SPAG5;RCC2,alpha,5
mitochondrial translational elongation (GO:0070125),10/88,10,88,0.010388566130036,0.746659900867233,0,0,2.33339555721486,10.6567329853542,MRPL42;MRPL20;MRPS23;MRPS34;MRPL27;MRPS18A;MRPL34;MRPS7;MRPL13;MRPL10,alpha,5
regulation of type I interferon-mediated signaling pathway (GO:0060338),6/40,6,40,0.0122189154078463,0.751242473810118,0,0,3.08008213552361,13.5670536488904,PTPN1;MAVS;CDC37;MUL1;PTPN11;CACTIN,alpha,5
ribosomal large subunit biogenesis (GO:0042273),8/64,8,64,0.0121514918148479,0.756208082087426,0,0,2.56673511293635,11.3200804250969,MRPL20;EBNA1BP2;NIP7;WDR18;SURF6;RPL23A;RPL26;RPL6,alpha,5
negative regulation of gene expression (GO:0010629),43/619,43,619,0.0124612637931519,0.757021775433979,0,0,1.4264246831181,6.25505815958085,HDAC5;NKAP;CBY1;EHMT1;RSF1;BRCA1;PPM1F;IKZF4;NKRF;CHMP1A;ATOH8;ZKSCAN3;CPNE1;MLX;FLOT2;METTL16;PATZ1;EID2B;SUZ12;SPEN;PCGF6;TLE2;MAP2K2;RING1;SMURF2;KLF4;TBX3;RBL2;EID2;CENPF;BMP2;TFAP4;WT1;THAP7;COPS2;ZNF417;BCL3;HAND1;RARA;TARDBP;ZNF674;PPARD;HSPA1A,alpha,5
lytic vacuole organization (GO:0080171),5/29,5,29,0.0121510184453476,0.765514162056897,0,0,3.5403242937053,15.6140419530063,CLN3;VPS11;ZKSCAN3;HPS4;NAGPA,alpha,5
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),10/90,10,90,0.0120768873371473,0.770354451018284,0,0,2.28154232261008,10.0763444910888,RPS15;RPS9;RPS28;RPS8;RPL23;RPL23A;RPL26;SRP68;RPL6;RPL19,alpha,5
mitochondrial translational termination (GO:0070126),10/90,10,90,0.0120768873371473,0.780105773183073,0,0,2.28154232261008,10.0763444910888,MRPL42;MRPL20;MRPS23;MRPS34;MRPL27;MRPS18A;MRPL34;MRPS7;MRPL13;MRPL10,alpha,5
ribosomal small subunit assembly (GO:0000028),4/19,4,19,0.0120570003128545,0.788806058929445,0,0,4.32292229547174,19.0991455696488,RPS15;RRP7A;RPS28;MRPS7,alpha,5
protein targeting to lysosome (GO:0006622),4/19,4,19,0.0120570003128545,0.799050293460996,0,0,4.32292229547174,19.0991455696488,HGS;LARS;NEDD4;NAGPA,alpha,5
positive regulation of chromosome segregation (GO:0051984),3/11,3,11,0.0141599347643477,0.802868301138513,0,0,5.60014933731566,23.8417330470306,FEN1;RCC2;DDX11,alpha,5
brain development (GO:0007420),12/120,12,120,0.0140867229735787,0.807691543080588,0,0,2.05338809034908,8.75261305604203,SRR;CENPF;SLC6A17;PITPNM1;MAP1S;NCOA6;CDK5RAP1;RARA;CTNS;PTPN11;SLC6A4;TGFBR2,alpha,5
positive regulation of chromosome organization (GO:2001252),4/19,4,19,0.0120570003128545,0.809564113111799,0,0,4.32292229547174,19.0991455696488,BECN1;FEN1;RTEL1;DDX11,alpha,5
semaphorin-plexin signaling pathway (GO:0071526),5/30,5,30,0.0140105118118799,0.812450474727534,0,0,3.42231348391513,14.6062538925506,SEMA7A;ARHGDIA;PLXNA2;MET;PLXNA3,alpha,5
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),8/66,8,66,0.0144903837461251,0.812576134686552,0,0,2.48895526102918,10.5389086913963,RASD2;PAXIP1;MUL1;BRCA1;SEPT4;UBE2L3;PIAS1;BIRC3,alpha,5
vacuolar transport (GO:0007034),5/30,5,30,0.0140105118118799,0.821788985931299,0,0,3.42231348391513,14.6062538925506,BECN1;CLN3;TMEM50A;VPS53;NEDD4,alpha,5
regulation of protein catabolic process (GO:0042176),10/92,10,92,0.0139642447483637,0.828599313382557,0,0,2.23194357646639,9.53320052405431,SNX3;MAD2L2;ITCH;SF3B3;SMURF2;HGS;NEDD4;SNF8;OAZ1;OAZ2,alpha,5
"positive regulation of transcription, DNA-templated (GO:0045893)",71/1121,71,1121,0.0138261520980136,0.830057107719568,0,0,1.30054018211226,5.56786404494002,FOXA1;RNF10;SMARCB1;FHOD1;RSF1;BRCA1;YBX1;MED16;IKZF4;DCAF6;NKRF;MLX;ZNF567;ATXN7L3;IER5;JUNB;YWHAH;MAP2K2;NCOA6;RPL23;EBF1;VEZF1;THOC5;ETV4;ILF2;PIAS1;NPAS4;MED25;MED24;RFX5;HAND1;RARA;MZF1;SQSTM1;MET;PPARD;CREB5;YAP1;HDAC5;CEBPB;DOT1L;CEBPG;FOXK2;NPAS1;RELB;DDN;RXRA;NUP85;ATOH8;ZKSCAN3;RPRD1B;E2F4;AAMDC;USP21;FZD7;CDC5L;INHBA;RRP1B;KLF4;SMAD5;KLF2;MAD2L2;BMP2;MAVS;TFAP4;FUBP3;WT1;BCL3;TCF4;SSBP4;CCDC62,alpha,5
liver development (GO:0001889),5/32,5,32,0.0182821355125404,0.848124886549941,0,0,3.20841889117043,12.8395498505849,CEBPB;DNAAF1;CEBPG;RARA;MET,alpha,5
termination of RNA polymerase II transcription (GO:0006369),8/69,8,69,0.0185883837005176,0.854563261475146,0,0,2.38073981489748,9.48776817687637,LSM10;SLBP;NCBP1;MAGOH;SRSF1;RNPS1;THOC5;SNRPB,alpha,5
lysosome organization (GO:0007040),5/32,5,32,0.0182821355125404,0.855905848811867,0,0,3.20841889117043,12.8395498505849,CLN3;VPS11;ZKSCAN3;HPS4;NAGPA,alpha,5
cofactor biosynthetic process (GO:0051188),5/32,5,32,0.0182821355125404,0.863830902967533,0,0,3.20841889117043,12.8395498505849,NFU1;SLC25A16;NFS1;COASY;ISCU,alpha,5
nucleosome organization (GO:0034728),9/80,9,80,0.0155786124404587,0.864104992213703,0,0,2.31006160164271,9.61414443667598,HIST1H2BN;NAA60;SMARCD2;SMARCB1;CHAF1A;HIST3H2A;H2AFX;RSF1;HIST3H2BB,alpha,5
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),36/513,36,513,0.0182116013738404,0.868540203838389,0,0,1.44097409849058,5.77210483065481,HDAC5;NKAP;CBY1;EHMT1;RSF1;BRCA1;PPM1F;IKZF4;NKRF;CHMP1A;ATOH8;ZKSCAN3;MLX;ANKRD1;PATZ1;EID2B;SPEN;PCGF6;TLE2;RING1;SMURF2;KLF4;TBX3;EID2;CENPF;BMP2;TFAP4;WT1;THAP7;COPS2;ZNF417;BCL3;HAND1;RARA;ZNF674;PPARD,alpha,5
negative regulation of ERBB signaling pathway (GO:1901185),6/44,6,44,0.0190837432805478,0.869503053219958,0,0,2.80007466865783,11.0852672489169,CDC42;ERBB3;HGS;NRG4;EPS15L1;PTPN3,alpha,5
regulation of sister chromatid cohesion (GO:0007063),3/12,3,12,0.0182064120650133,0.876484158186444,0,0,5.13347022587269,20.5645864254721,FEN1;ESPL1;DDX11,alpha,5
protein-DNA complex disassembly (GO:0032986),4/21,4,21,0.0172381819565041,0.879664425240405,0,0,3.91121541018872,15.8819926636023,SMARCD2;SMARCB1;HIST3H2A;RPL23,alpha,5
positive regulation of intracellular protein transport (GO:0090316),14/153,14,153,0.0174343704206343,0.880867250064325,0,0,1.87891720685536,7.60832144707603,YWHAE;LRRC46;NBPF3;HSPA1L;CSNK2A2;HPS4;NKAP;CIB1;ZDHHC8;OAZ1;OAZ2;UBE2L3;VPS11;RBM22,alpha,5
regulation of cellular component organization (GO:0051128),13/141,13,141,0.0202834197947662,0.884669155664032,0,0,1.89319469322964,7.37958106689505,PTPN1;RAB4A;CDK11A;LTBP4;FITM2;PTPN11;CAMSAP2;MAD2L2;ZMYM1;ITCH;NEDD4;RAPGEF1;PACSIN3,alpha,5
mitochondrial translation (GO:0032543),11/108,11,108,0.0161249199049499,0.8847899599458,0,0,2.09141379572591,8.63207909687482,MRPL20;MRPL42;NDUFA7;MRPS23;MRPS34;MRPL27;MRPS18A;MRPL34;MRPS7;MRPL13;MRPL10,alpha,5
endosome transport via multivesicular body sorting pathway (GO:0032509),3/12,3,12,0.0182064120650133,0.884831626359648,0,0,5.13347022587269,20.5645864254721,TMEM50A;SNF8;UBXN6,alpha,5
translational termination (GO:0006415),10/97,10,97,0.0196402154109583,0.886938223381593,0,0,2.1168949385042,8.31976969907188,MRPL20;MRPL42;MRPS23;MRPS34;MRPL27;MRPS18A;MRPL34;MRPS7;MRPL13;MRPL10,alpha,5
positive regulation of histone acetylation (GO:0035066),4/21,4,21,0.0172381819565041,0.888549924485258,0,0,3.91121541018872,15.8819926636023,PAXIP1;SMARCB1;TADA2A;BRCA1,alpha,5
DNA metabolic process (GO:0006259),24/315,24,315,0.0206037572672322,0.891025197751576,0,0,1.56448616407549,6.07377620526796,RFC5;UPF1;RTEL1;FEN1;SMG1;SMARCB1;RFC1;NCOA6;FANCL;DOT1L;FANCC;BRCA1;UBE2A;CDC25A;RAD51B;RAD51D;EID3;CDC34;SLX4;ORC6;RAD51;CDK2;KCTD13;FAN1,alpha,5
NLS-bearing protein import into nucleus (GO:0006607),4/22,4,22,0.0202757465557178,0.891958057532997,0,0,3.73343289154377,14.5541529145722,KPNA6;KPNA7;NUP54;TNPO2,alpha,5
protein localization to kinetochore (GO:0034501),3/12,3,12,0.0182064120650133,0.893339622766952,0,0,5.13347022587269,20.5645864254721,CENPT;MTBP;RCC2,alpha,5
positive regulation of protein catabolic process (GO:0045732),9/82,9,82,0.0180775194929884,0.895627009443882,0,0,2.25371863574899,9.04436699717827,ITCH;SMURF2;NEDD4;VPS11;PACSIN3;VPS35;SNF8;OAZ1;OAZ2,alpha,5
"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",4/21,4,21,0.0172381819565041,0.897616760449393,0,0,3.91121541018872,15.8819926636023,COX7A2L;COX6C;COX6A1;COX5A,alpha,5
regulation of ERBB signaling pathway (GO:1901184),4/22,4,22,0.0202757465557178,0.899714214555024,0,0,3.73343289154377,14.5541529145722,FER;ERBB3;NRG4;MVB12B,alpha,5
positive regulation of protein targeting to mitochondrion (GO:1903955),9/82,9,82,0.0180775194929884,0.904407666399214,0,0,2.25371863574899,9.04436699717827,NBPF3;LRRC46;HSPA1L;CSNK2A2;NKAP;VPS11;HPS4;ZDHHC8;UBE2L3,alpha,5
dendritic cell differentiation (GO:0097028),4/21,4,21,0.0172381819565041,0.906870541484954,0,0,3.91121541018872,15.8819926636023,BATF2;BATF3;AXL;TGFBR2,alpha,5
regulation of microtubule depolymerization (GO:0031114),4/22,4,22,0.0202757465557178,0.907606444507261,0,0,3.73343289154377,14.5541529145722,SPEF1;MAP1S;CIB1;CAMSAP2,alpha,5
"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",9/81,9,81,0.0167941323466025,0.911706993241625,0,0,2.28154232261008,9.32403768802957,NBAS;COG7;KDELR1;PITPNB;COG4;TMED2;KIF23;COPE;SCYL1,alpha,5
respiratory electron transport chain (GO:0022904),10/95,10,95,0.0171975059726664,0.914154926859548,0,0,2.16146114773587,8.78199698965879,COX7A2L;NDUFA7;NDUFS7;NDUFB6;NDUFA12;NDUFS6;COX6A1;SLC25A12;COX6C;COX5A,alpha,5
regulation of ion transmembrane transporter activity (GO:0032412),6/43,6,43,0.0171673746473331,0.922159082372007,0,0,2.86519268420801,11.6462762596975,YWHAE;FXYD2;NEDD4;UTRN;YWHAH;PTPN3,alpha,5
tRNA modification (GO:0006400),7/58,7,58,0.0220062682865393,0.928082537737275,0,0,2.47822700559371,9.45797479594879,CTU2;URM1;THUMPD2;CDK5RAP1;LCMT2;SEPHS2;FTSJ1,alpha,5
regulation of transcription from RNA polymerase II promoter (GO:0006357),89/1479,89,1479,0.02166149195873,0.928895743406716,0,0,1.23564259662656,4.73525323241156,FOXA1;RNF10;SMARCB1;FHOD1;CHD5;BRCA1;YBX1;MED16;IKZF4;DCAF6;ZMYM1;NKRF;MLX;ANKRD1;ZNF567;IER5;JUNB;TCF19;BATF2;BATF3;NCOA6;RPL23;EBF1;VEZF1;ETV2;MED26;POU3F2;ETV4;HIC1;NPAS4;MED25;RFX5;HAND1;RARA;MZF1;SQSTM1;MET;PPARD;YAP1;HDAC5;SMARCD2;CEBPB;DOT1L;CEBPG;DDX20;FOXK2;LIN9;NPAS1;LRP8;RELB;DDN;FAM83G;RXRA;ZKSCAN3;RPRD1B;E2F4;ZNF500;E2F6;ZBED4;AAMDC;SPEN;ABCA2;CBX7;SMURF2;PCGF2;CDC5L;SNF8;INHBA;RRP1B;KLF4;GDF5;SMAD5;TBX3;KLF2;THAP11;MAD2L2;BMP2;MAVS;TFAP4;TADA2A;FUBP3;WT1;DNAJA3;SP6;TRIM37;TCF4;NFKBID;SSBP4;CCDC62,alpha,5
recombinational repair (GO:0000725),8/72,8,72,0.0234544461851286,0.935062803771183,0,0,2.28154232261008,8.56193292102405,RAD51B;FEN1;RAD51D;SLX4;RAD51;BRCA1;ORAOV1;FAN1,alpha,5
regulation of autophagy (GO:0010506),17/204,17,204,0.0219934554407939,0.93527169261976,0,0,1.71115674195756,6.53150299425681,ATP6V1G2;PRKAA2;DAPK2;CSNK2A2;ZDHHC8;WDR24;CAPNS1;LARS;NEDD4;ZKSCAN3;ULK2;VPS35;BMF;ATP6V1E1;TRIM65;MET;ATP6V0A1,alpha,5
mitochondrial gene expression (GO:0140053),6/46,6,46,0.0233429921713734,0.937947157878098,0,0,2.67833229175966,10.0637223311836,NDUFA7;MRPS34;MRPS18A;POLRMT;MRPS7;MRPL10,alpha,5
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),7/59,7,59,0.0239557124462984,0.940353850872774,0,0,2.43622315804128,9.09088479324719,CDC42;FBXW8;ARHGDIA;PLXNA2;CIB1;TRIOBP;PLXNA3,alpha,5
intra-Golgi vesicle-mediated transport (GO:0006891),5/34,5,34,0.0233328531070335,0.944980550834856,0,0,3.01968836816041,11.3476654998787,COG8;COG4;COG2;COG1;COPE,alpha,5
mitochondrial ATP synthesis coupled electron transport (GO:0042775),9/86,9,86,0.0239287213817503,0.946575699310632,0,0,2.14889451315601,8.02112656769677,COX7A2L;NDUFA7;NDUFS7;NDUFB6;NDUFA12;NDUFS6;COX6A1;COX6C;COX5A,alpha,5
leukocyte differentiation (GO:0002521),3/13,3,13,0.022826298506778,0.947013018537302,0,0,4.73858790080556,17.9111133996839,BATF3;AXL;RELB,alpha,5
tRNA export from nucleus (GO:0006409),5/34,5,34,0.0233328531070335,0.952540395241534,0,0,3.01968836816041,11.3476654998787,XPOT;NUP85;NUP50;NUP54;RAE1,alpha,5
glycerolipid catabolic process (GO:0046503),3/13,3,13,0.022826298506778,0.954775420328592,0,0,4.73858790080556,17.9111133996839,PLA2G4C;ABHD6;PNPLA6,alpha,5
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),5/34,5,34,0.0233328531070335,0.960222172622515,0,0,3.01968836816041,11.3476654998787,XPOT;NUP85;NUP50;NUP54;RAE1,alpha,5
cellular protein complex assembly (GO:0043623),13/145,13,145,0.0248917081853671,0.96963654099182,0,0,1.84096863272676,6.79910315973322,CENPT;AHCTF1;DNAAF1;COG4;CCDC103;TBCD;SEPT4;TMEM170A;EID2;CENPF;PSMD4;PIH1D3;HSPA1A,alpha,5
maturation of SSU-rRNA (GO:0030490),6/47,6,47,0.0256937498163768,0.971223743059041,0,0,2.62134649831797,9.59807990160697,RPS28;NOB1;RPS8;RRP36;NOL10;DIEXF,alpha,5
macromolecule catabolic process (GO:0009057),5/35,5,35,0.026164165003007,0.974567401535364,0,0,2.93341155764154,10.6874876867496,BECN1;CLN3;BACE2;NEDD4;CTSD,alpha,5
lysosomal transport (GO:0007041),8/73,8,73,0.0252582396704767,0.976460583624563,0,0,2.25028831819077,8.27791702716547,HMGXB4;HGS;LARS;VPS53;NEDD4;VPS11;VPS35;NAGPA,alpha,5
RNA secondary structure unwinding (GO:0010501),6/47,6,47,0.0256937498163768,0.978471681440079,0,0,2.62134649831797,9.59807990160697,DDX28;DDX27;DDX49;DDX20;DDX31;DDX52,alpha,5
peptidyl-serine phosphorylation (GO:0018105),13/146,13,146,0.0261555751554092,0.981411029544508,0,0,1.82835925853,6.66197967114266,SMG1;MAP2K2;PNCK;PRKAA2;DAPK2;MAST1;CSNK1D;DCLK1;TGFBR2;MAPKAPK3;CDK2;CSNK1G2;PSKH1,alpha,5
nucleocytoplasmic transport (GO:0006913),6/47,6,47,0.0256937498163768,0.985828611375718,0,0,2.62134649831797,9.59807990160697,NCBP1;DDX20;GEMIN4;NUTF2;GEMIN7;SNRPB,alpha,5
"DNA damage response, signal transduction resulting in transcription (GO:0042772)",3/15,3,15,0.0337868725289824,0.996615089684375,0,0,4.10677618069815,13.9124556002108,MAD2L2;TFAP4;BRCA1,alpha,5
DNA replication (GO:0006260),11/121,11,121,0.0340273983598213,0.997941458794068,0,0,1.86671644577189,6.31060153959972,RFC5;UPF1;FEN1;ORC6;RFC1;NCOA6;CDK2;KCTD13;BRCA1;BAZ1A;CDC25A,alpha,5
protein deubiquitination (GO:0016579),20/258,20,258,0.0276945423771964,1,0,0,1.5917737134489,5.70892811756049,BECN1;INO80E;USP49;SMURF2;USP20;SHMT2;USP21;KEAP1;FOXK2;BRCA1;CDC25A;SNX3;RNF123;MAVS;PSMD4;HGS;PSME3;PSMD3;ATXN7L3;BIRC3,alpha,5
myeloid dendritic cell activation (GO:0001773),3/14,3,14,0.0280209182281648,1,0,0,4.40011733646231,15.7295569147315,BATF2;BATF3;TGFBR2,alpha,5
negative regulation of Rho protein signal transduction (GO:0035024),3/14,3,14,0.0280209182281648,1,0,0,4.40011733646231,15.7295569147315,KCTD13;ARAP3;MET,alpha,5
"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",3/14,3,14,0.0280209182281648,1,0,0,4.40011733646231,15.7295569147315,ANKRD1;RPL26;HIC1,alpha,5
regulation of protein targeting to mitochondrion (GO:1903214),9/89,9,89,0.0291225459453297,1,0,0,2.07645986664513,7.34286589998548,NBPF3;LRRC46;HSPA1L;CSNK2A2;NKAP;VPS11;HPS4;ZDHHC8;UBE2L3,alpha,5
tRNA transport (GO:0051031),5/36,5,36,0.0292056595304826,1,0,0,2.85192790326261,10.0769814309588,XPOT;NUP85;NUP50;NUP54;RAE1,alpha,5
regulation of mitochondrion organization (GO:0010821),6/49,6,49,0.0308552170487193,1,0,0,2.51435276369275,8.74604894462323,CSNK2A2;MUL1;VPS35;ZDHHC8;SQSTM1;MYO19,alpha,5
sphingosine-1-phosphate signaling pathway (GO:0003376),2/6,2,6,0.0311790612806247,1,0,0,6.84462696783025,23.7372246561546,SPNS2;SPNS1,alpha,5
negative regulation of mRNA catabolic process (GO:1902373),2/6,2,6,0.0311790612806247,1,0,0,6.84462696783025,23.7372246561546,NBAS;DHX34,alpha,5
protein localization to nuclear envelope (GO:0090435),2/6,2,6,0.0311790612806247,1,0,0,6.84462696783025,23.7372246561546,NUP54;NUTF2,alpha,5
mitochondrial ribosome assembly (GO:0061668),2/6,2,6,0.0311790612806247,1,0,0,6.84462696783025,23.7372246561546,DDX28;DHX30,alpha,5
negative regulation of type I interferon-mediated signaling pathway (GO:0060339),2/6,2,6,0.0311790612806247,1,0,0,6.84462696783025,23.7372246561546,MUL1;CACTIN,alpha,5
response to DNA damage checkpoint signaling (GO:0072423),2/6,2,6,0.0311790612806247,1,0,0,6.84462696783025,23.7372246561546,SLX4;EME1,alpha,5
male genitalia development (GO:0030539),2/6,2,6,0.0311790612806247,1,0,0,6.84462696783025,23.7372246561546,WT1;TBX3,alpha,5
mRNA 5'-splice site recognition (GO:0000395),2/6,2,6,0.0311790612806247,1,0,0,6.84462696783025,23.7372246561546,SRSF1;SNRPC,alpha,5
purine ribonucleoside monophosphate catabolic process (GO:0009169),2/6,2,6,0.0311790612806247,1,0,0,6.84462696783025,23.7372246561546,NUDT11;NUDT4,alpha,5
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),2/6,2,6,0.0311790612806247,1,0,0,6.84462696783025,23.7372246561546,YAP1;FOXA1,alpha,5
positive regulation of trophoblast cell migration (GO:1901165),2/6,2,6,0.0311790612806247,1,0,0,6.84462696783025,23.7372246561546,SMURF2;ACVR1B,alpha,5
regulation of t-circle formation (GO:1904429),2/6,2,6,0.0311790612806247,1,0,0,6.84462696783025,23.7372246561546,RTEL1;SLX4,alpha,5
regulation of chromosome organization (GO:0033044),4/25,4,25,0.0312650603337663,1,0,0,3.28542094455852,11.3848183596238,UPF1;SMG1;CENPV;SMG6,alpha,5
chaperone mediated protein folding requiring cofactor (GO:0051085),4/25,4,25,0.0312650603337663,1,0,0,3.28542094455852,11.3848183596238,DNAJB1;HSPA1L;HSPA6;HSPA1A,alpha,5
protein modification by small protein removal (GO:0070646),20/262,20,262,0.0318638717793399,1,0,0,1.56747182469395,5.40195065145463,BECN1;INO80E;USP49;SMURF2;USP20;USP21;KEAP1;FOXK2;BRCA1;SENP3;CDC25A;SNX3;RNF123;MAVS;PSMD4;HGS;PSME3;COPS2;PSMD3;BIRC3,alpha,5
regulation of cellular response to stress (GO:0080135),10/105,10,105,0.0319776145173077,1,0,0,1.95560770509436,6.73260813007383,YWHAE;DNAJB1;SMG1;HSPA1L;NUP85;NUP50;NUP54;CRYAB;RAE1;HSPA1A,alpha,5
centromere complex assembly (GO:0034508),5/37,5,37,0.0324612623635141,1,0,0,2.77484877074199,9.51137085252569,CENPT;CENPV;CENPF;RSF1;CENPQ,alpha,5
regulation of ubiquitin protein ligase activity (GO:1904666),5/37,5,37,0.0324612623635141,1,0,0,2.77484877074199,9.51137085252569,MAD2L2;ANAPC7;RPL23;CDK2;ANAPC1,alpha,5
double-strand break repair via homologous recombination (GO:0000724),8/77,8,77,0.0334398560957584,1,0,0,2.1333902237393,7.24927447479965,RAD51B;FEN1;RAD51D;SLX4;RAD51;BRCA1;ORAOV1;FAN1,alpha,5
nucleic acid-templated transcription (GO:0097659),8/77,8,77,0.0334398560957584,1,0,0,2.1333902237393,7.24927447479965,GTF3C4;FUBP3;BCL3;DRG1;BAZ2A;RNPS1;BAZ1A;ILF2,alpha,5
protein autoubiquitination (GO:0051865),6/50,6,50,0.0336721518561107,1,0,0,2.46406570841889,8.35585413797353,RNF10;ITCH;TRIM17;TRIM37;BRCA1;UBE2A,alpha,5
positive regulation of response to DNA damage stimulus (GO:2001022),6/50,6,50,0.0336721518561107,1,0,0,2.46406570841889,8.35585413797353,EID3;H2AFX;CEBPG;ANKRD1;BRCA1;HIC1,alpha,5
positive regulation of peptidyl-lysine acetylation (GO:2000758),3/15,3,15,0.0337868725289824,1,0,0,4.10677618069815,13.9124556002108,PAXIP1;TADA2A;BRCA1,alpha,5
nuclear pore organization (GO:0006999),3/15,3,15,0.0337868725289824,1,0,0,4.10677618069815,13.9124556002108,AHCTF1;NUP54;TMEM170A,alpha,5
selective autophagy (GO:0061912),3/15,3,15,0.0337868725289824,1,0,0,4.10677618069815,13.9124556002108,BECN1;LGALS8;SQSTM1,alpha,5
cardiac muscle cell differentiation (GO:0055007),3/15,3,15,0.0337868725289824,1,0,0,4.10677618069815,13.9124556002108,BMP2;WT1;CBY1,alpha,5
regulation of centriole replication (GO:0046599),3/15,3,15,0.0337868725289824,1,0,0,4.10677618069815,13.9124556002108,TRIM37;BRCA1;CEP76,alpha,5
intra-S DNA damage checkpoint (GO:0031573),3/15,3,15,0.0337868725289824,1,0,0,4.10677618069815,13.9124556002108,EME1;EME2;ORAOV1,alpha,5
regulation of cell cycle (GO:0051726),17/216,17,216,0.035451592948798,1,0,0,1.61609247851548,5.39708158061152,CDK11A;MAP2K2;INHBA;LIN9;CDC25A;TBX3;RBL2;CENPF;BMP2;TAOK1;CHMP1A;RARA;PIM3;RPRD1B;TARDBP;MAP2K7;JUNB,alpha,5
regulation of telomere maintenance (GO:0032204),4/26,4,26,0.0355696659338413,1,0,0,3.15905860053704,10.5394474328263,UPF1;SMG1;RTEL1;SMG6,alpha,5
"protein import into nucleus, translocation (GO:0000060)",4/26,4,26,0.0355696659338413,1,0,0,3.15905860053704,10.5394474328263,BCL3;NUTF2;TNPO2;RBM22,alpha,5
signal transduction in response to DNA damage (GO:0042770),4/26,4,26,0.0355696659338413,1,0,0,3.15905860053704,10.5394474328263,MAD2L2;PAXIP1;BCL3;CDC5L,alpha,5
negative regulation of ubiquitin protein ligase activity (GO:1904667),8/78,8,78,0.0357366292217068,1,0,0,2.10603906702469,7.01643571333628,MAD2L2;PSMD4;ANAPC7;RPL23;PSME3;PSMD3;CDK2;ANAPC1,alpha,5
response to ionizing radiation (GO:0010212),8/78,8,78,0.0357366292217068,1,0,0,2.10603906702469,7.01643571333628,RAD51B;RAD51D;PAXIP1;RAD51;BRAT1;H2AFX;BRCA1;CLK2,alpha,5
regulation of sodium ion transmembrane transporter activity (GO:2000649),5/38,5,38,0.0359343036009041,1,0,0,2.70182643466984,8.98644468728911,FXYD2;NEDD4;UTRN;YWHAH;PTPN3,alpha,5
positive regulation of axonogenesis (GO:0050772),5/38,5,38,0.0359343036009041,1,0,0,2.70182643466984,8.98644468728911,SEMA7A;ARHGDIA;PLXNA2;L1CAM;PLXNA3,alpha,5
protein stabilization (GO:0050821),13/153,13,153,0.0363537346064518,1,0,0,1.74470883493712,5.78276474895992,COG7;RPL23;HPS4;MUL1;ATP1B2;HYPK;CDC37;DNLZ;FLOT2;PFN1;CCT7;CRYAB;HSPA1A,alpha,5
myeloid leukocyte differentiation (GO:0002573),6/51,6,51,0.0366502118956526,1,0,0,2.41575069452832,7.98728365518987,CDC42;BATF2;BATF3;GPR183;THOC5;TGFBR2,alpha,5
positive regulation of cell cycle process (GO:0090068),10/108,10,108,0.037764621651312,1,0,0,1.90128526884174,6.22933787696374,CDC42;FEN1;MED25;CENPV;SPAG5;RPL23;DDX11;RCC2;KIF23;BRCA1,alpha,5
NADH dehydrogenase complex assembly (GO:0010257),7/65,7,65,0.0381664126223594,1,0,0,2.21134102037593,7.22179617944268,NDUFA7;COA1;NDUFS7;NDUFB6;NDUFA12;NDUFS6;NDUFAF4,alpha,5
mitochondrial respiratory chain complex I biogenesis (GO:0097031),7/65,7,65,0.0381664126223594,1,0,0,2.21134102037593,7.22179617944268,NDUFA7;COA1;NDUFS7;NDUFB6;NDUFA12;NDUFS6;NDUFAF4,alpha,5
mitochondrial respiratory chain complex I assembly (GO:0032981),7/65,7,65,0.0381664126223594,1,0,0,2.21134102037593,7.22179617944268,NDUFA7;COA1;NDUFS7;NDUFB6;NDUFA12;NDUFS6;NDUFAF4,alpha,5
positive regulation of transcription from RNA polymerase II promoter (GO:0045944),53/849,53,849,0.0381816102808933,1,0,0,1.28185593390461,4.18577401445192,FOXA1;RNF10;SMARCB1;FHOD1;BRCA1;YBX1;IKZF4;DCAF6;NKRF;MLX;ZNF567;JUNB;IER5;NCOA6;RPL23;EBF1;VEZF1;ETV4;NPAS4;MED25;RFX5;HAND1;RARA;MZF1;SQSTM1;MET;PPARD;YAP1;HDAC5;CEBPB;PAXIP1;DOT1L;CEBPG;FOXK2;NPAS1;RELB;DDN;RXRA;RPRD1B;E2F4;AAMDC;CDC5L;INHBA;RRP1B;KLF4;SMAD5;KLF2;BMP2;MAVS;FUBP3;TCF4;SSBP4;CCDC62,alpha,5
negative regulation of striated muscle cell differentiation (GO:0051154),3/16,3,16,0.0401166524562058,1,0,0,3.85010266940452,12.3817906480349,HDAC5;BMP2;FZD7,alpha,5
genitalia development (GO:0048806),3/16,3,16,0.0401166524562058,1,0,0,3.85010266940452,12.3817906480349,WT1;PTPN11;TBX3,alpha,5
circulatory system development (GO:0072359),10/110,10,110,0.0420017433291476,1,0,0,1.86671644577189,5.9175735555784,BMP2;CXADR;ERBB3;NCOA6;WT1;HAND1;RARA;PTPN11;ZDHHC16;TGFBR2,alpha,5
adherens junction assembly (GO:0034333),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,TBCD;PIP5K1C,alpha,5
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,SLC35F6;HSPA1A,alpha,5
progesterone receptor signaling pathway (GO:0050847),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,YAP1;NEDD4,alpha,5
regulation of chromatin assembly or disassembly (GO:0001672),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,MAP1S;TLK1,alpha,5
cellular response to laminar fluid shear stress (GO:0071499),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,KLF4;KLF2,alpha,5
ribosomal protein import into nucleus (GO:0006610),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,RPL23;TNPO2,alpha,5
positive regulation of histone H4 acetylation (GO:0090240),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,SMARCB1;BRCA1,alpha,5
reproductive system development (GO:0061458),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,WT1;TBX3,alpha,5
negative regulation of cardiac muscle cell differentiation (GO:2000726),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,BMP2;FZD7,alpha,5
retinoic acid receptor signaling pathway (GO:0048384),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,RXRA;RARA,alpha,5
determination of digestive tract left/right asymmetry (GO:0071907),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,CCDC103;DNAAF1,alpha,5
regulation of histone H3-K9 acetylation (GO:2000615),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,SMARCB1;BRCA1,alpha,5
negative regulation of cardiocyte differentiation (GO:1905208),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,BMP2;FZD7,alpha,5
positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,CPNE1;HSPA1A,alpha,5
protein maturation by iron-sulfur cluster transfer (GO:0097428),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,NFU1;ISCU,alpha,5
negative regulation of cardiac muscle tissue development (GO:0055026),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,BMP2;FZD7,alpha,5
glyoxylate metabolic process (GO:0046487),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,GRHPR;GOT2,alpha,5
regulation of transcription involved in cell fate commitment (GO:0060850),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,CEBPB;CHD5,alpha,5
membrane invagination (GO:0010324),2/7,2,7,0.0422600055088206,1,0,0,5.86682311528307,18.5621245904301,SNX3;HGS,alpha,5
regulation of DNA binding (GO:0051101),6/53,6,53,0.0430988527912823,1,0,0,2.32459029096122,7.30911371027466,TFAP4;DOT1L;CEBPG;BCL3;CPNE1;RSF1,alpha,5
RNA transport (GO:0050658),8/81,8,81,0.0432577327654912,1,0,0,2.02803762009785,6.36921290708036,SLBP;NCBP1;MAGOH;SRSF1;RNPS1;THOC5;RAE1;TGFBR2,alpha,5
positive regulation of fat cell differentiation (GO:0045600),5/40,5,40,0.0435430343446517,1,0,0,2.56673511293635,8.04416204989277,CEBPB;BMP2;METRNL;AAMDC;PPARD,alpha,5
mitotic DNA damage checkpoint (GO:0044773),5/40,5,40,0.0435430343446517,1,0,0,2.56673511293635,8.04416204989277,EME1;EME2;TAOK1;CDK2;ORAOV1,alpha,5
protein dephosphorylation (GO:0006470),11/126,11,126,0.0436793765707203,1,0,0,1.79264039633649,5.61254056635256,PPP1R15A;PTPN1;PTPRR;MTMR3;RPRD1B;PTPN11;SSH2;PTPRH;PPM1F;TIMM50;PTPN3,alpha,5
intracellular steroid hormone receptor signaling pathway (GO:0030518),7/67,7,67,0.0439154691855127,1,0,0,2.14533084066321,6.70520718810416,YAP1;MED24;NCOA6;NEDD4;BRCA1;MED16;PIAS1,alpha,5
macroautophagy (GO:0016236),10/111,10,111,0.0442373217327105,1,0,0,1.84989918049466,5.76833058271147,BECN1;CLN3;MTMR3;PRKAA2;HGS;CSNK2A2;LIX1L;SNF8;SQSTM1;UBXN6,alpha,5
telomere maintenance via telomere lengthening (GO:0010833),4/28,4,28,0.0451549655177898,1,0,0,2.93341155764154,9.08669705755555,RAD51;RFC1;SMG6;WRAP53,alpha,5
negative regulation of microtubule polymerization or depolymerization (GO:0031111),4/28,4,28,0.0451549655177898,1,0,0,2.93341155764154,9.08669705755555,SPEF1;TBCD;CIB1;CAMSAP2,alpha,5
modulation by host of viral transcription (GO:0043921),4/28,4,28,0.0451549655177898,1,0,0,2.93341155764154,9.08669705755555,SMARCB1;TFAP4;RRP1B;TARDBP,alpha,5
positive regulation of binding (GO:0051099),8/82,8,82,0.0459799203127431,1,0,0,2.0033054539991,6.16928029795921,MED25;BMP2;NCBP1;DDX11;CEBPG;RARA;B2M;MET,alpha,5
positive regulation of protein metabolic process (GO:0051247),9/97,9,97,0.0467064631527842,1,0,0,1.90520544465378,5.83730700045867,ITCH;SMURF2;NEDD4;INHBA;SNF8;KLF4;OAZ1;OAZ2;KLF2,alpha,5
protein localization to nucleus (GO:0034504),9/97,9,97,0.0467064631527842,1,0,0,1.90520544465378,5.83730700045867,NUP85;NUP50;BCL3;NUTF2;NUP62CL;GPN1;RAE1;SUPT7L;TNPO3,alpha,5
regulation of protein sumoylation (GO:0033233),3/17,3,17,0.0469991954396069,1,0,0,3.62362604179249,11.0796888358189,RASD2;MUL1;PIAS1,alpha,5
regulation of telomere maintenance via telomere lengthening (GO:1904356),3/17,3,17,0.0469991954396069,1,0,0,3.62362604179249,11.0796888358189,RTEL1;SLX4;SMG6,alpha,5
negative regulation of telomere maintenance (GO:0032205),3/17,3,17,0.0469991954396069,1,0,0,3.62362604179249,11.0796888358189,RTEL1;SLX4;SMG6,alpha,5
histone H2A ubiquitination (GO:0033522),3/17,3,17,0.0469991954396069,1,0,0,3.62362604179249,11.0796888358189,RING1;TRIM37;UBE2A,alpha,5
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),3/17,3,17,0.0469991954396069,1,0,0,3.62362604179249,11.0796888358189,SLC35F6;MUL1;HSPA1A,alpha,5
negative regulation of lipid biosynthetic process (GO:0051055),3/17,3,17,0.0469991954396069,1,0,0,3.62362604179249,11.0796888358189,ACADVL;BMP2;BRCA1,alpha,5
negative regulation of interleukin-8 production (GO:0032717),3/17,3,17,0.0469991954396069,1,0,0,3.62362604179249,11.0796888358189,BCL3;KLF4;CACTIN,alpha,5
spindle assembly checkpoint (GO:0071173),3/17,3,17,0.0469991954396069,1,0,0,3.62362604179249,11.0796888358189,MAD2L2;CENPF;TRIP13,alpha,5
negative regulation of intracellular transport (GO:0032387),3/17,3,17,0.0469991954396069,1,0,0,3.62362604179249,11.0796888358189,SLC35F6;CRYAB;HSPA1A,alpha,5
serine family amino acid metabolic process (GO:0009069),3/17,3,17,0.0469991954396069,1,0,0,3.62362604179249,11.0796888358189,SRR;SHMT2;SEPHS2,alpha,5
positive regulation by host of viral transcription (GO:0043923),3/17,3,17,0.0469991954396069,1,0,0,3.62362604179249,11.0796888358189,SMARCB1;TFAP4;RRP1B,alpha,5
regulation of lamellipodium organization (GO:1902743),3/17,3,17,0.0469991954396069,1,0,0,3.62362604179249,11.0796888358189,CDC42;FER;SSH2,alpha,5
regulation of early endosome to late endosome transport (GO:2000641),3/17,3,17,0.0469991954396069,1,0,0,3.62362604179249,11.0796888358189,SNX3;MAP2K2;VPS11,alpha,5
mitotic spindle assembly checkpoint (GO:0007094),3/17,3,17,0.0469991954396069,1,0,0,3.62362604179249,11.0796888358189,MAD2L2;CENPF;TRIP13,alpha,5
mitotic spindle checkpoint (GO:0071174),3/17,3,17,0.0469991954396069,1,0,0,3.62362604179249,11.0796888358189,MAD2L2;CENPF;TRIP13,alpha,5
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),5/41,5,41,0.0476824037200081,1,0,0,2.50413181749887,7.62055602720737,CDC42;GPRC5A;HGS;EPS15L1;PTPN3,alpha,5
regulation of intracellular transport (GO:0032386),5/41,5,41,0.0476824037200081,1,0,0,2.50413181749887,7.62055602720737,PTPN1;FER;SPAG5;MUL1;CRYAB,alpha,5
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",8/83,8,83,0.0488118340122405,1,0,0,1.97916924370995,5.97666063733335,RBL2;PAXIP1;TFAP4;BCL3;CDK2;BRCA1;RPL26;E2F4,alpha,5
intracellular transport of virus (GO:0075733),6/55,6,55,0.0502163111504356,1,0,0,2.24005973492626,6.7009491470864,NUP85;NUP50;MVB12B;KPNA7;NUP54;RAE1,alpha,5
positive regulation of response to stimulus (GO:0048584),6/55,6,55,0.0502163111504356,1,0,0,2.24005973492626,6.7009491470864,MAVS;MAP2K2;EID3;STX4;IER5;C2CD2L,alpha,5
transport of virus (GO:0046794),6/55,6,55,0.0502163111504356,1,0,0,2.24005973492626,6.7009491470864,NUP85;NUP50;MVB12B;KPNA7;NUP54;RAE1,alpha,5
negative regulation of supramolecular fiber organization (GO:1902904),6/55,6,55,0.0502163111504356,1,0,0,2.24005973492626,6.7009491470864,SPEF1;TBCD;CIB1;PFN1;CRYAB;CAMSAP2,alpha,5
protein K11-linked ubiquitination (GO:0070979),4/29,4,29,0.0504356031201996,1,0,0,2.83225943496424,8.46012303952597,ANAPC7;UBE2A;ANAPC1;UBE2L3,alpha,5
regulation of fatty acid biosynthetic process (GO:0042304),4/29,4,29,0.0504356031201996,1,0,0,2.83225943496424,8.46012303952597,ACADVL;PRKAA2;SLC45A3;BRCA1,alpha,5
positive regulation of homeostatic process (GO:0032846),8/84,8,84,0.051754580046984,1,0,0,1.95560770509436,5.7910283512848,RTEL1;SMARCB1;STX4;INHBA;METRNL;ACVR1B;C2CD2L;HSPA1A,alpha,5
response to UV (GO:0009411),9/99,9,99,0.0520091230406344,1,0,0,1.86671644577189,5.51864127814061,FEN1;NEDD4;BCL3;BMF;RPL26;UBE2A;MAP2K7;CDC25A;N4BP1,alpha,5
DNA recombination (GO:0006310),6/56,6,56,0.0540292107031297,1,0,0,2.20005866823115,6.42027817481464,RAD51B;RAD51D;RTEL1;RAD51;NCOA6;BRCA1,alpha,5
mitotic recombination (GO:0006312),3/18,3,18,0.0544203903758182,1,0,0,3.42231348391513,9.96241058269668,RAD51B;RAD51D;RAD51,alpha,5
iron-sulfur cluster assembly (GO:0016226),3/18,3,18,0.0544203903758182,1,0,0,3.42231348391513,9.96241058269668,NFU1;NFS1;ISCU,alpha,5
cellular response to gamma radiation (GO:0071480),3/18,3,18,0.0544203903758182,1,0,0,3.42231348391513,9.96241058269668,YAP1;RPL26;CRYAB,alpha,5
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),3/18,3,18,0.0544203903758182,1,0,0,3.42231348391513,9.96241058269668,EID2;SMURF2;LTBP4,alpha,5
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),3/18,3,18,0.0544203903758182,1,0,0,3.42231348391513,9.96241058269668,NEDD4;MVB12B;SNF8,alpha,5
negative regulation of microtubule depolymerization (GO:0007026),3/18,3,18,0.0544203903758182,1,0,0,3.42231348391513,9.96241058269668,SPEF1;CIB1;CAMSAP2,alpha,5
mRNA destabilization (GO:0061157),3/18,3,18,0.0544203903758182,1,0,0,3.42231348391513,9.96241058269668,UPF1;YTHDF2;METTL16,alpha,5
late endosome to vacuole transport (GO:0045324),2/8,2,8,0.0545592705517048,1,0,0,5.13347022587269,14.9305320081612,BECN1;TMEM50A,alpha,5
positive regulation of alpha-beta T cell differentiation (GO:0046638),2/8,2,8,0.0545592705517048,1,0,0,5.13347022587269,14.9305320081612,NKAP;TGFBR2,alpha,5
positive regulation of chromatin binding (GO:0035563),2/8,2,8,0.0545592705517048,1,0,0,5.13347022587269,14.9305320081612,MED25;DDX11,alpha,5
regulation of PERK-mediated unfolded protein response (GO:1903897),2/8,2,8,0.0545592705517048,1,0,0,5.13347022587269,14.9305320081612,PPP1R15A;PTPN1,alpha,5
regulation of striated muscle cell differentiation (GO:0051153),2/8,2,8,0.0545592705517048,1,0,0,5.13347022587269,14.9305320081612,HDAC5;RBM24,alpha,5
positive regulation of IRE1-mediated unfolded protein response (GO:1903896),2/8,2,8,0.0545592705517048,1,0,0,5.13347022587269,14.9305320081612,PTPN1;HSPA1A,alpha,5
kinetochore assembly (GO:0051382),2/8,2,8,0.0545592705517048,1,0,0,5.13347022587269,14.9305320081612,CENPT;CENPF,alpha,5
negative regulation of centriole replication (GO:0046600),2/8,2,8,0.0545592705517048,1,0,0,5.13347022587269,14.9305320081612,TRIM37;BRCA1,alpha,5
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),2/8,2,8,0.0545592705517048,1,0,0,5.13347022587269,14.9305320081612,TMEM50A;SNF8,alpha,5
regulation of gene expression (GO:0010468),62/1038,62,1038,0.0556199643896502,1,0,0,1.22649384972681,3.54360206142061,ZC3H3;BRCA1;YBX1;RPL6;UBE2L3;ZNF607;ZNF83;ZNF84;CPNE1;MLX;FLOT2;VPS35;METTL16;MAP2K2;ZFP3;RPL23;BAZ1A;MYT1;HIC1;RBL2;HGS;MZF1;ZNF28;HDAC5;ZNF274;CEBPB;ZNF197;CRABP2;FOXK2;BAZ2A;ACVR1B;TOB2;PPM1F;PHF21B;HMGXB4;ZNHIT3;ZNF623;ZNF468;ZNF500;PATZ1;MAPK6;ZNF267;MAPK4;SUZ12;ZNF781;CDK11A;ZNF580;FZD7;MOK;SNF8;INHBA;RRP1B;KLF4;CLK2;BMP2;FUBP3;WT1;ZNF417;CDK2;ZNF699;TARDBP;HSPA1A,alpha,5
regulation of myoblast differentiation (GO:0045661),4/30,4,30,0.0560394692749526,1,0,0,2.7378507871321,7.88966195216029,FLOT2;EID2B;KLHL41;TBX3,alpha,5
protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),7/71,7,71,0.0570131871272019,1,0,0,2.02446713133007,5.79903079896391,RMND5B;ITCH;SMURF2;NEDD4;SPOP;KLHL11;FBXO7,alpha,5
DNA-dependent DNA replication (GO:0006261),6/57,6,57,0.0580127186563288,1,0,0,2.16146114773587,6.15388091494122,RFC5;CDC34;ORC6;RAD51;RFC1;BAZ1A,alpha,5
protein import (GO:0017038),6/57,6,57,0.0580127186563288,1,0,0,2.16146114773587,6.15388091494122,NUP85;NUP50;NUTF2;NUP62CL;RAE1;TNPO3,alpha,5
negative regulation of protein metabolic process (GO:0051248),5/44,5,44,0.0614503473971448,1,0,0,2.33339555721486,6.50906708431913,SNX3;MAD2L2;SF3B3;FLOT2;CRYAB,alpha,5
response to unfolded protein (GO:0006986),5/44,5,44,0.0614503473971448,1,0,0,2.33339555721486,6.50906708431913,DNAJB1;HSPA1L;HSPA6;HSPB2;HSPA1A,alpha,5
'de novo' posttranslational protein folding (GO:0051084),4/31,4,31,0.0619635486178792,1,0,0,2.64953301980526,7.36890506021355,DNAJB1;HSPA1L;HSPA6;HSPA1A,alpha,5
protein localization to lysosome (GO:0061462),4/31,4,31,0.0619635486178792,1,0,0,2.64953301980526,7.36890506021355,LARS;HGS;NEDD4;NAGPA,alpha,5
regulation of sodium ion transmembrane transport (GO:1902305),4/31,4,31,0.0619635486178792,1,0,0,2.64953301980526,7.36890506021355,FXYD2;UTRN;YWHAH;PTPN3,alpha,5
negative regulation of cell morphogenesis involved in differentiation (GO:0010771),4/31,4,31,0.0619635486178792,1,0,0,2.64953301980526,7.36890506021355,GDI1;ARHGDIA;RCC2;YWHAH,alpha,5
negative regulation of transcription from RNA polymerase II promoter (GO:0000122),36/566,36,566,0.0621695743181552,1,0,0,1.30604189492167,3.6280401419344,HDAC5;CEBPB;DDX20;LRP8;RELB;DNAJB1;RXRA;ZKSCAN3;MLX;ZNF567;ZNF500;JUNB;E2F6;SPEN;CBX7;BATF3;SMURF2;RPL23;PCGF2;KLF4;HIC1;TBX3;KLF2;THAP11;MAD2L2;MED25;BMP2;WT1;DNAJA3;NEDD4;HAND1;RARA;TRIM37;MZF1;PPARD;HSPA1A,alpha,5
error-free translesion synthesis (GO:0070987),3/19,3,19,0.0623635351903001,1,0,0,3.2421917216038,8.99635106355423,RFC5;NPLOC4;RFC1,alpha,5
endothelial cell development (GO:0001885),3/19,3,19,0.0623635351903001,1,0,0,3.2421917216038,8.99635106355423,GSTM3;RAPGEF1;MET,alpha,5
regulation of mitochondrial fission (GO:0090140),3/19,3,19,0.0623635351903001,1,0,0,3.2421917216038,8.99635106355423,MUL1;VPS35;MYO19,alpha,5
nucleosome disassembly (GO:0006337),3/19,3,19,0.0623635351903001,1,0,0,3.2421917216038,8.99635106355423,SMARCD2;SMARCB1;HIST3H2A,alpha,5
chromatin disassembly (GO:0031498),3/19,3,19,0.0623635351903001,1,0,0,3.2421917216038,8.99635106355423,SMARCD2;SMARCB1;HIST3H2A,alpha,5
purine ribonucleotide catabolic process (GO:0009154),3/19,3,19,0.0623635351903001,1,0,0,3.2421917216038,8.99635106355423,NUDT11;PDE4A;NUDT4,alpha,5
histone deubiquitination (GO:0016578),3/19,3,19,0.0623635351903001,1,0,0,3.2421917216038,8.99635106355423,USP49;USP21;ATXN7L3,alpha,5
regulation of G2/M transition of mitotic cell cycle (GO:0010389),12/150,12,150,0.0627430679631274,1,0,0,1.64271047227926,4.54818427561349,YWHAE;RAD51B;CENPF;PSMD4;HAUS8;PSME3;RCC2;PSMD3;CDK2;CEP250;CSNK1D;CEP76,alpha,5
negative regulation of cell cycle (GO:0045786),7/73,7,73,0.0643784649578269,1,0,0,1.96900227841692,5.40092618435878,BRINP2;BMP2;TFAP4;CHMP1A;CDK5RAP1;INHBA;PTPN3,alpha,5
positive regulation of intracellular transport (GO:0032388),5/45,5,45,0.066489029134456,1,0,0,2.28154232261008,6.18461857255757,SPAG5;TBC1D20;NEDD4;OAZ1;OAZ2,alpha,5
negative regulation of type I interferon production (GO:0032480),5/45,5,45,0.066489029134456,1,0,0,2.28154232261008,6.18461857255757,ITCH;MAVS;NPLOC4;CACTIN;RELB,alpha,5
positive regulation of actin filament bundle assembly (GO:0032233),5/45,5,45,0.066489029134456,1,0,0,2.28154232261008,6.18461857255757,CDC42;ARHGEF10;FHOD1;PFN1;PPM1F,alpha,5
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),6/59,6,59,0.0664931570946552,1,0,0,2.08819127832109,5.66036871356399,CDC42;FER;HGS;MVB12B;EPS15L1;PTPN3,alpha,5
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901838),2/9,2,9,0.0679321689154737,1,0,0,4.56308464522017,12.2712552480268,SMARCB1;DDX11,alpha,5
RNA destabilization (GO:0050779),2/9,2,9,0.0679321689154737,1,0,0,4.56308464522017,12.2712552480268,YTHDF2;METTL16,alpha,5
regulation of macrophage cytokine production (GO:0010935),2/9,2,9,0.0679321689154737,1,0,0,4.56308464522017,12.2712552480268,SEMA7A;CUEDC2,alpha,5
anoikis (GO:0043276),2/9,2,9,0.0679321689154737,1,0,0,4.56308464522017,12.2712552480268,DAPK2;BMF,alpha,5
regulation of endothelial cell differentiation (GO:0045601),2/9,2,9,0.0679321689154737,1,0,0,4.56308464522017,12.2712552480268,ATOH8;VEZF1,alpha,5
multi-ciliated epithelial cell differentiation (GO:1903251),2/9,2,9,0.0679321689154737,1,0,0,4.56308464522017,12.2712552480268,CCDC78;E2F4,alpha,5
semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),2/9,2,9,0.0679321689154737,1,0,0,4.56308464522017,12.2712552480268,PLXNA2;PLXNA3,alpha,5
epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),2/9,2,9,0.0679321689154737,1,0,0,4.56308464522017,12.2712552480268,CCDC103;DNAAF1,alpha,5
positive regulation of establishment of protein localization to telomere (GO:1904851),2/9,2,9,0.0679321689154737,1,0,0,4.56308464522017,12.2712552480268,CCT7;WRAP53,alpha,5
mitotic DNA replication checkpoint (GO:0033314),2/9,2,9,0.0679321689154737,1,0,0,4.56308464522017,12.2712552480268,ZNF830;ORAOV1,alpha,5
atrioventricular valve development (GO:0003171),2/9,2,9,0.0679321689154737,1,0,0,4.56308464522017,12.2712552480268,BMP2;TGFBR2,alpha,5
regulation of cell-cell adhesion mediated by cadherin (GO:2000047),2/9,2,9,0.0679321689154737,1,0,0,4.56308464522017,12.2712552480268,FOXA1;MAD2L2,alpha,5
negative regulation of interferon-beta production (GO:0032688),2/9,2,9,0.0679321689154737,1,0,0,4.56308464522017,12.2712552480268,CACTIN;RELB,alpha,5
histone phosphorylation (GO:0016572),2/9,2,9,0.0679321689154737,1,0,0,4.56308464522017,12.2712552480268,PRKAA2;CDK2,alpha,5
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",8/89,8,89,0.0681606167391405,1,0,0,1.84574210368456,4.95745720988234,CDC42;PSMD4;SMURF2;PSME3;FZD7;PSMD3;PFN1;AP2A2,alpha,5
skeletal system morphogenesis (GO:0048705),4/32,4,32,0.0682037561462773,1,0,0,2.56673511293635,6.89233993888785,IFT140;RARA;FUZ;FGFR3,alpha,5
regulation of mitotic cell cycle phase transition (GO:1901990),14/185,14,185,0.0683983260417145,1,0,0,1.55391531161552,4.16823319697923,YWHAE;ANAPC7;CSNK1D;PPP1R9B;CENPF;TFAP4;PSMD4;HAUS8;PSME3;PSMD3;CDK2;CEP250;CEP76;ANAPC1,alpha,5
regulation of cell growth (GO:0001558),15/202,15,202,0.069223175984988,1,0,0,1.52479313639783,4.07183741540171,CDK11A;NCBP1;BRAT1;LTBP4;MUL1;CIB1;INHBA;ACVR1B;CXCL16;PPP1R9B;MAD2L2;CDC42;ITCH;WT1;HSPA1A,alpha,5
negative regulation of ion transport (GO:0043271),3/20,3,20,0.0708097506234214,1,0,0,3.08008213552361,8.15531386168981,HRH3;NEDD4;PACSIN3,alpha,5
error-prone translesion synthesis (GO:0042276),3/20,3,20,0.0708097506234214,1,0,0,3.08008213552361,8.15531386168981,RFC5;MAD2L2;RFC1,alpha,5
negative regulation of response to biotic stimulus (GO:0002832),3/20,3,20,0.0708097506234214,1,0,0,3.08008213552361,8.15531386168981,ITCH;NFKBIL1;CACTIN,alpha,5
negative regulation of protein depolymerization (GO:1901880),3/20,3,20,0.0708097506234214,1,0,0,3.08008213552361,8.15531386168981,SPEF1;CIB1;CAMSAP2,alpha,5
regulation of toll-like receptor signaling pathway (GO:0034121),3/20,3,20,0.0708097506234214,1,0,0,3.08008213552361,8.15531386168981,NFKBIL1;CACTIN;BIRC3,alpha,5
telomere maintenance via telomerase (GO:0007004),3/20,3,20,0.0708097506234214,1,0,0,3.08008213552361,8.15531386168981,RFC1;SMG6;WRAP53,alpha,5
negative regulation of interferon-gamma production (GO:0032689),3/20,3,20,0.0708097506234214,1,0,0,3.08008213552361,8.15531386168981,AXL;RARA;INHBA,alpha,5
regulation of establishment of planar polarity (GO:0090175),8/90,8,90,0.0717844342290851,1,0,0,1.82523385808807,4.80782590900815,CDC42;PSMD4;SMURF2;PSME3;FZD7;PSMD3;PFN1;AP2A2,alpha,5
mRNA 3'-end processing (GO:0031124),7/75,7,75,0.0722939254261302,1,0,0,1.91649555099247,5.03466289019765,SLBP;NCBP1;ZC3H3;MAGOH;SRSF1;RNPS1;THOC5,alpha,5
Golgi vesicle transport (GO:0048193),19/272,19,272,0.0735590591238135,1,0,0,1.43435197487619,3.74318054177273,SPTBN4;COG8;NBAS;MCFD2;COG7;KDELR1;PITPNB;COG4;COG2;COG1;KIF23;CYTH3;TBC1D20;TRAPPC6B;TMED2;STX4;TMED6;COPE;SCYL1,alpha,5
proteasomal protein catabolic process (GO:0010498),17/238,17,238,0.0742203107809884,1,0,0,1.46670577882077,3.81448729255512,ANAPC7;SMURF2;KEAP1;KLHL11;UBE2A;RMND5B;NSFL1C;ITCH;CDC34;PSMD4;PSME3;NEDD4;PSMD3;KCTD13;SPOP;UBXN6;ANAPC1,alpha,5
cellular response to glucagon stimulus (GO:0071377),4/33,4,33,0.0747550095866184,1,0,0,2.48895526102918,6.45520266585964,ADCY9;PRKAR1B;GNB2;GNG8,alpha,5
chromatin remodeling at centromere (GO:0031055),4/33,4,33,0.0747550095866184,1,0,0,2.48895526102918,6.45520266585964,CENPT;CENPV;RSF1;CENPQ,alpha,5
regulation of potassium ion transmembrane transport (GO:1901379),4/33,4,33,0.0747550095866184,1,0,0,2.48895526102918,6.45520266585964,YWHAE;NEDD4;KCNIP4;KCNAB2,alpha,5
regulation of cell cycle process (GO:0010564),8/91,8,91,0.0755232253562437,1,0,0,1.80517634316402,4.6633392141529,CDC42;BECN1;AHCTF1;YTHDF2;SPAG5;CSNK2A2;RPRD1B;MYO19,alpha,5
nucleosome assembly (GO:0006334),6/61,6,61,0.0756577231512527,1,0,0,2.01972599050729,5.21399485655271,HIST1H2BN;NAA60;CHAF1A;H2AFX;RSF1;HIST3H2BB,alpha,5
regulation of stress fiber assembly (GO:0051492),6/61,6,61,0.0756577231512527,1,0,0,2.01972599050729,5.21399485655271,CDC42;ARHGEF10;FHOD1;PFN1;MET;PPM1F,alpha,5
transcription from RNA polymerase II promoter (GO:0006366),31/486,31,486,0.0765419742223161,1,0,0,1.3097742963132,3.3660099283116,YAP1;SLBP;CEBPB;SRSF1;HSF2BP;YBX1;MED16;LSM10;RXRA;TRIM29;MAGOH;RPRD1B;BATF3;NCBP1;VEZF1;THOC5;KLF4;MED26;MED25;TADA2A;MED24;COPS2;HAND1;RARA;RNPS1;TCF4;TRIP13;TARDBP;PPARD;SNRPB;CREB5,alpha,5
"DNA-templated transcription, termination (GO:0006353)",9/107,9,107,0.0770658296292888,1,0,0,1.72714886104128,4.42684711452991,LSM10;SLBP;NCBP1;MAGOH;SRSF1;RNPS1;THOC5;POLR3K;SNRPB,alpha,5
protein methylation (GO:0006479),5/47,5,47,0.0772337245582168,1,0,0,2.18445541526497,5.59421353211604,EHMT1;LCMT2;EEF2;CAMKMT;SNRPB,alpha,5
"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",5/47,5,47,0.0772337245582168,1,0,0,2.18445541526497,5.59421353211604,NDUFA7;NDUFB6;NDUFS7;NDUFA12;NDUFS6,alpha,5
protein transport (GO:0015031),22/327,22,327,0.0791063778081468,1,0,0,1.38148434213088,3.50477297257809,RAB3B;RAB4A;COG7;ATP6V1G2;KDELR1;RAB3D;MCOLN1;HID1;GGA2;C16ORF70;CENPF;GGA3;APPBP2;TMED2;TBC1D25;TLK1;VPS35;STX4;ATP6V1E1;TMED6;ATP6V0A1;YWHAH,alpha,5
lipid transport (GO:0006869),8/92,8,92,0.0793770563592159,1,0,0,1.78555486117311,4.52378522492117,ABCA2;RXRA;PITPNM1;PITPNB;SLC10A3;GOT2;PLTP;PPARD,alpha,5
positive regulation of cellular protein metabolic process (GO:0032270),8/92,8,92,0.0793770563592159,1,0,0,1.78555486117311,4.52378522492117,BCL3;VPS11;ASPSCR1;VPS35;RPL26;INHBA;EEF2;KLF4,alpha,5
RNA-dependent DNA biosynthetic process (GO:0006278),3/21,3,21,0.0797383537191646,1,0,0,2.93341155764154,7.41861127266272,RFC1;SMG6;WRAP53,alpha,5
negative regulation of cytokine biosynthetic process (GO:0042036),3/21,3,21,0.0797383537191646,1,0,0,2.93341155764154,7.41861127266272,BCL3;INHBA;KLF4,alpha,5
non-motile cilium assembly (GO:1905515),3/21,3,21,0.0797383537191646,1,0,0,2.93341155764154,7.41861127266272,CEP250;FUZ;CSNK1D,alpha,5
hepaticobiliary system development (GO:0061008),3/21,3,21,0.0797383537191646,1,0,0,2.93341155764154,7.41861127266272,CEBPG;RARA;MET,alpha,5
viral life cycle (GO:0019058),9/108,9,108,0.0806386685543769,1,0,0,1.71115674195756,4.3083110639593,ITCH;TBC1D20;NUP85;AXL;NUP50;MVB12B;KPNA7;NUP54;RAE1,alpha,5
protein ubiquitination (GO:0016567),32/507,32,507,0.081154267237507,1,0,0,1.29602404124597,3.2548391860494,HIST1H2BN;RNF10;KEAP1;KLHL11;BRCA1;UBE2Z;UBE2L3;RMND5B;PSMD4;UBE2Q2;PSMD3;SPOP;UNKL;FBXO7;FBXW8;SMURF2;FANCL;FBXW9;MUL1;UBE2A;KLHL41;ITCH;CDC34;TRIM17;PSME3;NEDD4;PELI1;KCTD13;TRIM37;ZNF598;RNF166;BIRC3,alpha,5
positive regulation of cytokine-mediated signaling pathway (GO:0001961),4/34,4,34,0.0816113023974635,1,0,0,2.41575069452832,6.05335793412449,MAVS;AXL;CPNE1;HSPA1A,alpha,5
establishment of spindle localization (GO:0051293),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,ESPL1;SPAG5,alpha,5
cellular biogenic amine metabolic process (GO:0006576),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,OAZ1;OAZ2,alpha,5
response to laminar fluid shear stress (GO:0034616),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,KLF4;KLF2,alpha,5
mesenchymal to epithelial transition (GO:0060231),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,WT1;FZD7,alpha,5
negative regulation of inclusion body assembly (GO:0090084),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,DNAJB1;HSPA1A,alpha,5
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,YAP1;FOXA1,alpha,5
negative regulation of gluconeogenesis (GO:0045721),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,MST1;CLK2,alpha,5
nuclear pore complex assembly (GO:0051292),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,AHCTF1;TMEM170A,alpha,5
T cell chemotaxis (GO:0010818),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,GPR183;CXCL16,alpha,5
endosomal vesicle fusion (GO:0034058),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,VPS8;VPS11,alpha,5
regulation of establishment of protein localization to telomere (GO:0070203),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,CCT7;WRAP53,alpha,5
motor neuron axon guidance (GO:0008045),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,PLXNA2;PLXNA3,alpha,5
negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,NFKBIL1;CACTIN,alpha,5
negative regulation of centrosome duplication (GO:0010826),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,TRIM37;BRCA1,alpha,5
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,DNAJB1;HSPA1A,alpha,5
positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,STX4;C2CD2L,alpha,5
tRNA wobble base modification (GO:0002097),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,CTU2;URM1,alpha,5
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,PPP1R15A;PTPN1,alpha,5
telomeric loop disassembly (GO:0090657),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,RTEL1;SLX4,alpha,5
positive regulation of nuclease activity (GO:0032075),2/10,2,10,0.082245191448361,1,0,0,4.10677618069815,10.2589336906759,PTPN1;HSPA1A,alpha,5
cellular response to heat (GO:0034605),5/48,5,48,0.0829357034758654,1,0,0,2.13894592744695,5.32531149106892,YWHAE;HSPA1L;HSPA6;IER5;HSPA1A,alpha,5
nuclear export (GO:0051168),8/93,8,93,0.0833458617965032,1,0,0,1.76635534653684,4.38896260984323,NCBP1;MAGOH;SRSF1;NUTF2;RNPS1;CCHCR1;THOC5;RAE1,alpha,5
positive regulation of catabolic process (GO:0009896),6/63,6,63,0.085501660013368,1,0,0,1.95560770509436,4.80926857899065,ITCH;SMURF2;NEDD4;SNF8;OAZ1;OAZ2,alpha,5
establishment of protein localization to organelle (GO:0072594),6/63,6,63,0.085501660013368,1,0,0,1.95560770509436,4.80926857899065,NUP85;NUP50;NUTF2;NUP62CL;RAE1;TNPO3,alpha,5
regulation of double-strand break repair (GO:2000779),4/35,4,35,0.0887657768039133,1,0,0,2.34672924611323,5.68320117247428,RTEL1;RNF169;RAD51;DDX11,alpha,5
regulation of interleukin-8 production (GO:0032677),4/35,4,35,0.0887657768039133,1,0,0,2.34672924611323,5.68320117247428,MAVS;ZNF580;CACTIN;HSPA1A,alpha,5
negative regulation of DNA binding (GO:0043392),4/35,4,35,0.0887657768039133,1,0,0,2.34672924611323,5.68320117247428,MAD2L2;TFAP4;CPNE1;RSF1,alpha,5
regulation of axon extension (GO:0030516),4/35,4,35,0.0887657768039133,1,0,0,2.34672924611323,5.68320117247428,SEMA7A;PLXNA2;L1CAM;PLXNA3,alpha,5
response to glucagon (GO:0033762),4/35,4,35,0.0887657768039133,1,0,0,2.34672924611323,5.68320117247428,ADCY9;PRKAR1B;GNB2;GNG8,alpha,5
protein K48-linked ubiquitination (GO:0070936),5/49,5,49,0.0888539442694749,1,0,0,2.09529396974396,5.072206623043,ITCH;CDC34;UBE2Q2;PELI1;UBE2A,alpha,5
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),3/22,3,22,0.0891271942488657,1,0,0,2.80007466865783,6.76971471153898,PTPN1;HGS;NEDD4,alpha,5
peripheral nervous system development (GO:0007422),3/22,3,22,0.0891271942488657,1,0,0,2.80007466865783,6.76971471153898,GSTM3;ERBB3;SCN8A,alpha,5
positive regulation of erythrocyte differentiation (GO:0045648),3/22,3,22,0.0891271942488657,1,0,0,2.80007466865783,6.76971471153898,INHBA;ACVR1B;HSPA1A,alpha,5
negative regulation of sprouting angiogenesis (GO:1903671),3/22,3,22,0.0891271942488657,1,0,0,2.80007466865783,6.76971471153898,HDAC5;KLF4;KLF2,alpha,5
cellular response to unfolded protein (GO:0034620),3/22,3,22,0.0891271942488657,1,0,0,2.80007466865783,6.76971471153898,HSPA1L;HSPA6;HSPA1A,alpha,5
negative regulation of GTPase activity (GO:0034260),3/22,3,22,0.0891271942488657,1,0,0,2.80007466865783,6.76971471153898,RCC2;TMED2;RRP1B,alpha,5
positive regulation of RNA splicing (GO:0033120),3/22,3,22,0.0891271942488657,1,0,0,2.80007466865783,6.76971471153898,NCBP1;HSPA1A;RBM22,alpha,5
regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),3/22,3,22,0.0891271942488657,1,0,0,2.80007466865783,6.76971471153898,PIM3;STX4;C2CD2L,alpha,5
vesicle coating (GO:0006901),6/64,6,64,0.0906756245139471,1,0,0,1.92505133470226,4.62102163715692,MCFD2;TBC1D20;PPP6R1;TRAPPC6B;TMED2;CSNK1D,alpha,5
COPII vesicle coating (GO:0048208),6/64,6,64,0.0906756245139471,1,0,0,1.92505133470226,4.62102163715692,MCFD2;TBC1D20;PPP6R1;TRAPPC6B;TMED2;CSNK1D,alpha,5
"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",6/64,6,64,0.0906756245139471,1,0,0,1.92505133470226,4.62102163715692,MCFD2;TBC1D20;PPP6R1;TRAPPC6B;TMED2;CSNK1D,alpha,5
phosphorylation (GO:0016310),25/387,25,387,0.09254390659792,1,0,0,1.32647809454075,3.1571134790848,PRKAA2;DGKA;MAST1;ACVR1B;TLK1;PIM3;MARK4;MAPK6;MAPK4;MARK1;CDK11A;DAPK2;PHKB;CSNK1D;DCLK1;CLK2;TGFBR2;BMP2;FER;PRKAR1B;TAOK1;SHPK;CDK2;RARA;CSNK1G2,alpha,5
glucose metabolic process (GO:0006006),6/65,6,65,0.096015547157478,1,0,0,1.89543516032222,4.44146924859198,BRAT1;GOT2;SLC25A12;ENO3;GDPGP1;PPARD,alpha,5
"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",4/36,4,36,0.096210796297217,1,0,0,2.28154232261008,5.34157814279198,RPS8;RRP36;NOL10;DIEXF,alpha,5
positive regulation of ATPase activity (GO:0032781),4/36,4,36,0.096210796297217,1,0,0,2.28154232261008,5.34157814279198,DNAJB1;DNAJC24;ATP1B2;PFN1,alpha,5
regulation of nucleic acid-templated transcription (GO:1903506),37/608,37,608,0.0965241587142113,1,0,0,1.2495947260348,2.92150492563811,ZNF28;ZNF274;CEBPB;ZNF197;CRABP2;FOXK2;BAZ2A;YBX1;ACVR1B;RPL6;PHF21B;UBE2L3;HMGXB4;ZNF607;ZNHIT3;ZNF83;ZNF84;MLX;ZNF623;ZNF468;ZNF500;PATZ1;ZNF267;SUZ12;ZNF781;CDK11A;FZD7;ZFP3;BAZ1A;MYT1;HIC1;BMP2;WT1;COPS2;ZNF417;ZNF699;MZF1,alpha,5
regulation of histone H3-K9 methylation (GO:0051570),2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,ZNF274;BRCA1,alpha,5
negative regulation of defense response to virus (GO:0050687),2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,ITCH;MUL1,alpha,5
"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,CCT7;WRAP53,alpha,5
regulation of trophoblast cell migration (GO:1901163),2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,SMURF2;ACVR1B,alpha,5
positive regulation by host of viral process (GO:0044794),2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,TBC1D20;YTHDC2,alpha,5
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000059),2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,RPL23;SGTA,alpha,5
carnitine shuttle (GO:0006853),2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,PRKAA2;CPT2,alpha,5
negative regulation of fatty acid biosynthetic process (GO:0045717),2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,ACADVL;BRCA1,alpha,5
cell-substrate junction assembly (GO:0007044),2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,CD151;LAMC1,alpha,5
synaptonemal complex assembly (GO:0007130),2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,STAG3;TRIP13,alpha,5
regulation of chromatin binding (GO:0035561),2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,MED25;DDX11,alpha,5
response to sterol (GO:0036314),2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,ABCA2;TGFBR2,alpha,5
histone mRNA catabolic process (GO:0071044),2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,UPF1;EXOSC10,alpha,5
fatty acid transmembrane transport (GO:1902001),2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,PRKAA2;CPT2,alpha,5
modulation by host of viral genome replication (GO:0044827),2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,TBC1D20;YTHDC2,alpha,5
regulation of cardiac muscle cell differentiation (GO:2000725),2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,BMP2;FZD7,alpha,5
embryonic hemopoiesis (GO:0035162),2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,THOC5;TGFBR2,alpha,5
hemidesmosome assembly (GO:0031581),2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,CD151;LAMC1,alpha,5
synaptonemal complex organization (GO:0070193),2/11,2,11,0.0973752634786033,1,0,0,3.73343289154377,8.69584868016145,STAG3;TRIP13,alpha,5
mitotic G2/M transition checkpoint (GO:0044818),3/23,3,23,0.098952957153851,1,0,0,2.67833229175966,6.19527914127024,TAOK1;ZNF830;ORAOV1,alpha,5
regulation of axon extension involved in axon guidance (GO:0048841),3/23,3,23,0.098952957153851,1,0,0,2.67833229175966,6.19527914127024,SEMA7A;PLXNA2;PLXNA3,alpha,5
melanosome organization (GO:0032438),3/23,3,23,0.098952957153851,1,0,0,2.67833229175966,6.19527914127024,BLOC1S4;HPS4;AP1M1,alpha,5
regulation of telomere capping (GO:1904353),3/23,3,23,0.098952957153851,1,0,0,2.67833229175966,6.19527914127024,RTEL1;MAP2K7;SMG6,alpha,5
protein polyubiquitination (GO:0000209),26/284,26,284,3.61907757189525e-06,0.0184681528493815,0,0,2.74099687948048,34.3427485719156,LRSAM1;TNKS;TNFAIP3;PRPF19;FBXO21;FBXO22;ANAPC10;ANAPC11;HERC5;FBXL20;FZR1;PSMD7;HECTD1;UBB;SKP1;FBXW7;UBE2G1;RC3H2;RNF144A;PSMA5;RNF145;PSMA3;MKRN1;DZIP3;BIRC2;ANAPC2,alpha,6
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),25/292,25,292,1.76755143798772e-05,0.0300660499601712,0,0,2.56336641784923,28.0517652481605,FAF1;UBR3;ANAPC10;ANAPC11;BAG6;FBXL20;FZR1;PSMD7;KAT5;UBB;SKP1;FBXW7;ERLIN1;TMUB1;BTBD9;ABTB2;PSMA5;RNF145;PSMA3;DDIT3;PLAA;RNF185;DZIP3;BIRC2;ANAPC2,alpha,6
protein ubiquitination (GO:0016567),35/507,35,507,4.46001091414006e-05,0.032513479564081,0,0,2.06687217281414,20.7054588346303,KLHL18;LRSAM1;PRKDC;TNKS;FBXO25;UBR3;FBXO21;PRPF19;FBXO22;ANAPC11;FBXL20;HERC5;HERC3;PSMD7;HECTD1;UBB;SKP1;ATG3;FBXW7;UBE2G1;BTBD9;RC3H2;ABTB2;PSMA5;RNF144A;RNF145;PSMA3;RRAGA;MKRN1;RNF185;PDZRN3;DZIP3;BIRC2;RNF220;ANAPC2,alpha,6
ubiquitin-dependent protein catabolic process (GO:0006511),28/342,28,342,1.29930649390234e-05,0.0331518051919183,0,0,2.45123787512694,27.5791097326498,KLHL18;FAF1;OTUD7A;UBR3;TNFAIP3;PTPN23;FBXO21;FBXO22;ANAPC10;ANAPC11;BAG6;PSMD7;KAT5;UBB;SKP1;UBE2G1;VPS37A;BTBD9;ABTB2;RNF144A;PSMA5;RNF145;PSMA3;DDIT3;PLAA;RNF185;BIRC2;ANAPC2,alpha,6
ribosome biogenesis (GO:0042254),21/227,21,227,2.62775307900552e-05,0.033523559905413,0,0,2.76979081484608,29.2124195912547,LTV1;UTP15;NOP56;NPM1;PAK1IP1;RPLP1;RPL12;RPLP0;DDX56;NOC4L;URB2;GNL1;BYSL;SBDS;RPL38;RIOK1;EXOSC3;RPP14;ABCE1;RPL39;MPHOSPH6,alpha,6
regulation of response to biotic stimulus (GO:0002831),4/7,4,7,3.98303639755928e-05,0.0338757245612417,0,0,17.1086398631309,173.325594911637,HERC5;TRAF3;CD55;FOXP1,alpha,6
regulation of cell morphogenesis (GO:0022604),7/29,7,29,3.69111433291636e-05,0.0376715128817444,0,0,7.22692545942598,73.7652069552611,ARC;CAPZB;CFL1;QRICH1;KIAA1958;CAMSAP1;BCL9L,alpha,6
DNA metabolic process (GO:0006259),25/315,25,315,6.20632644027182e-05,0.0395886047808839,0,0,2.3761999809904,23.0190958548964,MUS81;SET;PRKDC;PDS5A;UNG;TATDN3;RNASEH1;KAT5;UBB;LONP1;POLI;POLG;TIPIN;ACD;NPM1;FANCA;CDC7;LRWD1;TICRR;SUPV3L1;MSH2;PAPD7;FANCD2;MCM4;RAD9A,alpha,6
cellular protein complex assembly (GO:0043623),15/145,15,145,0.000105443505024102,0.0597864673486656,0,0,3.09725376832542,28.3625910981209,CCT2;SMAD3;CENPW;ZFYVE9;CLTC;HIP1R;NUP153;PILRB;TOMM20;FCHO2;LONP1;PTGES3L;EIF4H;EPS15;SKP1,alpha,6
regulation of type I interferon production (GO:0032479),11/86,11,86,0.000133614915715188,0.0681836914894607,0,0,3.82955020192174,34.1616889164832,HERC5;UBB;POLR3B;TRAF3;PRKDC;POLR1C;POLR2E;TNFAIP3;GPATCH3;DDX41;RELA,alpha,6
viral process (GO:0016032),19/221,19,221,0.000165981901669382,0.0770005131108051,0,0,2.57403744547105,22.4034741690129,LRSAM1;PDCD6IP;CTBP2;NUP155;CTBP1;IST1;RPLP1;RPL12;RPLP0;NUP153;VPS37A;VPS37B;HCFC2;RRAGA;PARD6A;UBB;RPL38;RPL39;PPID,alpha,6
viral life cycle (GO:0019058),12/108,12,108,0.000260789218158673,0.110900615021975,0,0,3.32667997338656,27.451091384506,PDCD6IP;CTBP2;UBB;NUP155;IST1;CTBP1;KPNA4;NUP153;VPS37A;VPS37B;EPS15;PPID,alpha,6
positive regulation of ubiquitin protein ligase activity (GO:1904668),10/83,10,83,0.000436888703527066,0.131143709064625,0,0,3.60724334463603,27.9050287797069,GOLGA2;PSMA5;PSMA3;FZR1;PSMD7;UBB;ANAPC10;SKP1;ANAPC2;ANAPC11,alpha,6
regulation of G2/M transition of mitotic cell cycle (GO:0010389),14/150,14,150,0.000514205722858747,0.131199590187409,0,0,2.79441117764471,21.1617604530579,ODF2;SSNA1;CDC7;HMMR;CKAP5;HAUS2;MECP2;PSMA5;PSMA3;PSMD7;UBB;SKP1;PAFAH1B1;BRD4,alpha,6
regulation of mitotic cell cycle phase transition (GO:1901990),16/185,16,185,0.000496774331134289,0.133423126935699,0,0,2.58941576306846,19.6986559562107,ODF2;SSNA1;MAD2L1BP;HMMR;CKAP5;ANAPC10;HAUS2;ANAPC11;PSMA5;PSMA3;FZR1;PSMD7;UBB;SKP1;ANAPC2;PAFAH1B1,alpha,6
rRNA processing (GO:0006364),17/203,17,203,0.00048748969500932,0.138203328535142,0,0,2.50730066959677,19.1212801842523,LTV1;UTP15;NOP56;RPLP1;RPL12;RPLP0;TSR3;DDX56;NOC4L;BYSL;SBDS;RPL38;RIOK1;EXOSC3;RPP14;RPL39;MPHOSPH6,alpha,6
regulation of anatomical structure morphogenesis (GO:0022603),10/83,10,83,0.000436888703527066,0.139340190881164,0,0,3.60724334463603,27.9050287797069,ARC;CAPZB;CFL1;HEY2;NF1;TNFAIP3;QRICH1;KIAA1958;CAMSAP1;BCL9L,alpha,6
positive regulation of mitotic cell cycle phase transition (GO:1901992),7/41,7,41,0.000375536210406498,0.147412406284951,0,0,5.11172776398423,40.3169925604751,MECP2;DDX3X;LSM11;RDX;CDC7;ANAPC11;BRD4,alpha,6
rRNA metabolic process (GO:0016072),17/201,17,201,0.000435003937500657,0.147988339537723,0,0,2.53224893496589,19.6000004585226,LTV1;UTP15;NOP56;RPLP1;RPL12;RPLP0;DDX56;NOC4L;DEDD2;BYSL;SBDS;RPL38;RIOK1;EXOSC3;RPP14;RPL39;MPHOSPH6,alpha,6
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),10/88,10,88,0.000698576971028329,0.154992968832937,0,0,3.40228633641807,24.7225952320181,PSMA5;PSMA3;FZR1;PSMD7;UBB;FBXW7;ANAPC10;SKP1;ANAPC2;ANAPC11,alpha,6
proteasomal protein catabolic process (GO:0010498),19/238,19,238,0.000425383720922349,0.155052366276196,0,0,2.3901776279374,18.5537990676912,FAF1;PRPF19;BTBD9;ANAPC10;ANAPC11;ABTB2;PSMA5;BAG6;RNF145;PSMA3;PSMD7;KAT5;UBB;DDIT3;PLAA;RNF185;BIRC2;SKP1;ANAPC2,alpha,6
ncRNA processing (GO:0034470),18/228,18,228,0.000679906357479732,0.157707370100867,0,0,2.36369366530098,17.2397308829158,LTV1;UTP15;NOP56;SMAD3;RPLP1;RPL12;RPLP0;DDX56;NOC4L;BYSL;SBDS;DROSHA;RPL38;RIOK1;EXOSC3;RPP14;RPL39;MPHOSPH6,alpha,6
cellular macromolecule biosynthetic process (GO:0034645),25/368,25,368,0.000670088637489176,0.16283153890987,0,0,2.03397552720646,14.8644976885281,SET;MRPS16;LDB1;RPLP1;RPL12;RPLP0;MRPL37;ASCL2;KAT5;POLR2E;RPL38;RPL39;ST3GAL2;NCOA1;TIPIN;PABPC4;DHPS;CDC7;GTPBP2;TICRR;EEF1D;MED20;MCM4;FARSB;RAD9A,alpha,6
RNA secondary structure unwinding (GO:0010501),7/47,7,47,0.000883624773027854,0.187880717365048,0,0,4.4591667728373,31.3545332860019,DDX3X;DDX1;EIF4A3;DDX56;DDX42;DDX51;DDX41,alpha,6
clathrin coat assembly (GO:0048268),4/14,4,14,0.000944699975171245,0.192832158931955,0,0,8.55431993156544,59.5777858637412,CLTC;FCHO2;HIP1R;EPS15,alpha,6
positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),9/77,9,77,0.00104301167951722,0.204711100022168,0,0,3.49949451745859,24.0262797049568,PSMA5;PSMA3;FZR1;PSMD7;UBB;ANAPC10;SKP1;ANAPC2;ANAPC11,alpha,6
response to ionizing radiation (GO:0010212),9/78,9,78,0.0011448355648769,0.208646281698815,0,0,3.4546292031322,23.396456461597,KAT5;MSH2;EEF1D;FANCD2;FIGNL1;SWI5;RHOB;TICRR;RAD9A,alpha,6
intra-S DNA damage checkpoint (GO:0031573),4/15,4,15,0.00125439288560473,0.213372229841364,0,0,7.98403193612775,53.342144350791,MUS81;TIPIN;MSH2;RAD9A,alpha,6
regulation of mRNA stability (GO:0043488),12/129,12,129,0.00129901671774925,0.213834913247562,0,0,2.78512741957945,18.5103681149411,PSMA5;PSMA3;NPM1;PSMD7;SET;UBB;MAPKAPK2;CIRBP;HSPB1;TNPO1;EXOSC3;YWHAZ,alpha,6
macroautophagy (GO:0016236),11/111,11,111,0.00122081464832954,0.214821281049161,0,0,2.96703889518261,19.9035997960873,ATG3;UBB;TBC1D5;LAMP2;PLAA;MFN2;VDAC1;VPS37A;VPS37B;TOMM20;ATG13,alpha,6
positive regulation of type I interferon production (GO:0032481),8/63,8,63,0.0011378752125198,0.215058415166241,0,0,3.80191996958464,25.7716665882324,SETD2;DDX3X;POLR3B;PRKDC;POLR1C;POLR2E;DDX41;RELA,alpha,6
gene expression (GO:0010467),26/412,26,412,0.00153523904082082,0.244822650790895,0,0,1.88942503342829,12.2417155079537,MRPS16;LDB1;RPLP1;RPL12;RPLP0;EIF4A3;MRPL37;ASCL2;DEDD2;NXF1;POLR2E;DHX15;DROSHA;RPL38;RPL39;NCOA1;NUP155;PABPC4;ALYREF;DHPS;NUP153;THOC7;MED20;BUD13;FARSB;SRSF9,alpha,6
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),5/28,5,28,0.00212570828032714,0.309928267271696,0,0,5.3464499572284,32.9001829755743,MOAP1;DDX3X;BLOC1S2;FADD;DEDD2,alpha,6
regulation of early endosome to late endosome transport (GO:2000641),4/17,4,17,0.00207396458528206,0.311277684667481,0,0,7.04473406128919,43.5244328628653,MAP2K1;RDX;DNAJC13;PTPN23,alpha,6
positive regulation of cell cycle G2/M phase transition (GO:1902751),4/17,4,17,0.00207396458528206,0.320710341778617,0,0,7.04473406128919,43.5244328628653,MECP2;NPM1;CDC7;BRD4,alpha,6
regulation of adherens junction organization (GO:1903391),4/18,4,18,0.00259673924926986,0.368087788584003,0,0,6.65335994677312,39.6107701659097,LDB1;RDX;PTPN23;SLC9A1,alpha,6
regulation of cellular component organization (GO:0051128),12/141,12,141,0.00275939633897045,0.37055788204648,0,0,2.54809529876417,15.0152716038722,ARC;RAP1A;CAPZB;CFL1;HIP1R;QRICH1;ANKRA2;SGK1;KIAA1958;CDK11B;CAMSAP1;BCL9L,alpha,6
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),8/72,8,72,0.00270677551916857,0.373315553359925,0,0,3.32667997338656,19.6673226807842,PSMA5;PSMA3;FZR1;PSMD7;UBB;ANAPC10;ANAPC2;ANAPC11,alpha,6
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),8/73,8,73,0.00295299653689094,0.376728533193861,0,0,3.28110901484702,19.1122462438313,PSMA5;PSMA3;FZR1;PSMD7;UBB;ANAPC10;ANAPC2;ANAPC11,alpha,6
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),5/30,5,30,0.00291750808877388,0.381744712231105,0,0,4.99001996007984,29.1268733598086,UBB;TRAF3;FADD;TICAM1;BIRC2,alpha,6
positive regulation of neuron apoptotic process (GO:0043525),4/19,4,19,0.00320322334070113,0.39868411481946,0,0,6.30318310746927,36.2029478864639,FBXW7;DDIT3;NF1;CDK5R1,alpha,6
MyD88-independent toll-like receptor signaling pathway (GO:0002756),5/31,5,31,0.00338444147419178,0.411209639114302,0,0,4.82905157427081,27.4703804639304,UBB;TRAF3;FADD;TICAM1;BIRC2,alpha,6
regulation of defense response (GO:0031347),8/76,8,76,0.00379737190588035,0.421260626863205,0,0,3.15159155373464,17.5652255128701,HERC5;TRAF3;OTUD7A;TNFAIP3;BIRC2;RELA;FOXP1;BRD4,alpha,6
negative regulation of protein depolymerization (GO:1901880),4/20,4,20,0.0038994904439861,0.423385100758746,0,0,5.98802395209581,33.2150262860531,PLEKHH2;CAMSAP1;TTBK2;ANAPC2,alpha,6
protein K11-linked deubiquitination (GO:0035871),3/10,3,10,0.00373365074256642,0.423395994207032,0,0,8.98203592814371,50.2128931673617,OTUD7A;TNFAIP3;OTUD3,alpha,6
peptidyl-serine phosphorylation (GO:0018105),12/146,12,146,0.00367079439169423,0.425728722291265,0,0,2.46083176113526,13.7987380481575,PRKDC;TNKS;PRKCE;MAPKAPK2;LMTK2;DCLK2;CDC7;PKN2;SGK1;TTBK2;CAMKK2;CDK5R1,alpha,6
regulation of autophagy (GO:0010506),15/204,15,204,0.00364733142092451,0.432844935836692,0,0,2.20147939415287,12.3585758549213,ZBTB17;ATP6V0B;FBXW7;HSPB1;PIK3CB;TICAM1;ATG13;RASIP1;MTDH;GOLGA2;RRAGA;WDR6;VDAC1;ATP6V0C;CDK5R1,alpha,6
proteolysis involved in cellular protein catabolic process (GO:0051603),9/94,9,94,0.00417500887558971,0.443855631086131,0,0,2.8666072111097,15.7051054762156,PSMA5;BAG6;PSMA3;PDCD6IP;OTUD7A;LONP1;TNFAIP3;CTSV;PRPF19,alpha,6
negative regulation of ubiquitin protein ligase activity (GO:1904667),8/78,8,78,0.00445636343933682,0.464098421039506,0,0,3.07078151389529,16.6234368736159,PSMA5;PSMA3;FZR1;PSMD7;UBB;ANAPC10;ANAPC2;ANAPC11,alpha,6
translation (GO:0006412),16/233,16,233,0.00529872165938453,0.500729196811838,0,0,2.05597388913161,10.7738987615001,MRPS16;VARS;RPLP1;PABPC4;RPL12;RPLP0;DHPS;MRPL37;GTPBP2;AIMP2;EEF1D;EIF4H;RPL38;ABCE1;RPL39;FARSB,alpha,6
RNA metabolic process (GO:0016070),14/192,14,192,0.0052524975088323,0.505726316746627,0,0,2.18313373253493,11.459381610745,DDX3X;DDX1;PABPC4;EIF4A3;DDX56;DDX42;DDX51;DDX41;DEDD2;SUPV3L1;RNASEH1;DHX15;POLR2E;DROSHA,alpha,6
peptidyl-serine modification (GO:0018209),13/171,13,171,0.00497002408615303,0.507240658232778,0,0,2.27614945547502,12.0734491899533,GALNT16;PRKDC;TNKS;PRKCE;LMTK2;DCLK2;CDC7;TTBK2;CAMKK2;MAPKAPK2;PKN2;SGK1;CDK5R1,alpha,6
anaphase-promoting complex-dependent catabolic process (GO:0031145),8/80,8,80,0.00519986233282512,0.510286490084742,0,0,2.9940119760479,15.7458776293471,PSMA5;PSMA3;FZR1;PSMD7;UBB;ANAPC10;ANAPC2;ANAPC11,alpha,6
RNA transport (GO:0050658),8/81,8,81,0.00560539537190554,0.510791653264892,0,0,2.9570488652325,15.3294172715345,NXF1;NUP155;ALYREF;EIF4A3;NUP153;CKAP5;THOC7;SRSF9,alpha,6
regulation of DNA recombination (GO:0000018),5/34,5,34,0.00510547563119167,0.510847885215119,0,0,4.40295878830574,23.2363581456075,SETD2;PPP4R2;MSH2;FIGNL1;ALYREF,alpha,6
negative regulation of protein import into nucleus (GO:0042308),4/22,4,22,0.00558460288622109,0.518149609607022,0,0,5.44365813826892,28.2402936996185,SLC9A3R1;NF1;CABP1;ANAPC2,alpha,6
viral budding (GO:0046755),4/23,4,23,0.00658445705698792,0.550827612488678,0,0,5.20697734964853,26.1548732031694,LRSAM1;PDCD6IP;VPS37A;VPS37B,alpha,6
positive regulation of RNA metabolic process (GO:0051254),5/36,5,36,0.00654933534308627,0.557020970929488,0,0,4.1583499667332,20.9098124951007,UTP15;SUPV3L1;MAP2K1;RIOK1;RELA,alpha,6
regulation of apoptotic process (GO:0042981),41/816,41,816,0.00627606375664434,0.561872865792212,0,0,1.50434425267113,7.62854818670671,ANKLE2;RARG;RBM25;RTKN;DDX3X;PRKDC;FAF1;DDX42;HSPB1;AATF;HIGD1A;SH3RF1;RELA;MTDH;PNMA1;UBB;FIGNL1;CFL1;FADD;RELT;MAP4K3;MAP4K4;MOAP1;MAP2K1;NPM1;EGR3;RYK;HIP1R;LMTK2;NME4;YWHAZ;RHOB;SUPV3L1;ARHGAP10;BRMS1;SHQ1;RASA1;NF1;SGK1;BIRC2;PPID,alpha,6
ribosomal subunit export from nucleus (GO:0000054),3/12,3,12,0.00651209528714885,0.563241055090179,0,0,7.48502994011976,37.6803444449216,LTV1;NPM1;ABCE1,alpha,6
regulation of rRNA processing (GO:2000232),3/12,3,12,0.00651209528714885,0.572952107764148,0,0,7.48502994011976,37.6803444449216,UTP15;SHQ1;RIOK1,alpha,6
regulation of ubiquitin protein ligase activity (GO:1904666),5/37,5,37,0.00736890034648321,0.606508039808126,0,0,4.04596212979447,19.8676435937531,GOLGA2;FZR1;ANAPC10;ANAPC11;ANAPC2,alpha,6
positive regulation of cell cycle G1/S phase transition (GO:1902808),4/24,4,24,0.00769607163409417,0.623381802361628,0,0,4.99001996007984,24.2866529825231,DDX3X;LSM11;STXBP4;RDX,alpha,6
regulation of necrotic cell death (GO:0010939),3/13,3,13,0.00825782731564214,0.628950638682415,0,0,6.9092584062644,33.1409057777294,HEBP2;UBB;BIRC2,alpha,6
organelle assembly (GO:0070925),22/377,22,377,0.00838755181668077,0.629436425301793,0,0,1.7471687923887,8.35322552572865,ATG3;NPM1;CENPW;DDX3X;PDCD6IP;IST1;TNKS;TMOD3;ARL3;CIRBP;VPS37A;PTPN23;VPS37B;ATG13;WDR35;HAUS2;TTBK2;GOLGA2;IFT74;IFT81;BBS9;HYLS1,alpha,6
sodium ion export (GO:0071436),3/13,3,13,0.00825782731564214,0.638480193813967,0,0,6.9092584062644,33.1409057777294,ATP1B3;ATP1A1;SLC9A1,alpha,6
cellular response to vascular endothelial growth factor stimulus (GO:0035924),4/26,4,26,0.010273536043755,0.639339688186365,0,0,4.60617227084293,21.0879042203784,NR4A1;EGR3;MAPKAPK2;HSPB1,alpha,6
potassium ion homeostasis (GO:0055075),4/26,4,26,0.010273536043755,0.647232770756567,0,0,4.60617227084293,21.0879042203784,SLC12A2;ATP1B3;ATP1A1;SLC12A7,alpha,6
sodium ion export from cell (GO:0036376),3/13,3,13,0.00825782731564214,0.64830296602649,0,0,6.9092584062644,33.1409057777294,ATP1B3;ATP1A1;SLC9A1,alpha,6
cell migration involved in sprouting angiogenesis (GO:0002042),3/14,3,14,0.0102523227598179,0.653970038041886,0,0,6.41573994867408,29.3856992409502,NR4A1;EGR3;SRF,alpha,6
regulation of cell-matrix adhesion (GO:0001952),6/53,6,53,0.00821799470802735,0.655256671797868,0,0,3.38944752005423,16.2741917946111,LDB1;ADAM15;RASA1;NF1;PIK3CB;SLC9A1,alpha,6
neuron projection development (GO:0031175),12/168,12,168,0.0109237462524621,0.65581031913311,0,0,2.13857998289136,9.65957293431542,ARC;UBB;FLRT3;RYK;BLOC1S2;MICALL2;NPTXR;SGK1;ZNF335;CAMSAP1;MAP4K4;CDK5R1,alpha,6
endosomal transport (GO:0016197),15/230,15,230,0.0106776648241872,0.65648341684129,0,0,1.9526165061182,8.86410007571863,AP5Z1;ZFYVE9;CLTC;LMTK2;VPS37A;PTPN23;VPS37B;RHOB;RGP1;UBB;TBC1D5;KIF13A;MICALL2;CORO7;EPS15,alpha,6
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),7/73,7,73,0.0108911314589841,0.661636236133285,0,0,2.87097038799114,12.9762304732033,PSMA5;FBXL20;PSMA3;PSMD7;UBB;FBXW7;SKP1,alpha,6
regulation of defense response to virus (GO:0050688),3/14,3,14,0.0102523227598179,0.662248139789252,0,0,6.41573994867408,29.3856992409502,HERC5;TRAF3;TNFAIP3,alpha,6
transport of virus (GO:0046794),6/55,6,55,0.00981436518230265,0.667769407003872,0,0,3.26619488296135,15.1025850789246,UBB;NUP155;KPNA4;VPS37A;NUP153;VPS37B,alpha,6
mitotic DNA damage checkpoint (GO:0044773),5/40,5,40,0.0102513227724905,0.670673078307934,0,0,3.74251497005988,17.1420229444214,MUS81;TIPIN;MSH2;FOXN3;RAD9A,alpha,6
protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),7/71,7,71,0.00940824141609809,0.67620078797674,0,0,2.95184279328667,13.7737980062464,RNF144A;KLHL18;ABTB2;BTBD9;RNF185;ANAPC2;ANAPC11,alpha,6
intracellular transport of virus (GO:0075733),6/55,6,55,0.00981436518230265,0.67679331790933,0,0,3.26619488296135,15.1025850789246,UBB;NUP155;KPNA4;VPS37A;NUP153;VPS37B,alpha,6
cytoskeleton organization (GO:0007010),10/127,10,127,0.0102241414916625,0.677581740674722,0,0,2.35748974491961,10.8043838518409,FMNL3;ARHGAP10;ARC;RTKN;CAPZB;SH3KBP1;CFL1;QRICH1;KIAA1958;CAMSAP1,alpha,6
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),14/205,14,205,0.00917124043515691,0.678273042617474,0,0,2.04469110559369,9.5930419500418,SLC35B2;OTUD7A;TNFAIP3;HSPB1;RORA;TICAM1;RELA;MTDH;UBB;EEF1D;FADD;ZMYND11;BIRC2;BRD4,alpha,6
regulation of response to external stimulus (GO:0032101),9/108,9,108,0.0102065524365344,0.68531627741625,0,0,2.49500998003992,11.4389355518989,HERC5;TRAF3;OTUD7A;TNFAIP3;BIRC2;RELA;CD55;FOXP1;BRD4,alpha,6
cytoskeleton-dependent cytokinesis (GO:0061640),7/71,7,71,0.00940824141609809,0.685860799233551,0,0,2.95184279328667,13.7737980062464,RTKN;ALKBH4;PDCD6IP;IST1;RASA1;ARL3;RHOB,alpha,6
RNA modification (GO:0009451),6/55,6,55,0.00981436518230265,0.686064459250554,0,0,3.26619488296135,15.1025850789246,NOP56;WDR4;TSR3;MEPCE;PUS7;TARBP1,alpha,6
regulation of transcription from RNA polymerase II promoter (GO:0006357),66/1479,66,1479,0.00971329676102921,0.688429907937946,0,0,1.33607025300312,6.19169630547542,KDM5B;RARG;GMEB2;DDX3X;ONECUT2;LDB1;TCF25;RORA;AATF;MECP2;FOXQ1;ZNF609;MED13;KAT5;HEY2;WWC3;NCOA1;KDM6B;SMARCC1;TCF12;ABHD14B;HCFC2;FOXP1;BRMS1;DDIT3;ZSCAN21;MED20;ANKRA2;ZMYND11;CRK;PPID;SMARCD1;CTBP2;CTBP1;PRKDC;TNKS;SRF;ASCL2;RELA;MTDH;SLC9A1;RXRB;RAI1;UBB;ZNF821;CAMTA2;FADD;BRD4;BCL9L;CBX8;ZBTB17;STAT5B;NPM1;SMAD3;TARBP1;DRAP1;CDK8;NR4A1;CNOT7;FOSB;QRICH1;BCOR;AGRN;KIAA1958;PPIL4;NFE2L1,alpha,6
protein complex assembly (GO:0006461),13/190,13,190,0.0116114046137033,0.688988345857303,0,0,2.04853450992751,9.12779350732285,NAPA;HGSNAT;SEC24B;NPM1;TRAPPC10;TNFAIP3;SLC9A1;GOLGA2;KAT5;DDIT3;FADD;CRK;BCL9L,alpha,6
sodium ion homeostasis (GO:0055078),4/27,4,27,0.0117480999606107,0.689086828724099,0,0,4.43557329784875,19.7119705342544,SLC12A2;ATP1B3;ATP1A1;SLC9A1,alpha,6
proton transport (GO:0015992),4/32,4,32,0.0211248045980797,0.69102485810257,0,0,3.74251497005988,14.436030522368,ATP6V0B;COX15;ATP6V0C;SLC9A1,alpha,6
regulation of organelle assembly (GO:1902115),5/48,5,48,0.0214812371193874,0.693789576077431,0,0,3.1187624750499,11.9778424930997,ATG3;NPM1;KIF9;PDCD6IP;RDX,alpha,6
positive regulation of viral genome replication (GO:0045070),4/32,4,32,0.0211248045980797,0.695483082993555,0,0,3.74251497005988,14.436030522368,DDX3X;CNOT7;PKN2;PPID,alpha,6
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),5/48,5,48,0.0214812371193874,0.698208617963274,0,0,3.1187624750499,11.9778424930997,FAF1;OTUD7A;TNFAIP3;RORA;ZMYND11,alpha,6
multivesicular body organization (GO:0036257),4/32,4,32,0.0211248045980797,0.699999206909097,0,0,3.74251497005988,14.436030522368,PDCD6IP;IST1;VPS37A;VPS37B,alpha,6
cellular response to DNA damage stimulus (GO:0006974),19/330,19,330,0.0155215648925922,0.700942881830956,0,0,1.72382507711849,7.18063634852438,MUS81;MOAP1;NPM1;STXBP4;PRKDC;FANCA;AATF;PDS5A;GNL1;UNG;TICRR;MSH2;PAPD7;FANCD2;DDIT3;TIPRL;MAPKAPK2;POLI;RAD9A,alpha,6
protein modification by small protein conjugation (GO:0032446),22/399,22,399,0.0153958130416933,0.701471731712149,0,0,1.65083367100386,6.8900179425091,PIAS4;KLHL18;ATG3;NUP155;PRKDC;FBXW7;FBXO25;UBR3;UBE2G1;NUP153;ANAPC11;HERC5;RNF144A;HERC3;RRAGA;HECTD1;SENP5;UBB;PDZRN3;BIRC2;RNF220;SKP1,alpha,6
negative regulation of RIG-I signaling pathway (GO:0039536),2/7,2,7,0.0209219648506996,0.702399912060002,0,0,8.55431993156544,33.079176407855,SEC14L1;GPATCH3,alpha,6
SREBP signaling pathway (GO:0032933),2/6,2,6,0.0152796589191505,0.702451346526351,0,0,9.98003992015968,41.7288704345113,ERLIN1;SCAP,alpha,6
positive regulation of ubiquitin-protein transferase activity (GO:0051443),4/32,4,32,0.0211248045980797,0.704574365124189,0,0,3.74251497005988,14.436030522368,GOLGA2;FZR1;FBXW7;ANAPC10,alpha,6
protein localization to cytoplasmic stress granule (GO:1903608),2/7,2,7,0.0209219648506996,0.707051567106757,0,0,8.55431993156544,33.079176407855,DDX3X;DDX1,alpha,6
ribosomal small subunit export from nucleus (GO:0000056),2/6,2,6,0.0152796589191505,0.708837267858409,0,0,9.98003992015968,41.7288704345113,LTV1;NPM1,alpha,6
formation of translation preinitiation complex (GO:0001731),2/7,2,7,0.0209219648506996,0.711765244220802,0,0,8.55431993156544,33.079176407855,EIF4H;TICRR,alpha,6
white fat cell differentiation (GO:0050872),2/6,2,6,0.0152796589191505,0.715340362058945,0,0,9.98003992015968,41.7288704345113,CTBP2;CTBP1,alpha,6
exit from host cell (GO:0035891),2/7,2,7,0.0209219648506996,0.716542192168593,0,0,8.55431993156544,33.079176407855,IST1;PPID,alpha,6
negative regulation of apoptotic process (GO:0043066),25/486,25,486,0.022336229029194,0.716866520352056,0,0,1.54012961730859,5.85487250597654,ANKLE2;SET;DDX3X;PRKDC;HSPB1;AATF;HIGD1A;SH3RF1;RELA;MTDH;UBB;FIGNL1;CFL1;MAP4K4;NPM1;EGR3;RYK;LMTK2;YWHAZ;SUPV3L1;ARHGAP10;MSH2;PIK3CA;RASA1;BIRC2,alpha,6
cellular response to sterol depletion (GO:0071501),2/7,2,7,0.0209219648506996,0.721383693467029,0,0,8.55431993156544,33.079176407855,ERLIN1;SCAP,alpha,6
regulation of protein K63-linked ubiquitination (GO:1900044),2/6,2,6,0.0152796589191505,0.721963883929861,0,0,9.98003992015968,41.7288704345113,PLAA;BIRC2,alpha,6
glycolipid metabolic process (GO:0006664),6/66,6,66,0.0226699690021674,0.723030323862878,0,0,2.72182906913446,10.306788736565,SMPD2;HEXB;ARSK;ESYT2;GBA2;ST3GAL2,alpha,6
microtubule cytoskeleton organization involved in mitosis (GO:1902850),5/45,5,45,0.0166207615320168,0.724920906819502,0,0,3.32667997338656,13.6297494024848,MECP2;SETD2;TNKS;SBDS;WDR62,alpha,6
cellular sodium ion homeostasis (GO:0006883),3/15,3,15,0.0125018116151673,0.724963007638624,0,0,5.98802395209581,26.2388126704295,ATP1B3;ATP1A1;SLC9A1,alpha,6
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),2/7,2,7,0.0209219648506996,0.726291065531431,0,0,8.55431993156544,33.079176407855,LDB1;NUP155,alpha,6
regulation of catenin import into nucleus (GO:0035412),3/19,3,19,0.0241238026980449,0.728424645965225,0,0,4.72738733060195,17.6074200854959,SLC9A3R1;GNAQ;ANAPC2,alpha,6
nucleus localization (GO:0051647),2/6,2,6,0.0152796589191505,0.728711209947897,0,0,9.98003992015968,41.7288704345113,SLC9A3R1;PAFAH1B1,alpha,6
negative regulation of type I interferon production (GO:0032480),5/45,5,45,0.0166207615320168,0.731170224981739,0,0,3.32667997338656,13.6297494024848,HERC5;UBB;TRAF3;TNFAIP3;GPATCH3,alpha,6
glycoside catabolic process (GO:0016139),2/7,2,7,0.0209219648506996,0.731265661870687,0,0,8.55431993156544,33.079176407855,ABHD10;GBA2,alpha,6
mRNA transport (GO:0051028),8/105,8,105,0.0244037563387043,0.732543344684752,0,0,2.28115198175078,8.46995884852981,NXF1;NUP155;ALYREF;EIF4A3;NUP153;BUD13;THOC7;SRSF9,alpha,6
positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),3/19,3,19,0.0241238026980449,0.732760506953114,0,0,4.72738733060195,17.6074200854959,SMAD3;SRF;RELA,alpha,6
tumor necrosis factor-mediated signaling pathway (GO:0033209),9/124,9,124,0.0232981623403955,0.733892113722459,0,0,2.17307320842187,8.16940967724693,PSMA5;PSMA3;PSMD7;UBB;TRAF3;CDIP1;RELT;BIRC2;RELA,alpha,6
cardiolipin acyl-chain remodeling (GO:0035965),2/6,2,6,0.0152796589191505,0.735585844004009,0,0,9.98003992015968,41.7288704345113,HADHB;HADHA,alpha,6
regulation of cell cycle G2/M phase transition (GO:1902749),7/85,7,85,0.0235129829510843,0.736115042941,0,0,2.46565692145122,9.24671286039844,NPM1;ODF2;SSNA1;HMMR;CKAP5;HAUS2;PAFAH1B1,alpha,6
bone cell development (GO:0098751),2/7,2,7,0.0209219648506996,0.736308873331864,0,0,8.55431993156544,33.079176407855,ANXA2;FOXP1,alpha,6
chromatin disassembly (GO:0031498),3/19,3,19,0.0241238026980449,0.737148294419899,0,0,4.72738733060195,17.6074200854959,SMARCD1;SMARCC1;SET,alpha,6
positive regulation of viral life cycle (GO:1903902),5/45,5,45,0.0166207615320168,0.737528226938102,0,0,3.32667997338656,13.6297494024848,DDX3X;CNOT7;PKN2;VPS37B;PPID,alpha,6
ribonucleoprotein complex assembly (GO:0022618),11/157,11,157,0.0164780645677251,0.737610206044748,0,0,2.09771539723102,8.61264297445371,NPM1;SHQ1;DDX3X;DDX1;RPL12;CIRBP;EIF4H;RPL38;PRPF19;SRSF9;TICRR,alpha,6
cellular macromolecule catabolic process (GO:0044265),5/49,5,49,0.0232861647542117,0.738070178513927,0,0,3.05511426127337,11.4869115304439,TATDN3;SUPV3L1;RNASEH1;PABPC4;UBE2G1,alpha,6
neuron development (GO:0048666),10/145,10,145,0.0238201883542959,0.741185494951049,0,0,2.06483584555028,7.71674955128035,FLRT3;RYK;ARL3;BLOC1S2;SRF;MICALL2;NPTXR;GBA2;CAMSAP1;CDK5R1,alpha,6
mitochondrial DNA metabolic process (GO:0032042),2/7,2,7,0.0209219648506996,0.741422129396669,0,0,8.55431993156544,33.079176407855,LONP1;POLG,alpha,6
nucleosome disassembly (GO:0006337),3/19,3,19,0.0241238026980449,0.741588946795922,0,0,4.72738733060195,17.6074200854959,SMARCD1;SMARCC1;SET,alpha,6
protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),2/6,2,6,0.0152796589191505,0.742591423470714,0,0,9.98003992015968,41.7288704345113,OTUD7A;TNFAIP3,alpha,6
cellular monovalent inorganic cation homeostasis (GO:0030004),3/17,3,17,0.0177832405355242,0.743835052891638,0,0,5.28355054596689,21.2900606278381,ATP1B3;ATP1A1;SLC9A1,alpha,6
acetylcholine receptor signaling pathway (GO:0095500),3/19,3,19,0.0241238026980449,0.746083425261352,0,0,4.72738733060195,17.6074200854959,GNAQ;AGRN;CDK5R1,alpha,6
negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),2/7,2,7,0.0209219648506996,0.74660689953231,0,0,8.55431993156544,33.079176407855,SARM1;TICAM1,alpha,6
regulation of nuclear cell cycle DNA replication (GO:0033262),2/6,2,6,0.0152796589191505,0.749731725619471,0,0,9.98003992015968,41.7288704345113,TIPIN;CDC7,alpha,6
chaperone-mediated protein complex assembly (GO:0051131),3/17,3,17,0.0177832405355242,0.749982450022974,0,0,5.28355054596689,21.2900606278381,CCT2;PTGES3L;LONP1,alpha,6
rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),2/7,2,7,0.0209219648506996,0.751864694599439,0,0,8.55431993156544,33.079176407855,NPM1;ABCE1,alpha,6
blood vessel endothelial cell migration (GO:0043534),3/18,3,18,0.0208205475719966,0.753526625956727,0,0,4.99001996007984,19.320433711842,NR4A1;EGR3;SRF,alpha,6
protein K11-linked ubiquitination (GO:0070979),4/29,4,29,0.0150883033484349,0.754858941049639,0,0,4.12967169110056,17.3191635268021,FZR1;ANAPC10;ANAPC11;ANAPC2,alpha,6
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),8/101,8,101,0.0198270063535601,0.755053831509082,0,0,2.37149463449339,9.29794347157377,NXF1;NUP155;ALYREF;EIF4A3;NUP153;BUD13;THOC7;SRSF9,alpha,6
mitochondrial RNA metabolic process (GO:0000959),3/20,3,20,0.0276928058237712,0.755702610260452,0,0,4.49101796407186,16.1074069629102,SUPV3L1;MRPL12;SLC25A33,alpha,6
virion assembly (GO:0019068),3/17,3,17,0.0177832405355242,0.756232303773165,0,0,5.28355054596689,21.2900606278381,LRSAM1;PDCD6IP;UBB,alpha,6
viral release from host cell (GO:0019076),2/6,2,6,0.0152796589191505,0.757010674411893,0,0,9.98003992015968,41.7288704345113,IST1;PPID,alpha,6
regulation of autophagy of mitochondrion (GO:1903146),4/28,4,28,0.0133518356301005,0.757049080226699,0,0,4.27715996578272,18.4606561300519,ZBTB17;FBXW7;VDAC1;CAMKK2,alpha,6
negative regulation of microtubule depolymerization (GO:0007026),3/18,3,18,0.0208205475719966,0.758908958999275,0,0,4.99001996007984,19.320433711842,CAMSAP1;TTBK2;ANAPC2,alpha,6
"regulation of DNA-templated transcription, elongation (GO:0032784)",3/20,3,20,0.0276928058237712,0.759765527519917,0,0,4.49101796407186,16.1074069629102,LDB1;ALYREF;ZMYND11,alpha,6
negative regulation of programmed cell death (GO:0043069),22/409,22,409,0.0198270005468108,0.760730705190795,0,0,1.61047098956122,6.31419068982515,ANKLE2;NPM1;EGR3;DDX3X;PRKDC;RYK;LMTK2;HSPB1;AATF;HIGD1A;YWHAZ;SH3RF1;RELA;MTDH;SUPV3L1;ARHGAP10;UBB;FIGNL1;RASA1;CFL1;BIRC2;MAP4K4,alpha,6
succinate metabolic process (GO:0006105),2/8,2,8,0.0272853792863742,0.760859510920041,0,0,7.48502994011976,26.9566188437793,STAT5B;SDHA,alpha,6
carboxylic acid catabolic process (GO:0046395),4/29,4,29,0.0150883033484349,0.762332791951121,0,0,4.12967169110056,17.3191635268021,ABHD10;HEXB;HMMR;SLC9A1,alpha,6
DNA replication checkpoint (GO:0000076),3/17,3,17,0.0177832405355242,0.762587197082184,0,0,5.28355054596689,21.2900606278381,TIPIN;TICRR;RAD9A,alpha,6
NIK/NF-kappaB signaling (GO:0038061),7/81,7,81,0.0185388121493682,0.762931922566338,0,0,2.58741775707844,10.3183342698205,PSMA5;PSMA3;PSMD7;UBB;BIRC2;RELA;SKP1,alpha,6
positive regulation of transcription from RNA polymerase II promoter (GO:0045944),40/849,40,849,0.0184062420919879,0.763634580450522,0,0,1.41060634913918,5.63546465763554,RARG;DDX3X;CTBP2;ONECUT2;LDB1;PRKDC;TNKS;SRF;RORA;AATF;RELA;SLC9A1;RXRB;RAI1;ZNF609;MED13;KAT5;UBB;HEY2;SCAP;ZNF821;CAMTA2;FADD;BRD4;BCL9L;NCOA1;KDM6B;ZBTB17;STAT5B;NPM1;SMAD3;TCF12;ERLIN1;ABHD14B;CDK8;NR4A1;DDIT3;ZSCAN21;AGRN;NFE2L1,alpha,6
peptidyl-threonine phosphorylation (GO:0018107),6/69,6,69,0.027534983758408,0.763646859343239,0,0,2.60348867482426,9.35250701931916,MAP2K1;TNKS;LMTK2;DCLK2;CAMKK2;CDK5R1,alpha,6
error-prone translesion synthesis (GO:0042276),3/20,3,20,0.0276928058237712,0.763872368209214,0,0,4.49101796407186,16.1074069629102,UBB;PAPD7;POLI,alpha,6
regulation of proteolysis (GO:0030162),6/64,6,64,0.0197699418424141,0.764287978953326,0,0,2.80688622754491,11.0130779851597,BAG6;ABTB2;IST1;TRAF3;FADD;BTBD9,alpha,6
DNA repair (GO:0006281),17/289,17,289,0.0176731348445293,0.764288195861296,0,0,1.7611835153223,7.10762521632556,MUS81;SETD2;NPM1;PRKDC;DDX1;FANCA;PDS5A;UNG;TICRR;KAT5;MSH2;UBB;PAPD7;FANCD2;PMS2;POLI;RAD9A,alpha,6
modulation by virus of host morphology or physiology (GO:0019048),3/18,3,18,0.0208205475719966,0.764368735682723,0,0,4.99001996007984,19.320433711842,RRAGA;SMAD3;KPNA4,alpha,6
regulation of receptor binding (GO:1900120),2/8,2,8,0.0272853792863742,0.765040057683338,0,0,7.48502994011976,26.9566188437793,ADAM15;PTPRF,alpha,6
endocytic recycling (GO:0032456),4/28,4,28,0.0133518356301005,0.765555249667448,0,0,4.27715996578272,18.4606561300519,MICALL2;LMTK2;PTPN23;EPS15,alpha,6
mRNA export from nucleus (GO:0006406),8/106,8,106,0.0256544960292445,0.765584170977981,0,0,2.25963168003615,8.27711318254335,NXF1;NUP155;ALYREF;EIF4A3;NUP153;BUD13;THOC7;SRSF9,alpha,6
extrinsic apoptotic signaling pathway (GO:0097191),6/68,6,68,0.0258431251751058,0.766729463770726,0,0,2.64177527298345,9.65756603752661,MOAP1;DDX3X;SMAD3;BLOC1S2;FADD;DEDD2,alpha,6
negative regulation of intracellular signal transduction (GO:1902532),11/162,11,162,0.0203117999682102,0.767786038798345,0,0,2.03297109484734,7.92158019303707,SLC9A3R1;DDX3X;DDIT3;WWC3;NF1;OTUD7A;TNFAIP3;RORA;ZMYND11;RELA;OTUD3,alpha,6
viral mRNA export from host cell nucleus (GO:0046784),2/8,2,8,0.0272853792863742,0.769266798333522,0,0,7.48502994011976,26.9566188437793,ALYREF;THOC7,alpha,6
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),3/18,3,18,0.0208205475719966,0.769907639564481,0,0,4.99001996007984,19.320433711842,PLAA;VPS37A;PTPN23,alpha,6
negative regulation of homeostatic process (GO:0032845),4/29,4,29,0.0150883033484349,0.769956119870632,0,0,4.12967169110056,17.3191635268021,LDB1;TSC22D3;TNFAIP3;FADD,alpha,6
negative regulation of autophagy (GO:0010507),5/47,5,47,0.0197698515921577,0.770118722708249,0,0,3.18511912345522,12.497124310572,GOLGA2;RRAGA;PIK3CA;WDR6;RASIP1,alpha,6
regulation of wound healing (GO:0061041),4/35,4,35,0.0284527522931063,0.772310611445326,0,0,3.42172797262618,12.1796762418451,VTN;PRKCE;TNFAIP3;CRK,alpha,6
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),2/8,2,8,0.0272853792863742,0.773540502768709,0,0,7.48502994011976,26.9566188437793,PIK3CA;PIK3CB,alpha,6
multivesicular body assembly (GO:0036258),4/31,4,31,0.0189720443549261,0.774514738745501,0,0,3.86324125941665,15.316935418406,PDCD6IP;IST1;VPS37A;VPS37B,alpha,6
cellular response to radiation (GO:0071478),5/43,5,43,0.01382382569539,0.77519761014918,0,0,3.48140927447431,14.9051722456495,EEF1D;FIGNL1;SWI5;RHOB;RAD9A,alpha,6
actin filament polymerization (GO:0030041),3/18,3,18,0.0208205475719966,0.775527403356923,0,0,4.99001996007984,19.320433711842,COBLL1;MICALL2;CORO7,alpha,6
cellular response to interleukin-12 (GO:0071349),5/47,5,47,0.0197698515921577,0.776042712882928,0,0,3.18511912345522,12.497124310572,RALA;ANXA2;RPLP0;CFL1;LMNB1,alpha,6
toll-like receptor signaling pathway (GO:0002224),7/87,7,87,0.026315258865251,0.776224080863444,0,0,2.40897515314199,8.76290324913996,UBB;TRAF3;MAPKAPK2;CNPY3;FADD;TICAM1;BIRC2,alpha,6
hydrogen ion transmembrane transport (GO:1902600),4/29,4,29,0.0150883033484349,0.77773345441478,0,0,4.12967169110056,17.3191635268021,ATP6V0B;COX15;ATP6V0C;SLC9A1,alpha,6
glycosyl compound metabolic process (GO:1901657),2/8,2,8,0.0272853792863742,0.777861958091439,0,0,7.48502994011976,26.9566188437793,KL;NME4,alpha,6
RNA export from nucleus (GO:0006405),9/120,9,120,0.0192705996796299,0.780459287025011,0,0,2.24550898203593,8.86790720924512,NXF1;NPM1;NUP155;ALYREF;EIF4A3;NUP153;BUD13;THOC7;SRSF9,alpha,6
porphyrin-containing compound biosynthetic process (GO:0006779),3/18,3,18,0.0208205475719966,0.781229810734547,0,0,4.99001996007984,19.320433711842,SLC25A38;COX15;NFE2L1,alpha,6
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),3/16,3,16,0.0150110098582034,0.78164472761645,0,0,5.61377245508982,23.572069741237,DDX3X;LSM11;RDX,alpha,6
interleukin-12-mediated signaling pathway (GO:0035722),5/47,5,47,0.0197698515921577,0.782058547866517,0,0,3.18511912345522,12.497124310572,RALA;ANXA2;RPLP0;CFL1;LMNB1,alpha,6
regulation of cytoplasmic transport (GO:1903649),2/8,2,8,0.0272853792863742,0.782231969091952,0,0,7.48502994011976,26.9566188437793,MAP2K1;DNAJC13,alpha,6
regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),2/8,2,8,0.0272853792863742,0.786651358747839,0,0,7.48502994011976,26.9566188437793,SARM1;TICAM1,alpha,6
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",7/89,7,89,0.0293369859462902,0.787929680441678,0,0,2.35484088003768,8.31001267583767,PSMA5;PSMA3;PSMD7;PARD6A;UBB;RYK;CLTC,alpha,6
cellular response to ionizing radiation (GO:0071479),5/47,5,47,0.0197698515921577,0.788168380271724,0,0,3.18511912345522,12.497124310572,EEF1D;FIGNL1;SWI5;RHOB;RAD9A,alpha,6
G-protein coupled acetylcholine receptor signaling pathway (GO:0007213),3/16,3,16,0.0150110098582034,0.789702920684661,0,0,5.61377245508982,23.572069741237,GNAQ;AGRN;CDK5R1,alpha,6
negative regulation of cell cycle G2/M phase transition (GO:1902750),6/70,6,70,0.0292984345177621,0.791057731979577,0,0,2.56629597946963,9.05959245632446,PSMA5;PSMA3;FZR1;PSMD7;UBB;SKP1,alpha,6
positive regulation of early endosome to late endosome transport (GO:2000643),2/8,2,8,0.0272853792863742,0.791120968740724,0,0,7.48502994011976,26.9566188437793,RDX;PTPN23,alpha,6
protein catabolic process (GO:0030163),7/82,7,82,0.0197058753537282,0.791803794725,0,0,2.55586388199211,10.0364645555649,PSMA5;BAG6;LRSAM1;PSMA3;LAMP2;UBE2G1;PRPF19,alpha,6
SMAD protein complex assembly (GO:0007183),2/8,2,8,0.0272853792863742,0.795641659990672,0,0,7.48502994011976,26.9566188437793,SMAD3;ZFYVE9,alpha,6
positive regulation of apoptotic signaling pathway (GO:2001235),7/77,7,77,0.0143538785597147,0.796172198806786,0,0,2.72182906913446,11.5507215307278,SLC9A3R1;MOAP1;TRIM39;HIP1R;FADD;MFF;DEDD2,alpha,6
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),3/16,3,16,0.0150110098582034,0.797928992775126,0,0,5.61377245508982,23.572069741237,MECP2;CDC7;BRD4,alpha,6
negative regulation of peptidyl-lysine acetylation (GO:2000757),2/9,2,9,0.0343155865119477,0.799600173381139,0,0,6.65335994677312,22.4361650749737,SET;CTBP1,alpha,6
cellular response to hypoxia (GO:0071456),9/133,9,133,0.0344885025541954,0.799976493336633,0,0,2.02602314168655,6.82188182163805,PSMA5;CPEB1;PSMA3;PSMD7;UBB;HP1BP3;HILPDA;RORA;HIGD1A,alpha,6
translocation of molecules into host (GO:0044417),2/8,2,8,0.0272853792863742,0.800214313209009,0,0,7.48502994011976,26.9566188437793,ALYREF;THOC7,alpha,6
Golgi inheritance (GO:0048313),2/9,2,9,0.0343155865119477,0.803268064084722,0,0,6.65335994677312,22.4361650749737,GOLGA2;YWHAZ,alpha,6
negative regulation of cell cycle (GO:0045786),6/73,6,73,0.0350277958229244,0.805165955335059,0,0,2.46083176113526,8.24775662285302,SLC9A3R1;ZBTB17;NR4A1;SMAD3;TAF6;RHOB,alpha,6
heme biosynthetic process (GO:0006783),3/16,3,16,0.0150110098582034,0.806328245330654,0,0,5.61377245508982,23.572069741237,SLC25A38;COX15;NFE2L1,alpha,6
mitochondrial fragmentation involved in apoptotic process (GO:0043653),2/9,2,9,0.0343155865119477,0.806969760232578,0,0,6.65335994677312,22.4361650749737,ATG3;MFF,alpha,6
Rho protein signal transduction (GO:0007266),6/73,6,73,0.0350277958229244,0.808809240200828,0,0,2.46083176113526,8.24775662285302,RTKN;CDC42EP4;CFL1;ARHGAP29;CTNNAL1;RHOB,alpha,6
glycosphingolipid metabolic process (GO:0006687),5/55,5,55,0.0361600898384477,0.809319905463152,0,0,2.72182906913446,9.03592612681247,SMPD2;HEXB;ARSK;ESYT2;GBA2,alpha,6
toll-like receptor 3 signaling pathway (GO:0034138),2/9,2,9,0.0343155865119477,0.810705731344766,0,0,6.65335994677312,22.4361650749737,FADD;TICAM1,alpha,6
negative regulation of supramolecular fiber organization (GO:1902904),5/55,5,55,0.0361600898384477,0.812885191390302,0,0,2.72182906913446,9.03592612681247,PLEKHH2;HIP1R;CAMSAP1;ANAPC2;TTBK2,alpha,6
phosphorylation (GO:0016310),20/387,20,387,0.0365248158858934,0.813913255308796,0,0,1.54729301087747,5.12117371787834,MAP2K1;CTBP1;PRKDC;PRKCE;LMTK2;PIK3CB;DGKZ;CDK11B;UQCRH;CAMKK2;GNPTG;CDK8;SNRK;PPP4R1;PIK3CA;MAPKAPK2;PKN2;SGK1;MAP4K3;MAP4K4,alpha,6
endothelial cell chemotaxis (GO:0035767),2/9,2,9,0.0343155865119477,0.814476455676602,0,0,6.65335994677312,22.4361650749737,NR4A1;EGR3,alpha,6
regulation of RIG-I signaling pathway (GO:0039535),3/16,3,16,0.0150110098582034,0.814906205387363,0,0,5.61377245508982,23.572069741237,SEC14L1;GPATCH3;BIRC2,alpha,6
regulation of microtubule depolymerization (GO:0031114),3/22,3,22,0.0356224559881901,0.81516319689567,0,0,4.08274360370169,13.6150478516645,CAMSAP1;TTBK2;ANAPC2,alpha,6
protein modification by small protein removal (GO:0070646),15/262,15,262,0.030555263647889,0.816353457566375,0,0,1.71412899392056,5.97925614579107,MBD6;SMAD3;TNKS;OTUD7A;TNFAIP3;TOMM20;PSMA5;PSMA3;PSMD7;SENP5;UBB;ATXN7;TRAF3;BIRC2;OTUD3,alpha,6
cytoplasmic translation (GO:0002181),5/55,5,55,0.0361600898384477,0.816482028520348,0,0,2.72182906913446,9.03592612681247,RPLP1;RPLP0;EIF4H;RPL38;RPL39,alpha,6
protein-DNA complex disassembly (GO:0032986),3/21,3,21,0.0315263792477602,0.816645245184366,0,0,4.27715996578272,14.7858453685542,SMARCD1;SMARCC1;SET,alpha,6
generation of neurons (GO:0048699),9/131,9,131,0.0317334000851742,0.817856265831536,0,0,2.05695479270467,7.09728703683702,MAP2K1;LDB1;TUBB3;RYK;ADNP2;DCLK2;ASCL2;PAFAH1B1;CDK5R1,alpha,6
nuclear export (GO:0051168),7/93,7,93,0.0360636149301621,0.817922786616077,0,0,2.25355740132638,7.48737870391114,NXF1;NUP155;ALYREF;EIF4A3;NUP153;THOC7;SRSF9,alpha,6
positive regulation of rRNA processing (GO:2000234),2/9,2,9,0.0343155865119477,0.818282420422754,0,0,6.65335994677312,22.4361650749737,UTP15;RIOK1,alpha,6
protein targeting (GO:0006605),9/134,9,134,0.0359259955952669,0.818439087154675,0,0,2.01090356600232,6.68885673611828,ATG3;SPCS3;ZDHHC18;LAMP2;MFN2;AP4S1;SRP14;MFF;TOMM20,alpha,6
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),3/21,3,21,0.0315263792477602,0.820811802557755,0,0,4.27715996578272,14.7858453685542,BAG6;MSH2;CDIP1,alpha,6
peptidyl-threonine modification (GO:0018210),7/90,7,90,0.0309321478951406,0.822118493275534,0,0,2.32867598137059,8.09438281990501,MAP2K1;GALNT16;TNKS;LMTK2;DCLK2;CAMKK2;CDK5R1,alpha,6
negative regulation of alcohol biosynthetic process (GO:1902931),2/9,2,9,0.0343155865119477,0.822124121927086,0,0,6.65335994677312,22.4361650749737,ERLIN1;SCAP,alpha,6
regulation of programmed cell death (GO:0043067),15/269,15,269,0.0372201608471317,0.822227189623001,0,0,1.66952340671816,5.49424243636858,MOAP1;RARG;MAP2K1;RBM25;RTKN;DDX42;NME4;BRMS1;UBB;SGK1;RELT;MAP4K3;PPID;BIRC2;MAP4K4,alpha,6
regulation of protein complex assembly (GO:0043254),6/74,6,74,0.0370867524783319,0.822842164769251,0,0,2.42757727787668,7.99764229452499,NAPA;KIF9;DDX3X;FAF1;STXBP1;ANKRA2,alpha,6
hyaluronan catabolic process (GO:0030214),3/16,3,16,0.0150110098582034,0.823668637703356,0,0,5.61377245508982,23.572069741237,HEXB;HMMR;SLC9A1,alpha,6
apical junction assembly (GO:0043297),4/36,4,36,0.0311906835801513,0.824694602639959,0,0,3.32667997338656,11.5357146771716,PARD6A;PDCD6IP;MICALL2;PKN2,alpha,6
viral budding via host ESCRT complex (GO:0039702),3/21,3,21,0.0315263792477602,0.825021093852923,0,0,4.27715996578272,14.7858453685542,PDCD6IP;VPS37A;VPS37B,alpha,6
positive regulation of ribosome biogenesis (GO:0090070),2/9,2,9,0.0343155865119477,0.82600206589844,0,0,6.65335994677312,22.4361650749737,UTP15;RIOK1,alpha,6
hyaluronan metabolic process (GO:0030212),3/21,3,21,0.0315263792477602,0.829273779903712,0,0,4.27715996578272,14.7858453685542,HEXB;HMMR;SLC9A1,alpha,6
glycine transport (GO:0015816),2/9,2,9,0.0343155865119477,0.829916767632556,0,0,6.65335994677312,22.4361650749737,SLC25A38;SLC6A9,alpha,6
somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),2/9,2,9,0.0343155865119477,0.83386875224033,0,0,6.65335994677312,22.4361650749737,MSH2;EXOSC3,alpha,6
mitochondrion morphogenesis (GO:0070584),2/9,2,9,0.0343155865119477,0.837858554882628,0,0,6.65335994677312,22.4361650749737,SUPV3L1;MFF,alpha,6
nuclear migration (GO:0007097),2/9,2,9,0.0343155865119477,0.841886721011872,0,0,6.65335994677312,22.4361650749737,SLC9A3R1;PAFAH1B1,alpha,6
establishment of Golgi localization (GO:0051683),2/9,2,9,0.0343155865119477,0.845953806620625,0,0,6.65335994677312,22.4361650749737,SLC9A3R1;YWHAZ,alpha,6
positive regulation of vacuole organization (GO:0044090),2/10,2,10,0.0419610852664696,0.846353431283771,0,0,5.98802395209581,18.9880995896886,LRSAM1;ANXA2,alpha,6
regulation of neuroblast proliferation (GO:1902692),2/10,2,10,0.0419610852664696,0.849711976646008,0,0,5.98802395209581,18.9880995896886,NF1;ZNF335,alpha,6
negative regulation of catenin import into nucleus (GO:0035414),2/9,2,9,0.0343155865119477,0.850060378497424,0,0,6.65335994677312,22.4361650749737,SLC9A3R1;ANAPC2,alpha,6
fat cell differentiation (GO:0045444),5/56,5,56,0.0386571475239299,0.850290619890579,0,0,2.6732249786142,8.6960639210283,NR4A1;CTBP2;CTBP1;BBS9;ALOXE3,alpha,6
cytochrome complex assembly (GO:0017004),2/10,2,10,0.0419610852664696,0.853097283325873,0,0,5.98802395209581,18.9880995896886,COX15;COX11,alpha,6
negative regulation of T cell apoptotic process (GO:0070233),2/9,2,9,0.0343155865119477,0.854207014490094,0,0,6.65335994677312,22.4361650749737,TSC22D3;FADD,alpha,6
cardiovascular system development (GO:0072358),2/10,2,10,0.0419610852664696,0.856509672459177,0,0,5.98802395209581,18.9880995896886,PIK3CA;FBXW7,alpha,6
long-chain fatty acid biosynthetic process (GO:0042759),2/9,2,9,0.0343155865119477,0.858394303776811,0,0,6.65335994677312,22.4361650749737,ACOT7;ALOXE3,alpha,6
mitotic spindle organization (GO:0007052),6/75,6,75,0.039221547776274,0.859002396147322,0,0,2.39520958083832,7.75695567673932,MECP2;GOLGA2;TNKS;SBDS;WDR62;BIRC2,alpha,6
primary miRNA processing (GO:0031053),2/10,2,10,0.0419610852664696,0.859949470340539,0,0,5.98802395209581,18.9880995896886,SMAD3;DROSHA,alpha,6
regulation of cell size (GO:0008361),3/23,3,23,0.0399781625381374,0.860795626295844,0,0,3.9052330122364,12.572592725172,SLC9A3R1;RARG;RDX,alpha,6
ferric iron transport (GO:0015682),4/37,4,37,0.0340781766337891,0.86089571961498,0,0,3.23676970383557,10.9373622948114,ATP6V0B;CLTC;LMTK2;ATP6V0C,alpha,6
positive regulation of cellular protein metabolic process (GO:0032270),7/92,7,92,0.0342947750793272,0.862099690787225,0,0,2.27805259047123,7.68332981815832,NPM1;DDX3X;IST1;EIF4A3;RDX;CIRBP;FADD,alpha,6
aspartate family amino acid metabolic process (GO:0009066),2/10,2,10,0.0419610852664696,0.863417008527396,0,0,5.98802395209581,18.9880995896886,GOT1;ASS1,alpha,6
potassium ion import (GO:0010107),4/39,4,39,0.0403043611634342,0.864172920239516,0,0,3.07078151389529,9.86118715931105,SLC12A2;ATP1B3;ATP1A1;SLC12A7,alpha,6
regulation of dendritic spine morphogenesis (GO:0061001),3/23,3,23,0.0399781625381374,0.864443065390318,0,0,3.9052330122364,12.572592725172,ARC;CFL1;CDK5R1,alpha,6
regulation of filopodium assembly (GO:0051489),4/37,4,37,0.0340781766337891,0.865178782896646,0,0,3.23676970383557,10.9373622948114,RALA;CAPZB;DPYSL3;AGRN,alpha,6
positive regulation of receptor recycling (GO:0001921),2/10,2,10,0.0419610852664696,0.866912623946535,0,0,5.98802395209581,18.9880995896886,ANXA2;ECE1,alpha,6
protein K48-linked deubiquitination (GO:0071108),3/23,3,23,0.0399781625381374,0.868121546519639,0,0,3.9052330122364,12.572592725172,OTUD7A;TNFAIP3;OTUD3,alpha,6
transferrin transport (GO:0033572),4/37,4,37,0.0340781766337891,0.869504676811129,0,0,3.23676970383557,10.9373622948114,ATP6V0B;CLTC;LMTK2;ATP6V0C,alpha,6
chloride ion homeostasis (GO:0055064),2/10,2,10,0.0419610852664696,0.870436659003228,0,0,5.98802395209581,18.9880995896886,SLC12A2;SLC12A7,alpha,6
mitotic G2/M transition checkpoint (GO:0044818),3/23,3,23,0.0399781625381374,0.871831467658612,0,0,3.9052330122364,12.572592725172,MUS81;FOXN3;TICRR,alpha,6
glycosaminoglycan catabolic process (GO:0006027),5/57,5,57,0.0412568917029445,0.873584723486,0,0,2.62632629477886,8.37256305433821,HGSNAT;HEXB;HMMR;AGRN;SLC9A1,alpha,6
actin polymerization or depolymerization (GO:0008154),4/37,4,37,0.0340781766337891,0.873874047046361,0,0,3.23676970383557,10.9373622948114,COBLL1;CFL1;MICALL2;CORO7,alpha,6
positive regulation of cytoplasmic transport (GO:1903651),2/10,2,10,0.0419610852664696,0.873989461693037,0,0,5.98802395209581,18.9880995896886,RDX;PTPN23,alpha,6
negative regulation of cellular catabolic process (GO:0031330),5/57,5,57,0.0412568917029445,0.877224659833858,0,0,2.62632629477886,8.37256305433821,GOLGA2;RGP1;RRAGA;WDR6;RASIP1,alpha,6
negative regulation of cellular protein catabolic process (GO:1903363),2/10,2,10,0.0419610852664696,0.877571385716369,0,0,5.98802395209581,18.9880995896886,RGP1;ANXA2,alpha,6
regulation of hematopoietic stem cell differentiation (GO:1902036),6/77,6,77,0.0437211995719839,0.878382997700133,0,0,2.33299634497239,7.30209700236638,PSMA5;PSMA3;PSMD7;LDB1;UBB;TCF12,alpha,6
chromosome organization (GO:0051276),5/57,5,57,0.0412568917029445,0.880895055900109,0,0,2.62632629477886,8.37256305433821,CENPW;LDB1;MSH2;UBB;NUP155,alpha,6
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),2/10,2,10,0.0419610852664696,0.881182790595861,0,0,5.98802395209581,18.9880995896886,SEC14L1;GPATCH3,alpha,6
positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),2/10,2,10,0.0419610852664696,0.88482404179667,0,0,5.98802395209581,18.9880995896886,FBXW7;ADRA2C,alpha,6
ammonium transport (GO:0015696),3/24,3,24,0.0445898964222279,0.892322515461289,0,0,3.74251497005988,11.6401496378662,SLC12A2;SEC14L1;RHCE,alpha,6
protein phosphorylation (GO:0006468),23/471,23,471,0.0453767587039717,0.904521873696748,0,0,1.46204406473677,4.52174442453548,MAP2K1;CTBP1;PRKDC;TNKS;PRKCE;EIF2AK1;DCLK2;LMTK2;CDC7;PIK3CB;CDK11B;TTBK2;CAMKK2;CDK8;SNRK;PPP4R1;PIK3CA;MAPKAPK2;PKN2;SGK1;MAP4K3;MAP4K4;CDK5R1,alpha,6
cell part morphogenesis (GO:0032990),2/11,2,11,0.0501730618187609,0.907918916528854,0,0,5.44365813826892,16.2889331163371,SUPV3L1;MFF,alpha,6
protein targeting to ER (GO:0045047),7/98,7,98,0.0458071756302083,0.909548705217715,0,0,2.13857998289136,6.59391472836891,SPCS3;RPLP1;RPL12;RPLP0;RPL38;SRP14;RPL39,alpha,6
negative regulation of receptor binding (GO:1900121),2/11,2,11,0.0501730618187609,0.911149944701555,0,0,5.44365813826892,16.2889331163371,ADAM15;PTPRF,alpha,6
regulation of hematopoietic progenitor cell differentiation (GO:1901532),6/78,6,78,0.0460871608711986,0.911561170254754,0,0,2.30308613542147,7.08710473011815,PSMA5;PSMA3;PSMD7;LDB1;UBB;TCF12,alpha,6
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),5/59,5,59,0.0467665946074108,0.914367556634549,0,0,2.53729828478636,7.77069451275795,ZFYVE28;UBB;SH3KBP1;HIP1R;EPS15,alpha,6
negative regulation of nucleocytoplasmic transport (GO:0046823),2/11,2,11,0.0501730618187609,0.914404051646918,0,0,5.44365813826892,16.2889331163371,NUP153;CABP1,alpha,6
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),4/41,4,41,0.0471334799354729,0.914532882550259,0,0,2.92098729370527,8.92294933203418,ZFYVE28;UBB;SH3KBP1;EPS15,alpha,6
"positive regulation of transcription, DNA-templated (GO:0045893)",48/1121,48,1121,0.0464293544965534,0.914783768323984,0,0,1.28200334389206,3.93552383802358,SMARCD1;RARG;DDX3X;CTBP2;ONECUT2;LDB1;PRKDC;TNKS;SRF;RORA;GPATCH3;MRPL12;AATF;RELA;SLC9A1;CAMKK2;RXRB;RAI1;ZNF609;MED13;KAT5;UBB;HEY2;ZNF821;CAMTA2;FADD;BRD4;BCL9L;NCOA1;KDM6B;UTP15;ZBTB17;STAT5B;MAP2K1;SMARCC1;NPM1;SMAD3;ALYREF;TCF12;ABHD14B;FOXN3;CDK8;NR4A1;DDIT3;ZSCAN21;RFXAP;AGRN;NFE2L1,alpha,6
positive regulation of receptor-mediated endocytosis (GO:0048260),4/42,4,42,0.0507736178727454,0.915539830405017,0,0,2.85143997718848,8.49837009555625,VTN;ANXA2;TBC1D5;HIP1R,alpha,6
negative regulation of histone acetylation (GO:0035067),2/11,2,11,0.0501730618187609,0.917681485523788,0,0,5.44365813826892,16.2889331163371,SET;CTBP1,alpha,6
ubiquitin-dependent ERAD pathway (GO:0030433),5/59,5,59,0.0467665946074108,0.917884354929297,0,0,2.53729828478636,7.77069451275795,BAG6;TMUB1;ERLIN1;RNF185;DZIP3,alpha,6
intraciliary transport involved in cilium assembly (GO:0035735),4/41,4,41,0.0471334799354729,0.918023466071443,0,0,2.92098729370527,8.92294933203418,IFT74;IFT81;TNPO1;WDR35,alpha,6
stress granule assembly (GO:0034063),2/11,2,11,0.0501730618187609,0.920982498061644,0,0,5.44365813826892,16.2889331163371,DDX3X;CIRBP,alpha,6
regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),2/11,2,11,0.0501730618187609,0.924307344625043,0,0,5.44365813826892,16.2889331163371,PPIL4;BRD4,alpha,6
lymphocyte mediated immunity (GO:0002449),2/11,2,11,0.0501730618187609,0.927656284279482,0,0,5.44365813826892,16.2889331163371,MSH2;GNL1,alpha,6
positive regulation of protein deacetylation (GO:0090312),2/11,2,11,0.0501730618187609,0.93102957985868,0,0,5.44365813826892,16.2889331163371,BRMS1;CTBP1,alpha,6
protein deubiquitination (GO:0016579),14/258,14,258,0.0519192217512818,0.932900664073208,0,0,1.62465766142134,4.80584490845406,MBD6;SMAD3;TNKS;OTUD7A;TNFAIP3;TOMM20;PSMA5;PSMA3;PSMD7;UBB;ATXN7;TRAF3;BIRC2;OTUD3,alpha,6
T-helper cell differentiation (GO:0042093),2/11,2,11,0.0501730618187609,0.934427498033346,0,0,5.44365813826892,16.2889331163371,RORA;FOXP1,alpha,6
protein localization to pre-autophagosomal structure (GO:0034497),2/11,2,11,0.0501730618187609,0.937850309381454,0,0,5.44365813826892,16.2889331163371,MFN2;ATG13,alpha,6
immune response-regulating cell surface receptor signaling pathway (GO:0002768),2/11,2,11,0.0501730618187609,0.941298288460062,0,0,5.44365813826892,16.2889331163371,BAG6;MICB,alpha,6
positive regulation of cell cycle phase transition (GO:1901989),2/11,2,11,0.0501730618187609,0.944771713878734,0,0,5.44365813826892,16.2889331163371,NPM1;STXBP4,alpha,6
double-strand break repair (GO:0006302),9/142,9,142,0.0489197867202193,0.945597241035147,0,0,1.89761322425571,5.72618705225883,PIAS4;KAT5;MSH2;PAPD7;AP5Z1;PRKDC;DDX1;SWI5;PRPF19,alpha,6
dicarboxylic acid metabolic process (GO:0043648),5/60,5,60,0.049677316500842,0.945908007849988,0,0,2.49500998003992,7.49053607410017,STAT5B;GOT1;SDHA;GCLM;ASS1,alpha,6
isotype switching (GO:0045190),2/11,2,11,0.0501730618187609,0.948270868374581,0,0,5.44365813826892,16.2889331163371,MSH2;EXOSC3,alpha,6
DNA replication (GO:0006260),8/121,8,121,0.0500276967900186,0.949038426466412,0,0,1.97951205027961,5.92899191590918,TIPIN;SET;KAT5;MCM4;CDC7;RAD9A;POLG;TICRR,alpha,6
regulation of extrinsic apoptotic signaling pathway (GO:2001236),5/60,5,60,0.049677316500842,0.94945073447115,0,0,2.49500998003992,7.49053607410017,FADD;ZMYND11;SH3RF1;RELA;DEDD2,alpha,6
mitotic cytokinesis (GO:0000281),5/60,5,60,0.049677316500842,0.953020098134575,0,0,2.49500998003992,7.49053607410017,RTKN;PDCD6IP;RASA1;ARL3;RHOB,alpha,6
regulation of protein metabolic process (GO:0051246),5/60,5,60,0.049677316500842,0.956616400391686,0,0,2.49500998003992,7.49053607410017,ABTB2;TRAF3;FAF1;ODC1;BTBD9,alpha,6
regulation of translational initiation (GO:0006446),5/63,5,63,0.0590349482378412,0.968666690860783,0,0,2.3761999809904,6.72375645715245,NPM1;DDX3X;DDX1;EIF4H;HSPB1,alpha,6
3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),3/26,3,26,0.054563821955396,0.970171370865456,0,0,3.4546292031322,10.0473890513527,SLC35B2;PODXL2;ABHD14B,alpha,6
internal peptidyl-lysine acetylation (GO:0018393),3/27,3,27,0.0599157934026206,0.970635853122454,0,0,3.32667997338656,9.36398917431347,BAG6;KAT5;CPA4,alpha,6
regulation of cell cycle (GO:0051726),12/216,12,216,0.0593598026077878,0.970875233036991,0,0,1.66333998669328,4.69750167243686,ZBTB17;NR4A1;CDK8;MAP2K1;CTBP1;FIGNL1;TAF6;CDK11B;MAP4K3;BIRC2;RHOB;MAP4K4,alpha,6
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),5/63,5,63,0.0590349482378412,0.971791422121624,0,0,2.3761999809904,6.72375645715245,PSMA5;PSMA3;PSMD7;UBB;SKP1,alpha,6
positive regulation of apoptotic process (GO:0043065),16/308,16,308,0.0548526560918243,0.971920500127013,0,0,1.55533089664826,4.51528838756901,MOAP1;RARG;DDX3X;FAF1;HIP1R;RHOB;BRMS1;SHQ1;PNMA1;UBB;TRIM39;DDIT3;NF1;FADD;PPID;CDK5R1,alpha,6
regulation of catabolic process (GO:0009894),2/12,2,12,0.0589052683314701,0.972794771182821,0,0,4.99001996007984,14.1308620108212,FAF1;ODC1,alpha,6
positive regulation of filopodium assembly (GO:0051491),3/26,3,26,0.054563821955396,0.973563578455894,0,0,3.4546292031322,10.0473890513527,RALA;DPYSL3;AGRN,alpha,6
regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),3/27,3,27,0.0599157934026206,0.97372705010692,0,0,3.32667997338656,9.36398917431347,SMAD3;SRF;RELA,alpha,6
positive regulation of cellular amide metabolic process (GO:0034250),5/62,5,62,0.0558114799444914,0.975362952591573,0,0,2.41452578713541,6.9677798362539,SMPD2;NPM1;DDX3X;EIF4A3;CIRBP,alpha,6
positive regulation of neuron migration (GO:2001224),2/12,2,12,0.0589052683314701,0.975953195764584,0,0,4.99001996007984,14.1308620108212,ZNF609;PLAA,alpha,6
monovalent inorganic cation homeostasis (GO:0055067),3/27,3,27,0.0599157934026206,0.976837999148796,0,0,3.32667997338656,9.36398917431347,SLC12A2;SLC12A7;SLC9A1,alpha,6
misfolded or incompletely synthesized protein catabolic process (GO:0006515),3/26,3,26,0.054563821955396,0.97697959101188,0,0,3.4546292031322,10.0473890513527,BAG6;LONP1;RNF185,alpha,6
regulation of translation (GO:0006417),12/214,12,214,0.0561159660696278,0.977337115540309,0,0,1.67888522021378,4.83575170424671,NPM1;CNOT7;DDX3X;NUP155;DDX1;EIF4A3;CIRBP;EIF4H;POLR2E;HSPB1;NUP153;C12ORF65,alpha,6
RNA 3'-end processing (GO:0031123),5/62,5,62,0.0558114799444914,0.978714715315256,0,0,2.41452578713541,6.9677798362539,SUPV3L1;ALYREF;EIF4A3;THOC7;SRSF9,alpha,6
transcription from mitochondrial promoter (GO:0006390),2/12,2,12,0.0589052683314701,0.979132196402253,0,0,4.99001996007984,14.1308620108212,MRPL12;SLC25A33,alpha,6
regulation of cellular ketone metabolic process (GO:0010565),5/62,5,62,0.0558114799444914,0.982089593643929,0,0,2.41452578713541,6.9677798362539,PSMA5;PSMA3;PSMD7;ODC1;SIRT5,alpha,6
negative regulation of histone modification (GO:0031057),2/12,2,12,0.0589052683314701,0.982331974821868,0,0,4.99001996007984,14.1308620108212,SET;CTBP1,alpha,6
regulation of vesicle fusion (GO:0031338),5/62,5,62,0.0558114799444914,0.98548782753197,0,0,2.41452578713541,6.9677798362539,ANXA2;TBC1D5;STXBP1;RUNDC1;TBC1D9,alpha,6
cytoplasmic translational initiation (GO:0002183),2/12,2,12,0.0589052683314701,0.985552735395055,0,0,4.99001996007984,14.1308620108212,EIF4H;TICRR,alpha,6
somatic hypermutation of immunoglobulin genes (GO:0016446),2/12,2,12,0.0589052683314701,0.988794685182538,0,0,4.99001996007984,14.1308620108212,MSH2;PMS2,alpha,6
polyamine metabolic process (GO:0006595),2/12,2,12,0.0589052683314701,0.992058033978521,0,0,4.99001996007984,14.1308620108212,ODC1;DHPS,alpha,6
response to axon injury (GO:0048678),2/12,2,12,0.0589052683314701,0.995342994355933,0,0,4.99001996007984,14.1308620108212,FLRT3;DPYSL3,alpha,6
Golgi localization (GO:0051645),2/12,2,12,0.0589052683314701,0.998649781712597,0,0,4.99001996007984,14.1308620108212,SLC9A3R1;YWHAZ,alpha,6
negative regulation of ERBB signaling pathway (GO:1901185),4/44,4,44,0.0585017537161271,1,0,0,2.72182906913446,7.72645222411596,ZFYVE28;UBB;SH3KBP1;EPS15,alpha,6
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),4/44,4,44,0.0585017537161271,1,0,0,2.72182906913446,7.72645222411596,BAG6;HINT1;MSH2;CDIP1,alpha,6
regulation of ATP metabolic process (GO:1903578),4/44,4,44,0.0585017537161271,1,0,0,2.72182906913446,7.72645222411596,NUP155;PGAM1;NUP153;SLC25A33,alpha,6
nucleobase-containing compound catabolic process (GO:0034655),4/44,4,44,0.0585017537161271,1,0,0,2.72182906913446,7.72645222411596,TATDN3;SUPV3L1;RNASEH1;PABPC4,alpha,6
regulation of vasculogenesis (GO:2001212),2/12,2,12,0.0589052683314701,1,0,0,4.99001996007984,14.1308620108212,RAP1A;HEY2,alpha,6
regulation of DNA-dependent DNA replication (GO:0090329),2/12,2,12,0.0589052683314701,1,0,0,4.99001996007984,14.1308620108212,TIPIN;TICRR,alpha,6
mitochondrial outer membrane permeabilization (GO:0097345),2/12,2,12,0.0589052683314701,1,0,0,4.99001996007984,14.1308620108212,MOAP1;BLOC1S2,alpha,6
ribosomal small subunit biogenesis (GO:0042274),4/45,4,45,0.0625877080618244,1,0,0,2.66134397870925,7.37508017830068,LTV1;NPM1;TSR3;RIOK1,alpha,6
regulation of dendrite morphogenesis (GO:0048814),4/45,4,45,0.0625877080618244,1,0,0,2.66134397870925,7.37508017830068,ARC;CFL1;SARM1;CDK5R1,alpha,6
regulation of smooth muscle cell proliferation (GO:0048660),4/45,4,45,0.0625877080618244,1,0,0,2.66134397870925,7.37508017830068,PRKDC;TNFAIP3;MFN2;FOXP1,alpha,6
translational elongation (GO:0006414),7/106,7,106,0.0646223577734598,1,0,0,1.97717772003164,5.41587499365752,MRPS16;MRPS27;EEF1D;MRPL37;GTPBP2;MRPL12;C12ORF65,alpha,6
non-canonical Wnt signaling pathway (GO:0035567),8/128,8,128,0.065278508597224,1,0,0,1.87125748502994,5.10683460859051,PSMA5;PSMA3;PLCB3;PSMD7;PARD6A;UBB;RYK;CLTC,alpha,6
negative regulation of microtubule polymerization or depolymerization (GO:0031111),3/28,3,28,0.0655034743522688,1,0,0,3.20786997433704,8.74353751347819,CAMSAP1;TTBK2;ANAPC2,alpha,6
negative regulation of small GTPase mediated signal transduction (GO:0051058),3/28,3,28,0.0655034743522688,1,0,0,3.20786997433704,8.74353751347819,RASA1;NF1;MFN2,alpha,6
regulation of double-strand break repair via homologous recombination (GO:0010569),3/28,3,28,0.0655034743522688,1,0,0,3.20786997433704,8.74353751347819,SETD2;PPP4R2;FIGNL1,alpha,6
protein polymerization (GO:0051258),4/46,4,46,0.0668198458239015,1,0,0,2.60348867482426,7.04440288828638,COBLL1;MICALL2;CORO7;CKAP5,alpha,6
"DNA-templated transcription, termination (GO:0006353)",7/107,7,107,0.0672594775351725,1,0,0,1.95869942358274,5.28691627504948,LSM11;ALYREF;EIF4A3;POLR1C;POLR2E;THOC7;SRSF9,alpha,6
positive regulation of mitochondrion organization (GO:0010822),8/129,8,129,0.0676681627826581,1,0,0,1.85675161305296,5.00049107137231,ZBTB17;MOAP1;FBXW7;MICALL2;HIP1R;MFF;ATG13;CAMKK2,alpha,6
regulation of interleukin-1 beta production (GO:0032651),2/13,2,13,0.0681139063334432,1,0,0,4.60617227084293,12.3748221191658,HSPB1;FOXP1,alpha,6
signal transduction involved in DNA damage checkpoint (GO:0072422),2/13,2,13,0.0681139063334432,1,0,0,4.60617227084293,12.3748221191658,FZR1;PRPF19,alpha,6
mitochondrial genome maintenance (GO:0000002),2/13,2,13,0.0681139063334432,1,0,0,4.60617227084293,12.3748221191658,LONP1;SLC25A33,alpha,6
renal absorption (GO:0070293),2/13,2,13,0.0681139063334432,1,0,0,4.60617227084293,12.3748221191658,SLC9A3R1;SGK1,alpha,6
regulation of DNA-templated transcription in response to stress (GO:0043620),2/13,2,13,0.0681139063334432,1,0,0,4.60617227084293,12.3748221191658,DDIT3;RELA,alpha,6
tricarboxylic acid metabolic process (GO:0072350),2/13,2,13,0.0681139063334432,1,0,0,4.60617227084293,12.3748221191658,STAT5B;ASS1,alpha,6
alpha-linolenic acid metabolic process (GO:0036109),2/13,2,13,0.0681139063334432,1,0,0,4.60617227084293,12.3748221191658,SCP2;ELOVL5,alpha,6
cellular potassium ion homeostasis (GO:0030007),2/13,2,13,0.0681139063334432,1,0,0,4.60617227084293,12.3748221191658,ATP1B3;ATP1A1,alpha,6
cardiolipin metabolic process (GO:0032048),2/13,2,13,0.0681139063334432,1,0,0,4.60617227084293,12.3748221191658,HADHB;HADHA,alpha,6
response to UV-B (GO:0010224),2/13,2,13,0.0681139063334432,1,0,0,4.60617227084293,12.3748221191658,MSH2;RELA,alpha,6
B cell activation involved in immune response (GO:0002312),2/13,2,13,0.0681139063334432,1,0,0,4.60617227084293,12.3748221191658,MSH2;EXOSC3,alpha,6
ER-associated misfolded protein catabolic process (GO:0071712),2/13,2,13,0.0681139063334432,1,0,0,4.60617227084293,12.3748221191658,BAG6;RNF185,alpha,6
membrane repolarization (GO:0086009),2/13,2,13,0.0681139063334432,1,0,0,4.60617227084293,12.3748221191658,ATP1B3;ATP1A1,alpha,6
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),2/13,2,13,0.0681139063334432,1,0,0,4.60617227084293,12.3748221191658,SRF;HEY2,alpha,6
peptide biosynthetic process (GO:0043043),10/175,10,175,0.0693999644665502,1,0,0,1.71086398631309,4.56436086138387,MRPS16;RPLP1;PABPC4;RPL12;RPLP0;DHPS;RPL38;MRPL37;RPL39;FARSB,alpha,6
intraciliary transport (GO:0042073),4/47,4,47,0.0711965932158747,1,0,0,2.54809529876417,6.73285847827904,IFT74;IFT81;TNPO1;WDR35,alpha,6
regulation of generation of precursor metabolites and energy (GO:0043467),4/47,4,47,0.0711965932158747,1,0,0,2.54809529876417,6.73285847827904,NUP155;PGAM1;NUP153;SLC25A33,alpha,6
cellular response to hydrogen peroxide (GO:0070301),3/29,3,29,0.0713206153045314,1,0,0,3.09725376832542,8.17851494522205,TNFAIP3;RELA;RHOB,alpha,6
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),3/29,3,29,0.0713206153045314,1,0,0,3.09725376832542,8.17851494522205,UBB;TNFAIP3;RELA,alpha,6
bicellular tight junction assembly (GO:0070830),3/29,3,29,0.0713206153045314,1,0,0,3.09725376832542,8.17851494522205,PARD6A;PDCD6IP;MICALL2,alpha,6
protein stabilization (GO:0050821),9/153,9,153,0.0713472111694213,1,0,0,1.7611835153223,4.64987147313593,BAG6;CCT2;FBXW7;STXBP4;GNAQ;LAMP2;HIP1R;ATP1B3;OTUD3,alpha,6
circulatory system development (GO:0072359),7/110,7,110,0.0755538511704035,1,0,0,1.90528034839412,4.92116693388403,RARG;FLRT3;TCF25;SRF;NF1;ECE1;BCOR,alpha,6
postreplication repair (GO:0006301),4/48,4,48,0.075716174697436,1,0,0,2.49500998003992,6.43903062117874,UBB;MSH2;PAPD7;POLI,alpha,6
positive regulation of autophagy (GO:0010508),5/68,5,68,0.0767061590292602,1,0,0,2.20147939415287,5.65289995064659,SCOC;PIK3CB;TICAM1;MTDH;CAMKK2,alpha,6
regulation of stem cell differentiation (GO:2000736),6/89,6,89,0.0773148183082261,1,0,0,2.0184350400323,5.16693058550202,PSMA5;PSMA3;PSMD7;LDB1;UBB;TCF12,alpha,6
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),3/30,3,30,0.0773606073791173,1,0,0,2.9940119760479,7.66250771417655,UBB;FBXW7;HIP1R,alpha,6
lipid particle organization (GO:0034389),2/14,2,14,0.0777575151142359,1,0,0,4.27715996578272,10.9245512197433,HILPDA;PPID,alpha,6
cellular protein complex disassembly (GO:0043624),2/14,2,14,0.0777575151142359,1,0,0,4.27715996578272,10.9245512197433,NAPA;ABCE1,alpha,6
cellular response to osmotic stress (GO:0071470),2/14,2,14,0.0777575151142359,1,0,0,4.27715996578272,10.9245512197433,DDX3X;SERPINB6,alpha,6
necroptotic process (GO:0070266),2/14,2,14,0.0777575151142359,1,0,0,4.27715996578272,10.9245512197433,TRPM7;TICAM1,alpha,6
DNA modification (GO:0006304),2/14,2,14,0.0777575151142359,1,0,0,4.27715996578272,10.9245512197433,EXOSC3;UNG,alpha,6
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),2/14,2,14,0.0777575151142359,1,0,0,4.27715996578272,10.9245512197433,MSH2;GNL1,alpha,6
establishment of protein localization to chromosome (GO:0070199),2/14,2,14,0.0777575151142359,1,0,0,4.27715996578272,10.9245512197433,ACD;LRWD1,alpha,6
viral gene expression (GO:0019080),7/111,7,111,0.0784462405774884,1,0,0,1.88811566057075,4.80589956720331,NUP155;RPLP1;RPL12;RPLP0;RPL38;NUP153;RPL39,alpha,6
cellular response to peptide hormone stimulus (GO:0071375),7/111,7,111,0.0784462405774884,1,0,0,1.88811566057075,4.80589956720331,NR4A1;CPEB1;GOT1;GNG5;PRKDC;SLC25A33;RELA,alpha,6
interstrand cross-link repair (GO:0036297),4/49,4,49,0.0803766235999887,1,0,0,2.4440914090187,6.16163239965166,MUS81;UBB;FANCD2;FANCA,alpha,6
regulation of mitochondrion organization (GO:0010821),4/49,4,49,0.0803766235999887,1,0,0,2.4440914090187,6.16163239965166,ZBTB17;FBXW7;VDAC1;MFF,alpha,6
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),4/49,4,49,0.0803766235999887,1,0,0,2.4440914090187,6.16163239965166,BAG6;MOAP1;MSH2;CDIP1,alpha,6
regulation of actin filament polymerization (GO:0030833),5/69,5,69,0.0805476597020948,1,0,0,2.16957389568689,5.46495318875064,FCHSD2;PRKCE;RASA1;CDC42EP4;HIP1R,alpha,6
termination of RNA polymerase II transcription (GO:0006369),5/69,5,69,0.0805476597020948,1,0,0,2.16957389568689,5.46495318875064,LSM11;ALYREF;EIF4A3;THOC7;SRSF9,alpha,6
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),6/90,6,90,0.0806278682483214,1,0,0,1.99600798403194,5.02577031801597,RPLP1;RPL12;RPLP0;RPL38;SRP14;RPL39,alpha,6
regulation of establishment of planar polarity (GO:0090175),6/90,6,90,0.0806278682483214,1,0,0,1.99600798403194,5.02577031801597,PSMA5;PSMA3;PSMD7;PARD6A;UBB;CLTC,alpha,6
regulation of neuron apoptotic process (GO:0043523),6/90,6,90,0.0806278682483214,1,0,0,1.99600798403194,5.02577031801597,SET;MSH2;RASA1;DDIT3;NF1;CDK5R1,alpha,6
phosphatidylinositol 3-kinase signaling (GO:0014065),3/31,3,31,0.0836165302741524,1,0,0,2.89743094456249,7.19001559171005,PIK3CA;NF1;PIK3CB,alpha,6
response to estradiol (GO:0032355),3/31,3,31,0.0836165302741524,1,0,0,2.89743094456249,7.19001559171005,STAT5B;KAT5;STRN3,alpha,6
regulation of protein polymerization (GO:0032271),3/31,3,31,0.0836165302741524,1,0,0,2.89743094456249,7.19001559171005,FCHSD2;RASA1;CAMSAP1,alpha,6
regulation of Ras protein signal transduction (GO:0046578),6/91,6,91,0.0840191662033725,1,0,0,1.97407383036126,4.88920906181022,DENND4B;RASA1;RDX;NF1;MFN2;ASAP2,alpha,6
positive regulation of neurogenesis (GO:0050769),5/70,5,70,0.0844899103521244,1,0,0,2.13857998289136,5.28469451639247,ZNF609;TCF12;PLAA;ADRA2C;ZNF335,alpha,6
regulation of innate immune response (GO:0045088),5/70,5,70,0.0844899103521244,1,0,0,2.13857998289136,5.28469451639247,POLR3B;OTUD7A;TNFAIP3;ABCE1;BIRC2,alpha,6
non-recombinational repair (GO:0000726),4/50,4,50,0.0851757927022167,1,0,0,2.39520958083832,5.89949223648128,PIAS4;KAT5;PRKDC;PRPF19,alpha,6
viral transcription (GO:0019083),7/114,7,114,0.0875047476970544,1,0,0,1.8384284063452,4.47852599902026,NUP155;RPLP1;RPL12;RPLP0;RPL38;NUP153;RPL39,alpha,6
positive regulation of canonical Wnt signaling pathway (GO:0090263),7/114,7,114,0.0875047476970544,1,0,0,1.8384284063452,4.47852599902026,PSMA5;PSMA3;PSMD7;DDX3X;UBB;TNKS;RNF220,alpha,6
myeloid cell development (GO:0061515),2/15,2,15,0.0877968647874321,1,0,0,3.99201596806387,9.71149496027953,ANXA2;FOXP1,alpha,6
regulation of mRNA metabolic process (GO:1903311),2/15,2,15,0.0877968647874321,1,0,0,3.99201596806387,9.71149496027953,PTCD2;CDK11B,alpha,6
positive regulation of response to wounding (GO:1903036),2/15,2,15,0.0877968647874321,1,0,0,3.99201596806387,9.71149496027953,VTN;PRKCE,alpha,6
"protein localization to chromosome, telomeric region (GO:0070198)",2/15,2,15,0.0877968647874321,1,0,0,3.99201596806387,9.71149496027953,ACD;TNKS,alpha,6
sodium ion import (GO:0097369),2/15,2,15,0.0877968647874321,1,0,0,3.99201596806387,9.71149496027953,SLC9A8;SLC9A1,alpha,6
positive regulation of telomerase RNA localization to Cajal body (GO:1904874),2/15,2,15,0.0877968647874321,1,0,0,3.99201596806387,9.71149496027953,CCT2;SHQ1,alpha,6
negative regulation of interleukin-2 production (GO:0032703),2/15,2,15,0.0877968647874321,1,0,0,3.99201596806387,9.71149496027953,KAT5;TNFAIP3,alpha,6
regulation of clathrin-dependent endocytosis (GO:2000369),2/15,2,15,0.0877968647874321,1,0,0,3.99201596806387,9.71149496027953,HIP1R;PIK3CB,alpha,6
regulation of cell-substrate junction assembly (GO:0090109),2/15,2,15,0.0877968647874321,1,0,0,3.99201596806387,9.71149496027953,LDB1;SLC9A1,alpha,6
vasculature development (GO:0001944),2/15,2,15,0.0877968647874321,1,0,0,3.99201596806387,9.71149496027953,PIK3CA;FBXW7,alpha,6
sodium ion import across plasma membrane (GO:0098719),2/15,2,15,0.0877968647874321,1,0,0,3.99201596806387,9.71149496027953,SLC9A8;SLC9A1,alpha,6
negative regulation of DNA-dependent DNA replication (GO:2000104),2/15,2,15,0.0877968647874321,1,0,0,3.99201596806387,9.71149496027953,TIPIN;FBXW7,alpha,6
monovalent inorganic anion homeostasis (GO:0055083),2/15,2,15,0.0877968647874321,1,0,0,3.99201596806387,9.71149496027953,SLC12A2;SLC12A7,alpha,6
regulation of RNA export from nucleus (GO:0046831),2/15,2,15,0.0877968647874321,1,0,0,3.99201596806387,9.71149496027953,SETD2;NUP153,alpha,6
establishment of protein localization to endoplasmic reticulum (GO:0072599),2/15,2,15,0.0877968647874321,1,0,0,3.99201596806387,9.71149496027953,SPCS3;SRP14,alpha,6
stress-activated protein kinase signaling cascade (GO:0031098),5/71,5,71,0.0885319928375846,1,0,0,2.1084591380619,5.11172997238833,MAP2K1;UBB;MAP4K3;SKP1;MAP4K4,alpha,6
vascular endothelial growth factor receptor signaling pathway (GO:0048010),5/71,5,71,0.0885319928375846,1,0,0,2.1084591380619,5.11172997238833,PIK3CA;MAPKAPK2;HSPB1;PIK3CB;CRK,alpha,6
negative regulation of toll-like receptor signaling pathway (GO:0034122),3/32,3,32,0.0900811967500984,1,0,0,2.80688622754491,6.75629817346075,SARM1;TNFAIP3;TICAM1,alpha,6
regulation of dendritic spine development (GO:0060998),3/32,3,32,0.0900811967500984,1,0,0,2.80688622754491,6.75629817346075,ARC;CFL1;CDK5R1,alpha,6
fatty acid beta-oxidation (GO:0006635),4/51,4,51,0.0901113648121257,1,0,0,2.3482446870964,5.65154159159934,HADHB;HADHA;SCP2;ACADS,alpha,6
double-strand break repair via nonhomologous end joining (GO:0006303),4/51,4,51,0.0901113648121257,1,0,0,2.3482446870964,5.65154159159934,PIAS4;KAT5;PRKDC;PRPF19,alpha,6
transcription initiation from RNA polymerase II promoter (GO:0006367),9/161,9,161,0.0911045788762096,1,0,0,1.67367129095846,4.00969333228374,RXRB;NR4A1;CDK8;RARG;MED13;MED20;POLR2E;RORA;TAF6,alpha,6
regulation of cell communication (GO:0010646),5/72,5,72,0.0926728933803642,1,0,0,2.0791749833666,4.94569041389085,SAMD5;GRIK4;BTBD9;CRK;BIRC2,alpha,6
activation of protein kinase activity (GO:0032147),12/234,12,234,0.0941813671935282,1,0,0,1.53539075694764,3.62741120444994,MAP2K1;MAP3K15;RAP1A;UBB;MAPKAPK2;PILRB;PIK3CB;ADRA2C;ATG13;CRK;MAP4K3;MAP4K4,alpha,6
response to cytokine (GO:0034097),8/139,8,139,0.094493489410441,1,0,0,1.72317236031534,4.06535017788899,SETD2;SMAD3;SRF;DPYSL3;MAPKAPK2;PTPN23;RELA;MAP4K3,alpha,6
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),23/513,23,513,0.0946541354717781,1,0,0,1.34234455066475,3.16461178990807,PIAS4;SET;DDX3X;CTBP2;LDB1;CTBP1;EIF2AK1;EIF4A3;FOXN3;PDS5A;RELA;DEDD2;FOXP1;MECP2;CNOT7;BRMS1;KAT5;DDIT3;HEY2;PAX9;BCOR;MTA3;CDK5R1,alpha,6
cotranslational protein targeting to membrane (GO:0006613),6/94,6,94,0.0946582453418991,1,0,0,1.91107147407313,4.50531715715761,RPLP1;RPL12;RPLP0;RPL38;SRP14;RPL39,alpha,6
regulation of cellular amine metabolic process (GO:0033238),4/52,4,52,0.0951808632117405,1,0,0,2.30308613542147,5.41680417797047,PSMA5;PSMA3;PSMD7;ODC1,alpha,6
regulation of cellular amino acid metabolic process (GO:0006521),4/52,4,52,0.0951808632117405,1,0,0,2.30308613542147,5.41680417797047,PSMA5;PSMA3;PSMD7;ODC1,alpha,6
ceramide biosynthetic process (GO:0046513),3/33,3,33,0.0967471940844421,1,0,0,2.72182906913446,6.35725081438214,SMPD2;B4GALT6;ALOXE3,alpha,6
endodermal cell differentiation (GO:0035987),3/33,3,33,0.0967471940844421,1,0,0,2.72182906913446,6.35725081438214,VTN;SETD2;ITGB5,alpha,6
G2 DNA damage checkpoint (GO:0031572),3/33,3,33,0.0967471940844421,1,0,0,2.72182906913446,6.35725081438214,MUS81;FZR1;FOXN3,alpha,6
positive regulation of telomere maintenance via telomerase (GO:0032212),3/33,3,33,0.0967471940844421,1,0,0,2.72182906913446,6.35725081438214,CCT2;ACD;TNKS,alpha,6
mismatch repair (GO:0006298),3/33,3,33,0.0967471940844421,1,0,0,2.72182906913446,6.35725081438214,SETD2;MSH2;PMS2,alpha,6
vasculogenesis (GO:0001570),3/33,3,33,0.0967471940844421,1,0,0,2.72182906913446,6.35725081438214,RASA1;HEY2;RASIP1,alpha,6
regulation of macroautophagy (GO:0016241),7/117,7,117,0.0971309672598066,1,0,0,1.79128921643892,4.17674016901901,SCOC;RRAGA;ATP6V0B;PIK3CA;ATG13;ATP6V0C;CDK5R1,alpha,6
sphingolipid metabolic process (GO:0006665),7/117,7,117,0.0971309672598066,1,0,0,1.79128921643892,4.17674016901901,SMPD2;ELOVL5;HEXB;ARSK;ESYT2;GBA2;ALOXE3,alpha,6
"DNA-templated transcription, initiation (GO:0006352)",10/187,10,187,0.0972587997549171,1,0,0,1.60107592302027,3.73111501275328,RXRB;NR4A1;CDK8;RARG;MED13;MED20;POLR1C;POLR2E;RORA;TAF6,alpha,6
neuron differentiation (GO:0030182),8/140,8,140,0.0974678216935109,1,0,0,1.71086398631309,3.98328997324931,MAP2K1;LDB1;TUBB3;RYK;SRF;ADNP2;DCLK2;CDK5R1,alpha,6
lipopolysaccharide-mediated signaling pathway (GO:0031663),2/16,2,16,0.0981948539025022,1,0,0,3.74251497005988,8.68563424119151,PRKCE;MTDH,alpha,6
protein transport along microtubule (GO:0098840),2/16,2,16,0.0981948539025022,1,0,0,3.74251497005988,8.68563424119151,IFT74;IFT81,alpha,6
sympathetic nervous system development (GO:0048485),2/16,2,16,0.0981948539025022,1,0,0,3.74251497005988,8.68563424119151,NF1;SEMA3F,alpha,6
negative regulation of steroid biosynthetic process (GO:0010894),2/16,2,16,0.0981948539025022,1,0,0,3.74251497005988,8.68563424119151,ERLIN1;SCAP,alpha,6
negative regulation of transcription regulatory region DNA binding (GO:2000678),2/16,2,16,0.0981948539025022,1,0,0,3.74251497005988,8.68563424119151,DDIT3;HEY2,alpha,6
mRNA transcription from RNA polymerase II promoter (GO:0042789),2/16,2,16,0.0981948539025022,1,0,0,3.74251497005988,8.68563424119151,SRF;DDIT3,alpha,6
regulation of necroptotic process (GO:0060544),2/16,2,16,0.0981948539025022,1,0,0,3.74251497005988,8.68563424119151,UBB;BIRC2,alpha,6
mitochondrial fusion (GO:0008053),2/16,2,16,0.0981948539025022,1,0,0,3.74251497005988,8.68563424119151,MFN2;MFF,alpha,6
linoleic acid metabolic process (GO:0043651),2/16,2,16,0.0981948539025022,1,0,0,3.74251497005988,8.68563424119151,ELOVL5;ALOXE3,alpha,6
positive regulation of response to endoplasmic reticulum stress (GO:1905898),2/16,2,16,0.0981948539025022,1,0,0,3.74251497005988,8.68563424119151,BAG6;DDIT3,alpha,6
programmed necrotic cell death (GO:0097300),2/16,2,16,0.0981948539025022,1,0,0,3.74251497005988,8.68563424119151,TRPM7;TICAM1,alpha,6
cellular response to fibroblast growth factor stimulus (GO:0044344),6/95,6,95,0.0983579376374876,1,0,0,1.89095493224078,4.38539305895864,KL;NR4A1;EGR3;UBB;FLRT3;POLR2E,alpha,6
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),9/164,9,164,0.0992666067130385,1,0,0,1.64305535270922,3.79536922416623,SLC35B2;UBB;EEF1D;FADD;TICAM1;BIRC2;RELA;MTDH;BRD4,alpha,6
"positive regulation of transcription, DNA-templated (GO:0045893)",71/1121,71,1121,2.09348880972469e-08,0.000106830733960251,0,0,1.99484431083046,35.2725354492073,ATF1;RB1;CD81;PHF1;ARRB1;CTCF;TRIAP1;PKD2;GLI3;IKBKB;TBK1;ZMIZ1;HYAL2;ZC3H12A;ZXDC;NUP62;SOX8;MYBL2;PITX3;MAP3K5;PELP1;IL11;NCOA4;FOS;EBF4;POU3F1;TGFBR1;KARS;ZNF639;GPRIN1;CKS2;MAPRE3;ATF5;RHOQ;TLR3;NFAT5;NUFIP1;TAF9;RNF4;NSD1;TP53INP2;TP53INP1;TBL1X;E2F5;ZBED3;BPTF;TFAP2A;JUN;CDKN2B;SMAD4;ECD;HMGA1;FOXJ1;FOXN4;INO80;HNRNPAB;BMP6;HIPK2;NFKB2;FOSL1;NR4A3;ASXL3;AGO2;SNAI1;CTNNB1;TAF4B;CEBPZ;NAA16;TAF4;TAF3;LPIN2,alpha,7
positive regulation of nucleic acid-templated transcription (GO:1903508),37/503,37,503,2.10765573874347e-06,0.00537768361740396,0,0,2.31680781453014,30.2805258113868,RB1;PHF1;CTCF;RNF4;GLI3;IKBKB;NSD1;TP53INP2;ZXDC;TP53INP1;NUP62;SOX8;MYBL2;TBL1X;PITX3;MAP3K5;BPTF;TFAP2A;JUN;SMAD4;NCOA4;HMGA1;FOXN4;FOS;POU3F1;HNRNPAB;TGFBR1;HIPK2;KARS;SNAI1;CKS2;CTNNB1;MAPRE3;NAA16;ATF5;TAF4;TAF3,alpha,7
positive regulation of gene expression (GO:0010628),49/772,49,772,3.45600748465284e-06,0.00587866873139448,0,0,1.99910244380074,25.1395059575295,RB1;PHF1;CTCF;CLU;GLI3;ACTB;IKBKB;ZC3H12A;ZXDC;NUP62;SOX8;MYBL2;PITX3;MAP3K5;FOXD1;NCOA4;FOS;POU3F1;WNT16;TGFBR1;ERN1;KARS;CKS2;MAPRE3;ATF5;TLR3;RNF4;DLL4;NSD1;TP53INP2;TP53INP1;POLR2H;TBL1X;BPTF;TFAP2A;JUN;SMAD4;FN1;HMGA1;DTNBP1;FOXN4;DEK;HNRNPAB;HIPK2;SNAI1;CTNNB1;NAA16;TAF4;TAF3,alpha,7
positive regulation of transcription from RNA polymerase II promoter (GO:0045944),50/849,50,849,2.09357056100304e-05,0.0267087264319963,0,0,1.85489181343498,19.984705404708,ATF1;CD81;ARRB1;TRIAP1;PKD2;GLI3;IKBKB;TBK1;ZMIZ1;HYAL2;ZC3H12A;SOX8;MYBL2;PELP1;IL11;FOS;EBF4;GNL3;ZNF639;SUB1;GPRIN1;ATF5;RHOQ;TLR3;NFAT5;NUFIP1;TAF9;RNF4;TBL1X;E2F5;ZBED3;TFAP2A;JUN;CDKN2B;SMAD4;ECD;HMGA1;FOXJ1;INO80;BMP6;HIPK2;NFKB2;NR4A3;ASXL3;AGO2;CTNNB1;TAF4B;CEBPZ;TAF4;LPIN2,alpha,7
positive regulation of protein import into nucleus (GO:0042307),9/54,9,54,4.59313260063354e-05,0.0468775113220659,0,0,5.249343832021,52.4323527028125,KANK1;SMAD4;BAG3;HYAL2;ZC3H12A;TGFBR1;BMP6;IPO5;DACT1,alpha,7
regulation of transcription from RNA polymerase II promoter (GO:0006357),74/1479,74,1479,6.4067261709034e-05,0.0544892060835334,0,0,1.57586792523146,15.2159141920432,ATF1;RB1;CD81;ARRB1;CTCF;TRIAP1;BMI1;PKD2;GLI3;IKBKB;TBK1;ZMIZ1;HYAL2;ZC3H12A;SOX8;MYBL2;ZNF202;PELP1;DACT1;IL11;ZHX2;FOXD1;ZGPAT;TGIF2;FOS;EBF4;FOXP4;ZNF639;SUB1;GPRIN1;CRY1;ATF5;JDP2;RHOQ;TLR3;NFAT5;NUFIP1;TAF9;RNF4;PHF21A;DLL4;NSD1;TBL1X;SUDS3;E2F5;SKIL;ZBED3;BPTF;TFAP2A;JUN;CDKN2B;SMAD4;UBE2I;CBX4;ECD;BMP8A;HMGA1;FOXJ1;INO80;DEK;BMP6;HIPK2;NFKB2;FOSL1;NR4A3;ASXL3;AGO2;SNAI1;CTNNB1;TAF4B;CEBPZ;TAF4;TAF3;LPIN2,alpha,7
positive regulation of nucleocytoplasmic transport (GO:0046824),7/34,7,34,8.01700548701274e-05,0.0584439700003229,0,0,6.48448355720241,61.1575020420678,CPSF6;XPO4;BAG3;NCBP2;HYAL2;ZC3H12A;IPO5,alpha,7
positive regulation of p38MAPK cascade (GO:1900745),5/18,5,18,0.000192930935732403,0.123065820630307,0,0,8.74890638670166,74.8309560721577,GADD45B;KARS;ZC3H12A;MAP3K4;GADD45G,alpha,7
positive regulation of stress-activated MAPK cascade (GO:0032874),10/81,10,81,0.000239444439443772,0.135764997164618,0,0,3.88840283853407,32.418349970437,MAP4K2;KARS;GADD45B;ZC3H12A;WNT16;RASGRP1;MAP3K4;MAP3K5;HIPK2;GADD45G,alpha,7
negative regulation of supramolecular fiber organization (GO:1902904),8/55,8,55,0.000322312902762111,0.149523885708641,0,0,4.58124552612742,36.8331578482009,KANK1;LIMA1;SMAD4;STMN1;TWF1;SLIT2;CLU;CLASP2,alpha,7
regulation of ion transmembrane transporter activity (GO:0032412),7/43,7,43,0.000374993184888919,0.159465851874013,0,0,5.12726606848563,40.4469649811536,FXYD6-FXYD2;HOMER1;FXYD3;STK39;PPIF;CACNA1D;FXYD6,alpha,7
regulation of sister chromatid cohesion (GO:0007063),4/12,4,12,0.000406518348114286,0.159574086955939,0,0,10.498687664042,81.9725091147772,RB1;CTNNB1;AXIN2;CTCF,alpha,7
regulation of epithelial to mesenchymal transition (GO:0010717),9/69,9,69,0.000320854605079913,0.163732104972279,0,0,4.10818212940774,33.0483634965581,PHLDB1;SMAD4;SNAI1;CTNNB1;AXIN2;PHLDB2;TGFBR1;VASN;CLASP2,alpha,7
mitotic nuclear division (GO:0140014),9/75,9,75,0.000600905784818388,0.204428147995215,0,0,3.77952755905512,28.0330295423514,DSN1;TUBGCP2;UBE2S;NUP62;BCCIP;MYBL2;INO80;TUBGCP4;CLASP2,alpha,7
positive regulation of Wnt signaling pathway (GO:0030177),13/141,13,141,0.000565549840353146,0.206142916808722,0,0,2.90389233260736,21.7144709234485,USP47;KANK1;PSMD12;GSKIP;NRARP;AXIN2;SULF1;PSMD6;TNKS2;PSMF1;TBL1X;ZBED3;DACT1,alpha,7
regulation of microtubule cytoskeleton organization (GO:0070507),5/23,5,23,0.000664335621009682,0.211881542125775,0,0,6.84697021567956,50.0973850247074,PHLDB1;STMN1;ATF5;PHLDB2;CLASP2,alpha,7
positive regulation of mitotic sister chromatid separation (GO:1901970),3/8,3,8,0.00158305741255932,0.218333566926762,0,0,11.8110236220472,76.1621720142726,RB1;CUL3;NSMCE2,alpha,7
positive regulation of JNK cascade (GO:0046330),9/77,9,77,0.000729781315857272,0.219063179695274,0,0,3.68135801206667,26.5895861434417,MAP4K2;PAK1;GADD45B;WNT16;RASGRP1;MAP3K4;MAP3K5;HIPK2;GADD45G,alpha,7
cellular response to osmotic stress (GO:0071470),4/14,4,14,0.000781456390446943,0.221542886691708,0,0,8.99887514060742,64.3811132691195,CAB39;STK39;PKD2;MYLK,alpha,7
protein K6-linked ubiquitination (GO:0085020),3/8,3,8,0.00158305741255932,0.224398388230283,0,0,11.8110236220472,76.1621720142726,BARD1;UBE2S;RNF4,alpha,7
regulation of apoptotic process (GO:0042981),43/816,43,816,0.000838068661062541,0.225087598810639,0,0,1.65971900571252,11.7581307949301,TAF9;STK39;TRIAP1;CLU;IGF1R;IKBKB;PAK1;GRK5;BAG3;TP53INP1;NUP62;DIP2A;SOX8;SUDS3;SLIT2;PAK2;MAP3K4;MAP3K5;BARD1;TFAP2A;MAP4K2;USP47;JUN;PRELID1;ARHGEF12;GADD45B;CBX4;ACTN2;SPHK1;BNIP3;BMP8A;BMP6;GADD45G;NET1;LATS1;GCLC;TYRO3;PPIF;CTNNB1;NAA16;TNIK;ATF5;SOS1,alpha,7
protein ubiquitination (GO:0016567),29/507,29,507,0.00174893443362987,0.22884134396957,0,0,1.80154995418472,11.4375876982373,RNF11;PSMD12;CUL5;HIST1H2BJ;CUL3;HIST1H2BK;FBXO45;ARRB1;KLHL12;RNF4;ZNRF1;PSMD6;TNKS2;BTBD3;HECTD4;PSMF1;BARD1;BRAP;FBXW4;UBE2H;ANKIB1;MSL2;MARCH8;FBXL14;FBXO30;KLHL5;UBE2S;FBXL3;FBXL5,alpha,7
stress-activated protein kinase signaling cascade (GO:0031098),8/71,8,71,0.0018079449778139,0.230648580544608,0,0,3.54885216812687,22.4130045916834,IKBKB;MAP4K2;PAK1;STK39;TNIK;PAK2;MAP3K4;MAP3K5,alpha,7
negative regulation of potassium ion transmembrane transporter activity (GO:1901017),3/8,3,8,0.00158305741255932,0.230809770751149,0,0,11.8110236220472,76.1621720142726,CAB39;ACTN2;STK39,alpha,7
protein modification by small protein removal (GO:0070646),18/262,18,262,0.00186460009665674,0.232074494957057,0,0,2.16385165594759,13.5991772719541,BARD1;USP47;PSMD12;SMAD4;USP10;INO80;STAM;AXIN2;JOSD1;ACTB;TGFBR1;PSMD6;UCHL1;TNKS2;ZC3H12A;PSMF1;SUDS3;USP30,alpha,7
autophagy of mitochondrion (GO:0000422),6/41,6,41,0.00174550066943254,0.234402366213533,0,0,4.60917995006722,29.2715829363558,MAP1LC3A;BNIP3;AMBRA1;USP30;GABARAP;ATG2B,alpha,7
positive regulation of extracellular matrix assembly (GO:1901203),3/8,3,8,0.00158305741255932,0.2375982934203,0,0,11.8110236220472,76.1621720142726,PHLDB1;PHLDB2;CLASP2,alpha,7
negative regulation of release of cytochrome c from mitochondria (GO:0090201),4/15,4,15,0.0010390092543017,0.241002919304617,0,0,8.3989501312336,57.6964842832406,PRELID1;PPIF;TRIAP1;CLU,alpha,7
protein deubiquitination (GO:0016579),18/258,18,258,0.00157322671686564,0.243278058671677,0,0,2.1973997436367,14.183394693396,BARD1;USP47;PSMD12;SMAD4;USP10;INO80;STAM;AXIN2;JOSD1;ACTB;TGFBR1;PSMD6;UCHL1;TNKS2;ZC3H12A;PSMF1;SUDS3;USP30,alpha,7
purine ribonucleoside monophosphate metabolic process (GO:0009167),6/40,6,40,0.00153050664875824,0.244067982144165,0,0,4.7244094488189,30.6243612066817,ATIC;IMPDH1;NDUFAF7;ENTPD5;IMPDH2;NT5C2,alpha,7
regulation of protein import into nucleus (GO:0042306),5/26,5,26,0.00120048509739815,0.24504301808091,0,0,6.05693519079346,40.7330681771201,HYAL2;ZC3H12A;TXN;IPO5;DACT1,alpha,7
"positive regulation of DNA-templated transcription, initiation (GO:2000144)",4/16,4,16,0.0013507859271384,0.246180735220973,0,0,7.8740157480315,52.0241628950813,FOSL1;JUN;SUB1;CTNNB1,alpha,7
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),3/7,3,7,0.00101327341123932,0.246225438931154,0,0,13.4983127109111,93.0650509015882,RB1;CUL3;NSMCE2,alpha,7
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),20/292,20,292,0.001112050049101,0.246730060894018,0,0,2.15726458850178,14.6727431258381,FBXW4;PSMD12;RNF11;CUL3;FBXO45;ARRB1;RNF4;ZNRF1;PSMD6;UCHL1;RNF216;PTTG1;UBE2S;BTBD3;HECTD4;CTNNB1;FBXL3;PSMF1;TBL1X;FBXL5,alpha,7
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),9/83,9,83,0.0012571678096145,0.246743358940878,0,0,3.41523574613414,22.8099970491375,SMAD4;CDKN2B;HSP90AB1;FOXD1;BMP8A;SULF1;TGFBR1;BMP6;HIPK2,alpha,7
ubiquitin-dependent protein catabolic process (GO:0006511),22/342,22,342,0.00145181325313636,0.246953434358496,0,0,2.02606253165723,13.2402011011332,FBXW4;PSMD12;UBE2H;RNF11;ANKIB1;UBE2I;CUL5;CUL3;FBXO45;ARRB1;RNF4;FBXL14;ZNRF1;PSMD6;UCHL1;RNF216;UBE2S;BTBD3;HECTD4;CTNNB1;PSMF1;TBL1X,alpha,7
regulation of cell cycle (GO:0051726),16/216,16,216,0.00152477913105239,0.250998319540657,0,0,2.33304170312044,15.1318885074569,RB1;ANKRD17;MAP4K2;JUN;GADD45B;STK39;YY1AP1;GADD45G;HIPK2;PAK1;GRK5;CKS2;MYBL2;TNIK;PAK2;MAP3K4,alpha,7
mitochondrion disassembly (GO:0061726),6/39,6,39,0.00133626589709621,0.252554254551183,0,0,4.84554815263477,32.0672377899352,MAP1LC3A;BNIP3;AMBRA1;USP30;GABARAP;ATG2B,alpha,7
regulation of p38MAPK cascade (GO:1900744),5/27,5,27,0.00143526694619092,0.25255749056594,0,0,5.83260425780111,38.1825863041758,GADD45B;KARS;ZC3H12A;MAP3K4;GADD45G,alpha,7
negative regulation of cytoskeleton organization (GO:0051494),5/25,5,25,0.000995353675826661,0.253964490387173,0,0,6.2992125984252,43.5427554700601,KANK1;LIMA1;SMAD4;TWF1;SLIT2,alpha,7
protein depolymerization (GO:0051261),5/26,5,26,0.00120048509739815,0.255253143834282,0,0,6.05693519079346,40.7330681771201,MICAL1;NCKAP5L;STMN1;TWF1;DSTN,alpha,7
modulation by virus of host morphology or physiology (GO:0019048),4/18,4,18,0.00215938707559865,0.256264005739068,0,0,6.99912510936133,42.9601459937067,HYAL2;KPNA2;HIPK2;KPNA1,alpha,7
mitotic recombination (GO:0006312),4/18,4,18,0.00215938707559865,0.262365529685236,0,0,6.99912510936133,42.9601459937067,GEN1;SNRNP40;NSMCE2;SMC6,alpha,7
negative regulation of potassium ion transmembrane transport (GO:1901380),3/9,3,9,0.00231875439170082,0.262946748018873,0,0,10.498687664042,63.6926523634159,CAB39;ACTN2;STK39,alpha,7
regulation of JNK cascade (GO:0046328),9/91,9,91,0.00239801951707958,0.266023773818633,0,0,3.11499524097949,18.7931154284327,MAP4K2;GADD45B;WNT16;RASGRP1;IGF1R;MAP3K5;DACT1;HIPK2;GADD45G,alpha,7
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),4/19,4,19,0.00266721829023898,0.266878724217441,0,0,6.63075010360547,39.2985938733403,SMAD4;CDKN2B;HSP90AB1;HIPK2,alpha,7
positive regulation of mitotic metaphase/anaphase transition (GO:0045842),3/9,3,9,0.00231875439170082,0.268922810473847,0,0,10.498687664042,63.6926523634159,RB1;CUL3;NSMCE2,alpha,7
negative regulation of cell junction assembly (GO:1901889),4/19,4,19,0.00266721829023898,0.27221629870179,0,0,6.63075010360547,39.2985938733403,IKBKB;PHLDB2;CORO1C;CLASP2,alpha,7
"regulation of gene expression, epigenetic (GO:0040029)",8/75,8,75,0.00256748712924631,0.272955975427999,0,0,3.35958005249344,20.0393159193731,CREBZF;PHF1;CTCF;POLR2H;DEK;BMI1;PPM1D;ACTB,alpha,7
branching morphogenesis of an epithelial tube (GO:0048754),6/44,6,44,0.00252904395901117,0.27458960261349,0,0,4.29491768074445,25.6832380650185,DLL4;PAK1;CTNNB1;NRARP;SLIT2;PKD2,alpha,7
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),4/19,4,19,0.00266721829023898,0.277771733369174,0,0,6.63075010360547,39.2985938733403,SMAD4;CDKN2B;HSP90AB1;HIPK2,alpha,7
MAPK cascade (GO:0000165),18/279,18,279,0.00366017456246241,0.287351858342241,0,0,2.03200406400813,11.4000394981851,BRAP;DUSP5;MAP4K2;PSMD12;ACTN2;CUL3;RASAL2;RASAL3;RASGRP1;IKBKB;PSMD6;KARS;GPRIN1;PSMF1;TNIK;SOS1;SPTAN1;MAP3K5,alpha,7
substrate adhesion-dependent cell spreading (GO:0034446),5/33,5,33,0.00360805973968954,0.287686388306808,0,0,4.77213075638273,26.8412556399676,FN1;TYRO3;PARVA;RADIL;BVES,alpha,7
regulation of canonical Wnt signaling pathway (GO:0060828),15/214,15,214,0.00357380400449713,0.289478124364267,0,0,2.2076679667378,12.4382766274306,USP47;PSMD12;CUL3;GSKIP;KLHL12;NRARP;AXIN2;GLI3;LATS1;PSMD6;TNKS2;PSMF1;TBL1X;ZBED3;DACT1,alpha,7
positive regulation of canonical Wnt signaling pathway (GO:0090263),10/114,10,114,0.00342135718464437,0.290986428554004,0,0,2.76281254316895,15.6864704213608,USP47;PSMD6;PSMD12;TNKS2;GSKIP;NRARP;PSMF1;AXIN2;TBL1X;ZBED3,alpha,7
negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),4/20,4,20,0.00325122409204014,0.291070114766331,0,0,6.2992125984252,36.0864485659733,KANK1;TBC1D30;TBC1D7;SLIT2,alpha,7
pyruvate metabolic process (GO:0006090),6/47,6,47,0.00355092105780548,0.292263712225506,0,0,4.02077399899481,22.6793697687811,SLC16A1;TPI1;DLAT;HAGH;SLC16A3;PGM1,alpha,7
negative regulation of embryonic development (GO:0045992),3/10,3,10,0.00323474821754366,0.294766431323666,0,0,9.44881889763779,54.1776773367127,LFNG;CTNNB1;SULF1,alpha,7
positive regulation of GTPase activity (GO:0043547),14/193,14,193,0.00353545321349468,0.295760946696121,0,0,2.28468850720085,12.8968696381202,CDKL5;GRTP1;SNX13;FOXJ1;RASGRP1;CORO1C;NET1;ARHGAP21;TBC1D1;SGSM2;TBC1D30;TBC1D7;SNX9;S100A10,alpha,7
positive regulation of developmental process (GO:0051094),10/114,10,114,0.00342135718464437,0.295918401919326,0,0,2.76281254316895,15.6864704213608,DLX2;JUN;HSP90AB1;FOXD1;TFRC;BNIP3;AGO2;SOX8;PLD6;CORO1C,alpha,7
activation of protein kinase activity (GO:0032147),16/234,16,234,0.00340938376584682,0.299966988915798,0,0,2.15357695672656,12.2349524847601,DUSP5;MAP4K2;GADD45B;CD81;STK39;ADCY3;TXN;TGFBR1;GADD45G;PAK1;KARS;TNIK;PAK2;TLR3;MAP3K4;MAP3K5,alpha,7
telomere maintenance via recombination (GO:0000722),3/10,3,10,0.00323474821754366,0.300125820984096,0,0,9.44881889763779,54.1776773367127,SNRNP40;NSMCE2;SMC6,alpha,7
regulation of stress fiber assembly (GO:0051492),7/61,7,61,0.00310631310425049,0.304836841749812,0,0,3.61430231057183,20.8701336112137,PAK1;STMN1;TESK1;PHLDB2;TGFBR1;S100A10;CLASP2,alpha,7
actin filament depolymerization (GO:0030042),3/10,3,10,0.00323474821754366,0.305683706557876,0,0,9.44881889763779,54.1776773367127,MICAL1;DSTN;TWF1,alpha,7
"regulation of DNA-templated transcription, initiation (GO:2000142)",3/10,3,10,0.00323474821754366,0.311451323662741,0,0,9.44881889763779,54.1776773367127,FOSL1;JUN;CTNNB1,alpha,7
negative regulation of mitochondrion organization (GO:0010823),5/34,5,34,0.00412152375654158,0.318668723176238,0,0,4.63177396943029,25.4355365455086,PRELID1;BNIP3;PPIF;TRIAP1;CLU,alpha,7
protein polyubiquitination (GO:0000209),18/284,18,284,0.00440242110775806,0.320936498755563,0,0,1.99622934457137,10.8307432047576,BARD1;FBXW4;PSMD12;UBE2H;ANKIB1;CUL3;MARCH8;RNF4;FBXL14;FBXO30;ZNRF1;PSMD6;RNF216;TNKS2;UBE2S;FBXL3;PSMF1;FBXL5,alpha,7
glutathione biosynthetic process (GO:0006750),3/11,3,11,0.00434354211947959,0.321233267184121,0,0,8.5898353614889,46.7206737911155,GCLC;CHAC2;HAGH,alpha,7
negative regulation of potassium ion transport (GO:0043267),3/11,3,11,0.00434354211947959,0.325957285819181,0,0,8.5898353614889,46.7206737911155,CAB39;ACTN2;STK39,alpha,7
negative regulation of morphogenesis of an epithelium (GO:1905331),3/11,3,11,0.00434354211947959,0.330822319935886,0,0,8.5898353614889,46.7206737911155,SULF1;PHLDB2;CLASP2,alpha,7
negative regulation of protein polymerization (GO:0032272),4/22,4,22,0.00466833761468481,0.330868428440786,0,0,5.72655690765927,30.73415743355,KANK1;STMN1;TWF1;SLIT2,alpha,7
GTP metabolic process (GO:0046039),4/22,4,22,0.00466833761468481,0.335528547151219,0,0,5.72655690765927,30.73415743355,MOCS3;IMPDH1;IMPDH2;RHOQ,alpha,7
regulation of signal transduction by p53 class mediator (GO:1901796),11/139,11,139,0.00484358443773227,0.338586457339011,0,0,2.49249419362148,13.2852439146851,BARD1;MEAF6;TAF9;TP53INP1;RAD17;TAF4B;TAF5;TAF4;ATRIP;TAF3;HIPK2,alpha,7
regulation of programmed cell death (GO:0043067),17/269,17,269,0.00571297241174704,0.347063074013633,0,0,1.99045751251354,10.2807445576558,MAP4K2;USP47;PRELID1;ACTN2;BNIP3;BMP8A;STK39;TRIAP1;CLU;BMP6;PAK1;NUP62;TP53INP1;DIP2A;TNIK;PAK2;MAP3K4,alpha,7
insulin receptor signaling pathway (GO:0008286),7/68,7,68,0.00570966054331257,0.351040936777398,0,0,3.2422417786012,16.7481102112653,PIK3C2A;SOS1;BAIAP2;ATP6V1E2;RHOQ;ATP6V1C1;IGF1R,alpha,7
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),7/68,7,68,0.00570966054331257,0.355321923811269,0,0,3.2422417786012,16.7481102112653,LATS1;CDKN2B;CCNE2;BCCIP;CKS2;MAPRE3;IPO5,alpha,7
regulation of protein ubiquitination (GO:0031396),9/102,9,102,0.005161697324868,0.355947857416235,0,0,2.77906438165818,14.6359142602575,LATS1;HSP90AB1;CUL3;SPHK1;TBC1D7;SPRTN;CRY1;ARRB1;TGFBR1,alpha,7
positive regulation of SMAD protein import into nucleus (GO:0060391),3/12,3,12,0.00565588847464282,0.356320973902497,0,0,7.8740157480315,40.7484887294804,SMAD4;TGFBR1;BMP6,alpha,7
positive regulation of JUN kinase activity (GO:0043507),6/51,6,51,0.00535403884827887,0.359495529510093,0,0,3.70541917554423,19.3789868567847,ERN1;MAP4K2;PAK1;TNIK;MAP3K4;MAP3K5,alpha,7
actin filament bundle organization (GO:0061572),5/36,5,36,0.00530129265825093,0.360699952467393,0,0,4.37445319335083,22.9212799229182,LIMA1;FSCN1;BAIAP2;ADD1;RND1,alpha,7
purine nucleoside monophosphate biosynthetic process (GO:0009127),3/12,3,12,0.00565588847464282,0.360774986076279,0,0,7.8740157480315,40.7484887294804,ATIC;IMPDH1;IMPDH2,alpha,7
activation of GTPase activity (GO:0090630),8/85,8,85,0.00556343586102732,0.363977092292595,0,0,2.96433534043539,15.3894637175352,TBC1D1;GRTP1;TBC1D30;TBC1D7;SGSM2;FOXJ1;RASGRP1;CORO1C,alpha,7
nonribosomal peptide biosynthetic process (GO:0019184),3/12,3,12,0.00565588847464282,0.365341758051928,0,0,7.8740157480315,40.7484887294804,GCLC;CHAC2;HAGH,alpha,7
regulation of cell differentiation (GO:0045595),10/122,10,122,0.00553785845475815,0.367008983047154,0,0,2.58164450755131,13.414605430411,TFAP2A;PHLDB1;DLX2;JUN;HSP90AB1;PLEKHB2;PHLDB2;SKIL;TGFBR1;CLASP2,alpha,7
positive regulation of protein phosphorylation (GO:0001934),23/413,23,413,0.00684106605971131,0.3794560880729,0,0,1.75401803588111,8.74344963219843,IL11;SMAD4;CAB39;CD81;SPHK1;BMP8A;ARRB1;TXN;AXIN2;RASGRP1;BMP6;TGFBR1;IGF1R;LATS1;PAK1;TBK1;TEC;TYRO3;TERF2IP;SNX9;MAPRE3;TNIK;PAK2,alpha,7
actin filament bundle assembly (GO:0051017),5/38,5,38,0.00670162303178749,0.379982025902351,0,0,4.14421881475342,20.7434958075884,LIMA1;FSCN1;BAIAP2;ADD1;RND1,alpha,7
"negative regulation of transcription, DNA-templated (GO:0045892)",39/814,39,814,0.0072039016229162,0.382932395643139,0,0,1.50902513107238,7.4442209289674,RB1;CREBZF;CTCF;BMI1;GLI3;PHF21A;DLL4;NSD1;SOX8;TBL1X;SUDS3;ZNF202;SKIL;BPTF;DACT1;TFAP2A;C11ORF84;USP47;JUN;ZHX2;SMAD4;FOXD1;ZGPAT;UBE2I;TGIF2;CBX4;SFMBT1;HMGA1;FOXJ1;BMP6;NFKB2;GCLC;NR4A3;ZNF639;SNAI1;CRY1;CTNNB1;ATF5;TAF3,alpha,7
regulation of mitotic cell cycle (GO:0007346),12/166,12,166,0.00683288857163287,0.383167366824643,0,0,2.2768238307561,11.35226131267,RB1;MAP4K2;PAK1;SPHK1;NUP62;STK39;CKS2;HECA;TNIK;PAK2;EIF4E;MAP3K4,alpha,7
calcium ion transmembrane transport (GO:0070588),8/87,8,87,0.00639485440829833,0.383916965241722,0,0,2.89618970042538,14.6323080407644,MCUR1;GPRIN1;ATP2A2;CACNA1D;SPG7;PKD2;MICU1;TMCO1,alpha,7
regulation of calcium ion transport (GO:0051924),6/53,6,53,0.00647183072531886,0.384020374317467,0,0,3.56559203684445,17.9716401883607,HOMER1;STIM2;CTNNB1;CACNA1D;PKD2;MYLK,alpha,7
negative regulation of Ras protein signal transduction (GO:0046580),5/38,5,38,0.00670162303178749,0.384251486867546,0,0,4.14421881475342,20.7434958075884,KANK1;CUL3;STMN1;RASAL2;RASAL3,alpha,7
neuron fate commitment (GO:0048663),3/13,3,13,0.00718091148642994,0.385728329634231,0,0,7.26832222895215,35.8788294803765,DLL4;FOXN4;TGFBR1,alpha,7
positive regulation of neuron death (GO:1901216),5/39,5,39,0.00749064817419299,0.386108864978857,0,0,4.03795679386231,19.762164129161,TFAP2A;CTNNB1;FOS;CLU;MAP3K5,alpha,7
regulation of sodium ion transmembrane transporter activity (GO:2000649),5/38,5,38,0.00670162303178749,0.388617981036495,0,0,4.14421881475342,20.7434958075884,FXYD6-FXYD2;FXYD3;SLMAP;STK39;FXYD6,alpha,7
mRNA cleavage involved in mRNA processing (GO:0098787),3/13,3,13,0.00718091148642994,0.38983182250268,0,0,7.26832222895215,35.8788294803765,ERN1;CPSF6;NCBP2,alpha,7
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),4/25,4,25,0.00748905744103357,0.389965919608105,0,0,5.03937007874016,24.6642511203297,TAF9;SNAI1;TRIAP1;CLU,alpha,7
viral life cycle (GO:0019058),9/108,9,108,0.00746511398782093,0.392726563709796,0,0,2.6246719160105,12.8543689723705,HSP90AB1;NUP188;CD81;ZNF639;HYAL2;NUP62;DEK;KPNA2;KPNA1,alpha,7
epithelial to mesenchymal transition (GO:0001837),5/38,5,38,0.00670162303178749,0.393084854381742,0,0,4.14421881475342,20.7434958075884,SNAI1;CTNNB1;FAM83D;HNRNPAB;TGFBR1,alpha,7
modulation by virus of host process (GO:0019054),3/13,3,13,0.00718091148642994,0.394023562529591,0,0,7.26832222895215,35.8788294803765,ZC3H12A;KPNA2;KPNA1,alpha,7
cell morphogenesis involved in differentiation (GO:0000904),6/55,6,55,0.00774999881428643,0.395482439493036,0,0,3.43593414459556,16.6988549930841,RB1;TYRO3;FN1;PARVA;RADIL;BVES,alpha,7
proteasomal protein catabolic process (GO:0010498),15/238,15,238,0.00930582204460646,0.402437371979888,0,0,1.9850459868987,9.28428845707777,PSMD12;RNF11;CUL3;FBXO45;ARRB1;RNF4;ZNRF1;PSMD6;UCHL1;RNF216;BTBD3;HECTD4;CTNNB1;PSMF1;TBL1X,alpha,7
regulation of release of cytochrome c from mitochondria (GO:0090199),5/41,5,41,0.00925829547364366,0.403804117965843,0,0,3.84098329172268,17.9843876373663,PRELID1;BNIP3;PPIF;TRIAP1;CLU,alpha,7
protein modification by small protein conjugation (GO:0032446),22/399,22,399,0.00898851418894422,0.405914937222853,0,0,1.73662502713477,8.18264320597383,BARD1;BRAP;RNF11;UBE2H;MOCS3;UBE2I;NUP188;HIST1H2BJ;CUL3;HIST1H2BK;MSL2;FBXO45;ARRB1;KLHL12;RNF4;ZNRF1;KLHL5;UBE2S;HECTD4;NUP62;FBXL3;FBXL5,alpha,7
regulation of gastrulation (GO:0010470),3/14,3,14,0.00892622309736239,0.406701039873574,0,0,6.74915635545557,31.8476619953961,PHLDB1;PHLDB2;CLASP2,alpha,7
positive regulation of epithelial to mesenchymal transition (GO:0010718),5/41,5,41,0.00925829547364366,0.407285187948307,0,0,3.84098329172268,17.9843876373663,SMAD4;SNAI1;CTNNB1;AXIN2;TGFBR1,alpha,7
autophagosome organization (GO:1905037),6/57,6,57,0.00920053980528816,0.408263953272917,0,0,3.31537505180274,15.5441131277599,MAP1LC3A;TP53INP2;TP53INP1;AMBRA1;GABARAP;ATG2B,alpha,7
negative regulation of focal adhesion assembly (GO:0051895),3/14,3,14,0.00892622309736239,0.410365013205768,0,0,6.74915635545557,31.8476619953961,PHLDB2;CORO1C;CLASP2,alpha,7
negative regulation of transcription from RNA polymerase II promoter (GO:0000122),29/566,29,566,0.00813057875283442,0.410795478967466,0,0,1.61375587768843,7.76559205079005,RB1;CTCF;BMI1;GLI3;PHF21A;DLL4;BAG3;NSD1;TBL1X;SUDS3;ZNF202;SKIL;BPTF;DACT1;TFAP2A;JUN;ZHX2;SMAD4;ZGPAT;UBE2I;TGIF2;CBX4;FOXJ1;BMP6;NFKB2;NR4A3;SNAI1;CRY1;TAF3,alpha,7
regulation of BMP signaling pathway (GO:0030510),6/57,6,57,0.00920053980528816,0.411845216020925,0,0,3.31537505180274,15.5441131277599,SMAD4;FOXD1;SULF1;NBL1;SKIL;HIPK2,alpha,7
negative regulation of Rho protein signal transduction (GO:0035024),3/14,3,14,0.00892622309736239,0.414095604234912,0,0,6.74915635545557,31.8476619953961,KANK1;CUL3;STMN1,alpha,7
purine ribonucleoside monophosphate biosynthetic process (GO:0009168),5/40,5,40,0.00834209907158736,0.417350309434415,0,0,3.93700787401575,18.8442535710186,ATIC;IMPDH1;IMPDH2;ATP5C1;ATP5F1,alpha,7
regulation of phosphate metabolic process (GO:0019220),3/14,3,14,0.00892622309736239,0.417894646475599,0,0,6.74915635545557,31.8476619953961,BARD1;IKBKB;RAD17,alpha,7
negative regulation of gene expression (GO:0010629),31/619,31,619,0.00868243843312784,0.41798569173822,0,0,1.57734725808708,7.48680441112189,RB1;CREBZF;PHF1;CTCF;PPM1D;BMI1;GLI3;DLL4;ZC3H12A;ANXA7;DIP2A;SOX8;SUDS3;TFAP2A;C11ORF84;USP47;JUN;ZHX2;SMAD4;FOXD1;ZGPAT;UBE2I;CBX4;SFMBT1;HMGA1;ERN1;GCLC;ZNF639;CRY1;CTNNB1;ATF5,alpha,7
regulation of potassium ion transmembrane transporter activity (GO:1901016),4/26,4,26,0.00863243739083877,0.419536457194764,0,0,4.84554815263477,23.0271514546476,CAB39;ACTN2;STK39;CACNA1D,alpha,7
regulation of protein phosphorylation (GO:0001932),16/262,16,262,0.00982958281497269,0.421515639536182,0,0,1.92342369417563,8.89075441140801,FN1;BMP8A;TWF1;ARRB1;AXIN2;RASGRP1;BMP6;CORO1C;PAK1;NSD1;ZC3H12A;TERF2IP;TNIK;SLIT2;PAK2;ZBED3,alpha,7
ribonucleoside monophosphate biosynthetic process (GO:0009156),3/14,3,14,0.00892622309736239,0.421764041350373,0,0,6.74915635545557,31.8476619953961,ATIC;IMPDH1;IMPDH2,alpha,7
"negative regulation of gene expression, epigenetic (GO:0045814)",4/26,4,26,0.00863243739083877,0.423570461590868,0,0,4.84554815263477,23.0271514546476,CREBZF;PHF1;PPM1D;BMI1,alpha,7
positive regulation of cell death (GO:0010942),6/58,6,58,0.00999413394080876,0.425000545832892,0,0,3.25821341297855,15.0065391171147,BNIP3;ZC3H12A;AXIN2;FOS;CLU;MAP3K5,alpha,7
branching involved in blood vessel morphogenesis (GO:0001569),3/14,3,14,0.00892622309736239,0.425705761362993,0,0,6.74915635545557,31.8476619953961,DLL4;CTNNB1;NRARP,alpha,7
negative regulation of wound healing (GO:0061045),4/26,4,26,0.00863243739083877,0.42768279616942,0,0,4.84554815263477,23.0271514546476,SERPINE2;PHLDB2;CLASP2;AJAP1,alpha,7
regulation of protein localization to cell surface (GO:2000008),4/28,4,28,0.0112477817747585,0.428339032810391,0,0,4.49943757030371,20.1916056033763,HSP90AB1;ACTN2;CTNNB1;RAB11FIP5,alpha,7
transcription elongation from RNA polymerase II promoter (GO:0006368),8/96,8,96,0.0113468254731333,0.428910002884439,0,0,2.6246719160105,11.7554259007177,PBRM1;NCBP2;TAF9;TAF4B;POLR2H;TAF5;TAF4;TAF3,alpha,7
purine ribonucleotide biosynthetic process (GO:0009152),7/76,7,76,0.0103756815156368,0.430464250197516,0,0,2.90095317032739,13.252396886606,GUCY1B3;IMPDH1;IMPDH2;ATP5C1;ADCY3;ATP5F1;ACAT1,alpha,7
protein localization to chromosome (GO:0034502),4/28,4,28,0.0112477817747585,0.431559627042048,0,0,4.49943757030371,20.1916056033763,RB1;TNKS2;TERF2IP;CTCF,alpha,7
mesenchymal cell differentiation (GO:0048762),5/42,5,42,0.0102414945921014,0.431920222342919,0,0,3.74953130858643,17.1777567070171,SNAI1;CTNNB1;FAM83D;HNRNPAB;TGFBR1,alpha,7
"transcription, DNA-templated (GO:0006351)",20/357,20,357,0.0105226456688119,0.433040813289896,0,0,1.76448532168773,8.03586424731018,CREBZF;NFAT5;NCBP2;ECD;TAF9;YBX2;ARRB1;DEK;PWP1;FOSL1;PTTG1;NUP62;TAF4B;CEBPZ;POLR2H;TAF5;TAF4;ZNF202;TAF3;BPTF,alpha,7
negative regulation of phosphorylation (GO:0042326),7/76,7,76,0.0103756815156368,0.433992645690938,0,0,2.90095317032739,13.252396886606,CDKN2B;ZC3H12A;PPIF;TERF2IP;SLIT2;CORO1C;ZBED3,alpha,7
positive regulation of protein import (GO:1904591),3/15,3,15,0.0108980324613647,0.434473903518312,0,0,6.2992125984252,28.4672315853372,HYAL2;ZC3H12A;IPO5,alpha,7
negative regulation of organelle assembly (GO:1902116),4/28,4,28,0.0112477817747585,0.434829018156003,0,0,4.49943757030371,20.1916056033763,SMAD4;TBC1D30;FEZ2;TBC1D7,alpha,7
regulation of mitotic metaphase/anaphase transition (GO:0030071),3/15,3,15,0.0108980324613647,0.437894957876724,0,0,6.2992125984252,28.4672315853372,RB1;CUL3;NSMCE2,alpha,7
purine ribonucleoside triphosphate biosynthetic process (GO:0009206),4/28,4,28,0.0112477817747585,0.43814832363811,0,0,4.49943757030371,20.1916056033763,IMPDH1;IMPDH2;ATP5C1;ATP5F1,alpha,7
negative regulation of adherens junction organization (GO:1903392),3/15,3,15,0.0108980324613647,0.44137031468527,0,0,6.2992125984252,28.4672315853372,PHLDB2;CORO1C;CLASP2,alpha,7
microtubule polymerization (GO:0046785),4/28,4,28,0.0112477817747585,0.441518695358403,0,0,4.49943757030371,20.1916056033763,MAP7D3;TUBGCP2;TUBGCP4;CLASP2,alpha,7
autophagosome assembly (GO:0000045),6/59,6,59,0.0108352031380279,0.442336332906852,0,0,3.20298945682637,14.4933828240267,MAP1LC3A;TP53INP2;TP53INP1;AMBRA1;GABARAP;ATG2B,alpha,7
negative regulation of cell-matrix adhesion (GO:0001953),4/28,4,28,0.0112477817747585,0.444941320903817,0,0,4.49943757030371,20.1916056033763,PHLDB2;CORO1C;CLASP2;AJAP1,alpha,7
neuron remodeling (GO:0016322),2/6,2,6,0.0138679106825533,0.447898406411831,0,0,10.498687664042,44.9152513566703,ANKS1A;RND1,alpha,7
negative regulation of mononuclear cell migration (GO:0071676),2/6,2,6,0.0138679106825533,0.450751262503626,0,0,10.498687664042,44.9152513566703,SLIT2;NBL1,alpha,7
regulation of cell death (GO:0010941),8/97,8,97,0.0120341537078014,0.451546223315518,0,0,2.59761344264957,11.4814683775545,JUN;TBK1;BNIP3;ZC3H12A;CTNNB1;AXIN2;WNT16;CLU,alpha,7
response to catecholamine (GO:0071869),2/6,2,6,0.0138679106825533,0.453640693673521,0,0,10.498687664042,44.9152513566703,NR4A3;GNB1,alpha,7
regulation of phosphorylation (GO:0042325),9/120,9,120,0.014332313550549,0.454272025145661,0,0,2.36220472440945,10.0281226821825,BARD1;IKBKB;CDKN2B;NUP188;ECD;NUP62;FN1;RAD17;CORO1C,alpha,7
positive regulation of kidney development (GO:0090184),2/6,2,6,0.0138679106825533,0.456567407826253,0,0,10.498687664042,44.9152513566703,FOXD1;SOX8,alpha,7
regulation of embryonic development (GO:0045995),4/30,4,30,0.014324408087171,0.456859090430211,0,0,4.1994750656168,17.8300906561778,LFNG;PHLDB1;PHLDB2;CLASP2,alpha,7
positive regulation of phospholipid transport (GO:2001140),2/6,2,6,0.0138679106825533,0.459532131253697,0,0,10.498687664042,44.9152513566703,PRELID1;TRIAP1,alpha,7
negative regulation of Notch signaling pathway (GO:0045746),4/30,4,30,0.014324408087171,0.459732418042979,0,0,4.1994750656168,17.8300906561778,DLL4;LFNG;NRARP;ARRB1,alpha,7
positive regulation of RNA export from nucleus (GO:0046833),2/6,2,6,0.0138679106825533,0.462535609235747,0,0,10.498687664042,44.9152513566703,CPSF6;NCBP2,alpha,7
positive regulation of type I interferon production (GO:0032481),6/63,6,63,0.0147021355732819,0.463117270558379,0,0,2.99962504686914,12.6577053427976,TBK1;POLR3D;CTNNB1;POLR2H;TLR3;NFKB2,alpha,7
viral entry into host cell (GO:0046718),3/17,3,17,0.0155395813728995,0.463733823075474,0,0,5.55812876331635,23.1460761820455,CD81;ZNF639;HYAL2,alpha,7
negative regulation of nucleic acid-templated transcription (GO:1903507),23/445,23,445,0.0156503337342656,0.464323564220682,0,0,1.62788640184022,6.76755196737527,RB1;TFAP2A;CREBZF;C11ORF84;USP47;JUN;ZHX2;SMAD4;FOXD1;ZGPAT;UBE2I;CBX4;SFMBT1;HMGA1;CTCF;GLI3;GCLC;ZNF639;CRY1;CTNNB1;SOX8;SUDS3;ATF5,alpha,7
positive regulation of reactive oxygen species biosynthetic process (GO:1903428),4/31,4,31,0.0160434106005316,0.465167751673368,0,0,4.06400812801626,16.7943391138052,HSP90AB1;GPRIN1;PKD2;CLU,alpha,7
positive regulation of ion transport (GO:0043270),5/47,5,47,0.0162365235501839,0.465477413913417,0,0,3.35064499916234,13.8063060287189,ACTN2;STIM2;KIF5B;CACNA1D;MYLK,alpha,7
interphase microtubule nucleation by interphase microtubule organizing center (GO:0051415),2/6,2,6,0.0138679106825533,0.46557860666493,0,0,10.498687664042,44.9152513566703,TUBGCP2;TUBGCP4,alpha,7
negative regulation of cellular process (GO:0048523),27/535,27,535,0.0125104485240058,0.465991378233587,0,0,1.58952093605122,6.96399498132432,CUL5;CAB39;STK39;CTCF;PPM1D;PKD2;CLU;RND1;DLL4;HYAL2;TP53INP1;NUP62;SLIT2;SKIL;ZBTB7C;TFAP2A;CDKN2B;PBRM1;SMAD4;NOS3;BNIP3;HMGA1;AXIN2;WNT16;KARS;CTNNB1;ATF5,alpha,7
negative regulation of stress fiber assembly (GO:0051497),3/17,3,17,0.0155395813728995,0.466461669093565,0,0,5.55812876331635,23.1460761820455,STMN1;PHLDB2;CLASP2,alpha,7
regulation of sodium ion transmembrane transport (GO:1902305),4/31,4,31,0.0160434106005316,0.467825853111502,0,0,4.06400812801626,16.7943391138052,FXYD6-FXYD2;FXYD3;SLMAP;FXYD6,alpha,7
regulation of G1/S transition of mitotic cell cycle (GO:2000045),5/47,5,47,0.0162365235501839,0.468107229811233,0,0,3.35064499916234,13.8063060287189,RB1;ANKRD17;INO80;PKD2;DACT1,alpha,7
spinal cord dorsal/ventral patterning (GO:0021513),2/6,2,6,0.0138679106825533,0.468661908695823,0,0,10.498687664042,44.9152513566703,DLL4;FOXN4,alpha,7
ureteric bud development (GO:0001657),3/17,3,17,0.0155395813728995,0.469221797313053,0,0,5.55812876331635,23.1460761820455,FOXJ1;SLIT2;PKD2,alpha,7
cellular response to metal ion (GO:0071248),8/101,8,101,0.0150919075596401,0.469597587053922,0,0,2.49473766274265,10.4619233854141,TFAP2A;JUN;BNIP3;PPIF;FOS;PKD2;BMP6;ADD1,alpha,7
regulation of cation transmembrane transport (GO:1904062),4/31,4,31,0.0160434106005316,0.470514507439729,0,0,4.06400812801626,16.7943391138052,HOMER1;SLMAP;PPIF;CACNA1D,alpha,7
calcium ion import (GO:0070509),4/29,4,29,0.0127268269698858,0.470615927734254,0,0,4.34428455063807,18.9586452504121,MCUR1;ATP2A2;CACNA1D;MICU1,alpha,7
DNA replication (GO:0006260),9/121,9,121,0.0150639011403423,0.471601763921268,0,0,2.34268237131516,9.82861624328197,BARD1;RECQL4;ACHE;KIN;ORC1;POLN;REV1;RAD17;ATRIP,alpha,7
spermine metabolic process (GO:0008215),2/6,2,6,0.0138679106825533,0.471786321420462,0,0,10.498687664042,44.9152513566703,AMD1;PAOX,alpha,7
microtubule nucleation (GO:0007020),3/17,3,17,0.0155395813728995,0.472014784201821,0,0,5.55812876331635,23.1460761820455,TUBGCP2;TUBGCP4;CLASP2,alpha,7
positive regulation of binding (GO:0051099),7/82,7,82,0.0153566079126998,0.472076928786188,0,0,2.68868830420588,11.2285254091325,EPB41;STMN1;TXN;SPPL3;ADD1;DACT1;HIPK2,alpha,7
modification-dependent protein catabolic process (GO:0019941),10/142,10,142,0.015289323296138,0.472857071395105,0,0,2.21803260507929,9.27270825764206,FBXW4;UBE2H;RNF11;UBE2I;UBE2S;CUL3;FBXO45;ARRB1;PSMF1;FBXL14,alpha,7
connective tissue development (GO:0061448),4/31,4,31,0.0160434106005316,0.473234244476953,0,0,4.06400812801626,16.7943391138052,HYAL2;SOX8;SLC39A13;SULF1,alpha,7
regulation of protein sumoylation (GO:0033233),3/17,3,17,0.0155395813728995,0.474841220035365,0,0,5.55812876331635,23.1460761820455,CTNNB1;RNF4;GNL3,alpha,7
"regulation of wound healing, spreading of epidermal cells (GO:1903689)",2/6,2,6,0.0138679106825533,0.474952672570935,0,0,10.498687664042,44.9152513566703,PHLDB2;CLASP2,alpha,7
regulation of intracellular signal transduction (GO:1902531),22/423,22,423,0.0167089563121133,0.476345274082201,0,0,1.63809311070159,6.7027664219596,BARD1;ARHGEF12;MEAF6;ENTPD5;TAF9;BMP8A;BMP6;HIPK2;NET1;ARHGAP21;PAK1;TP53INP1;RAD17;TAF4B;TAF5;SOS1;FAM83D;TAF4;ATRIP;PAK2;TAF3;RHOQ,alpha,7
regulation of SMAD protein import into nucleus (GO:0060390),3/16,3,16,0.013101249287258,0.477540536520554,0,0,5.90551181102362,25.6006753221407,SMAD4;TGFBR1;BMP6,alpha,7
cellular response to monoamine stimulus (GO:0071868),2/6,2,6,0.0138679106825533,0.478161812250468,0,0,10.498687664042,44.9152513566703,NR4A3;GNB1,alpha,7
heme biosynthetic process (GO:0006783),3/16,3,16,0.013101249287258,0.480976079948759,0,0,5.90551181102362,25.6006753221407,ALAS1;UROS;HMBS,alpha,7
N-terminal peptidyl-methionine acetylation (GO:0017196),2/6,2,6,0.0138679106825533,0.481414613694349,0,0,10.498687664042,44.9152513566703,NAA30;NAA16,alpha,7
cellular response to iron ion (GO:0071281),2/6,2,6,0.0138679106825533,0.484711974062118,0,0,10.498687664042,44.9152513566703,TFAP2A;BMP6,alpha,7
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),7/80,7,80,0.0135393995081293,0.486560251337916,0,0,2.75590551181102,11.8563226510569,SMAD4;CDKN2B;HSP90AB1;SKIL;TGFBR1;VASN;HIPK2,alpha,7
polyamine biosynthetic process (GO:0006596),2/6,2,6,0.0138679106825533,0.488054815262547,0,0,10.498687664042,44.9152513566703,AMD1;PAOX,alpha,7
negative regulation of mitotic cell cycle phase transition (GO:1901991),7/80,7,80,0.0135393995081293,0.490011033262298,0,0,2.75590551181102,11.8563226510569,RB1;USP47;PSMD6;PSMD12;PSMF1;PKD2;DACT1,alpha,7
protein transport (GO:0015031),18/327,18,327,0.0172921051110063,0.490231179897028,0,0,1.73372823809868,7.03461139973175,CTSA;UNC119B;TFRC;GRTP1;TIMM9;SNX13;CLU;ARCN1;ARFRP1;TBC1D1;RAB36;SGSM2;TBC1D30;RAB24;KDELR2;SNX9;ATP6V1E2;ATP6V1C1,alpha,7
negative regulation of membrane potential (GO:0045837),2/6,2,6,0.0138679106825533,0.491444084812981,0,0,10.498687664042,44.9152513566703,PRELID1;BNIP3,alpha,7
positive regulation of nucleobase-containing compound transport (GO:0032241),2/6,2,6,0.0138679106825533,0.49488075673475,0,0,10.498687664042,44.9152513566703,CPSF6;NCBP2,alpha,7
negative regulation of dendrite development (GO:2000171),2/7,2,7,0.0190097814927177,0.502626502369629,0,0,8.99887514060742,35.6607569573137,GORASP1;KIAA0319,alpha,7
regulation of mitochondrial membrane permeability (GO:0046902),3/18,3,18,0.0182156265777981,0.505186643622304,0,0,5.249343832021,21.0261178483597,BNIP3;PPIF;SPG7,alpha,7
store-operated calcium entry (GO:0002115),2/7,2,7,0.0190097814927177,0.505244348736138,0,0,8.99887514060742,35.6607569573137,STIM2;ORAI2,alpha,7
spermidine metabolic process (GO:0008216),2/7,2,7,0.0190097814927177,0.507889607106484,0,0,8.99887514060742,35.6607569573137,AMD1;PAOX,alpha,7
porphyrin-containing compound biosynthetic process (GO:0006779),3/18,3,18,0.0182156265777981,0.507947226374339,0,0,5.249343832021,21.0261178483597,ALAS1;UROS;HMBS,alpha,7
regulation of nitric oxide biosynthetic process (GO:0045428),4/33,4,33,0.0198558914616438,0.50916891521994,0,0,3.81770460510618,14.962556017408,HSP90AB1;ZC3H12A;PKD2;CLU,alpha,7
cellular response to reactive oxygen species (GO:0034614),6/66,6,66,0.0181673037321916,0.509383246952604,0,0,2.86327845382964,11.4763974195243,NET1;JUN;PPIF;FOS;PKD2;MAP3K5,alpha,7
box C/D snoRNP assembly (GO:0000492),2/7,2,7,0.0190097814927177,0.510562710301781,0,0,8.99887514060742,35.6607569573137,NUFIP1;TAF9,alpha,7
purine ribonucleotide metabolic process (GO:0009150),6/67,6,67,0.019436642179059,0.511263840411022,0,0,2.82054295451874,11.1146180908222,SULT1B1;NDUFAF7;ENTPD5;NT5C2;RHOQ;ACAT1,alpha,7
positive regulation of transcription factor import into nucleus (GO:0042993),4/33,4,33,0.0198558914616438,0.511740475397819,0,0,3.81770460510618,14.962556017408,BAG3;SPHK1;SPPL3;TLR3,alpha,7
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),6/66,6,66,0.0181673037321916,0.512197519035215,0,0,2.86327845382964,11.4763974195243,SPHK1;CUL3;ZC3H12A;TBC1D7;SPRTN;GNL3,alpha,7
activation of MAPKKK activity (GO:0000185),2/7,2,7,0.0190097814927177,0.513264100303378,0,0,8.99887514060742,35.6607569573137,GADD45B;GADD45G,alpha,7
mitochondrial transmembrane transport (GO:1990542),4/33,4,33,0.0198558914616438,0.514338142785625,0,0,3.81770460510618,14.962556017408,MCUR1;TIMM9;UCP2;MICU1,alpha,7
positive regulation of extracellular matrix disassembly (GO:0090091),2/7,2,7,0.0190097814927177,0.515994228496481,0,0,8.99887514060742,35.6607569573137,FSCN1;CLASP2,alpha,7
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),4/33,4,33,0.0198558914616438,0.516962316983511,0,0,3.81770460510618,14.962556017408,ARFGEF2;CLU;RASGRP1;TLR3,alpha,7
regulation of mitochondrial fusion (GO:0010635),2/7,2,7,0.0190097814927177,0.518753555921596,0,0,8.99887514060742,35.6607569573137,BNIP3;PLD6,alpha,7
sister chromatid segregation (GO:0000819),4/33,4,33,0.0198558914616438,0.519613405788554,0,0,3.81770460510618,14.962556017408,RB1;LATS1;DSN1;INO80,alpha,7
positive regulation of lipid transport (GO:0032370),2/7,2,7,0.0190097814927177,0.521542553534078,0,0,8.99887514060742,35.6607569573137,PRELID1;TRIAP1,alpha,7
modulation by symbiont of host cellular process (GO:0044068),2/7,2,7,0.0190097814927177,0.5243617024721,0,0,8.99887514060742,35.6607569573137,KPNA2;KPNA1,alpha,7
regulation of peptidyl-serine phosphorylation (GO:0033135),7/87,7,87,0.0206456717438902,0.52677431454536,0,0,2.53416598787221,9.83319651598219,LATS1;IL11;PAK1;TBK1;NSD1;TERF2IP;TXN,alpha,7
regulation of catenin import into nucleus (GO:0035412),3/19,3,19,0.021130959557292,0.528584738337553,0,0,4.9730625777041,19.1811821117446,KANK1;AXIN2;DACT1,alpha,7
mitochondrial membrane organization (GO:0007006),3/19,3,19,0.021130959557292,0.53118860404365,0,0,4.9730625777041,19.1811821117446,BNIP3;PPIF;SPG7,alpha,7
protein heterotetramerization (GO:0051290),3/19,3,19,0.021130959557292,0.533818250598321,0,0,4.9730625777041,19.1811821117446,CPSF6;GPRIN1;S100A10,alpha,7
positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),3/19,3,19,0.021130959557292,0.536474062790353,0,0,4.9730625777041,19.1811821117446,JUN;FOS;GNL3,alpha,7
negative regulation of programmed cell death (GO:0043069),21/409,21,409,0.0216275798749995,0.538368488303036,0,0,1.61715726854437,6.19983478711207,BARD1;TFAP2A;USP47;PRELID1;CBX4;SPHK1;BNIP3;TAF9;TRIAP1;IGF1R;IKBKB;GCLC;GRK5;BAG3;NUP62;TYRO3;PPIF;SOX8;NAA16;ATF5;PAK2,alpha,7
positive regulation of calcium ion transport (GO:0051928),4/34,4,34,0.0219538110004147,0.538607199688059,0,0,3.70541917554423,14.1503085971087,STIM2;GPRIN1;CACNA1D;MYLK,alpha,7
entry into host cell (GO:0030260),4/34,4,34,0.0219538110004147,0.541209166836311,0,0,3.70541917554423,14.1503085971087,CD81;ZNF639;HYAL2;CTNNB1,alpha,7
activation of MAPKK activity (GO:0000186),4/34,4,34,0.0219538110004147,0.543836395801535,0,0,3.70541917554423,14.1503085971087,TNIK;MAP3K4;TGFBR1;MAP3K5,alpha,7
positive regulation of protein kinase activity (GO:0045860),11/173,11,173,0.0224947392436558,0.549237580671653,0,0,2.00263984342998,7.59896443375956,ERN1;MAP4K2;PAK1;CAB39;STK39;SNX9;MAPRE3;TNIK;CLU;PAK2;MAP3K4,alpha,7
"DNA-templated transcription, elongation (GO:0006354)",8/109,8,109,0.0228337150884229,0.554859276648676,0,0,2.31163765079824,8.73687403787232,PBRM1;NCBP2;TAF9;TAF4B;POLR2H;TAF5;TAF4;TAF3,alpha,7
negative regulation of cilium assembly (GO:1902018),2/8,2,8,0.0248187050030858,0.560397573587376,0,0,7.8740157480315,29.1036037488766,TBC1D30;TBC1D7,alpha,7
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),25/513,25,513,0.0231865233908318,0.560762222101492,0,0,1.53489585731608,5.77763051590471,RB1;CREBZF;CTCF;GLI3;SOX8;SUDS3;TFAP2A;C11ORF84;USP47;JUN;ZHX2;SMAD4;FOXD1;ZGPAT;UBE2I;CBX4;SFMBT1;HMGA1;GCLC;CDAN1;ZNF639;CRY1;RAD17;CTNNB1;ATF5,alpha,7
ventricular trabecula myocardium morphogenesis (GO:0003222),2/8,2,8,0.0248187050030858,0.562888229469986,0,0,7.8740157480315,29.1036037488766,DLL4;TGFBR1,alpha,7
cellular response to insulin stimulus (GO:0032869),8/111,8,111,0.0251390025842559,0.565129207874264,0,0,2.26998652195503,8.36112024075458,SLC2A4;PIK3C2A;SOS1;BAIAP2;ATP6V1E2;ATP6V1C1;RHOQ;IGF1R,alpha,7
protein localization to microtubule cytoskeleton (GO:0072698),2/8,2,8,0.0248187050030858,0.565401123351549,0,0,7.8740157480315,29.1036037488766,CRIPT;FAM83D,alpha,7
lung epithelium development (GO:0060428),2/8,2,8,0.0248187050030858,0.567936554397968,0,0,7.8740157480315,29.1036037488766,ERRFI1;FOXJ1,alpha,7
mitotic cell cycle phase transition (GO:0044772),13/222,13,222,0.025442412545545,0.569441364999632,0,0,1.84436404908846,6.77128328852075,RB1;CDKN2B;CUL5;CUL3;HAUS3;TUBB4B;TUBA4A;LATS1;CCNE2;ORC1;UBE2S;EIF4E;CLASP2,alpha,7
positive regulation of catenin import into nucleus (GO:0035413),2/8,2,8,0.0248187050030858,0.570494827165526,0,0,7.8740157480315,29.1036037488766,KANK1;DACT1,alpha,7
regulation of toll-like receptor signaling pathway (GO:0034121),3/20,3,20,0.0242862134623689,0.571117729486031,0,0,4.7244094488189,17.5646288355855,LRRC14;TYRO3;TLR3,alpha,7
establishment of integrated proviral latency (GO:0075713),2/8,2,8,0.0248187050030858,0.573076251722837,0,0,7.8740157480315,29.1036037488766,HMGA1;PSIP1,alpha,7
negative regulation of actin filament bundle assembly (GO:0032232),3/20,3,20,0.0242862134623689,0.573761793048466,0,0,4.7244094488189,17.5646288355855,STMN1;PHLDB2;CLASP2,alpha,7
telomere maintenance (GO:0000723),5/52,5,52,0.024201096499085,0.574410211324795,0,0,3.02846759539673,11.2700101058946,RECQL4;SNRNP40;NSMCE2;TERF2IP;SMC6,alpha,7
microtubule nucleation by microtubule organizing center (GO:0051418),2/8,2,8,0.0248187050030858,0.575681143776122,0,0,7.8740157480315,29.1036037488766,TUBGCP2;TUBGCP4,alpha,7
regulation of interferon-beta production (GO:0032648),4/35,4,35,0.0241820372034342,0.576639887145441,0,0,3.59955005624297,13.3980479127287,TBK1;RNF216;POLR3D;TLR3,alpha,7
positive regulation of mitochondrial calcium ion concentration (GO:0051561),2/8,2,8,0.0248187050030858,0.578309824797931,0,0,7.8740157480315,29.1036037488766,MCUR1;MICU1,alpha,7
embryonic limb morphogenesis (GO:0030326),4/35,4,35,0.0241820372034342,0.579347116662556,0,0,3.59955005624297,13.3980479127287,FBXW4;TFAP2A;CTNNB1;GLI3,alpha,7
barbed-end actin filament capping (GO:0051016),2/8,2,8,0.0248187050030858,0.580962622159389,0,0,7.8740157480315,29.1036037488766,TWF1;ADD1,alpha,7
epithelial tube morphogenesis (GO:0060562),4/35,4,35,0.0241820372034342,0.582079886080776,0,0,3.59955005624297,13.3980479127287,PAK1;CTNNB1;SLIT2;PKD2,alpha,7
negative regulation of epithelial cell migration (GO:0010633),4/36,4,36,0.0265421341909902,0.591460745749445,0,0,3.49956255468066,12.6999889385192,DLL4;KRIT1;SLIT2;CORO1C,alpha,7
positive regulation of growth (GO:0045927),6/72,6,72,0.026690893643448,0.592189696793544,0,0,2.6246719160105,9.51032239840936,USP47;ZNF639;SPHK1;TAF9;INO80;TGFBR1,alpha,7
positive regulation of MAP kinase activity (GO:0043406),11/178,11,178,0.0270276431307124,0.597065207342101,0,0,1.94638591524374,7.02819539728295,DUSP5;PAK1;KARS;GADD45B;CD81;STK39;RASGRP1;MAP3K4;TGFBR1;MAP3K5;GADD45G,alpha,7
mitochondrial calcium ion transmembrane transport (GO:0006851),3/21,3,21,0.0276811569091048,0.598546371640517,0,0,4.49943757030371,16.1394976524496,MCUR1;SPG7;MICU1,alpha,7
positive regulation of BMP signaling pathway (GO:0030513),3/21,3,21,0.0276811569091048,0.601093377477285,0,0,4.49943757030371,16.1394976524496,SMAD4;FOXD1;SULF1,alpha,7
negative regulation of protein tyrosine kinase activity (GO:0061099),3/21,3,21,0.0276811569091048,0.603662152594709,0,0,4.49943757030371,16.1394976524496,ERRFI1;ZGPAT;HYAL2,alpha,7
zinc II ion transport (GO:0006829),3/21,3,21,0.0276811569091048,0.606252977283957,0,0,4.49943757030371,16.1394976524496,SLC30A5;SLC30A4;SLC39A13,alpha,7
negative regulation of ion transmembrane transporter activity (GO:0032413),3/21,3,21,0.0276811569091048,0.608866136668801,0,0,4.49943757030371,16.1394976524496,CAB39;ACTN2;STK39,alpha,7
cell cycle G1/S phase transition (GO:0044843),7/93,7,93,0.0285208036763269,0.608960925356889,0,0,2.37067140800948,8.43276624538855,RB1;LATS1;CCNE2;CUL5;ORC1;CUL3;EIF4E,alpha,7
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),6/73,6,73,0.0283303221892049,0.609998456251108,0,0,2.58871750620214,9.22572993415867,FBXW4;PSMD6;PSMD12;FBXL3;PSMF1;FBXL5,alpha,7
nuclear export (GO:0051168),7/93,7,93,0.0285208036763269,0.611519584707128,0,0,2.37067140800948,8.43276624538855,NXT1;NUP188;XPO4;NCBP2;NUP62;SRSF2;EIF4E,alpha,7
NLS-bearing protein import into nucleus (GO:0006607),3/22,3,22,0.0313147664296205,0.612257674675683,0,0,4.29491768074445,14.8761582896373,KPNA2;IPO5;KPNA1,alpha,7
positive regulation of multicellular organismal process (GO:0051240),12/203,12,203,0.0291077794723745,0.613789250609617,0,0,1.86183623598774,6.58484894403558,SMAD4;FOXD1;TFRC;CAPN7;AGO2;SNAI1;CTNNB1;FOXJ1;SOX8;AXIN2;TGFBR1;CLASP2,alpha,7
positive regulation of stress fiber assembly (GO:0051496),4/38,4,38,0.0316629175302486,0.614356913143948,0,0,3.31537505180274,11.4466939969844,PAK1;TESK1;TGFBR1;S100A10,alpha,7
cytosolic calcium ion transport (GO:0060401),3/22,3,22,0.0313147664296205,0.614612511885974,0,0,4.29491768074445,14.8761582896373,MCUR1;ATP2A2;MICU1,alpha,7
mitotic spindle organization (GO:0007052),6/75,6,75,0.0318049714491805,0.614775641307455,0,0,2.51968503937008,8.68820829363185,TUBGCP2;STMN1;BCCIP;MYBL2;TUBGCP4;CLASP2,alpha,7
regulation of cell morphogenesis involved in differentiation (GO:0010769),4/37,4,37,0.0290354093062732,0.614803708256897,0,0,3.40497978293254,12.0510378659687,PAK1;KIF13B;TNIK;CORO1C,alpha,7
epithelium development (GO:0060429),8/116,8,116,0.0316024159297816,0.615523391181968,0,0,2.17214227531903,7.50371264260133,ERRFI1;SULT1B1;CDHR2;ANXA7;FOXJ1;TPP1;PKD2;DACT1,alpha,7
"regulation of transcription, DNA-templated (GO:0006355)",64/1599,64,1599,0.0322610621648612,0.616585019577852,0,0,1.2606304136936,4.32887156890935,RB1;CREBZF;PHF1;JMJD1C;CTCF;GLI3;IKBKB;ZXDC;NUP62;SOX8;MYBL2;PITX3;MAP3K5;HES6;C11ORF84;USP47;ZHX2;FOXD1;ZGPAT;TGIF2;SFMBT1;NCOA4;FOS;FOXP4;POU3F1;TGFBR1;KARS;ZNF639;SUB1;CKS2;CRY1;TERF2IP;MAPRE3;ATF5;JDP2;RNF4;PHF21A;ORC1;NSD1;TP53INP2;TP53INP1;TBL1X;SUDS3;BPTF;TFAP2A;JUN;SMAD4;UBE2I;CBX4;HMGA1;FOXJ1;FOXN4;DEK;HNRNPAB;YY1AP1;HIPK2;NFKB2;FOSL1;GCLC;SNAI1;CTNNB1;NAA16;TAF4;TAF3,alpha,7
negative regulation of actin filament polymerization (GO:0030837),3/22,3,22,0.0313147664296205,0.616985533167387,0,0,4.29491768074445,14.8761582896373,KANK1;TWF1;SLIT2,alpha,7
actin polymerization or depolymerization (GO:0008154),4/37,4,37,0.0290354093062732,0.617365390374634,0,0,3.40497978293254,12.0510378659687,MICAL1;TWF1;DSTN;CAP2,alpha,7
Fc-epsilon receptor signaling pathway (GO:0038095),11/183,11,183,0.032185294939797,0.617449473976631,0,0,1.89320597220429,6.5055207101116,IKBKB;PSMD6;PSMD12;JUN;PAK1;NR4A3;TEC;PSMF1;FOS;SOS1;PAK2,alpha,7
negative regulation of cellular response to growth factor stimulus (GO:0090288),5/56,5,56,0.0321186135205175,0.618495414321512,0,0,2.81214848143982,9.66906511937013,SLIT2;SULF1;NBL1;SKIL;HIPK2,alpha,7
negative regulation of cell cycle G1/S phase transition (GO:1902807),3/22,3,22,0.0313147664296205,0.619376949962609,0,0,4.29491768074445,14.8761582896373,RB1;PKD2;DACT1,alpha,7
nuclear transport (GO:0051169),3/22,3,22,0.0313147664296205,0.621786977005265,0,0,4.29491768074445,14.8761582896373,NXT1;HMGA1;PSIP1,alpha,7
negative regulation of chromatin silencing (GO:0031936),2/9,2,9,0.0312472772684884,0.622870530863658,0,0,6.99912510936133,24.2577290218996,PHF2;HMGA1,alpha,7
Notch signaling involved in heart development (GO:0061314),2/9,2,9,0.0312472772684884,0.625313160396456,0,0,6.99912510936133,24.2577290218996,DLL4;SNAI1,alpha,7
intracellular protein transport (GO:0006886),18/348,18,348,0.0298525782814413,0.626904143910268,0,0,1.62910670648928,5.72058224537488,CTSA;NXT1;NUP188;GRTP1;SNX13;GABARAP;ARCN1;IPO5;TBC1D1;XPO4;RAB36;SGSM2;TBC1D30;NUP62;RAB24;KIF13B;KDELR2;SNX9,alpha,7
negative regulation of protein sumoylation (GO:0033234),2/9,2,9,0.0312472772684884,0.627775023232663,0,0,6.99912510936133,24.2577290218996,CTNNB1;RNF4,alpha,7
regulation of autophagy (GO:0010506),12/204,12,204,0.0300743614706521,0.628973223707941,0,0,1.85270958777212,6.49204677828679,CTSA;ERN1;UCHL1;EXOC8;USP10;BNIP3;ZC3H12A;PSAP;TP53INP1;DRAM2;ATP6V1E2;ATP6V1C1,alpha,7
mitochondrial calcium uptake (GO:0036444),2/9,2,9,0.0312472772684884,0.630256347435164,0,0,6.99912510936133,24.2577290218996,MCUR1;MICU1,alpha,7
regulation of cytoskeleton organization (GO:0051493),7/96,7,96,0.0331312425710991,0.630853473284772,0,0,2.29658792650919,7.82511479730383,PHLDB1;STMN1;FSCN1;BAIAP2;PHLDB2;RHOQ;RND1,alpha,7
establishment of viral latency (GO:0019043),2/9,2,9,0.0312472772684884,0.63275736468689,0,0,6.99912510936133,24.2577290218996,HMGA1;PSIP1,alpha,7
small nucleolar ribonucleoprotein complex assembly (GO:0000491),2/9,2,9,0.0312472772684884,0.635278310362934,0,0,6.99912510936133,24.2577290218996,NUFIP1;TAF9,alpha,7
regulation of microvillus organization (GO:0032530),2/9,2,9,0.0312472772684884,0.637819423604385,0,0,6.99912510936133,24.2577290218996,CDHR2;FSCN1,alpha,7
regulation of interferon-gamma secretion (GO:1902713),2/9,2,9,0.0312472772684884,0.640380947393961,0,0,6.99912510936133,24.2577290218996,ZC3H12A;RASGRP1,alpha,7
neuron maturation (GO:0042551),2/9,2,9,0.0312472772684884,0.642963128633453,0,0,6.99912510936133,24.2577290218996,ANKS1A;RND1,alpha,7
positive regulation of protein sumoylation (GO:0033235),2/9,2,9,0.0312472772684884,0.645566218223062,0,0,6.99912510936133,24.2577290218996,UBE2I;GNL3,alpha,7
megakaryocyte differentiation (GO:0030219),2/9,2,9,0.0312472772684884,0.648190471142668,0,0,6.99912510936133,24.2577290218996,IL11;CDKN2B,alpha,7
negative regulation of leukocyte chemotaxis (GO:0002689),2/9,2,9,0.0312472772684884,0.650836146535087,0,0,6.99912510936133,24.2577290218996,SLIT2;NBL1,alpha,7
chordate embryonic development (GO:0043009),5/57,5,57,0.0343222772713121,0.651102531284407,0,0,2.76281254316895,9.31609518581157,SOX8;PKD2;SULF1;TGFBR1;DACT1,alpha,7
cellular response to DNA damage stimulus (GO:0006974),17/330,17,330,0.0352153539070535,0.658256230724154,0,0,1.62252445717013,5.42940994664605,BARD1;USP47;CUL5;USP10;PHF1;TAF9;FBXO45;SMC6;INIP;RECQL4;KIN;ZC3H12A;SPRTN;CRY1;RAD17;ATRIP;MICA,alpha,7
apoptotic nuclear changes (GO:0030262),3/23,3,23,0.0351852946041909,0.660112346930831,0,0,4.10818212940774,13.750607534105,ENDOG;BLCAP;KPNA1,alpha,7
zinc II ion transmembrane transport (GO:0071577),3/23,3,23,0.0351852946041909,0.662548185849395,0,0,4.10818212940774,13.750607534105,SLC30A5;SLC30A4;SLC39A13,alpha,7
microtubule polymerization or depolymerization (GO:0031109),3/23,3,23,0.0351852946041909,0.665002068019207,0,0,4.10818212940774,13.750607534105,MAP7D3;NCKAP5L;STMN1,alpha,7
inorganic cation transmembrane transport (GO:0098662),9/141,9,141,0.0360820906165701,0.6695523942413,0,0,2.0103869994974,6.67842246583647,SLC30A5;SLC30A4;UCP2;ATP2A2;CACNA1D;SLC39A13;PKD2;ATP6V1C1;TMCO1,alpha,7
calcium ion transport (GO:0006816),8/119,8,119,0.0359820604567822,0.670133045660437,0,0,2.11738238602528,7.03973487275635,MCUR1;STIM2;ORAI2;ATP2A2;CACNA1D;PKD2;MICU1;TMCO1,alpha,7
chaperone-mediated protein transport (GO:0072321),2/10,2,10,0.0382504238639598,0.673075561992368,0,0,6.2992125984252,20.5581142510884,TIMM9;CLU,alpha,7
regulation of mRNA 3'-end processing (GO:0031440),2/10,2,10,0.0382504238639598,0.675404543175733,0,0,6.2992125984252,20.5581142510884,BARD1;NCBP2,alpha,7
negative regulation of protein autophosphorylation (GO:0031953),2/10,2,10,0.0382504238639598,0.677749697839538,0,0,6.2992125984252,20.5581142510884,ERRFI1;TESK1,alpha,7
stress fiber assembly (GO:0043149),2/10,2,10,0.0382504238639598,0.680111195044553,0,0,6.2992125984252,20.5581142510884,CUL3;ARRB1,alpha,7
tRNA wobble base modification (GO:0002097),2/10,2,10,0.0382504238639598,0.682489206216038,0,0,6.2992125984252,20.5581142510884,MOCS3;NAT10,alpha,7
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),2/10,2,10,0.0382504238639598,0.684883905185217,0,0,6.2992125984252,20.5581142510884,JUN;BAG3,alpha,7
intraciliary retrograde transport (GO:0035721),2/10,2,10,0.0382504238639598,0.687295468231644,0,0,6.2992125984252,20.5581142510884,IFT43;TTC21A,alpha,7
regulation of GTPase activity (GO:0043087),11/189,11,189,0.0392529872720351,0.688343622162182,0,0,1.83310419530892,5.93509228294632,NET1;ARHGAP21;CDKL5;TBC1D30;TBC1D7;SGSM2;SNX13;SNX9;BVES;RASGRP1;S100A10,alpha,7
actin filament capping (GO:0051693),2/10,2,10,0.0382504238639598,0.689724074126455,0,0,6.2992125984252,20.5581142510884,TWF1;ADD1,alpha,7
virion attachment to host cell (GO:0019062),2/10,2,10,0.0382504238639598,0.692169904176549,0,0,6.2992125984252,20.5581142510884,HSP90AB1;CD81,alpha,7
contractile actin filament bundle assembly (GO:0030038),2/10,2,10,0.0382504238639598,0.694633142269704,0,0,6.2992125984252,20.5581142510884,CUL3;ARRB1,alpha,7
positive regulation of apoptotic process (GO:0043065),16/308,16,308,0.0376994345734323,0.697029763145743,0,0,1.63615911647408,5.36350986021939,BARD1;TFAP2A;JUN;ARHGEF12;GADD45B;BNIP3;TGFBR1;GADD45G;NET1;LATS1;ZC3H12A;CTNNB1;SUDS3;SLIT2;SOS1;MAP3K5,alpha,7
cellular biogenic amine metabolic process (GO:0006576),2/10,2,10,0.0382504238639598,0.697113974920667,0,0,6.2992125984252,20.5581142510884,SULT1B1;AMD1,alpha,7
negative regulation of apoptotic process (GO:0043066),23/486,23,486,0.0379287711146844,0.698738335733698,0,0,1.49055442143806,4.87716162271046,BARD1;TFAP2A;USP47;PRELID1;CBX4;SPHK1;BNIP3;TAF9;TRIAP1;IGF1R;IKBKB;GCLC;GRK5;BAG3;ZC3H12A;NUP62;TYRO3;PPIF;CTNNB1;SOX8;NAA16;ATF5;PAK2,alpha,7
regulation of sequestering of zinc ion (GO:0061088),2/10,2,10,0.0382504238639598,0.699612591318232,0,0,6.2992125984252,20.5581142510884,SLC30A5;SLC30A4,alpha,7
positive regulation of cell growth (GO:0030307),7/99,7,99,0.0382134409413048,0.701450320588051,0,0,2.22699435297861,7.27017442999509,USP47;CDKL5;ZNF639;SPHK1;TAF9;INO80;TGFBR1,alpha,7
androgen receptor signaling pathway (GO:0030521),4/41,4,41,0.0403577158035805,0.702885405275329,0,0,3.07278663337815,9.8635611466068,RB1;NCOA4;CTNNB1;RNF4,alpha,7
positive regulation of mitotic cell cycle phase transition (GO:1901992),4/41,4,41,0.0403577158035805,0.705292547074217,0,0,3.07278663337815,9.8635611466068,RB1;ANKRD17;CUL3;NSMCE2,alpha,7
negative regulation of cell migration (GO:0030336),8/122,8,122,0.0407537136847513,0.707368030385326,0,0,2.06531560604105,6.6094401653895,KANK1;HYAL2;TP53INP1;SLIT2;SULF1;PHLDB2;CORO1C;CLASP2,alpha,7
renal system development (GO:0072001),5/60,5,60,0.0414845844825955,0.717612998693847,0,0,2.6246719160105,8.35284351444594,TFAP2A;ITGB4;HYAL2;SULF1;TGFBR1,alpha,7
anaphase-promoting complex-dependent catabolic process (GO:0031145),6/80,6,80,0.0416680811751656,0.718352088638074,0,0,2.36220472440945,7.50713358122882,PSMD6;PSMD12;PTTG1;UBE2S;CUL3;PSMF1,alpha,7
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),7/101,7,101,0.0418708716266702,0.719417703403696,0,0,2.18289545489982,6.92668719794742,NXT1;NUP188;NCBP2;NUP62;SRSF2;EIF4E;AGFG1,alpha,7
spindle assembly (GO:0051225),6/81,6,81,0.0438473220695036,0.726470404287912,0,0,2.33304170312044,7.29551853550208,TUBGCP2;BCCIP;HAUS3;MYBL2;INO80;TUBGCP4,alpha,7
regulation of cardiac muscle cell action potential (GO:0098901),3/25,3,25,0.0436268781813931,0.727542350848527,0,0,3.77952755905512,11.8377896561298,SLMAP;ATP2A2;DSG2,alpha,7
positive regulation of protein binding (GO:0032092),5/61,5,61,0.0440577285023336,0.727594137693878,0,0,2.58164450755131,8.06055116453363,EPB41;SPPL3;ADD1;DACT1;HIPK2,alpha,7
RNA transport (GO:0050658),6/81,6,81,0.0438473220695036,0.728836757396342,0,0,2.33304170312044,7.29551853550208,NXT1;NUP188;NCBP2;NUP62;SRSF2;EIF4E,alpha,7
negative regulation of interleukin-6 production (GO:0032715),3/25,3,25,0.0436268781813931,0.729927735605407,0,0,3.77952755905512,11.8377896561298,ZC3H12A;FOXJ1;ARRB1,alpha,7
cellular senescence (GO:0090398),3/25,3,25,0.0436268781813931,0.732328813683056,0,0,3.77952755905512,11.8377896561298,NSMCE2;HMGA1;SMC6,alpha,7
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),3/25,3,25,0.0436268781813931,0.734745740460888,0,0,3.77952755905512,11.8377896561298,LATS1;CDKN2B;IPO5,alpha,7
plasma membrane bounded cell projection assembly (GO:0120031),13/242,13,242,0.0459037886354116,0.736625891215426,0,0,1.69193726817206,5.21321001043678,UNC119B;ACTN2;CEP19;FOXJ1;PARVA;DYNLL2;MYLK;IFT43;KIAA0586;FSCN1;TNIK;WHAMM;IFT46,alpha,7
hepatocyte growth factor receptor signaling pathway (GO:0048012),2/11,2,11,0.0457853001246713,0.737042228820813,0,0,5.72655690765927,17.6595115095584,PAK1;STMN1,alpha,7
cellular modified amino acid biosynthetic process (GO:0042398),3/25,3,25,0.0436268781813931,0.737178673376322,0,0,3.77952755905512,11.8377896561298,GCLC;CHAC2;HAGH,alpha,7
cyclooxygenase pathway (GO:0019371),2/11,2,11,0.0457853001246713,0.739374640937335,0,0,5.72655690765927,17.6595115095584,TBXAS1;PTGDS,alpha,7
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),3/25,3,25,0.0436268781813931,0.739627771958967,0,0,3.77952755905512,11.8377896561298,RB1;PKD2;DACT1,alpha,7
negative regulation of T cell differentiation (GO:0045581),2/11,2,11,0.0457853001246713,0.741721862019676,0,0,5.72655690765927,17.6595115095584,FOXJ1;GLI3,alpha,7
positive regulation of histone methylation (GO:0031062),3/25,3,25,0.0436268781813931,0.742093197865497,0,0,3.77952755905512,11.8377896561298,SMAD4;PHF1;CTNNB1,alpha,7
translesion synthesis (GO:0019985),4/43,4,43,0.0468338996062598,0.742215495933986,0,0,2.92986632484893,8.96875440457845,POLN;USP10;REV1;SPRTN,alpha,7
regulation of tumor necrosis factor production (GO:0032680),5/62,5,62,0.0467244369746701,0.742787544802933,0,0,2.54000508001016,7.78127502026772,ARFGEF2;ZC3H12A;CLU;RASGRP1;TLR3,alpha,7
gluconeogenesis (GO:0006094),4/42,4,42,0.0435278482790105,0.742884982500971,0,0,2.99962504686914,9.4018878302207,TPI1;CRY1;SLC37A4;PGM1,alpha,7
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),2/11,2,11,0.0457853001246713,0.74408403355477,0,0,5.72655690765927,17.6595115095584,TAF9;TRIAP1,alpha,7
ephrin receptor signaling pathway (GO:0048013),6/83,6,83,0.048416273807582,0.74418146156654,0,0,2.2768238307561,6.89403878815352,PAK1;GPRIN1;ARHGEF28;ANKS1A;ACTB;GIT1,alpha,7
peptidyl-serine phosphorylation (GO:0018105),9/146,9,146,0.0434906854353447,0.744741502605919,0,0,1.9415381296516,6.08712683111927,ERN1;IKBKB;LATS1;TBK1;CAB39;STK39;PAK2;TGFBR1;HIPK2,alpha,7
regulation of vesicle fusion (GO:0031338),5/62,5,62,0.0467244369746701,0.745108755880442,0,0,2.54000508001016,7.78127502026772,TBC1D1;GRTP1;TBC1D30;SGSM2;VPS41,alpha,7
positive regulation of cell cycle (GO:0045787),6/83,6,83,0.048416273807582,0.746429743927768,0,0,2.2768238307561,6.89403878815352,ANKRD17;HSP90AB1;SPHK1;CKS2;MAPRE3;EIF4E,alpha,7
intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),2/11,2,11,0.0457853001246713,0.746461298837693,0,0,5.72655690765927,17.6595115095584,GSKIP;MAP3K5,alpha,7
positive regulation of actin filament bundle assembly (GO:0032233),4/45,4,45,0.0538522118799923,0.746760427238046,0,0,2.79965004374453,8.17921064255025,PAK1;TESK1;TGFBR1;S100A10,alpha,7
RNA splicing (GO:0008380),7/107,7,107,0.0541736229292468,0.747156750832287,0,0,2.06049010228862,6.00748489387533,SNRNP40;LSM6;NCBP2;SRSF2;DHX16;RP9;PPIG,alpha,7
actin cytoskeleton reorganization (GO:0031532),5/62,5,62,0.0467244369746701,0.747444520005459,0,0,2.54000508001016,7.78127502026772,PAK1;DTNBP1;PARVA;TNIK;WHAMM,alpha,7
positive regulation of nitric oxide metabolic process (GO:1904407),3/26,3,26,0.0481913766425921,0.74747901217978,0,0,3.63416111447608,11.020866802283,HSP90AB1;PKD2;CLU,alpha,7
negative regulation of canonical Wnt signaling pathway (GO:0090090),9/149,9,149,0.0483930558933629,0.748332618860094,0,0,1.90244675791365,5.7613677618716,LATS1;PSMD6;PSMD12;CUL3;KLHL12;PSMF1;AXIN2;GLI3;DACT1,alpha,7
metaphase plate congression (GO:0051310),4/45,4,45,0.0538522118799923,0.748795196794553,0,0,2.79965004374453,8.17921064255025,CUL3;NUP62;FAM83D;GEM,alpha,7
positive regulation of extracellular matrix organization (GO:1903055),2/11,2,11,0.0457853001246713,0.748853803000634,0,0,5.72655690765927,17.6595115095584,FSCN1;CLASP2,alpha,7
positive regulation of cellular catabolic process (GO:0031331),7/107,7,107,0.0541736229292468,0.749181565875193,0,0,2.06049010228862,6.00748489387533,ENTPD5;BNIP3;ZC3H12A;TP53INP1;SNX9;ABHD5;DACT1,alpha,7
positive regulation of nitric oxide biosynthetic process (GO:0045429),3/26,3,26,0.0481913766425921,0.749757911607157,0,0,3.63416111447608,11.020866802283,HSP90AB1;PKD2;CLU,alpha,7
hexose biosynthetic process (GO:0019319),4/45,4,45,0.0538522118799923,0.750841085310385,0,0,2.79965004374453,8.17921064255025,TPI1;CRY1;SLC37A4;PGM1,alpha,7
regulation of lamellipodium morphogenesis (GO:2000392),2/11,2,11,0.0457853001246713,0.751261693042437,0,0,5.72655690765927,17.6595115095584,KANK1;CORO1C,alpha,7
protein autophosphorylation (GO:0046777),10/176,10,176,0.054658894848935,0.751817629148559,0,0,1.78954903364352,5.20158073967488,ERN1;PAK1;CDKL5;TEC;GRK5;TYRO3;STK39;TNIK;PAK2;IGF1R,alpha,7
positive regulation of embryonic development (GO:0040019),3/26,3,26,0.0481913766425921,0.752050749257332,0,0,3.63416111447608,11.020866802283,PHLDB1;PHLDB2;CLASP2,alpha,7
regulation of focal adhesion assembly (GO:0051893),4/45,4,45,0.0538522118799923,0.752898184174249,0,0,2.79965004374453,8.17921064255025,PHLDB2;CORO1C;S100A10;CLASP2,alpha,7
regulation of lipid kinase activity (GO:0043550),2/11,2,11,0.0457853001246713,0.753685117858703,0,0,5.72655690765927,17.6595115095584,RB1;PPP2R5A,alpha,7
regulation of lamellipodium assembly (GO:0010591),3/26,3,26,0.0481913766425921,0.754357653396158,0,0,3.63416111447608,11.020866802283,FSCN1;TWF1;SLIT2,alpha,7
microtubule anchoring (GO:0034453),2/12,2,12,0.0538111953952623,0.75439156621435,0,0,5.249343832021,15.3400196357689,BCCIP;CLASP2,alpha,7
protein import into nucleus (GO:0006606),7/104,7,104,0.04777005149066,0.754707655593925,0,0,2.11992731677771,6.44745445664968,NXT1;NUP188;NUP62;CTNNB1;KPNA2;IPO5;KPNA1,alpha,7
plasma membrane tubulation (GO:0097320),2/12,2,12,0.0538111953952623,0.756469779895381,0,0,5.249343832021,15.3400196357689,SNX9;WHAMM,alpha,7
response to alcohol (GO:0097305),3/26,3,26,0.0481913766425921,0.756678753868146,0,0,3.63416111447608,11.020866802283,GPRIN1;TGFBR1;ADH6,alpha,7
glucose metabolic process (GO:0006006),5/65,5,65,0.055288178086977,0.758428959080225,0,0,2.42277407631738,7.01440622924272,TPI1;HECTD4;CRY1;SLC37A4;PGM1,alpha,7
peptidyl-methionine modification (GO:0018206),2/12,2,12,0.0538111953952623,0.758559475419954,0,0,5.249343832021,15.3400196357689,NAA30;NAA16,alpha,7
positive regulation of intracellular protein transport (GO:0090316),9/153,9,153,0.0554789170721396,0.759005130882382,0,0,1.85270958777212,5.35757703191047,CYB5R1;XPO4;BAG3;HYAL2;ZC3H12A;FAM20B;DPH6;IPO5;ZBED3,alpha,7
regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),3/26,3,26,0.0481913766425921,0.759014182120826,0,0,3.63416111447608,11.020866802283,LATS1;CLU;HIPK2,alpha,7
regulation of blood vessel size (GO:0050880),2/12,2,12,0.0538111953952623,0.760660748205051,0,0,5.249343832021,15.3400196357689,GCLC;NOS3,alpha,7
regulation of type I interferon production (GO:0032479),6/86,6,86,0.0558008296617837,0.761368004716797,0,0,2.1973997436367,6.34162213780918,TBK1;RNF216;POLR3D;CTNNB1;POLR2H;NFKB2,alpha,7
mRNA transport (GO:0051028),7/105,7,105,0.0498481120360508,0.761601544071758,0,0,2.0997375328084,6.29663969803499,NXT1;NUP188;NCBP2;NUP62;SRSF2;EIF4E;AGFG1,alpha,7
positive regulation of hydrolase activity (GO:0051345),10/173,10,173,0.0497307565531148,0.762090242313949,0,0,1.82058167584543,5.46380536736163,NET1;ARHGAP21;CDKL5;TBC1D30;TBC1D7;SGSM2;SNX13;SNX9;RASGRP1;S100A10,alpha,7
positive regulation of DNA-dependent DNA replication (GO:2000105),2/12,2,12,0.0538111953952623,0.762773694727843,0,0,5.249343832021,15.3400196357689,INO80;BMP6,alpha,7
positive regulation of peptidase activity (GO:0010952),2/12,2,12,0.0538111953952623,0.764898412540455,0,0,5.249343832021,15.3400196357689,PRELID1;KARS,alpha,7
regulation of multicellular organismal development (GO:2000026),4/44,4,44,0.0502755348383813,0.765838968000776,0,0,2.86327845382964,8.56188032962862,PHLDB1;PHLDB2;TGFBR1;CLASP2,alpha,7
regulation of mononuclear cell migration (GO:0071675),2/12,2,12,0.0538111953952623,0.767035000284981,0,0,5.249343832021,15.3400196357689,KARS;SLIT2,alpha,7
positive regulation of peptidyl-serine phosphorylation (GO:0033138),6/84,6,84,0.0508067002607025,0.767060921391612,0,0,2.24971878515186,6.70354789246198,LATS1;IL11;PAK1;TBK1;TERF2IP;TXN,alpha,7
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),19/397,19,397,0.0506183319797862,0.768765916943004,0,0,1.50736825403122,4.49714496899901,NCBP2;ARHGEF28;SULF1;PIK3C2A;BAIAP2;ACTB;IGF1R;PAK1;TEC;GPRIN1;STMN1;POLR2H;ANKS1A;SOS1;ATP6V1E2;PAK2;ATP6V1C1;GIT1;RHOQ,alpha,7
negative regulation by host of viral transcription (GO:0043922),2/12,2,12,0.0538111953952623,0.769183557708749,0,0,5.249343832021,15.3400196357689,JUN;ZNF639,alpha,7
positive regulation of protein ubiquitination (GO:0031398),6/84,6,84,0.0508067002607025,0.769337066558946,0,0,2.24971878515186,6.70354789246198,SPHK1;CUL3;TBC1D7;SPRTN;BMI1;CLU,alpha,7
regulation of establishment of endothelial barrier (GO:1903140),2/12,2,12,0.0538111953952623,0.771344185679841,0,0,5.249343832021,15.3400196357689,IKBKB;ADD1,alpha,7
polyamine metabolic process (GO:0006595),2/12,2,12,0.0538111953952623,0.773516986202882,0,0,5.249343832021,15.3400196357689,AMD1;PAOX,alpha,7
organelle assembly (GO:0070925),18/377,18,377,0.0569940847211896,0.775575504885948,0,0,1.5037908059901,4.30807162057454,UNC119B;CEP19;HAUS3;FOXJ1;PARVA;INO80;STAM;AMBRA1;DYNLL2;GABARAP;MAP1LC3A;IFT43;KIAA0586;TP53INP2;NUP62;TP53INP1;IFT46;ATG2B,alpha,7
exit from mitosis (GO:0010458),2/12,2,12,0.0538111953952623,0.775702062435094,0,0,5.249343832021,15.3400196357689,UBE2S;CLASP2,alpha,7
negative regulation of apoptotic signaling pathway (GO:2001234),5/66,5,66,0.0583308754178635,0.777186572473518,0,0,2.38606537819136,6.78030000073547,PRELID1;PPIF;TRIAP1;CLU;TGFBR1,alpha,7
negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),2/12,2,12,0.0538111953952623,0.777899518702616,0,0,5.249343832021,15.3400196357689,KANK1;CORO1C,alpha,7
regulation of angiogenesis (GO:0045765),10/178,10,178,0.0581172735161312,0.778405372054638,0,0,1.76944174113067,5.03457905452563,TMEM2;NOS3;SPHK1;ZC3H12A;AGO2;KRIT1;CTNNB1;SULF1;HSPG2;HIPK2,alpha,7
regulation of microtubule-based process (GO:0032886),3/27,3,27,0.0529797894772868,0.779123532284134,0,0,3.49956255468066,10.2811715442599,PHLDB1;PHLDB2;CLASP2,alpha,7
hexose metabolic process (GO:0019318),4/46,4,46,0.0575631892436104,0.779164336101177,0,0,2.73878808627183,7.81888939735141,HECTD4;FUCA1;SLC37A4;PGM1,alpha,7
DNA synthesis involved in DNA repair (GO:0000731),5/66,5,66,0.0583308754178635,0.779221092296747,0,0,2.38606537819136,6.78030000073547,BARD1;POLN;USP10;REV1;SPRTN,alpha,7
pre-mRNA cleavage required for polyadenylation (GO:0098789),2/12,2,12,0.0538111953952623,0.780109460517112,0,0,5.249343832021,15.3400196357689,CPSF6;NCBP2,alpha,7
mRNA export from nucleus (GO:0006406),7/106,7,106,0.0519825448933813,0.780196842914485,0,0,2.07992868815926,6.1500315088862,NXT1;NUP188;NCBP2;NUP62;SRSF2;EIF4E;AGFG1,alpha,7
regulation of cell growth (GO:0001558),11/202,11,202,0.0581118720686936,0.780381271490904,0,0,1.71513214313557,4.88021178329071,NET1;USP47;SMAD4;CISH;ZNF639;HYAL2;SPHK1;TAF9;INO80;SLIT2;TGFBR1,alpha,7
protein localization to plasma membrane (GO:0072659),8/131,8,131,0.0575235727237906,0.780698913855062,0,0,1.92342369417563,5.4924526388669,IKBKB;ARFRP1;ACTN2;PACS1;SLMAP;TNIK;S100A10;CLASP2,alpha,7
cellular response to glucose stimulus (GO:0071333),3/28,3,28,0.0579876363253476,0.78076756772625,0,0,3.37457817772778,9.60919727096741,ERN1;IGF1R;RAB11FIP5,alpha,7
regulation of NF-kappaB import into nucleus (GO:0042345),3/27,3,27,0.0529797894772868,0.781375334400563,0,0,3.49956255468066,10.2811715442599,SPHK1;ZC3H12A;TLR3,alpha,7
cellular response to arsenic-containing substance (GO:0071243),2/12,2,12,0.0538111953952623,0.782331994592659,0,0,5.249343832021,15.3400196357689,ZC3H12A;PPIF,alpha,7
G1/S transition of mitotic cell cycle (GO:0000082),7/106,7,106,0.0519825448933813,0.782498308527802,0,0,2.07992868815926,6.1500315088862,RB1;LATS1;CCNE2;CUL5;ORC1;CUL3;EIF4E,alpha,7
negative regulation of small GTPase mediated signal transduction (GO:0051058),3/28,3,28,0.0579876363253476,0.782833090392192,0,0,3.37457817772778,9.60919727096741,RASAL2;SLIT2;RASAL3,alpha,7
negative regulation of protein modification process (GO:0031400),5/64,5,64,0.0523395389883842,0.783251224216202,0,0,2.46062992125984,7.25886611696861,ZC3H12A;TERF2IP;SLIT2;CORO1C;ZBED3,alpha,7
regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),3/27,3,27,0.0529797894772868,0.783640190442303,0,0,3.49956255468066,10.2811715442599,JUN;FOS;GNL3,alpha,7
Golgi localization (GO:0051645),2/12,2,12,0.0538111953952623,0.784567228862924,0,0,5.249343832021,15.3400196357689,ARHGAP21;ARCN1,alpha,7
regulation of centrosome cycle (GO:0046605),3/27,3,27,0.0529797894772868,0.785918214251729,0,0,3.49956255468066,10.2811715442599,GEN1;CTNNB1;ATF5,alpha,7
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),2/12,2,12,0.0538111953952623,0.786815272498634,0,0,5.249343832021,15.3400196357689,TAF9;TRIAP1,alpha,7
positive regulation of interferon-beta production (GO:0032728),3/27,3,27,0.0529797894772868,0.788209520998818,0,0,3.49956255468066,10.2811715442599,TBK1;POLR3D;TLR3,alpha,7
establishment of apical/basal cell polarity (GO:0035089),2/12,2,12,0.0538111953952623,0.789076235925354,0,0,5.249343832021,15.3400196357689,FSCN1;FOXJ1,alpha,7
cytoskeleton-dependent intracellular transport (GO:0030705),3/27,3,27,0.0529797894772868,0.790514227200569,0,0,3.49956255468066,10.2811715442599,KIF5B;KIF13B;DYNLL2,alpha,7
positive regulation of macromolecule metabolic process (GO:0010604),14/277,14,277,0.0595692141471437,0.791619009877277,0,0,1.59185877938543,4.49002294701643,TFAP2A;FOXD1;FN1;DTNBP1;ARRB1;CTCF;POU3F1;WNT16;CLU;TGFBR1;DLL4;ZC3H12A;BVES;TLR3,alpha,7
negative regulation of protein phosphorylation (GO:0001933),10/179,10,179,0.0598988933586133,0.793932604698711,0,0,1.75955659173888,4.95332292059273,RB1;ERRFI1;CISH;ZC3H12A;TESK1;TERF2IP;SLIT2;PAK2;CORO1C;ZBED3,alpha,7
cellular response to nitrogen levels (GO:0043562),2/13,2,13,0.0622894410254223,0.794657543881824,0,0,4.84554815263477,13.4510640993404,MAP1LC3A;GABARAP,alpha,7
negative regulation of hormone secretion (GO:0046888),2/13,2,13,0.0622894410254223,0.796649166798821,0,0,4.84554815263477,13.4510640993404,IL11;RAB11FIP5,alpha,7
positive regulation of fibroblast proliferation (GO:0048146),3/29,3,29,0.0632100431815263,0.798417946424081,0,0,3.25821341297855,8.99687889010347,SPHK1;FN1;BMI1,alpha,7
motile cilium assembly (GO:0044458),2/13,2,13,0.0622894410254223,0.79865079787118,0,0,4.84554815263477,13.4510640993404,DNAAF3;RSPH9,alpha,7
protein K11-linked ubiquitination (GO:0070979),3/29,3,29,0.0632100431815263,0.800399132395356,0,0,3.25821341297855,8.99687889010347,UBE2H;UBE2S;RNF4,alpha,7
establishment of chromosome localization (GO:0051303),2/13,2,13,0.0622894410254223,0.800662512727279,0,0,4.84554815263477,13.4510640993404,FAM83D;GEM,alpha,7
regulation of DNA metabolic process (GO:0051052),4/47,4,47,0.0614075339534714,0.801438991725229,0,0,2.68051599932987,7.47923671913191,ANKRD17;TERF2IP;KPNA2;KPNA1,alpha,7
negative regulation of proteasomal protein catabolic process (GO:1901799),3/29,3,29,0.0632100431815263,0.802390175013255,0,0,3.25821341297855,8.99687889010347,HSP90AB1;TAF9;PSMF1,alpha,7
positive regulation of protein complex disassembly (GO:0043243),2/13,2,13,0.0622894410254223,0.802684387759419,0,0,4.84554815263477,13.4510640993404,BNIP3;IGF1R,alpha,7
mitotic spindle assembly (GO:0090307),4/47,4,47,0.0614075339534714,0.803493963498884,0,0,2.68051599932987,7.47923671913191,TUBGCP2;BCCIP;MYBL2;TUBGCP4,alpha,7
cellular response to hydrogen peroxide (GO:0070301),3/29,3,29,0.0632100431815263,0.804391148018276,0,0,3.25821341297855,8.99687889010347,NET1;PPIF;MAP3K5,alpha,7
negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),2/13,2,13,0.0622894410254223,0.804716500133493,0,0,4.84554815263477,13.4510640993404,ERRFI1;ZGPAT,alpha,7
regulation of fibroblast proliferation (GO:0048145),4/47,4,47,0.0614075339534714,0.805559500680115,0,0,2.68051599932987,7.47923671913191,SPHK1;FN1;CTNNB1;BMI1,alpha,7
cellular response to nitrogen starvation (GO:0006995),2/13,2,13,0.0622894410254223,0.806758927798806,0,0,4.84554815263477,13.4510640993404,MAP1LC3A;GABARAP,alpha,7
negative regulation of protein kinase activity (GO:0006469),7/110,7,110,0.0610889489784919,0.807608566417731,0,0,2.00429491768074,5.60285471112932,RB1;CISH;HYAL2;TESK1;PAK2;IGF1R;CORO1C,alpha,7
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),4/47,4,47,0.0614075339534714,0.807635684960218,0,0,2.68051599932987,7.47923671913191,CRY1;CTNNB1;ARRB1;RNF4,alpha,7
positive regulation of histone H3-K4 methylation (GO:0051571),2/13,2,13,0.0622894410254223,0.80881174949804,0,0,4.84554815263477,13.4510640993404,SMAD4;CTNNB1,alpha,7
intraciliary transport (GO:0042073),4/47,4,47,0.0614075339534714,0.809722598874844,0,0,2.68051599932987,7.47923671913191,IFT43;TTC21A;IFT46;DYNLL2,alpha,7
response to iron ion (GO:0010039),2/13,2,13,0.0622894410254223,0.810875044777372,0,0,4.84554815263477,13.4510640993404,TFAP2A;BMP6,alpha,7
negative regulation of protein serine/threonine kinase activity (GO:0071901),5/68,5,68,0.0646978655127983,0.815193105461258,0,0,2.31588698471515,6.34096125184831,LATS1;UCHL1;HYAL2;TESK1;IPO5,alpha,7
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),4/48,4,48,0.0653841295741158,0.815782917400276,0,0,2.6246719160105,7.15872891608884,SMAD4;BMP8A;TGFBR1;BMP6,alpha,7
post-translational protein modification (GO:0043687),17/358,17,358,0.0655458071648694,0.815805497469094,0,0,1.49562310297805,4.07558198131305,FBXW4;PSMD12;CISH;CUL5;CUL3;FN1;FBXL14;FBXO30;ANKRD9;PSMD6;KLHL5;NEURL2;CALU;FBXL3;PSMF1;DCAF10;FBXL5,alpha,7
"positive regulation of gene expression, epigenetic (GO:0045815)",4/48,4,48,0.0653841295741158,0.817782385335081,0,0,2.6246719160105,7.15872891608884,HMGA1;POLR2H;DEK;ACTB,alpha,7
regulation of protein binding (GO:0043393),7/112,7,112,0.0659858687866446,0.819284400044398,0,0,1.96850393700787,5.35101312829457,EPB41;XIRP1;SPPL3;ACTB;ADD1;DACT1;HIPK2,alpha,7
postreplication repair (GO:0006301),4/48,4,48,0.0653841295741158,0.819791678665142,0,0,2.6246719160105,7.15872891608884,POLN;USP10;REV1;SPRTN,alpha,7
positive regulation of tumor necrosis factor production (GO:0032760),4/48,4,48,0.0653841295741158,0.821810869991904,0,0,2.6246719160105,7.15872891608884,ARFGEF2;CLU;RASGRP1;TLR3,alpha,7
positive regulation of signal transduction (GO:0009967),11/207,11,207,0.0667317547665985,0.826534331490175,0,0,1.67370383049945,4.53084071890843,ERN1;DLL4;KANK1;HOMER1;ZMIZ1;GPRIN1;SULF1;TLR3;BMP6;TGFBR1;DACT1,alpha,7
negative regulation of cation transmembrane transport (GO:1904063),2/14,2,14,0.071183322119947,0.829334458397465,0,0,4.49943757030371,11.8897490568776,CAB39;STK39,alpha,7
negative regulation of cell cycle G2/M phase transition (GO:1902750),5/70,5,70,0.0714384157871438,0.830410559821857,0,0,2.24971878515186,5.93682681235476,USP47;PSMD6;PSMD12;PSMF1;ATF5,alpha,7
regulation of protein modification by small protein conjugation or removal (GO:1903320),2/14,2,14,0.071183322119947,0.831232248920113,0,0,4.49943757030371,11.8897490568776,HSP90AB1;TGFBR1,alpha,7
histone H4-K16 acetylation (GO:0043984),2/14,2,14,0.071183322119947,0.833138744903875,0,0,4.49943757030371,11.8897490568776,KANSL1;MSL2,alpha,7
glycoside metabolic process (GO:0016137),2/14,2,14,0.071183322119947,0.835054006386413,0,0,4.49943757030371,11.8897490568776,AKR7A2;FUCA1,alpha,7
positive regulation of vascular smooth muscle cell proliferation (GO:1904707),2/14,2,14,0.071183322119947,0.836978093958732,0,0,4.49943757030371,11.8897490568776,ERN1;JUN,alpha,7
response to ethanol (GO:0045471),2/14,2,14,0.071183322119947,0.838911068771569,0,0,4.49943757030371,11.8897490568776,GPRIN1;ADH6,alpha,7
regulation of actin filament polymerization (GO:0030833),5/69,5,69,0.0680216339285564,0.840470697185045,0,0,2.28232340522652,6.1347243601405,LATS1;KANK1;TWF1;SLIT2;BAIAP2,alpha,7
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031657),2/14,2,14,0.071183322119947,0.840852992541874,0,0,4.49943757030371,11.8897490568776,CDKN2B;PKD2,alpha,7
regulation of cell proliferation (GO:0042127),31/741,31,741,0.0725173784352572,0.841036777625267,0,0,1.31764905904981,3.45741763490492,CXCL6;CUL5;CD81;CUL3;CTCF;PPM1D;PKD2;IGF1R;DLL4;PAK1;GRK5;TP53INP1;NUP62;ZBTB7C;TFAP2A;IL11;JUN;CDKN2B;PBRM1;NOS3;FN1;HMGA1;AXIN2;TGFBR1;GNL3;FOSL1;NR4A3;TEC;KARS;CTNNB1;ATF5,alpha,7
histone H4-K5 acetylation (GO:0043981),2/15,2,15,0.0804579927520401,0.841346592241108,0,0,4.1994750656168,10.5827614065094,MEAF6;KANSL1,alpha,7
coenzyme biosynthetic process (GO:0009108),3/30,3,30,0.0686417860235222,0.842016908841427,0,0,3.1496062992126,8.43733481569997,MOCS3;LIAS;ACAT1,alpha,7
positive regulation of cellular process (GO:0048522),23/520,23,520,0.0696818149934069,0.842621568510321,0,0,1.3930950938825,3.71094886021703,ANKRD17;IL11;USP47;JUN;DLX2;HSP90AB1;ACTN2;CD81;SPHK1;CUL3;TAF9;FN1;SMC6;INO80;AXIN2;TGFBR1;IGF1R;FOSL1;PAK1;GRK5;ZNF639;GPRIN1;ZC3H12A,alpha,7
smooth muscle contraction (GO:0006939),2/14,2,14,0.071183322119947,0.842803927559372,0,0,4.49943757030371,11.8897490568776,PIK3C2A;MYLK,alpha,7
regulation of Ras protein signal transduction (GO:0046578),6/91,6,91,0.0695366994260424,0.842864078791198,0,0,2.07666349398633,5.5361784888496,NUP62;RASAL2;RASAL3;RASGRP1;GIT1;AGFG1,alpha,7
cytoplasmic sequestering of protein (GO:0051220),2/15,2,15,0.0804579927520401,0.843074203313471,0,0,4.1994750656168,10.5827614065094,LATS1;PKD2,alpha,7
positive regulation of programmed cell death (GO:0043068),13/258,13,258,0.0689374344665537,0.843615654874876,0,0,1.58701092595984,4.24454948711108,BARD1;JUN;ARHGEF12;GADD45B;BNIP3;GADD45G;NET1;LATS1;CTNNB1;SUDS3;SLIT2;SOS1;MAP3K5,alpha,7
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),3/30,3,30,0.0686417860235222,0.844045865248274,0,0,3.1496062992126,8.43733481569997,IKBKB;TBK1;TLR3,alpha,7
mitochondrial transport (GO:0006839),8/136,8,136,0.0684856927669789,0.844160604323414,0,0,1.85270958777212,4.96735603565515,TIMM9;BNIP3;UCP2;PPIF;ATP5C1;SLC25A51;SPG7;ATP5F1,alpha,7
negative regulation of developmental process (GO:0051093),5/71,5,71,0.0749477231383201,0.844278656015115,0,0,2.21803260507929,5.74684359166678,KANK1;SFMBT1;BNIP3;FOXJ1;SKIL,alpha,7
cell surface receptor signaling pathway involved in heart development (GO:0061311),2/14,2,14,0.071183322119947,0.844763936693231,0,0,4.49943757030371,11.8897490568776,DLL4;SNAI1,alpha,7
positive regulation of protein export from nucleus (GO:0046827),2/15,2,15,0.0804579927520401,0.844808923896421,0,0,4.1994750656168,10.5827614065094,XPO4;BAG3,alpha,7
protein tetramerization (GO:0051262),6/91,6,91,0.0695366994260424,0.844870898026415,0,0,2.07666349398633,5.5361784888496,CPSF6;ACTN2;GPRIN1;PKD2;IGF1R;S100A10,alpha,7
cellular protein modification process (GO:0006464),40/1002,40,1002,0.0810188623795282,0.845479048512745,0,0,1.25732786395713,3.15975706229919,PHLPP2;PSMD12;CUL5;CUL3;STK39;PPM1D;IKBKB;ANKRD9;PSMD6;PAK1;TBK1;PSMF1;DCAF10;PAK2;MAP3K5;FBXW4;DUSP5;MAP4K2;CDKL5;UBE2I;CISH;FN1;PPP2R5A;DOLK;FBXL14;FBXO30;TGFBR1;HIPK2;ERN1;LATS1;TEC;UBLCP1;KLHL5;NEURL2;UBE2S;CALU;FAM20B;FBXL3;TNIK;FBXL5,alpha,7
negative regulation of cell morphogenesis involved in differentiation (GO:0010771),3/31,3,31,0.0742773316853505,0.846065231228446,0,0,3.04800609601219,7.9246618202481,KANK1;GORASP1;CORO1C,alpha,7
snRNA transcription from RNA polymerase II promoter (GO:0042795),5/71,5,71,0.0749477231383201,0.846146529147892,0,0,2.21803260507929,5.74684359166678,NCBP2;TAF9;INTS2;POLR2H;TAF5,alpha,7
protein phosphorylation (GO:0006468),21/471,21,471,0.0752918430634267,0.846286949675477,0,0,1.4042830633432,3.63201451050987,MAP4K2;CDKL5;CAB39;STK39;TGFBR1;HIPK2;IGF1R;IKBKB;ERN1;LATS1;PAK1;TBK1;TEC;GRK5;TYRO3;FAM20B;CRY1;TNIK;PAK2;TLR3;MAP3K5,alpha,7
protein K48-linked ubiquitination (GO:0070936),4/49,4,49,0.0694916843786258,0.846339058196008,0,0,2.57110718303069,6.85598118669024,ZNRF1;UBE2H;RNF216;RNF4,alpha,7
Fc receptor signaling pathway (GO:0038093),10/184,10,184,0.0693372705749266,0.846478688382417,0,0,1.71174255391989,4.56825180147705,IKBKB;PSMD6;PSMD12;JUN;PAK1;TEC;PSMF1;FOS;SOS1;PAK2,alpha,7
embryonic cranial skeleton morphogenesis (GO:0048701),2/15,2,15,0.0804579927520401,0.84655079796631,0,0,4.1994750656168,10.5827614065094,TFAP2A;TGFBR1,alpha,7
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),2/14,2,14,0.071183322119947,0.84673308339881,0,0,4.49943757030371,11.8897490568776,TAF9;TRIAP1,alpha,7
phosphatidylinositol 3-kinase signaling (GO:0014065),3/31,3,31,0.0742773316853505,0.84795799460927,0,0,3.04800609601219,7.9246618202481,TYRO3;PIK3C2A;IGF1R,alpha,7
snRNA transcription (GO:0009301),5/71,5,71,0.0749477231383201,0.848022685531812,0,0,2.21803260507929,5.74684359166678,NCBP2;TAF9;INTS2;POLR2H;TAF5,alpha,7
positive regulation of potassium ion transport (GO:0043268),2/15,2,15,0.0804579927520401,0.848299869862935,0,0,4.1994750656168,10.5827614065094,ACTN2;KIF5B,alpha,7
regulation of calcineurin-NFAT signaling cascade (GO:0070884),2/14,2,14,0.071183322119947,0.848711431724508,0,0,4.49943757030371,11.8897490568776,RCAN2;SPPL3,alpha,7
MyD88-independent toll-like receptor signaling pathway (GO:0002756),3/31,3,31,0.0742773316853505,0.849859245718259,0,0,3.04800609601219,7.9246618202481,IKBKB;TBK1;TLR3,alpha,7
protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),5/71,5,71,0.0749477231383201,0.84990718038855,0,0,2.21803260507929,5.74684359166678,ANKIB1;CUL5;CUL3;BTBD3;FBXO45,alpha,7
regulation of RNA export from nucleus (GO:0046831),2/15,2,15,0.0804579927520401,0.850056184293293,0,0,4.1994750656168,10.5827614065094,CPSF6;NCBP2,alpha,7
regulation of extracellular matrix disassembly (GO:0010715),2/14,2,14,0.071183322119947,0.850699046318711,0,0,4.49943757030371,11.8897490568776,FSCN1;CLASP2,alpha,7
activation of MAPK activity (GO:0000187),7/118,7,118,0.0820581372656879,0.851102996883751,0,0,1.86841051648205,4.67163780681124,ERN1;DUSP5;MAP4K2;KARS;CD81;STK39;MAP3K5,alpha,7
activation of JUN kinase activity (GO:0007257),3/31,3,31,0.0742773316853505,0.851769041776053,0,0,3.04800609601219,7.9246618202481,ERN1;MAP4K2;MAP3K5,alpha,7
regulation of Notch signaling pathway (GO:0008593),5/71,5,71,0.0749477231383201,0.851800069431731,0,0,2.21803260507929,5.74684359166678,LFNG;DLL4;ZMIZ1;NRARP;ARRB1,alpha,7
regulation of protein complex disassembly (GO:0043244),2/15,2,15,0.0804579927520401,0.851819786335395,0,0,4.1994750656168,10.5827614065094,BNIP3;IGF1R,alpha,7
protein complex assembly (GO:0006461),10/190,10,190,0.0818440705203285,0.85234753441885,0,0,1.65768752590137,4.14909145633645,ANKRD28;NUFIP1;CUL3;GORASP1;ZC3H12A;FN1;CTNNB1;KLHL12;AXIN2;RASGRP1,alpha,7
neurotransmitter biosynthetic process (GO:0042136),2/14,2,14,0.071183322119947,0.85269599243683,0,0,4.49943757030371,11.8897490568776,ACHE;DAGLB,alpha,7
protein localization to cell periphery (GO:1990778),7/118,7,118,0.0820581372656879,0.85283640420938,0,0,1.86841051648205,4.67163780681124,IKBKB;ACTN2;PACS1;SLMAP;TNIK;S100A10;CLASP2,alpha,7
microtubule depolymerization (GO:0007019),2/15,2,15,0.0804579927520401,0.853590721442122,0,0,4.1994750656168,10.5827614065094,NCKAP5L;STMN1,alpha,7
regulation of leukocyte chemotaxis (GO:0002688),3/31,3,31,0.0742773316853505,0.853687440518792,0,0,3.04800609601219,7.9246618202481,CXCL6;MTUS1;SLIT2,alpha,7
negative regulation of cell proliferation (GO:0008285),17/364,17,364,0.0738353244323866,0.854380182717617,0,0,1.47096997490698,3.83322715131966,TFAP2A;PBRM1;CDKN2B;CUL5;NOS3;HMGA1;CTCF;AXIN2;PKD2;PPM1D;DLL4;KARS;NUP62;TP53INP1;CTNNB1;ATF5;ZBTB7C,alpha,7
positive regulation of neural precursor cell proliferation (GO:2000179),2/14,2,14,0.071183322119947,0.854702335948446,0,0,4.49943757030371,11.8897490568776,DLL4;CTNNB1,alpha,7
positive regulation of NF-kappaB import into nucleus (GO:0042346),2/15,2,15,0.0804579927520401,0.855369035445126,0,0,4.1994750656168,10.5827614065094,SPHK1;TLR3,alpha,7
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),3/31,3,31,0.0742773316853505,0.855614500203936,0,0,3.04800609601219,7.9246618202481,CKS2;MAPRE3;PKD2,alpha,7
regulation of fibroblast migration (GO:0010762),2/14,2,14,0.071183322119947,0.856718143344551,0,0,4.49943757030371,11.8897490568776,HYAL2;CORO1C,alpha,7
negative regulation of platelet activation (GO:0010544),2/15,2,15,0.0804579927520401,0.85715477455879,0,0,4.1994750656168,10.5827614065094,SERPINE2;NOS3,alpha,7
negative regulation of endothelial cell proliferation (GO:0001937),3/31,3,31,0.0742773316853505,0.857550279616162,0,0,3.04800609601219,7.9246618202481,DLL4;KRIT1;SULF1,alpha,7
negative regulation of hydrogen peroxide-induced cell death (GO:1903206),2/14,2,14,0.071183322119947,0.858743481744892,0,0,4.49943757030371,11.8897490568776,NR4A3;TXN,alpha,7
regulation of macrophage chemotaxis (GO:0010758),2/15,2,15,0.0804579927520401,0.858947985384227,0,0,4.1994750656168,10.5827614065094,KARS;MTUS1,alpha,7
N-terminal protein amino acid acetylation (GO:0006474),2/15,2,15,0.0804579927520401,0.860748714913335,0,0,4.1994750656168,10.5827614065094,NAA30;NAA16,alpha,7
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),2/15,2,15,0.0804579927520401,0.8625570105329,0,0,4.1994750656168,10.5827614065094,ACOX3;ACAD10,alpha,7
regulation of establishment of cell polarity (GO:2000114),2/15,2,15,0.0804579927520401,0.864372920028759,0,0,4.1994750656168,10.5827614065094,KANK1;KRIT1,alpha,7
"protein localization to chromosome, centromeric region (GO:0071459)",2/15,2,15,0.0804579927520401,0.866196491590001,0,0,4.1994750656168,10.5827614065094,RB1;CTCF,alpha,7
G-protein coupled glutamate receptor signaling pathway (GO:0007216),2/15,2,15,0.0804579927520401,0.868027773813236,0,0,4.1994750656168,10.5827614065094,HOMER1;DAGLB,alpha,7
transport along microtubule (GO:0010970),2/15,2,15,0.0804579927520401,0.869866815706908,0,0,4.1994750656168,10.5827614065094,ARHGAP21;DYNLL2,alpha,7
"protein localization to chromosome, telomeric region (GO:0070198)",2/15,2,15,0.0804579927520401,0.87171366669567,0,0,4.1994750656168,10.5827614065094,TNKS2;TERF2IP,alpha,7
positive regulation of response to wounding (GO:1903036),2/15,2,15,0.0804579927520401,0.87356837662481,0,0,4.1994750656168,10.5827614065094,KANK1;MYLK,alpha,7
phosphatidylethanolamine biosynthetic process (GO:0006646),2/15,2,15,0.0804579927520401,0.875430995764735,0,0,4.1994750656168,10.5827614065094,CEPT1;LPIN2,alpha,7
neuron differentiation (GO:0030182),8/140,8,140,0.0781185893145302,0.876130024773731,0,0,1.79977502812148,4.58857544398907,RB1;UNC119B;CTNNB1;FOXN4;WNT16;SKIL;TGFBR1;PITX3,alpha,7
cellular transition metal ion homeostasis (GO:0046916),6/94,6,94,0.0786353053330651,0.876148391079981,0,0,2.0103869994974,5.11228246566881,SMAD4;TFRC;SLC30A5;SLC39A13;FBXL5;BMP6,alpha,7
recombinational repair (GO:0000725),5/72,5,72,0.0785489815708964,0.877101647606749,0,0,2.18722659667542,5.56437637735241,GEN1;RECQL4;POLN;NSMCE2;INO80,alpha,7
histone H4-K8 acetylation (GO:0043982),2/15,2,15,0.0804579927520401,0.877301574815514,0,0,4.1994750656168,10.5827614065094,MEAF6;KANSL1,alpha,7
aminoglycan catabolic process (GO:0006026),3/33,3,33,0.086136379535261,0.877353183170533,0,0,2.86327845382964,7.02025320041722,HYAL2;FUCA1;HSPG2,alpha,7
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),2/16,2,16,0.0900803946050488,0.87892973932995,0,0,3.93700787401575,9.47658556690426,SNAI1;CLU,alpha,7
chromatin remodeling (GO:0006338),7/117,7,117,0.0792356575052664,0.87899904402038,0,0,1.88437983713574,4.77752258514926,RB1;PBRM1;INO80;DEK;ACTB;BPTF;KDM6A,alpha,7
actomyosin structure organization (GO:0031032),5/72,5,72,0.0785489815708964,0.879025116132203,0,0,2.18722659667542,5.56437637735241,ACTN2;EPB41;EPB41L1;CUL3;ARRB1,alpha,7
positive regulation of telomere maintenance (GO:0032206),3/33,3,33,0.086136379535261,0.879107889536874,0,0,2.86327845382964,7.02025320041722,TNKS2;MAP3K4;GNL3,alpha,7
regulation of protein export from nucleus (GO:0046825),3/32,3,32,0.0801108760138931,0.879152258707305,0,0,2.95275590551181,7.45377063093617,BARD1;XPO4;BAG3,alpha,7
maintenance of protein location in nucleus (GO:0051457),2/15,2,15,0.0804579927520401,0.879180164911479,0,0,4.1994750656168,10.5827614065094,ARL2BP;TAF3,alpha,7
programmed necrotic cell death (GO:0097300),2/16,2,16,0.0900803946050488,0.880613512776943,0,0,3.93700787401575,9.47658556690426,PPIF;TLR3,alpha,7
positive regulation of T cell differentiation (GO:0045582),3/33,3,33,0.086136379535261,0.880869628794463,0,0,2.86327845382964,7.02025320041722,ZMIZ1;TNFSF9;GLI3,alpha,7
regulation of macroautophagy (GO:0016241),7/117,7,117,0.0792356575052664,0.880914074617374,0,0,1.88437983713574,4.77752258514926,ERN1;UCHL1;TBK1;EXOC8;BNIP3;ATP6V1E2;ATP6V1C1,alpha,7
positive regulation of protein dephosphorylation (GO:0035307),3/32,3,32,0.0801108760138931,0.881046983402795,0,0,2.95275590551181,7.45377063093617,HSP90AB1;PPP2R5A;SPPL3,alpha,7
apoptotic DNA fragmentation (GO:0006309),2/15,2,15,0.0804579927520401,0.881066817625881,0,0,4.1994750656168,10.5827614065094,ENDOG;KPNA1,alpha,7
mesenchyme development (GO:0060485),2/16,2,16,0.0900803946050488,0.882303749845612,0,0,3.93700787401575,9.47658556690426,PKD2;TGFBR1,alpha,7
cellular macromolecule biosynthetic process (GO:0034645),17/368,17,368,0.0797336329247584,0.882604617820048,0,0,1.45498117083191,3.6797401916104,BARD1;CREBZF;ACHE;REV1;PWP1;RPL9;MRPS6;MRPL43;RECQL4;KIN;ORC1;AGO2;NUP62;RAD17;POLR2H;ATRIP;BPTF,alpha,7
purine ribonucleoside triphosphate metabolic process (GO:0009205),3/33,3,33,0.086136379535261,0.882638443310114,0,0,2.86327845382964,7.02025320041722,NDUFAF7;ENTPD5;RHOQ,alpha,7
positive regulation of secretion by cell (GO:1903532),4/53,4,53,0.0871999837011442,0.882899834974085,0,0,2.3770613578963,5.79896273357469,ACHE;DTNBP1;BMP6;CLASP2,alpha,7
positive regulation of ubiquitin-protein transferase activity (GO:0051443),3/32,3,32,0.0801108760138931,0.882949892654204,0,0,2.95275590551181,7.45377063093617,UBE2S;GORASP1;BMI1,alpha,7
mitochondrial fusion (GO:0008053),2/16,2,16,0.0900803946050488,0.884000487826085,0,0,3.93700787401575,9.47658556690426,PLD6;USP30,alpha,7
GPI anchor biosynthetic process (GO:0006506),3/33,3,33,0.086136379535261,0.884414375791623,0,0,2.86327845382964,7.02025320041722,DPM1;PIGF;PIGX,alpha,7
positive regulation of mitotic cell cycle (GO:0045931),4/53,4,53,0.0871999837011442,0.884655103035664,0,0,2.3770613578963,5.79896273357469,GEN1;SPHK1;NUP62;EIF4E,alpha,7
negative regulation of toll-like receptor signaling pathway (GO:0034122),3/32,3,32,0.0801108760138931,0.884861039608001,0,0,2.95275590551181,7.45377063093617,LRRC14;TYRO3;TLR3,alpha,7
RNA processing (GO:0006396),10/194,10,194,0.0909033180418408,0.885266473220446,0,0,1.62350840165598,3.89310622023611,KIN;SNRNP40;CPSF6;LSM6;NUFIP1;NCBP2;SRSF2;DHX16;RP9;PPIG,alpha,7
aorta morphogenesis (GO:0035909),2/16,2,16,0.0900803946050488,0.885703764295885,0,0,3.93700787401575,9.47658556690426,DLL4;MYLK,alpha,7
negative regulation of receptor activity (GO:2000272),3/33,3,33,0.086136379535261,0.886197469291203,0,0,2.86327845382964,7.02025320041722,ERRFI1;ZGPAT;PKD2,alpha,7
brain development (GO:0007420),7/120,7,120,0.0878747619736989,0.886215237849379,0,0,1.83727034120735,4.46795235244834,DLX2;GPRIN1;ROGDI;FOXJ1;HSPG2;MDGA1;BPTF,alpha,7
plasma membrane bounded cell projection morphogenesis (GO:0120039),4/53,4,53,0.0871999837011442,0.88641736419709,0,0,2.3770613578963,5.79896273357469,PAK1;DTNBP1;TNIK;NBL1,alpha,7
artery development (GO:0060840),2/16,2,16,0.0900803946050488,0.887413617122711,0,0,3.93700787401575,9.47658556690426,PKD2;TGFBR1,alpha,7
RNA export from nucleus (GO:0006405),7/120,7,120,0.0878747619736989,0.887970119508486,0,0,1.83727034120735,4.46795235244834,NXT1;NUP188;NCBP2;NUP62;SRSF2;EIF4E;AGFG1,alpha,7
regulation of potassium ion transmembrane transport (GO:1901379),3/33,3,33,0.086136379535261,0.887987767208963,0,0,2.86327845382964,7.02025320041722,CAB39;STK39;CACNA1D,alpha,7
negative regulation of DNA replication (GO:0008156),2/16,2,16,0.0900803946050488,0.889130084467242,0,0,3.93700787401575,9.47658556690426,CDAN1;RAD17,alpha,7
negative regulation of BMP signaling pathway (GO:0030514),3/33,3,33,0.086136379535261,0.889785313296431,0,0,2.86327845382964,7.02025320041722,SKIL;NBL1;HIPK2,alpha,7
central nervous system development (GO:0007417),11/218,11,218,0.0884803222759622,0.890562296990601,0,0,1.58925088492379,3.85389382177397,UGT8;DLX2;GPRIN1;ROGDI;FOXJ1;SOX8;TPP1;PKD2;HSPG2;MDGA1;BPTF,alpha,7
DNA methylation or demethylation (GO:0044728),2/16,2,16,0.0900803946050488,0.890853204785977,0,0,3.93700787401575,9.47658556690426,FOS;PPM1D,alpha,7
phosphatidylcholine biosynthetic process (GO:0006656),3/33,3,33,0.086136379535261,0.891590151660115,0,0,2.86327845382964,7.02025320041722,ACHE;CEPT1;LPIN2,alpha,7
regulation of energy homeostasis (GO:2000505),2/16,2,16,0.0900803946050488,0.892583016834105,0,0,3.93700787401575,9.47658556690426,NR4A3;BMP8A,alpha,7
regulation of bicellular tight junction assembly (GO:2000810),2/16,2,16,0.0900803946050488,0.894319559668413,0,0,3.93700787401575,9.47658556690426,IKBKB;SNAI1,alpha,7
regulation of histone H3-K4 methylation (GO:0051569),2/16,2,16,0.0900803946050488,0.896062872650222,0,0,3.93700787401575,9.47658556690426,SMAD4;CTNNB1,alpha,7
regulation of DNA recombination (GO:0000018),3/34,3,34,0.0923476007033077,0.897618678836151,0,0,2.77906438165818,6.62027481189672,TERF2IP;KPNA2;KPNA1,alpha,7
hyaluronan catabolic process (GO:0030214),2/16,2,16,0.0900803946050488,0.897812995448367,0,0,3.93700787401575,9.47658556690426,TMEM2;HYAL2,alpha,7
DNA alkylation (GO:0006305),2/16,2,16,0.0900803946050488,0.8995699680422,0,0,3.93700787401575,9.47658556690426,FOS;PPM1D,alpha,7
regulation of systemic arterial blood pressure by hormone (GO:0001990),2/16,2,16,0.0900803946050488,0.901333830724635,0,0,3.93700787401575,9.47658556690426,AVPR1B;NOS3,alpha,7
neural tube development (GO:0021915),2/16,2,16,0.0900803946050488,0.903104624105234,0,0,3.93700787401575,9.47658556690426,PKD2;DACT1,alpha,7
positive regulation of cell differentiation (GO:0045597),10/195,10,195,0.0932583743568529,0.904748069093194,0,0,1.61518271754492,3.83182946748243,JUN;DLX2;SMAD4;HSP90AB1;ZC3H12A;SNAI1;CTNNB1;AXIN2;BMP6;TGFBR1,alpha,7
peptidyl-threonine dephosphorylation (GO:0035970),2/16,2,16,0.0900803946050488,0.904882389113315,0,0,3.93700787401575,9.47658556690426,DUSP5;PPM1D,alpha,7
regulation of actin cytoskeleton organization (GO:0032956),5/76,5,76,0.0938591424991768,0.908848584769069,0,0,2.07210940737671,4.90252819024767,FSCN1;TWF1;BAIAP2;RHOQ;RND1,alpha,7
response to UV (GO:0009411),6/99,6,99,0.0952101591632085,0.920184549639873,0,0,1.90885230255309,4.48898807726861,USP47;REV1;SPRTN;INO80;TRIAP1;MAP3K4,alpha,7
peptidyl-serine modification (GO:0018209),9/171,9,171,0.0954129733411682,0.920401517882763,0,0,1.65768752590137,3.89480434458751,IKBKB;LATS1;TBK1;CAB39;STK39;PAK2;GALNT10;TGFBR1;HIPK2,alpha,7
transcription from RNA polymerase II promoter (GO:0006366),21/486,21,486,0.0960670225819137,0.924962294783973,0,0,1.36094099348693,3.18828895781048,NFAT5;PBRM1;NCBP2;INTS2;ECD;TAF9;ARRB1;YBX2;DEK;PPM1D;FOSL1;NR4A3;PTTG1;SRSF2;TAF4B;CEBPZ;POLR2H;TAF5;TAF4;ZNF202;TAF3,alpha,7
response to glucagon (GO:0033762),3/35,3,35,0.098738126934574,0.92621445174105,0,0,2.69966254218223,6.25048580248407,GNB1;CRY1;ADCY3,alpha,7
glycosphingolipid metabolic process (GO:0006687),4/55,4,55,0.0967947943142349,0.926723893781502,0,0,2.29062276306371,5.34897537899198,CTSA;UGT8;PSAP;CLN6,alpha,7
negative regulation of endothelial cell migration (GO:0010596),3/35,3,35,0.098738126934574,0.927920187379615,0,0,2.69966254218223,6.25048580248407,DLL4;KRIT1;SLIT2,alpha,7
transport of virus (GO:0046794),4/55,4,55,0.0967947943142349,0.928465855987858,0,0,2.29062276306371,5.34897537899198,NUP188;NUP62;KPNA2;KPNA1,alpha,7
ventricular cardiac muscle tissue morphogenesis (GO:0055010),3/35,3,35,0.098738126934574,0.929632217245629,0,0,2.69966254218223,6.25048580248407,DLL4;SMAD4;TGFBR1,alpha,7
intracellular transport of virus (GO:0075733),4/55,4,55,0.0967947943142349,0.930214379257139,0,0,2.29062276306371,5.34897537899198,NUP188;NUP62;KPNA2;KPNA1,alpha,7
positive regulation of cell migration (GO:0030335),11/222,11,222,0.0973493962348789,0.930288331435556,0,0,1.56061573384408,3.6353743691654,FAM83H;PAK1;CAPN7;SPHK1;AGO2;FN1;SNAI1;TGFBR1;MYLK;IGF1R;CLASP2,alpha,7
positive regulation of apoptotic signaling pathway (GO:2001235),5/77,5,77,0.0979086790029254,0.930405938457967,0,0,2.0451988955926,4.75246974467682,HYAL2;BNIP3;PPIF;PAK2;TGFBR1,alpha,7
regulation of JUN kinase activity (GO:0043506),3/35,3,35,0.098738126934574,0.931350576242386,0,0,2.69966254218223,6.25048580248407,PAK1;MAP3K4;MAP3K5,alpha,7
nucleic acid-templated transcription (GO:0097659),5/77,5,77,0.0979086790029254,0.932141770432702,0,0,2.0451988955926,4.75246974467682,CREBZF;NUP62;POLR2H;PWP1;BPTF,alpha,7
regulation of wound healing (GO:0061041),3/35,3,35,0.098738126934574,0.933075299531724,0,0,2.69966254218223,6.25048580248407,KANK1;MYLK;AJAP1,alpha,7
double-strand break repair via homologous recombination (GO:0000724),5/77,5,77,0.0979086790029254,0.933884091498931,0,0,2.0451988955926,4.75246974467682,GEN1;RECQL4;POLN;NSMCE2;INO80,alpha,7
apoptotic mitochondrial changes (GO:0008637),3/35,3,35,0.098738126934574,0.934806422536421,0,0,2.69966254218223,6.25048580248407,BNIP3;PPIF;CLU,alpha,7
small GTPase mediated signal transduction (GO:0007264),6/100,6,100,0.098733262440605,0.9364978405844,0,0,1.88976377952756,4.37543316630999,RB1;BRAP;JUN;GNB1;KRIT1;SOS1,alpha,7
